<SEC-DOCUMENT>0001048477-21-000032.txt : 20211029
<SEC-HEADER>0001048477-21-000032.hdr.sgml : 20211029
<ACCEPTANCE-DATETIME>20211029135544
ACCESSION NUMBER:		0001048477-21-000032
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		73
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211029
DATE AS OF CHANGE:		20211029

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMARIN PHARMACEUTICAL INC
		CENTRAL INDEX KEY:			0001048477
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680397820
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26727
		FILM NUMBER:		211362295

	BUSINESS ADDRESS:	
		STREET 1:		105 DIGITAL DRIVE
		CITY:			NOVATO
		STATE:			CA
		ZIP:			94949
		BUSINESS PHONE:		4155066700

	MAIL ADDRESS:	
		STREET 1:		105 DIGITAL DRIVE
		CITY:			NOVATO
		STATE:			CA
		ZIP:			94949
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bmrn-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:f95636f6-9f25-4ee3-86c2-7b0315cdf3d9,g:ce424ef1-ab97-4f04-a4e9-8c3801ecff3b,d:37555ce43f7244d3afa231a2a50e7423--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bmrn="http://www.bmrn.com/20210930" xmlns:country="http://xbrl.sec.gov/country/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bmrn-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV8yLTEtMS0xLTA_50399816-70dd-4ef6-84ae-ad72110d84f9">false</ix:nonNumeric><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV8zLTEtMS0xLTA_df3653c7-86c1-4f21-8814-72415d6529b8">2021</ix:nonNumeric><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV80LTEtMS0xLTA_f9f91dfa-514d-4785-bd97-207162235243">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV81LTEtMS0xLTA_9b506237-5c70-4c05-8242-942159fbe068">0001048477</ix:nonNumeric><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV82LTEtMS0xLTA_550863e5-3316-46e7-bf59-825edd40cc29">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="ic294b781dea64354bcafffc53a309b98_D20210101-20210930" name="bmrn:LongTermMarketableSecuritiesMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_846ad3c9-24f9-4d1a-9f5f-7c49adee4aad">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ia39f9739911c4c249c40c8527867d977_D20200101-20201231" name="bmrn:LongTermMarketableSecuritiesMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_a635e30b-c744-47ea-a80a-981c71554d83">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bmrn-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i8c2ba3fa4ed8493e8f1f5c6fdc1abfac_I20211026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="icce161e9967344ce804b1ab36f4ae711_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b17bc4d253c44789e173a8f801f46a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9940e707613405199a97fc351ad73ef_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i055b5a733006483d91da202b094f7799_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:RoyaltyAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f40e6fd2d594084b575d40ed0c6f0c8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:RoyaltyAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i342150f2921d4dc2a5acc57613812db0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:RoyaltyAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4549f3adaa5948939b7e0555d551796b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:RoyaltyAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea54e8805bf4cd2bf97a56c86ecfccd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bcd0ccc805b4b2f9e84aa347f9675e2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99f00eb5b129417a84d6a7ccff242457_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac1a61de8d9a4f648cd0094a00ba3a7c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a1d232828b343fc85f1f99a3762f4b6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0ad0618f364452792421d091dfef160_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0d7c667fbcb49a492cc496e20a9533b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17802777da7643c6ab25cac57f541c1e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icebcf4632bc041ecb270987af3929f4b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaca57bc041147b381f06e8aa17857c6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42ac9247fd2e436cb417f1972275fb4a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c5c0d0d2b0e4255835d887bcfa9bc17_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7268a9baa84143e28737ef38b1cfc7a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64cc87601ea34f3381da0fca0b298bc6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i731188fc3d2044b7a23a6e217ea305e4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b52d173ad54772a29d1b6f7bbf6459_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4caba0337f8f4b2e8f9100f7d140d5ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7778fc67467846b8a67a75902f463e54_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5f0aad336a3452ea25f24ba710ac93a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i627eef1092454bb98b2d4c1cea40f20e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc9d74897922454eac93c39ab9193ed7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia07691e24f2f4f37b1f16b61b6cc50ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6703cd6e3a77492f925f347aaebd345a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88dc8a11226046f1a9d9868cad8f27ca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f1406297b474f139305e89552bbcad7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f2a6e362d84481d9b46790a952c3eb8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifedfb7039355401494da9d79b4b019f7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1bb9f866ca4475eaf5dfcb3fa669cb2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8d3c91fa0884ce985a56dd462a786fd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76ba0bfe4241498cabc063f575c0fe8c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if019850925824862b004fe4ce0fba35f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd15da83cca44176a0b4b0f67a931a98_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5e64d06d88e4e6bacfa1c4bee506c2d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dd786401f3846dc9ebfe35c03ae7cf0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80fd59e3ac5943d4a4576ec081be6729_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib796b32eb4e84dd39329cb270e0eb237_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdb4d2c8bde5486194ee9f8978433d7b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42144fd1c7cc40b4a19862971243a6c2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe71756343b8462d9a1e0b2139797942_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice2e3bd0516f4927a3ea54940b0473b8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10986a90b6074a24befea81408205ba6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i847ccef2e0f749cdbc16c784f8bc20d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5980981b2d94a21af89adbff48bff67_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib502302b9e2f484da8ae334c586b7015_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i139ebe39eaac4c3d89f8d6a430777353_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cfe02f4a80f4b47b9a60dde2af5de31_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2a90b89293d4d568258cb84a8b82013_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0db40041dc54511b7a5f5d17ab13fa6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51c38a2eb11344c1ac10d203ceb97e13_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i768baa6d2e434ec181651dc6bc5d351d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65c51e81a86e484d8e7ecfbdeae9fe9b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d51116bdb2447edbdb006552af68df6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i803bcd43ae324221accf1b091be40cd1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if010a0db0da649f79724c29782c82b57_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6033594232bd45b1956bdbbb3ec09c3b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d08ea1a9cb14bb59451b5d3e37c8e09_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f6ffb6089bc436588ddb4e558536c98_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84daa993a3914c4c816bec79eb0a2d5a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6c0821a737d46339e19959fec1fb613_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69394941701f4792bc6f78d5bfdc9119_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i092d463f25cb4152ba73021fba9889ce_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d20f611273a4520a0ddf24ac3708e9a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2bca3ca974d463382d836efec728b90_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec348bbb7f64676b204903ae8051084_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83982dff494c4b33a4599c8c6a1968ad_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bmrn:ForeignGovernmentAndOtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia86cd7b86979490aa97d8927574181fd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a59471cdb774223b5fed280196aaf44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488ef63d388c46e596c31f59acedb699_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i298462249e6b46a59433814c9c95bc6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25d3fa48aabf431f9fa22df5de090b3f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i162aeed19afc494baff177a2e9200423_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bmrn:ForeignGovernmentAndOtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16cd77d91ae74138b0023e6dd344da16_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0773e69a8654dc28600db905fe0c0c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i006e8ae23bc74eac869d8244cb0ea0e0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic294b781dea64354bcafffc53a309b98_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia39f9739911c4c249c40c8527867d977_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00b5b9602a84434ca20f4f840240bef5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:StrategicInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91df24e30587451888b969c1c50cf8b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:StrategicInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7c76bf362194f4c9c4a2b8976accd00_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">bmrn:VoxzogoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90bb59f2a5034770af163bb6ee32ed42_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66dbe62d10fc46af9552314aa77c1455_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa92d196dfad4856ba23ebe72dc99f42_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cd9d72b38ed4e9ab14a43d4125dd712_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i702edec792f8459193e0e7428f963179_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eac74c17ffb48aaa66512c312d26ffc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if941c596ef754cf388dd3fe27f85f62f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if961eb44a8474191b0fe4f51e700bec0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id075d2f472a347109be07404276f404d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d63e3d6780541b5a95aef5456b53700_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c71299431fd4b1d9395950472c5dd54_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f9c820d5a2d477c8a45f38d368f4ad4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaf21895256243eba4baadc21bba8dfd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1a690d1f00e43688891861ad4caf2bb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i120bad79c9cf44618fab7a064046a548_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a982d145fec445ab50db51d29d51ec4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4853afdcb6b3425eade1470b05d78550_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85d0caf2974040c1832284f6ac9f30c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48430041f0f14488a182cdf2a6fba1ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf61805c0d2a4049b81025cec2ddb75a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1deec9d3e3eb4a42adefe62e56bfd128_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c1a81b9cccd4a1cba5fc0003b7aea8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4efa93be091e41e2a53f2f9cfc80f758_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671e3945deec4183bb208f00b654f148_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29763c9514834fa79c4c3fc2e884e8dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i357642068229410d9b9eb92835bff095_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a7e416850cb47f6aefc2fb4df37b5f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if27816fb13254b9694f700f40dbdbbff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5add67eb11e7443caf320c8d4619f132_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33751b4c2ccd47d3bf56b6c79e05210a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c8d2de98a23439b8a9c5086c8a66fc1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i615edf13dd9645ddb17b1b2bd0c8b9e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8fcd6f6536d4855824ff24db3d6b5c7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie591deab87f84651a1f0e8a8b378340d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14bf2ac4d92840cb8a1f7aae38462abd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61c318f76764a7fa034c58b06aedb1b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i801ae299848e42d9a8bba895edfc93ae_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4255a1344130421b867098a0db4b4234_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3b9c04057d24a85901bdc543d7f5881_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8911e37b2bf14742badb679e3603864b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c536cb7054e4cb6b74a31bf41dbf674_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d28061c88a44b7aa46deded1cf2e6a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87c65af7fe274f899122097d464a1bf4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6af4b58a85d47a2a7ed411542576cd3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia65f45b20e934503b719a9058ffc0aa1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4fa8d281e98402cbfe0bbf358bd183d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i998dfa69cd654bfbbac7b62ef70c8ee1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2959731ccc2d46129ed431c7d2b06d80_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib57861f66fb846acac9f83cdc9e47785_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d72a61dbc164a95830296964a405193_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i653a9dcd97a14cdd9a1732d3b2674534_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45acdc04438043e3a8bd6387c422da66_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a8390484ae4b6f877f15cfcbcb0f27_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd69df912beb45dbad86a43d5165bd04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcf858e58d4a42deb0197ad3a84b8e2a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d22d4a686e04d89add5ad2e6c2dbb50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife95d4f1adbe4a8fa995aa600c1b72ae_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2ddd51b05b44b81b4cac9334ce55095_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a0867d2abd245aeb03cd68ad004aa7a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa5e54ce01d4462f8417aa877f5454bd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a85736fa1a4177831386b25c03128a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dc4e113aded47d28e12f99a50683bbe_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5396b9f8638140eab847f0bdfcab099a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6257cb31e6a74435a04b92f18161c169_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbedd8a5f7224c52a0e6a43b72b26b32_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63cb5ebbe7144d7cbd04769985192b4d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f69cb4b88254f89ae7a84113b9ef9e4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia10f257e647949e8a3b8943db642b6ba_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bd960385e494621870825c06ea5d0dc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2d0ec83a5e8c401ab387d676b8db9044_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:A125SeniorSubordinatedConvertibleNotesDueInMay2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e007e38fb6a46adacda2d712f243e5e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:A125SeniorSubordinatedConvertibleNotesDueInMay2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ffe2646b01c4c7c8c425382618ea995_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43b959de93cc4964a01bc54cd284fd1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38a00422432443d785988f4c838194eb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba2ae00a5eea4923b638351403ec6b48_I20181031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee37fe35ae7740dbbf5492520ad69a15_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a1454c700cf4b51a23d6f33d90c7c8a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8717ee13ca8c430dbecd711039a7e46f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if511f9ed24f948619a2e53651da7e114_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5608486f3aab45158217508c7361b8db_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4f8068feed342d0852f9c527519b97c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3faf010302b3404ebb5a5088bb42c52b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a6b9095a67c4e829c8badebfb6d9376_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2825e372b0ea4c4db7b030d62cb5b3f7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2551e7c9a1f04acdbbd714ef15b18e6f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75e63c14188b429a96626e5e45c2c116_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica6ad443b63d459f92df9ffbcae2b88a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99ca830558c94af29e572b85e6fb0ab0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd5abfbe741a48819ae2f94da173f77b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id254242e029e4cd29e695890e7e368f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02c79f2fe3684a398bd2294ebbe2c99b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e57bf81424a40c5b3adb66b880dae12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c8a1231bd26440ca6973d994e0f4e4d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieadae4e29a7041f4a3ad734dc312b2df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67f6d6511e9149758c5097fab5fffa22_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81fa1b38663f441883ba5f2445470397_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bmrn:Segment</xbrli:measure></xbrli:unit><xbrli:context id="id6aa5a87b7f84d18a23293902aaa2e41_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68586ccb7def4122a05e7dc73d213d39_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b53329fe7c14a3683433e7d34adb246_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b96c70e0c2243afb027cbcdf282e765_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10f485d362c24177a8d80735201ecbee_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i430f9e39597d43d393863a8ba5c47dc4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3df6603453545b7adf0538e4c3b867e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i750ce40f585c411fa47c2bf163efafec_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d097b6776c84a1290432379dfafe6e5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a82d895132f4cf6aee55df85842bf75_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cc4be5e7bfe4c5887dec731969031b7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i692ea98645da4650a217fb7fa5bc5f98_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c01dec0e80c49a8a216d3ccf0b483f5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadfc6366c9ee4fde9f1d3c3304473be1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b3baec2de8a480aa194af6ef4b7e7ce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief7778f7e8ed4c60a7007014fbf78a94_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26cfa0a05050405c8fc26ff4270b410b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia499a895b89d43c8802609e44742ca26_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56ce74ad21854f5b8073837e7f9d4f30_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2a8b2e0af7d4f48bdd2df8ec9a9c5ba_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54e5f5c18fb24ebbbdbdc5dbbd131b25_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39e0766182094853983cc6543e242eda_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75f418730286417b9103ef1bc9d70fec_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id740cf897d394b40be718d4aa51cddf7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d38170f263d4c87b138198d14dfb01d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52c332e9563842deac7a1a89d768fb91_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8d768a033874a13a0aece3c89f824e3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieee6144f7440430d96c3ea711e06e0dd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3631083badb04533a1ccf53e70983c60_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i875080367e32474e9692930d4f70440d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9cac278154a4c64a3a2d789e69239d0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fc0dde4f53c44c9ab53a2e5cd3dac81_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a6844bfd4f4df3937b1bc5c15c6c0c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ec5b3fcbcc741d5a41938c2bff9a968_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba2fef5336cd4754aac2a52f8ee715a2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1e72a8e38a54f589382be95578b29c1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i670eba932fa44bb4bd105fa2472fdee7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7163a6ce6d8a4b90ba5be5da895aca0d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77f222cc3eb0499293097be2613706be_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i631b06fa4a4a46759658c5e1ed96fe88_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ce796da9cb04582bb8c002435a42a15_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i596ae291f078453886ecff564ae864a5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5625d09abfec4da9b5135b5a49fd61c5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c767f53af74489081063ce938ee5371_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78de7c806e9548728df05080cfa9fdef_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i765f4a74e39242298ebb8e42f5429fd3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6306c147c133472a919f7ac957a8c7b2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2b11e951dfb403a9db9d7fa77793d35_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icca877ecc41644f7a512279ba3a5aebf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12c53d3790994dfb8fd77b8b0750df93_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf2f153984e34dcfb6ebf47a69c25d0e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i587f8139747846de862e02316f943301_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i807900e9e70040c78da438a82a6b9728_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ea93a722dde4f8eb67bfd01814148e7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f6996af9c2645e7ad8462878e32a8fa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id813d823802b4adeae79cd8494384ba1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1624a814864c43ecbbd5abad76321c1f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i673c282af5fc4cf3828509c09115858e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e031326bd7645bf8c67c80bc0590247_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3fada62c864453b990f024e22826a2a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8815ae63b15048de91d1036580169b4f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b38429ecef7410fb6e6cb17cf99bc23_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36276fddfb9440c49f578739c2e2e93b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a9b8c4c57440bd972de38d327ff06d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i903cb5741f0c454ab0cd6e60497f87f1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12e8c0e180a24083884a28374d6b19aa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib327b203d9f641f4b16be80c7a022310_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c17cda19c7411bbf1a312a56665382_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d24f4221ce54b7587582cc1483c6c20_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia22dd234fb9743fd92d299421432bd77_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4522cd9712214bb087ea4996aa558624_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida8af263c560424abb1f9b025ffbc888_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85eed5105d974313b640fec757ed2132_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic605b00f4bfb47dd91d3f6f7057661fb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd471de3fee2400e88e55081b5edc7f4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35e7d66a6cac42129aa948cfaf2eb317_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie383b687557e497388831485ea18b47a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bae986f7e264602844d3457fa91c27c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb287505a9684940b9d27b688febaea4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i687b7d4238fe4663857bbb9e1446ee16_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06311aaf1fc84255bf7c628cde958a0e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneTwoAndThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17442b5bbd98454d91144658893a0d26_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneTwoAndThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad3b61ba06404cd29a53bc8482a92839_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneTwoAndThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c313f30b00c4ffbbe6049bf40e5fce8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneTwoAndThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id03d4506cf9848689c776b8acd1a1fd9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc7289dbd839469db4eb56c8b0923f40_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice7397073cd84c17909c8a881afdc5a5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9318c02208c342038447a03fa145e77f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88011345f9af4a4eb848131cb3723ff8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4642aed64b8147e68d905a18605026ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i366685cece5e413497a14d201c6aaeec_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i600447fd1d334ac4a8cf19039623fed1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4341d0928f7b46a9bb9a16aba139dad9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1af7d3e6ac447faad8ad74652f4be9c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bbe544e6bb7468ab675761c05ac7036_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i240305f0192242b4933888c226e238e1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd8bde7f09ba4955bdcbbb6490d77c3c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb2e6a3e17a54d9294f3f2237cb340fe_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5f1a069c36941e09fb5bea33a6ddbe9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8128c3889a44d2e9cc52bdcfafa283e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic471c1470b9e42899741b0b5a360a28d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea947a2a70cd4cc48f0e3fa73c7b87e4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e0d79598b4a4fe0894f5f0b5c8d05d2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12651120f91f4b4f8cebb3b98050584d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90f88b98995241caafd2941a4333cb2b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5acc9dcae0254e3a91a091eaad031510_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide7de364296046cd8ec673ebf4f708e4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99d8ea1fded44a5dbe57d52c95b8740d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb006a5635c4e3786096f48ad41e1c1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e1a43efe88f4d2b8dbb12448e0fcfbb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc32bd96b3014e92b2f0efc81b2ae66a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i483fea5cfb454ba7a3044cf8f94b872c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0936ac22ba0641e3baa0b8544e010e8f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6693bf5374b04cec9cbcc298b6b9df9b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i712f67daf8994797927c8bdb430e55c9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9264da2f9bbd4f2fb33480144d2f85a9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0589f3a72cba42008e9af75b85655bfc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i747d9cadb0334a97b76371c9665c4ff0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6195d3f0e2374354b38eb0cc2ab77d14_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ec953e8f554e02994b61549a84b786_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i210b958efc1e4be3928a76fb8c2b4d1b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id68539b93ebe41578d0997661f7c7067_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i635b1aa8136841889975e9745d917b9f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:CommonStockIssuableToEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70906b8925394dfeb8414b49b6c11841_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:CommonStockIssuableToEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7b754b4139a4554aa9b7b4108bd3cb4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:CommonStockIssuableToEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cfa47a706aa4d73921235a75ded8670_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:CommonStockIssuableToEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6a4e7a972ff46bea3882f3ced06ea4b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i857f8284e96b4d529652faaf70a41f4f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7718da1375c940c7aad6f404d81e8204_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a415fe6e6094b7ab63c7d3ca2b9aa95_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic20a7b693de94d51a8059e3b28b30754_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib965f565ed34406a849028c30350f306_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0c45fdc691545eca329a4b5abc34572_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmrn:KuvanAndPalynziqMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmrn:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f2e2c7117c147a3bf29ed90d8327de7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmrn:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmrn:EarlyStageDevelopmentProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eacd8a06aed4d4fa25cd448dd9cefbe_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmrn:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmrn:ProgramsNoLongerBeingDevelopedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTktMy0xLTEtMA_be2bf46a-bb44-4592-afef-c68248e5b1e1 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzAtMy0xLTEtMA_3a751c61-52c3-4c35-b74f-7be0a7f656ae id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTMtMy0xLTEtMA_e43ea724-b6c9-4507-90eb-1e0e5d1f128a id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzItMy0xLTEtMA_aee410e3-2710-492c-be12-ff105db632d4 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMy0zLTEtMS0w_963a8511-19cd-4d3b-b379-dc85f72b46aa id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTYtMy0xLTEtMA_1c993f34-625e-4306-a646-d7023a602565 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTUtMy0xLTEtMA_7754568c-0ccf-4705-b267-dcd4e8a01736 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzMtMy0xLTEtMA_768b19d3-3929-492e-b163-68865a2bb538 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTItMy0xLTEtMA_440b4086-be9e-4834-8028-38898b0ec0a3 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjUtMy0xLTEtMA_ef878db6-765a-4c07-8bdd-66a9d9ab891f id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNy0zLTEtMS0w_d739060c-a214-4c3a-96e9-aa59f7e45b2e id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjEtMy0xLTEtMA_720e73e0-635b-439e-9636-dce68aecaac9 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjQtMy0xLTEtMA_848e667a-fd89-455e-959c-16985e3ddf57 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjAtMy0xLTEtMA_e50909c2-33f9-467b-81bb-cc16fc65ec8c id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNi0zLTEtMS0w_04862746-47e9-481f-b137-44e29e1163a1 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNS0zLTEtMS0w_ef7e6176-5a24-43b3-b8a2-3739ebaf709a id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzUtMy0xLTEtMA_c5cca7ad-592b-43c3-90e3-1ecd7964bf98 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTEtMy0xLTEtMA_8a434401-71b4-4fed-860e-e33037f86e30 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzEtMy0xLTEtMA_f90ceb0a-0a8d-484c-bd86-7b5eb48578b3 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjctMy0xLTEtMA_2b8ca420-b415-4866-8e39-2de9ae3b70d0 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTAtMy0xLTEtMA_5021714b-41f4-4186-97af-827af3879f97 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfOC0zLTEtMS0w_b171cb64-0d12-49c8-b234-4ba21419be22 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTQtMy0xLTEtMA_db827f36-5b7a-4bc7-942c-a859676323d1 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzQtMy0xLTEtMA_ab8e1abd-438c-4bbf-8e67-ef972f7e8e57 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNC0zLTEtMS0w_2af7c84e-15a2-469f-b3a2-40f9942c0465 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMy0xLTEtMA_f77147f8-14f4-46ce-ba75-39ed2a695044 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjYtMy0xLTEtMA_eb2dac2a-2bb4-4a15-ae9d-a418aee0af6a" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC01LTEtMS0w_622fde87-890f-4579-a8c4-8f538731d0a5 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNS0xLTEtMA_a69260cb-11f7-4d4f-98bc-513018bfe44b id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNy0xLTEtMA_b899b85f-8b47-41ff-89c6-effe257d0c28 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMy0xLTEtMA_9b2f553e-3253-4009-8223-5f14dee5a1a4 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMy0xLTEtMA_67818c24-e760-4a44-8b3b-cae1351b1f8e id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMy0xLTEtMA_6606cdb6-977b-49ba-8a09-d376a76e6dda id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNy0xLTEtMA_478d5aec-1723-40c5-beea-a858d1dbfc9b id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNy0xLTEtMA_52688cf7-cdb3-44b7-9af1-18d255bc03c2 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0xLTEtMS0w_72870b1f-4e17-4559-9fab-07aecaab6bde id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMS0xLTEtMA_b3ac2687-39cd-4b15-a8e0-278133489a77 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNy0xLTEtMA_ee908d3a-c4e8-4e65-b4e2-151b4adb3de0 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNS0xLTEtMA_c754fec8-9ca8-4726-a876-e54479025051 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNS0xLTEtMA_989d4272-2948-4a7a-bd0c-3fd121d0047c id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNS0xLTEtMA_ce5b790a-8f10-4f4d-a51c-6f62fbf0f0fe id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMS0xLTEtMA_817fdbd8-1213-4898-be7c-f08d3b5d4c12 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0xLTEtMS0w_9da5c243-f2ba-428d-88f4-fff099590b2f id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0zLTEtMS0w_80e1e025-549a-45c2-84d4-d428b04bc25d id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNS0xLTEtMA_2ba8b51a-3d12-4c40-9732-b59b4096cb92 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMS0xLTEtMA_fa8c23b8-dffb-4769-aae5-62ccbe33d132 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNy0xLTEtMA_d6836a05-7ef2-4eea-b180-796e09dfac57 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMy0xLTEtMA_19f99bfb-dc72-4b96-857a-b4f591a35d5b id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMy0xLTEtMA_0472a5e3-0a8f-4691-b9c8-b0387c815ce1 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy01LTEtMS0w_80590d6d-6042-4df1-a54f-e96d14ee3755 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNy0xLTEtMA_e1dc97ee-6443-43a8-9e6f-fe83e219f499 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMy0xLTEtMA_7f4a62eb-845e-49ff-9889-65ebd2382598 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC03LTEtMS0w_40abc157-7a92-4b2e-b4c1-636c8a1c095f id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMS0xLTEtMA_1615b675-9dc0-4931-b33b-c18a216d1013 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMS0xLTEtMA_83aea445-0665-4f90-8ba3-7712949883a1 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy03LTEtMS0w_9945da9e-d5c5-4a4b-9e1f-fa7bd5cb744a id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMS0xLTEtMA_f2211914-b58c-4762-a749-aae4b1cd3052 id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNS0xLTEtMA_8cbf41fe-e697-457e-a1ff-f93d617fb15a id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0zLTEtMS0w_abf81c9d-4f10-4caa-8485-a937624d5b0a" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i37555ce43f7244d3afa231a2a50e7423_1"></div><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8xMjU_8320ec15-320c-4f78-b6a5-c3dc42d1a808">10-Q</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6ZjRmZTkwZTFlMWZiNDNmYjg5MjNiZGYxMjFmMjdmMDMvdGFibGVyYW5nZTpmNGZlOTBlMWUxZmI0M2ZiODkyM2JkZjEyMWYyN2YwM18wLTAtMS0xLTA_27a96363-0096-455f-b6f7-398f1be83834"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6ZjRmZTkwZTFlMWZiNDNmYjg5MjNiZGYxMjFmMjdmMDMvdGFibGVyYW5nZTpmNGZlOTBlMWUxZmI0M2ZiODkyM2JkZjEyMWYyN2YwM18wLTAtMS0xLTA_ec38811f-b825-4ae0-b2af-a4802478ef2e">&#9746;</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8yMTE_b39ad858-a0bf-4aa1-bb95-b6eed6ad9ec3">September&#160;30, 2021</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.801%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6M2Q0ODkyNDlhMzExNDVjYWExNzM3ZWEwYjM3MDEwYmIvdGFibGVyYW5nZTozZDQ4OTI0OWEzMTE0NWNhYTE3MzdlYTBiMzcwMTBiYl8wLTAtMS0xLTA_030ed44c-b17e-43e7-810f-8e5be59d9915"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6M2Q0ODkyNDlhMzExNDVjYWExNzM3ZWEwYjM3MDEwYmIvdGFibGVyYW5nZTozZDQ4OTI0OWEzMTE0NWNhYTE3MzdlYTBiMzcwMTBiYl8wLTAtMS0xLTA_9c5801b3-e7e4-4988-ab0d-b534a5b5abe8">&#9744;</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> .</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8zMjE_74b1ceed-a644-4c14-b232-82972881bcea">000-26727</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8zNjU_4b4c0165-d6e0-4109-9259-3bdd939711de">BioMarin Pharmaceutical Inc</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8wLTAtMS0xLTA_83eff6d1-7fb1-4580-97a5-2af14fc31e4d"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8wLTAtMS0xLTA_c3225537-fea5-4f62-b023-9eaa1031e5a3">Delaware</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8wLTMtMS0xLTA_13dc1af7-79e8-439d-8427-e53317e834f7"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8wLTMtMS0xLTA_82671717-caaf-4fe4-af3c-22ccf1598ef3">68-0397820</ix:nonNumeric></ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTAtMS0xLTA_7a784409-7ada-4993-bfea-6cb76a8853c7"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTAtMS0xLTA_9602357d-4c24-4a20-8970-fa397292e754">770 Lindaro Street</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTEtMS0xLTA_04852476-b636-48eb-87b7-327407feea9a"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTEtMS0xLTA_ae3137d5-4c53-45fc-bf2e-f3eed93cff56">San Rafael</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTItMS0xLTA_3c314a6b-f48f-4795-9b87-dda1e1c110c6"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTItMS0xLTA_d4754644-618d-489c-94b1-317f1d887f60">California</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTMtMS0xLTA_9b6f9526-fda8-4909-8b8d-bd72c9804b39"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTMtMS0xLTA_f8086c0c-4620-4ae9-8dc1-7e43665a48fe">94901</ix:nonNumeric></ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl80Njk_f7a7cccf-20cd-43cd-baaa-b764d836f82b">415</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl80NzM_d62faba4-c919-4433-8b42-1d9b36c04fc5">506-6700</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.701%"><tr><td style="width:1.0%"></td><td style="width:31.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.637%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTAtMS0xLTA_681853f8-9738-498d-83d6-88a0378c96c4"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTAtMS0xLTA_8fc6cfc8-fecc-4e48-96c1-e1de0517fd48">Common Stock, par value $0.001</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTItMS0xLTA_86d3f9c1-db4b-4a82-8104-8c72ca26d9cb"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTItMS0xLTA_b49cb37a-0a7d-47d9-a06d-964c41149230">BMRN</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTQtMS0xLTA_456c598d-2e9d-449e-9f44-ef17cd4b1c8a"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTQtMS0xLTA_7bbafa67-3fbb-45c4-ad79-6003775c246e">The Nasdaq Global Select Market</ix:nonNumeric></ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8xMDE5_d4203ada-28c2-4407-946b-af6ab0c29ef7">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8xMzQ3_aefc1c1a-1e16-4998-b3d0-a7805ec5cbfe">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:26.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8wLTAtMS0xLTA_94f4eb4d-3ce3-49a4-b829-156b1d97a2c7"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8wLTAtMS0xLTA_f4ca7ae7-4ffb-4d48-bd1c-0ff2d13bb189">Large Accelerated Filer</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;Filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated Filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;Reporting&#160;Company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8yLTYtMS0xLTA_19382a66-f01e-417b-80e1-603c2f0856fb"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8yLTYtMS0xLTA_2a44f3f9-e686-4a2e-89e8-3aceff1358f5">&#9744;</ix:nonNumeric></ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8zLTItMS0xLTA_19e1d111-b42b-4b11-9f8c-99cc72ec24cb"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8zLTItMS0xLTA_8112a4ef-23ad-4f35-8ef9-7c4434e94f65">&#9744;</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8yMDg3_55033c35-524b-401e-af0c-5f2fc73aa0d2">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Applicable only to corporate issuers:</span></div><div style="margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date: <ix:nonFraction unitRef="shares" contextRef="i8c2ba3fa4ed8493e8f1f5c6fdc1abfac_I20211026" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8zMjk4NTM0ODg1NzYw_69501a2c-10f2-40bf-9127-71faf37af0ab">183,593,434</ix:nonFraction> shares of common stock, par value $0.001, outstanding as of October&#160;26, 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_4"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unless the context suggests otherwise, references in this Quarterly Report on Form 10-Q to &#8220;BioMarin,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to BioMarin Pharmaceutical Inc. and, where appropriate, its wholly owned subsidiaries.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">BioMarin</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, Brineura</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, Kuvan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, Naglazyme</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, Palynziq</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and Vimizim</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are our registered trademarks. VOXZOGO</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> is our trademark. Aldurazyme</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> is a registered trademark of BioMarin/Genzyme LLC. All other brand names and service marks, trademarks and other trade names appearing in this report are the property of their respective owners.</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:12pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; as defined under securities laws. Many of these statements can be identified by the use of terminology such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; would,&#8221; &#8220;projects,&#8221; &#8220;continues,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; &#8220;opportunity&#8221; or the negative versions of these terms and other similar expressions. Our actual results or experience could differ significantly from the forward-looking statements. Factors that could cause or contribute to these differences include those discussed in &#8220;Risk Factors,&#8221; in Part II, Item&#160;1A of this Quarterly Report on Form 10-Q as well as information provided elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December&#160;31, 2020, which was filed with the Securities and Exchange Commission (the SEC) on February&#160;26, 2021. You should carefully consider that information before you make an investment decision.</span></div><div style="margin-top:12pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">You should not place undue reliance on these types of forward-looking statements, which speak only as of the date that they were made. These forward-looking statements are based on the beliefs and assumptions of the Company&#8217;s management based on information currently available to management and should be considered in connection with any written or oral forward-looking statements that the Company may issue in the future as well as other cautionary statements the Company has made and may make. Except as required by law, the Company does not undertake any obligation to release publicly any revisions to these forward-looking statements after completion of the filing of this Quarterly Report on Form 10-Q to reflect later events or circumstances or the occurrence of unanticipated events.</span></div><div style="margin-top:12pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The discussion of the Company&#8217;s financial condition and results of operations should be read in conjunction with the Company&#8217;s Condensed Consolidated Financial Statements and the related Notes thereto included in this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:6pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Factors Summary</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of the principal risks that could adversely affect our business, financial condition, operating results, cash flows or stock price. Discussion of the risks listed below, and other risks that we face, are discussed in the section titled &#8220;Risk Factors&#8221; in Part II, Item 1A of this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business and Operational Risks</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">The COVID-19 pandemic could continue to materially adversely affect our business, results of operations, and financial condition.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Because the target patient populations for our products are small, we must achieve significant market share and maintain high per-patient prices for our products to achieve and maintain profitability.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we fail to obtain and maintain an adequate level of coverage and reimbursement for our products by third-party payers, the sales of our products would be adversely affected or there may be no commercially viable markets for our products.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we fail to compete successfully with respect to product sales, we may be unable to generate sufficient sales to recover our expenses related to the development of a product program or to justify continued marketing of a product and our revenues could be adversely affected.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Changes in methods of treatment of disease could reduce demand for our products and adversely affect revenues.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we fail to develop new products and product candidates or compete successfully with respect to acquisitions, joint ventures, licenses or other collaboration opportunities, our ability to continue to expand our product pipeline and our growth and development would be impaired.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">The sale of generic versions of Kuvan by generic manufacturers has adversely affected and will continue to adversely affect our revenues and results of operations.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we do not achieve our projected development goals in the timeframes we announce and expect, the commercialization of our product candidates may be delayed and the credibility of our management may be adversely affected and, as a result, our stock price may decline.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Risks</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we fail to obtain regulatory approval to commercially market and sell our product candidates, or if approval of our product candidates is delayed, we will be unable to generate revenues from the sale of these product candidates, our potential for generating positive cash flow will be diminished, and the capital necessary to fund our operations will increase.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Any product for which we have obtained regulatory approval, or for which we obtain approval in the future, is subject to, or will be subject to, extensive ongoing regulatory requirements by the Food and Drug Administration (FDA), the European Medicines Agency (EMA) and other comparable international regulatory authorities, and if we fail to comply with regulatory requirements or if we experience unanticipated problems with our products, we may be subject to penalties, we will be unable to generate revenues from the sale of such products, our potential for generating positive cash flow will be diminished, and the capital necessary to fund our operations will be increased.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">To obtain regulatory approval to market our products, preclinical studies and costly and lengthy clinical trials are required and the results of the studies and trials are highly uncertain. Likewise, preliminary, initial or interim data from clinical trials should be considered carefully and with caution because the final data may be materially different from the preliminary, initial or interim data, particularly as more patient data become available.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Government price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our current and future products, which would adversely affect our revenues and results of operations.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Government healthcare reform could increase our costs and adversely affect our revenues and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Risks Related to Valoctocogene Roxaparvovec</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our valoctocogene roxaparvovec program is based on a gene therapy approach, which, as a novel technology, presents additional development and treatment risks in relation to our other, more traditional drug development programs.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">As compared to our other, more traditional products, our gene therapy product candidate valoctocogene roxaparvovec, if approved, may present additional problems with respect to the pricing, coverage, and reimbursement and acceptance of the product candidate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial and Financing Risks</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we continue to incur operating losses or are unable to sustain positive cash flows for a period longer than anticipated, we may be unable to continue our operations at planned levels and be forced to reduce our operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Manufacturing Risks</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we fail to comply with manufacturing regulations, our financial results and financial condition will be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we are unable to successfully develop and maintain manufacturing processes for our product candidates to produce sufficient quantities at acceptable costs, we may be unable to support a clinical trial or be forced to terminate a program, or if we are unable to produce sufficient quantities of our products at acceptable costs, we may be unable to meet commercial demand, lose potential revenue, have reduced margins or be forced to terminate a program.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Supply interruptions may disrupt our inventory levels and the availability of our products and product candidates and cause delays in obtaining regulatory approval for our product candidates, or harm our business by reducing our revenues.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Risks Related to International Operations</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">We conduct a significant amount of our sales and operations outside of the United States (U.S.), which subjects us to additional business risks that could adversely affect our revenues and results of operations.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">A significant portion of our international sales are made based on special access programs, and changes to these programs could adversely affect our product sales and revenues in these countries.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Risks</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we are unable to protect our intellectual property, we may not be able to compete effectively or preserve our market shares.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Competitors and other third parties may have developed intellectual property that could limit our ability to market and commercialize our products and product candidates, if approved.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Page</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_13">PART I.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_16">Item 1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets as of September&#160;30, 2021 (Unaudited) and December&#160;31, 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and nine months ended September&#160;30, 2021 and 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Condensed Consolidated Statement of Stockholders&#8217; Equity (Unaudited) for the three and nine months ended September&#160;30, 2021 and 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September&#160;30, 2021 and 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_121">Item 2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_82">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_106">Item 3.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_106">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_109">Item 4.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Controls and Procedures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_109">35</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_112">PART II.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_112">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_115">Item 1.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Legal Proceedings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_115">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_118">Item 1A.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk Factors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_118">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_121">Item 2.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_121">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_124">Item 3.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Defaults Upon Senior Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_124">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_127">Item 4.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mine Safety Disclosures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_127">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_130">Item 5.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_130">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_133">Item 6.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibits</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_133">65</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i37555ce43f7244d3afa231a2a50e7423_136">67</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_13"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="i37555ce43f7244d3afa231a2a50e7423_16"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Financial Statements</span></div><div id="i37555ce43f7244d3afa231a2a50e7423_19"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September&#160;30, 2021 and December&#160;31, 2020 </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands, except share amounts)</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMy0xLTEtMS0w_1c2fe5d2-e79f-4105-8204-a916d8649e78">617,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMy0zLTEtMS0w_963a8511-19cd-4d3b-b379-dc85f72b46aa">649,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNC0xLTEtMS0w_e1910c4c-214f-4943-99a8-a8efe8f60c2e">462,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNC0zLTEtMS0w_2af7c84e-15a2-469f-b3a2-40f9942c0465">416,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNS0xLTEtMS0w_75ed21e9-2ba8-42ea-b200-73c3cb171b49">374,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNS0zLTEtMS0w_ef7e6176-5a24-43b3-b8a2-3739ebaf709a">448,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNi0xLTEtMS0w_cb9067dc-2c7f-4209-aff1-a441dd1e7f2b">749,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNi0zLTEtMS0w_04862746-47e9-481f-b137-44e29e1163a1">698,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNy0xLTEtMS0w_79f7ff89-9f00-4657-84d5-0a08128da7e6">107,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNy0zLTEtMS0w_d739060c-a214-4c3a-96e9-aa59f7e45b2e">129,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfOC0xLTEtMS0w_cf13643a-3257-438b-8526-37674e5d90fc">2,311,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfOC0zLTEtMS0w_b171cb64-0d12-49c8-b234-4ba21419be22">2,342,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTAtMS0xLTEtMA_65099031-c6f3-4a13-9181-3c22d53d03e6">466,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTAtMy0xLTEtMA_5021714b-41f4-4186-97af-827af3879f97">285,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTEtMS0xLTEtMA_7dccf76e-62a7-41ae-a769-3a49b87b5388">1,024,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTEtMy0xLTEtMA_8a434401-71b4-4fed-860e-e33037f86e30">1,032,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTItMS0xLTEtMA_694faf1c-d80d-4b11-8962-297d6c8c83df">388,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTItMy0xLTEtMA_440b4086-be9e-4834-8028-38898b0ec0a3">417,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTMtMS0xLTEtMA_0bd282f7-6ab3-46cd-8ca2-726c8532a3b9">196,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTMtMy0xLTEtMA_e43ea724-b6c9-4507-90eb-1e0e5d1f128a">196,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTQtMS0xLTEtMA_8c0c5f5e-5571-485e-8871-dbad4853e2ef">1,445,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTQtMy0xLTEtMA_db827f36-5b7a-4bc7-942c-a859676323d1">1,432,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTUtMS0xLTEtMA_d79ae7cd-d8c3-4ca2-aebe-70f7f45e14da">144,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTUtMy0xLTEtMA_7754568c-0ccf-4705-b267-dcd4e8a01736">142,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTYtMS0xLTEtMA_f3dc5a40-9979-4ed6-84ab-ba535f859c7a">5,977,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTYtMy0xLTEtMA_1c993f34-625e-4306-a646-d7023a602565">5,848,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTktMS0xLTEtMA_6997f921-efe4-41bd-b7bc-c3cc68a7e822">466,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTktMy0xLTEtMA_be2bf46a-bb44-4592-afef-c68248e5b1e1">492,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjAtMS0xLTEtMA_50f3cfd7-5914-4904-b65d-86d53868c905">48,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjAtMy0xLTEtMA_e50909c2-33f9-467b-81bb-cc16fc65ec8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjEtMS0xLTEtMA_de7fb1af-ea17-48e5-8ce1-b0b3f2d32a66">514,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjEtMy0xLTEtMA_720e73e0-635b-439e-9636-dce68aecaac9">492,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term convertible debt, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjQtMS0xLTEtMA_31027e45-2405-40eb-8c8c-57ab3fe3659e">1,078,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjQtMy0xLTEtMA_848e667a-fd89-455e-959c-16985e3ddf57">1,075,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjUtMS0xLTEtMA_9f87f94c-3ef6-402d-ade5-faa6d304059c">15,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjUtMy0xLTEtMA_ef878db6-765a-4c07-8bdd-66a9d9ab891f">60,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjYtMS0xLTEtMA_63f67b24-cc6e-46d4-bd11-a0a9b8dcf7e3">103,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjYtMy0xLTEtMA_eb2dac2a-2bb4-4a15-ae9d-a418aee0af6a">114,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjctMS0xLTEtMA_da1fa412-8ce6-4d65-ad04-4a583158af75">1,711,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjctMy0xLTEtMA_2b8ca420-b415-4866-8e39-2de9ae3b70d0">1,742,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzE4_37ab95b7-bde9-4b5b-a43a-08563ccc10f0"><ix:nonFraction unitRef="usdPerShare" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzE4_a6b05af5-ceea-4db8-bc89-bb903d3954af">0.001</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzMy_2272e61f-c28d-406f-9d32-89451ca7a17f"><ix:nonFraction unitRef="shares" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzMy_8fd4fa30-ae08-457e-9662-559af063282d">500,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzU0_47df38e5-ef0a-4658-9abc-48b776f23986"><ix:nonFraction unitRef="shares" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzU0_feb1116a-a305-4122-b296-77d558c61644">183,567,424</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzYx_c8319fc3-a057-4179-b234-17dfc4ce6573"><ix:nonFraction unitRef="shares" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzYx_d3ed7f40-9005-433b-aa7a-a6b7b335a0f2">181,740,999</ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMS0xLTEtMA_50abd420-260f-4c87-8109-baf30c88a89e">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMy0xLTEtMA_f77147f8-14f4-46ce-ba75-39ed2a695044">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzAtMS0xLTEtMA_5079317e-e77e-4d28-ba8f-4190feadcd76">5,133,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzAtMy0xLTEtMA_3a751c61-52c3-4c35-b74f-7be0a7f656ae">4,993,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Company common stock held by Nonqualified Deferred Compensation Plan (the NQDC)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockIssuedEmployeeStockTrust" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzEtMS0xLTEtMA_6204fa3a-8746-43c6-a44c-ea30f1b78271">10,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockIssuedEmployeeStockTrust" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzEtMy0xLTEtMA_f90ceb0a-0a8d-484c-bd86-7b5eb48578b3">9,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzItMS0xLTEtMA_b90dacff-7483-41de-855e-8e8525c315a9">10,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzItMy0xLTEtMA_aee410e3-2710-492c-be12-ff105db632d4">16,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzMtMS0xLTEtMA_904561a6-b894-46d5-83eb-f54cca5b1062">867,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzMtMy0xLTEtMA_768b19d3-3929-492e-b163-68865a2bb538">861,609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzQtMS0xLTEtMA_7ef8e509-7e86-4a43-94ea-882baa084134">4,266,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzQtMy0xLTEtMA_ab8e1abd-438c-4bbf-8e67-ef972f7e8e57">4,106,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzUtMS0xLTEtMA_130b9be1-6fbb-4a83-9213-73db4c1dfc40">5,977,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzUtMy0xLTEtMA_c5cca7ad-592b-43c3-90e3-1ecd7964bf98">5,848,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></ix:footnote></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_22"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three and Nine Months Ended September&#160;30, 2021 and 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">REVENUES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMy0xLTEtMS0w_b9bed7b5-40fc-4a87-bba8-2884ca9ad03b">393,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMy0zLTEtMS0w_a4acdcb0-07cb-460a-b8be-6a8e64d51732">460,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9940e707613405199a97fc351ad73ef_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMy01LTEtMS0w_50f61e94-c61e-4f6d-bbb0-47e170fc84c0">1,348,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMy03LTEtMS0w_6798dbb7-2eb5-4b3b-84be-dc9fdb7bbbdf">1,368,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalty and other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055b5a733006483d91da202b094f7799_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNC0xLTEtMS0w_574e1ae7-e0d7-4f55-a878-77a075e15929">14,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f40e6fd2d594084b575d40ed0c6f0c8_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNC0zLTEtMS0w_93479910-9ebf-4547-a468-90271bfedcfa">16,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342150f2921d4dc2a5acc57613812db0_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNC01LTEtMS0w_0ad2d95a-2053-4d33-aaa8-379d093a4ffa">48,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4549f3adaa5948939b7e0555d551796b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNC03LTEtMS0w_1b144a5f-cb5e-4ab2-b734-029808c0dcbe">39,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNS0xLTEtMS0w_88ea3993-f1a5-4ead-8066-1c0bb147dba1">408,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNS0zLTEtMS0w_e2ea8023-ac80-4d71-a1ec-5997b69ebaa6">476,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNS01LTEtMS0w_ff849845-0a5b-408c-82bb-77c9b20ae5cd">1,396,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNS03LTEtMS0w_771c7ad1-0d05-4288-853a-c3a110d1ce8e">1,408,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING EXPENSES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNy0xLTEtMS0w_00204dd7-977b-4a69-9f71-67108d7cb794">103,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNy0zLTEtMS0w_4e658f80-6cf0-4838-9662-c45db5fe25d2">188,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNy01LTEtMS0w_179deeba-8295-410f-b34c-00e39cf3da54">350,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNy03LTEtMS0w_9ce2ef30-5ceb-4781-8931-a3c1a5bdc03a">398,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOC0xLTEtMS0w_1d994998-6887-4624-a949-c2026044319d">157,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOC0zLTEtMS0w_adc2a920-a82e-4828-ab8a-2b2c05782365">147,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOC01LTEtMS0w_80c5e24c-cc1c-4ac2-a597-f17f1917e03c">467,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOC03LTEtMS0w_4cb66aa6-e244-4a09-a37b-dcdd36e1163c">471,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOS0xLTEtMS0w_bbda2c8f-9862-4cfb-9fd8-65fcf0eec62a">183,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOS0zLTEtMS0w_02cbe313-0f58-4dcb-bb87-b51ab3665f55">179,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOS01LTEtMS0w_c4e0ba58-a277-4dfc-b875-55a524468507">541,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOS03LTEtMS0w_d16953ed-a726-470b-a42d-d169c8b1e957">542,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization and contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:IntangibleAssetAmortizationAndContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTAtMS0xLTEtMA_5ed43ede-19cf-4c0a-a80e-8392c2883777">17,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:IntangibleAssetAmortizationAndContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTAtMy0xLTEtMA_83dd3be3-8a22-4f43-9891-6a42e2688ca8">17,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:IntangibleAssetAmortizationAndContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTAtNS0xLTEtMA_11588718-4714-414a-99be-2e8727876579">52,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:IntangibleAssetAmortizationAndContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTAtNy0xLTEtMA_0ec4f7de-da3d-4afb-a480-fb963878dc56">48,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of nonfinancial assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTEtMS0xLTEtMA_7203943b-cbf7-4536-b6e1-a7970149556d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTEtMy0xLTEtMA_94760e64-a7dd-4af4-8372-391b440aa547">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTEtNS0xLTEtMA_ebaf22b5-900f-4020-baae-4d6383e4b3e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTEtNy0xLTEtMA_d3a2e566-aaa7-4771-b3b8-0e2fc56662eb">59,495</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTItMS0xLTEtMA_91afa0b1-99fd-4813-a2fb-f1bccda7e52e">461,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTItMy0xLTEtMA_c6d564df-f84d-4f60-a8d8-e5daaeb23109">532,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTItNS0xLTEtMA_9b05afdc-d7b0-4918-b54c-65aca3a2f090">1,412,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTItNy0xLTEtMA_755f2124-c156-4866-8f6b-8b484f518333">1,400,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INCOME (LOSS) FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTMtMS0xLTEtMA_8637f2e6-13d6-4fc4-9bdb-060a65ec748f">53,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTMtMy0xLTEtMA_7ad543b7-e6d9-4396-8870-95828f620b05">55,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTMtNS0xLTEtMA_ddf3f4fe-e0dc-420f-9ec6-cc2a4c7b51ef">16,461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTMtNy0xLTEtMA_4d20126f-75fb-4b19-b63e-72e283ed30fc">8,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in the income (loss) of BioMarin/Genzyme LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTUtMS0xLTEtMA_4d65e0c4-99e9-4ab8-ba0f-f29640593e3b">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTUtMy0xLTEtMA_e5b97a84-e338-4d8c-9910-153b5b73b7f7">921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTUtNS0xLTEtMA_0c933173-93c7-452c-9458-e9dc072c07ba">1,349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTUtNy0xLTEtMA_61e2c0a1-de22-46d0-af28-c6c697eb12fa">1,077</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTYtMS0xLTEtMA_c648754e-20dc-4a94-8c45-b2d18b240ee1">1,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTYtMy0xLTEtMA_887ee7d8-8afb-4864-918a-87ec2fe7695f">4,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTYtNS0xLTEtMA_79acbacf-8b84-4847-a6f4-edbecf1d0f1e">8,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTYtNy0xLTEtMA_820811b6-e31b-472a-89a4-b5815f95a18e">13,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTctMS0xLTEtMA_5d934d62-539a-463b-92f0-2f4f0e019f8d">3,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTctMy0xLTEtMA_008f6cd1-80b8-4c89-92a0-8050f7038480">9,597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTctNS0xLTEtMA_51dd6dc2-89a3-4f33-819b-c972d1d0d0b0">11,491</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTctNy0xLTEtMA_53977175-0dcd-4b9a-90b9-95ac609a1a13">24,560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTgtMS0xLTEtMA_a4046502-54a2-4fff-9fab-eaa7d962e262">8,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTgtMy0xLTEtMA_b9cc218b-f974-4936-ac0c-82340fdb4723">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTgtNS0xLTEtMA_dcca6ad0-42f3-4373-8733-a9c6a16924d5">11,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTgtNy0xLTEtMA_bde16a17-71f5-402d-85cc-591183c24aa1">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INCOME (LOSS) BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTktMS0xLTEtMA_0ab6dfb9-5167-46fd-b757-5beaaec4eb0d">46,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTktMy0xLTEtMA_9745e203-2742-4699-a03e-87d76df35c91">61,216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTktNS0xLTEtMA_9a6741bc-52ea-4361-9c04-7cdb8c458aea">8,776</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTktNy0xLTEtMA_742ce445-4461-439d-8a9f-8a563707b4b8">2,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjAtMS0xLTEtMA_c097066f-1231-40c2-a096-ef256d4c1cfa">9,666</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjAtMy0xLTEtMA_da6bd3bd-a7fa-4a3f-aa31-2103cd60961c">846,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjAtNS0xLTEtMA_6d550cbc-fe2b-4460-b252-e0eab4bf5699">2,594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjAtNy0xLTEtMA_be0bcbfa-9df7-40ea-ba7d-20b8d0c30346">839,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCOME (LOSS)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjEtMS0xLTEtMA_293df2f5-09f5-41f1-8e06-232e4d3ecc95">36,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjEtMy0xLTEtMA_8eb7d823-2848-4b30-84ff-bc8869c530ca">784,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjEtNS0xLTEtMA_2d794241-35d9-4d02-bd38-3a87ebacd79c">6,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjEtNy0xLTEtMA_9e2ce1a2-5842-49d3-86f7-8e39e2c5028b">837,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCOME (LOSS) PER SHARE, BASIC</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjItMS0xLTEtMA_88d22610-2f60-473d-a7e2-eb7b352a52c7">0.20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjItMy0xLTEtMA_394f29bd-4d03-4982-a9c0-938c84888273">4.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjItNS0xLTEtMA_29541864-e9e4-47e4-8188-96f001927a02">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjItNy0xLTEtMA_92887749-a834-402d-ae52-48ba280deb64">4.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCOME (LOSS) PER SHARE, DILUTED</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjMtMS0xLTEtMA_75902beb-5b17-4c3e-baee-b56b44d133c3">0.20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjMtMy0xLTEtMA_aebb4f0f-c098-4b62-b4b2-029a23a13131">4.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjMtNS0xLTEtMA_fe87e3fe-799e-40a6-ada0-b48cde12c92c">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjMtNy0xLTEtMA_12b8b658-9540-48fe-996c-093f1f3ec755">4.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjQtMS0xLTEtMA_413e258b-4f08-44c0-b590-57118bd1feaf">183,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjQtMy0xLTEtMA_914bf33d-153b-4aee-a6d2-d7b2b47f06c6">181,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjQtNS0xLTEtMA_74acf773-f3fb-4730-a830-de766a1bf137">182,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjQtNy0xLTEtMA_44b96c31-6a6b-41dd-98a6-9e77b95fe454">180,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjUtMS0xLTEtMA_85564155-fe20-4016-a5b9-6c06d4489a2b">183,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjUtMy0xLTEtMA_e1f2611d-43f7-4f79-90c7-55fc35d573c1">197,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjUtNS0xLTEtMA_0d4d6213-a419-4f5d-be48-adc6bffa2eb4">182,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjUtNy0xLTEtMA_609170db-5953-4cc4-b4cb-e80c2964ac7a">194,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME (LOSS)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjctMS0xLTEtMA_bd724870-368c-4e3a-86fd-bb4c5278c91d">25,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjctMy0xLTEtMA_761a5e46-586d-41d6-98f9-9ad0cfa59eff">765,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjctNS0xLTEtMA_9fab06d8-cc4a-488f-bcd6-abd54ca8322b">20,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjctNy0xLTEtMA_94aaf25f-250f-44a1-8618-de460594963d">827,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">Three and Nine Months Ended September&#160;30, 2021 and 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">(unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares of common stock, beginning balances </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ea54e8805bf4cd2bf97a56c86ecfccd_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0xLTEtMS0w_9da5c243-f2ba-428d-88f4-fff099590b2f">183,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bcd0ccc805b4b2f9e84aa347f9675e2_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0zLTEtMS0w_80e1e025-549a-45c2-84d4-d428b04bc25d">181,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99f00eb5b129417a84d6a7ccff242457_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy01LTEtMS0w_80590d6d-6042-4df1-a54f-e96d14ee3755">181,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac1a61de8d9a4f648cd0094a00ba3a7c_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy03LTEtMS0w_9945da9e-d5c5-4a4b-9e1f-fa7bd5cb744a">179,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under equity incentive plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a1d232828b343fc85f1f99a3762f4b6_D20210701-20210930" decimals="-3" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNC0xLTEtMS0w_49606c83-ec19-4481-b000-4ad04e15fe88">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0ad0618f364452792421d091dfef160_D20200701-20200930" decimals="-3" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNC0zLTEtMS0w_2a02a7d7-5f83-4ac8-ac30-3af836cb7878">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0d7c667fbcb49a492cc496e20a9533b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNC01LTEtMS0w_f9a1cef7-8548-4acf-8a52-569165b8fc58">1,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17802777da7643c6ab25cac57f541c1e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNC03LTEtMS0w_37486d0a-3d74-4f3f-9a16-82124531df0b">2,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a1d232828b343fc85f1f99a3762f4b6_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNS0xLTEtMS0w_e9f5fe69-e6ef-40b2-9168-3d9aaa8d9f5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0ad0618f364452792421d091dfef160_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNS0zLTEtMS0w_945e266b-ebc0-4287-94a6-3504b16af84d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0d7c667fbcb49a492cc496e20a9533b_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNS01LTEtMS0w_5bec2ca3-f68e-4573-89fd-10d6f88ce260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i17802777da7643c6ab25cac57f541c1e_D20200101-20200930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNS03LTEtMS0w_9a1c8bcb-61ac-4930-9b05-45d5427242d0">518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares of common stock, ending balances</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icebcf4632bc041ecb270987af3929f4b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNi0xLTEtMS0w_e6f5a670-6fb0-4984-9cf0-9ac25141ef02">183,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaca57bc041147b381f06e8aa17857c6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNi0zLTEtMS0w_a0a7b74c-9c06-4c27-878e-62ff8a3654f1">181,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icebcf4632bc041ecb270987af3929f4b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNi01LTEtMS0w_cf743d6c-2968-4b38-83fd-00c4dfc4786d">183,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaca57bc041147b381f06e8aa17857c6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNi03LTEtMS0w_33658d31-e90b-40f4-be36-a66b800bfa1f">181,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity, beginning balances</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ac9247fd2e436cb417f1972275fb4a_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0xLTEtMS0w_72870b1f-4e17-4559-9fab-07aecaab6bde">4,241,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5c0d0d2b0e4255835d887bcfa9bc17_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0zLTEtMS0w_abf81c9d-4f10-4caa-8485-a937624d5b0a">3,236,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC01LTEtMS0w_622fde87-890f-4579-a8c4-8f538731d0a5">4,106,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7268a9baa84143e28737ef38b1cfc7a8_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC03LTEtMS0w_40abc157-7a92-4b2e-b4c1-636c8a1c095f">3,122,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balances</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea54e8805bf4cd2bf97a56c86ecfccd_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMS0xLTEtMA_fa8c23b8-dffb-4769-aae5-62ccbe33d132">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bcd0ccc805b4b2f9e84aa347f9675e2_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMy0xLTEtMA_67818c24-e760-4a44-8b3b-cae1351b1f8e">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f00eb5b129417a84d6a7ccff242457_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNS0xLTEtMA_2ba8b51a-3d12-4c40-9732-b59b4096cb92">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac1a61de8d9a4f648cd0094a00ba3a7c_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNy0xLTEtMA_478d5aec-1723-40c5-beea-a858d1dbfc9b">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under equity incentive plans, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1d232828b343fc85f1f99a3762f4b6_D20210701-20210930" decimals="-3" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTEtMS0xLTEtMA_7f175401-ee57-4119-b075-aa7395fd1b81">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0ad0618f364452792421d091dfef160_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTEtMy0xLTEtMA_fb062550-e987-4bc0-918a-d8994087deaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d7c667fbcb49a492cc496e20a9533b_D20210101-20210930" decimals="-3" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTEtNS0xLTEtMA_2299fe53-37d9-474b-9aa5-a2feacbf52d0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17802777da7643c6ab25cac57f541c1e_D20200101-20200930" decimals="-3" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTEtNy0xLTEtMA_d44d7c62-0ddc-4439-ac6c-8710bcaefed0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebcf4632bc041ecb270987af3929f4b_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTItMS0xLTEtMA_ba5e6501-e176-4de8-a9f7-bc1a37527060">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaca57bc041147b381f06e8aa17857c6_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTItMy0xLTEtMA_8de59c76-dabd-4f11-8996-a9d68092f007">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebcf4632bc041ecb270987af3929f4b_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTItNS0xLTEtMA_597bbbea-5c30-42f7-84fc-3132d8d5a1bd">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaca57bc041147b381f06e8aa17857c6_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTItNy0xLTEtMA_2f8c9bba-e901-4be7-9f60-39c3f08f5f57">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64cc87601ea34f3381da0fca0b298bc6_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMS0xLTEtMA_1615b675-9dc0-4931-b33b-c18a216d1013">5,083,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i731188fc3d2044b7a23a6e217ea305e4_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMy0xLTEtMA_19f99bfb-dc72-4b96-857a-b4f591a35d5b">4,885,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b52d173ad54772a29d1b6f7bbf6459_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNS0xLTEtMA_c754fec8-9ca8-4726-a876-e54479025051">4,993,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4caba0337f8f4b2e8f9100f7d140d5ce_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNy0xLTEtMA_52688cf7-cdb3-44b7-9af1-18d255bc03c2">4,832,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances under equity incentive plans, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930" decimals="-3" sign="-" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTUtMS0xLTEtMA_ca39dd88-979c-4ba7-934e-1fed8aac400a">460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTUtMy0xLTEtMA_6cdc526d-4911-4ed5-a4b2-09e780696c36">7,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTUtNS0xLTEtMA_9354acc3-db7c-4dea-9b10-d3f3e9811c7e">11,551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTUtNy0xLTEtMA_12652ffb-652f-44a7-95f0-5da48d5acea0">17,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTYtMS0xLTEtMA_98d89863-ef3f-48e1-af24-9c454a57c728">50,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTYtMy0xLTEtMA_0927ce2c-6d9b-4af6-bd8d-5d7838f99394">44,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTYtNS0xLTEtMA_0654ee6c-4b65-4196-b33c-c84c92db4127">151,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTYtNy0xLTEtMA_190d0281-1ba7-452b-b3c7-50c158817def">136,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTctMS0xLTEtMA_7b1b3f38-398d-4d70-8654-221ac54568ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTctMy0xLTEtMA_1c648f56-72b4-4f64-9156-c59e64e9c0da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTctNS0xLTEtMA_376371e0-f73c-491d-92c3-5cd8fd7fe094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTctNy0xLTEtMA_98bc1c3a-8ffe-44f8-a8ba-6dd9667fe8e9">50,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held by the NQDC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930" decimals="-3" sign="-" name="bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTgtMS0xLTEtMA_2c1a99ca-3290-4be0-8b16-d64c07cb384a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930" decimals="-3" sign="-" name="bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTgtMy0xLTEtMA_74a8652f-c4c5-431e-9d39-4f60bede6273">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930" decimals="-3" sign="-" name="bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTgtNS0xLTEtMA_4a5d6f92-791e-4d95-86e4-0827b9ff2f9e">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930" decimals="-3" sign="-" name="bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTgtNy0xLTEtMA_6c154eba-b4a0-4b06-a266-c393f36e62b1">795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7778fc67467846b8a67a75902f463e54_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTktMS0xLTEtMA_a2384674-8677-49fc-83f4-4b9c03f41b19">5,133,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5f0aad336a3452ea25f24ba710ac93a_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTktMy0xLTEtMA_a2faade8-ff9d-4418-a096-34812c02830e">4,937,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7778fc67467846b8a67a75902f463e54_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTktNS0xLTEtMA_93afa54b-a90e-4077-9851-6d9e20f0f606">5,133,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5f0aad336a3452ea25f24ba710ac93a_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTktNy0xLTEtMA_fe3af8d3-83da-433a-a3b7-56d631199bfa">4,937,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i627eef1092454bb98b2d4c1cea40f20e_I20210630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMS0xLTEtMA_b3ac2687-39cd-4b15-a8e0-278133489a77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9d74897922454eac93c39ab9193ed7_I20200630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMy0xLTEtMA_6606cdb6-977b-49ba-8a09-d376a76e6dda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07691e24f2f4f37b1f16b61b6cc50ad_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNS0xLTEtMA_ce5b790a-8f10-4f4d-a51c-6f62fbf0f0fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6703cd6e3a77492f925f347aaebd345a_I20191231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNy0xLTEtMA_e1dc97ee-6443-43a8-9e6f-fe83e219f499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88dc8a11226046f1a9d9868cad8f27ca_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjItMS0xLTEtMA_f1fed961-7f0f-46e9-8139-13970fe7188d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1406297b474f139305e89552bbcad7_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjItMy0xLTEtMA_91656744-cd17-4eed-9757-5f328ac5e578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f2a6e362d84481d9b46790a952c3eb8_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjItNS0xLTEtMA_7fc070cc-8f14-46a5-921d-caec167bdc8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifedfb7039355401494da9d79b4b019f7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjItNy0xLTEtMA_cce7c11c-9c73-4203-8409-b7c54bc80793">50,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88dc8a11226046f1a9d9868cad8f27ca_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjMtMS0xLTEtMA_9f4cb137-765e-42f4-a686-8f51d3c101c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1406297b474f139305e89552bbcad7_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjMtMy0xLTEtMA_a343ce42-a66e-4290-9b35-a1b6f3908169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f2a6e362d84481d9b46790a952c3eb8_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjMtNS0xLTEtMA_932ee5ef-2afb-4d33-a2f0-4933065cfdf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifedfb7039355401494da9d79b4b019f7_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjMtNy0xLTEtMA_1d08813b-49ea-446e-baea-6f94267585d2">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bb9f866ca4475eaf5dfcb3fa669cb2_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjQtMS0xLTEtMA_dad45229-2531-4302-be7c-73d04d10b781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d3c91fa0884ce985a56dd462a786fd_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjQtMy0xLTEtMA_d0de676d-95cc-42b2-bde2-b2eb32fe78ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bb9f866ca4475eaf5dfcb3fa669cb2_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjQtNS0xLTEtMA_58b91e21-0123-450e-87ed-97e123e59a16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d3c91fa0884ce985a56dd462a786fd_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjQtNy0xLTEtMA_3a63b088-f04f-49df-9a97-e2e529453617">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Company common stock held by the NQDC:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ba0bfe4241498cabc063f575c0fe8c_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMS0xLTEtMA_817fdbd8-1213-4898-be7c-f08d3b5d4c12">10,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if019850925824862b004fe4ce0fba35f_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMy0xLTEtMA_9b2f553e-3253-4009-8223-5f14dee5a1a4">10,678</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd15da83cca44176a0b4b0f67a931a98_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNS0xLTEtMA_a69260cb-11f7-4d4f-98bc-513018bfe44b">9,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5e64d06d88e4e6bacfa1c4bee506c2d_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNy0xLTEtMA_b899b85f-8b47-41ff-89c6-effe257d0c28">9,961</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock held by the NQDC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dd786401f3846dc9ebfe35c03ae7cf0_D20210701-20210930" decimals="-3" name="bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjctMS0xLTEtMA_d304c08e-d933-402f-8051-59d09de16576">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80fd59e3ac5943d4a4576ec081be6729_D20200701-20200930" decimals="-3" name="bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjctMy0xLTEtMA_45df67b7-aefb-4615-8333-d8ed23426247">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib796b32eb4e84dd39329cb270e0eb237_D20210101-20210930" decimals="-3" name="bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjctNS0xLTEtMA_f888b597-7e56-4409-b4e6-d78d107c9fd7">386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdb4d2c8bde5486194ee9f8978433d7b_D20200101-20200930" decimals="-3" name="bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjctNy0xLTEtMA_ce5ff3b0-d27c-473d-a002-2fd13b1301f8">795</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42144fd1c7cc40b4a19862971243a6c2_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjgtMS0xLTEtMA_41abc8b2-f2a4-40ad-99fa-ed10d2553672">10,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe71756343b8462d9a1e0b2139797942_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjgtMy0xLTEtMA_d69c7fce-5d64-4ab0-9e08-97843d79a3cb">10,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42144fd1c7cc40b4a19862971243a6c2_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjgtNS0xLTEtMA_b880a846-6257-41b2-a0bd-d2cf6fd0bf49">10,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe71756343b8462d9a1e0b2139797942_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjgtNy0xLTEtMA_8a0f7292-97bf-4c80-9f12-41806c21c341">10,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2e3bd0516f4927a3ea54940b0473b8_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMS0xLTEtMA_83aea445-0665-4f90-8ba3-7712949883a1">939</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10986a90b6074a24befea81408205ba6_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMy0xLTEtMA_7f4a62eb-845e-49ff-9889-65ebd2382598">30,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847ccef2e0f749cdbc16c784f8bc20d7_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNS0xLTEtMA_8cbf41fe-e697-457e-a1ff-f93d617fb15a">16,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5980981b2d94a21af89adbff48bff67_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNy0xLTEtMA_d6836a05-7ef2-4eea-b180-796e09dfac57">20,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib502302b9e2f484da8ae334c586b7015_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzItMS0xLTEtMA_cbdddbf4-37af-4798-95d4-50eb1675d0a1">11,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i139ebe39eaac4c3d89f8d6a430777353_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzItMy0xLTEtMA_1c47be15-28b2-4000-9300-ffe1f0d9e48c">19,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cfe02f4a80f4b47b9a60dde2af5de31_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzItNS0xLTEtMA_250dc50a-4b99-477c-ad1e-44b8e1b75a04">26,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2a90b89293d4d568258cb84a8b82013_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzItNy0xLTEtMA_a94411d2-60a0-4c8d-8286-650d2e0dc67e">9,779</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzMtMS0xLTEtMA_0c820c9a-6c94-4ad7-9793-2bd5eb41e390">10,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0db40041dc54511b7a5f5d17ab13fa6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzMtMy0xLTEtMA_da8fdcfe-0516-41fc-a985-deb1c2d9d7d3">10,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzMtNS0xLTEtMA_e973faa7-0248-4258-8f1e-499b663902b3">10,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0db40041dc54511b7a5f5d17ab13fa6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzMtNy0xLTEtMA_5ba6a709-7a88-43c2-89c4-b404520228ee">10,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated Deficit:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51c38a2eb11344c1ac10d203ceb97e13_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMS0xLTEtMA_f2211914-b58c-4762-a749-aae4b1cd3052">831,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i768baa6d2e434ec181651dc6bc5d351d_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMy0xLTEtMA_0472a5e3-0a8f-4691-b9c8-b0387c815ce1">1,668,511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65c51e81a86e484d8e7ecfbdeae9fe9b_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNS0xLTEtMA_989d4272-2948-4a7a-bd0c-3fd121d0047c">861,609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d51116bdb2447edbdb006552af68df6_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNy0xLTEtMA_ee908d3a-c4e8-4e65-b4e2-151b4adb3de0">1,720,709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i803bcd43ae324221accf1b091be40cd1_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzctMS0xLTEtMA_519c8878-2c5b-4c2e-8667-3fa89c0a845f">36,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if010a0db0da649f79724c29782c82b57_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzctMy0xLTEtMA_c906cdf7-dcc0-45dd-8c55-ded5d31e895f">784,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6033594232bd45b1956bdbbb3ec09c3b_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzctNS0xLTEtMA_17648dab-0b78-4226-bfe4-f85571d474ce">6,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d08ea1a9cb14bb59451b5d3e37c8e09_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzctNy0xLTEtMA_6743ccfe-176d-4b91-8e39-2ff1b49c4588">837,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f6ffb6089bc436588ddb4e558536c98_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzgtMS0xLTEtMA_8bf4c9bf-f18b-47d6-b9b0-33f2ca36c0f9">867,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84daa993a3914c4c816bec79eb0a2d5a_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzgtMy0xLTEtMA_44dd2803-d9e1-4109-8763-7e65189a59fa">883,708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f6ffb6089bc436588ddb4e558536c98_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzgtNS0xLTEtMA_4588c5e0-ed62-46dd-8f32-00e3558437a6">867,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84daa993a3914c4c816bec79eb0a2d5a_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzgtNy0xLTEtMA_ba4218cb-47e7-4d72-a6a8-cb1086404515">883,708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity, ending balances</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzktMS0xLTEtMA_218e0414-a7ab-40ee-999b-4312e94abbcb">4,266,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6c0821a737d46339e19959fec1fb613_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzktMy0xLTEtMA_149a8c38-1916-479c-a45f-e72674c3b349">4,053,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzktNS0xLTEtMA_d4b8c083-d47a-4ea1-86bb-121ce100bfa5">4,266,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6c0821a737d46339e19959fec1fb613_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzktNy0xLTEtMA_3d1c06d5-56ac-40e2-aa4a-1a1a1ccb9fb9">4,053,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13" footnoteRole="http://www.xbrl.org/2003/role/footnote">The beginning balances for the nine-month periods were derived from the audited Consolidated Financial Statements included in Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</ix:footnote></span></div><div style="margin-top:10pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September&#160;30, 2021 and 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:110%">(unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMy0xLTEtMS0w_4d308df3-d8f7-4ef4-b12a-8418a98ed988">6,182</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMy0zLTEtMS0w_f34aa016-27a8-4859-a28b-b8f8f7060bef">837,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNS0xLTEtMS0w_84bdcc4e-d88f-4078-afaf-08a45c650ee4">82,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNS0zLTEtMS0w_04691889-aeba-4bf5-902a-d3d4dac0901a">77,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNi0xLTEtMS0w_331e2feb-7eb3-41fe-950f-c15aea111c11">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNi0zLTEtMS0w_bcdc801a-9050-4a81-b81d-b91a882b6291">14,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of premium on investments</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNy0xLTEtMS0w_e9910fab-facd-4dc4-ad95-c6a972cda97f">3,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNy0zLTEtMS0w_ac237bce-0a84-4f12-b4c7-cebb55ec3f6b">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfOC0xLTEtMS0w_1d046325-0a9d-4047-8065-cd9713391ae4">153,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfOC0zLTEtMS0w_a05304d3-d71a-4234-b7b6-4d63ac2bcfd9">142,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of nonfinancial assets</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfOS0xLTEtMS0w_3ff686b0-253f-45ae-ad43-5ec762753495">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfOS0zLTEtMS0w_50b6b91f-faba-488c-865f-8c92a1193b3c">59,495</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory reserves, net of stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTAtMS0xLTEtMA_d7e5a27a-1cfa-4fcd-bc3a-84c144d22d2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTAtMy0xLTEtMA_95ee27fd-fb7c-455e-a2fc-13121e7bc5ad">75,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTEtMS0xLTEtMA_5d012338-0ee6-4f11-9214-5d47421fcb02">12,020</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTEtMy0xLTEtMA_7ac62b82-f320-4e3e-95ba-54663ac4271e">854,199</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized foreign exchange (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTItMS0xLTEtMA_e2cc8593-63ce-43dc-84c6-29f980eee167">1,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTItMy0xLTEtMA_e76de4f9-583c-4b73-8567-d136be3088aa">9,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash changes in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTMtMS0xLTEtMA_6ac2f09f-c874-4c3f-8ef9-f1e71d753a37">6,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTMtMy0xLTEtMA_52d8965a-836f-4189-9941-67bae9e066a4">1,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTQtMS0xLTEtMA_3a2eff2e-279c-48b3-9466-5ab13d9bd0bd">1,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTQtMy0xLTEtMA_db4654bd-73fa-4bc5-99f0-86afdef631bf">388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTYtMS0xLTEtMA_5ab09045-e001-4464-9ba0-f111a667f7b3">65,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTYtMy0xLTEtMA_3014d124-6c60-40eb-87b8-8b184c6a914e">32,915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTctMS0xLTEtMA_5194dc79-3956-470a-a64d-eefb7e20c2d0">19,125</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTctMy0xLTEtMA_6818a23a-42eb-4b9e-9d8f-0a5356a8638e">73,310</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTgtMS0xLTEtMA_8b1b866e-e14a-442d-ac19-1f18086809bb">27,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTgtMy0xLTEtMA_7a1facd9-624b-495c-84b3-4de9902ed136">32,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTktMS0xLTEtMA_5e741220-f244-4a11-995c-7d09a17cca83">407</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTktMy0xLTEtMA_918f99f8-5a54-42e1-b942-2d6b2117c087">5,543</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjAtMS0xLTEtMA_ce576303-1964-4ca8-ba6a-520061d35904">7,129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjAtMy0xLTEtMA_ec514857-69db-4c63-bfd3-85124d65767d">76,174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjEtMS0xLTEtMA_90e23185-08a0-429b-9152-7ff3a7c5b557">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjEtMy0xLTEtMA_3cf5788d-0966-4e08-9197-91e3693ca717">9,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjItMS0xLTEtMA_c24fa730-f4c9-4149-b8c1-3a83a5b9f5c4">293,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjItMy0xLTEtMA_1c53a2fd-1644-468d-9b06-ef0407efb87d">98,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjQtMS0xLTEtMA_832b3d5a-b519-4570-831d-a8908dc0f2a7">66,840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjQtMy0xLTEtMA_29eab5d9-b1cf-417a-90d4-3c34603b91c1">83,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Maturities and sales of investments</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjUtMS0xLTEtMA_8025a369-0c4d-46d8-acdc-95ae1ef17b85">502,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjUtMy0xLTEtMA_46aa4c9a-a8e4-46b9-b17f-0d804602f9c3">345,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of available-for-sale securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjYtMS0xLTEtMA_6a6f756b-bd64-4923-a7bd-23be9e55fc4c">737,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjYtMy0xLTEtMA_c7a19a90-b06d-4fcf-8d99-c430f2a594a2">369,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of nonfinancial assets</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:ProceedsFromSaleOfNonfinancialAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjctMS0xLTEtMA_2f8945e7-b823-4cb4-ac94-1db20101a8f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:ProceedsFromSaleOfNonfinancialAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjctMy0xLTEtMA_46179ecd-9476-4566-a81a-3a300a14c277">67,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjgtMS0xLTEtMA_3d397b65-33e7-4d4f-9a0a-f9e4e2f2256c">8,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjgtMy0xLTEtMA_c3c33200-44cc-4393-b0e7-20d29ede58a5">14,369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in convertible note</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjktMS0xLTEtMA_ec30a43d-0cb6-4d7a-8fd8-b49d8f1670af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjktMy0xLTEtMA_4c961909-213c-4c01-82f0-617cf87ce36a">8,709</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzAtMS0xLTEtMA_10ddef88-c38a-4570-9517-d2ce35ea20b5">994</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzAtMy0xLTEtMA_21149010-0478-4060-9aaf-4f73e505c8ee">725</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzEtMS0xLTEtMA_0a4fca3f-c0b8-45d8-b362-7c5c57835e90">310,892</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzEtMy0xLTEtMA_4845c269-7ce0-4e3a-b595-702dfd5cae58">64,648</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercises of awards under equity incentive plans</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzMtMS0xLTEtMA_1e3b2a75-0b3b-466c-bd42-24bd36c3b1b2">32,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzMtMy0xLTEtMA_ba16c361-95e8-4b48-8296-ba2b64fe0478">60,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzQtMS0xLTEtMA_05eea483-443e-4028-aaf9-c5298542202f">44,428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzQtMy0xLTEtMA_178ef52c-0511-4703-bb4c-bb7d9297ec34">42,667</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzYtMS0xLTEtMA_d473aba2-37fa-4603-a8e6-17d785094fb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzYtMy0xLTEtMA_428320f2-8f27-48cd-82c3-8abb0a83440b">50,000</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from convertible senior subordinated note offering, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzctMS0xLTEtMA_64ab9af7-5edf-4887-973f-dfa4ee076bc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzctMy0xLTEtMA_57199112-f166-4843-9ccc-9ab31d0d823d">585,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal repayments of financing leases</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzktMS0xLTEtMA_67c39635-f48c-4e5c-a211-bad3bfa20d4c">2,492</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzktMy0xLTEtMA_cdce8c69-7fda-4264-96c0-b95cd07be015">6,080</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDAtMS0xLTEtMA_6db144de-e5b8-4f73-9c26-2aa89fe57293">401</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDAtMy0xLTEtMA_c760de28-c16f-4fe7-aa41-f21e88e1ed34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDEtMS0xLTEtMA_f05f3d58-690f-4cc6-8ff6-ba6854b56f71">14,444</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDEtMy0xLTEtMA_c1f5c9e2-e743-4af0-b8fa-f2f297c8595d">547,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDItMS0xLTEtMA_28fda695-14ee-4a69-a1f1-260dece34550">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDItMy0xLTEtMA_bde334c0-a4c7-4b40-94cf-a5ff25d0f465">3,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDMtMS0xLTEtMA_09728d6d-af51-48e8-a278-cd9d683c0142">32,015</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDMtMy0xLTEtMA_533046a3-0f2e-4092-ad05-c777e1889ba6">578,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning of period</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDUtMS0xLTEtMA_525b463d-a598-4419-96a2-aa6d029741c9">649,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7268a9baa84143e28737ef38b1cfc7a8_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDUtMy0xLTEtMA_1b4b31b4-81f6-44ea-ae01-9d8edde0b248">437,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">End of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDYtMS0xLTEtMA_abc1a436-db6a-4338-adf6-66a52e75d467">617,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6c0821a737d46339e19959fec1fb613_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDYtMy0xLTEtMA_8329b9d1-d5d7-4f5c-95f5-1e5fe1fe01bb">1,015,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUPPLEMENTAL CASH FLOW DISCLOSURES:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDgtMS0xLTEtMA_d322c2f4-2d2d-42b8-89ad-94b773d82052">15,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDgtMy0xLTEtMA_77832153-45f6-4f13-b8f9-511431e02b72">4,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDktMS0xLTEtMA_d8048cdb-54af-41e0-bc7f-1ac84c591002">6,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDktMy0xLTEtMA_5e65c33e-ec60-40e1-b5c9-1767a9624a53">5,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUPPLEMENTAL CASH FLOW DISCLOSURES FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease in accounts payable and accrued liabilities related to fixed assets</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNTEtMS0xLTEtMA_08f8e845-36ce-4597-acb3-127f2888ce6d">7,690</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNTEtMy0xLTEtMA_af57d4ee-a1f3-4d27-a0dd-77c4adebbf86">13,281</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase (decrease) in accounts payable and accrued liabilities related to intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNTItMS0xLTEtMA_10dc5300-60e7-418d-8a53-7f0c38ee5e94">9,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNTItMy0xLTEtMA_cf758706-f992-4a50-8bd9-528addcea960">3,043</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:103%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center;text-indent:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:103%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center;text-indent:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:103%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><div><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(1) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18zNC9mcmFnOjNhNDViOWZkYWM5YjQ2ZDA5YjJjZjkyZjVhYWFmNGQzL3RleHRyZWdpb246M2E0NWI5ZmRhYzliNDZkMDliMmNmOTJmNWFhYWY0ZDNfMTIyMg_e50f818b-9163-4415-abf2-bc296676296f" continuedAt="i099b920b9f4f4861ab47bc2e43f7938c" escape="true">NATURE OF OPERATIONS</ix:nonNumeric></span></div><ix:continuation id="i099b920b9f4f4861ab47bc2e43f7938c"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">BioMarin Pharmaceutical Inc. (the Company) is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions. The Company selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market or offer a significant benefit over existing products. The Company&#8217;s portfolio consists of several commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. Voxzogo (formerly known as vosoritide) was granted marketing approval in the European Union (EU) on August 27, 2021.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company expects to continue to finance future cash needs that exceed its operating activities primarily through its current cash, cash equivalents and investments and through proceeds from debt or equity offerings, commercial borrowing, or through collaborative agreements with corporate partners. If the Company elects to increase its spending on development programs significantly above current long-term plans or enters into potential licenses and other acquisitions of complementary technologies, products or companies, the Company may need additional capital.</span></div></ix:continuation><div><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(2) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:BasisOfAccounting" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18zNy9mcmFnOjk3NWQzMzIyZmE5MDQ5YzNiN2VlMzE2ODY4YzU2ZDQ4L3RleHRyZWdpb246OTc1ZDMzMjJmYTkwNDljM2I3ZWUzMTY4NjhjNTZkNDhfMjcwOA_2d986584-1095-43d8-b605-e14dcce229da" continuedAt="i463e0c01470347fda4d610ccb4677eed" escape="true">BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="i463e0c01470347fda4d610ccb4677eed"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18zNy9mcmFnOjk3NWQzMzIyZmE5MDQ5YzNiN2VlMzE2ODY4YzU2ZDQ4L3RleHRyZWdpb246OTc1ZDMzMjJmYTkwNDljM2I3ZWUzMTY4NjhjNTZkNDhfMjcxMQ_b8fdd6af-ed1f-4b66-a5be-3b76ba4ac8cc" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements have been prepared pursuant to United States generally accepted accounting principles (U.S. GAAP) and the rules and regulations of the Securities and Exchange Commission (the SEC) for Quarterly Reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, although the Company believes that the disclosures herein are adequate to ensure that the information presented is not misleading. The Condensed Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended December&#160;31, 2020 included in the Company&#8217;s Annual Report on Form 10-K. The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions have been eliminated. The results of operations for the three and nine months ended September&#160;30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending December&#160;31, 2021 or any other period.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying disclosures. Although these estimates are based on management&#8217;s best knowledge of current events and actions that the Company may undertake in the future, actual results may be different from those estimates. The Condensed Consolidated Financial Statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair presentation of results for these interim periods. The full extent to which the novel coronavirus (referred to as COVID-19) pandemic could continue to directly or indirectly impact the Company&#8217;s business, results of operations and financial condition, including revenues, expenses, reserves and allowances, manufacturing, clinical trials and research and development costs, will depend on future developments that remain uncertain at this time, particularly as virus variants continue to spread. As events continue to evolve and additional information becomes available, the Company&#8217;s estimates may change materially in future periods.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management performed an evaluation of the Company&#8217;s activities through the date of filing of this Quarterly Report on Form 10-Q, and has concluded that there were no subsequent events or transactions that occurred subsequent to the balance sheet date prior to filing this Quarterly Report on Form 10-Q that would require recognition or disclosure in the Condensed Consolidated Financial Statements.</span></div></ix:continuation><div><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(3) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180MC9mcmFnOjUwZjg1YTBmYjEwYTQ1ZDliNjIxZGJiZDBhZmU3YjRjL3RleHRyZWdpb246NTBmODVhMGZiMTBhNDVkOWI2MjFkYmJkMGFmZTdiNGNfMzYw_976eb767-af2c-4b76-a079-bab9adc40c63" continuedAt="ia10948933ae2448e8a0f353e43f7d6af" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><ix:continuation id="ia10948933ae2448e8a0f353e43f7d6af"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no material changes to the Company&#8217;s significant accounting policies during the nine months ended September&#160;30, 2021, as compared to the significant accounting policies disclosed in Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(4) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180My9mcmFnOmZkNTQ1NDZkMDRkNTQ5ZTQ5MGY1Mzg0MzI1ODA2ZWExL3RleHRyZWdpb246ZmQ1NDU0NmQwNGQ1NDllNDkwZjUzODQzMjU4MDZlYTFfNDU2_33d2ba06-4ee0-46f3-a34f-e84eba813ae9" continuedAt="i93a56a514ebb47dd8dea4f387794fd94" escape="true">RECENT ACCOUNTING PRONOUNCEMENTS</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i93a56a514ebb47dd8dea4f387794fd94">There have been no new accounting pronouncements adopted by the Company or new accounting pronouncements issued by the Financial Accounting Standards Board during the nine months ended September&#160;30, 2021, as compared to the recent accounting pronouncements described in Note 4 of the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, that the Company believes are of significance or potential significance to the Company.</ix:continuation></span></div><div style="margin-top:6pt;text-indent:36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_46"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(5) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMTM4OQ_8bfa6d8c-7f5b-429e-99da-55784986e350" continuedAt="icc1bbdbd463d4d14960735b7018249a6" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="icc1bbdbd463d4d14960735b7018249a6" continuedAt="i5cc0a6df14884285897f7d671f788049"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities were classified as available-for-sale at September&#160;30, 2021 and December&#160;31, 2020.</span></div><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="bmrn:ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMTM5MA_30251fd6-2b9f-46dc-9d34-805714e0d04f" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s cash, cash equivalents and available-for-sale securities by significant investment category for each period presented:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:20.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.851%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Short-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy0xLTEtMS0w_6c4eeccd-10ee-4c5e-9c80-76826d3848c6">294,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy0zLTEtMS0w_1154ed87-7206-45ef-8874-d7ba1fcee2c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy01LTEtMS0w_cb31cb3c-4356-4071-8e60-6ada2da892f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy03LTEtMS0w_7d56e416-3cd6-4a81-9193-6e1135d9bdc4">294,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy05LTEtMS0w_f6133d2f-9717-4a87-9b1e-cb18663d4d40">294,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy0xMS0xLTEtMA_82889ede-c36b-4543-a7d8-5f235fafc8e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy0xMy0xLTEtMA_6e7aca07-b61d-4a8c-959e-6414c4263402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi0xLTEtMS0w_28ef5d0a-9da1-47e9-b6ef-a169dc8fe8e3">291,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi0zLTEtMS0w_b06f4d1b-9d90-4f2a-b21c-f3b252fee959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi01LTEtMS0w_fbd222d5-c02f-49f7-973f-4aaaf58ade2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi03LTEtMS0w_3b990191-f0d2-4a61-acb9-bd2846120ef9">291,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi05LTEtMS0w_9456caad-1b82-4b08-85ca-0159b6d24f1c">291,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi0xMS0xLTEtMA_37bcd209-1923-447a-af05-8de08c8bcaa4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi0xMy0xLTEtMA_3ef468ca-2347-4005-95af-2c3973a99492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy0xLTEtMS0w_74f8a77f-35c9-4182-942b-af17f90ea48b">560,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy0zLTEtMS0w_df516537-cf30-40b2-aaa7-c183766be6b7">1,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy01LTEtMS0w_b774a08e-a6b4-44d6-b93c-9ed373a2ade0">198</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy03LTEtMS0w_9a6a51d9-8eb8-488e-ad01-6952a25456fe">561,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy05LTEtMS0w_6df2f3fc-ddee-488b-a86e-95287b79faaa">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy0xMS0xLTEtMA_bf842795-cf7f-4129-8476-b54424ad5584">177,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy0xMy0xLTEtMA_fe535943-415b-4479-9c22-29487f9a8f68">382,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bca3ca974d463382d836efec728b90_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC0xLTEtMS0w_b556ca92-07f6-44a5-9b59-a20f4cb5f454">210,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bca3ca974d463382d836efec728b90_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC0zLTEtMS0w_2a4ed63e-413f-4f6a-8ef4-3ca615ee546e">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2bca3ca974d463382d836efec728b90_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC01LTEtMS0w_819ca301-a62b-48f5-b98f-96ae7209f328">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bca3ca974d463382d836efec728b90_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC03LTEtMS0w_ddf42b2c-1a01-4cc2-a562-a1bde49911a1">210,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bca3ca974d463382d836efec728b90_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC05LTEtMS0w_34d13fc8-69f1-483d-b4a0-88a45eab7fc6">12,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bca3ca974d463382d836efec728b90_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC0xMS0xLTEtMA_bd256efd-147a-4278-8752-2951b36f3ff2">161,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bca3ca974d463382d836efec728b90_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC0xMy0xLTEtMA_7d9ceb9d-01ee-4863-8acb-20dff30c3371">36,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS0xLTEtMS0w_989ad440-08f4-433c-bfb0-781123872328">129,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS0zLTEtMS0w_3cc2809f-a342-4c1a-96f1-25239ff8e20f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS01LTEtMS0w_39b35d9c-508e-44d2-9059-d488c13323ef">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS03LTEtMS0w_3fa9a06f-070c-4d4f-b009-9e4a08ea1121">129,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS05LTEtMS0w_3fb129f4-25de-46aa-b2e1-e2b4eb539da2">17,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS0xMS0xLTEtMA_aead4f3e-2fde-4258-a824-ebfc12ac25ac">112,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS0xMy0xLTEtMA_94b65ea5-432a-46bf-8d46-537413febba1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtMS0xLTEtMA_595bc127-0257-4a46-9e1f-86be7655a85e">55,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtMy0xLTEtMA_79a7eccd-a6ce-4c74-b4cb-6837c98e33bd">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtNS0xLTEtMA_1e256bea-cb65-48cc-88cc-6f99d9c5e0bc">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtNy0xLTEtMA_593030da-b60a-4bd9-933c-8f1a39938917">55,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtOS0xLTEtMA_d4087c48-06bc-4286-aeee-0ecc372f7473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtMTEtMS0xLTA_8702bf29-dd70-4e3d-81f1-e031abd91526">8,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtMTMtMS0xLTA_9b1a8adb-2b43-4e12-bb63-24012f399d75">46,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtMS0xLTEtMA_f1c1350e-1e88-4980-9839-ca1e05c45e1c">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtMy0xLTEtMA_a274defd-15f8-4c75-9c13-2b38c42a1927">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtNS0xLTEtMA_eedcb849-84c2-45d9-bd9a-0a51fae0974d">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtNy0xLTEtMA_7c5b5d9b-92cc-4316-89e4-4d9910a34580">3,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtOS0xLTEtMA_95c4d562-0c9a-4350-9abd-cd6a7b5ef410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtMTEtMS0xLTA_c722a98f-81ba-4f82-99b8-7f66c106ab7d">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtMTMtMS0xLTA_26c529eb-1ff6-43f5-ab57-0bf4c0eb6d99">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItMS0xLTEtMA_7a53ea46-40fc-449d-95fc-2e40e5641b4b">1,250,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItMy0xLTEtMA_6a7e1143-2959-4db6-97f5-f2db7d1182a4">1,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItNS0xLTEtMA_e273dddc-39b2-4755-8f8f-3a2bdea86202">235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItNy0xLTEtMA_36e5bd83-da83-4100-9b7a-8dc29c1ab102">1,251,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItOS0xLTEtMA_42ec599c-f1db-49e0-81e9-8d5499486c0e">322,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItMTEtMS0xLTA_242202ac-bafa-4240-b071-a542ad3fedd2">462,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItMTMtMS0xLTA_4223f894-cbab-477f-9673-c50364c304b9">466,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtMS0xLTEtMA_e11c20b5-a0e5-4705-a1ff-20868c049dc0">1,544,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtMy0xLTEtMA_baf638cc-cfd0-4335-83b8-ca8a25187aee">1,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtNS0xLTEtMA_04c94dcb-aecc-4ad9-9b75-5349fe957f07">235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtNy0xLTEtMA_7068bfe8-d595-4ea4-b680-5130baf3e662">1,546,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtOS0xLTEtMA_337f1fc6-7f32-453c-a7c3-624b47238cd2">617,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtMTEtMS0xLTA_685c553e-63d0-42b7-8ae4-81f56424584b">462,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtMTMtMS0xLTA_13452680-9612-4556-a7c9-8fa04caeb1ef">466,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:20.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.851%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Short-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy0xLTEtMS0w_0233fd25-eb79-48b8-88fa-18ad4740c6cd">370,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy0zLTEtMS0w_6490935e-99df-4c61-bfbc-e5bcea805715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy01LTEtMS0w_534175dc-b4e7-411a-a896-b6169019cead">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy03LTEtMS0w_ff5e5d2c-374a-4e2f-8969-7b4a141556bf">370,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy05LTEtMS0w_88548675-d721-43b0-b0f4-75c2a6c0bfc5">370,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy0xMS0xLTEtMA_82c8624f-6acd-4ce2-bd4a-445755cf41c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy0xMy0xLTEtMA_6e6d60fa-0f65-4e9c-8ef9-49dd77a3cdf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi0xLTEtMS0w_12af5fa7-642e-4ee4-8091-25ea902b1ff8">264,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi0zLTEtMS0w_9c30b2a2-ff01-444d-8bee-3785df635a82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi01LTEtMS0w_470009ca-5e9d-4238-b247-6d1f7d89dd20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi03LTEtMS0w_89505106-ce5a-43d3-9bec-836db98ae66c">264,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi05LTEtMS0w_f81dfb50-124b-4418-92b5-95090762d205">264,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi0xMS0xLTEtMA_b64c6d71-d0d9-4229-bb29-3ad5303ded32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi0xMy0xLTEtMA_7837766f-2a3c-4397-a414-1102ad814d53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488ef63d388c46e596c31f59acedb699_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy0xLTEtMS0w_7e1ead5d-05a9-4053-a598-9c4aa14be79e">413,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488ef63d388c46e596c31f59acedb699_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy0zLTEtMS0w_5c0a236c-5316-479f-b302-98882e474796">3,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488ef63d388c46e596c31f59acedb699_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy01LTEtMS0w_a5305b24-c50d-4f97-902c-a2daf2c008e6">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488ef63d388c46e596c31f59acedb699_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy03LTEtMS0w_3fd8508f-4e72-4956-bbff-fcfa3d2500e4">416,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488ef63d388c46e596c31f59acedb699_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy05LTEtMS0w_12e527cc-5495-4ad8-b37e-735fc3abebdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488ef63d388c46e596c31f59acedb699_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy0xMS0xLTEtMA_e9bb92d3-43a7-46d9-8605-b6d9783f8324">220,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488ef63d388c46e596c31f59acedb699_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy0xMy0xLTEtMA_9b1a59b5-37d1-40f3-9e2c-76f5aa986b34">195,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS0xLTEtMS0w_60f9e24b-03e8-492e-8bfa-779c7e8c0963">265,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS0zLTEtMS0w_0d5113b7-ae34-48b5-b318-77484a98258e">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS01LTEtMS0w_d2f448f2-a283-415e-84ad-172d13372a8f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS03LTEtMS0w_21bfc741-b852-495d-b5d6-4f8d752f5acd">266,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS05LTEtMS0w_4560e25e-3ff5-4258-9f96-bc6790b4b264">14,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS0xMS0xLTEtMA_b1e9a6a8-b2de-4ea8-b4a1-dce9867592c6">192,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS0xMy0xLTEtMA_d76b0e4e-c400-492f-bddc-f763f936b806">60,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtMS0xLTEtMA_3832fbf3-f4fc-427d-a326-c449f2c414cd">31,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtMy0xLTEtMA_7ff718b9-8d75-429d-a4ea-c73f8f6b8a60">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtNS0xLTEtMA_1b8be465-ca1b-4a21-ac7b-3d424ac45596">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtNy0xLTEtMA_025d701a-ee0d-41f9-a522-bfc3c139eb03">31,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtOS0xLTEtMA_1fc0ffc1-4a0f-4c59-81ba-f6352f0fc298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtMTEtMS0xLTA_c004be35-fc63-420b-bac4-263da19ecc20">3,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtMTMtMS0xLTA_e0730e13-27f6-4b82-a23a-f0b7266ccab1">28,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162aeed19afc494baff177a2e9200423_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtMS0xLTEtMA_0818149e-3432-482b-a306-ace829c5f2a0">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162aeed19afc494baff177a2e9200423_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtMy0xLTEtMA_7a569dc9-892a-4a6a-8a3b-14660a030259">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162aeed19afc494baff177a2e9200423_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtNS0xLTEtMA_d9a1f0ef-74ff-400b-b14e-f85a0f7df825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162aeed19afc494baff177a2e9200423_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtNy0xLTEtMA_bf876f17-20a6-47b1-baf9-61cd362f69a6">717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162aeed19afc494baff177a2e9200423_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtOS0xLTEtMA_078e8b03-694e-4fdd-b7f7-409fd580bf01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162aeed19afc494baff177a2e9200423_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtMTEtMS0xLTA_39660b7c-fcf4-45a9-ae8b-a858c17f7291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162aeed19afc494baff177a2e9200423_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtMTMtMS0xLTA_92c94fcd-af57-4d9d-9b37-1c07619b0915">717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItMS0xLTEtMA_b62c1e37-79c5-4611-89e3-939837a1ab95">975,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItMy0xLTEtMA_fb9c7272-af07-4126-8b0c-059567a71c48">5,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItNS0xLTEtMA_ce1d1053-6f70-460a-8e1a-01e91cb2ad4e">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItNy0xLTEtMA_f3502d77-15bf-4fd8-894a-0a3b5b812aa5">980,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItOS0xLTEtMA_2968c50d-754b-4b60-a2a1-6f010674fca7">278,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItMTEtMS0xLTA_363c479c-2d1e-474e-a102-c4048f233413">416,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItMTMtMS0xLTA_939eae97-9a01-429b-b425-0d2e54d03936">285,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtMS0xLTEtMA_cf7075ee-bfbb-4bc2-ae36-469bda444b57">1,345,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtMy0xLTEtMA_4a5e28d8-dcd7-4d8e-b027-92752a1076a1">5,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtNS0xLTEtMA_1f9755bf-c531-418a-88cc-47c912379c88">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtNy0xLTEtMA_232bdc22-b492-48d2-b477-dd046c0d7682">1,350,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtOS0xLTEtMA_059a33fa-758e-4220-946c-69d4d9c6e57b">649,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtMTEtMS0xLTA_4dc7b79e-95ca-4721-8cd8-14a3aab684f2">416,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtMTMtMS0xLTA_88cb2411-f76f-4d25-ab47-aaa1e3a9c43a">285,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Company&#8217;s short-term marketable securities mature in <ix:nonNumeric contextRef="ib0773e69a8654dc28600db905fe0c0c1_D20200101-20201231" format="ixt-sec:durwordsen" name="bmrn:ShortTermMarketableSecuritiesMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMzMz_2677288f-9ab8-4d2d-b72e-4b5274b4cb2b"><ix:nonNumeric contextRef="i006e8ae23bc74eac869d8244cb0ea0e0_D20210101-20210930" format="ixt-sec:durwordsen" name="bmrn:ShortTermMarketableSecuritiesMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMzMz_bc7eabe4-ee53-4fc9-af85-d319fd5749e1">one year</ix:nonNumeric></ix:nonNumeric> or less.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The Company&#8217;s long-term marketable securities mature between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_846ad3c9-24f9-4d1a-9f5f-7c49adee4aad"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_a635e30b-c744-47ea-a80a-981c71554d83">one</span></span> and <ix:nonNumeric contextRef="i006e8ae23bc74eac869d8244cb0ea0e0_D20210101-20210930" format="ixt-sec:durwordsen" name="bmrn:LongTermMarketableSecuritiesMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDE3_29520578-063e-4af9-b628-3591b00c012a"><ix:nonNumeric contextRef="ib0773e69a8654dc28600db905fe0c0c1_D20200101-20201231" format="ixt-sec:durwordsen" name="bmrn:LongTermMarketableSecuritiesMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDE3_f22d2fb7-412c-4549-91e6-138f5b8b793d">five years</ix:nonNumeric></ix:nonNumeric>.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company had the ability and intent to hold all investments that were in an unrealized loss position until maturity. The Company considered its intent and ability to hold the securities until recovery of amortized cost basis, the extent to which fair value is less than amortized cost basis, conditions specifically related to the security&#8217;s industry and geography, payment structure and history and changes to the ratings (if any) in determining that the decline in fair value compared to carrying value is not related to a credit loss.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has certain investments in non-marketable equity securities, measured using unobservable valuation inputs and remeasured on a nonrecurring basis, which are collectively considered strategic investments. As of September&#160;30, 2021 and </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i5cc0a6df14884285897f7d671f788049">December&#160;31, 2020, the fair value of the Company&#8217;s strategic investments was $<ix:nonFraction unitRef="usd" contextRef="i00b5b9602a84434ca20f4f840240bef5_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMTI1OA_60a056f4-156f-4a17-944d-1035b56fc224">16.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i91df24e30587451888b969c1c50cf8b1_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMTI2NQ_9084f08e-691e-4849-9f23-8b2fcb7073c1">10.5</ix:nonFraction> million, respectively. These investments were recorded in Other Assets in the Company&#8217;s Condensed Consolidated Balance Sheets.</ix:continuation> </span></div><div style="margin-top:12pt;text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(6) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1Nw_2c7abd9a-97c2-4662-8b58-266be67e4d89" continuedAt="ia2274d9d6b854fd09af546bfa14bc225" escape="true">SUPPLEMENTAL BALANCE SHEET INFORMATION</ix:nonNumeric></span></div><ix:continuation id="ia2274d9d6b854fd09af546bfa14bc225" continuedAt="ia6762b25ee4845748fd9364339ad2398"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1MQ_fe9ad556-98e8-41bf-8db1-138170a865db" escape="true"><div style="margin-bottom:12pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventory consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMS0xLTEtMS0w_8f0a4c2c-edd4-40f7-bd67-a95221bc868f">75,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMS0zLTEtMS0w_e5c3b21d-5c03-496b-a9b9-27dc60c201e2">76,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMi0xLTEtMS0w_331179ab-f990-4f27-a146-415c64aa2538">412,434</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMi0zLTEtMS0w_c026db11-9738-4a8b-9de4-8200a4b57b27">308,286</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMy0xLTEtMS0w_1287bbd9-f989-4a52-9c64-9bf669bd2de6">261,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMy0zLTEtMS0w_4eac469a-fdf1-4bae-8be0-b3c7a68bace6">313,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfNC0xLTEtMS0w_acd2a44d-e4b9-417c-bb6c-dc5cca310bc8">749,406</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfNC0zLTEtMS0w_9c6e45e0-47e0-4c27-9898-96570e601451">698,548</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventory as of September&#160;30, 2021 included $<ix:nonFraction unitRef="usd" contextRef="ib7c76bf362194f4c9c4a2b8976accd00_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTA0NDUzNjA0NzczNzA_e358aa58-26c4-4a65-8036-6e22adf0fa66">4.8</ix:nonFraction> million of Voxzogo pre-launch manufacturing-related costs incurred during the third quarter of 2021 that are intended for the U.S. Voxzogo, which was granted marketing approval in the EU on August 27, 2021, is still a product candidate in other regions, including the U.S., for the treatment of achondroplasia in children, the most common form of disproportionate short stature in humans. The Company must receive marketing approval from the U.S. Food and Drug Administration (FDA) before the Voxzogo inventory can be sold commercially in the U.S. Starting in 2021, the Company believed that material uncertainties related to the ultimate regulatory approval of Voxzogo had been significantly reduced. A number of factors were taken into consideration, including the current status in the drug development process, pivotal clinical trial results for the underlying product candidate, results from meetings with the relevant regulatory authorities, historical experience, as well as potential impediments to the approval process such as product safety or efficacy, as well as commercialization and marketplace trends.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020 for additional information related to the Company&#8217;s policies on inventory produced prior to regulatory approval.</span></div><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1Ng_6e7c0d95-ebde-4669-a58a-3bc7a9c6bb77" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, Plant and Equipment, Net consisted of the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, gross</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMS0xLTEtMS0w_c2796d65-db27-45b3-8a03-1a0c9e1ca109">1,724,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMS0zLTEtMS0w_8bd646e3-ef55-4e0a-a395-3f810505af36">1,668,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMi0xLTEtMS0w_9a2905a6-5365-42fc-93d2-41acedd714e0">699,915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMi0zLTEtMS0w_730d9c7d-d292-4c8d-b968-b94ce5b3b3a8">635,595</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMy0xLTEtMS0w_32312f5d-074e-4d78-b5f8-8a7124e9fd6e">1,024,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMy0zLTEtMS0w_71120d1d-8f01-4f93-9cb5-3036559dfacb">1,032,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:1pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation expense, net of amounts capitalized into inventory, for the three and nine months ended September&#160;30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTU3NA_da624f96-df3f-4581-bf45-8df032a63f98">11.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTU4MQ_71bc878d-6171-46da-a516-b5a880c101fd">35.7</ix:nonFraction> million, respectively. Depreciation expense, net of amounts capitalized into inventory, for the three and nine months ended September&#160;30, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTcwMg_65a80fa4-81a5-4138-9f28-e6ee80ce5c9a">11.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTcwOQ_95bfa2cc-f103-403d-ac9a-5e6c1c6ac80a">31.1</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1Mg_e7689a2c-6bac-47d1-ac3a-3aa9726397ef" continuedAt="i81aed33225684419a7636456d4d89d43" escape="true">Intangible Assets, Net consisted of the following:</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i81aed33225684419a7636456d4d89d43"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finite-lived intangible assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMS0xLTEtMS0w_980de1fa-9f0c-4431-9c00-755059979029">661,781</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMS0zLTEtMS0w_eac94ee3-7c94-4ae0-adca-f21da31be296">644,087</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMi0xLTEtMS0w_fbe2cdd6-63b4-43f1-a63f-2544cd6bc5d2">273,294</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMi0zLTEtMS0w_77e64e27-fb23-41e2-b84e-9efb9935d736">226,816</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying value</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMy0xLTEtMS0w_cfe23456-1665-4593-9ada-6ee28fcd210a">388,487</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMy0zLTEtMS0w_55dde98a-aaa9-4283-a0a5-4cb79172c6cf">417,271</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><ix:continuation id="ia6762b25ee4845748fd9364339ad2398"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1Mw_407fcd19-0a48-40d5-aa74-bcf74a4ccb7b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts Payable and Accrued Liabilities consisted of the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMS0xLTEtMS0w_d3001fdd-9986-4b8f-b032-efa148bf09ac">203,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMS0zLTEtMS0w_3b80d4ba-07f8-4bdf-ba26-124ac125c67e">191,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMi0xLTEtMS0w_8f680079-c0a5-4f86-8309-7830ddc08aac">158,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMi0zLTEtMS0w_109b4572-c18e-4bcb-acfa-9a59bc3d6df3">165,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued rebates payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:AccruedGovernmentAndOtherRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMy0xLTEtMS0w_c3d87101-b0ea-4044-b50b-9263b82571e6">68,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:AccruedGovernmentAndOtherRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMy0zLTEtMS0w_0181e83a-867d-488d-b193-0f49022d0aed">65,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued royalties payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNC0xLTEtMS0w_5b12e60c-eebf-4bb4-9f10-bd4733b7cfeb">14,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNC0zLTEtMS0w_41cba6a3-edd7-476e-b24f-24b8d9d082b0">17,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNi0xLTEtMS0w_18019f76-b141-432f-8aa8-acf20da425e3">9,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNi0zLTEtMS0w_5db86edb-3268-4255-91af-960cac91b06f">11,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward foreign currency exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNS0xLTEtMS0w_1239b45a-87c4-4e0b-97dd-da6474025133">5,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNS0zLTEtMS0w_78b96de4-3af7-4dc4-8ed5-f7ed511a272e">17,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value added taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNy0xLTEtMS0w_d7d15e6c-1327-4305-bf20-067492025c4d">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNy0zLTEtMS0w_fa170cea-0f7a-4bbf-bee7-483c839c4279">9,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" name="us-gaap:AccruedIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfOC0xLTEtMS0w_393a0e11-1e09-4405-b980-f366deb797f9">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfOC0zLTEtMS0w_269d180f-7263-43b5-8dfc-487b70b0bc5e">9,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfOS0xLTEtMS0w_6f5ccccb-6a19-41fa-8d16-9e02d2d19da0">5,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfOS0zLTEtMS0w_9e4ebc5c-9671-467b-89a4-446728b52539">4,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMTAtMS0xLTEtMA_02627ae8-fc1e-4f04-a0b6-d561f78c4fe4">466,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMTAtMy0xLTEtMA_2f00bdcc-9d02-4dbc-b7b3-053b5ad5e949">492,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(7) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfMTE5Mg_de48f9e4-ac3c-4759-9cb9-d71071c7e8e7" continuedAt="if3412382fca44ff988dd3123352a8345" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="if3412382fca44ff988dd3123352a8345" continuedAt="ibc2a695656ae40e5bb1096aede094c91"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value in accordance with the policy described in Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfMTE4NQ_f6da709b-2af6-455c-ba43-27e25071e0b0" continuedAt="if28aef9b080643bfba78ff100ad797b2" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables present the classification within the fair value hierarchy of financial assets and liabilities not disclosed elsewhere in these Condensed Consolidated Financial Statements that are remeasured on a recurring basis as of September&#160;30, 2021 and December&#160;31, 2020.&#160;Other than the Company&#8217;s fixed-rate convertible debt disclosed in Note 9 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, there were <ix:nonFraction unitRef="usd" contextRef="i90bb59f2a5034770af163bb6ee32ed42_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfNjIz_0264608c-16ec-482e-a04e-63809c787672"><ix:nonFraction unitRef="usd" contextRef="i66dbe62d10fc46af9552314aa77c1455_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfNjIz_add938db-e823-43eb-8d69-046ebba36f46"><ix:nonFraction unitRef="usd" contextRef="i66dbe62d10fc46af9552314aa77c1455_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfNjIz_c4f03a11-3a2f-43a9-beba-576db7913410"><ix:nonFraction unitRef="usd" contextRef="i90bb59f2a5034770af163bb6ee32ed42_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfNjIz_e9e3db0f-9642-4b9b-873d-b840effa8e2f">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> financial assets or liabilities that were remeasured using a quoted price in active markets for identical assets (Level 1) as of September&#160;30, 2021 or December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements as of September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant&#160;Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa92d196dfad4856ba23ebe72dc99f42_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNC0yLTEtMS0w_22d5c860-f5be-4083-815f-5031e8a54e11">2,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd9d72b38ed4e9ab14a43d4125dd712_I20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherAssetsCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNC00LTEtMS0w_838bec18-b5b6-4d4c-b65d-3379ab7ec579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702edec792f8459193e0e7428f963179_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNC02LTEtMS0w_bde1d914-473e-49ed-b2ed-e3357238783a">2,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa92d196dfad4856ba23ebe72dc99f42_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNy0yLTEtMS0w_8c76ef7c-e3df-49f2-a510-57a3a1b3edb1">22,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd9d72b38ed4e9ab14a43d4125dd712_I20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNy00LTEtMS0w_1c636831-b9cb-44ae-8985-17bf76bc3d48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702edec792f8459193e0e7428f963179_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNy02LTEtMS0w_5b801bf5-c755-4480-850d-9661e6ef6285">22,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eac74c17ffb48aaa66512c312d26ffc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOC0yLTEtMS0w_97d371e5-4986-411a-8116-c41cd75deb11">2,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if941c596ef754cf388dd3fe27f85f62f_I20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOC00LTEtMS0w_c9daa615-c956-4c74-983f-aec2dff8cb44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if961eb44a8474191b0fe4f51e700bec0_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOC02LTEtMS0w_7019d577-57f1-4c28-a394-fac1d0b1985a">2,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id075d2f472a347109be07404276f404d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOS0yLTEtMS0w_e89cca5a-707e-4743-aee8-95e8e2429bae">25,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOS00LTEtMS0w_aa791181-9db7-4f89-b9b2-47cf37b5e102">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOS02LTEtMS0w_f9c07add-c327-45e8-84f8-da54b5ba19ba">25,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id075d2f472a347109be07404276f404d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTAtMi0xLTEtMA_e1622cda-5be9-4b07-90b8-adbccf617594">27,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTAtNC0xLTEtMA_0f682f05-b25f-4d0b-9f18-d0c7b69b8921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTAtNi0xLTEtMA_0e567090-a39e-4a27-b7b3-315908823d05">27,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c71299431fd4b1d9395950472c5dd54_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTMtMi0xLTEtMA_68b3b6d5-e32f-4ea2-b9af-861753c5a4bf">2,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9c820d5a2d477c8a45f38d368f4ad4_I20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTMtNC0xLTEtMA_8c6178bd-dbb7-4a56-ba01-71e215950d3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf21895256243eba4baadc21bba8dfd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTMtNi0xLTEtMA_fd9b5496-e9ba-45da-bb17-f5e851117d0d">2,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a690d1f00e43688891861ad4caf2bb_I20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTQtMi0xLTEtMA_44893cb1-4556-46ab-95b5-3701ded6c57d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i120bad79c9cf44618fab7a064046a548_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTQtNC0xLTEtMA_835c60ae-9946-400a-b9e7-1285c023d439">48,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a982d145fec445ab50db51d29d51ec4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTQtNi0xLTEtMA_2fac3e80-429f-4046-9a80-70af8c445c3f">48,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id075d2f472a347109be07404276f404d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTUtMi0xLTEtMA_340ec48d-4746-4049-899f-dcf21c88ce39">2,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTUtNC0xLTEtMA_f61397d0-e09e-4bbc-85ee-0a60dcc59f86">48,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTUtNi0xLTEtMA_481d349a-f4a9-422c-b6ca-65ff5a51ec0f">50,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c71299431fd4b1d9395950472c5dd54_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTctMi0xLTEtMA_d4c0708d-0e91-411e-954a-1cf8c5e4db47">22,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9c820d5a2d477c8a45f38d368f4ad4_I20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTctNC0xLTEtMA_40491300-26ef-4b38-981b-fbaa716d14cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf21895256243eba4baadc21bba8dfd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTctNi0xLTEtMA_73a97073-c624-405c-8eb9-9511b3da2d6f">22,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a690d1f00e43688891861ad4caf2bb_I20210930" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTgtMi0xLTEtMA_9a5c41f4-d050-4d5c-a8e1-9b50daff9e22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i120bad79c9cf44618fab7a064046a548_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTgtNC0xLTEtMA_bec3ec8d-c218-43d7-b825-1d7e3ebaba9c">15,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a982d145fec445ab50db51d29d51ec4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTgtNi0xLTEtMA_08fa7123-b254-4a9b-bcd7-143d7ea02e54">15,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id075d2f472a347109be07404276f404d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTktMi0xLTEtMA_76845012-00e5-4f0a-a06f-d50c5531d04e">22,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTktNC0xLTEtMA_01064d20-46b2-4459-902e-6eab337bcb77">15,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTktNi0xLTEtMA_10acac83-2eb7-4462-ac8d-fbcc53b21848">37,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id075d2f472a347109be07404276f404d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMjAtMi0xLTEtMA_f6a05980-1cf0-4ecd-bda5-c709acbf2979">24,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMjAtNC0xLTEtMA_d23aca56-fc62-418b-bc4c-3657f371118a">63,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMjAtNi0xLTEtMA_9be3e342-bef5-4528-8b93-7cd14a8464cc">88,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><ix:continuation id="ibc2a695656ae40e5bb1096aede094c91"><ix:continuation id="if28aef9b080643bfba78ff100ad797b2"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.917%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant&#160;Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4853afdcb6b3425eade1470b05d78550_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfNC0zLTEtMS0w_3e289e8f-e547-4c87-80e7-58fe8fd26893">2,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d0caf2974040c1832284f6ac9f30c9_I20201231" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherAssetsCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfNC01LTEtMS0w_7975f3ba-6b0f-4fc5-819d-44786c6c046b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48430041f0f14488a182cdf2a6fba1ea_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfNC03LTEtMS0w_6dae20c6-2d81-4319-a390-f388db8cccd7">2,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4853afdcb6b3425eade1470b05d78550_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOC0zLTEtMS0w_7bd6cae6-6390-40b7-acdd-e5fae6b22c44">19,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d0caf2974040c1832284f6ac9f30c9_I20201231" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOC01LTEtMS0w_6ad3aea9-c05f-4870-ac99-9173ccd95f30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48430041f0f14488a182cdf2a6fba1ea_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOC03LTEtMS0w_2ea9167d-8528-4de0-b99c-34a7dfc1aafb">19,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf61805c0d2a4049b81025cec2ddb75a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOS0zLTEtMS0w_c5f2ec1e-f7b3-4eb4-8221-32b20465d319">4,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1deec9d3e3eb4a42adefe62e56bfd128_I20201231" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOS01LTEtMS0w_f2b405f3-2b24-43a5-b224-ae1809bb2d88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c1a81b9cccd4a1cba5fc0003b7aea8f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOS03LTEtMS0w_b97d85b8-1c83-423a-9336-3a8d9745b88d">4,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4efa93be091e41e2a53f2f9cfc80f758_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTEtMy0xLTEtMA_86e1ad60-4203-4858-aad1-f6822dcf0fcd">24,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671e3945deec4183bb208f00b654f148_I20201231" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTEtNS0xLTEtMA_dc938788-7adf-4a81-a71a-ff0faf9237e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29763c9514834fa79c4c3fc2e884e8dd_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherAssetsNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTEtNy0xLTEtMA_338e2897-44dc-435e-be99-c0d1a90b04d6">24,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4efa93be091e41e2a53f2f9cfc80f758_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTItMy0xLTEtMA_d5e4862c-105d-4928-ae25-58b47fe53774">26,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671e3945deec4183bb208f00b654f148_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTItNS0xLTEtMA_7be11e6e-6e81-4a03-808d-4978065bc7dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29763c9514834fa79c4c3fc2e884e8dd_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTItNy0xLTEtMA_40a5d563-b396-4eb6-b7d4-6c66206b2468">26,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357642068229410d9b9eb92835bff095_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTUtMy0xLTEtMA_167b2e89-79cd-4ebc-953a-059db75efecf">2,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7e416850cb47f6aefc2fb4df37b5f0_I20201231" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTUtNS0xLTEtMA_7752412d-5d8f-446f-9747-fb013f85dbd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27816fb13254b9694f700f40dbdbbff_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesCurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTUtNy0xLTEtMA_ef4d36ad-da47-4894-9198-6f2787c46d81">2,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357642068229410d9b9eb92835bff095_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTktMy0xLTEtMA_b5f605d5-ebfe-4237-ae1d-45591a1b519f">19,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7e416850cb47f6aefc2fb4df37b5f0_I20201231" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTktNS0xLTEtMA_ee1650d0-e1d1-4931-a643-499b9d002fe7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27816fb13254b9694f700f40dbdbbff_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTktNy0xLTEtMA_af89d82f-114d-484f-a18f-c0a7f0178b2a">19,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5add67eb11e7443caf320c8d4619f132_I20201231" decimals="-3" format="ixt:fixed-zero" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjAtMy0xLTEtMA_a395b517-2e2c-4317-a6bd-9e0e6d417ae8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33751b4c2ccd47d3bf56b6c79e05210a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjAtNS0xLTEtMA_9a3498e3-c779-486a-9493-073f8f1a02bc">60,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c8d2de98a23439b8a9c5086c8a66fc1_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjAtNy0xLTEtMA_61fe4791-ab5b-4988-95e4-debf9b716bf8">60,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4efa93be091e41e2a53f2f9cfc80f758_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjEtMy0xLTEtMA_2e225846-1649-40aa-99eb-8b7414c271c5">19,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671e3945deec4183bb208f00b654f148_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjEtNS0xLTEtMA_ce9bf3ce-e2fe-4cc0-a99d-492823a670d6">60,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29763c9514834fa79c4c3fc2e884e8dd_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjEtNy0xLTEtMA_600301bd-50aa-4765-b34c-51fba03969ee">80,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4efa93be091e41e2a53f2f9cfc80f758_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjItMy0xLTEtMA_57ec63fb-e17c-4c39-83e6-a3fcf95fd195">22,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671e3945deec4183bb208f00b654f148_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjItNS0xLTEtMA_2a32ca27-fdf0-4c66-b9ce-c194697a6a5b">60,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29763c9514834fa79c4c3fc2e884e8dd_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjItNy0xLTEtMA_46411722-b6df-421a-8504-c8484925da7d">82,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The restricted investments at September&#160;30, 2021 and December&#160;31, 2020 secure the Company's irrevocable standby letters of credit obtained in connection with certain commercial agreements.</span></div></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no transfers between levels during the three and nine months ended September&#160;30, 2021.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfMTE4Ng_b3ad6b20-6b42-4732-82ca-87ca0cccd162" continuedAt="iab0a8b9121584481afcd137b3d2325d8" escape="true">Liabilities measured at fair value using Level 3 inputs primarily consisted of contingent consideration. The following tables represent a roll-forward of contingent consideration.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div><ix:continuation id="iab0a8b9121584481afcd137b3d2325d8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615edf13dd9645ddb17b1b2bd0c8b9e1_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmRkZTQwNGRlODA0NTQ5Y2NhNmMzM2YxODRlNmE4M2YzL3RhYmxlcmFuZ2U6ZGRlNDA0ZGU4MDQ1NDljY2E2YzMzZjE4NGU2YTgzZjNfMC0xLTEtMS0w_a67822b7-33fc-4f03-b3d6-b225e61f1239">60,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8fcd6f6536d4855824ff24db3d6b5c7_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmRkZTQwNGRlODA0NTQ5Y2NhNmMzM2YxODRlNmE4M2YzL3RhYmxlcmFuZ2U6ZGRlNDA0ZGU4MDQ1NDljY2E2YzMzZjE4NGU2YTgzZjNfMS0xLTEtMS0w_45f76e93-3966-4e53-9876-19e177a6fe72">6,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange remeasurement of Euro denominated contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8fcd6f6536d4855824ff24db3d6b5c7_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="bmrn:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmRkZTQwNGRlODA0NTQ5Y2NhNmMzM2YxODRlNmE4M2YzL3RhYmxlcmFuZ2U6ZGRlNDA0ZGU4MDQ1NDljY2E2YzMzZjE4NGU2YTgzZjNfMi0xLTEtMS0w_47412fac-d540-4d08-a55b-ed1d0f33028a">2,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie591deab87f84651a1f0e8a8b378340d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmRkZTQwNGRlODA0NTQ5Y2NhNmMzM2YxODRlNmE4M2YzL3RhYmxlcmFuZ2U6ZGRlNDA0ZGU4MDQ1NDljY2E2YzMzZjE4NGU2YTgzZjNfMy0xLTEtMS0w_7c4f8029-f78d-49ad-a2a5-d38ba5c53e8e">63,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div id="i37555ce43f7244d3afa231a2a50e7423_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(8) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMjIzMg_d495bc05-4c8a-400b-a654-3e3fa299f764" continuedAt="i6b744aff0f1e4d40959ee96d43d151e9" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES</ix:nonNumeric></span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i6b744aff0f1e4d40959ee96d43d151e9" continuedAt="i8455d3bed3b94ea8b8620d946840dd72">The Company uses foreign currency exchange forward contracts (forward contracts) to protect against the reduction in value of forecasted foreign currency cash flows resulting from product revenues, royalty revenues and operating expenses denominated in currencies other than the U.S. Dollar (USD), primarily the Euro. Certain of these forward contracts are designated as cash flows hedges and have maturities of up to <ix:nonNumeric contextRef="i14bf2ac4d92840cb8a1f7aae38462abd_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:DerivativeRemainingMaturity1" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMzI5ODUzNDg4NTYxOQ_c1bc60e7-2274-488b-8979-fbde72735f22">two years</ix:nonNumeric>. The Company also enters into forward contracts to manage foreign exchange risk related to asset or liability positions denominated in currencies other than USD. Such forward contracts are considered to be economic hedges, are not designated as hedging instruments and have maturities of up to <ix:nonNumeric contextRef="id61c318f76764a7fa034c58b06aedb1b_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:DerivativeRemainingMaturity1" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfNzky_015ef936-b5e2-4c1c-9d6d-9edf259cbfda">three months</ix:nonNumeric>. The Company does not use derivative instruments for speculative trading purposes. The Company is exposed to counterparty credit risk on its derivatives. The Company has established and maintains strict counterparty credit guidelines and enters into hedging </ix:continuation></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><ix:continuation id="i8455d3bed3b94ea8b8620d946840dd72" continuedAt="i291aba72b2e24fc2ab62039ce9979aef"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">agreements with financial institutions that are investment grade or better to minimize the Company&#8217;s exposure to potential defaults. The Company is not required to pledge collateral under these agreements.</span></div><ix:nonNumeric contextRef="i14bf2ac4d92840cb8a1f7aae38462abd_D20210101-20210930" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMjIzMw_9c1a2466-18f4-456d-b745-c8627ae7d92c" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the aggregate notional amounts for the Company&#8217;s derivatives outstanding as of the periods presented.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sell</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i801ae299848e42d9a8bba895edfc93ae_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfMi0xLTEtMS0w_5857ef05-304d-4ceb-b9f4-aa119a56fb7c">654,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4255a1344130421b867098a0db4b4234_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfMi0zLTEtMS0w_e068eef4-0d91-4568-8621-b14ec865ab3b">782,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3b9c04057d24a85901bdc543d7f5881_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfMy0xLTEtMS0w_860da84f-2d4c-4ca3-b0ad-c170987d22de">168,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8911e37b2bf14742badb679e3603864b_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfMy0zLTEtMS0w_9c7c8c8b-a7a2-4da2-8651-2992b34e5f42">189,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sell</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c536cb7054e4cb6b74a31bf41dbf674_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfNi0xLTEtMS0w_6bf13c38-4931-4033-a4bd-080f6807b34b">77,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d28061c88a44b7aa46deded1cf2e6a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfNi0zLTEtMS0w_76715b01-03a4-45bc-9275-39f716a80635">98,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87c65af7fe274f899122097d464a1bf4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfNy0xLTEtMS0w_94bd3e9b-e9e5-40a8-9f4c-979fc5b05dc6">37,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6af4b58a85d47a2a7ed411542576cd3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfNy0zLTEtMS0w_3ca389cb-9252-4bb7-b8ce-3bc19edfa4cd">12,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMjIzNA_8fca06f1-6a07-4490-a46d-3cbd88922573" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value carrying amounts of the Company&#8217;s derivatives, as classified within the fair value hierarchy, were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#160;current&#160;assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65f45b20e934503b719a9058ffc0aa1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMy0xLTEtMS0w_a5dd5193-0c7d-42d4-88b9-d0e918564621">11,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4fa8d281e98402cbfe0bbf358bd183d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMy0zLTEtMS0w_086c6b83-b657-4ded-aa95-cdb87d957586">6,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998dfa69cd654bfbbac7b62ef70c8ee1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfNC0xLTEtMS0w_51806f6e-74ed-4eb5-8542-9270529447df">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2959731ccc2d46129ed431c7d2b06d80_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfNC0zLTEtMS0w_8313a3ec-8323-4f9e-89da-442127cef3bf">3,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57861f66fb846acac9f83cdc9e47785_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfNS0xLTEtMS0w_3b4785a5-b181-4f0b-8770-78d9ae24b93e">16,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d72a61dbc164a95830296964a405193_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfNS0zLTEtMS0w_221e3d0b-3010-4161-991f-4db56602cb9c">9,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts&#160;payable&#160;and accrued&#160;liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i653a9dcd97a14cdd9a1732d3b2674534_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfOC0xLTEtMS0w_8b3e7240-679e-45fd-ad4c-eb800af46514">5,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45acdc04438043e3a8bd6387c422da66_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfOC0zLTEtMS0w_8e98037f-838f-4b0d-9e7c-49dfdafa7e38">17,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a8390484ae4b6f877f15cfcbcb0f27_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfOS0xLTEtMS0w_0bb9a075-55a0-431e-add0-bcbe3a62fb86">1,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd69df912beb45dbad86a43d5165bd04_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfOS0zLTEtMS0w_cd0347ac-a344-45af-ac64-595f2fda5557">11,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57861f66fb846acac9f83cdc9e47785_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTAtMS0xLTEtMA_b476d512-7a9d-4729-940b-86dd7f1ac4ee">6,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d72a61dbc164a95830296964a405193_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTAtMy0xLTEtMA_6bd7381a-7850-4332-b625-d4e087b8bb8e">28,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#160;current&#160;assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf858e58d4a42deb0197ad3a84b8e2a_I20210930" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTQtMS0xLTEtMA_18607fd7-791a-4d26-8177-179d15f1b790">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d22d4a686e04d89add5ad2e6c2dbb50_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTQtMy0xLTEtMA_69fafe17-f04d-40c6-9f25-8cb0bd6f5e21">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts&#160;payable&#160;and accrued&#160;liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife95d4f1adbe4a8fa995aa600c1b72ae_I20210930" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTgtMS0xLTEtMA_b0116829-0744-4502-a14b-ac19b1bc6e71">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ddd51b05b44b81b4cac9334ce55095_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTgtMy0xLTEtMA_1926b597-9f45-4da7-9bbc-299658b2d95b">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Derivatives Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMjItMS0xLTEtMA_d1b57ad8-2448-46d3-9149-e384cda4513a">16,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMjItMy0xLTEtMA_b1adb7ea-a2ce-4d47-8452-00523f954bcd">9,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Derivatives Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMjMtMS0xLTEtMA_cf08ce0b-8b53-473f-9727-05fb81314c0a">6,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMjMtMy0xLTEtMA_a9a0522e-30df-413d-8987-4e4e1aa8af7c">28,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;For additional discussion of fair value measurements, see Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMjIzNw_0350a842-6560-456f-8649-a3443bff0c70" continuedAt="ie1dd01914a204a8c8f4f8d114dd7e962" escape="true">The following tables summarize the impact of gains and losses from the Company's derivatives on its Condensed Consolidated Statements of Comprehensive Income (Loss) for the periods presented.</ix:nonNumeric></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><ix:continuation id="i291aba72b2e24fc2ab62039ce9979aef"><ix:continuation id="ie1dd01914a204a8c8f4f8d114dd7e962"><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues as reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNC0xLTEtMS0w_069b9be1-21c4-4ade-8505-93fa9c1df770">393,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0867d2abd245aeb03cd68ad004aa7a_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNC0zLTEtMS0w_d67cf104-a9a8-4544-a3c0-5e7cba569d92">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNC01LTEtMS0w_27c90a8b-cae1-4bca-b6de-c18745c62391">460,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5e54ce01d4462f8417aa877f5454bd_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNC03LTEtMS0w_6ceb89ef-a3b0-4a0d-9cfb-1547f7bcebc8">2,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses as reported</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNS0xLTEtMS0w_a206f99d-f40b-4849-bd10-0c2339a130d6">461,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93a85736fa1a4177831386b25c03128a_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNS0zLTEtMS0w_31a7b404-e930-48a7-a85c-b92b208d5499">268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNS01LTEtMS0w_6e122948-419e-4a80-a7b8-63e70369000c">532,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dc4e113aded47d28e12f99a50683bbe_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNS03LTEtMS0w_ba2d707d-f78d-4d51-b19e-d89c9250c83f">815</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5396b9f8638140eab847f0bdfcab099a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfOC0zLTEtMS0w_54114474-ac96-4222-85ec-472bc2404f89">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6257cb31e6a74435a04b92f18161c169_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfOC03LTEtMS0w_aa4bd56d-be47-4d92-80ea-39079914b0af">4,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues as reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9940e707613405199a97fc351ad73ef_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNC0xLTEtMS0w_18531048-a517-4fbe-9713-5df7eb2de8ad">1,348,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbedd8a5f7224c52a0e6a43b72b26b32_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNC0zLTEtMS0w_0f0c336b-4c3a-4ce8-ab03-526d60c76a88">5,034</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNC01LTEtMS0w_a8a35845-3015-475e-a6bd-44e699a74ec4">1,368,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63cb5ebbe7144d7cbd04769985192b4d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNC03LTEtMS0w_364dd5b4-e7b5-489d-ad0d-33fa0d45b6cb">17,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses as reported</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNS0xLTEtMS0w_185ca6a7-8da1-4426-889a-5534c1e18c09">1,412,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f69cb4b88254f89ae7a84113b9ef9e4_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNS0zLTEtMS0w_b5fb7ee3-ff09-493a-a0fc-0d14f37f6baf">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNS01LTEtMS0w_0ca34d78-5fb0-40fd-a4bb-203ef0cf116e">1,400,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia10f257e647949e8a3b8943db642b6ba_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNS03LTEtMS0w_a6c4a03b-177d-439a-8792-80ed02d2df55">4,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61c318f76764a7fa034c58b06aedb1b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfOC0zLTEtMS0w_0a8731dc-3123-468b-9d94-67628b0a7bfa">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd960385e494621870825c06ea5d0dc_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfOC03LTEtMS0w_30efb188-601c-46a9-ba6a-8d4fdbe0ef42">9,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:15pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company expects to reclassify unrealized gains of $<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMTk3Mg_70ae9ebb-21e8-420e-a0d4-5a67c045348b">6.2</ix:nonFraction> million from Accumulated Other Comprehensive Income (AOCI) to earnings as the forecasted revenues and operating expense transactions occur over the next 12 months. For additional discussion of balances in AOCI see Note 10 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="margin-top:15pt;text-indent:45pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_61"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(9) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTc2Mw_034864a4-ede7-4be7-9e23-51fc082d8ca3" continuedAt="ib21d820f063f4bec8bb3dce9782db65a" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="ib21d820f063f4bec8bb3dce9782db65a"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company had outstanding fixed-rate notes with varying maturities for an undiscounted aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTYx_7faeda8f-d615-4c0b-bddf-52458c22cd05">1.1</ix:nonFraction> billion (collectively the Notes). The Notes are senior subordinated convertible obligations, and interest is payable in arrears, semi-annually. <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ConvertibleDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTc1OA_fd34ea68-e12a-44bf-b02d-3e8d2c7cb6ea" continuedAt="ia36b7668ba394c84b0b8a7cad401812b" escape="true">The following table summarizes information regarding the Company&#8217;s convertible debt:</ix:nonNumeric></span></div><ix:continuation id="ia36b7668ba394c84b0b8a7cad401812b"><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMS0wLTEtMS0wL3RleHRyZWdpb246YWY3ZWFhMzY2ZTQwNGMzYmEzY2ZlZTUwNjJkY2RiNmJfNA_28ee94f2-769a-4636-8d7b-4aec5ab48d09"><ix:nonFraction unitRef="number" contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMS0wLTEtMS0wL3RleHRyZWdpb246YWY3ZWFhMzY2ZTQwNGMzYmEzY2ZlZTUwNjJkY2RiNmJfNA_6c454736-2873-4de9-be18-d2d07ee00099">1.25</ix:nonFraction></ix:nonFraction>% senior subordinated convertible notes due in May 2027 (the 2027 Notes)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMS0xLTEtMS0w_d0fe202a-8669-43de-b528-b4f45b27dd9f">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMS0zLTEtMS0w_4fc44851-832b-4bf7-a9db-2e15dcb7ad51">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount net of deferred offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMi0xLTEtMS0w_08ad92d6-6a8c-40a5-bacf-7023df6d4836">11,478</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMi0zLTEtMS0w_90b6f7fd-c3cb-4bdc-8568-fa98342c6e48">12,995</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 Notes, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMy0xLTEtMS0w_f3533cb1-0d17-41a7-a363-c3efe207c688">588,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMy0zLTEtMS0w_2dbe5e6e-2886-4bba-90a0-8490f53f96ed">587,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNS0wLTEtMS0wL3RleHRyZWdpb246ZmI4NDNlMjNjYzFhNDIwYjlkNjZmNTQ4ZTNhZjJiZTVfNA_30e8355d-4598-4881-aa1a-d86f1e4fb0ed"><ix:nonFraction unitRef="number" contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNS0wLTEtMS0wL3RleHRyZWdpb246ZmI4NDNlMjNjYzFhNDIwYjlkNjZmNTQ4ZTNhZjJiZTVfNA_efadfbbf-6c56-42ee-96fe-af3b9b8fae74">0.599</ix:nonFraction></ix:nonFraction>% senior subordinated convertible notes due in August 2024 (the 2024 Notes)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNS0xLTEtMS0w_b1b735fe-21e0-473a-a03c-f78d6e958a84">495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNS0zLTEtMS0w_5acff0d7-d674-4005-b601-2773b449d21e">495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount net of deferred offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNi0xLTEtMS0w_716322f8-fdbe-4105-aab0-dd4c28c13b27">5,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNi0zLTEtMS0w_a18cd714-3820-4015-9cf8-b6b7ad4afd1c">6,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Notes, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNy0xLTEtMS0w_7f19c4ce-d023-490b-943a-5e5dc32078e6">489,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNy0zLTEtMS0w_63557254-1401-4af6-8127-5a57721dc90b">488,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total convertible debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfOS0xLTEtMS0w_46dad1d3-9db1-4c2d-9996-873863b6dcb2">1,078,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfOS0zLTEtMS0w_53174bf0-31e1-4d26-894f-bea34b4e9949">1,075,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value of fixed rate convertible debt </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 Notes</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTItMS0xLTEtMA_ce08b061-ce99-4619-a062-fca040ee5041">600,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTItMy0xLTEtMA_7b042bca-c729-47f5-99ee-fa0db261eb13">627,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTMtMS0xLTEtMA_9286cdf6-f664-4703-8f8a-b6e5f05fa0ee">510,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTMtMy0xLTEtMA_e7e08db8-cb4c-4617-82e6-b6df6496178d">530,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value of fixed rate convertible debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTQtMS0xLTEtMA_9c26bce0-8b9b-4b2a-a3c6-6e9bdf997c31">1,111,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTQtMy0xLTEtMA_5fbbb260-81d1-403a-a19d-c716a0313abe">1,157,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The fair value of the Company&#8217;s fixed-rate convertible debt is based on open market trades and is classified as Level 1 in the fair value hierarchy. For additional discussion of fair value measurements, see Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div></ix:continuation><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTc1OQ_a65b3f6f-ef1a-4f50-a2dd-9a081cc30121" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense on the Company&#8217;s convertible debt consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.672%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Coupon interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMi0xLTEtMS0w_fd9ad274-1fde-4bc5-9315-f4bf8c071243">2,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a00422432443d785988f4c838194eb_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMi0zLTEtMS0w_62467fdb-d512-48de-ad4c-98b2e56f1adc">4,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMi01LTEtMS0w_8c0843ac-71fb-42b2-9fa4-70465fd5fb26">7,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMi03LTEtMS0w_d4ca8688-98c4-4799-a605-e5e7811ef09f">9,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accretion of discount on convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMy0xLTEtMS0w_cde68393-a498-4611-b144-b159da1f7377">835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a00422432443d785988f4c838194eb_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMy0zLTEtMS0w_326483b2-60e2-4db3-bbf4-547a4a5b3dcc">4,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMy01LTEtMS0w_1375d978-445a-45a0-98a9-6a1158e7ca3f">2,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMy03LTEtMS0w_5737c0a0-39cf-4d4b-8cc1-62926a9a3cd9">13,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNC0xLTEtMS0w_6d4af28e-3ed5-4d77-857f-f41ca506d222">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a00422432443d785988f4c838194eb_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNC0zLTEtMS0w_f1898a96-e11a-4d23-bba1-cc4c1b45e5c8">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNC01LTEtMS0w_03fe06d6-485a-4474-a505-7132acfba856">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNC03LTEtMS0w_1b5c52e7-b4d7-4ba6-86e7-7bf55e5aeee9">1,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total interest expense on convertible debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNS0xLTEtMS0w_a934f71a-0a7f-424e-896a-16149d7681b2">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a00422432443d785988f4c838194eb_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNS0zLTEtMS0w_6055a8fa-de14-47ec-abbb-90fbc527d202">9,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNS01LTEtMS0w_28fcdab4-525a-42d3-b73a-34a3320ef85a">10,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNS03LTEtMS0w_5c162d5c-30ae-4ae7-a869-9ce163b405e3">24,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 13 - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 for additional information related to the Company&#8217;s convertible debt.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2018, the Company entered into an unsecured revolving credit facility of up to $<ix:nonFraction unitRef="usd" contextRef="iba2ae00a5eea4923b638351403ec6b48_I20181031" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTA4OA_37307291-514b-445c-8bd5-8dd71b620aad">200.0</ix:nonFraction>&#160;million which includes a letter of credit subfacility and a swingline loan subfacility. The credit facility is intended to finance ongoing working capital needs and for other general corporate purposes. In May 2021, the Company entered into an amendment agreement in respect of the credit facility, extending the maturity date from October 19, 2021 to May 28, 2024, among other changes. The amended credit facility contains financial covenants including a maximum leverage ratio and a minimum interest coverage ratio. As of September&#160;30, 2021, there were <ix:nonFraction unitRef="usd" contextRef="iee37fe35ae7740dbbf5492520ad69a15_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTU5OA_70c7d84d-ea83-4478-973f-df942859dce0">no</ix:nonFraction> amounts outstanding under the credit facility and the Company and certain of its subsidiaries that serve as guarantors were in compliance with all covenants.</span></div></ix:continuation><div style="text-indent:45pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(10) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RleHRyZWdpb246YzQ4MmMzMGQ5Y2RjNGUxY2FjZTEwNjVkMDU0ZmJhMWRfNDUw_ecfa5896-997d-4475-8475-c774582f55f5" continuedAt="ia6cd6b1bedc043e684735ca10b5d2312" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ix:nonNumeric></span></div><ix:continuation id="ia6cd6b1bedc043e684735ca10b5d2312" continuedAt="i8e36541d1cb74bf9bd93b4e90fe69627"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RleHRyZWdpb246YzQ4MmMzMGQ5Y2RjNGUxY2FjZTEwNjVkMDU0ZmJhMWRfNDQ1_7bfec557-ffba-41f4-98c3-06503c9315f9" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables summarize changes in the accumulated balances for each component of Accumulated Other Comprehensive Income (Loss) (AOCI), including current-period other comprehensive income (loss) and reclassifications out of AOCI, for the periods presented.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.404%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a1454c700cf4b51a23d6f33d90c7c8a_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMi0xLTEtMS0w_5720740d-40fb-42bc-ac23-5e830c93d4cb">2,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8717ee13ca8c430dbecd711039a7e46f_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMi0zLTEtMS0w_8f6eb418-1a66-4ef7-a578-9da8da410cfd">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if511f9ed24f948619a2e53651da7e114_I20210630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMi01LTEtMS0w_d8c39402-010e-4848-a922-1bc01cd3e907">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2e3bd0516f4927a3ea54940b0473b8_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMi03LTEtMS0w_b8c2e94e-e926-4ded-8e28-91627cd58223">939</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMy0xLTEtMS0w_cd5540b2-9de9-49c6-a3a2-1ec7e83f0eca">11,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMy0zLTEtMS0w_b22bce46-f0e6-4020-8e43-e0a7018880e8">786</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5608486f3aab45158217508c7361b8db_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMy01LTEtMS0w_6d899b15-1952-4cc0-a958-95492dd8a906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMy03LTEtMS0w_e1c1e0c4-8a77-46db-a335-0d3d6ffa9de3">11,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNC0xLTEtMS0w_b7762818-0f8a-446b-821e-01c4c6e054e6">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNC0zLTEtMS0w_11be99a9-2cc7-426e-bc07-16ff29c8fb83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5608486f3aab45158217508c7361b8db_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNC01LTEtMS0w_efed474b-dded-4587-a559-d3f02e0f0a65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNC03LTEtMS0w_1d24c725-c0e0-4687-b5e8-707c9bd329d8">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNS0xLTEtMS0w_da11cbd5-183b-4749-922a-d77243927b9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNS0zLTEtMS0w_a3e06573-0dac-42ad-ac52-20eabd6d6067">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5608486f3aab45158217508c7361b8db_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNS01LTEtMS0w_537014ae-8303-462f-835d-0d628b08e91a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNS03LTEtMS0w_66775d4d-6d75-4a6b-9ce1-ab0256306812">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNi0xLTEtMS0w_21513818-c906-4600-a455-6108a21098b5">11,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNi0zLTEtMS0w_eefa96d6-93df-42c3-b0db-051e1e0ba428">603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5608486f3aab45158217508c7361b8db_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNi01LTEtMS0w_15f7ba77-a819-44c8-a1dd-457cb09c121a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNi03LTEtMS0w_8a93fe31-2ac0-45c2-ab8b-417bfe5c535c">11,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f8068feed342d0852f9c527519b97c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNy0xLTEtMS0w_7082fbce-baf6-46a5-9333-9e5f217fce93">9,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3faf010302b3404ebb5a5088bb42c52b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNy0zLTEtMS0w_7d20b93b-cb70-4d56-b0aa-845d600e58c9">1,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6b9095a67c4e829c8badebfb6d9376_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNy01LTEtMS0w_21cc4aac-1b2f-40eb-9eff-afe1974ae4ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNy03LTEtMS0w_99e6cc74-81f2-454e-a9c9-24ec77cf8e05">10,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.991%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.404%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2825e372b0ea4c4db7b030d62cb5b3f7_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMi0xLTEtMS0w_9c39d2c6-92cf-4424-b127-6b48f324ce24">22,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2551e7c9a1f04acdbbd714ef15b18e6f_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMi0zLTEtMS0w_ae7e1ef7-e988-4d08-bbc5-a12848cb7cd6">7,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e63c14188b429a96626e5e45c2c116_I20200630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMi01LTEtMS0w_b966aa3a-4678-434e-a105-4162865ee38b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10986a90b6074a24befea81408205ba6_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMi03LTEtMS0w_2f4a0c6c-a8cc-4f59-9205-cb8e7d33cd11">30,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMy0xLTEtMS0w_0efc305f-4d29-494f-8e8d-6152e9cdaa59">16,094</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMy0zLTEtMS0w_786ad413-1cba-4bd1-8309-96f51edda8ba">2,201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMy01LTEtMS0w_7c6a18c9-ed4a-479d-8d0d-f6fed3427eca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMy03LTEtMS0w_1f4ac6eb-0eee-42de-b05a-b3b7624281ca">18,295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNC0xLTEtMS0w_3950d7fc-d654-4e15-aca9-60bc823939c0">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNC0zLTEtMS0w_b7708a86-bae9-44a8-acd1-29a334044445">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNC01LTEtMS0w_e102ce3b-bdf6-4a96-90e4-255e5bea6c72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNC03LTEtMS0w_b8be6bab-4777-4bb0-a741-2f5eb783304a">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNS0xLTEtMS0w_b62b7a9a-a37f-4da3-ad53-b59d0e5242ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNS0zLTEtMS0w_b63a3b30-2640-4b44-850a-d885c4fc7589">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNS01LTEtMS0w_cfa26517-8581-420b-965f-bde49f8d7e86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNS03LTEtMS0w_bfdd6d67-6bdc-47a1-96a5-ed2cab6c1179">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNi0xLTEtMS0w_5fce4f07-bc05-4773-bd7b-b6fc80277e6e">17,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNi0zLTEtMS0w_d96ad423-fc13-4082-8824-202f36ea09ae">1,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNi01LTEtMS0w_def537fe-e347-465b-b508-f5fd90e8d2b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNi03LTEtMS0w_e39e439e-5588-4591-b14b-d4a954256d7b">19,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica6ad443b63d459f92df9ffbcae2b88a_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNy0xLTEtMS0w_3abfe1e3-d39b-4510-8430-f4c09cad9f23">4,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ca830558c94af29e572b85e6fb0ab0_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNy0zLTEtMS0w_f6c75b09-a641-4340-a421-1f03465de7fd">5,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5abfbe741a48819ae2f94da173f77b_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNy01LTEtMS0w_72cbed96-5994-4baa-9f66-a3d36674a5c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0db40041dc54511b7a5f5d17ab13fa6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNy03LTEtMS0w_8e7bef74-305a-4330-a73d-312375a3d108">10,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.404%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id254242e029e4cd29e695890e7e368f3_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMi0xLTEtMS0w_287a5a57-f517-438f-adb0-71db0c617c02">20,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02c79f2fe3684a398bd2294ebbe2c99b_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMi0zLTEtMS0w_85da3798-f1f5-4a28-94a4-f89b070bead0">3,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e57bf81424a40c5b3adb66b880dae12_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMi01LTEtMS0w_84c44634-1940-4945-b5df-1e09fcb655a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847ccef2e0f749cdbc16c784f8bc20d7_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMi03LTEtMS0w_18e72576-73fe-47d8-bb4f-ee3611f923dd">16,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMy0xLTEtMS0w_467f3ef1-5c89-4529-8b48-22bb7c7cea2a">24,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMy0zLTEtMS0w_b71d1643-5128-462a-ac87-60a45edc9e01">3,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMy01LTEtMS0w_c73cd050-54bf-401b-8438-5e82f07b815b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMy03LTEtMS0w_3072fe72-30ed-44bd-8de2-554b03427db0">20,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNC0xLTEtMS0w_cc694db7-52ef-47dd-a4a9-cf478ff0dfd1">4,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNC0zLTEtMS0w_04b217e0-b04d-4037-9a89-f74ae8b21a6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNC01LTEtMS0w_02777d1f-231f-4d75-a5de-7c99bc944b10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNC03LTEtMS0w_164a4ade-7f14-46ef-85d8-33fdf8bcec03">4,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNS0xLTEtMS0w_63582961-de5b-46af-87f1-1f3660820258">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNS0zLTEtMS0w_c46e1181-128e-488e-aa71-4ba2167e8e43">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNS01LTEtMS0w_d6de13a7-8a58-4a44-a9b1-f50da9475fb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNS03LTEtMS0w_d95babfb-22f0-4520-b7fb-2e31c9d05dfb">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNi0xLTEtMS0w_22fe6e32-4e48-4b40-bf64-50772762e64d">29,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNi0zLTEtMS0w_e6f625c6-0109-4f34-980e-b016e27dd1fe">2,671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNi01LTEtMS0w_3c583bef-d126-4214-8364-931ece581ac2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNi03LTEtMS0w_7b3b174d-9062-4491-acc9-418811457e51">26,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f8068feed342d0852f9c527519b97c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNy0xLTEtMS0w_f7d6fc9d-f211-4995-8e36-1318b221b5ce">9,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3faf010302b3404ebb5a5088bb42c52b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNy0zLTEtMS0w_3d2fd1ab-0f9f-4e83-9379-406b41ce481b">1,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6b9095a67c4e829c8badebfb6d9376_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNy01LTEtMS0w_198f66e6-8ac1-41ed-ba47-be590fe15082">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNy03LTEtMS0w_b7bd9877-07ab-4a0f-8a7a-83da711d386a">10,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.404%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8a1231bd26440ca6973d994e0f4e4d_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMi0xLTEtMS0w_446abfca-fe21-4241-ad2f-d5ff74e171fd">16,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieadae4e29a7041f4a3ad734dc312b2df_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMi0zLTEtMS0w_8b799a44-e722-45f3-9ba4-2d10e8d0d5f8">3,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67f6d6511e9149758c5097fab5fffa22_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMi01LTEtMS0w_a2e2ebe0-00cd-43ad-8d09-0dc73596286a">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5980981b2d94a21af89adbff48bff67_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMi03LTEtMS0w_58a54881-b457-41b6-a75c-7d17fa3d29c9">20,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMy0xLTEtMS0w_484fa505-1318-4c5c-917e-e0dd7936b580">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fa1b38663f441883ba5f2445470397_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMy0zLTEtMS0w_a19ab418-bbad-4730-8de1-55419b36bfc7">2,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930" decimals="-3" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMy01LTEtMS0w_4fe5cae1-e75f-42b3-988c-9e0378dacd9d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMy03LTEtMS0w_a22cd8c9-9e39-4edc-b74c-aa757b0ba637">3,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNC0xLTEtMS0w_ec6fdd0f-0e43-4055-8659-14d529d3a704">13,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fa1b38663f441883ba5f2445470397_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNC0zLTEtMS0w_ce92128d-775f-4ce2-8c88-ad134ad75ccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNC01LTEtMS0w_9481ad55-b1a0-4d2a-ae30-0fad8612d7e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNC03LTEtMS0w_b5865119-9a4b-4109-a3ab-bfbc0e8c7661">13,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNS0xLTEtMS0w_faab192f-481e-4fca-b7f4-5ad007dbac76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81fa1b38663f441883ba5f2445470397_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNS0zLTEtMS0w_10289f3c-3a8b-4bbb-85e2-47878f78114a">550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNS01LTEtMS0w_186406c1-bf2b-4d9c-9d3a-c8a7d93b494f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNS03LTEtMS0w_1a6ce92e-b90c-4efd-a515-4e1de8758e85">550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNi0xLTEtMS0w_3640069d-5cdd-42e0-ae3d-8ea1e3d017cf">11,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fa1b38663f441883ba5f2445470397_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNi0zLTEtMS0w_161905e9-2caf-41f2-8448-e9b42a0b5326">1,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNi01LTEtMS0w_f3666e39-e055-40f5-9edc-6519367f64ff">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNi03LTEtMS0w_a547f70c-bd65-476e-a36d-0a45487c6ae7">9,779</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica6ad443b63d459f92df9ffbcae2b88a_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNy0xLTEtMS0w_9e270087-7705-43b2-9fa1-be45aaaae1b6">4,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ca830558c94af29e572b85e6fb0ab0_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNy0zLTEtMS0w_c4519103-0dd8-4bc1-9740-341419f1c2d5">5,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5abfbe741a48819ae2f94da173f77b_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNy01LTEtMS0w_53a2cfe3-d1d4-4ff4-b9a5-bf77ec784755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0db40041dc54511b7a5f5d17ab13fa6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNy03LTEtMS0w_bd3c3521-6910-49d5-9585-6f285ba4e1fa">10,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><div style="margin-top:12pt;text-indent:36pt"><ix:continuation id="i8e36541d1cb74bf9bd93b4e90fe69627"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For additional discussion of reclassifications from AOCI see Note 8 &#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Derivative Instruments and Hedging Strategies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div id="i37555ce43f7244d3afa231a2a50e7423_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(11) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="bmrn:ConcentrationRiskAndSegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQzMg_5b8cc248-df39-4a6b-8589-9402c5f3093c" continuedAt="i9394a65d784549e6a825d27e76ced85c" escape="true">REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i9394a65d784549e6a825d27e76ced85c" continuedAt="icab25e8aaf854e488e7f5b7197fb7a09"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates in <ix:nonFraction unitRef="segment" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfOTI_b048afc1-c0ae-45dc-b39b-df869086368e">one</ix:nonFraction> business segment, which primarily focuses on the development and commercialization of innovative therapies for people with serious and life-threatening rare diseases and medical conditions. The Company considers there to be revenue concentration risks for regions where Net Product Revenues exceed 10% of consolidated Net Product Revenues. The concentration of the Company&#8217;s Net Product Revenues within the regions below may have a material adverse effect on the Company&#8217;s revenues and results of operations if sales in the respective regions experience difficulties.</span></div><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQ0MA_de2c37ae-a5ca-427a-9208-2a6caa74d082" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table disaggregates Total Revenues from external customers and collaborative partners by geographic region. Net product revenues by geographic region are based on patient location for the Company&#8217;s commercial products, except for Aldurazyme, which is sold exclusively to Sanofi Genzyme (Genzyme) who markets and sells Aldurazyme worldwide. Aldurazyme revenues earned by the Company are included in the U.S. region as the transactions are with Genzyme, whose headquarters is located in the U.S.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues by geographic region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6aa5a87b7f84d18a23293902aaa2e41_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfMy0xLTEtMS0w_a083d789-7d78-47e8-ab78-5c3161096fbe">196,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68586ccb7def4122a05e7dc73d213d39_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfMy0zLTEtMS0w_c3957e48-f9c7-4ca5-9b44-c1d515be1542">252,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b53329fe7c14a3683433e7d34adb246_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfMy01LTEtMS0w_8b9333e6-d6bc-4039-aa09-1214ef4014ac">608,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b96c70e0c2243afb027cbcdf282e765_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfMy03LTEtMS0w_89aba76a-be07-4640-8ff3-f1ddd40a9b67">729,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f485d362c24177a8d80735201ecbee_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNC0xLTEtMS0w_462cad23-570a-4eb9-ad12-10000a1bfd0b">115,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430f9e39597d43d393863a8ba5c47dc4_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNC0zLTEtMS0w_27ad9f37-d98e-458f-8ccf-b0b1b965e7d2">121,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3df6603453545b7adf0538e4c3b867e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNC01LTEtMS0w_09d678b2-26b2-46a9-8043-0b79aea94655">450,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750ce40f585c411fa47c2bf163efafec_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNC03LTEtMS0w_3f580bc8-6ce2-49f8-83fb-2726834d9828">375,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d097b6776c84a1290432379dfafe6e5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNS0xLTEtMS0w_f37e5fc6-850e-4b78-ac28-41c1ec65d885">38,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a82d895132f4cf6aee55df85842bf75_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNS0zLTEtMS0w_6607dde1-8cf1-42c6-a6f9-5d088cf2ea9c">44,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cc4be5e7bfe4c5887dec731969031b7_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNS01LTEtMS0w_edeeee70-532b-42eb-898f-5de94437937a">140,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692ea98645da4650a217fb7fa5bc5f98_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNS03LTEtMS0w_22ce2293-4190-41bf-950c-cbfa7bb3613e">141,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c01dec0e80c49a8a216d3ccf0b483f5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNi0xLTEtMS0w_f2714a1b-d5bd-4919-984f-7eeeb5d7bc84">58,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfc6366c9ee4fde9f1d3c3304473be1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNi0zLTEtMS0w_23b34c2f-8245-4cf9-9b43-5db9a0f099ec">58,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3baec2de8a480aa194af6ef4b7e7ce_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNi01LTEtMS0w_f9162897-3f6c-4797-bc1b-6e17bf1f7ca7">196,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7778f7e8ed4c60a7007014fbf78a94_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNi03LTEtMS0w_ddc0b0ae-bc82-446e-a280-5102f3545ef5">161,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNy0xLTEtMS0w_34f26a51-9050-4324-bc6b-cd297adf8623">408,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNy0zLTEtMS0w_c2c1d973-b7e3-4a91-aa8a-c7b857f953ae">476,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNy01LTEtMS0w_bac07061-1093-4c48-86ef-eec5de5bfaff">1,396,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNy03LTEtMS0w_e0355f16-293c-4962-b5ec-dab446ea02ef">1,408,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQzMw_f90b2a60-0300-4569-ac74-033d2314ad36" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table disaggregates total Net Product Revenues by product.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues by product:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vimizim</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26cfa0a05050405c8fc26ff4270b410b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMy0xLTEtMS0w_8e636f13-ce32-4f24-813d-a5cf6b410f44">136,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia499a895b89d43c8802609e44742ca26_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMy0zLTEtMS0w_1addb43e-ec59-4139-9fc9-ada279a752ed">147,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ce74ad21854f5b8073837e7f9d4f30_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMy01LTEtMS0w_0496e420-1b1b-4e92-ba7d-31206198bbca">466,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a8b2e0af7d4f48bdd2df8ec9a9c5ba_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMy03LTEtMS0w_f838a34e-a47a-4915-aec8-bbb19d747220">401,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Naglazyme</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54e5f5c18fb24ebbbdbdc5dbbd131b25_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNC0xLTEtMS0w_478ec7d9-0fbc-41b0-bb7d-bd595940fd25">71,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39e0766182094853983cc6543e242eda_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNC0zLTEtMS0w_ebaeda6a-3827-466e-8a53-64dee247d2a0">76,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f418730286417b9103ef1bc9d70fec_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNC01LTEtMS0w_fb648830-3a00-45ce-9ccd-e335ab624953">297,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id740cf897d394b40be718d4aa51cddf7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNC03LTEtMS0w_67e5d419-0ac4-4ee6-bb4a-9ad57285c1fd">271,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kuvan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d38170f263d4c87b138198d14dfb01d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNS0xLTEtMS0w_9e07c6a8-4f65-4f44-88d0-4f72960fce11">67,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c332e9563842deac7a1a89d768fb91_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNS0zLTEtMS0w_9135cb73-29d4-41a7-9909-f08b3ae4f753">123,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d768a033874a13a0aece3c89f824e3_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNS01LTEtMS0w_a4d53ea7-f702-40eb-be38-a9971a1482ac">217,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieee6144f7440430d96c3ea711e06e0dd_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNS03LTEtMS0w_8abca16c-ac9f-4b47-b2d5-9844e9d96771">368,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palynziq</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3631083badb04533a1ccf53e70983c60_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNi0xLTEtMS0w_2866ca84-5a92-4ca6-8294-e6c8db097021">60,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875080367e32474e9692930d4f70440d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNi0zLTEtMS0w_10101dd2-67fe-4c01-81b1-b13ca83ac22a">46,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cac278154a4c64a3a2d789e69239d0_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNi01LTEtMS0w_dc73ccbd-18ae-4d01-99f1-133be79b8c11">173,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fc0dde4f53c44c9ab53a2e5cd3dac81_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNi03LTEtMS0w_6ffc10f1-90b2-4365-8de7-a5b47729e202">121,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brineura</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0a6844bfd4f4df3937b1bc5c15c6c0c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNy0xLTEtMS0w_94addb5a-f031-41f4-96ff-1cb836751309">32,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec5b3fcbcc741d5a41938c2bff9a968_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNy0zLTEtMS0w_dce5f6a0-eee5-4172-b138-28fbede6af9f">25,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2fef5336cd4754aac2a52f8ee715a2_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNy01LTEtMS0w_b7caf807-48ba-4423-befd-58f6f4c56a9b">90,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e72a8e38a54f589382be95578b29c1_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNy03LTEtMS0w_90505ed2-85d3-4eab-aa0d-bbe9eea692b2">75,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voxzogo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670eba932fa44bb4bd105fa2472fdee7_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC0xLTEtMS0xNjI3Mg_01a06a84-8a5b-4af2-bf0c-d0f09b765042">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7163a6ce6d8a4b90ba5be5da895aca0d_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC0zLTEtMS0xNjI3Mg_7d0f2e6e-39ba-49a0-ac36-230ffe4ac0d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77f222cc3eb0499293097be2613706be_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC01LTEtMS0xNjI3Mg_d41ee35d-b0f9-4efe-b3a9-e5faca5ea681">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631b06fa4a4a46759658c5e1ed96fe88_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC03LTEtMS0xNjI3Mg_8b2c2129-b09e-4b2d-9d2c-f945aba8b52d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Firdapse</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce796da9cb04582bb8c002435a42a15_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC0xLTEtMS0w_365e5b72-a1df-478d-bcc6-068383796e3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596ae291f078453886ecff564ae864a5_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC0zLTEtMS0w_97c7cf7f-3a9b-479d-aba2-164037b90e6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5625d09abfec4da9b5135b5a49fd61c5_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC01LTEtMS0w_2ac4ea84-d103-43d3-86e6-90fc58935781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c767f53af74489081063ce938ee5371_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC03LTEtMS0w_eed546e7-7e2e-4779-a964-3f96b29c514f">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues marketed by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78de7c806e9548728df05080cfa9fdef_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOS0xLTEtMS0w_9487ebb6-6436-43ea-8f13-3df2f3c3fa20">369,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765f4a74e39242298ebb8e42f5429fd3_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOS0zLTEtMS0w_1d5031b6-4c9c-4609-8748-32d44772c2f6">419,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6306c147c133472a919f7ac957a8c7b2_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOS01LTEtMS0w_4f60aead-c803-4063-851d-19a312356441">1,245,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b11e951dfb403a9db9d7fa77793d35_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOS03LTEtMS0w_52776924-6a8f-4865-a3ea-06a8e9174cbd">1,239,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldurazyme net product revenues marketed by Genzyme</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icca877ecc41644f7a512279ba3a5aebf_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTAtMS0xLTEtMA_38c52555-4afc-4b92-8737-28cc5882ca4a">24,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12c53d3790994dfb8fd77b8b0750df93_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTAtMy0xLTEtMA_accb93a4-1b54-4e21-8474-dd8f758bbf4d">40,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf2f153984e34dcfb6ebf47a69c25d0e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTAtNS0xLTEtMA_961a0c81-b561-468a-8e05-ce68b156cd98">102,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i587f8139747846de862e02316f943301_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTAtNy0xLTEtMA_5c0bcf0a-34d0-4ef2-ad9d-5181d0133cdb">128,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTEtMS0xLTEtMA_930aef44-e255-45f9-aac9-4d87b2160e60">393,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTEtMy0xLTEtMA_3a467504-eaff-417c-a561-1f078d8de7d0">460,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9940e707613405199a97fc351ad73ef_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTEtNS0xLTEtMA_e02e10ec-1b2f-4f76-b808-d7bce0e32955">1,348,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTEtNy0xLTEtMA_92cac183-fb3c-4af5-8a37-c4db6fe1d399">1,368,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><ix:continuation id="icab25e8aaf854e488e7f5b7197fb7a09"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQzNg_1d8909d0-612b-4cac-9f6e-902e952ddb30" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The table below disaggregates total Net Product Revenues based on patient location for products sold directly by the Company, and global sales of Aldurazyme, which is marketed by Genzyme.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807900e9e70040c78da438a82a6b9728_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMi0xLTEtMS0w_5df4409d-315d-4cc5-a90c-c890c4e0c318">166,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea93a722dde4f8eb67bfd01814148e7_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMi0zLTEtMS0w_0943e01b-1a36-4d72-99bc-294f81b417f5">203,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6996af9c2645e7ad8462878e32a8fa_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMi01LTEtMS0w_db0af8e6-dfa4-4653-a1c5-8d7e9ed43037">491,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id813d823802b4adeae79cd8494384ba1_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMi03LTEtMS0w_b1d47d45-4fbc-464b-8efe-ba87453858d5">582,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1624a814864c43ecbbd5abad76321c1f_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMy0xLTEtMS0w_e3a24c99-0f30-4b61-a5db-df2ae21ecc90">108,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673c282af5fc4cf3828509c09115858e_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMy0zLTEtMS0w_e819795d-bab7-4f31-b957-a0533ae60904">115,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e031326bd7645bf8c67c80bc0590247_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMy01LTEtMS0w_a2e92b2a-b35c-4388-980b-f6dccd139328">424,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3fada62c864453b990f024e22826a2a_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMy03LTEtMS0w_d882f8e1-b236-4ba8-830d-6f3d6ac73b11">360,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8815ae63b15048de91d1036580169b4f_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNC0xLTEtMS0w_88050e50-721f-4af8-a475-1ec945f68de7">38,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b38429ecef7410fb6e6cb17cf99bc23_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNC0zLTEtMS0w_18730bbc-4faf-4881-8570-5ed9671f84a3">44,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36276fddfb9440c49f578739c2e2e93b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNC01LTEtMS0w_112e620b-327e-4269-8586-ae01887dd26e">140,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a9b8c4c57440bd972de38d327ff06d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNC03LTEtMS0w_053f81d4-bd72-4bb3-bc36-bc1ed4313e17">141,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903cb5741f0c454ab0cd6e60497f87f1_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNS0xLTEtMS0w_d8db8aae-a7cc-49e8-b50c-f26fdb580eba">55,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e8c0e180a24083884a28374d6b19aa_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNS0zLTEtMS0w_226409a0-8616-476c-81cf-4dbc77cd9849">56,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib327b203d9f641f4b16be80c7a022310_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNS01LTEtMS0w_9ecbac18-5ef3-48ba-b123-cd269714d3c1">189,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c17cda19c7411bbf1a312a56665382_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNS03LTEtMS0w_e5c3137b-0483-4797-923d-fab0d82f7925">154,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues marketed by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78de7c806e9548728df05080cfa9fdef_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNi0xLTEtMS0w_ff1518e3-302e-4cb4-ae11-5e00d742a318">369,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765f4a74e39242298ebb8e42f5429fd3_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNi0zLTEtMS0w_169e1b90-6d80-4b9d-b9a6-cf8d32e7ffdf">419,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6306c147c133472a919f7ac957a8c7b2_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNi01LTEtMS0w_0e2a94e5-bfc9-4493-a98e-7cacea8f66b8">1,245,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b11e951dfb403a9db9d7fa77793d35_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNi03LTEtMS0w_8e3a84a1-7fbb-4053-b16c-e030b7cdec06">1,239,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldurazyme net product revenues marketed by Genzyme</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icca877ecc41644f7a512279ba3a5aebf_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNy0xLTEtMS0w_17e79f25-a83b-4424-b843-cb8ccd27ab9d">24,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12c53d3790994dfb8fd77b8b0750df93_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNy0zLTEtMS0w_8b5771c7-0b05-4a98-80f7-4a1e99a86ea6">40,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf2f153984e34dcfb6ebf47a69c25d0e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNy01LTEtMS0w_ed2b9b76-49dc-4504-91b4-9644c398d2ea">102,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i587f8139747846de862e02316f943301_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNy03LTEtMS0w_35282173-95b1-42d4-bbc0-614e2a6c34fe">128,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfOC0xLTEtMS0w_d500f25c-d87e-437a-bb72-236a89f2849c">393,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfOC0zLTEtMS0w_f4a064b2-e95d-46a2-a5b7-05b9bc2e5f2e">460,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9940e707613405199a97fc351ad73ef_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfOC01LTEtMS0w_69a9069b-78ac-4111-ab3f-926bd7f74e18">1,348,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfOC03LTEtMS0w_678f59b5-f428-412a-bea5-19ff01c5fce6">1,368,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQzNw_37984278-3e24-41b6-aedf-e7134d9bf4b3" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table illustrates the percentage of the Company&#8217;s total Net Product Revenues attributed to the Company&#8217;s largest customers for the periods presented.&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d24f4221ce54b7587582cc1483c6c20_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMi0xLTEtMS0w_455588d4-eee2-434c-a4f5-6ee9f0d5262b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia22dd234fb9743fd92d299421432bd77_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMi0zLTEtMS0w_c8aa5366-007b-4020-bad6-e25fd88b5c0a">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4522cd9712214bb087ea4996aa558624_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMi01LTEtMS0w_52853080-9a38-47cc-8c34-e40edf64f45a">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida8af263c560424abb1f9b025ffbc888_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMi03LTEtMS0w_01e9e8f4-6ec0-4bd7-8a70-83fd54c40d9e">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i85eed5105d974313b640fec757ed2132_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMy0xLTEtMS0w_4cf1dcbc-d199-4617-b4a2-47bf6d4c21b6">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic605b00f4bfb47dd91d3f6f7057661fb_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMy0zLTEtMS0w_ceb91e19-6b0e-4e6e-b69b-e397fe481100">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd471de3fee2400e88e55081b5edc7f4_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMy01LTEtMS0w_7f30c085-8409-487b-8913-3efc325f6fd6">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35e7d66a6cac42129aa948cfaf2eb317_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMy03LTEtMS0w_c37990a0-1699-4c9d-83ae-e272a8e12ef9">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie383b687557e497388831485ea18b47a_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNC0xLTEtMS0w_8bc65bd7-9954-4430-a218-1f52476668d2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bae986f7e264602844d3457fa91c27c_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNC0zLTEtMS0w_27980409-7496-408a-9d18-9759b814eea8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieb287505a9684940b9d27b688febaea4_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNC01LTEtMS0w_ebcd47d3-7ed5-48d4-b1fd-f47a02f8ce53">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i687b7d4238fe4663857bbb9e1446ee16_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNC03LTEtMS0w_4748e16e-8dac-4045-8173-b38d61ede9aa">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06311aaf1fc84255bf7c628cde958a0e_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNi0xLTEtMS0w_663b39d9-31cb-4eba-ab62-c3d68ff8fcb2">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17442b5bbd98454d91144658893a0d26_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNi0zLTEtMS0w_15a25d11-04b4-40cc-b33f-2d6a7835e6c0">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3b61ba06404cd29a53bc8482a92839_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNi01LTEtMS0w_1c338091-77dc-428f-ac96-3815471de425">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c313f30b00c4ffbbe6049bf40e5fce8_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNi03LTEtMS0w_5049338e-d8cd-4918-82fd-adbf058e37a7">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On a consolidated basis, two customers accounted for <ix:nonFraction unitRef="number" contextRef="id03d4506cf9848689c776b8acd1a1fd9_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTY1OA_3ef39a7e-2964-4937-ab8b-4c0c32b9cb8f">31</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="icc7289dbd839469db4eb56c8b0923f40_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTY2NQ_6896c156-e167-40eb-b85e-443a683f489f">14</ix:nonFraction>% of the Company&#8217;s September&#160;30, 2021 accounts receivable balance, respectively, compared to December&#160;31, 2020, when two customers accounted for <ix:nonFraction unitRef="number" contextRef="ice7397073cd84c17909c8a881afdc5a5_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTc3OQ_0c3c43de-7d9a-42d8-b118-94243daa6446">24</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9318c02208c342038447a03fa145e77f_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTc4Ng_3a61188c-cddf-4569-97a7-7ca37b16ad6c">22</ix:nonFraction>% of the accounts receivable balance, respectively. As of September&#160;30, 2021, and December&#160;31, 2020, the accounts receivable balance for Genzyme included $<ix:nonFraction unitRef="usd" contextRef="i88011345f9af4a4eb848131cb3723ff8_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTkxMA_3a5bbf90-987e-4f7c-94c3-e4bd4f46a287">83.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4642aed64b8147e68d905a18605026ae_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTkxNw_1be2a761-50cc-4d6d-aa3f-db64774bdb79">72.1</ix:nonFraction> million, respectively, of unbilled accounts receivable, which becomes payable to the Company when the product is sold through by Genzyme. The Company does not require collateral from its customers, but does perform periodic credit evaluations of its customers&#8217; financial condition and requires prepayments in certain circumstances.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to affect economies and business around the world. The Company&#8217;s global revenue sources, mostly in the form of demand interruptions such as missed patient infusions and delayed treatment starts for new patients, and its business operations were impacted by the COVID-19 pandemic during the nine months ended September&#160;30, 2021 and 2020, and the Company anticipates a continued impact due to COVID-19 on its financial results in the remainder of 2021. The extent and duration of such effects remain uncertain and difficult to predict, particularly as virus variants continue to spread. The Company is actively monitoring and managing its response and assessing actual and potential impacts to its operating results and financial condition, as well as developments in its business, which could further impact developments, trends and expectations. See the risk factor related to the impact of the coronavirus pandemic, &#8220;The COVID-19 pandemic could continue to materially adversely affect our business, results of operations and financial condition.&#8221; described in &#8220;Risk Factors&#8221; in Part II, Item&#160;1A of this Quarterly Report, for additional details on the impact of the COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is mindful that conditions in the current macroeconomic environment could affect the Company&#8217;s ability to achieve its goals. The Company sells its products in countries that face economic volatility and weakness. Although the Company has historically collected receivables from customers in certain countries, sustained weakness or further deterioration of the local economies and currencies and effects of the impact of the ongoing COVID-19 pandemic may cause customers in those countries to delay payment or be unable to pay for the Company&#8217;s products. The Company believes that the allowances for doubtful accounts related to these countries, if any, are adequate based on its analysis of the specific business circumstances and expectations of collection for each of the underlying accounts in these countries. The Company will continue to monitor these conditions and will attempt to adjust its business processes, as appropriate, to mitigate macroeconomic risks to its business.</span></div></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(12) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RleHRyZWdpb246YzVlZDY5NTk3YmU3NGZlMGE0MTc3ZTJlOTkxMzk1MWVfNDg5_d359dd73-1ea9-4875-8c64-91fa8174591b" continuedAt="i836a8e53944849a99b980623fa7caa81" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i836a8e53944849a99b980623fa7caa81" continuedAt="i45769b0b412d4156a0e1762c00853930">The Company has stockholder-approved equity incentive plans that provide for the granting of service-based restricted stock units (RSUs), market-based RSUs, performance-based RSUs, stock options and other types of awards to its employees, </ix:continuation></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><ix:continuation id="i45769b0b412d4156a0e1762c00853930"><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">officers and non-employee directors. <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RleHRyZWdpb246YzVlZDY5NTk3YmU3NGZlMGE0MTc3ZTJlOTkxMzk1MWVfNDg3_148fe7f7-453f-4745-bd36-48edfa33a014" continuedAt="i7534fab85d714bc3a5dfe81c327516ac" escape="true">Compensation expense included in the Company&#8217;s Condensed Consolidated Statements of Comprehensive Income (Loss) for all stock-based compensation arrangements was as follows:&#160;</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:9pt"><ix:continuation id="i7534fab85d714bc3a5dfe81c327516ac"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i366685cece5e413497a14d201c6aaeec_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMi0xLTEtMS0w_e517d2f6-39a2-4adb-b080-da040b0e1968">4,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600447fd1d334ac4a8cf19039623fed1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMi0zLTEtMS0w_0a1683fc-e7b1-40d4-9558-7b50b8bd5371">10,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4341d0928f7b46a9bb9a16aba139dad9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMi01LTEtMS0w_44e99d2e-f0f2-46cd-b69c-9eea8aafca9b">16,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1af7d3e6ac447faad8ad74652f4be9c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMi03LTEtMS0w_7e1d5604-26d7-4d9b-ad2f-66793f3627b9">20,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bbe544e6bb7468ab675761c05ac7036_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMy0xLTEtMS0w_4796511d-499b-4594-afba-10ca88c93024">17,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240305f0192242b4933888c226e238e1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMy0zLTEtMS0w_eb84fc78-497c-4eab-8174-bb9d3cfe5b2d">15,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8bde7f09ba4955bdcbbb6490d77c3c_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMy01LTEtMS0w_0cdef3ad-d2f1-4ed6-bab8-8eeffe3aa434">56,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2e6a3e17a54d9294f3f2237cb340fe_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMy03LTEtMS0w_7b8a13a5-0c1f-4ec7-a71a-286d1d61c56d">45,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f1a069c36941e09fb5bea33a6ddbe9_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNC0xLTEtMS0w_c427fbe3-454f-4a7a-98dd-2222b5093a42">26,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8128c3889a44d2e9cc52bdcfafa283e_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNC0zLTEtMS0w_7a691711-6927-4657-a525-4109f50827e9">24,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic471c1470b9e42899741b0b5a360a28d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNC01LTEtMS0w_4e6ad8bf-1cd1-4dc1-9e88-cc9f9ad1d20c">80,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea947a2a70cd4cc48f0e3fa73c7b87e4_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNC03LTEtMS0w_299fc8cf-b4ad-464a-ba28-64148ececc33">76,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNS0xLTEtMS0w_617f88fb-2883-4496-a4ae-7d9660b92cb7">49,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNS0zLTEtMS0w_471c23a8-1401-4ce8-ad6d-15b2c6bda9fa">50,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNS01LTEtMS0w_31713cb0-46bf-43e8-b781-d015993dffee">153,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNS03LTEtMS0w_6478efc9-d0e8-46fc-a744-5deb73095a4c">142,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:6pt;text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(13) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfMTMyMw_befd743a-446c-4bcd-ae60-78b6011e779d" continuedAt="i813f7a1dfb1b4c559cc6eb4a4a6ba5f3" escape="true">NET INCOME (LOSS) PER COMMON SHARE</ix:nonNumeric></span></div><ix:continuation id="i813f7a1dfb1b4c559cc6eb4a4a6ba5f3" continuedAt="ia9656ad72db94f7ca0f5455acb238724"><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Potentially issuable shares of common stock include shares issuable upon the exercise of outstanding employee stock option awards, common stock issuable under the Company&#8217;s Employee Share Purchase Plan (ESPP), unvested RSUs, the Company&#8217;s common stock held by the NQDC and contingent issuances of common stock related to the Company&#8217;s convertible debt.</span></div><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfMTMyMA_8d3c8884-5432-453e-be7a-46d463d0ebba" escape="true"><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per common share (common shares in thousands):</span></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (loss), basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMy0xLTEtMS0w_563efecf-7998-4c17-9f84-8eb228b4898c">36,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMy0zLTEtMS0w_b3c2af08-02da-4685-9efa-124288fe3e81">784,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMy01LTEtMS0w_20d5b98f-7278-416d-97ad-fc755ed37468">6,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMy03LTEtMS0w_51afacb3-4cf1-4f11-9e8b-2b726f8f2aa3">837,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Interest on convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNC0xLTEtMS0w_27214026-6ca8-495f-8a4a-4541a2c13e3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNC0zLTEtMS0w_4f79750d-c20a-4981-84b7-ada59066a173">7,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNC01LTEtMS0w_21e3e58e-a8a3-4b8f-8b4d-45cc31e1576f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNC03LTEtMS0w_f97c0f9f-6df9-46fd-84dd-94a565500a25">18,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (loss), diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNS0xLTEtMS0w_65f34039-ce22-4ad3-bca3-6f44f8e9579a">36,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNS0zLTEtMS0w_14f5209a-1c8b-4741-af0b-16673ce3da74">791,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNS01LTEtMS0w_e0f64896-3e97-4ad0-9268-355909bbb538">6,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNS03LTEtMS0w_00c9cf77-e5f5-4a43-95e5-89643a9386ae">855,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding, basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNy0xLTEtMS0w_f29d8d7a-2c33-45f9-a0f9-490073d3baea">183,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNy0zLTEtMS0w_76ccb48a-1de6-4e74-b5a4-8c7aff803eb0">181,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNy01LTEtMS0w_acadb1c8-204a-4693-a85b-64d2b3c445d7">182,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNy03LTEtMS0w_20168c09-1fea-4164-8fb7-b381200dd2f6">180,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e0d79598b4a4fe0894f5f0b5c8d05d2_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfOS0xLTEtMS0w_c5debedd-5b1a-497a-ab48-262b825b919d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12651120f91f4b4f8cebb3b98050584d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfOS0zLTEtMS0w_0207b357-2c88-4b0f-86ab-658e83ea04ec">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90f88b98995241caafd2941a4333cb2b_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfOS01LTEtMS0w_1ee1b7bb-0e57-486c-886b-811d2071b73a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5acc9dcae0254e3a91a091eaad031510_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfOS03LTEtMS0w_e7cf9364-4315-4728-a4bf-1a2847effd94">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2020 notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide7de364296046cd8ec673ebf4f708e4_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtMS0xLTEtMjQz_7afbaa74-66a8-4561-891a-4d685fc1a136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99d8ea1fded44a5dbe57d52c95b8740d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtMy0xLTEtMjQz_5755f066-c442-404f-a4e3-c8fdc5bf170e">3,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icfb006a5635c4e3786096f48ad41e1c1_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtNS0xLTEtMjQz_43e5fb48-2f53-4695-9c46-00877d69ab64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e1a43efe88f4d2b8dbb12448e0fcfbb_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtNy0xLTEtMjQz_e95eb378-f8b7-4c75-91b6-79e2eaf30b4e">3,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2024 notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc32bd96b3014e92b2f0efc81b2ae66a_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtMS0xLTEtMA_0620c3ec-10b8-48e5-8502-2f69ce5564e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i483fea5cfb454ba7a3044cf8f94b872c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtMy0xLTEtMA_9c2716cb-58dd-4e98-a6c8-c8524f68ca25">3,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0936ac22ba0641e3baa0b8544e010e8f_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtNS0xLTEtMA_35d8d4b5-0414-41d8-8b8d-edc4562530d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6693bf5374b04cec9cbcc298b6b9df9b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtNy0xLTEtMA_50d6b8ca-39ee-4841-b162-8982f7bde4a0">3,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2027 notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i712f67daf8994797927c8bdb430e55c9_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTEtMS0xLTEtMA_e7d46580-6966-4a4b-b436-dc981a4d6062">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9264da2f9bbd4f2fb33480144d2f85a9_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTEtMy0xLTEtMA_6eed5dde-aa6c-43c1-8627-dd79d3800387">4,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0589f3a72cba42008e9af75b85655bfc_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTEtNS0xLTEtMA_b2223fb8-4c63-4010-af84-b4fa3737ab58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i747d9cadb0334a97b76371c9665c4ff0_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTEtNy0xLTEtMA_17d96542-41d5-47c3-80a5-4b8bc3779a58">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6195d3f0e2374354b38eb0cc2ab77d14_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTItMS0xLTEtMA_4d373f89-9b22-4215-83a9-0a2083b6dc06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88ec953e8f554e02994b61549a84b786_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTItMy0xLTEtMA_0a94eee2-c2fd-42e0-96ec-2b5649a1fc57">1,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i210b958efc1e4be3928a76fb8c2b4d1b_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTItNS0xLTEtMA_f4f64642-9947-4003-b10d-4cdd52e29f62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id68539b93ebe41578d0997661f7c7067_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTItNy0xLTEtMA_457e2dcc-70c5-46d6-83bb-dc94ab140136">1,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock potentially issuable for ESPP purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i635b1aa8136841889975e9745d917b9f_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTMtMS0xLTEtMA_ca6f3b79-0a35-4216-b7dc-308e072aa07d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70906b8925394dfeb8414b49b6c11841_D20200701-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTMtMy0xLTEtMA_9bd0ceb1-1a55-4821-adfb-e483b5fb162c">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7b754b4139a4554aa9b7b4108bd3cb4_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTMtNS0xLTEtMA_8b50b763-c3d6-4ae2-bd51-e0a81fb8403d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9cfa47a706aa4d73921235a75ded8670_D20200101-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTMtNy0xLTEtMA_12797e68-0c26-488c-a904-494f99714403">337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Company&#8217;s common stock held by the NQDC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6a4e7a972ff46bea3882f3ced06ea4b_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTQtMS0xLTEtMA_17233818-503b-4984-a9ae-ca713f124ec7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i857f8284e96b4d529652faaf70a41f4f_D20200701-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTQtMy0xLTEtMA_cbf116ef-3096-48df-9966-103eb789dc51">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7718da1375c940c7aad6f404d81e8204_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTQtNS0xLTEtMA_b02972d4-c470-480e-8e0a-965be19a4583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a415fe6e6094b7ab63c7d3ca2b9aa95_D20200101-20200930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTQtNy0xLTEtMA_6f40d5c9-0659-4a0c-9bfe-8965bf690127">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding, diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTUtMS0xLTEtMA_8b2a582a-b66e-43d8-ae30-415be800c3de">183,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTUtMy0xLTEtMA_8743f73f-7537-4943-9c67-3982caba64c4">197,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTUtNS0xLTEtMA_8c2afd90-d8b6-46af-b52d-66908fc5e882">182,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTUtNy0xLTEtMA_42524e41-35ec-4ffd-9747-73559b4595a5">194,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) per common share, basic</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTYtMS0xLTEtMA_69226396-05dc-48fc-a0ba-7051dc52ed04">0.20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTYtMy0xLTEtMA_62ff7cd6-9928-41ba-a149-ee3fa1aa0f96">4.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTYtNS0xLTEtMA_505ff8eb-9361-43b2-96dc-7bb17ff3781c">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTYtNy0xLTEtMA_f37d6b6d-8843-46e8-9d9a-c43f752281dc">4.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) per common share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTctMS0xLTEtMA_6fafbcce-c6b2-4edf-8b38-909387f61548">0.20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTctMy0xLTEtMA_182028c8-e545-4c6e-9f95-d613ea97b01e">4.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTctNS0xLTEtMA_c34c8198-2509-4d21-bf1e-d793efd019fd">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTctNy0xLTEtMA_78aad338-d186-44e6-86c1-05cd64389472">4.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. Dollars, except per share amounts or as otherwise disclosed)</span></div></div><ix:continuation id="ia9656ad72db94f7ca0f5455acb238724"><ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfMTMyMQ_2c5dab5d-a862-41aa-be7d-152814bfd2a5" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the equity instruments included in the table above, the table below presents potential shares of common stock that were excluded from the computation of basic and diluted income (loss) per common share as they were anti-dilutive (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e0d79598b4a4fe0894f5f0b5c8d05d2_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfMi0xLTEtMS0w_e9522eb7-0f7a-4955-91b5-5150efbf48d2">6,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12651120f91f4b4f8cebb3b98050584d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfMi0zLTEtMS0w_3d9d8540-4ba5-4521-9c6d-8479827c5e22">5,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90f88b98995241caafd2941a4333cb2b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfMi01LTEtMS0w_204fefe7-5e18-40dc-8028-ee10df8f373d">6,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5acc9dcae0254e3a91a091eaad031510_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfMi03LTEtMS0w_9abed0db-b6c2-43ba-8b5d-c95e1a9440a6">5,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2024 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc32bd96b3014e92b2f0efc81b2ae66a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNC0xLTEtMS0w_5283e59c-c035-4c72-8958-5d9cb0c1965d">3,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i483fea5cfb454ba7a3044cf8f94b872c_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNC0zLTEtMS0w_819fd6b1-623b-46ab-b308-b7f17e5ecb5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0936ac22ba0641e3baa0b8544e010e8f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNC01LTEtMS0w_db61891c-d870-4400-8107-adf8a9ed6f83">3,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6693bf5374b04cec9cbcc298b6b9df9b_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNC03LTEtMS0w_8b8ff82b-bd93-4208-82ff-3981e96f9b91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2027 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i712f67daf8994797927c8bdb430e55c9_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNS0xLTEtMS0w_a847c97f-fc29-4168-878f-d7c3ca4a1a3f">4,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9264da2f9bbd4f2fb33480144d2f85a9_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNS0zLTEtMS0w_323aacdf-40cc-4cc8-b754-0993aeace6f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0589f3a72cba42008e9af75b85655bfc_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNS01LTEtMS0w_321d35c5-d8e6-478e-8109-e2c792c5ed28">4,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i747d9cadb0334a97b76371c9665c4ff0_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNS03LTEtMS0w_4b2fdb36-3c41-4a6d-aa78-952a0ad3dd10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6195d3f0e2374354b38eb0cc2ab77d14_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNi0xLTEtMS0w_0e0eb4ca-dbe7-40e3-996d-f1d89a20e44f">5,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88ec953e8f554e02994b61549a84b786_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNi0zLTEtMS0w_1c39cd13-6b19-4072-8f3c-67825d07e1dd">2,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i210b958efc1e4be3928a76fb8c2b4d1b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNi01LTEtMS0w_762ac765-9c71-4775-b8d9-37c407002a8f">5,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id68539b93ebe41578d0997661f7c7067_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNi03LTEtMS0w_36d63ad1-739e-4669-8523-36cad0cb1efe">3,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock potentially issuable for ESPP purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i635b1aa8136841889975e9745d917b9f_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNy0xLTEtMS0w_fa729b9c-ae27-4d5b-bec5-6827600f05aa">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70906b8925394dfeb8414b49b6c11841_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNy0zLTEtMS0w_6eae8480-4040-48e3-a527-292cbd8691e6">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7b754b4139a4554aa9b7b4108bd3cb4_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNy01LTEtMS0w_d3552162-5885-464e-88e1-8784ad25a1f0">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9cfa47a706aa4d73921235a75ded8670_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNy03LTEtMS0w_4dac7772-f873-471e-92c3-0d191b7c5439">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Company&#8217;s common stock held by the NQDC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6a4e7a972ff46bea3882f3ced06ea4b_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOC0xLTEtMS0w_7404050d-d93f-4c6f-a6cf-bca5cb4deb9e">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i857f8284e96b4d529652faaf70a41f4f_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOC0zLTEtMS0w_08cf2464-0a17-486f-8bb1-b14e155b0139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7718da1375c940c7aad6f404d81e8204_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOC01LTEtMS0w_a7deb219-c719-460a-9992-429e6cdd5a0e">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a415fe6e6094b7ab63c7d3ca2b9aa95_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOC03LTEtMS0w_c6db50c3-6832-47c5-9943-bad0de35314f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total number of potentially issuable shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOS0xLTEtMS0w_32648edf-0aff-463e-8cc4-58482c50a62c">21,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOS0zLTEtMS0w_ee8ebaae-69cf-4e8e-a5e6-96fd73e85607">8,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOS01LTEtMS0w_631adbee-a89c-40cc-8365-63bddce5e1e9">21,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOS03LTEtMS0w_c35d0fa8-5ff5-43c6-a92f-908e183a5480">8,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company&#8217;s <ix:nonFraction unitRef="number" contextRef="ic20a7b693de94d51a8059e3b28b30754_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfODAw_a372ffb6-f7c2-4fbf-8653-175053e81617">1.50</ix:nonFraction>% senior subordinated convertible notes due in October 2020 (the 2020 Notes) matured on October 15, 2020 and were settled in cash. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The potential effect of the capped call transactions and potential shares issuable under the 2020 Notes were excluded from the calculation of diluted net income (loss) per share in the three and nine months ended September&#160;30, 2020, as the Company&#8217;s closing price on September&#160;30, 2020 did not exceed the conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib965f565ed34406a849028c30350f306_I20200930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfMTIxMw_fa5b7561-52e3-4764-9894-61ca0074ff66">94.15</ix:nonFraction> per share. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There is no similar capped call transaction associated with the 2024 Notes or the 2027 Notes.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(14) <ix:nonNumeric contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMjM3OA_da75a051-cc67-4e7b-844e-7714ba614263" continuedAt="iba59fdf4d3f646eda87a16d35e29699e" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="iba59fdf4d3f646eda87a16d35e29699e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time the Company is involved in legal actions arising in the normal course of its business. The process of</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">resolving matters through litigation or other means is inherently uncertain and it is possible that an unfavorable resolution of these</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">matters could adversely affect the Company, its results of operations, financial condition or cash flows. The Company&#8217;s general</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">practice is to expense legal fees as services are rendered in connection with legal matters, and to accrue for liabilities when losses are probable and reasonably estimable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contingent Payments</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company was subject to contingent payments totaling approximately $<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfNzEx_4381d491-c1d4-4d78-b424-c4e20fc731f6">708.8</ix:nonFraction> million upon achievement of certain development and regulatory activities and commercial sales milestones if they occur before certain dates in the future. Of this amount, $<ix:nonFraction unitRef="usd" contextRef="ib0c45fdc691545eca329a4b5abc34572_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfODc4_9bab2276-eb04-4e47-ad37-8d12c8e554f6">70.0</ix:nonFraction> million were considered probable and comprised of commercial milestones related to the acquisition of certain rights and other assets with respect to Kuvan and Palynziq from a third party, $<ix:nonFraction unitRef="usd" contextRef="i0f2e2c7117c147a3bf29ed90d8327de7_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMTA2Mg_66964ff2-d439-44c5-8834-e489c06a21ef">405.5</ix:nonFraction> million were considered reasonably possible and primarily related to development milestones and $<ix:nonFraction unitRef="usd" contextRef="i5eacd8a06aed4d4fa25cd448dd9cefbe_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="bmrn:ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMTIyNg_86312f09-7e79-4633-95c7-6135ec8d9837">233.3</ix:nonFraction> million were considered remote as the Company is no longer developing the related programs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the fair value of contingent liabilities recorded on the Company&#8217;s Condensed Consolidated Balance Sheet was $<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMTQzMg_de8001cf-bdf2-4a14-a78d-32a9394d581d">63.4</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMTQ0NA_5d97b9a4-39ef-4182-b860-245538ea7dec">48.2</ix:nonFraction> million was short term. See Note 7 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to these Condensed Consolidated Financial Statements for further information regarding the fair value of the Company&#8217;s contingent consideration. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses experts and laboratories at universities and other institutions to perform certain research and development (R&amp;D) activities. These amounts are included as R&amp;D expense as services are provided. In the normal course of business, the Company enters into various firm purchase commitments primarily related to active pharmaceutical ingredients, certain inventory-related items and certain third-party R&amp;D services. As of September&#160;30, 2021, such commitments and other minimum contractual obligations for clinical and post-marketing services were estimated at approximately $<ix:nonFraction unitRef="usd" contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMjIzNQ_bb37a454-ac03-48c9-ba92-dbc9558b063a">107.7</ix:nonFraction> million. The Company has also licensed technology, for which it is required to pay royalties upon future sales, subject to certain annual minimums.</span></div></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-90pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The following discussion of our financial condition and results of operations should be read in conjunction with our Condensed Consolidated Financial Statements and the related Notes thereto included in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. When reviewing the discussion below, you should keep in mind the substantial risks and uncertainties that could impact our business. In particular, we encourage you to review the risk factor related to the impact of the coronavirus pandemic, &#8220;The COVID-19 pandemic could continue to materially adversely affect our business, results of operations and financial condition.&#8221; described in &#8220;Risk Factors&#8221; in Part II, Item&#160;1A in this Quarterly Report on Form 10-Q, amongst the other risk factors. These risks and uncertainties could cause actual results to differ significantly from those projected in forward-looking statements contained in this report or implied by past results and trends. Forward-looking statements are statements that attempt to forecast or anticipate future developments in our business, financial condition or results of operations. See the section titled &#8220;Forward-Looking Statements&#8221; that appears at the beginning of this Quarterly Report on Form 10-Q. These statements, like all statements in this report, speak only as of the date of this Quarterly Report on Form 10-Q (unless another date is indicated), and, except as required by law, we undertake no obligation to update or revise these statements in light of future developments. Our Condensed Consolidated Financial Statements have been prepared in accordance with United States (U.S.) generally accepted accounting principles (U.S GAAP) and are presented in U.S. Dollars (USD).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions, except as otherwise disclosed)</span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a global biotechnology company that develops and commercializes innovative therapies for people with serious</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and life-threatening rare diseases and medical conditions. We select product candidates for diseases and conditions that represent</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market or offer a</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">significant benefit over existing products.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our portfolio consists of several commercial therapies and multiple clinical and preclinical product candidates. A summary of our commercial products, as of September&#160;30, 2021, is provided below:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.377%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commercial Products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States Orphan Drug Exclusivity </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expiration </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States Biologic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exclusivity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expiration</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">European Union Orphan Drug Exclusivity </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expiration </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldurazyme (laronidase)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;MPS I (3) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brineura (cerliponase alfa)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;CLN2 (4) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kuvan (sapropterin dihydrochloride)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;PKU (5) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not Applicable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Naglazyme (galsulfase)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;MPS VI (6) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palynziq (pegvaliase-pqpz)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;PKU (7) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vimizim (elosulfase alpha)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;MPS IVA (8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voxzogo (vosoritide) (9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Achondroplasia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not Applicable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Not Applicable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2031</span></td></tr></table></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">See &#8220;Government Regulation&#8212;Orphan Drug Designation&#8221; in Part I, Item 1 of our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021 for further discussion</span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">See &#8220;Government Regulation&#8212; Healthcare Reform&#8221; in Part I, Item 1 of our Annual Report on Form 10-K for the year ended December 31, 2020 for further discussion</span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">For the treatment of Mucopolysaccharidosis I (MPS I)</span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">For the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2)</span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">For the treatment of phenylketonuria (PKU)</span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">For the treatment of Mucopolysaccharidosis VI (MPS VI)</span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">For adult patients with PKU</span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">For the treatment of Mucopolysaccharidosis IV Type A (MPS IVA)</span></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">Voxzogo (formerly known as vosoritide) was approved by the European Commission (EC) in August 2021 and our New Drug Application (NDA) submission for Voxzogo is under review by the U.S. Food and Drug Administration (FDA) with a Prescription Drug User Fee Act (PDUFA) target action date of November 20, 2021.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of our on-going major development programs, as of September&#160;30, 2021, is provided below:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.652%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.296%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Major Product Candidates<br/>in Development</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Target<br/>Indication</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. Orphan<br/>Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EU Orphan<br/>Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stage</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valoctocogene roxaparvovec</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Severe Hemophilia A</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Phase 3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voxzogo (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Achondroplasia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Phase 3</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BMN 307</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PKU</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Phase 1/2</span></td></tr></table></div><div style="margin-top:6pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;In August 2021, the EC granted marketing approval for Voxzogo in Europe and our NDA submission for Voxzogo is under review by the FDA.</span></div><div style="margin-top:9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Uncertainty Relating to the COVID-19 Pandemic</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to affect economies and business around the world. Our global revenue sources, mostly in the form of demand interruptions such as missed patient infusions and delayed treatment starts for new patients, and our overall business operations were impacted by the COVID-19 pandemic during the nine months ended September&#160;30, 2021 and 2020, and we anticipate a continued impact due to the COVID-19 pandemic on our financial results for the remainder of 2021. The extent and duration of such effects remain uncertain and difficult to predict, particularly as virus variants continue to spread. We are </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions, except as otherwise disclosed)</span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">actively monitoring and managing our response and assessing actual and potential impacts to our operating results and financial condition, as well as developments in our business, which could further impact the developments, trends and expectations described below. See the risk factor related to the impact of the coronavirus pandemic, &#8220;The COVID-19 pandemic could continue to materially adversely affect our business, results of operations and financial condition.&#8221; described in &#8220;Risk Factors&#8221; in Part II, Item&#160;1A of this Quarterly Report, for additional details on the impact of the COVID-19 pandemic. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Developments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continued to advance our product candidate pipeline during 2021. We believe that the combination of our internal research programs, acquisitions and partnerships will allow us to continue to develop and commercialize innovative therapies for people with serious and life-threatening rare diseases and medical conditions. Below is a summary of key business developments:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Continued Emphasis on Research and Development</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">Voxzogo &#8211; During the quarter, the EC approved Voxzogo for the treatment of children, ages two years and older. The commercial launch of Voxzogo in Europe is underway, with revenues for the remainder of 2021 expected from France, Germany and select early-access countries. Marketing authorization reviews are in process in Japan, Brazil and Australia, with potential approvals in those countries in 2022. The FDA is reviewing the Voxzogo NDA with the PDUFA target action date of November 20, 2021.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">Valoctocogene roxaparvovec &#8211; The European Medicines Agency (EMA) validated our Marketing Authorization Application for valoctocogene roxaparvovec resulting in an anticipated Committee for Medicinal Products for Human Use opinion in the first half of 2022, assuming favorable results from the two-year follow-up safety and efficacy data from the GENEr8-1 study. In the U.S., we are targeting a Biologics License Application resubmission for valoctocogene roxaparvovec in the second quarter of 2022 also assuming favorable results from the two-year follow-up safety and efficacy data from the GENEr8-1 study, followed by an expected six-month review procedure by the FDA.</span></div><div style="margin-top:6pt;padding-left:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In July 2021, we announced new data from our Phase 3 study, GENEr8-1, at the International Society on Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress. The pivotal study demonstrated superiority to Factor VIII prophylaxis in key clinical efficacy endpoints. Over 90 percent of all participants in the GENEr8-1 study (N=134) had an Annualized Bleed Rate (ABR) of zero or a lower bleed rate than baseline after week 4 following treatment with valoctocogene roxaparvovec. Mean annualized Factor VIII utilization rate, among a pre-specified group of prior participants in a non-interventional baseline observational study (rollover population; N=112) decreased from baseline on Factor VIII prophylaxis by 99% from 3961.2 (median 3754.4) to 56.9 (median 0) IU/kg/year after week 4 after treatment with valoctocogene roxaparvovec (p-value &lt;0.001).</span></div><div style="margin-top:6pt;padding-left:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we announced at ISTH new data from our open-label Phase 1/2 study with valoctocogene roxaparvovec. Five-year and four-year post-treatment follow-up of the 6e13 vg/kg and 4e13 vg/kg cohorts, respectively, demonstrated that all participants in both cohorts remain off prophylactic Factor VIII treatment. The mean ABR in year five for the 6e13 vg/kg cohort was 0.7 with an ABR reduction of 95% and Factor VIII use reduction of 96% through five years, compared to pre-infusion. The mean ABR in year four for the 4e13 vg/kg cohort was 1.7 with a mean cumulative ABR reduction of 92% and Factor VIII use reduction of 95% through four years, compared to pre-infusion. Mean Factor VIII activity levels of 11.6 IU/dL in year five for the 6e13 vg/kg cohort and 5.6 IU/dL in year four for the 4e13 vg/kg cohort as measured by the Chromogenic Substrate Assay.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">BMN 307 &#8211; our gene therapy product candidate for PKU. In September 2021, the FDA placed a clinical hold on PHEarless, our Phase 1/2 study evaluating BMN 307, an investigational AAV5-phenylalanine hydroxylase gene therapy, in adults with PKU. The hold was based on pre-clinical study findings from a model designed to understand the durability of BMN 307 activity in mice bearing two germline mutations, one rendering the mice immunodeficient. The clinical significance of these findings is being evaluated to assure safe and appropriate use of BMN 307. To date, findings appear specific to mice and have no known translatability to humans or other gene therapy vectors. We are working with health authorities to address the clinical hold and resume study investigations, as appropriate.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">BMN 255 &#8211; for the treatment of a subset of chronic renal disease. The Investigational New Drug application (IND) for BMN 255 is active and we are dosing subjects. Kidney damage can progress to end stage renal disease, and the availability of a potent, orally bioavailable, small molecule like BMN 255, may be able to significantly reduce disease and treatment burden in certain people with chronic renal disease.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">BMN 331 &#8211; for the treatment of Hereditary Angioedema (HAE). We are leveraging our broad expertise in gene therapy to improve efficiencies in the development process of BMN 331. The IND for BMN 331 has been allowed by FDA and the first patient is expected to be enrolled around the end of 2021. Patients with HAE may experience benefit from the constitutive expression and stable C1-INH protein levels potentially provided by gene </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions, except as otherwise disclosed)</span></div></div><div style="margin-top:6pt;padding-left:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">therapy, thus reducing the frequency and severity of attacks and reducing the burden associated with current standard of care.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">BMN 351 &#8211; an antisense oligonucleotide therapy for individuals with 51-skip-amenable Duchenne Muscular Dystrophy. IND-enabling studies continue. BMN 351 was developed using familiar chemistry and superior biology, by targeting a novel, upstream, splice enhancer site demonstrating improved binding affinity and metabolic stability in preclinical models. Preclinical data suggest that restored expression of near-full-length dystrophin protein at previously achieved levels of up to 40% will convert phenotypes from rapid loss to durable preservation of strength and ambulation. We anticipate filing an IND for BMN 351 in the first half of 2022.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Highlights</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Key components of our results of operations include the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">476.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,408.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">398.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development (R&amp;D) expense</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">471.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative (SG&amp;A) expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization and contingent consideration</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of nonfinancial assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-operating income (expense), net</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(846.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(839.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.5)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">837.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Net Loss for the three months ended September&#160;30, 2021 as compared to the Net Income for the three months ended September&#160;30, 2020 was primarily attributed to:</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">decreased benefit from income taxes of $836.3 million, primarily due to the completion of an intra-entity transfer of certain intellectual property (IP) rights to an Irish subsidiary where our Ex-US regional headquarters are located and we have significant manufacturing and commercial operations, to better align ownership of IP rights with how the business operates, resulting in a tax benefit of $835.1 million based on the fair value of the transferred IP rights in the three months ended September 30, 2020. There was no similar transaction in the three months ended September 30, 2021; partially offset by</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">an increase in gross profit primarily driven by the absence of the $81.2 million inventory charge related to pre-launch valoctocogene roxaparvovec inventory reserves following regulatory responses received requesting additional data extending the anticipated regulatory approval timelines in the three months ended September 30, 2020.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Net Loss for the nine months ended September&#160;30, 2021 as compared to the Net Income for the nine months ended September&#160;30, 2020 was primarily attributed to:</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">decreased benefit from income taxes of $836.5 million, primarily due to the completion of an intra-entity transfer of certain IP rights to an Irish subsidiary where our Ex-US regional headquarters are located and we have significant manufacturing and commercial operations, to better align ownership of IP rights with how the business operates, resulting in a tax benefit of $835.1 million based on the fair value of the transferred IP rights in the three months ended September 30, 2020. There was no similar transaction in the three months ended September 30, 2021; and</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">decreased gain on sale of nonfinancial assets of $59.5 million due to the divestiture and sale of the Firdapse business in the three months ended March 31, 2020; partially offset by</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">an increase in gross profit primarily driven by the absence of the $81.2 million inventory charge related to pre-launch valoctocogene roxaparvovec inventory reserves following regulatory responses received requesting additional data extending the anticipated regulatory approval timelines in the three months ended September 30, of 2020. </span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See &#8220;Results of Operations&#8221; below for additional information related to the Net Income fluctuations presented above. Our cash, cash equivalents and investments totaled $1.55 billion as of September&#160;30, 2021 compared to $1.35 billion as of December 31, 2020. We have historically financed our operations primarily through our cash flows from operating activities and the issuance </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions, except as otherwise disclosed)</span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of common stock and convertible debt. We will be highly dependent on our net product revenues to supplement our current liquidity and fund our operations for the foreseeable future. We may in the future elect to supplement this with further debt or equity offerings or commercial borrowing. Further, depending on market conditions, our financial position and performance and other factors, we may in the future choose to use a portion of our cash, cash equivalents or investments to repurchase our convertible debt or other securities. See &#8220;Financial Position, Liquidity and Capital Resources&#8221; below for a further discussion of our liquidity and capital resources.</span></div><div style="margin-top:10pt;text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_88"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Critical Accounting Policies, Estimates and Judgments</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In preparing our Condensed Consolidated Financial Statements in accordance with U.S. GAAP and pursuant to the rules and regulations promulgated by the Securities and Exchange Commission (the SEC), we make assumptions, judgments and estimates that can have a significant impact on our net income/loss and affect the reported amounts of certain assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, we evaluate our estimates and discuss our critical accounting policies and estimates with the Audit Committee of our Board of Directors. We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The full extent to which the ongoing COVID-19 pandemic could continue to directly or indirectly impact our business, results of operations and financial condition, including revenues, expenses, reserves and allowances, manufacturing, clinical trials and research and development costs will depend on future developments that continue to remain uncertain at this time, particularly as virus variants continue to spread. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no significant changes to our critical accounting policies, estimates and judgments during the nine months ended September&#160;30, 2021, compared to the critical accounting policies, estimates and judgments disclosed in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="margin-top:12pt;text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_91"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 4 to our accompanying Condensed Consolidated Financial Statements for a description of recent accounting pronouncements and our expectation of their impact on our results of operations and financial condition.</span></div><div style="margin-top:10pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except as otherwise disclosed)</span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net Product Revenues</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net Product Revenues consisted of the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues by product:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vimizim</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Naglazyme</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kuvan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palynziq</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brineura</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voxzogo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Firdapse</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues marketed by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,245.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,239.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldurazyme net product revenues marketed by Sanofi Genzyme</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,348.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,368.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net Product Revenues include revenues generated from our approved products. In the U.S., our commercial products, except for Palynziq and Aldurazyme, are generally sold to specialty pharmacies or end-users, such as hospitals, which act as retailers. Palynziq is distributed in the U.S. through certain certified specialty pharmacies under the Palynziq Risk Evaluation and Mitigation Strategy (REMS) program, and Aldurazyme is marketed worldwide by Sanofi Genzyme (Genzyme). Outside the U.S., our commercial products are sold to authorized distributors or directly to government purchasers or hospitals, which act as the end-users. In certain countries, governments place large periodic orders for our products. The timing of these large government orders can be inconsistent and can create significant quarter to quarter variation in our revenues.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The decrease in Net Product Revenues for the three months ended September&#160;30, 2021 as compared to the three ended September&#160;30, 2020 was primarily attributed to the following:</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a decrease in Kuvan product revenues primarily due to generic competition due to the loss of exclusivity in the U.S.;</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a decrease in Aldurazyme product revenues due to timing of product fulfillment to Genzyme; and</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a decrease in Vimizim and Naglazyme product revenues primarily driven by timing of orders from Europe and the Middle East; partially offset by</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">an increase in Palynziq product revenues primarily due to a combination of revenues from more patients in the U.S. achieving maintenance dosing and new patients initiating therapy and to a lesser extent incremental growth in the European, Middle East and African (EMEA) region; and</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">an increase in Brineura product revenues due to new patients initiating therapy driven by growth in EMEA and North America.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The decrease in Net Product Revenues for the nine months ended September&#160;30, 2021 as compared to the nine ended September&#160;30, 2020 was primarily attributed to the following:</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a decrease in Kuvan product revenues due to generic competition due to the loss of exclusivity in the U.S.;</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a decrease in Aldurazyme revenues due to timing of product fulfillment to Genzyme; partially offset by</span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">an increase in Vimizim and Naglazyme product revenues primarily driven by larger government orders primarily from Europe and the Middle East; and </span></div><div style="margin-top:6pt;padding-left:67.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">an increase in Palynziq revenues primarily due to a combination of revenue from more U.S. patients achieving maintenance dosing and new patients initiating therapy and to a lesser extent incremental growth in the EMEA region. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except as otherwise disclosed)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We anticipate the COVID-19 pandemic could have a continued impact on future Net Product Revenues during the remainder of 2021 as many of our products are administered via infusions in a clinic or hospital setting and/or by a healthcare professional. Although we worked with our patient community and health care providers to find alternative arrangements where necessary, such as providing infusions at home, the revenues from the doses of our products that were missed by patients and the lost revenues from delayed treatment starts for new patients will never be recouped. See the risk factor &#8220;The COVID-19 pandemic could continue to materially adversely affect our business, results of operations and financial condition&#8221; in &#8220;Risk Factors&#8221; included in Part II, Item 1A of this Quarterly Report for additional information. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In October 2020, we lost U.S market exclusivity for Kuvan. We anticipated and prepared for this loss of exclusivity and the reduction in our market share, as well as the adverse effect on our revenues and results of operations. We may continue to experience adverse effects on our market share and revenues in the future. See the risk factor &#8220;The sale of generic versions of Kuvan by generic manufacturers has adversely affected and will continue to adversely affect our revenues and results of operations&#8221; in &#8220;Risk Factors&#8221; included in Part II, Item 1A of this Quarterly Report for additional information. Additionally, we received European approval for Voxzogo in the third quarter of 2021 and are focused on markets where early market access and reimbursement are possible, such as France and Germany. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We face exposure to movements in foreign currency exchange rates, primarily the Euro. We use foreign currency exchange contracts to hedge a percentage of our foreign currency exposure. The following table shows our Net Product Revenues denominated in USD and foreign currencies:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales denominated in USD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">846.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales denominated in foreign currencies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">522.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,348.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,368.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Favorable (unfavorable) impact of foreign currency exchange rates on product sales denominated in currencies other than USD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The unfavorable impact in the three months ended September 30, 2021 was primarily driven by the weakening of the Argentinian Peso relative to the USD, partially offset by the strengthening of the Canadian Dollar and Great British Pound. The favorable impact for the nine months ended September 30, 2021 was largely driven by the strengthening of the Euro, Great British Pound, Australian Dollar and Canadian Dollar, partially offset by the weakening of the Argentinian Peso and Brazilian Real relative to the USD. This compares to an unfavorable impact for the three and nine months ended September 30, 2020, which were driven primarily by weakening of currencies in certain Latin American markets, such as the Brazilian Real and Colombian Peso relative to the USD.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Royalty and Other Revenues</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Royalty and Other Revenues include royalties earned on net sales of products sold and milestones achieved by licensees or sublicensees and rental income associated with the tenants in our facilities.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total royalty and other revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The decrease in Royalty and Other Revenues for the three months ended September&#160;30, 2021 compared to the same period in 2020 was primarily due to lower licensing revenues earned from third parties. The increase in Royalty and Other </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except as otherwise disclosed)</span></div></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues for the nine months ended September&#160;30, 2021 compared to the same period in 2020 was primarily due to a license payment received from a third party due to their achievement of a regulatory milestone in the three months ended March 31, 2021. </span></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect to continue to earn royalties from third parties in the future.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales and Gross Margin</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of Sales includes raw materials, personnel and facility and other costs associated with manufacturing our commercial products. These costs include production materials, production costs at our manufacturing facilities, third-party manufacturing costs, and internal and external final formulation and packaging costs. Cost of Sales also includes royalties payable to third parties based on sales of our products and charges for inventory valuation reserves. Gross margin is calculated on Total Revenues, which includes Royalty and Other Revenues that usually do not have associated costs.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes our Cost of Sales and gross margin:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#fefefe;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">476.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,408.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">398.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of Sales decreased for the three and nine months ended September&#160;30, 2021 compared to the same periods in 2020 primarily due to the $81.2 million pre-launch valoctocogene roxaparvovec inventory charge following regulatory responses received in third quarter of 2020 requesting additional data extending the anticipated regulatory approval timelines. Gross margin for the three and nine months ended September&#160;30, 2021 compared to the same periods in 2020 increased primarily due to the pre-launch valoctocogene roxaparvovec inventory charge in the three months ended September 30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">R&amp;D expense includes costs associated with the research and development of product candidates and post-marketing research commitments related to our approved products. R&amp;D expense primarily includes preclinical and clinical studies, personnel and raw materials costs associated with manufacturing clinical product, quality control and assurance, other R&amp;D activities, facilities and regulatory costs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We manage our R&amp;D expense by identifying the R&amp;D activities we anticipate will be performed during a given period and then prioritizing efforts based on scientific data, probability of successful development, market potential, available human and capital resources and other similar considerations. We continually review our product pipeline and the development status of product candidates and, as necessary, reallocate resources among the research and development portfolio that we believe will best support the future growth of our business. Continued material investment in R&amp;D activities that we have strategically prioritized remains a core component of our business model and future growth plans. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We evaluate the recoverability of costs associated with pre-launch manufacturing activities and capitalize the costs incurred if recoverability is highly likely. We have capitalized $4.8&#160;million of manufacturing-related costs for Voxzogo pre-launch inventory as of September&#160;30, 2021. Voxzogo, which was granted marketing approval in the EU on August 27, 2021, is still a product candidate in other regions, including the U.S. See Note 6 to our accompanying Consolidated Financial Statements for additional information regarding our inventory. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except as otherwise disclosed)</span></div></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">R&amp;D expense consisted of the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and early development</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valoctocogene roxaparvovec</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voxzogo</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.8&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Approved products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BMN 307</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total R&amp;D expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.9&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147.1&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467.7&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">471.4&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The increase in R&amp;D expense for the three months ended September&#160;30, 2021 as compared to the same period in 2020 primarily comprised the following:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">higher spend in research and early development programs due to increased pre-clinical activities and a $10.0 million development milestone earned by a third party in the three months ended September 30, 2021; partially offset by</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">a reduction in clinical activities related to approved products as the long-term post marketing studies were completed;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">a decrease in Voxzogo manufacturing costs for which capitalization began in the three months ended March 31, 2021 for estimated European demand; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">a decrease in BMN 307 manufacturing costs due to clinical manufacturing activities that occurred during 2020.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The decrease in R&amp;D expense for the nine months ended September&#160;30, 2021 as compared to the same period in 2020 primarily comprised the following:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">a reduction in clinical activities related to approved products as the long-term post marketing studies were completed;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">a decrease in BMN 307 manufacturing costs due to clinical manufacturing activities that occurred during 2020;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">a decrease in clinical trial activities related to valoctocogene roxaparvovec as patients transitioned to the monitoring phase of the study; partially offset by</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">higher spend in research and early development programs due to increased pre-clinical activities and a $10.0 million development milestone earned by a third party in the three months ended September 30, 2021.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect R&amp;D expense to increase in future periods, primarily due to increased activities for our research and early development programs while we continue to develop our later stage programs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing (S&amp;M) expense primarily consisted of employee-related expenses for our sales group, brand marketing, patient support groups and pre-commercialization expenses related to our product candidates. General and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except as otherwise disclosed)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">administrative (G&amp;A) expense primarily consisted of corporate support and other administrative expenses, including administrative employee-related expenses.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">SG&amp;A expenses consisted of the following: </span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S&amp;M expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">G&amp;A expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total SG&amp;A expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.3&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179.5&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541.8&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542.2&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">S&amp;M expenses by product were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PKU Products (Kuvan and Palynziq)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MPS Products (Aldurazyme, Naglazyme and Vimizim)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voxzogo</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valoctocogene roxaparvovec</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brineura</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total S&amp;M expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.1&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293.0&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The decrease in S&amp;M expense for the three and nine months ended September&#160;30, 2021 as compared to the same periods in 2020 was primarily due to a reduction in valoctocogene roxaparvovec activities based on a change in anticipated timelines for potential approval following regulatory responses received in the third quarter of 2020 requesting additional data, partially offset by an increase in pre-commercialization activities related to Voxzogo. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The increase in G&amp;A expense for the three months ended September&#160;30, 2021 as compared to the same period in 2020 was primarily due to the idle plant time related to maintaining our valoctocogene roxaparvovec manufacturing capabilities. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">G&amp;A expense for the nine months ended September&#160;30, 2021 compared to the same period in 2020 was relatively flat.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect SG&amp;A expense to increase in future periods as a result of preparing to launch new products and support of our global business as it grows.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except as otherwise disclosed)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible Asset Amortization and Contingent Consideration and Gain on Sale of Nonfinancial Assets</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes during the periods presented for Intangible Asset Amortization and Contingent Consideration and Gain on Sale of Nonfinancial Assets were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="background-color:#fefefe;padding:0 1pt"></td><td colspan="15" style="background-color:#fefefe;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in the fair value of contingent consideration (gain) / loss</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible asset amortization and contingent consideration</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of nonfinancial assets</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59.5)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of contingent consideration &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the increase in the fair value of contingent consideration for the nine months ended September&#160;30, 2021 as compared to the same period in 2020 was attributable to changes in the estimated probability of achieving sales milestones related to our PKU products.</span></div><div style="margin-top:6pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Amortization of intangible assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#8211; the expense for the three and nine months ended September&#160;30, 2021 as compared to the same periods in 2020 was relatively flat.</span></div><div style="margin-top:6pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Gain on Sale of Nonfinancial Assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#8211; the decrease in the nine months ended September&#160;30, 2021 is due to the recognition of a gain of $59.5 million in the nine months ended September&#160;30, 2020 related to the divestiture and sale of the Firdapse business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We invest our cash equivalents and investments in U.S. government securities and other high credit quality debt securities in order to limit default and market risk. Interest Income was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest Income for the three and nine months ended September&#160;30, 2021 decreased as compared to same period in 2020 primarily due to lower interest rates and total portfolio returns.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect interest income to be lower over the next 12 months due to lower interest rates and yields on our cash equivalents and investments. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We incur interest expense primarily on our convertible debt. Interest Expense for the periods presented was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest Expense for the three and nine months ended September&#160;30, 2021 compared to 2020 was lower due primarily to the settlement of the 2020 Notes in the fourth quarter of 2020. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect interest expense to fluctuate significantly over the next 12 months. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except as otherwise disclosed)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Other Income, Net for the periods presented was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other Income, Net for the three and nine months September 30, 2021 increased compared to the same periods in 2020 primarily due to the receipt of insurance proceeds in excess of direct costs incurred in the third quarter of 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Benefit from Income Taxes</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes our income tax benefit:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(846.0)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836.3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(839.1)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836.5&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Tax benefit was computed using a forecasted annual effective tax rate for the three and nine months ended September&#160;30, 2021 and 2020. The Benefit from Income Taxes for the three and nine months ended September&#160;30, 2021 and 2020 consisted of state, federal and foreign current tax expense which was offset by tax benefits related to stock option exercises and deferred tax benefits from federal orphan drug credits and R&amp;D credits.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the three month ended September 30, 2020, we completed an intra-entity transfer of certain IP rights to an Irish subsidiary where our Ex-US regional headquarters are located. The transaction did not result in a taxable gain however, our Irish subsidiary recognized a deferred tax asset for the book and tax basis difference of the transferred IP. As a result, we recognized a deferred tax asset of $835.1 million, and related tax benefit on our Condensed Consolidated Financial Statements based on the fair value of the transferred intellectual property rights.</span></div><div><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financial Position, Liquidity and Capital Resources </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had $1.55 billion in cash, cash equivalents and investments. We expect to fund our operations with our net product revenues from our commercial products, cash, cash equivalents and investments, supplemented as may become necessary by proceeds from equity or debt financings and loans, or collaborative agreements with corporate partners. We believe that our existing cash, cash equivalents and investments and cash we expect to generate from operations will be sufficient to satisfy our liquidity requirements for the next 12 months. We may require additional financing to fund the repayment of our convertible debt, future milestone payments and our future operations, including the commercialization of our products and product candidates currently under development, preclinical studies and clinical trials, and potential licenses and acquisitions. We will need to raise additional funds from equity or debt securities, loans or collaborative agreements if we are unable to satisfy our liquidity requirements. The timing and mix of our funding options could change depending on many factors, including how much we elect to spend on our development programs, potential licenses and acquisitions of complementary technologies, products and companies or if we elect to settle all or a portion of our convertible debt in cash. Our ability to raise additional capital may also be adversely impacted by potential worsening global economic conditions and the recent disruptions to, and volatility in, financial markets in the U.S. and worldwide resulting from the ongoing COVID-19 pandemic.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In managing our liquidity needs in the U.S., we do not rely on unrepatriated earnings as a source of funds. As of September&#160;30, 2021, $192.3 million of our $1.55 billion balance of cash, cash equivalents and investments was held in non-U.S. subsidiaries, a significant portion of which is required to fund the liquidity needs of these non-U.S. subsidiaries. For additional discussion regarding income taxes, see Note 18 to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are mindful that conditions in the current macroeconomic environment could affect our ability to achieve our goals. We sell our products in countries that face economic volatility and weakness. Although we have historically collected receivables from customers in such countries, sustained weakness or further deterioration of the local economies and currencies and adverse effects of the impact of the ongoing COVID-19 pandemic may cause customers in those countries to be unable to pay for our products. We will continue to monitor these conditions and will attempt to adjust our business processes, as appropriate, to mitigate macroeconomic risks to our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except as otherwise disclosed)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our liquidity and capital resources as of September&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">617.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and investments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,350.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total convertible debt, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,075.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our cash flows for the nine months ended September&#160;30, 2021 and 2020 are summarized as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">437.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(310.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(246.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(561.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at the end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">617.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(398.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term and long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">929.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">755.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,770.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(224.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash Provided by Operating Activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by operating activities increased by $194.7 million to $293.4 million in the nine months ended September&#160;30, 2021, compared to cash provided by operating activities of $98.7 million in the nine months ended September&#160;30, 2020. The increase was primarily attributed to the timing of cash receipts from our customers and licensees, lower employee compensation related payments and tax refund proceeds.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash Used in Investing Activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities increased by $246.3 million to $310.9 million in the nine months ended September&#160;30, 2021, compared to cash used in investing activities of $64.6 million in the nine months ended September&#160;30, 2020. The increase in cash used in investing activities was primarily attributable to higher net purchases of available-for-sale debt securities and the absence of the proceeds received from divestiture and sale of Firdapse to a third party in the first quarter of 2020 partially offset by lower purchases of property, plant and equipment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash Provided by (Used in) Financing Activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in financing activities increased by $561.7 million to $14.4 million in the nine months ended September&#160;30, 2021, compared to cash provided by financing activities of $547.3 million in the nine months ended September&#160;30, 2020 primarily due to the proceeds from the issuance of the 2027 Notes in the second quarter of 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Other Information</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our $1.1 billion (undiscounted) of total convertible debt as of September&#160;30, 2021 will impact our liquidity due to the semi-annual cash interest payments. As of September&#160;30, 2021, our indebtedness consisted of our 0.599% senior subordinated convertible notes due in 2024 (the 2024 Notes) and our 1.25% senior subordinated convertible notes due in 2027 (the 2027 Notes and together with the 2024 Notes, the Notes), which, if not converted, will be required to be repaid in cash at maturity in August 2024 and May 2027, respectively. We will need cash not only to pay the ongoing interest due on the Notes during their term, but also to repay the principal amount of the Notes if not converted.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2018, we entered into an unsecured revolving credit facility of up to $200.0&#160;million which includes a letter of credit subfacility and a swingline loan subfacility. The credit facility is intended to finance ongoing working capital needs and for other general corporate purposes. In May 2021, we amended the credit facility agreement, extending the maturity date from October&#160;19, 2021 to May&#160;28, 2024, among other changes. The amended credit facility contains financial covenants including a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except as otherwise disclosed)</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">maximum leverage ratio and a minimum interest coverage ratio. As of September&#160;30, 2021, there were no amounts outstanding under the credit facility and we and certain of our subsidiaries that serve as guarantors were in compliance with all covenants.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For additional information related to our convertible debt see Note 9 to our accompanying Condensed Consolidated Financial Statements and Note 13 - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Funding Commitments</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We cannot estimate with certainty the cost to complete any of our product development programs. Additionally, we cannot precisely estimate the time to complete any of our product development programs or when we expect to receive net cash inflows from any of our product development programs. Please see &#8220;Risk Factors&#8221; included in Part II, Item&#160;1A of this Quarterly Report on Form 10-Q, for a discussion of the reasons we are unable to estimate such information.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investment in our product development programs and continued development of our existing commercial products has a major impact on our operating performance. Our R&amp;D expenses for the period since inception as of September&#160;30, 2021 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.263%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Since Program Inception</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valoctocogene roxaparvovec</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">794.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voxzogo</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BMN 307</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224.6&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Approved products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,345.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We may need or elect to increase our spending above our current long-term plans to be able to achieve our long-term goals. This may increase our capital requirements, including: costs associated with the commercialization of our products&#894; additional clinical trials; investments in the manufacturing of our commercial products&#894; preclinical studies and clinical trials for our product candidates; potential licenses and other acquisitions of complementary technologies, products and companies; and general corporate purposes.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including, but not limited to:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">our ability to successfully market and sell our products;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">the time and cost necessary to develop commercial manufacturing processes, including quality systems, and to build or acquire manufacturing capabilities;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">the progress and success of our preclinical studies and clinical trials (including the manufacture of materials for use in such studies and trials);</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">the timing, number, size and scope of our preclinical studies and clinical trials;</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">the time and cost necessary to obtain regulatory approvals and the costs of post-marketing studies which may be required by regulatory authorities; and</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.5pt">the progress of research programs carried out by us.</span></div><div style="margin-top:6pt;padding-left:90pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not have any off-balance sheet arrangements that are currently material or reasonably likely to be material to our consolidated financial position or results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Contractual and Commercial Obligations</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have contractual and commercial obligations under our convertible debt, leases and other obligations related to R&amp;D activities, purchase commitments, licenses and sales royalties with annual minimums. As of September&#160;30, 2021, such commitments and other minimum contractual obligations for clinical and post-marketing services were estimated at approximately $107.7 million. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we were also subject to contingent payments totaling approximately $708.8 million upon achievement of certain development and regulatory activities and commercial sales milestones if they occur before certain dates in the future. Of this amount, $70.0 million were considered probable and comprised of commercial milestones related to the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions, except as otherwise disclosed)</span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">acquisition of certain rights and other assets with respect to Kuvan and Palynziq from a third party, $405.5 million were considered reasonably possible and primarily related to development milestones and $233.3 million were considered remote as we are no longer developing the related programs.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the fair value of the contingent liabilities recorded on our Condensed Consolidated Balance Sheet was $63.4 million, of which $48.2 million was short term. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other than as set forth above, there have been no material changes to our contractual and commercial obligations during the nine months ended September&#160;30, 2021, as compared to the obligations disclosed in Management&#8217;s Discussion and Analysis in our Annual Report on Form 10-K for the year ended December&#160;31, 2020. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_106"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="padding-left:90pt;text-indent:-90pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our market risks during the nine months ended September&#160;30, 2021 have not materially changed from those discussed in Part II, Item&#160;7A of our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="text-indent:45pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_109"></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-90pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(a) Controls and Procedures</span></div><div style="margin-top:6pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An evaluation was carried out, under the supervision of and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)), as of the end of the period covered by this report.</span></div><div style="margin-top:6pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Based on the evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective, at the reasonable assurance level, as of September&#160;30, 2021.</span></div><div style="margin-top:6pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In designing and evaluating our disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management must apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Accordingly, our disclosure controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of our disclosure controls system are met.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(b) Change in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting. We continue to utilize the Committee of Sponsoring Organizations of the Treadway Commission (COSO) 2013 Framework on internal control.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_112"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="i37555ce43f7244d3afa231a2a50e7423_115"></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-90pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 25, 2020, a purported shareholder class action lawsuit was filed against us, our Chief Executive Officer, our President of Worldwide Research and Development and our Chief Financial Officer in the United States District Court in the Northern District of California, alleging violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 as amended (the Exchange Act). The complaint alleges that the Company made materially false or misleading statements regarding the clinical trials and Biologics License Application (BLA) for valoctocogene roxaparvovec by purportedly failing to disclose that differences between the Company&#8217;s Phase 1/2 and Phase 3 clinical studies limited the ability of the Phase 1/2 study to support valoctocogene roxaparvovec&#8217;s durability of effect and, as a result, that it was foreseeable that the FDA would not approve the BLA without additional data. The complaint seeks an unspecified amount of damages, pre-judgment and post-judgment interest, attorneys&#8217; fees, expert fees, and other costs. In December 2020, the court hearing the case appointed Arbejdsmarkedets Till&#230;gspension as lead plaintiff. The lead plaintiff filed an amended complaint in February 2021, dropping our Chief Financial Officer as a defendant, and asserting that the Company misled investors about the progress of the FDA's review of our BLA for valoctocogene roxaparvovec. Our motion to dismiss the complaint was filed on April 22, 2021. We believe that the claims have no merit and we intend to vigorously defend this action.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 22, 2021, a purported securities class action lawsuit was filed against us, our Chief Executive Officer, our current and prior Chief Financial Officers, and our President of Worldwide Research &amp; Development in the United States District Court for the Northern District of California, alleging violations under Sections 10(b) and 20(a) of the Exchange Act. The complaint alleges that the Company made materially false or misleading statements regarding BMN 307 by purportedly failing to disclose information about BMN 307&#8217;s safety profile, and by purportedly overstating BMN 307&#8217;s clinical and commercial prospects. The complaint seeks an unspecified amount of damages, pre-judgment and post-judgment interest, attorneys&#8217; fees, expert fees, and other costs. We believe that the claims have no merit and we intend to vigorously defend this action.</span></div><div style="margin-top:6pt;text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_118"></div><div style="margin-top:10pt;padding-left:90pt;text-indent:-90pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">An investment in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">our </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">securities involves a high degree of risk. We operate in a dynamic and rapidly changing industry that involves numerous risks and uncertainties. The risks and uncertainties described below are not the only ones we face. Other risks and uncertainties, including those that we do not currently consider material, may impair our business. If any of the risks discussed below actually occur, our business, financial condition, operating results or cash flows could be materially adversely affected. This could cause the value of our securities to decline, and you may lose all or part of your investment.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have marked with an asterisk (*)&#160;those risk factors below that include a substantive change from or update to the risk factors included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, which was filed with the SEC on February&#160;26, 2021.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Business and Operational Risks</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*The COVID-19 pandemic could continue to materially adversely affect our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 pandemic has resulted in travel restrictions, quarantines, &#8220;work-from-home&#8221; and &#8220;shelter-in-place&#8221; orders and extended shutdown of certain businesses around the world, including in many countries in which we operate. Our global revenue sources, mostly in the form of demand interruptions such as missed patient infusions and delayed treatment starts for new patients, and our overall business operations were impacted by the COVID-19 pandemic, and we expect that the pandemic will continue to adversely impact our financial results and our business generally for at least the remainder of 2021 and potentially longer if the pandemic continues to impact countries in which we operate. Ongoing and future effects of the COVID-19 pandemic (or any future pandemic) on all aspects of our business and operations, including revenues, expenses, reserves and allowances, manufacturing, clinical trials and research and development costs, and the duration of such effects, are highly uncertain and difficult to predict.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 pandemic has adversely affected and will likely continue to adversely impact our product development programs, including preclinical study and clinical trial operations. We have been, and will likely continue to be, unable to initiate or continue conducting clinical trials as originally planned due to the prioritization of hospital resources toward the outbreak, difficulty in recruiting and retaining healthcare providers and staff due to their diversion toward treating COVID-19 patients or their heightened exposure to COVID-19, potential unwillingness of patients to enroll or continue in trials for fear of exposure to COVID-19 at sites, or the inability of patients to comply with clinical trial protocols as quarantines or travel restrictions impede patient movement or otherwise interrupt healthcare services. For example, we experienced delays in certain clinical trials and have had to reevaluate expected timelines for those trials. In addition, we rely on independent clinical investigators, contract research organizations (CROs) and other third-party service providers to assist us in managing, monitoring and otherwise carrying out our preclinical studies and clinical trials, and the outbreak may affect their ability to devote sufficient time and resources to our programs or to travel to sites to perform work for us. Additionally, the COVID-19 pandemic has delayed, and may continue to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">postpone, necessary regulatory inspections and other interactions with regulators regarding our products in development, which could delay review or approval of our regulatory submissions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">COVID-19 could adversely affect our ability to source materials and supplies and successfully manufacture and distribute our product candidates and products. The outbreak could result in reduced operations of third-party suppliers of raw materials and supplies upon whom we rely or otherwise limit our ability to obtain sufficient materials and supplies necessary for production of our therapies. Our manufacturing facilities and those of our contract manufacturers are located in areas impacted by the COVID-19 pandemic, which may result in delays or disruptions in our ability to produce product candidates and products. If we or any third party in our supply or distribution chain are adversely impacted by the COVID-19 pandemic, including as a result of required closures, staffing shortages, production slowdowns and disruptions in delivery systems, our operations may be disrupted, limiting our ability to manufacture and distribute our product candidates for clinical trials and research and development operations and our products for commercial sales. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our commercial operations have also been, and will likely continue to be, adversely impacted by the COVID-19 pandemic. Many of our products are administered via infusions in a clinic or hospital setting and/or by a healthcare professional. Treating COVID-19 patients has become the priority for many healthcare facilities and workers, so it has become, and may continue to be, difficult for some of our patients to receive our therapies that are administered by infusion. Although we are working with our patient community and healthcare providers to find alternative arrangements where necessary, such as providing infusions at home, the revenue from doses of our products that are missed by patients and the lost revenues from delayed treatment starts for new patients will never be recouped. Moreover, some patients may choose to skip infusions because they do not want to risk exposure to COVID-19 by having a healthcare provider administer the therapy at a healthcare facility or at home. The pandemic has also hindered our ability to find new patients and start treating newly found patients, and it has limited our sales force&#8217;s ability to promote our products to distributors, hospitals, clinics, doctors and pharmacies, which could adversely affect our revenues and results of operations. In addition, the COVID-19 pandemic could adversely affect our workforce and the employees of companies with which we do business, thereby disrupting our business operations. We have implemented work-from-home policies for employees whose jobs do not require them to be onsite. Increased reliance by us and the companies with which we do business on personnel working from home may negatively impact productivity, increase cyber security risk, create data accessibility issues, increase the risk for communication disruptions, or otherwise disrupt or delay normal business operations. For our employees whose jobs require them to be onsite, we have taken precautions to avoid the spread of COVID-19 among our employees, but we cannot guarantee our workforce will not face an outbreak that could adversely impact our operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While the long-term economic impact and the duration of the COVID-19 pandemic may be difficult to predict, the pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, which could reduce our ability to access capital and could negatively affect our liquidity and the liquidity and stability of markets for our common stock and convertible notes. In addition, a recession, further market correction or depression resulting from the COVID-19 pandemic could materially adversely affect our business and the value of our common stock and convertible notes.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the extent the COVID-19 pandemic continues to adversely affect our business and financial results, it may also have the effect of heightening many of the other risks described in this Risk Factors section, such as those relating to our conducting a significant amount of our sales and operations outside of the U.S., exposure to changes in foreign exchange rates, our substantial indebtedness, our need to generate sufficient cash flows to service our indebtedness and finance our operations, our ability to comply with the covenants contained in the agreements that govern our indebtedness and the volatility of our stock price.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*Because the target patient populations for our products are small, we must achieve significant market share and maintain high per-patient prices for our products to achieve and maintain profitability.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All of our products target diseases with small patient populations. As a result, our per-patient prices must be relatively high in order to recover our development and manufacturing costs and achieve and maintain profitability. For Brineura, Naglazyme and Vimizim in particular, we must market worldwide to achieve significant market penetration of the product. In addition, because the number of potential patients in each disease population is small, it is not only important to find patients who begin therapy to achieve significant market penetration of the product, but we also need to be able to maintain these patients on therapy for an extended period of time. Due to the expected costs of treatment for our products, we may be unable to maintain or obtain sufficient market share at a price high enough to justify our product development efforts and manufacturing expenses.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*If we fail to obtain and maintain an adequate level of coverage and reimbursement for our products by third-party payers, the sales of our products would be adversely affected or there may be no commercially viable markets for our products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The course of treatment for patients using our products is expensive. We expect patients to need treatment for extended periods, and for some products throughout the lifetimes of the patients. We expect that most families of patients will not be capable of paying for this treatment themselves. There will be no commercially viable market for our products without coverage and reimbursement from third-party payers. Additionally, even if there is a commercially viable market, if the level of reimbursement is below our expectations, our revenues and gross margin will be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Third-party payers, such as government or private healthcare insurers, carefully review and increasingly challenge the prices charged for drugs. Reimbursement rates from private companies vary depending on the third-party payer, the insurance plan and other factors. Obtaining coverage and adequate reimbursement for our products may be particularly difficult because of the higher prices often associated with drugs administered under the supervision of a physician. Reimbursement systems in international markets vary significantly by country and by region, and reimbursement approvals must be obtained on a country-by-country basis.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government authorities and other third-party payers are developing increasingly sophisticated methods of controlling healthcare costs, such as by limiting coverage and the amount of reimbursement for particular medications. Increasingly, third-party payers are requiring that drug companies provide them with predetermined discounts from list prices as a condition of coverage, are using restrictive formularies and preferred drug lists to leverage greater discounts in competitive classes, and are challenging the prices charged for medical products. Further, no uniform policy requirement for coverage and reimbursement for drug products exists among third-party payers in the U.S. Therefore, coverage and reimbursement for drug products can differ significantly from payer to payer. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payer separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We cannot be sure that coverage and reimbursement will be available for any product that we commercialize or will continue to be available for any product that we have commercialized and, if reimbursement is available, what the level of reimbursement will be. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. Coverage and reimbursement may impact the demand for, or the price of, any product candidate for which we obtain marketing approval. If coverage and reimbursement are not available or reimbursement is available only to limited levels, we may not successfully commercialize any product candidate for which we obtain marketing approval or continue to market any product that has already been commercialized.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursement in the European Union (EU) and many other territories must be negotiated on a country-by-country basis and in many countries the product cannot be commercially launched until reimbursement is approved. The timing to complete the negotiation process in each country is highly uncertain, and in some countries, we expect that it will exceed 12 months. Even after a price is negotiated, countries frequently request or require reductions to the price and other concessions over time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For our future products, we will not know what the reimbursement rates will be until we are ready to market the product and we actually negotiate the rates. If we are unable to obtain sufficiently high reimbursement rates for our products, they may not be commercially viable or our future revenues and gross margin may be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If we fail to compete successfully with respect to product sales, we may be unable to generate sufficient sales to recover our expenses related to the development of a product program or to justify continued marketing of a product and our revenues could be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our competitors may develop, manufacture and market products that are more effective or less expensive than ours. They may also obtain regulatory approvals for their products faster than we can obtain them (including those products with orphan drug designation, which may prevent us from marketing our product entirely) or commercialize their products before we do. With respect to valoctocogene roxaparvovec, if the product candidate is approved, we will face a highly developed and competitive market for hemophilia A treatments. As we commercialize valoctocogene roxaparvovec, if approved, we may face intense competition from large pharmaceutical companies with extensive resources and established relationships in the hemophilia A community. If we do not compete successfully, our revenues would be adversely affected, and we may be unable to generate sufficient sales to recover our expenses related to the development of a product program or to justify continued marketing of a product.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Changes in methods of treatment of disease could reduce demand for our products and adversely affect revenues.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Even if our product candidates are approved, if doctors elect a course of treatment which does not include our products, this decision would reduce demand for our products and adversely affect revenues. For example, if gene therapy becomes widely used as a treatment of genetic diseases, the use of enzyme replacement therapy, such as Aldurazyme, Naglazyme, and Vimizim in MPS diseases, could be greatly reduced. Moreover, if we obtain regulatory approval for valoctocogene roxaparvovec, the commercial success of valoctocogene roxaparvovec will still depend, in part, on the acceptance of physicians, patients and healthcare payers of gene therapy products in general, and our product candidate in particular, as medically necessary, cost effective and safe. Changes in treatment method can be caused by the introduction of other companies&#8217; products or the development of new technologies or surgical procedures which may not directly compete with ours, but which have the effect of changing how doctors decide to treat a disease.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If we fail to develop new products and product candidates or compete successfully with respect to acquisitions, joint ventures, licenses or other collaboration opportunities, our ability to continue to expand our product pipeline and our growth and development would be impaired.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our future growth and development depend in part on our ability to successfully develop new products from our research and development activities. The development of biopharmaceutical products is very expensive and time intensive and involves a great degree of risk. The outcomes of research and development programs, especially for innovative biopharmaceuticals, are inherently uncertain and may not result in the commercialization of any products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our competitors compete with us to attract organizations for acquisitions, joint ventures, licensing arrangements or other collaborations. To date, several of our former and current product programs have been acquired through acquisitions and several of our former and current product programs have been developed through licensing or collaborative arrangements, such as Aldurazyme, Kuvan and Naglazyme. These collaborations include licensing proprietary technology from, and other relationships with, academic research institutions. Our future success will depend, in part, on our ability to identify additional opportunities and to successfully enter into partnering or acquisition agreements for those opportunities. If our competitors successfully enter into partnering arrangements or license agreements with academic research institutions, we will then be precluded from pursuing those specific opportunities. Because each of these opportunities is unique, we may not be able to find a substitute. Several pharmaceutical and biotechnology companies have already established themselves in the field of genetic diseases. These companies have already begun many drug development programs, some of which may target diseases that we are also targeting, and have already entered into partnering and licensing arrangements with academic research institutions, reducing the pool of available opportunities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Universities and public and private research institutions also compete with us. While these organizations primarily have educational or basic research objectives, they may develop proprietary technology and acquire patents that we may need for the development of our product candidates. We will attempt to license this proprietary technology, if available. These licenses may not be available to us on acceptable terms, if at all. If we are unable to compete successfully with respect to acquisitions, joint venture and other collaboration opportunities, we may be limited in our ability to develop new products and to continue to expand our product pipeline.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*The sale of generic versions of Kuvan by generic manufacturers has adversely affected and will continue to adversely affect our revenues and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, permits the Food and Drug Administration (FDA) to approve abbreviated new drug applications (ANDAs) for generic versions of branded drugs. We refer to this process as the ANDA process. The ANDA process permits competitor companies to obtain marketing approval for a drug with the same active ingredient as a branded drug, but does not generally require the conduct and submission of clinical efficacy studies for the generic product. In place of such clinical studies, an ANDA applicant usually needs only to submit data demonstrating that its product is bioequivalent to the branded product.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Hatch-Waxman Act, companies were permitted to file ANDA applications for proposed generic versions of Kuvan at any time after December 2011. We own several patents that cover Kuvan, and we have listed those patents in conjunction with that product in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations (the Orange Book). The Hatch-Waxman Act requires an ANDA applicant seeking FDA approval of its proposed generic product prior to the expiration of our Orange Book-listed patents to certify that the applicant believes that our patents are invalid or will not be infringed by the manufacture, use or sale of the drug for which the application has been submitted (a paragraph IV certification) and notify us of such certification (a paragraph IV notice). Upon receipt of a paragraph IV notice, the Hatch-Waxman Act allows us, with proper basis, to bring an action for patent infringement against the ANDA filer, asking that the proposed generic product not be approved until after our patents expire. If we commence a lawsuit within 45 days from receipt of the paragraph IV notice, the Hatch-Waxman Act provides a 30-month stay, during which time the FDA cannot finally approve the applicant&#8217;s ANDA. If the litigation is resolved in favor of the ANDA applicant during the 30-month stay period, the stay is lifted and the FDA may approve the ANDA if it is otherwise ready for approval. The discovery, trial and appeals process in such a lawsuit is costly, time consuming, and may result in generic competition if the ANDA applicant prevails.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Between 2014 and 2016 we received paragraph IV notice letters from two pharmaceutical companies notifying us that each had filed ANDAs seeking approval of proposed generic versions of Kuvan. We filed lawsuits alleging patent infringement against each company, and between 2015 and 2017 we entered into settlement agreements with the companies that resolved the patent litigation in the U.S. The settlement agreements granted the companies non-exclusive licenses to our Kuvan-related patents to allow them to market generic versions of sapropterin dihydrochloride in the U.S. for the indications approved for Kuvan beginning on October 1, 2020, or earlier under certain circumstances. Generic versions of Kuvan first became available in the U.S. in October 2020, and as expected, our U.S. sales of Kuvan in the fiscal quarters since October 2020 have significantly declined as compared to prior periods. We expect that the continued availability of generic versions of sapropterin dihydrochloride in the U.S. will continue to adversely affect our U.S. sales of Kuvan.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any future ANDA or related legal proceeding could have an adverse impact on our stock price, and litigation to enforce our patents has, and is likely to continue to, cost a substantial amount and require significant management attention. If the patents covering Kuvan and its use are not upheld in litigation, or if any ANDA filer we bring suit against is found to not infringe our asserted patents, the resulting generic competition following the expiration of regulatory exclusivity would have a material adverse effect on our revenues and results of operations. Moreover, generic competition following the settlements described above could have a material adverse effect on our revenues and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also face generic competition for Kuvan in certain non-U.S. countries, and there is a process equivalent to the ANDA process under Article 10 of Directive 2001/83/EC in the EU. Our ability to successfully market and sell Kuvan in many countries in which we operate is based upon patent rights or certain regulatory forms of exclusivity, or both. The scope of our patent rights and regulatory exclusivity for Kuvan vary from country to country and are dependent on the availability of meaningful legal remedies in each country. If our patent rights and regulatory exclusivity for Kuvan are successfully challenged, expire, or otherwise terminate in a particular country, the resulting generic competition could have a material adverse effect on our revenues and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If we do not achieve our projected development goals in the timeframes we announce and expect, the commercialization of our product candidates may be delayed and the credibility of our management may be adversely affected and, as a result, our stock price may decline.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For planning purposes, we estimate the timing of the accomplishment of various scientific, clinical, regulatory and other product development goals, which we sometimes refer to as milestones. These milestones may include the commencement or completion of scientific studies and clinical trials and the submission of regulatory filings. From time to time, we publicly announce the expected timing of some of these milestones. All of these milestones are based on a variety of assumptions. The actual timing of these milestones can vary dramatically compared to our estimates, in many cases for reasons beyond our control. If we do not meet these milestones as publicly announced, the commercialization of our products may be delayed and the credibility of our management may be adversely affected and, as a result, our stock price may decline.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Regulatory Risks</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If we fail to obtain regulatory approval to commercially market and sell our product candidates, or if approval of our product candidates is delayed, we will be unable to generate revenues from the sale of these product candidates, our potential for generating positive cash flow will be diminished, and the capital necessary to fund our operations will increase.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We must obtain regulatory approval to market and sell our product candidates. For example, in the U.S., we must obtain FDA approval for each product candidate that we intend to commercialize, and in the EU we must obtain approval from the European Commission, based on the opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). The FDA and EMA approval processes are typically lengthy and expensive, and approval is never certain. Accordingly, there are no assurances that we will obtain regulatory approval for any of our product candidates. Furthermore, there can be no assurance that approval of one of our product candidates by one regulatory agency will mean that other agencies will also approve the same product candidate. Similarly, regulatory authorities may approve a product candidate for fewer or more limited indications than requested. In addition, regulatory authorities may not approve the labeling claims that are necessary or desirable for the successful commercialization of our product candidates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have had fewer interactions with regulatory authorities outside the U.S. and the EU as compared to our interactions with the FDA and EMA. The approval procedures vary among countries and can involve additional clinical testing, and the time required to obtain approval may differ from that required to obtain FDA or EMA approval. Moreover, clinical trials conducted in one country may not be accepted by regulatory authorities in other countries. Approval by the FDA or EMA does not ensure approval by regulatory authorities in other countries, and approval by one or more non-U.S. regulatory authorities does not ensure approval by regulatory authorities in other non-U.S. countries or by the FDA or EMA. However, a failure or delay in obtaining regulatory approval in one country may have a negative effect on the regulatory process in others. The non-U.S. regulatory approval process may include all of the risks associated with obtaining FDA or EMA approval. We may not obtain non-U.S. regulatory approvals on a timely basis, if at all. We may not be able to file for regulatory approvals and even if we file, we may not receive necessary approvals to commercialize our product candidates in any market.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of the risks and uncertainties in pharmaceutical development, our product candidates could take a significantly longer time to gain regulatory approval than we expect or may never gain approval. We also rely on independent third-party CROs to file some of our non-U.S. marketing applications and important aspects of the services performed for us by the CROs are out of our direct control. If we fail to adequately manage our CROs, if the CRO elects to prioritize work on our projects below other projects or if there is any dispute or disruption in our relationship with our CROs, the filing of our applications may be delayed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although the FDA and the EMA have programs to facilitate expedited development and accelerated approval processes, the timelines agreed under legislative goals or mandated by regulations are subject to the possibility of substantial delays. In </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">addition, the FDA, the EMA and other international regulatory authorities have substantial discretion over the approval process for pharmaceutical products. These regulatory agencies may not agree that we have demonstrated the requisite level of product safety and efficacy to grant approval and may require additional data. If we fail to obtain regulatory approval for our product candidates, we will be unable to market and sell those product candidates, which would have a negative effect on our business and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With respect to valoctocogene roxaparvovec, we may experience challenges specific to gene therapy that cause significant delays or unanticipated costs, or that cannot be solved. Although numerous companies are currently advancing gene therapy product candidates through clinical trials, the FDA has only approved a very small number of vector-based gene therapy products thus far. Moreover, there are very few approved gene therapy products outside the U.S. As a result, it is difficult to determine how long it will take or how much it will cost to obtain regulatory approvals for valoctocogene roxaparvovec in any jurisdiction. Regulatory requirements governing gene and cell therapy products are still evolving and may continue to change in the future. For example, in October 2020, it was reported that the Director of the Center for Biologics Evaluation and Research, the center of the FDA responsible for reviewing marketing applications for gene therapies, stated that the FDA will assess the importance of durability of effect differently for a gene therapy that treats a disease that has no other available therapies versus a condition for which there are multiple approved treatments. Regulatory review agencies and the new requirements and guidelines they promulgate may lengthen the regulatory review process, require us to perform additional or larger studies, increase our development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of our treatment candidate or lead to significant post-approval studies, limitations or restrictions. For example, on August 18, 2020 the FDA issued a Complete Response Letter (CRL) to our BLA for valoctocogene roxaparvovec for the treatment of adults with severe hemophilia A. In the CRL, the FDA introduced a new request for two-year follow-up safety and efficacy data on all study participants from our ongoing Phase 3 study of valoctocogene roxaparvovec. The trial will not complete two years of follow-up until November 2021. Continued delay or failure to obtain, or unexpected costs in obtaining, the regulatory approval necessary to bring valoctocogene roxaparvovec to market could have a negative effect on our business and financial condition. Even if we do obtain regulatory approval, ethical, social and legal concerns about gene therapy arising in the future could result in additional regulations restricting or prohibiting sale of our product.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, some of our product candidates are intended to be used in combination with a delivery device, such as an injector or other delivery system. Medical products containing a combination of new drugs, biological products or medical devices may be regulated as &#8220;combination products&#8221; in the U.S. A combination product generally is defined as a product consisting of components from two or more regulatory categories (e.g., drug/device, device/biologic, drug/biologic). Each component of a combination product is subject to the requirements established by the FDA for that type of component, whether a new drug, biologic or device. In order to facilitate pre-market review of combination products, the FDA designates one of its centers to have primary jurisdiction for the pre-market review and regulation of the overall product based upon a determination by the FDA of the primary mode of action of the combination product. The determination whether a product is a combination product or two separately regulated products is made by the FDA on a case-by-case basis. Our product candidates intended for use with such devices, or expanded indications that we may seek for our products used with such devices, may not be approved or may be substantially delayed in receiving approval if the devices do not gain and/or maintain their own regulatory approvals or clearances. Where approval of the drug or biologic product and device is sought under a single application, the increased complexity of the review process may delay approval. The FDA review process and criteria are not well-established areas, which could also lead to delays in the approval process. In addition, because these delivery devices are provided by unaffiliated third-party companies, we are dependent on the sustained cooperation and effort of those third-party companies both to obtain regulatory approval and to maintain their own regulatory compliance. Failure of third-party companies to assist in the approval process or to maintain their own regulatory compliance could delay or prevent approval of our product candidates, or limit our ability to sell a product once it is approved.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time during the development and regulatory approval process for our products and product candidates, we engage in discussions with the FDA and comparable international regulatory authorities regarding our development programs, including discussions about the regulatory requirements for approval. As part of these discussions, we sometimes seek advice in the design of our clinical programs from various regulatory agencies globally, but we do not always follow such guidance. This increases the chance of adverse regulatory actions, but we try to always provide appropriate scientific evidence to support approval. For example, when the FDA accepted our new drug application for Voxzogo (formerly known as vosoritide) in late 2020, the agency reiterated its position raised during the Voxzogo Pediatric Advisory Committee and Endocrinologic and Metabolic Drugs Advisory Committee held in May 2018, recommending two, two-year placebo-controlled trials in different age groups. Although our Voxzogo clinical program does not meet every element of the FDA&#8217;s recommendation, we designed our studies of Voxzogo in a manner that we believe can demonstrate efficacy and safety of the product candidate for the target patient population. However, the FDA may ultimately disagree with our position that our Voxzogo trials support regulatory approval. Moreover, sometimes different regulatory agencies provide different or conflicting advice. While we attempt to harmonize the advice we receive from multiple regulatory authorities, it is not always practical to do so. Also, we may choose not to harmonize conflicting advice when harmonization would significantly delay clinical trial data or is otherwise inappropriate. If we are unable to effectively and efficiently resolve and comply with the inquiries and requests of the FDA and other non-U.S. regulatory authorities, the approval of our product candidates may be delayed and their value may be reduced.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*Any product for which we have obtained regulatory approval, or for which we obtain approval in the future, is subject to, or will be subject to, extensive ongoing regulatory requirements by the FDA, the EMA and other comparable international regulatory authorities, and if we fail to comply with regulatory requirements or if we experience unanticipated problems with our products, we may be subject to penalties, we will be unable to generate revenues from the sale of such products, our potential for generating positive cash flow will be diminished, and the capital necessary to fund our operations will be increased.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Aldurazyme, Brineura, Kuvan, Naglazyme and Vimizim have received regulatory approval to be commercially marketed and sold in the U.S., the EU and certain other countries, Palynziq has received regulatory approval to be commercially marketed in the U.S., the EU, and Australia, and Voxzogo has received regulatory approval to be commercially marketed in the EU. Any product for which we have obtained regulatory approval, or for which we obtain regulatory approval in the future, along with the manufacturing processes and practices, post-approval clinical research, product labeling, advertising and promotional activities for such product, are subject to continual requirements of, and review by, the FDA, the EMA and other comparable international regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, current good manufacturing practices (cGMP) requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, import and export requirements and record keeping.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An example of the ongoing regulatory requirements our products are subject to is the Palynziq Risk Evaluation and Mitigation Strategy (REMS) program. In the U.S., Palynziq is only available through the REMS program, which is required by the FDA to mitigate the risk of anaphylaxis while using the product. Notable requirements of our REMS program include the following:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">prescribers must be certified by enrolling in the REMS program and completing training;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">prescribers must prescribe auto-injectable epinephrine with Palynziq;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">pharmacies must be certified with the REMS program and must dispense Palynziq only to patients who are authorized to receive it;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">patients must enroll in the REMS program and be educated about the risk of anaphylaxis by a certified prescriber to ensure they understand the risks and benefits of treatment with Palynziq; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">patients must have auto-injectable epinephrine available at all times while taking Palynziq.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Failure of prescribers, pharmacies or patients to enroll in our REMS program or to successfully complete and comply with its requirements may result in regulatory action from the FDA or decreased sales of Palynziq. The restrictions and requirements under our REMS program, as well as potential changes to these restrictions and requirements in the future, subject us to increased risks and uncertainties, any of which could harm our business. The requirement for a REMS program can materially affect the potential market for and profitability of a drug. We cannot predict whether the FDA will request, seek to require or ultimately require modifications to, or impose additional requirements on, the Palynziq REMS program, or whether the FDA will permit modifications to the Palynziq REMS program that we consider warranted. Any modifications required or rejected by the FDA could make it more difficult or expensive for us to distribute Palynziq in the U.S., impair the safety profile of Palynziq, disrupt continuity of care for Palynziq patients and/or negatively affect sales of Palynziq.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, promotional communications with respect to prescription drugs, including biologics, are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product's approved labeling. In particular, a product may not be promoted for uses that are not approved by the FDA as reflected in the product&#8217;s approved labeling. Although the FDA and other regulatory authorities do not regulate a physician&#8217;s choice of drug treatment made in the physician&#8217;s independent medical judgment, they do restrict promotional communications from companies or their sales force with respect to off-label uses of products for which marketing clearance has not been issued. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant civil, criminal and administrative penalties. Thus, we will not be able to promote any products we develop for indications or uses for which they are not approved.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, if original FDA approval for one of our product candidates is granted via the accelerated approval pathway, we will be required to conduct a post-marketing confirmatory trial to verify and describe the clinical benefit in support of full approval. An unsuccessful post-marketing study or failure to complete such a study with due diligence could result in the withdrawal of the FDA&#8217;s marketing approval for a product candidate. In addition, the FDA often requires post-marketing testing and surveillance to monitor the effects of products. The FDA, the EMA and other comparable international regulatory agencies may condition approval of our product candidates on the completion of such post-marketing clinical studies. These post-marketing studies may suggest that a product causes undesirable side effects or may present a risk to the patient. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Discovery after approval of previously unknown problems with any of our products, manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in actions such as:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restrictions on our ability to conduct clinical trials, including full or partial clinical holds on ongoing or planned trials;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restrictions on product manufacturing processes;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restrictions on the marketing of a product;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restrictions on product distribution;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">requirements to conduct post-marketing clinical trials;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">untitled or warning letters or other adverse publicity;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">withdrawal of the products from the market;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">refusal to approve pending applications or supplements to approved applications that we submit;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">recall of products;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">refusal to permit the import or export of our products;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">product seizure;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">fines, restitution or disgorgement of profits or revenue;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">injunctions; or</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">imposition of civil or criminal penalties.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If such regulatory actions are taken, our value and our operating results will be adversely affected. Additionally, if the FDA, the EMA or any other comparable international regulatory agency withdraws its approval of a product, we will be unable to generate revenues from the sale of that product in the relevant jurisdiction, our potential for generating positive cash flow will be diminished and the capital necessary to fund our operations will be increased. Accordingly, we continue to expend significant time, money and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance, post-marketing studies and quality control.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">To obtain regulatory approval to market our products, preclinical studies and costly and lengthy clinical trials are required and the results of the studies and trials are highly uncertain. Likewise, preliminary, initial or interim data from clinical trials should be considered carefully and with caution because the final data may be materially different from the preliminary, initial or interim data, particularly as more patient data become available.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As part of the drug development process we must conduct, at our own expense, preclinical studies in the laboratory, including studies in animals, and clinical trials on humans for each product candidate. The number of preclinical studies and clinical trials that regulatory authorities require varies depending on the product candidate, the disease or condition the drug is being developed to address and regulations applicable to the particular drug. Generally, new drugs for diseases or conditions that affect larger patient populations, are less severe, or are treatable by alternative strategies must be validated through additional preclinical and clinical trials and/or clinical trials with higher enrollments. With respect to our early stage product candidates, we may need to perform multiple preclinical studies using various doses and formulations before we can begin clinical trials, which could result in delays to our development timeline. Furthermore, even if we obtain favorable results in preclinical studies, the results in humans may be significantly different. After we have conducted preclinical studies, we must demonstrate that our product candidates are safe and efficacious for use in the targeted human patients in order to receive regulatory approval for commercial sale. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process. The results of preclinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials, and favorable data from interim analyses do not ensure the final results of a trial will be favorable. From time to time, we have and may in the future publish or report preliminary, initial or interim data from our clinical trials, such as the data we have announced from the GENEr-8-1 study for valoctocogene roxaparvovec. Preliminary, initial or interim data from our clinical trials may not be indicative of the final results of the trial and are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and/or more patient data become available. In this regard, such data may show initial evidence of clinical benefit, but as patients continue to be followed and more patient data become available, there is a risk that any therapeutic effects will not be durable in patients and/or will decrease over time or cease entirely. Preliminary, initial or interim data also remain subject to audit and verification procedures that may result in the final data being materially different from such preliminary, initial or interim data. As a result, preliminary, initial or interim data should be considered carefully and with caution until the final data are available. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Product candidates may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical trials, or despite having favorable data in connection with an interim analysis. A number of companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier trials. Also, as noted above, we do not always follow the advice of regulatory authorities or comply with all of their requests regarding the design of our clinical programs. In those cases, we may choose a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">development program that is inconsistent with the advice of regulatory authorities, which may limit the jurisdictions where we conduct clinical trials and/or adversely affect our ability to obtain approval in those jurisdictions where we do not follow the regulatory advice.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adverse or inconclusive clinical results could stop us from obtaining regulatory approval of our product candidates. Additional factors that can cause delay or termination of our clinical trials include:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">slow or insufficient patient enrollment;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">slow recruitment of, and completion of necessary institutional approvals at, clinical sites;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">budgetary constraints or prohibitively high clinical trial costs;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">longer treatment time required to demonstrate efficacy;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">lack of sufficient supplies of the product candidate;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">adverse medical events or side effects in treated patients, including immune reactions;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">lack of effectiveness of the product candidate being tested;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">availability of competitive therapies to treat the same indication as our product candidates;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">regulatory requests for additional clinical trials or preclinical studies;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">deviations in standards for Good Clinical Practice (GCP); and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">disputes with or disruptions in our relationships with clinical trial partners, including CROs, clinical laboratories, clinical sites, and principal investigators.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services reportable to the FDA or other regulatory authority. If the FDA or other regulatory authority concludes that a financial relationship between us and a principal investigator has created a conflict of interest, the FDA or other regulatory authority may question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Similar rules governing clinical trials to those in place in the United States apply in the EU and the U.K. Following the U.K.&#8217;s exit from the EU, commonly referred to as Brexit, and the end of the transition period that was in place until the end of 2020, clinical trials that take place in the U.K. are seen as trials that have taken place in a &#8220;third country&#8221; and will only be considered during the course of a marketing authorization application if they are carried out on a basis that is in line with the regulations governing clinical trials in the EU. Clinical trials in the EU must be conducted in accordance with the requirements of the EU Clinical Trials Directive, as implemented in national law by individual member states, and applicable good clinical practice standards. The EU Clinical Trials Directive is due to be replaced with the new EU Clinical Trials Regulation (EU CTR), which will become effective on January 31, 2022. Should the U.K. not seek to align its regulations governing clinical trials with the EU CTR then trials that take place in the U.K. may carry less weight than they currently do when applying for a marketing authorization in the EU.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our current and future products, which would adversely affect our revenues and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect that coverage and reimbursement may be increasingly restricted in all the markets in which we sell our products. The escalating cost of healthcare has led to increased pressure on the healthcare industry to reduce costs. In particular, drug pricing by pharmaceutical companies has recently come under increased scrutiny and continues to be subject to intense political and public debate in the U.S. and abroad. Governmental and private third-party payers have proposed healthcare reforms and cost reductions. A number of federal and state proposals to control the cost of healthcare, including the cost of drug treatments, have been made in the U.S. Specifically, there have been several recent U.S. congressional inquiries and proposed bills and enacted legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. Further, Congress and the executive branch have each indicated that they will continue to seek new legislative and/or administrative measures to control drug costs. In some international markets, the government controls the pricing, which can affect the profitability of drugs. Current government regulations and possible future legislation regarding healthcare may affect coverage and reimbursement for medical treatment by third-party payers, which may render our products not commercially viable or may adversely affect our future revenues and gross margins.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">International operations are also generally subject to extensive price and market regulations, and there are many proposals for additional cost-containment measures, including proposals that would directly or indirectly impose additional price controls or mandatory price cuts or reduce the value of our intellectual property portfolio. As part of these cost containment measures, some countries have imposed and continue to propose revenue caps limiting the annual volume of sales of our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">products. Some of these caps are significantly below the actual demand in certain countries, and if the trend regarding revenue caps continues, our future revenues and gross margins may be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We cannot predict the extent to which our business may be affected by these or other potential future legislative or regulatory developments. However, future price controls or other changes in pricing regulation or negative publicity related to our product pricing or the pricing of pharmaceutical drugs generally could restrict the amount that we are able to charge for our current and future products or our sales volume, which would adversely affect our revenues and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*Government healthcare reform could increase our costs and adversely affect our revenues and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our industry is highly regulated and changes in law may adversely impact our business, operations or financial results. In the U.S., there have been and continue to be a number of legislative initiatives to contain healthcare costs. For example, the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the PPACA) is a sweeping measure intended to, among other things, expand healthcare coverage within the U.S., primarily through the imposition of health insurance mandates on employers and individuals and expansion of the Medicaid program. Several provisions of the law have affected us and increased certain of our costs. Since its enactment, there have been executive, judicial and congressional challenges to certain aspects of the PPACA. Although the PPACA has generally been upheld thus far, it is unclear how continued challenges to the law may impact the PPACA and our business. In addition, other legislative changes have been adopted since the PPACA was enacted. Some of these changes have resulted in additional reductions in Medicare and other healthcare funding, which could have a material adverse effect on our customers and, accordingly, our financial operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We anticipate that the PPACA, as well as other healthcare reform measures that may be adopted in the future in the U.S. or abroad, may result in more rigorous coverage criteria and an additional downward pressure on the reimbursement our customers may receive for our products. Recently there has been heightened governmental scrutiny in countries worldwide over the manner in which manufacturers set prices for their marketed products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the U.S., there have been several recent congressional inquiries, proposed and enacted federal and state legislation, and executive action designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, reduce the cost of drugs under Medicare, and reform government program reimbursement methodologies for drug products. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payers. In addition, individual states in the U.S. have also increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Moreover, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. Further, it is possible that additional governmental action is taken in response to the COVID-19 pandemic.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Likewise, in many EU countries, legislators and other policymakers continue to propose and implement healthcare cost-containing measures in response to the increased attention being paid to healthcare costs in the EU. Certain of these changes could impose limitations on the prices we will be able to charge for our products and any approved product candidates or the amounts of reimbursement available for these products from governmental and private third-party payers, may increase the tax obligations on pharmaceutical companies or may facilitate the introduction of generic competition with respect to our products. Further, an increasing number of EU countries and other non-U.S. countries use prices for medicinal products established in other countries as &#8220;reference prices&#8221; to help determine the price of the product in their own territory. If the price of one of our products decreases substantially in a reference price country, it could impact the price for that product in other countries. Consequently, a downward trend in prices of our products in some countries could contribute to similar downward trends elsewhere, which would have a material adverse effect on our revenues and results of operations. Moreover, in order to obtain reimbursement for our products in some countries, we may be required to conduct clinical trials that compare the cost-effectiveness of our products to other available therapies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Legally mandated price controls on payment amounts by governmental and private third-party payers or other restrictions could harm our business, results of operations, financial condition and prospects. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For more information regarding government healthcare reform, see &#8220;Government Regulation - Health Reform&#8221; in Part I, Item 1 of our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February 26, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If we fail to obtain or maintain orphan drug exclusivity for some of our products, our competitors may obtain approval to sell the same drugs to treat the same conditions and our revenues will be reduced.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As part of our business strategy, we have developed and may in the future develop some drugs that may be eligible for FDA and EU orphan drug designation. Under the Orphan Drug Act, the FDA may designate a product as an orphan drug if it is intended to treat a rare disease or condition, defined as a patient population of fewer than 200,000 in the U.S. In the EU, orphan drug designation is available if a sponsor can establish that: (1) the medicine is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition, (2) such condition affects no more than five in 10,000 people in the EU or without incentives it is unlikely that the marketing of the medicine in the EU would generate sufficient return to justify the necessary investment and (3) the applicant must demonstrate that there exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been authorized in the EU or, if such method exists, the medicine will be of significant benefit to those affected by that condition. The company that first obtains FDA approval for a designated orphan drug for a given rare disease receives marketing exclusivity for use of that drug for the stated condition for a period of seven years. Orphan drug exclusive marketing rights may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the drug. In addition, the FDA may approve another drug during a period of orphan drug exclusivity if the second drug is found to be clinically superior to the first drug. In the EU, a ten-year period of market exclusivity (extendable to twelve years for orphan drugs that have complied with an agreed pediatric investigation plan pursuant to Regulation 1901/2006), during which similar medicines for the same indication cannot be placed on the market, is available. Orphan drug marketing exclusivity may be lost in the EU if a manufacturer is unable to supply sufficient quantities and marketing authorization may also be granted to a similar medicinal product with the same orphan indication if this medicinal product is safer, more effective or otherwise clinically superior to the original orphan medicinal product. The period of market exclusivity may, in addition, be reduced to six years if, at the end of the fifth year, it can be demonstrated on the basis of available evidence that the criteria for its designation as an orphan medicine are no longer satisfied, for example if the original orphan medicinal product has become sufficiently profitable not to justify maintenance of market exclusivity. Because the extent and scope of patent protection for some of our products is limited, orphan drug designation is especially important for our products that are eligible for orphan drug designation. For eligible products, we plan to rely on the exclusivity period under the Orphan Drug Act to maintain a competitive position. If we do not obtain orphan drug exclusivity for our products that do not have broad patent protection, our competitors may then sell the same drug to treat the same condition and our revenues will be reduced.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Even though we have obtained orphan drug designation for certain of our product candidates and even if we obtain orphan drug designation for our future product candidates, due to the uncertainties associated with developing biopharmaceutical products, we may not be the first to obtain marketing approval for any particular orphan indication, which means that we may not obtain orphan drug exclusivity and could also potentially be blocked from approval of certain product candidates until the competitor product&#8217;s orphan drug exclusivity period expires. Moreover, with respect to certain biologics and gene therapies, it is uncertain how similarity between product candidates designed to treat the same rare disease or condition may affect such product candidates&#8217; orphan drug exclusivities. Further, even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different drugs can be approved for the same condition and the same drug can be approved for different conditions and potentially used off-label in the orphan indication. Even after an orphan drug is approved and granted orphan drug exclusivity, the FDA can subsequently approve the same drug for the same condition if the FDA concludes that the later drug is safer or more effective or makes a major contribution to patient care. Orphan drug designation neither shortens the development time or regulatory review time of a drug, nor gives the drug any advantage in the regulatory review or approval process.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may face competition from biosimilars approved through an abbreviated regulatory pathway.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Aldurazyme, Brineura, Naglazyme, Palynziq and Vimizim products are regulated by the FDA as biologics under the Federal Food, Drug, and Cosmetic Act (the FDC Act) and the Public Health Service Act (the PHS Act). Biologics require the submission of a BLA and approval by the FDA prior to being marketed in the U.S. The Biologics Price Competition and Innovation Act of 2009 (BPCIA) created a regulatory pathway under the PHS Act for the abbreviated approval of biological products that are demonstrated to be &#8220;biosimilar&#8221; or &#8220;interchangeable&#8221; with an FDA-approved biological product. A similar abridged marketing authorization process is available to biosimilar products in the EU. In order to meet the standard of interchangeability, a sponsor must demonstrate that the biosimilar product can be expected to produce the same clinical result as the reference product, and for a product that is administered more than once, that the risk of switching between the reference product and biosimilar product is not greater than the risk of maintaining the patient on the reference product. The BPCIA establishes a period of 12 years of exclusivity for reference products. In the EU, a medicinal product containing a new active substance benefits from eight years of data exclusivity, during which biosimilar applications referring to the data of that product may not be accepted by the regulatory authorities, and a further two years of market exclusivity, during which such biosimilar products may not be placed on the market. The two-year period may be extended to three years if during the first eight years a new therapeutic indication with significant clinical benefit over existing therapies is approved. Our products approved under BLAs in the U.S. or Marketing Authorization </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Applications (MAAs) in the EU, as well as products in development that may be approved under those regimes in the future, could be reference products for biosimilar marketing applications.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Changes in funding for the FDA, the EMA and other government agencies or government shutdowns could hinder the ability of such agencies to hire and retain key leadership and other personnel or otherwise prevent those agencies from performing normal functions on which the operation of our business may rely, which could negatively impact our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in funding levels of government agencies can affect their ability to hire and retain key personnel and carry out their normal functions that support our business. For example, the ability of the FDA to timely review and approve INDs or marketing authorizations for our product candidates may be hindered by a lack of resources and qualified personnel. In addition, funding of other government agencies on which our operations rely, including those that fund research and development activities, is subject to the political budget process, which is inherently fluid and unpredictable.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government shutdowns could also impact the ability of government agencies to function normally and support our operations. For example, the U.S. federal government has shut down repeatedly since 1980, including for a period of 35 days beginning on December 22, 2018. During a shutdown, certain regulatory agencies, such as the FDA, have had to furlough key personnel and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risks Related to Valoctocogene Roxaparvovec</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our valoctocogene roxaparvovec program is based on a gene therapy approach, which, as a novel technology, presents additional development and treatment risks in relation to our other, more traditional drug development programs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the risks set forth in this Risk Factors section associated with developing more traditional pharmaceutical drugs, there are additional, unique development and treatment risks associated with gene therapy products like our product candidate valoctocogene roxaparvovec. The goal of gene therapy is to be able to correct an inborn genetic defect through one-time administration of therapeutic genetic material containing non-defective gene copies. The gene copies are designed to reside permanently in a patient, allowing the patient to produce an essential protein or ribonucleic acid (RNA) molecule that a healthy person would normally produce. There is a risk, however, that the new gene copies will produce too little or too much of the desired protein or RNA. Although a one-time administration of a gene therapy product like our product candidate valoctocogene roxaparvovec is intended to correct an inborn genetic defect for the entire lifetime of a patient, there is a risk that the therapeutic effect will not be durable and production of the desired protein or RNA will decrease over time or cease entirely. Because the treatment is irreversible, there may be challenges in managing side effects, particularly those caused by potential overproduction of the desired protein. Adverse effects would not be able to be reversed or relieved by stopping dosing, and we may have to develop additional clinical safety procedures. Furthermore, because the new gene copies are designed to reside permanently in a patient, there is a risk that they will disrupt other normal biological molecules and processes, including other healthy genes, and we may not learn the nature and magnitude of these side effects until long after clinical trials have been completed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As compared to our other, more traditional products, our gene therapy product candidate valoctocogene roxaparvovec, if approved, may present additional problems with respect to the pricing, coverage, and reimbursement and acceptance of the product candidate.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the risks set forth in this Risk Factors section associated with commercializing more traditional pharmaceutical drugs, there are additional, unique commercial risks associated with gene therapy products like our product candidate valoctocogene roxaparvovec. Due to the relative novelty of gene therapy and the potential to provide extended duration therapeutic treatment with a one-time administration, we face uncertainty with respect to the pricing, coverage and reimbursement of valoctocogene roxaparvovec, if approved. In order to recover our research and development costs and commercialize this one-time treatment on a profitable basis, we expect the cost of a single administration of valoctocogene roxaparvovec to be substantial. Therefore, we expect that coverage and reimbursement by governments and other third-party payers will be essential for the vast majority of patients to be able to afford valoctocogene roxaparvovec. Accordingly, sales of valoctocogene roxaparvovec, if approved, will depend substantially, both domestically and internationally, on the extent to which its cost will be paid by third-party payers. Even if coverage is provided, the reimbursement amounts approved by third-party payers may not be high enough to allow us to realize sufficient revenues from our investment in the development of valoctocogene roxaparvovec.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also face uncertainty as to whether gene therapy will gain the acceptance of the public or the medical community. Even if we obtain regulatory approval for valoctocogene roxaparvovec, the commercial success of valoctocogene roxaparvovec will depend, in part, on the acceptance of physicians, patients and third-party payers of gene therapy products in general, and our product candidate in particular, as medically necessary, cost-effective and safe. In particular, our success will depend upon physicians prescribing our product candidate in lieu of existing treatments they are already familiar with and for which greater clinical data may be available. Moreover, physicians and patients may delay acceptance of valoctocogene roxaparvovec until the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">product candidate has been on the market for a certain amount of time. Negative public opinion or more restrictive government regulations could have a negative effect on our business and financial condition and may delay or impair the successful commercialization of, and demand for, valoctocogene roxaparvovec</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We have implemented a data access plan for valoctocogene roxaparvovec, which restricts our management&#8217;s review of emerging data from these trials. Without access to ongoing data, management does not have the ability to adjust the trials based on such emerging data, which could adversely impact the ultimate outcome of these trials.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In order to preserve the scientific integrity of the valoctocogene roxaparvovec trials and to allow us to only report on data at intervals that we believe will be meaningful to investors, we have implemented a data access plan related to the ongoing open label trials, which is designed to significantly mirror blinded trials. Pursuant to this plan, the ongoing emerging data are generally not collected by us, with the exception that certain specific data points are collected and reviewed by a small group of medical personnel monitoring and managing the trial, and then, only to the extent necessary to allow them to perform their monitoring responsibilities. As we disclose and publicly discuss prior data from these trials, such discussions do not incorporate any of the currently emerging data that are being collected and reviewed by personnel monitoring the trial and, accordingly, this prior data may differ significantly from more recent data that are only available to such personnel. Further, because our management does not have access to any of the ongoing data and does not have the ability to adjust the trials based on such emerging data, the data access plan could adversely impact the ultimate outcome of the trials.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financial and Financing Risks</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If we continue to incur operating losses or are unable to sustain positive cash flows for a period longer than anticipated, we may be unable to continue our operations at planned levels and be forced to reduce our operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since we began operations in March 1997, we have been engaged in substantial research and development and capital investments, and we have operated at a net loss for each year since our inception, with the exception of 2008, 2010 and 2020. Our future profitability and cash flows depend on our marketing and selling of our products, the receipt of regulatory approval of our product candidates, our ability to successfully manufacture and market any products, either by ourselves or jointly with others, our spending on our development programs, the impact of any possible future business development transactions and other risks set forth in this Risk Factors section. The extent of our future losses and the timing of profitability and positive cash flows are highly uncertain. If we fail to become profitable or are unable to sustain profitability and positive cash flows on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce our operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*If we fail to obtain the capital necessary to fund our operations, our financial results and financial condition will be adversely affected and we will have to delay or terminate some or all of our product development programs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had cash, cash equivalents and investments totaling $1.55 billion and debt obligations of $1.1 billion (undiscounted), which consisted of our 0.599% senior subordinated convertible notes due in 2024 (the 2024 Notes) and our 1.25% senior subordinated convertible notes due in 2027 (the 2027 Notes). The 2024 Notes and the 2027 Notes (collectively, the Notes), if not converted, will be required to be repaid in cash at maturity in August 2024 and May 2027, respectively. We will need cash not only to pay the ongoing interest due on the Notes during their term, but also to repay the principal amount of the Notes if not converted.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2016, we terminated our License and Commercialization Agreement with Ares Trading, S.A. (Merck Serono). Pursuant to the Termination and Transition Agreement related to Kuvan and the Termination Agreement related to Palynziq, we are obligated to make certain payments to Merck Serono if sales and development milestones are achieved. The remaining milestone payments that may become payable include up to a maximum of &#8364;60 million, in cash, if future sales milestones are met with respect to Kuvan and Palynziq.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We may require additional financing to fund the repayment of the Notes, future milestone payments and our future operations, including the commercialization of our products and product candidates currently under development, preclinical studies and clinical trials, and potential licenses and acquisitions. We may be unable to raise additional financing due to a variety of factors, including our financial condition, the status of our product programs, and the general condition of the financial markets. If we fail to raise any necessary additional financing we may have to delay or terminate some or all of our product development programs and our financial condition and operating results will be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect to continue to spend substantial amounts of capital for our operations for the foreseeable future. The amount of capital we will need depends on many factors, including:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to successfully market and sell our products;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">the time and cost necessary to develop commercial manufacturing processes, including quality systems, and to build or acquire manufacturing capabilities the progress and success of our preclinical studies and clinical trials (including studies and the manufacture of materials);</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">the timing, number, size and scope of our preclinical studies and clinical trials;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">the time and cost necessary to obtain regulatory approvals and the costs of post-marketing studies which may be required by regulatory authorities;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">the progress of research programs carried out by us;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">our possible achievement of development and commercial milestones under agreements with third parties, such as the Kuvan and Palynziq milestones under the termination agreements with Merck Serono;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">any changes made to, or new developments in, our existing collaborative, licensing and other commercial relationships or any new collaborative, licensing and other commercial relationships that we may establish;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Sanofi Genzyme&#8217;s (Genzyme) ability to continue to successfully commercialize Aldurazyme; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">whether our convertible debt is converted to common stock in the future.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, our fixed expenses such as rent, license payments, interest expense and other contractual commitments are substantial and may increase in the future. These fixed expenses may increase because we may enter into:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">additional licenses and collaborative agreements;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">additional contracts for product manufacturing; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">additional financing facilities or arrangements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We will need to raise additional funds from equity or debt securities, loans or collaborative agreements if we are unable to satisfy our liquidity requirements. The sale of additional equity and/or equity-linked securities will result in additional dilution to our stockholders. Furthermore, additional financing may not be available in amounts or on terms satisfactory to us or at all. This could result in the delay, reduction or termination of our research, which could harm our business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*We have incurred substantial indebtedness that may decrease our business flexibility, access to capital, and/or increase our borrowing costs, which may adversely affect our operations and financial results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had $1.1 billion (undiscounted) principal amount of indebtedness, including $495.0 million (undiscounted) principal amount of indebtedness under the 2024 Notes and $600.0 million (undiscounted) principal amount of indebtedness under the 2027 Notes. In October 2018, we also entered into an unsecured credit agreement (the 2018 Credit Facility) with Bank of America, N.A., as the administrative agent, swingline lender and a lender, Citibank N.A. as letter of credit issuer and each of Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, Citibank, N.A. and Wells Fargo Securities, LLC as joint lead arrangers and joint bookrunners, providing up to $200.0&#160;million in revolving loan commitments. In May 2021, we amended the 2018 Credit Agreement to, among other things, extend the maturity date of the revolving credit facility from October 18, 2021 to May 28, 2024. Our indebtedness may:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">limit our ability to borrow additional funds for working capital, capital expenditures, acquisitions or other general business purposes;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">limit our ability to use our cash flow or obtain additional financing for future working capital, capital expenditures, acquisitions or other general business purposes;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">require us to use a substantial portion of our cash flow from operations to make debt service payments;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">limit our flexibility to plan for, or react to, changes in our business and industry;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">place us at a competitive disadvantage compared to our less leveraged competitors; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">increase our vulnerability to the impact of adverse economic and industry conditions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, the 2018 Credit Facility contains, and any future indebtedness that we may incur may contain, financial and other restrictive covenants that limit our ability to operate our business, raise capital or make payments under our other indebtedness. If we fail to comply with these covenants or to make payments under our indebtedness when due, then we would be in default under that indebtedness, which could, in turn, result in that and our other indebtedness becoming immediately payable in full. If we default under the 2018 Credit Facility, the outstanding borrowings thereunder could become immediately due and payable, the 2018 Credit Facility lenders could refuse to permit additional borrowings under the facility, or it could lead to defaults under agreements governing our current or future indebtedness, including the indentures governing the Notes. If we default under any of the Notes, such Notes could become immediately due and payable and it could lead to defaults under the other Notes and/or the 2018 Credit Facility.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*In addition, our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our outstanding indebtedness consists primarily of the 2024 Notes and 2027 Notes, which, if not converted, will be required to be repaid in cash at maturity in August 2024 and May 2027, respectively. While we could seek to obtain additional third-party financing to pay for any amounts due in cash upon maturity of the Notes, we cannot be sure that such third-party financing will be available on commercially reasonable terms, if at all.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also may borrow up to $200.0&#160;million in revolving loans under the 2018 Credit Facility, which would be required to be repaid in cash at maturity on May 28, 2024.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Manufacturing Risks</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*If we fail to comply with manufacturing regulations, our financial results and financial condition will be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Before we can begin commercial manufacture of our products, regulatory authorities must approve marketing applications that identify manufacturing facilities operated by us or our contract manufacturers that have passed regulatory inspection and manufacturing processes that are acceptable to the regulatory authorities. In addition, our pharmaceutical manufacturing facilities are continuously subject to scheduled and unannounced inspection by the FDA and international regulatory authorities, before and after product approval, to monitor and ensure compliance with cGMP and other regulations. Our manufacturing facility in the U.S. has been approved by the FDA and the European Commission (EC) for the manufacture of Palynziq, by the EC for the manufacture of Voxzogo, and it has been approved by the FDA, the EC, and health agencies in other countries for the manufacture of Aldurazyme, Brineura, Naglazyme and Vimizim. Our manufacturing facility in Shanbally, Cork, Ireland has been approved by the FDA, the EC, and health agencies in other countries for the manufacture of Vimizim, and it has been approved by the FDA and the EMA as a formulated bulk drug substance manufacturing and quality control facility for Brineura. In addition, our third-party manufacturers&#8217; facilities involved with the manufacture of our products have also been inspected and approved by various regulatory authorities. Although we are not involved in the day-to-day operations of our contract manufacturers, we are ultimately responsible for ensuring that our products are manufactured in accordance with cGMP regulations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the complexity of the processes used to manufacture our products and product candidates, we may be unable to continue to pass or initially pass federal or international regulatory inspections in a cost-effective manner. For the same reason, any potential third-party manufacturer of our products or our product candidates may be unable to comply with cGMP regulations in a cost-effective manner and may be unable to initially or continue to pass a federal or international regulatory inspection.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we, or third-party manufacturers with whom we contract, are unable to comply with manufacturing regulations, we may be subject to delay of approval of our product candidates, warning or untitled letters, fines, unanticipated compliance expenses, recall or seizure of our products, total or partial suspension of production and/or enforcement actions, including injunctions, and criminal or civil prosecution. These possible sanctions would adversely affect our financial results and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If we are unable to successfully develop and maintain manufacturing processes for our product candidates to produce sufficient quantities at acceptable costs, we may be unable to support a clinical trial or be forced to terminate a program, or if we are unable to produce sufficient quantities of our products at acceptable costs, we may be unable to meet commercial demand, lose potential revenue, have reduced margins or be forced to terminate a program.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the complexity of manufacturing our product candidates and products, we may not be able to manufacture sufficient quantities. Our inability to produce enough of our product candidate at acceptable costs may result in the delay or termination of development programs. With respect to our commercial portfolio, we may not be able to manufacture our products successfully with a commercially viable process or at a scale large enough to support their respective commercial markets or at acceptable margins.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The development of commercially viable manufacturing processes typically is very difficult to achieve and is often very expensive and may require extended periods of time. Changes in manufacturing processes (including manufacturing cell lines), </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">equipment or facilities (including moving manufacturing from one of our facilities to another one of our facilities or a third-party facility, or from a third-party facility to one of our facilities) may require us to complete clinical trials to receive regulatory approval of any manufacturing modifications.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With respect to valoctocogene roxaparvovec, gene therapy products are relatively novel and complex and have only in limited cases been manufactured at scales sufficient for pivotal trials and commercialization. Few pharmaceutical contract manufacturers specialize in gene therapy products and those that do are still developing appropriate processes and facilities for large-scale production. We invested a considerable amount of capital building our own commercial gene therapy manufacturing facility, which may be subject to significant impairment if our gene therapy programs are unsuccessful. As we develop, seek to optimize and operate the valoctocogene roxaparvovec manufacturing process, we will likely face technical and scientific challenges, considerable capital costs, and potential difficulty in recruiting and hiring experienced, qualified personnel. There may also be unexpected technical or operational issues during clinical or commercial manufacturing campaigns. As a result, we could experience manufacturing delays that prevent us from completing our clinical studies in a timely manner, if at all, or commercializing valoctocogene roxaparvovec on a profitable basis, if at all.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Also, we may be required to demonstrate product comparability between a biological product made after a manufacturing change and the product made before implementation of the change through additional types of analytical and functional testing or may have to complete additional clinical studies. If we contract for manufacturing services with an unproven process, our contractor is subject to the same uncertainties, high standards and regulatory controls, and may therefore experience difficulty if further process development is necessary.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Even a developed manufacturing process can encounter difficulties. Problems may arise during manufacturing for a variety of reasons, including human error, mechanical breakdowns, problems with raw materials and cell banks, malfunctions of internal information technology systems, and other events that cannot always be prevented or anticipated. Many of the processes include biological systems, which add significant complexity, as compared to chemical synthesis. We expect that, from time to time, consistent with biotechnology industry expectations, certain production lots will fail to produce product that meets our quality control release acceptance criteria. To date, our historical failure rates for all of our product programs have been within our expectations, which are based on industry norms. If the failure rate increased substantially, we could experience increased costs, lost revenue, damage to customer relations, time and expense investigating the cause and, depending upon the cause, similar losses with respect to other lots or products. If problems are not discovered before the product is released to the market, recall and product liability costs may also be incurred.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In order to produce product within our time and cost parameters, we must continue to produce product within our expected success rate and yield expectations. Because of the complexity of our manufacturing processes, it may be difficult or impossible for us to determine the cause of any particular lot failure and we must effectively take corrective action in response to any failure in a timely manner.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We currently rely on third parties for portions of the manufacture of each of our commercial products. If those manufacturers are unwilling or unable to fulfill their contractual obligations or satisfy demand outside of or in excess of the contractual obligations, we may be unable to meet demand for these products or sell these products at all and we may lose potential revenue. Further, the availability of suitable contract manufacturing capacity at scheduled or optimum times is not certain.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, our manufacturing processes subject us to a variety of federal, state and local laws and regulations governing the use, generation, manufacture, storage, handling and disposal of hazardous materials and wastes resulting from their use. We incur significant costs in complying with these laws and regulations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Supply interruptions may disrupt our inventory levels and the availability of our products and product candidates and cause delays in obtaining regulatory approval for our product candidates, or harm our business by reducing our revenues.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We depend on single-source suppliers for critical raw materials and a limited number of manufacturing facilities to manufacture our finished products and product candidates. Numerous factors could cause interruptions in the supply or manufacture of our products and product candidates, including:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">timing, scheduling and prioritization of production by our contract manufacturers or a breach of our agreements by our contract manufacturers;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">labor interruptions;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">changes in our sources for manufacturing;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">the timing and delivery of shipments;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">our failure to locate and obtain replacement suppliers and manufacturers as needed on a timely basis; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">conditions affecting the cost and availability of raw materials.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If one of our suppliers or manufacturers fails or refuses to supply us with necessary raw materials or finished products or product candidates on a timely basis or at all, it would take a significant amount of time and expense to qualify a new supplier or manufacturer. We may not be able to obtain active ingredients or finished products from new suppliers or manufacturers on acceptable terms and at reasonable prices, or at all.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any interruption in the supply of finished products could hinder our ability to distribute finished products to meet commercial demand and adversely affect our financial results and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With respect to our product candidates, production of product is necessary to perform clinical trials and successful registration batches are necessary to file for approval to commercially market and sell product candidates. Delays in obtaining clinical material or registration batches could adversely impact our clinical trials and delay regulatory approval for our product candidates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If our Manufacturing, Marketing and Sales Agreement with Genzyme were terminated, we could be prevented from continuing to commercialize Aldurazyme or our ability to successfully commercialize Aldurazyme would be delayed or diminished.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Either party may terminate the Manufacturing, Marketing and Sales Agreement (the MMS Agreement) between Genzyme and us related to Aldurazyme for specified reasons, including if the other party is in material breach of the MMS Agreement, has experienced a change of control, as such term is defined in the MMS Agreement, or has declared bankruptcy and also is in breach of the MMS Agreement. Although we are not currently in breach of the MMS Agreement, there is a risk that either party could breach the MMS Agreement in the future. Either party may also terminate the MMS Agreement upon one-year prior written notice for any reason.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the MMS Agreement is terminated for breach, the breaching party will transfer its interest in the BioMarin/Genzyme LLC to the non-breaching party, and the non-breaching party will pay a specified buyout amount for the breaching party&#8217;s interest in Aldurazyme and in the BioMarin/Genzyme LLC. If we are the breaching party, we would lose our rights to Aldurazyme and the related intellectual property and regulatory approvals. If the MMS Agreement is terminated without cause, the non-terminating party would have the option, exercisable for one year, to buy out the terminating party&#8217;s interest in Aldurazyme and in the BioMarin/Genzyme LLC at a specified buyout amount. If such option is not exercised, all rights to Aldurazyme will be sold and the BioMarin/Genzyme LLC will be dissolved. In the event of termination of the buyout option without exercise by the non-terminating party as described above, all right and title to Aldurazyme is to be sold to the highest bidder, with the proceeds to be split between Genzyme and us in accordance with our percentage interest in the BioMarin/Genzyme LLC.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the MMS Agreement is terminated by either party because the other party declared bankruptcy, the terminating party would be obligated to buy out the other party and would obtain all rights to Aldurazyme exclusively. If the MMS Agreement is terminated by a party because the other party experienced a change of control, the terminating party shall notify the other party, the offeree, of its intent to buy out the offeree&#8217;s interest in Aldurazyme and the BioMarin/Genzyme LLC for a stated amount set by the terminating party at its discretion. The offeree must then either accept this offer or agree to buy the terminating party&#8217;s interest in Aldurazyme and the BioMarin/Genzyme LLC on those same terms. The party who buys out the other party would then have exclusive worldwide rights to Aldurazyme. The Amended and Restated Collaboration Agreement between us and Genzyme will automatically terminate upon the effective date of the termination of the MMS Agreement and may not be terminated independently from the MMS Agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we were obligated or given the option to buy out Genzyme&#8217;s interest in Aldurazyme and the BioMarin/Genzyme LLC, and thereby gain exclusive rights to Aldurazyme, we may not have sufficient funds to do so and we may not be able to obtain the financing to do so. If we fail to buy out Genzyme&#8217;s interest, we may be held in breach of the agreement and may lose any claim to the rights to Aldurazyme and the related intellectual property and regulatory approvals. We would then effectively be prohibited from developing and commercializing Aldurazyme. If this happened, not only would our product revenues decrease, but our share price would also decline.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risks Related to International Operations</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*We conduct a significant amount of our sales and operations outside of the U.S., which subjects us to additional business risks that could adversely affect our revenues and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A significant portion of the sales of Aldurazyme, Brineura, Kuvan, Naglazyme and Vimizim are generated from countries other than the U.S. Similarly, we expect a significant portion of the sales of Palynziq and Voxzogo to be generated from countries </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">other than the U.S. We have operations in Canada and in several European, Middle Eastern, Asian, and Latin American countries. We expect that we will continue to expand our international operations in the future. International operations inherently subject us to a number of risks and uncertainties, including:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">the increased complexity and costs inherent in managing international operations;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">diverse regulatory and compliance requirements, and changes in those requirements that could restrict our ability to manufacture, market and sell our products;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">political and economic instability;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">diminished protection of intellectual property in some countries outside of the U.S.;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">trade protection measures and import or export licensing requirements;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">difficulty in staffing and managing international operations;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">differing labor regulations and business practices;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">potentially negative consequences from changes in or interpretations of tax laws;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">changes in international medical reimbursement policies and programs;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">financial risks such as longer payment cycles, difficulty collecting accounts receivable, exposure to fluctuations in foreign currency exchange rates and potential currency controls imposed by non-U.S. governments;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">regulatory and compliance risks that relate to maintaining accurate information and control over sales and distributors&#8217; and service providers&#8217; activities that may fall within the purview of the Foreign Corrupt Practices Act (the FCPA); and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">rapidly evolving global laws and regulations relating to data protection and the privacy and security of commercial and personal information.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any of these factors may, individually or as a group, have a material adverse effect on our business and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As we continue to expand our existing international operations, we may encounter new risks. For example, as we focus on building our international sales and distribution networks in new geographic regions, we must continue to develop relationships with qualified local distributors and trading companies. If we are not successful in developing and maintaining these relationships, we may not be able to grow sales in these geographic regions. These or other similar risks could adversely affect our revenues and profitability.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*A significant portion of our international sales are made based on special access programs, and changes to these programs could adversely affect our product sales and revenues in these countries.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We make a significant portion of our international sales of Naglazyme and Vimizim through special access or &#8220;named patient&#8221; programs, which do not require full product approval, and we expect a significant portion of our international sales of Brineura and Voxzogo will also be through such programs. The specifics of the programs vary from country to country. Generally, special approval must be obtained for each patient. The approval normally requires an application or a lawsuit accompanied by evidence of medical need. Generally, the approvals for each patient must be renewed from time to time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These programs are not well defined in some countries and are subject to changes in requirements and funding levels. Any change to these programs could adversely affect our ability to sell our products in those countries and delay sales. If the programs are not funded by the respective government, there could be insufficient funds to pay for all patients. Further, governments have and may continue to undertake unofficial measures to limit purchases of our products, including initially denying coverage for purchasers, delaying orders and denying or taking excessively long to approve customs clearance. Any such actions could materially delay or reduce our revenues from such countries.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Without the special access programs, we would need to seek full product approval to commercially market and sell our products in certain jurisdictions. This can be an expensive and time-consuming process and may subject our products to additional price controls. Because the number of patients is so small in some countries, it may not be economically feasible to seek and maintain a full product approval, and therefore the sales in such country would be permanently reduced or eliminated. For all of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">these reasons, if the special access programs that we are currently using are eliminated or restricted, our revenues could be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">U.S. export control and economic sanctions may adversely affect our business, financial condition and operating results. Moreover, compliance with such regulatory requirements may increase our costs and negatively impact our ability to sell our products and collect cash from customers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our products are subject to U.S. export control laws and regulations, including the U.S. Export Administration Regulations and various economic and trade sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control (OFAC). Exports of our products and solutions must be made in compliance with these laws and regulations. Changes to these laws and regulations, or to the countries, governments, persons or activities targeted by such laws, could result in decreased use of our products, or hinder our ability to export or sell our products to existing or potential customers, which would likely adversely affect our results of operations, financial condition or strategic objectives. If we fail to comply with these laws and regulations, we could be subject to substantial civil or criminal penalties, including the possible loss of export or import privileges and fines.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We rely on a general license from OFAC to sell our medicines for eventual use by hospital and clinic end-users in Iran. The use of this OFAC general license requires us to observe strict conditions with respect to products sold, end-user limitations and payment requirements. Although we believe we have maintained compliance with the general license requirements, there can be no assurance that the general license will not be revoked, be renewed in the future or that we will remain in compliance. A violation of the OFAC general license could result in substantial fines, sanctions, civil or criminal penalties, competitive or reputational harm, litigation or regulatory action and other consequences that might adversely affect our results of operations, financial condition or strategic objectives.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, U.S. export control and economic sanctions may make operating in certain countries more difficult and expensive. For example, we may be unable to find distributors or financial institutions willing to facilitate the sale of our products and collection of cash from such sales in a cost-effective manner, if at all.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Failure to comply with applicable anti-corruption legislation could result in fines, criminal penalties and materially adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are required to comply with anti-corruption and anti-bribery laws in the jurisdictions in which we operate, including the FCPA in the U.S., the United Kingdom (U.K.) Bribery Act 2010 and other similar laws in other countries in which we do business. We operate in a number of countries that are recognized to have a reputation for corruption and pose an increased risk of corrupt practices. We also regularly interact with government regulators in many countries, including those that are considered higher risk for corruption, in order to secure regulatory approval to manufacture and distribute our products. The anti-corruption and anti-bribery laws to which we are subject generally prohibit companies and their intermediaries from making improper payments to non-U.S. officials or other persons for the purposes of influencing official decisions or obtaining or retaining business and/or other benefits. These laws also require us to make and keep books and records that accurately and fairly reflect our transactions and to devise and maintain an adequate system of internal accounting controls. As part of our business, we deal with state-owned business enterprises, the employees and representatives of which may be considered non-U.S. officials for purposes of applicable anti-corruption laws.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we have adopted policies and procedures designed to ensure that we, our employees and third-party agents will comply with such laws, there can be no assurance that such policies or procedures will work effectively at all times or protect us against liability under these or other laws for actions taken by our employees, partners and other third parties with respect to our business. If we are not in compliance with anti-corruption laws and other laws governing the conduct of business with government entities and/or officials (including local laws), we may be subject to criminal and civil penalties and other remedial measures, which could harm our business, financial condition, results of operations, cash flows and prospects. Investigations of any actual or alleged violations of such laws or policies related to us could harm our business, financial condition, results of operations, cash flows and prospects.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, there has been enhanced scrutiny of company-sponsored patient assistance programs, including insurance premium and co-pay assistance programs and donations to third-party charities that provide such assistance. There has also been enhanced scrutiny by governments on reimbursement support offerings, clinical education programs and promotional speaker programs. If we, our third-party agents or donation recipients are deemed to have failed to comply with laws, regulations or government guidance in any of these areas, we could be subject to criminal or civil sanctions. Any similar violations by our competitors could also negatively impact our industry reputation and increase scrutiny over our business and our products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our international operations pose currency risks, which may adversely affect our operating results and net income.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A significant and growing portion of our revenues and earnings, as well as our substantial international net assets, are exposed to changes in foreign exchange rates. As we operate in multiple foreign currencies, including the Euro, the Brazilian Real, the Great British Pound, the Canadian Dollar and several other currencies, changes in those currencies relative to the U.S. Dollar (USD) will impact our revenues and expenses. If the USD were to weaken against another currency, assuming all other variables remained constant, our revenues would increase, having a positive impact on earnings, and our overall expenses would increase, having a negative impact on earnings. Conversely, if the USD were to strengthen against another currency, assuming all other variables remained constant, our revenues would decrease, having a negative impact on earnings, and our overall expenses would decrease, having a positive impact on earnings. In addition, because our financial statements are reported in USD, changes in currency exchange rates between the USD and other currencies have had, and will continue to have, an impact on our results of operations. Therefore, significant changes in foreign exchange rates can impact our results and our financial guidance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We implement currency hedges intended to reduce our exposure to changes in certain foreign currency exchange rates. However, our hedging strategies may not be successful, and any of our unhedged foreign exchange exposures will continue to be subject to market fluctuations. These risks could cause a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We face credit risks from government-owned or sponsored customers outside of the U.S. that may adversely affect our results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our product sales to government-owned or supported customers in various countries outside of the U.S. are subject to significant payment delays due to government funding and reimbursement practices. This has resulted and may continue to result in an increase in days sales outstanding due to the average length of time that we have accounts receivable outstanding. If significant changes were to occur in the reimbursement practices of these governments or if government funding becomes unavailable, we may not be able to collect on amounts due to us from these customers and our results of operations would be adversely affected.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Intellectual Property Risks</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If we are unable to protect our intellectual property, we may not be able to compete effectively or preserve our market shares.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where appropriate, we seek patent protection for certain aspects of our technology. Patent protection may not be available for some of the products we are developing. If we must spend significant time and money protecting or enforcing our patents, designing around patents held by others or licensing, potentially for large fees, patents or other proprietary rights held by others, our business and financial prospects may be harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The patent positions of biopharmaceutical products are complex and uncertain. The scope and extent of patent protection for some of our products and product candidates are particularly uncertain because key information on some of our product candidates has existed in the public domain for many years. The composition and genetic sequences of animal and/or human versions of Aldurazyme, Naglazyme and many of our product candidates have been published and are believed to be in the public domain. The chemical structure of 6R-BH4 (the active ingredient in Kuvan) has also been published. Publication of this information may prevent us from obtaining or enforcing patents relating to our products and product candidates, including without limitation composition-of-matter patents, which are generally believed to offer the strongest patent protection.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We own or have licensed patents and patent applications related to our products. However, these patents and patent applications do not ensure the protection of our intellectual property for a number of reasons, including without limitation the following:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">With respect to pending patent applications, unless and until actually issued, the protective value of these applications is impossible to determine. We do not know whether our patent applications will result in issued patents.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Patents have limited duration and expire. </span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Enforcing patents is expensive and may absorb significant time of our management. Management would spend less time and resources on developing products, which could increase our operating expenses and delay product programs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Receipt of a patent may not provide much, if any, practical protection. For example, if we receive a patent with a narrow scope, then it will be easier for competitors to design products that do not infringe on our patent.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">The Leahy-Smith America Invents Act of 2011, which reformed certain patent laws in the U.S., may create additional uncertainty. Among the significant changes are switching from a &#8220;first-to-invent&#8221; system to a &#8220;first-to-file&#8221; system, and the implementation of new procedures that permit competitors to challenge our patents in the U.S. Patent and Trademark Office after grant.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">It is also unclear whether our trade secrets are adequately protected. Our current and former employees, consultants or contractors may unintentionally or willfully disclose trade secrets to competitors. Enforcing a claim that someone else illegally obtained and is using our trade secrets, as with patent litigation, is expensive and time consuming, requires significant resources and has an unpredictable outcome. In addition, courts outside of the U.S. are sometimes less willing to protect trade secrets. Furthermore, our competitors may independently develop equivalent knowledge, methods and know-how, in which case we would not be able to enforce our trade secret rights against such competitors.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the EU, clinical trial data submitted to the EMA in MAAs that were traditionally regarded as confidential commercial information are now subject to public disclosure. Subject to our ability to review and redact a narrow sub-set of confidential commercial information, the EU policies have resulted and will continue to result in the EMA&#8217;s public disclosure of certain of our clinical study reports, clinical trial data summaries and clinical overviews for recently completed and future MAA submissions. The move toward public disclosure of development data could adversely affect our business in many ways, including, for example, resulting in the disclosure of our confidential methodologies for development of our products, preventing us from obtaining intellectual property right protection for innovations, requiring us to allocate significant resources to prevent other companies from violating our intellectual property rights, adding even more complexity to processing health data from clinical trials consistent with applicable data privacy regulations, and enabling competitors to use our data to gain approvals for their own products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Competitors may interfere with our patent process in a variety of ways. Competitors may claim that they invented the claimed invention prior to us or that they filed their application for a patent on a claimed invention before we did. Competitors may also claim that we are infringing on their patents and therefore we cannot practice our technology. Competitors may also contest our patents by showing the patent examiner or a court that the invention was not original, was not novel or was obvious, for example. In litigation, a competitor could claim that our issued patents are not valid or are unenforceable for a number of reasons. If a court agrees, we would not be able to enforce that patent. Moreover, generic manufacturers may use litigation and regulatory means to obtain approval for generic versions of our products notwithstanding our filed patents or patent applications.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we are unable to protect our intellectual property, third parties could develop competing products, which could adversely affect our revenues and financial results generally.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competitors and other third parties may have developed intellectual property that could limit our ability to market and commercialize our products and product candidates, if approved.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Similar to us, competitors continually seek intellectual property protection for their technology. Several of our development programs, such as valoctocogene roxaparvovec, focus on therapeutic areas that have been the subject of extensive research and development by third parties for many years. Due to the amount of intellectual property in our field of technology, we cannot be certain that we do not infringe intellectual property rights of competitors or that we will not infringe intellectual property rights of competitors granted or created in the future. For example, if a patent holder believes our product infringes its patent, the patent holder may sue us even if we have received patent protection for our technology. If someone else claims we infringe its intellectual property, we would face a number of issues, including the following:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Defending a lawsuit takes significant executive resources and can be very expensive.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">If a court decides that our product infringes a competitor&#8217;s intellectual property, we may have to pay substantial damages.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">With respect to patents, in addition to requiring us to pay substantial damages, a court may prohibit us from making, selling, offering to sell, importing or using our product unless the patent holder licenses the patent to us. The patent holder is not required to grant us a license. If a license is available, it may not be available on commercially reasonable terms. For example, we may have to pay substantial royalties or grant cross licenses to our patents and patent applications.</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">We may need to redesign our product so it does not infringe the intellectual property rights of others. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Redesigning our product so it does not infringe the intellectual property rights of competitors may not be possible or could require substantial funds and time.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We may also support and collaborate in research conducted by government organizations, hospitals, universities or other educational institutions. These research partners may be unwilling to grant us any exclusive rights to technology or products derived from these collaborations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we do not obtain required licenses or rights, we could encounter delays in our product development efforts while we attempt to design around other patents or may be prohibited from making, using, importing, offering to sell or selling products requiring these licenses or rights. There is also a risk that disputes may arise as to the rights to technology or products developed in collaboration with other parties. If we are not able to resolve such disputes and obtain the licenses or rights we need, we may not be able to develop or market our products.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Securities</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our stock price may be volatile, and an investment in our stock could suffer a decline in value.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our valuation and stock price may have no meaningful relationship to current or historical earnings, asset values, book value or many other criteria based on conventional measures of stock value. The market price of our common stock will fluctuate due to factors including: </span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">product sales and profitability of our products;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">manufacturing, supply or distribution of our product candidates and commercial products;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">progress of our product candidates through the regulatory process and our ability to successfully commercialize any such products that receive regulatory approval;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">results of clinical trials, announcements of technological innovations or new products by us or our competitors;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">generic competition to Kuvan tablets and powder relating to our settlements with the two pharmaceutical companies described above in this Risk Factors section or potential generic competition from future competitors;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">government regulatory action affecting our product candidates, our products or our competitors&#8217; product candidates and products in both the U.S. and non-U.S. countries;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">developments or disputes concerning patent or proprietary rights;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">general market conditions and fluctuations for the emerging growth and pharmaceutical market sectors;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">economic conditions in the U.S. or abroad;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">negative publicity about us or the pharmaceutical industry;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">changes in the structure of healthcare payment systems;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">cybersecurity incidents experienced by us or others in our industry;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">broad market fluctuations in the U.S., the EU or in other parts of the world;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">actual or anticipated fluctuations in our operating results, including due to timing of large orders for our products, in particular in Latin America, where governments place large periodic orders for Naglazyme and Vimizim;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">changes in company assessments or financial estimates by securities analysts;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">acquisitions of products, businesses, or other assets; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">sales of our shares of stock by us, our significant stockholders, or members of our management or Board of Directors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Furthermore, the stock markets have recently experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. In some cases, these fluctuations have been unrelated or disproportionate to the operating performance of those companies. In the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. For example, in September 2020, after a substantial drop in our stock price that followed an announcement providing a regulatory update regarding valoctocogene roxaparvovec, we and certain of our officers were sued in a putative class action lawsuit alleging violations of the federal securities laws for allegedly making materially false and misleading statements. We may be the target of additional litigation of this type in the future as well. Securities litigation against us could result in substantial costs and divert our management&#8217;s time and attention from other business concerns, which could harm our business. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, our stock price can be materially adversely affected by factors beyond our control, such as disruptions in global financial markets or negative trends in the biotechnology sector of the economy, even if our business is operating well.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Conversion of the Notes will dilute the ownership interest of existing stockholders, including holders who had previously converted their Notes, or may otherwise depress the price of our common stock.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The conversion of some or all of the Notes will dilute the ownership interests of existing stockholders. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Notes may encourage short selling by market participants because the conversion of the Notes could be used to satisfy short positions, or anticipated conversion of the Notes into shares of our common stock could depress the price of our common stock.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Anti-takeover provisions in our charter documents and under Delaware law may make an acquisition of us, which may be beneficial to our stockholders, more difficult.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are incorporated in Delaware. Certain anti-takeover provisions of Delaware law and our charter documents as currently in effect may make a change in control of us more difficult, even if a change in control would be beneficial to the stockholders. Our anti-takeover provisions include provisions in our restated certificate of incorporation and amended and restated bylaws providing that stockholders&#8217; meetings may only be called by our Chairman, the lead independent director or the majority of our Board of Directors and that the stockholders may not take action by written consent and requiring that stockholders that desire to nominate any person for election to our Board of Directors or to make any proposal with respect to business to be conducted at a meeting of our stockholders be submitted in appropriate form to our Secretary within a specified period of time in advance of any such meeting. Additionally, our Board of Directors has the authority to issue shares of preferred stock and to determine the terms of those shares of stock without any further action by our stockholders. The rights of holders of our common stock are subject to the rights of the holders of any preferred stock that may be issued. The issuance of preferred stock could make it more difficult for a third party to acquire a majority of our outstanding voting stock. Delaware law also prohibits corporations from engaging in a business combination with any holders of 15% or more of their capital stock until the holder has held the stock for three years unless, among other possibilities, our Board of Directors approves the transaction. Our Board of Directors may use these provisions to prevent changes in the management and control of us. Also, under applicable Delaware law, our Board of Directors may adopt additional anti-takeover measures in the future.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The fundamental change repurchase feature of the Notes may delay or prevent an otherwise beneficial attempt to take us over.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The terms of the Notes require us to repurchase the Notes in the event of a fundamental change. A takeover of us would trigger options by the respective holders of the applicable Notes to require us to repurchase such Notes. This may have the effect of delaying or preventing a takeover of us that would otherwise be beneficial to our stockholders or investors in the Notes.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our amended and restated bylaws designate the Court of Chancery of the State of Delaware and the federal district courts of the U.S. as the exclusive forums for the adjudication of certain disputes, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that the Court of Chancery of the State of Delaware is the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common law:</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">any derivative claim or cause of action brought on our behalf;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">any claim or cause of action for breach of a fiduciary duty owed by any director, officer or other employee of BioMarin to us or our stockholders;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">any claim or cause of action against us or any of our directors, officers or other employees arising pursuant to any provision of the General Corporation Law of the State of Delaware, our restated certificate of incorporation </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:81pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">or our amended and restated bylaws; any claim or cause of action seeking to interpret, apply, enforce or determine the validity of our restated certificate of incorporation or our amended and restated bylaws;</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">any claim or cause of action as to which the General Corporation Law of the State of Delaware confers jurisdiction to the Court of Chancery of the State of Delaware; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">any claim or cause of action against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This exclusive-forum provision would not apply to suits brought to enforce a duty or liability created by the Securities Act of 1933, as amended, the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. In addition, our amended and restated bylaws provide that the federal district courts of the U.S. of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated bylaws. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers, and other employees. If a court were to find either of our exclusive forum provisions to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could seriously harm our business. Our amended and restated bylaws further provide that any person or entity that acquires any interest in shares of our capital stock will be deemed to have notice of and consented to the provisions of such provisions.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We depend upon our key personnel and our ability to attract and retain employees.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our future growth and success will depend in large part on our continued ability to attract, retain, manage and motivate our employees. The loss of the services of any member of our senior management or the inability to hire or retain experienced management personnel could adversely affect our ability to execute our business plan and harm our operating results.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of the specialized scientific and managerial nature of our business, we rely heavily on our ability to attract and retain qualified scientific, technical and managerial personnel. In particular, the loss of one or more of our senior executive officers could be detrimental to us if we do not have an adequate succession plan or if we cannot recruit suitable replacements in a timely manner. While our senior executive officers are parties to employment agreements with us, these agreements do not guarantee that they will remain employed with us in the future. In addition, in many cases, these agreements do not restrict our senior executive officers&#8217; ability to compete with us after their employment is terminated. The competition for qualified personnel in the pharmaceutical field is intense, and there is a limited pool of qualified potential employees to recruit. Due to this intense competition, we may be unable to continue to attract and retain qualified personnel necessary for the development of our business or to recruit suitable replacement personnel. If we are unsuccessful in our recruitment and retention efforts, our business may be harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our success depends on our ability to manage our growth.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Product candidates that we are currently developing or may license or acquire in the future may be intended for patient populations that are significantly larger than any of the patient populations we currently target. In order to continue development and marketing of these products, if approved, we will need to significantly expand our operations. To manage expansion effectively, we need to continue to develop and improve our research and development capabilities, manufacturing and quality capacities, sales and marketing capabilities, financial and administrative systems and standard processes for global operations. Our staff, financial resources, systems, procedures or controls may be inadequate to support our operations and may increase our exposure to regulatory and corruption risks and our management may be unable to manage successfully future market opportunities or our relationships with customers and other third parties.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">New tax laws or regulations could be enacted at any time, and existing tax laws or regulations could be interpreted, modified or applied in a manner that is adverse to us or our customers, which could adversely affect our business and financial </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">condition. For example, legislation enacted in 2017, informally titled the Tax Cuts and Jobs Act (TCJA), enacted many significant changes to the U.S. tax laws, including changes in corporate tax rates, the application of certain tax credits (including a reduction of tax credits under the Orphan Drug Act), the deductibility of expenses, the utilization of net operating losses (NOLs) and other deferred tax assets, and the taxation of non-U.S. earnings. Future guidance from the Internal Revenue Service and other tax authorities with respect to the TCJA may affect us, and certain aspects of the TCJA could be repealed or modified in future legislation. For example, the Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, enacted in 2020, modified certain provisions of the TCJA, including provisions relating to NOL utilization. In addition, it is uncertain if and to what extent various states will conform to the TCJA, the CARES Act, or any newly enacted federal tax legislation. The impact of changes under the TCJA, the CARES Act, or future reform legislation, including certain legislative proposals by the current presidential administration, could increase our future U.S. tax expense and could have a material adverse impact on our business and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, changes in the tax laws of non-U.S. jurisdictions could arise, including as a result of the base erosion and profit shifting (BEPS) project that was undertaken by the Organization for Economic Co-operation and Development (OECD), or other initiatives led by the OECD or the European Commission. The OECD, which represents a coalition of member countries including the U.S. and other countries in which we have operations, made several recommendations with the aim of addressing tax avoidance and ensuring that profits are taxed where economic activities generating the profits are performed and where value is created. These changes, as adopted by countries, may increase tax uncertainty and may adversely affect our provision for income taxes, results of operations and cash flows. It is not uncommon for taxing authorities in different countries to have conflicting views, for instance, with respect to, among other things, the manner in which the arm's length standard is applied for transfer pricing purposes, or with respect to the valuation of intellectual property. If tax authorities successfully challenge our transfer prices as not reflecting arm's length transactions, they could require us to adjust our transfer prices and thereby reallocate our income to reflect these revised transfer prices, resulting in a higher tax liability. In addition, if a country from which income is reallocated does not agree with the reallocation, both that country and the other country to which the income was allocated could tax the same income, potentially resulting in double taxation. If tax authorities were to allocate income to a higher tax jurisdiction, subject our income to double taxation or assess interest and penalties, it would increase our consolidated tax liability, which could adversely affect our business, financial condition, results of operations and cash flows. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If we are found in violation of healthcare laws or privacy and data protection laws, we may be required to pay penalties, be subjected to scrutiny by regulators or governmental entities, or be suspended from participation in government healthcare programs, which may adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to various healthcare laws and regulations in the U.S. and internationally, including anti-kickback laws, false claims laws, data privacy and security laws, and laws related to ensuring compliance. In the U.S., the federal Anti-Kickback Statute makes it illegal for any person or entity, including a pharmaceutical company, to knowingly and willfully offer, solicit, pay or receive any remuneration, directly or indirectly, in exchange for or to induce the referral of business, including the purchase, order or prescription of a particular drug, for which payment may be made under federal healthcare programs, such as Medicare and Medicaid. Under the federal Anti-Kickback Statute and related regulations, certain arrangements are deemed not to violate the federal Anti-Kickback Statute if they fit within a statutory exception or regulatory safe harbor. However, the exceptions and safe harbors are drawn narrowly, and practices that involve remuneration not intended to induce prescribing, purchases or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Our practices may not in all cases meet all of the criteria for safe harbor protection from Anti-Kickback liability, although we seek to comply with these safe harbors. Many states have adopted laws similar to the federal Anti-Kickback Statute, some of which apply to referral of patients for healthcare services reimbursed by any source, not just governmental payers.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal and state false claims laws, including the civil False Claims Act and the Civil Monetary Penalties Law, prohibit any person or entity from knowingly presenting, or causing to be presented, a false claim for payment to the federal government, or knowingly making, or causing to be made, a false statement to have a false claim paid, or knowingly making, using, or causing to be made or used, a false record or statement to avoid, decrease or conceal an obligation to pay money to the federal government. In addition, certain marketing practices, including off-label promotion, may also violate false claims laws. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), we also are prohibited from, among other things, knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payers, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, recent healthcare reform legislation has strengthened these laws in the U.S. For example, the PPACA, among other things, amends the intent requirement of the federal Anti-Kickback Statute and criminal healthcare fraud statutes. A person or entity no longer needs to have actual knowledge of these statutes or specific intent to violate them in order to commit a violation. Moreover, the PPACA provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act and its implementing regulations, also imposes obligations, including mandatory contractual terms, on certain types of individuals and entities, with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">respect to safeguarding the privacy, integrity, availability, security and transmission of individually identifiable health information. Many state and non-U.S. laws also govern the privacy and security of health information. They often differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. The global data protection landscape is rapidly evolving, and implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. In the United States, California recently enacted the California Consumer Privacy Act (CCPA), which took effect on January 1, 2020. The CCPA gives California consumers expanded rights to access and delete their personal information, opt out of certain personal information sales, and receive detailed information about how their personal information is used. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. The CCPA will be expanded substantially on January 1, 2023 when the California Privacy Rights Act of 2020 (CPRA), becomes fully operative. The CPRA will, among other things, give consumers the ability to limit use of information deemed to be sensitive, increase the maximum penalties for violations concerning consumers under age 16, expand an individual&#8217;s private right of action and establish the California Privacy Protection Agency to implement and enforce the new law and impose administrative fines. In addition to California, other U.S. states have recently adopted consumer data protection and privacy laws, and more U.S. states may do so in the future. Aspects of the CCPA, CPRA and similar laws in other states and their interpretation and enforcement remain uncertain. The potential effects of these laws are far-reaching and may require us to modify our data processing practices and policies and to incur substantial costs and expenses in an effort to comply. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The European Regulation 2016/679, known as the General Data Protection Regulation (GDPR), as well as EU Member State implementing legislations, apply to the processing of personal data of individuals located in the EEA, including health-related information, by companies located in the EEA, or in certain circumstances, by companies located outside of the EEA. These laws impose strict obligations on the ability to collect, record, store, disclose, use and transmit personal data, including health-related information. These include several requirements relating to (i) obtaining, in some situations, the consent of the individuals to whom the personal data relates, (ii) the information provided to the individuals about how their personal information is used, (iii) ensuring the security and confidentiality of the personal data, (iv) the obligation to notify regulatory authorities and affected individuals of personal data breaches, (v) extensive internal privacy governance obligations, and (vi) obligations to honor rights of individuals in relation to their personal data (for example, the right to access, correct and delete their data). The GDPR prohibits the transfer of personal data to countries outside of the EEA, such as the United States, which are not considered by the European Commission to provide an adequate level of data protection. Switzerland has adopted similar restrictions. Potential pecuniary fines for noncompliant companies may be up to the greater of &#8364;20 million or 4% of annual global revenue. The GDPR has increased our responsibility and liability in relation to personal data that we process and has increased our compliance costs. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The GDPR and other European data protection laws generally restrict the transfer of personal information from Europe, including the EEA and Switzerland, to the U.S. and most other countries unless the parties to the transfer have implemented specific safeguards to protect the transferred personal information. One of the primary safeguards allowing U.S. companies to import personal information from Europe has been the European Commission&#8217;s Standard Contractual Clauses (SCCs). However, the Court of Justice of the EU issued a decision that called into question whether the SCCs can lawfully be used for transfers of personal information from Europe to the United States or most other countries. At present, there are few, if any, viable alternatives to the SCCs, on which we have relied for personal information transfers from Europe to the United States and other &#8220;third countries.&#8221; The Court of Justice of the EU ruled that subject to their containing &#8220;effective mechanisms&#8221; to ensure compliance with the protections offered by EU law, namely implementation of transfer impact assessments regarding country surveillance laws, the SCCs were generally upheld. New SCCs were published in June 2021 and will require implementation within 12 months from publication. Compliance with the regulations covering the transfer of personal information from Europe to the U.S. has increased our compliance costs. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Following the U.K.&#8217;s withdrawal from the EU on January 31, 2020 and the end of the transitional arrangements agreed to between the U.K. and EU, the GDPR no longer has effect in law in the U.K. However, the data protection obligations of the GDPR continue to apply to U.K.-related processing of personal data in substantially unvaried form under the so-called &#8220;UK GDPR&#8221; (i.e., the GDPR as it continues to form part of law in the U.K. However, going forward, there will be increasing scope for divergence in application, interpretation and enforcement of the data protection law as between the U.K. and EEA. Furthermore, the relationship between the U.K. and the EEA in relation to certain aspects of data protection law remains unclear, which could expose us to two parallel regimes, each of which potentially authorizes similar fines and other potentially divergent enforcement actions for certain violations. Also in the event of a violation of the GDPR affecting data subjects across the U.K. and the EEA, we could potentially be investigated by, and ultimately fined by the U.K. Information Commissioner&#8217;s Office and the supervisory authority in each and every EEA Member State where data subjects have been affected by such violation.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Substantial new laws and regulations affecting compliance have also been adopted in the U.S. and certain non-U.S. countries, which may require us to modify our business practices with healthcare practitioners. For example, in the U.S., the PPACA, through the Physician Payments Sunshine Act, requires certain drug, biologicals and medical supply manufacturers to collect and report to CMS information on payments or transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as investment and ownership interests held by such physicians and their immediate family members during the preceding calendar year. Effective January 1, 2022, manufacturers will also be required to report on payments or transfers of value during the previous year to physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists, and certified nurse-midwives. In </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">addition, there has been a recent trend of increased state regulation of payments made to physicians. Certain states and/or local jurisdictions mandate implementation of compliance programs, compliance with the Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers and the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals, the registration of pharmaceutical sales representatives and/or the tracking and reporting of gifts, compensation and other remuneration to physicians, marketing expenditures, and drug pricing. Likewise, in many non-U.S. countries there is an increasing focus on the relationship between drug companies and healthcare practitioners. Recently enacted non-U.S. legislation creates reporting obligations on payments, gifts and benefits made to these professionals; however, implementing regulations enacting such laws are still pending and subject to varying interpretations by courts and government agencies. The shifting regulatory environment and the need to implement systems to comply with multiple jurisdictions with different compliance and/or reporting requirements increases the costs of maintaining compliance and the possibility that we may violate one or more of the requirements and be subject to fines or sanctions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the breadth of the healthcare and privacy and data protection laws described above, the narrowness of available statutory and regulatory exceptions and safe harbors and the increased focus by law enforcement agencies in enforcing such laws, our business activities could be subject to challenge under one or more of such laws. If we are found in violation of one of these laws, we may be subject to significant criminal, civil or administrative sanctions, including damages, fines, disgorgement, imprisonment, contractual damages, reputational harm, diminished profits and future earnings, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, curtailment of our operations, and debarment, suspension or exclusion from participation in government healthcare programs, any of which could adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If product liability lawsuits are successfully brought against us, we may incur substantial liabilities.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to the potential product liability risks inherent in the testing, manufacturing and marketing of human pharmaceuticals. We currently maintain insurance against product liability lawsuits for the commercial sale of our products and for the clinical trials of our product candidates. Pharmaceutical companies must balance the cost of insurance with the level of coverage based on estimates of potential liability. Historically, the potential liability associated with product liability lawsuits for pharmaceutical products has been unpredictable. Although we believe that our current insurance is a reasonable estimate of our potential liability and represents a commercially reasonable balancing of the level of coverage as compared to the cost of the insurance, we may be subject to claims in connection with our clinical trials and commercial use of our products and product candidates for which our insurance coverage may not be adequate and we may be unable to avoid significant liability if any product liability lawsuit is brought against us. If we are the subject of a successful product liability claim that exceeds the limits of any insurance coverage we obtain, we may incur substantial charges that would adversely affect our earnings and require the commitment of capital resources that might otherwise be available for the development and commercialization of our product programs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We rely significantly on information technology systems and any failure, inadequacy, interruption or security lapse of that technology, including any cybersecurity incidents, could harm our ability to operate our business effectively and have a material adverse effect on our business, reputation, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We rely significantly on our information technology systems to effectively manage and maintain our operations, inventory and internal reports, to manufacture and ship products to customers and to timely invoice them. Any failure, inadequacy or interruption of that infrastructure or security lapse of that technology, including cybersecurity incidents or attacks, could harm our ability to operate our business effectively. Our ability to manage and maintain our operations, inventory and internal reports, to manufacture and ship our products to customers and timely invoice them depends significantly on our enterprise resource planning, production management and other information systems. Our technology systems, including our cloud technologies, continue to increase in multitude and complexity, making them potentially vulnerable to breakdown, cyberattack and other disruptions. Potential problems and interruptions associated with the implementation of new or upgraded technology systems or with maintenance or adequate support of existing systems could disrupt or reduce the efficiency of our operations and expose us to greater risk of security breaches. Cybersecurity incidents, including phishing attacks and attempts to misappropriate or compromise confidential or proprietary information or sabotage enterprise IT systems are becoming increasingly frequent and more sophisticated. Cybersecurity incidents resulting in the failure of our enterprise resource planning system, production management or other systems to operate effectively or to integrate with other systems, or a breach in security or other unauthorized access or unavailability of these systems, have occurred in the past and may affect our ability in the future to manage and maintain our operations, inventory and internal reports, and result in delays in product fulfillment and reduced efficiency of our operations. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As part of our business, we collect, store and transmit large amounts of confidential information, proprietary data, intellectual property and personal data. The information and data processed and stored in our technology systems, and those of our research collaborators, CROs, contract manufacturers, suppliers, distributors, or other third parties for which we depend to operate our business, may be vulnerable to loss, damage, denial-of-service, unauthorized access or misappropriation. Data security breaches may be the result of unauthorized or unintended activity (or lack of activity) by our employees or contractors or malware, hacking, business email compromise, phishing or other cyberattacks directed by third parties. These third parties for which we depend on to operate our business have experienced and may continue to experience cybersecurity incidents. While we </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">have implemented measures to protect our information and data stored in our technology systems and those of the third parties that we rely on, our efforts may not be successful.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have experienced and may continue to experience cybersecurity incidents. Although to our knowledge we have not experienced any material incident or interruption to date, if such an event were to occur it could result in a material disruption of our development programs and commercial operations, including due to a loss, corruption or unauthorized disclosure of our trade secrets, personal data or other proprietary or sensitive information. Further, these cybersecurity incidents can lead to the public disclosure of personal information (including sensitive personal information) of our employees, clinical trial patients and others and result in demands for ransom or other forms of blackmail. Such attacks are of ever-increasing levels of sophistication and are made by groups and individuals with a wide range of motives (including industrial espionage) and expertise, including by organized criminal groups, &#8220;hacktivists&#8221;, nation states and others. Moreover, the costs to us to investigate and mitigate cybersecurity incidents could be significant. For example, the loss of clinical trial data could result in delays in our product development or regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Any security breach that results in the unauthorized access, use or disclosure of personal data may require us to notify individuals, governmental authorities, credit reporting agencies, or other parties pursuant to privacy and security laws and regulations or other obligations. Such a security compromise could harm our reputation, erode confidence in our information security measures, and lead to regulatory scrutiny. To the extent that any disruption or security breach resulted in a loss of, or damage to, our data or systems, or inappropriate disclosure of confidential, proprietary or personal information, we could be exposed to a risk of loss, enforcement measures, penalties, fines, indemnification claims, litigation and potential civil or criminal liability, which could materially adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*If a natural disaster, terrorist or criminal activity or other unforeseen event caused significant damage to our facilities or those of our third-party manufacturers and suppliers or significantly disrupted our operations or those of our third-party manufacturers and suppliers, we may be unable to meet demand for our products and lose potential revenue, have reduced margins, or be forced to terminate a program.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The occurrence of an earthquake or other catastrophic disaster could cause damage to our facility and equipment, or that of our third-party manufacturers or single-source suppliers, which could materially impair the ability for us or our third-party manufacturers to manufacture our products and product candidates. Our Galli Drive facility, located in Novato, California, is currently our only manufacturing facility for Aldurazyme, Naglazyme, Voxzogo and Palynziq and is one of two manufacturing facilities for Brineura and Vimizim. Our gene therapy manufacturing facility is also located in Novato, California, and it is currently our only manufacturing facility to support valoctocogene roxaparvovec clinical development activities and the anticipated commercial demand for valoctocogene roxaparvovec, if approved. These facilities are located in the San Francisco Bay Area near known earthquake fault zones and are vulnerable to significant damage from earthquakes. We, the third-party manufacturers with whom we contract and our single-source suppliers of raw materials, which include many of our critical raw materials, are also vulnerable to damage from other types of disasters, including fires, explosions, floods, and similar events. If any disaster were to occur, or any terrorist or criminal activity caused significant damage to our facilities or the facilities of our third-party manufacturers and suppliers, our ability to manufacture our products, or to have our products manufactured, could be seriously, or potentially completely, impaired, and our commercialization efforts and revenues could be seriously impaired. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, other unforeseen events, such as power outages, could significantly disrupt our operations or those of our third-party manufacturers and suppliers, which could result in significant delays in the manufacture of our products and adversely impact our commercial operations and revenues. Pacific Gas and Electric Company, the electric utility in the San Francisco Bay Area where many of our facilities are located, commenced widespread blackouts during the fall of 2019 to avoid and contain wildfires sparked during strong wind events by downed power lines or equipment failures. While we have not experienced damage to our facilities or material disruption to our operations as a result of these power outages, ongoing blackouts, particularly if prolonged or frequent, could impact our business going forward. The insurance that we carry, the inventory that we maintain and our risk mitigation plans may not be adequate to cover our losses resulting from disasters or other business interruptions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our business is affected by macroeconomic conditions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Various macroeconomic factors could adversely affect our business and the results of our operations and financial condition, including changes in inflation, interest rates and foreign currency exchange rates and overall economic conditions and uncertainties, including those resulting from the current and future conditions in the global financial markets. For instance, if inflation or other factors were to significantly increase our business costs, it may not be feasible to pass price increases on to our customers due to the process by which healthcare providers are reimbursed for our products by the government. Interest rates, the liquidity of the credit markets and the volatility of the capital markets could also affect the value of our investments and our ability to liquidate our investments in order to fund our operations. We purchase or enter into a variety of financial instruments and transactions, including investments in commercial paper, the extension of credit to corporations, institutions and governments and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">hedging contracts. If any of the issuers or counter parties to these instruments were to default on their obligations, it could materially reduce the value of the transaction and adversely affect our cash flows.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We sell our products in countries that face economic volatility and weakness. Although we have historically collected receivables from customers in those countries, sustained weakness or further deterioration of the local economies and currencies may cause customers in those countries to be unable to pay for our products. Additionally, if one or more of these countries were unable to purchase our products, our revenues would be adversely affected.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest rates and the ability to access credit markets could also adversely affect the ability of our customers/distributors to purchase, pay for and effectively distribute our products. Similarly, these macroeconomic factors could affect the ability of our contract manufacturers, sole-source or single-source suppliers to remain in business or otherwise manufacture or supply product. Failure by any of them to remain a going concern could affect our ability to manufacture products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_121"></div><div style="margin-top:10pt;padding-left:90pt;text-indent:-90pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:6pt;text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_124"></div><div style="margin-top:10pt;padding-left:90pt;text-indent:-90pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:6pt;text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_127"></div><div style="margin-top:10pt;padding-left:90pt;text-indent:-90pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-top:6pt;text-indent:36pt"><span><br/></span></div><div id="i37555ce43f7244d3afa231a2a50e7423_130"></div><div style="margin-top:10pt;padding-left:90pt;text-indent:-90pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;Other Information</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None</span></div><div style="margin-top:12pt;text-indent:36pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_133"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.304%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1048477/000119312516423476/d117941dex21.htm">Amended and Restated Termination and Transition Agreement, dated as of December 23, 2015, between BioMarin Pharmaceutical Inc. and Ares Trading S.A., previously filed with the SEC on January 7, 2016 as Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K (File No. 000-26727), which is incorporated herein by reference. Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment. Omitted portions have been filed separately with the SEC.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1048477/000119312516423476/d117941dex23.htm">Termination and Transition Agreement, dated as of October 1, 2015, between BioMarin Pharmaceutical Inc. and Ares Trading S.A., previously filed with the SEC on January 7, 2016 as Exhibit 2.3 to the Company&#8217;s Current Report on Form 8-K (File No. 000-26727), which is incorporated herein by reference. Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment. Omitted portions have been filed separately with the SEC.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1048477/000156459017002483/bmrn-ex26_494.htm">First Amendment, dated as of December 12, 2016, to the Amended and Restated Termination and Transition Agreement, dated as of December 23, 2015 and effective as of October 1, 2015, between BioMarin Pharmaceutical Inc. and Ares Trading S.A., previously filed with the SEC on February 27, 2017 as Exhibit 2.6 to the Company&#8217;s Annual Report on Form 10-K (File No. 000-26727), which is incorporated herein by reference. Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment. Omitted portions have been filed separately with the SEC.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1048477/000119312517201414/d403853dex32.htm">Restated Certificate of Incorporation of BioMarin Pharmaceutical Inc., previously filed with the SEC on June 12, 2017 as Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K (File No. 000-26727), which is incorporated herein by reference.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1048477/000119312520321537/d52330dex31.htm">Amended and Restated Bylaws of BioMarin Pharmaceutical Inc., previously filed with the SEC on December 18, 2020 as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K (File No. 000-26727), which is incorporated herein by reference.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="exhibit311-30sep21x10q.htm">Certification of Chief Executive Officer pursuant to Rules 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="exhibit312-30sep21x10q.htm">Certification of Chief Financial Officer pursuant to Rules 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1*+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:none" href="exhibit321-30sep21x10q.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. This Certification accompanies this report and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed for purposes of &#167;18 of the Securities Exchange Act of 1934, as amended.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Document</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Labels Linkbase Document</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Link Document</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL tags for the cover page from the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2021, are embedded within the Inline XBRL document.</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;The certifications attached as Exhibit&#160;32.1 accompany this Quarterly Report on Form&#160;10-Q pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed &#8220;filed&#8221; by the Registrant for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any of the Registrant&#8217;s filings under the Securities Act of 1933, as amended, irrespective of any general incorporation language contained in any such filing.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Attached as Exhibit 101 to this report are documents formatted in XBRL (Extensible Business Reporting Language): (i)&#160;Condensed Consolidated Balance Sheets as of September&#160;30, 2021 and December&#160;31, 2020, (ii)&#160;Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September&#160;30, 2021 and 2020, (iii)&#160;Condensed Consolidated Statement of Stockholders&#8217; Equity for the three and nine months ended September&#160;30, 2021 and 2020, (iv)&#160;Condensed Consolidated Statements of Cash Flows for the nine months ended September&#160;30, 2021 and 2020, and (v)&#160;Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i37555ce43f7244d3afa231a2a50e7423_136"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-top:6pt;padding-left:45pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i37555ce43f7244d3afa231a2a50e7423_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:6pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.616%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BIOMARIN PHARMACEUTICAL INC.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dated: October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;BRIAN R. MUELLER</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Brian R. Mueller<br/>Executive&#160;Vice&#160;President, Finance &amp; Chief&#160;Financial&#160;Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-30sep21x10q.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ibd1c674edbf042b7852a62ee5df2539e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Jean-Jacques Bienaim&#233;, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:85.5pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:33pt">I have reviewed this Quarterly Report on Form 10-Q of BioMarin Pharmaceutical Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:85.5pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:33pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:85.5pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:33pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:85.5pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:33pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:126pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:126pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:126pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:30.02pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:126pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:85.5pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:33pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:126pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:126pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.52pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; October&#160;29, 2021 </font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.929%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; JEAN-JACQUES BIENAIM&#201;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jean-Jacques Bienaim&#233;<br>Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-30sep21x10q.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib6795635b6a9452c832700fc44263e14_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Brian R. Mueller, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of BioMarin Pharmaceutical Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:19.01pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:19.01pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:19.51pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:19.01pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:19.01pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:19.01pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; October&#160;29, 2021</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;BRIAN R. MUELLER</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brian R. Mueller<br>Executive Vice&#160;President, Finance &#38;<br>Chief&#160;Financial&#160;Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-30sep21x10q.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2fd0bf62af03472496d72ce8b03dc0ba_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We, Jean-Jacques Bienaim&#233; and Brian R. Mueller, hereby certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that BioMarin Pharmaceutical Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended September&#160;30, 2021, fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of BioMarin Pharmaceutical Inc.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.267%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; JEAN-JACQUES&#160;BIENAIM&#201;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jean-Jacques Bienaim&#233;<br>Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; October&#160;29, 2021 </font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.267%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;BRIAN R. MUELLER</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brian R. Mueller<br>Executive&#160;Vice&#160;President, Finance &#38; <br>Chief&#160;Financial&#160;Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; October&#160;29, 2021 </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of BioMarin Pharmaceutical Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>bmrn-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f95636f6-9f25-4ee3-86c2-7b0315cdf3d9,g:ce424ef1-ab97-4f04-a4e9-8c3801ecff3b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bmrn="http://www.bmrn.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bmrn.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmrn-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmrn-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmrn-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmrn-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.bmrn.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFOPERATIONS" roleURI="http://www.bmrn.com/role/NATUREOFOPERATIONS">
        <link:definition>2101101 - Disclosure - NATURE OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATION" roleURI="http://www.bmrn.com/role/BASISOFPRESENTATION">
        <link:definition>2102102 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONPolicies" roleURI="http://www.bmrn.com/role/BASISOFPRESENTATIONPolicies">
        <link:definition>2203201 - Disclosure - BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.bmrn.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2104103 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGPRONOUNCEMENTS" roleURI="http://www.bmrn.com/role/RECENTACCOUNTINGPRONOUNCEMENTS">
        <link:definition>2105104 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://www.bmrn.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2106105 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://www.bmrn.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2307301 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail" roleURI="http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail">
        <link:definition>2408401 - Disclosure - Financial Instruments - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsAdditionalInformationDetail" roleURI="http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail">
        <link:definition>2409402 - Disclosure - Financial Instruments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETINFORMATION" roleURI="http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATION">
        <link:definition>2110106 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALBALANCESHEETINFORMATIONTables" roleURI="http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATIONTables">
        <link:definition>2311302 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationScheduleofInventoryDetail" roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail">
        <link:definition>2412403 - Disclosure - Supplemental Balance Sheet Information - Schedule of Inventory (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationNarrativeDetails" roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails">
        <link:definition>2413404 - Disclosure - Supplemental Balance Sheet Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails">
        <link:definition>2414405 - Disclosure - Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails" roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails">
        <link:definition>2415406 - Disclosure - Supplemental Balance Sheet Information - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail" roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail">
        <link:definition>2416407 - Disclosure - Supplemental Balance Sheet Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.bmrn.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2117107 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.bmrn.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2318303 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail" roleURI="http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail">
        <link:definition>2419408 - Disclosure - Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail" roleURI="http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail">
        <link:definition>2420409 - Disclosure - Fair Value Measurements - Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIES" roleURI="http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIES">
        <link:definition>2121108 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables" roleURI="http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables">
        <link:definition>2322304 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail" roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail">
        <link:definition>2423410 - Disclosure - Derivative Instruments and Hedging Strategies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail" roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail">
        <link:definition>2424411 - Disclosure - Derivative Instruments and Hedging Strategies - Summary of Derivatives Designated as and Not Designated as Hedging Instruments Outstanding (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail" roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail">
        <link:definition>2425412 - Disclosure - Derivative Instruments and Hedging Strategies - Fair Value Carrying Amount of Derivatives (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail" roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail">
        <link:definition>2426413 - Disclosure - Derivative Instruments and Hedging Strategies - Summary of Impact of Gains and Losses from Derivatives Designated as Hedging Instruments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.bmrn.com/role/DEBT">
        <link:definition>2127109 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.bmrn.com/role/DEBTTables">
        <link:definition>2328305 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAdditionalInformationDetail" roleURI="http://www.bmrn.com/role/DebtAdditionalInformationDetail">
        <link:definition>2429414 - Disclosure - Debt - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofConvertibleDebtDetail" roleURI="http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail">
        <link:definition>2430415 - Disclosure - Debt - Summary of Convertible Debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofInterestExpenseonConvertibleDebtDetail" roleURI="http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail">
        <link:definition>2431416 - Disclosure - Debt - Summary of Interest Expense on Convertible Debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" roleURI="http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS">
        <link:definition>2132110 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" roleURI="http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables">
        <link:definition>2333306 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail" roleURI="http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail">
        <link:definition>2434417 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Summary of Changes in Accumulated Balances of AOCI Including Current Period Other Comprehensive Income (Loss) and Reclassifications Out of AOCI (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATION" roleURI="http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATION">
        <link:definition>2135111 - Disclosure - REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables" roleURI="http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables">
        <link:definition>2336307 - Disclosure - REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail" roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail">
        <link:definition>2437418 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail" roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail">
        <link:definition>2438419 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Revenues from External Customers and Collaborative Partners by Geographic Region (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail" roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail">
        <link:definition>2439420 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Disaggregates of Net Product Revenues by Product (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail" roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail">
        <link:definition>2440421 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Net Product Revenues Based on Patient Location (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail" roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail">
        <link:definition>2441422 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Total Net Product Revenue Concentrations Attributed to Largest Customers (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.bmrn.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2142112 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.bmrn.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2343308 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationExpenseDetail" roleURI="http://www.bmrn.com/role/StockBasedCompensationExpenseDetail">
        <link:definition>2444423 - Disclosure - Stock-Based Compensation - Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERCOMMONSHARE" roleURI="http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARE">
        <link:definition>2145113 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERCOMMONSHARETables" roleURI="http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARETables">
        <link:definition>2346309 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails" roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails">
        <link:definition>2447424 - Disclosure - Net Income (Loss) Per Common Share - Schedule of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail" roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail">
        <link:definition>2448425 - Disclosure - Net Income (Loss) Per Common Share - Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerCommonShareAdditionalInformationDetail" roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail">
        <link:definition>2449426 - Disclosure - Net Income (Loss) Per Common Share - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.bmrn.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2150114 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>2451427 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bmrn_RestrictedInvestmentsMember" abstract="true" name="RestrictedInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure" abstract="false" name="OtherLiabilitiesNoncurrentFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_ConcentrationRiskAndGeographicInformationTable" abstract="true" name="ConcentrationRiskAndGeographicInformationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_KuvanAndPalynziqMember" abstract="true" name="KuvanAndPalynziqMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ShortTermMarketableSecuritiesMaturityPeriod" abstract="false" name="ShortTermMarketableSecuritiesMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bmrn_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember" abstract="true" name="ConvertibleSeniorNotesDueTwentyTwentyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ContingentPaymentMember" abstract="true" name="ContingentPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" abstract="false" name="ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable" abstract="true" name="ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember" abstract="true" name="ConvertibleSeniorNotesDueTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_AccruedGovernmentAndOtherRebates" abstract="false" name="AccruedGovernmentAndOtherRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember" abstract="true" name="ForeignGovernmentAndOtherDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ProductSevenMember" abstract="true" name="ProductSevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" abstract="false" name="PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_ConcentrationRiskAndGeographicInformationLineItems" abstract="true" name="ConcentrationRiskAndGeographicInformationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember" abstract="true" name="ConvertibleSeniorNotesDueTwoThousandTwentySevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember" abstract="true" name="CommonStockIssuableToEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ProductTwoMember" abstract="true" name="ProductTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_IntangibleAssetAmortizationAndContingentConsideration" abstract="false" name="IntangibleAssetAmortizationAndContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones" abstract="false" name="ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_ProductOneMember" abstract="true" name="ProductOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ScheduleOfInterestExpensesLineItems" abstract="true" name="ScheduleOfInterestExpensesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_CustomerThreeMember" abstract="true" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ProductThreeMember" abstract="true" name="ProductThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_AccumulatedGainLossFromOtherMember" abstract="true" name="AccumulatedGainLossFromOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ConcentrationRiskAndGeographicInformationAbstract" abstract="true" name="ConcentrationRiskAndGeographicInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" abstract="false" name="SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember" abstract="true" name="SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_RoyaltyAndOtherMember" abstract="true" name="RoyaltyAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ProductFourMember" abstract="true" name="ProductFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ProgramsNoLongerBeingDevelopedMember" abstract="true" name="ProgramsNoLongerBeingDevelopedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_StrategicInvestmentMember" abstract="true" name="StrategicInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ScheduleOfInterestExpensesTable" abstract="true" name="ScheduleOfInterestExpensesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_NonqualifiedDeferredCompensationPlanAssetsMember" abstract="true" name="NonqualifiedDeferredCompensationPlanAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_OtherAssetsCurrentFairValueDisclosure" abstract="false" name="OtherAssetsCurrentFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_ProductFiveMember" abstract="true" name="ProductFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember" abstract="true" name="ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member" abstract="true" name="A125SeniorSubordinatedConvertibleNotesDueInMay2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember" abstract="true" name="NonqualifiedDeferredCompensationPlanLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_CustomerOneTwoAndThreeMember" abstract="true" name="CustomerOneTwoAndThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ProductSixMember" abstract="true" name="ProductSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock" abstract="false" name="ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmrn_ThirdPartyMember" abstract="true" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_EarlyStageDevelopmentProgramMember" abstract="true" name="EarlyStageDevelopmentProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock" abstract="false" name="ConcentrationRiskAndSegmentReportingDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmrn_VoxzogoMember" abstract="true" name="VoxzogoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ProductsExcludingProductOneMember" abstract="true" name="ProductsExcludingProductOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_CustomerTwoMember" abstract="true" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_OtherAssetsNoncurrentFairValueDisclosure" abstract="false" name="OtherAssetsNoncurrentFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_ProceedsFromSaleOfNonfinancialAssets" abstract="false" name="ProceedsFromSaleOfNonfinancialAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_LongTermMarketableSecuritiesMaturityPeriod" abstract="false" name="LongTermMarketableSecuritiesMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bmrn_OtherLiabilitiesCurrentFairValueDisclosure" abstract="false" name="OtherLiabilitiesCurrentFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" abstract="false" name="SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember" abstract="true" name="OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems" abstract="true" name="ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmrn_ProductEightMember" abstract="true" name="ProductEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmrn_CustomersMember" abstract="true" name="CustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>bmrn-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f95636f6-9f25-4ee3-86c2-7b0315cdf3d9,g:ce424ef1-ab97-4f04-a4e9-8c3801ecff3b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7e59979b-56bf-473e-a50c-6656f5b982fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8eccb127-1c93-4ffc-b34f-ccc1084ddc59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7e59979b-56bf-473e-a50c-6656f5b982fb" xlink:to="loc_us-gaap_Liabilities_8eccb127-1c93-4ffc-b34f-ccc1084ddc59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0b67fee7-de36-4b3d-a3c4-b4a566a9c258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7e59979b-56bf-473e-a50c-6656f5b982fb" xlink:to="loc_us-gaap_StockholdersEquity_0b67fee7-de36-4b3d-a3c4-b4a566a9c258" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9073c863-2c32-401e-a44f-496c44687c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d02fd8a6-b504-4bc3-86df-86e205454f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9073c863-2c32-401e-a44f-496c44687c35" xlink:to="loc_us-gaap_AssetsCurrent_d02fd8a6-b504-4bc3-86df-86e205454f69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_ac8f1d4e-1ef2-432b-b113-e6de88c05103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9073c863-2c32-401e-a44f-496c44687c35" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_ac8f1d4e-1ef2-432b-b113-e6de88c05103" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0283d927-f131-4117-9965-82d9f123cbed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9073c863-2c32-401e-a44f-496c44687c35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0283d927-f131-4117-9965-82d9f123cbed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_50c8042f-6759-4494-a782-d3e2d022c7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9073c863-2c32-401e-a44f-496c44687c35" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_50c8042f-6759-4494-a782-d3e2d022c7af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6c57b2d8-1a80-436f-b2c7-de2318559bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9073c863-2c32-401e-a44f-496c44687c35" xlink:to="loc_us-gaap_Goodwill_6c57b2d8-1a80-436f-b2c7-de2318559bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5c85c5d0-e103-43e5-a1d8-a8fef3cd8a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9073c863-2c32-401e-a44f-496c44687c35" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5c85c5d0-e103-43e5-a1d8-a8fef3cd8a3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_eaa771a6-d5df-4b2b-a9a7-f85868415cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9073c863-2c32-401e-a44f-496c44687c35" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_eaa771a6-d5df-4b2b-a9a7-f85868415cdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_80bc1c97-bab2-43cc-b746-2f3a1ba29276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0036aaf1-9b83-4d7f-b525-381ef9ee93ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_80bc1c97-bab2-43cc-b746-2f3a1ba29276" xlink:to="loc_us-gaap_CommonStockValue_0036aaf1-9b83-4d7f-b525-381ef9ee93ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_cb18c59f-de49-4f64-b933-f80a723f9bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_80bc1c97-bab2-43cc-b746-2f3a1ba29276" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_cb18c59f-de49-4f64-b933-f80a723f9bec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIssuedEmployeeStockTrust_de860d6b-4153-48af-82a7-9d76d291665a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIssuedEmployeeStockTrust"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_80bc1c97-bab2-43cc-b746-2f3a1ba29276" xlink:to="loc_us-gaap_CommonStockIssuedEmployeeStockTrust_de860d6b-4153-48af-82a7-9d76d291665a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_172e2fe9-b8a1-43c0-9f07-949c3608a29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_80bc1c97-bab2-43cc-b746-2f3a1ba29276" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_172e2fe9-b8a1-43c0-9f07-949c3608a29c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bfafb321-fa0e-4d68-9844-58b2a23af876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_80bc1c97-bab2-43cc-b746-2f3a1ba29276" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bfafb321-fa0e-4d68-9844-58b2a23af876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4800584e-03f7-4fa1-8f88-5b6e887fabd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b05214b4-6025-450b-8b7f-5a11fcbd8ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4800584e-03f7-4fa1-8f88-5b6e887fabd7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b05214b4-6025-450b-8b7f-5a11fcbd8ccd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_73da927b-6ef8-457a-8c3c-3b5ef2fbb986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4800584e-03f7-4fa1-8f88-5b6e887fabd7" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_73da927b-6ef8-457a-8c3c-3b5ef2fbb986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_36ef05f2-fa13-46e6-95e9-93154bb44a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_966b875f-3600-4e49-8805-749cb51a941b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_36ef05f2-fa13-46e6-95e9-93154bb44a4e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_966b875f-3600-4e49-8805-749cb51a941b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_8e8cfeb6-5221-45e0-8bc9-6e58e9ae3cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_36ef05f2-fa13-46e6-95e9-93154bb44a4e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_8e8cfeb6-5221-45e0-8bc9-6e58e9ae3cd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4d828fc4-6bb9-4c35-9f97-e2616a727280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_36ef05f2-fa13-46e6-95e9-93154bb44a4e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4d828fc4-6bb9-4c35-9f97-e2616a727280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b7ff7799-e1d4-4e21-b642-94694e3ddb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_36ef05f2-fa13-46e6-95e9-93154bb44a4e" xlink:to="loc_us-gaap_InventoryNet_b7ff7799-e1d4-4e21-b642-94694e3ddb6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4b7f1011-66eb-401e-9fcb-e2e768b371af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_36ef05f2-fa13-46e6-95e9-93154bb44a4e" xlink:to="loc_us-gaap_OtherAssetsCurrent_4b7f1011-66eb-401e-9fcb-e2e768b371af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ca62b9ce-6381-4b45-b1f1-3dccd7056a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a5646606-a69a-4b4d-bac3-2efe1a578af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ca62b9ce-6381-4b45-b1f1-3dccd7056a45" xlink:to="loc_us-gaap_LiabilitiesCurrent_a5646606-a69a-4b4d-bac3-2efe1a578af3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_5c27f44a-7460-4a75-b5ec-3bf39d45caf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ca62b9ce-6381-4b45-b1f1-3dccd7056a45" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_5c27f44a-7460-4a75-b5ec-3bf39d45caf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ebdf0bf1-834c-44c2-9068-db3499cd1645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ca62b9ce-6381-4b45-b1f1-3dccd7056a45" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ebdf0bf1-834c-44c2-9068-db3499cd1645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_647b3056-35c3-4732-b0ba-cd640a15dead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ca62b9ce-6381-4b45-b1f1-3dccd7056a45" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_647b3056-35c3-4732-b0ba-cd640a15dead" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_dff6c5a7-9c27-41f7-8ca4-1dc4769d23c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_890eb4e3-2ecc-43db-a268-249678794112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_dff6c5a7-9c27-41f7-8ca4-1dc4769d23c2" xlink:to="loc_us-gaap_CostOfRevenue_890eb4e3-2ecc-43db-a268-249678794112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e438edf3-3242-4a9a-aef9-64316d688f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_dff6c5a7-9c27-41f7-8ca4-1dc4769d23c2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e438edf3-3242-4a9a-aef9-64316d688f17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5c1791cc-f719-415d-bdf2-2622976b622e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_dff6c5a7-9c27-41f7-8ca4-1dc4769d23c2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5c1791cc-f719-415d-bdf2-2622976b622e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_IntangibleAssetAmortizationAndContingentConsideration_6f16c9f2-697c-4784-833b-75b109094e42" xlink:href="bmrn-20210930.xsd#bmrn_IntangibleAssetAmortizationAndContingentConsideration"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_dff6c5a7-9c27-41f7-8ca4-1dc4769d23c2" xlink:to="loc_bmrn_IntangibleAssetAmortizationAndContingentConsideration_6f16c9f2-697c-4784-833b-75b109094e42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_a00e16f0-63d0-4988-a92f-634d113122a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_dff6c5a7-9c27-41f7-8ca4-1dc4769d23c2" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_a00e16f0-63d0-4988-a92f-634d113122a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_36b1ec6f-ab70-4b04-b9ab-1ea82002da6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34902bbe-3ef4-44de-8ae1-e0910c8a9f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_36b1ec6f-ab70-4b04-b9ab-1ea82002da6f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34902bbe-3ef4-44de-8ae1-e0910c8a9f0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_32c69488-29bf-488f-afb2-59b72118afee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_36b1ec6f-ab70-4b04-b9ab-1ea82002da6f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_32c69488-29bf-488f-afb2-59b72118afee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6c32a7a0-b421-48b6-ae14-5f41f12f19b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9d3e6a1c-ab2e-4e02-9f52-c5f984911a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6c32a7a0-b421-48b6-ae14-5f41f12f19b5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9d3e6a1c-ab2e-4e02-9f52-c5f984911a82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_63e230f2-6bec-4749-ad68-92053fe4896e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6c32a7a0-b421-48b6-ae14-5f41f12f19b5" xlink:to="loc_us-gaap_CostsAndExpenses_63e230f2-6bec-4749-ad68-92053fe4896e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2125f255-e83e-445f-9739-5e27860712b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dc7c8730-3e7e-427b-b8ec-8fadc067e816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2125f255-e83e-445f-9739-5e27860712b1" xlink:to="loc_us-gaap_OperatingIncomeLoss_dc7c8730-3e7e-427b-b8ec-8fadc067e816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_12362333-c3f4-4499-8348-a1ebe558ac07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2125f255-e83e-445f-9739-5e27860712b1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_12362333-c3f4-4499-8348-a1ebe558ac07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_2bb6c264-f491-44b3-9706-93a1fefd812f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2125f255-e83e-445f-9739-5e27860712b1" xlink:to="loc_us-gaap_InvestmentIncomeInterest_2bb6c264-f491-44b3-9706-93a1fefd812f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a5576dbe-b573-4a0a-aa1b-0f4023b3b2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2125f255-e83e-445f-9739-5e27860712b1" xlink:to="loc_us-gaap_InterestExpense_a5576dbe-b573-4a0a-aa1b-0f4023b3b2aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_0848aabf-d852-4af7-ab56-091817b7bbef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2125f255-e83e-445f-9739-5e27860712b1" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_0848aabf-d852-4af7-ab56-091817b7bbef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5df755be-d2d1-4f50-83df-818b95564ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_NetIncomeLoss_5df755be-d2d1-4f50-83df-818b95564ec6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a2bf2e67-7c30-451d-a77a-93d0bbfe2afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a2bf2e67-7c30-451d-a77a-93d0bbfe2afc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_ebd92f3a-04d1-4bb1-a3e2-ef348d03ba1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_ebd92f3a-04d1-4bb1-a3e2-ef348d03ba1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_c5a0806f-d96a-4bc2-afdf-cfd5e4e8abbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_c5a0806f-d96a-4bc2-afdf-cfd5e4e8abbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7066ed1b-7d7c-4c06-a70d-b19095a548a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_ShareBasedCompensation_7066ed1b-7d7c-4c06-a70d-b19095a548a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_696af498-2220-4fcd-85b6-23e6375a0395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_696af498-2220-4fcd-85b6-23e6375a0395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_d9ad35c4-ad80-4497-81e4-894388cdbb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_d9ad35c4-ad80-4497-81e4-894388cdbb0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ea40d65f-62c5-480a-a6de-52d35ec36f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ea40d65f-62c5-480a-a6de-52d35ec36f74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_50b7eae4-d654-4c30-af82-b7ee15a79bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_50b7eae4-d654-4c30-af82-b7ee15a79bcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_da846d21-0759-413c-bc43-54e31d821752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_da846d21-0759-413c-bc43-54e31d821752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8daf875b-5637-42e1-b080-8940ebc364ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8daf875b-5637-42e1-b080-8940ebc364ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_601ed058-e7b5-425c-ba0b-027965a95997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_601ed058-e7b5-425c-ba0b-027965a95997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_f61782a2-f16a-4890-9469-6805a27d4749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_f61782a2-f16a-4890-9469-6805a27d4749" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_655774e3-35ca-4bb0-b02c-a09e1dc9c060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_655774e3-35ca-4bb0-b02c-a09e1dc9c060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5fcac43f-4f66-4c6b-821d-017486728d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5fcac43f-4f66-4c6b-821d-017486728d8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_d881a353-53ac-4910-b994-b57fc4b9d123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_d881a353-53ac-4910-b994-b57fc4b9d123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_0c7503f8-bf6e-4f05-b396-8561830e9ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_525bf9e8-01c7-47b7-a7cc-76f809c247c1" xlink:to="loc_us-gaap_InventoryWriteDown_0c7503f8-bf6e-4f05-b396-8561830e9ea5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8be66d73-745a-49b6-9615-074c50035407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_35e73678-a12e-4330-ad7b-ba34575dc2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8be66d73-745a-49b6-9615-074c50035407" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_35e73678-a12e-4330-ad7b-ba34575dc2b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_eea0b062-32c7-4693-acd4-7df1325f3501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8be66d73-745a-49b6-9615-074c50035407" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_eea0b062-32c7-4693-acd4-7df1325f3501" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8b457829-3007-479b-9995-5429c02b6069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8be66d73-745a-49b6-9615-074c50035407" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8b457829-3007-479b-9995-5429c02b6069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f7ae10ca-dfe8-4d51-8186-2f7bb0748f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8be66d73-745a-49b6-9615-074c50035407" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f7ae10ca-dfe8-4d51-8186-2f7bb0748f96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_618c1576-4411-48cd-8686-ea4b502c1d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8be66d73-745a-49b6-9615-074c50035407" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_618c1576-4411-48cd-8686-ea4b502c1d12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProceedsFromSaleOfNonfinancialAssets_e77ad5bc-9c32-43ad-80cb-4ef0528d3b1b" xlink:href="bmrn-20210930.xsd#bmrn_ProceedsFromSaleOfNonfinancialAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8be66d73-745a-49b6-9615-074c50035407" xlink:to="loc_bmrn_ProceedsFromSaleOfNonfinancialAssets_e77ad5bc-9c32-43ad-80cb-4ef0528d3b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable_256606a8-9fa8-4138-be95-30634f35f6cf" xlink:href="bmrn-20210930.xsd#bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8be66d73-745a-49b6-9615-074c50035407" xlink:to="loc_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable_256606a8-9fa8-4138-be95-30634f35f6cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f49660f-4ae6-4334-8d38-50f9577c9728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bde2540e-bdc9-44d8-a4b1-041103e6c7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f49660f-4ae6-4334-8d38-50f9577c9728" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bde2540e-bdc9-44d8-a4b1-041103e6c7e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_20703494-bea6-4c38-b58a-e220383b6027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f49660f-4ae6-4334-8d38-50f9577c9728" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_20703494-bea6-4c38-b58a-e220383b6027" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_3c7bb382-9b82-4b5d-acf3-0844a46a982f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f49660f-4ae6-4334-8d38-50f9577c9728" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_3c7bb382-9b82-4b5d-acf3-0844a46a982f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_daf21807-9213-4871-9636-e82b07c7fcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f49660f-4ae6-4334-8d38-50f9577c9728" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_daf21807-9213-4871-9636-e82b07c7fcc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3ec1ff1a-d404-400b-a413-df721310c274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f49660f-4ae6-4334-8d38-50f9577c9728" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3ec1ff1a-d404-400b-a413-df721310c274" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_e8a4b2fd-2e6a-49ea-9a6d-098df8affd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1f49660f-4ae6-4334-8d38-50f9577c9728" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_e8a4b2fd-2e6a-49ea-9a6d-098df8affd4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65703128-7df5-49ba-91de-97e149ff9ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ff426c67-1fed-47aa-80ce-16845bbfc06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65703128-7df5-49ba-91de-97e149ff9ce3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ff426c67-1fed-47aa-80ce-16845bbfc06c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39ab4fc9-b8bc-4202-83d5-eb2669ee1fee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65703128-7df5-49ba-91de-97e149ff9ce3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39ab4fc9-b8bc-4202-83d5-eb2669ee1fee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e8bcd29c-5b84-469d-9d50-6f9c3de1de96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65703128-7df5-49ba-91de-97e149ff9ce3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e8bcd29c-5b84-469d-9d50-6f9c3de1de96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eeaaef8f-414e-4fe8-ab77-3755550bffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65703128-7df5-49ba-91de-97e149ff9ce3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eeaaef8f-414e-4fe8-ab77-3755550bffd0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8332aa51-dfe9-43c2-8633-25784fd75bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a533428f-68e4-4801-a58f-6f8eae45953f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8332aa51-dfe9-43c2-8633-25784fd75bb6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a533428f-68e4-4801-a58f-6f8eae45953f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f4db7e12-92a4-4eb4-9412-97adc460f78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8332aa51-dfe9-43c2-8633-25784fd75bb6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f4db7e12-92a4-4eb4-9412-97adc460f78b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6aa50cc7-c2e6-40d4-afc0-a22659bba269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8332aa51-dfe9-43c2-8633-25784fd75bb6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6aa50cc7-c2e6-40d4-afc0-a22659bba269" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationScheduleofInventoryDetail"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4a5f4de6-672a-4a7e-9271-9f86633c6511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_57f7c0a7-5043-4c59-91f5-f923b10246ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4a5f4de6-672a-4a7e-9271-9f86633c6511" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_57f7c0a7-5043-4c59-91f5-f923b10246ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_41f8d5fa-18ba-4c49-a1dc-b748762b07c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4a5f4de6-672a-4a7e-9271-9f86633c6511" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_41f8d5fa-18ba-4c49-a1dc-b748762b07c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d4064a24-573a-4b55-80a7-96454b012e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4a5f4de6-672a-4a7e-9271-9f86633c6511" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d4064a24-573a-4b55-80a7-96454b012e0e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2432caef-079f-4bdd-a69b-3c3a586597f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_86b1f4c2-25f3-4300-985b-78165dd11144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_2432caef-079f-4bdd-a69b-3c3a586597f7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_86b1f4c2-25f3-4300-985b-78165dd11144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_762519a3-a579-463c-9652-e585fe205e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_2432caef-079f-4bdd-a69b-3c3a586597f7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_762519a3-a579-463c-9652-e585fe205e74" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4df248d5-3e22-4757-9d09-ab0a069d2fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_783ca42e-f0a0-403e-9099-aa98f05e66c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4df248d5-3e22-4757-9d09-ab0a069d2fe3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_783ca42e-f0a0-403e-9099-aa98f05e66c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2c1b7672-5e61-4911-ac67-25ef8aeb73c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4df248d5-3e22-4757-9d09-ab0a069d2fe3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2c1b7672-5e61-4911-ac67-25ef8aeb73c8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8fa0da20-cca2-4d3b-8fec-2b8f42464fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8fa0da20-cca2-4d3b-8fec-2b8f42464fc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d97d5fdb-0f97-474e-a201-12ca1edf9f43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d97d5fdb-0f97-474e-a201-12ca1edf9f43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_3ce41371-514b-44e0-9031-02df92a499c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:to="loc_us-gaap_AccruedIncomeTaxes_3ce41371-514b-44e0-9031-02df92a499c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_AccruedGovernmentAndOtherRebates_5be2ac95-52e2-4eb9-9f66-c7f92fd1745e" xlink:href="bmrn-20210930.xsd#bmrn_AccruedGovernmentAndOtherRebates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:to="loc_bmrn_AccruedGovernmentAndOtherRebates_5be2ac95-52e2-4eb9-9f66-c7f92fd1745e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_4d79e43b-ac0b-4a7e-b0ae-a2eec5c885c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_4d79e43b-ac0b-4a7e-b0ae-a2eec5c885c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_5890c9ae-462a-4f3c-b5af-33a44ec4d879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_5890c9ae-462a-4f3c-b5af-33a44ec4d879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_05d9cdb8-0d42-4599-ae0f-4f747b38576f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_05d9cdb8-0d42-4599-ae0f-4f747b38576f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_42c8c89f-f7bf-46d6-802f-2d4954403a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_42c8c89f-f7bf-46d6-802f-2d4954403a67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8c70b4d9-2c5b-43cd-8cf3-8231f269042c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_74186250-2aa5-43b4-bfac-4fc1e430f854" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8c70b4d9-2c5b-43cd-8cf3-8231f269042c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9fb1fe49-4b07-45c9-afdc-7c42252d5d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherAssetsCurrentFairValueDisclosure_667b3833-3f9b-43b8-a342-1aa520f29071" xlink:href="bmrn-20210930.xsd#bmrn_OtherAssetsCurrentFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9fb1fe49-4b07-45c9-afdc-7c42252d5d8e" xlink:to="loc_bmrn_OtherAssetsCurrentFairValueDisclosure_667b3833-3f9b-43b8-a342-1aa520f29071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherAssetsNoncurrentFairValueDisclosure_d5404b4b-f166-4ad7-8b3e-0e1d937e3a31" xlink:href="bmrn-20210930.xsd#bmrn_OtherAssetsNoncurrentFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9fb1fe49-4b07-45c9-afdc-7c42252d5d8e" xlink:to="loc_bmrn_OtherAssetsNoncurrentFairValueDisclosure_d5404b4b-f166-4ad7-8b3e-0e1d937e3a31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_c319d206-306b-4eb6-a660-77b7194d1080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherLiabilitiesCurrentFairValueDisclosure_420e1497-e24a-4339-a5ab-24c46168ad14" xlink:href="bmrn-20210930.xsd#bmrn_OtherLiabilitiesCurrentFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_c319d206-306b-4eb6-a660-77b7194d1080" xlink:to="loc_bmrn_OtherLiabilitiesCurrentFairValueDisclosure_420e1497-e24a-4339-a5ab-24c46168ad14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure_d78a5ddf-6733-41a3-83f0-95a574e29708" xlink:href="bmrn-20210930.xsd#bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_c319d206-306b-4eb6-a660-77b7194d1080" xlink:to="loc_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure_d78a5ddf-6733-41a3-83f0-95a574e29708" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DebtSummaryofConvertibleDebtDetail"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_fac400ac-8147-45b7-8b36-d193b339ee7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b2862d3d-537d-4c1a-a5a5-b9c32b89e7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent_fac400ac-8147-45b7-8b36-d193b339ee7e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b2862d3d-537d-4c1a-a5a5-b9c32b89e7cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c41e498e-3b3e-4ed9-9c2f-bfd548a1c616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent_fac400ac-8147-45b7-8b36-d193b339ee7e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c41e498e-3b3e-4ed9-9c2f-bfd548a1c616" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_583ccbb7-0895-416d-aba9-565dbfcf266b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_72d2e1e1-4124-4ad0-9f73-195edc8d2f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleDebtCurrent_583ccbb7-0895-416d-aba9-565dbfcf266b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_72d2e1e1-4124-4ad0-9f73-195edc8d2f24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_7e54cb1d-f5f1-4ffe-af50-f989431ff92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleDebtCurrent_583ccbb7-0895-416d-aba9-565dbfcf266b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_7e54cb1d-f5f1-4ffe-af50-f989431ff92c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DebtSummaryofInterestExpenseonConvertibleDebtDetail"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4212ce0a-d808-4ac3-9493-0f0e5d7b4534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_10667f18-3cfa-436d-8340-a912d9fc4b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_4212ce0a-d808-4ac3-9493-0f0e5d7b4534" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_10667f18-3cfa-436d-8340-a912d9fc4b55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_d5a41aff-d98d-43b3-8443-c0b515b549c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_4212ce0a-d808-4ac3-9493-0f0e5d7b4534" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_d5a41aff-d98d-43b3-8443-c0b515b549c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_c48fdc38-1ffa-47fe-9431-0f350e38c986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_4212ce0a-d808-4ac3-9493-0f0e5d7b4534" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_c48fdc38-1ffa-47fe-9431-0f350e38c986" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a16b018a-fe51-4395-b57f-cd3dce404a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_4b09cb93-92b1-4c3f-9719-e5ff0759bf98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a16b018a-fe51-4395-b57f-cd3dce404a01" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_4b09cb93-92b1-4c3f-9719-e5ff0759bf98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_bb5e8c7c-b1bf-45e1-914b-986a84e3d550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a16b018a-fe51-4395-b57f-cd3dce404a01" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_bb5e8c7c-b1bf-45e1-914b-986a84e3d550" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_d4e534ba-fce8-4780-83a8-3c2b1ad5d782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a16b018a-fe51-4395-b57f-cd3dce404a01" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_d4e534ba-fce8-4780-83a8-3c2b1ad5d782" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c294bf44-f90c-49f6-8910-c5bb21a3d47a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_c558e242-b6c3-4042-bca5-ae638f02e38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c294bf44-f90c-49f6-8910-c5bb21a3d47a" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_c558e242-b6c3-4042-bca5-ae638f02e38d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6638e5a7-197f-4984-8531-0a09b62a093b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c294bf44-f90c-49f6-8910-c5bb21a3d47a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6638e5a7-197f-4984-8531-0a09b62a093b" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>bmrn-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f95636f6-9f25-4ee3-86c2-7b0315cdf3d9,g:ce424ef1-ab97-4f04-a4e9-8c3801ecff3b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended" id="ic86a0051ed9f4fe799c6eeeef8e19d31_CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_5ff694dc-8c70-4078-ac79-4d89a81c226b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_RevenuesAbstract_5ff694dc-8c70-4078-ac79-4d89a81c226b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f14bd97-69f7-414e-b353-a9bb89e51954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_5ff694dc-8c70-4078-ac79-4d89a81c226b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f14bd97-69f7-414e-b353-a9bb89e51954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_51d5708e-f318-49a2-a92f-847248293af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_CostOfRevenue_51d5708e-f318-49a2-a92f-847248293af0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_27c35778-b63b-45cd-b972-05fc294fcabb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_27c35778-b63b-45cd-b972-05fc294fcabb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d803d5f4-ede5-43e3-966d-4f120d9a01ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d803d5f4-ede5-43e3-966d-4f120d9a01ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_IntangibleAssetAmortizationAndContingentConsideration_6096a2e9-1ab1-4db4-ac45-0a32463aee76" xlink:href="bmrn-20210930.xsd#bmrn_IntangibleAssetAmortizationAndContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_bmrn_IntangibleAssetAmortizationAndContingentConsideration_6096a2e9-1ab1-4db4-ac45-0a32463aee76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_f52d51b9-6bdc-4658-a3c0-d1b84cb22daa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_f52d51b9-6bdc-4658-a3c0-d1b84cb22daa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f10c886e-b39c-436b-ad91-ca467c6bed3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_CostsAndExpenses_f10c886e-b39c-436b-ad91-ca467c6bed3b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_48d93e1e-a966-42bc-bcc6-14038fade335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_OperatingIncomeLoss_48d93e1e-a966-42bc-bcc6-14038fade335" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_96fd0c50-6598-46bd-bb3a-e222793f5f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_96fd0c50-6598-46bd-bb3a-e222793f5f9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c7775f39-5ce1-4c25-a0f1-c5662a865137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c7775f39-5ce1-4c25-a0f1-c5662a865137" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0e66a231-8790-4f5f-8c2b-07db34a3ebf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_InterestExpense_0e66a231-8790-4f5f-8c2b-07db34a3ebf5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_b87f6518-d507-4017-99a1-3c4b6f7ffe41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_b87f6518-d507-4017-99a1-3c4b6f7ffe41" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e892cdfe-9971-46ac-9a08-bc9010b093d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e892cdfe-9971-46ac-9a08-bc9010b093d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dbbd16cd-af6f-44b9-a8e4-c9d13fc08c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dbbd16cd-af6f-44b9-a8e4-c9d13fc08c9a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d77a24d9-71ae-4f7d-aa06-70db009cc707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_NetIncomeLoss_d77a24d9-71ae-4f7d-aa06-70db009cc707" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e25030b1-df4c-4dcb-b130-2cf586a929de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_EarningsPerShareBasic_e25030b1-df4c-4dcb-b130-2cf586a929de" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e47941d4-8ab4-4de2-8a1e-de5b7f26f75a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e47941d4-8ab4-4de2-8a1e-de5b7f26f75a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_974c6e6f-5779-4b8a-9d89-7fd905014e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_974c6e6f-5779-4b8a-9d89-7fd905014e01" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_09360373-9ba2-4a2d-a2b8-597af59ef9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_09360373-9ba2-4a2d-a2b8-597af59ef9de" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1db5c18d-8079-4813-826b-92e04c796506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1db5c18d-8079-4813-826b-92e04c796506" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2c6e2121-0067-46ae-adab-35d126912360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_StatementTable_2c6e2121-0067-46ae-adab-35d126912360" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_15b876c5-cb88-4e6d-817d-bbcbef63b75a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2c6e2121-0067-46ae-adab-35d126912360" xlink:to="loc_srt_ProductOrServiceAxis_15b876c5-cb88-4e6d-817d-bbcbef63b75a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_15b876c5-cb88-4e6d-817d-bbcbef63b75a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_15b876c5-cb88-4e6d-817d-bbcbef63b75a" xlink:to="loc_srt_ProductsAndServicesDomain_15b876c5-cb88-4e6d-817d-bbcbef63b75a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d3abb5d9-ef70-4abd-a027-d0996c966b7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_15b876c5-cb88-4e6d-817d-bbcbef63b75a" xlink:to="loc_srt_ProductsAndServicesDomain_d3abb5d9-ef70-4abd-a027-d0996c966b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_413d590a-bb1f-42b1-8a6c-8d23d4ee86c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3abb5d9-ef70-4abd-a027-d0996c966b7b" xlink:to="loc_us-gaap_ProductMember_413d590a-bb1f-42b1-8a6c-8d23d4ee86c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RoyaltyAndOtherMember_3b86b774-f9e1-449c-ad90-a47dec34e496" xlink:href="bmrn-20210930.xsd#bmrn_RoyaltyAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3abb5d9-ef70-4abd-a027-d0996c966b7b" xlink:to="loc_bmrn_RoyaltyAndOtherMember_3b86b774-f9e1-449c-ad90-a47dec34e496" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i30238009a4f040809c423e036cad1ecc_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_67a3fcfb-2199-4041-b775-12f4aa183a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_67a3fcfb-2199-4041-b775-12f4aa183a05" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_eef44e20-1301-4196-9f43-56360baed22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_SharesOutstanding_eef44e20-1301-4196-9f43-56360baed22c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares_fd884aae-b96c-409b-a0f6-bb9e8ae75d75" xlink:href="bmrn-20210930.xsd#bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares_fd884aae-b96c-409b-a0f6-bb9e8ae75d75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_95bad75f-4cc6-405b-9f83-a6bff77200c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_95bad75f-4cc6-405b-9f83-a6bff77200c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0c95342c-fc32-4856-a06b-647caf4b0477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ecbeb28b-4981-4497-bf50-f3fdd55c9488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_StockholdersEquity_ecbeb28b-4981-4497-bf50-f3fdd55c9488" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency_e69af9ed-e2f0-4d00-93b5-a5797476d194" xlink:href="bmrn-20210930.xsd#bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency_e69af9ed-e2f0-4d00-93b5-a5797476d194" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_36ca81f4-149f-4451-bc08-3a3096575774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_36ca81f4-149f-4451-bc08-3a3096575774" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_88c7ede4-36ef-4411-90e1-417975b772f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_88c7ede4-36ef-4411-90e1-417975b772f2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_ee214b18-f065-4d0d-b2e2-c149725e528a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_ee214b18-f065-4d0d-b2e2-c149725e528a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan_bc18acd8-9f56-4420-a222-607c2aae60d0" xlink:href="bmrn-20210930.xsd#bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan_bc18acd8-9f56-4420-a222-607c2aae60d0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e92859d-21e0-45b2-8717-cfc19d12ab88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e92859d-21e0-45b2-8717-cfc19d12ab88" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e0e83d8d-5e33-441b-9ed8-d90d8fd0d8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_NetIncomeLoss_e0e83d8d-5e33-441b-9ed8-d90d8fd0d8ea" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_848b95c6-f6ad-443b-bd99-cb5b8e6b767e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1c9ec3b0-99f7-4cc1-b4de-06128012a7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_67a3fcfb-2199-4041-b775-12f4aa183a05" xlink:to="loc_us-gaap_StatementTable_1c9ec3b0-99f7-4cc1-b4de-06128012a7fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dd931dfa-5f1f-44a5-83de-1293e5ee138f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1c9ec3b0-99f7-4cc1-b4de-06128012a7fe" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dd931dfa-5f1f-44a5-83de-1293e5ee138f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dd931dfa-5f1f-44a5-83de-1293e5ee138f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dd931dfa-5f1f-44a5-83de-1293e5ee138f" xlink:to="loc_us-gaap_EquityComponentDomain_dd931dfa-5f1f-44a5-83de-1293e5ee138f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dd931dfa-5f1f-44a5-83de-1293e5ee138f" xlink:to="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bbd10b6c-adc8-4b69-9c1f-82eb188da93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_CommonStockMember_bbd10b6c-adc8-4b69-9c1f-82eb188da93a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a1202625-de2e-4547-975b-a2fe07bf159d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a1202625-de2e-4547-975b-a2fe07bf159d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_56c50783-de88-4ae6-90a3-4606b652f478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_TreasuryStockMember_56c50783-de88-4ae6-90a3-4606b652f478" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_a23f522f-5ce0-40b3-a303-e57e1a25d8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_a23f522f-5ce0-40b3-a303-e57e1a25d8f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b53dd3ab-f503-4b3e-a0a8-7b678dfc274b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b53dd3ab-f503-4b3e-a0a8-7b678dfc274b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_491e3dbf-a78f-4d69-a9d5-da471b9126f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_RetainedEarningsMember_491e3dbf-a78f-4d69-a9d5-da471b9126f5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail" xlink:type="extended" id="i124f176fd92d4de08a365019515b6fb8_FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_032f92b9-41e0-4502-92e7-795ea1b4801e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_032f92b9-41e0-4502-92e7-795ea1b4801e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_ee2e08d4-5034-409b-b379-aecf93d092c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_Cash_ee2e08d4-5034-409b-b379-aecf93d092c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3ed0a361-0447-4f37-b5b9-2a33faeac8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3ed0a361-0447-4f37-b5b9-2a33faeac8e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_35412f33-379b-404a-bff4-a1f0773d270c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_35412f33-379b-404a-bff4-a1f0773d270c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3126c87f-21a9-4702-acc3-b42bddf850cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3126c87f-21a9-4702-acc3-b42bddf850cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e71935b2-9f60-4014-99cf-2d5881b463c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e71935b2-9f60-4014-99cf-2d5881b463c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_051d58c2-36c0-4a8e-b1f6-c52c1ae8b1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_051d58c2-36c0-4a8e-b1f6-c52c1ae8b1fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_cf23b699-dbe7-45c9-8892-e312174d0997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_cf23b699-dbe7-45c9-8892-e312174d0997" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ShortTermMarketableSecuritiesMaturityPeriod_65cd6cc9-1c82-4167-a80a-c79dc65c4f38" xlink:href="bmrn-20210930.xsd#bmrn_ShortTermMarketableSecuritiesMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_bmrn_ShortTermMarketableSecuritiesMaturityPeriod_65cd6cc9-1c82-4167-a80a-c79dc65c4f38" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_LongTermMarketableSecuritiesMaturityPeriod_cc37a9e7-1963-48d9-a13b-4f5232c5653e" xlink:href="bmrn-20210930.xsd#bmrn_LongTermMarketableSecuritiesMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_bmrn_LongTermMarketableSecuritiesMaturityPeriod_cc37a9e7-1963-48d9-a13b-4f5232c5653e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e339e35-5ab4-48b8-8577-cad6e872eff1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:to="loc_srt_RangeAxis_4e339e35-5ab4-48b8-8577-cad6e872eff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e339e35-5ab4-48b8-8577-cad6e872eff1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4e339e35-5ab4-48b8-8577-cad6e872eff1" xlink:to="loc_srt_RangeMember_4e339e35-5ab4-48b8-8577-cad6e872eff1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae228a3f-5721-4b9e-b518-600b92fa6404" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4e339e35-5ab4-48b8-8577-cad6e872eff1" xlink:to="loc_srt_RangeMember_ae228a3f-5721-4b9e-b518-600b92fa6404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_02dab176-2162-4f9a-b3a4-569491506b2a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae228a3f-5721-4b9e-b518-600b92fa6404" xlink:to="loc_srt_MinimumMember_02dab176-2162-4f9a-b3a4-569491506b2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bbea59a8-e18a-4e9e-bce6-602fa612262e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ae228a3f-5721-4b9e-b518-600b92fa6404" xlink:to="loc_srt_MaximumMember_bbea59a8-e18a-4e9e-bce6-602fa612262e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dcd1577-6e28-4fb9-8275-2e7171f0543d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dcd1577-6e28-4fb9-8275-2e7171f0543d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3dcd1577-6e28-4fb9-8275-2e7171f0543d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dcd1577-6e28-4fb9-8275-2e7171f0543d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3dcd1577-6e28-4fb9-8275-2e7171f0543d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76d467d7-d8c3-4e9a-b1dc-f7c6fb60d2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dcd1577-6e28-4fb9-8275-2e7171f0543d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76d467d7-d8c3-4e9a-b1dc-f7c6fb60d2f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_453f92fc-da1f-4407-a7d5-cbe2c3cefe24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76d467d7-d8c3-4e9a-b1dc-f7c6fb60d2f3" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_453f92fc-da1f-4407-a7d5-cbe2c3cefe24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6894d795-7215-4eb7-a940-42befbd22fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76d467d7-d8c3-4e9a-b1dc-f7c6fb60d2f3" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6894d795-7215-4eb7-a940-42befbd22fe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_39366da1-c40f-497d-943f-e09107059ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:to="loc_us-gaap_InvestmentTypeAxis_39366da1-c40f-497d-943f-e09107059ba2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_39366da1-c40f-497d-943f-e09107059ba2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_39366da1-c40f-497d-943f-e09107059ba2" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_39366da1-c40f-497d-943f-e09107059ba2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_39366da1-c40f-497d-943f-e09107059ba2" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_d6ecfdb4-62c5-4139-84e4-1e1d40bcf847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_CashMember_d6ecfdb4-62c5-4139-84e4-1e1d40bcf847" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ca224623-ca99-49c4-8651-b9dd6c0c5505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ca224623-ca99-49c4-8651-b9dd6c0c5505" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e9aa49fb-31f1-45fd-820d-b7607f5dd14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e9aa49fb-31f1-45fd-820d-b7607f5dd14b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5a9c1ecd-3284-4692-8a64-cd51ee79d879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5a9c1ecd-3284-4692-8a64-cd51ee79d879" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0415861c-ae51-4b11-9211-1af5729897d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_CommercialPaperMember_0415861c-ae51-4b11-9211-1af5729897d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_cbeebddf-e768-45ad-8e64-bf7d5249a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_cbeebddf-e768-45ad-8e64-bf7d5249a7a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember_fe69f263-5549-4acc-a325-e9412a8679e9" xlink:href="bmrn-20210930.xsd#bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember_fe69f263-5549-4acc-a325-e9412a8679e9" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FinancialInstrumentsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail" xlink:type="extended" id="i5f68c78f9d6341ac86f59c9cfaafea51_FinancialInstrumentsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_1c54431e-cf77-4fcf-b5f4-45702a96c761" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_449156fe-270e-4e6e-9d12-d4f1702f5e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_1c54431e-cf77-4fcf-b5f4-45702a96c761" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_449156fe-270e-4e6e-9d12-d4f1702f5e0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_e4eba98e-dd80-40e8-b3c7-bd055a2e8cf8" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_1c54431e-cf77-4fcf-b5f4-45702a96c761" xlink:to="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_e4eba98e-dd80-40e8-b3c7-bd055a2e8cf8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b0617a98-b23b-4fa2-92b9-e000369dd774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_e4eba98e-dd80-40e8-b3c7-bd055a2e8cf8" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b0617a98-b23b-4fa2-92b9-e000369dd774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b0617a98-b23b-4fa2-92b9-e000369dd774_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b0617a98-b23b-4fa2-92b9-e000369dd774" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b0617a98-b23b-4fa2-92b9-e000369dd774_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cb213680-3e0e-4e98-aa30-252eca6d9041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b0617a98-b23b-4fa2-92b9-e000369dd774" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cb213680-3e0e-4e98-aa30-252eca6d9041" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_StrategicInvestmentMember_66a90efe-ee22-47d2-9f79-b649505fd5ca" xlink:href="bmrn-20210930.xsd#bmrn_StrategicInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cb213680-3e0e-4e98-aa30-252eca6d9041" xlink:to="loc_bmrn_StrategicInvestmentMember_66a90efe-ee22-47d2-9f79-b649505fd5ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a79282d7-c2a7-40aa-956c-670b04efd88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_e4eba98e-dd80-40e8-b3c7-bd055a2e8cf8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a79282d7-c2a7-40aa-956c-670b04efd88a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a79282d7-c2a7-40aa-956c-670b04efd88a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a79282d7-c2a7-40aa-956c-670b04efd88a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a79282d7-c2a7-40aa-956c-670b04efd88a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3fc0cbc0-624e-49c4-9b29-6bfd2a237d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a79282d7-c2a7-40aa-956c-670b04efd88a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3fc0cbc0-624e-49c4-9b29-6bfd2a237d7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ad5c2f11-63cd-4cb1-bde4-38a077f0faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3fc0cbc0-624e-49c4-9b29-6bfd2a237d7e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ad5c2f11-63cd-4cb1-bde4-38a077f0faa2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails" xlink:type="extended" id="i24975d7515f24054a7a27b3488086f0a_SupplementalBalanceSheetInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_71bd9559-a3a0-4723-8e92-daa73717efea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_31cad102-61e7-49d5-aafc-123997b76a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_71bd9559-a3a0-4723-8e92-daa73717efea" xlink:to="loc_us-gaap_InventoryNet_31cad102-61e7-49d5-aafc-123997b76a9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7ad35184-3de4-4d3f-b399-6eab967140b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_71bd9559-a3a0-4723-8e92-daa73717efea" xlink:to="loc_us-gaap_Depreciation_7ad35184-3de4-4d3f-b399-6eab967140b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_4716dd9f-b1dc-4919-9589-b5ebda0c14b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_71bd9559-a3a0-4723-8e92-daa73717efea" xlink:to="loc_us-gaap_InventoryCurrentTable_4716dd9f-b1dc-4919-9589-b5ebda0c14b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_5fc10249-89b2-4e52-98bd-86e0ca6769c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_4716dd9f-b1dc-4919-9589-b5ebda0c14b5" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_5fc10249-89b2-4e52-98bd-86e0ca6769c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_5fc10249-89b2-4e52-98bd-86e0ca6769c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_5fc10249-89b2-4e52-98bd-86e0ca6769c8" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_5fc10249-89b2-4e52-98bd-86e0ca6769c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_664f1c95-298a-456b-9629-626c8e94f4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_5fc10249-89b2-4e52-98bd-86e0ca6769c8" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_664f1c95-298a-456b-9629-626c8e94f4fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_VoxzogoMember_f12096d8-c87f-40fa-9c00-19a3c576b6fa" xlink:href="bmrn-20210930.xsd#bmrn_VoxzogoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_664f1c95-298a-456b-9629-626c8e94f4fe" xlink:to="loc_bmrn_VoxzogoMember_f12096d8-c87f-40fa-9c00-19a3c576b6fa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail" xlink:type="extended" id="ibe823b71da6944f4af3c38d2f25ad516_FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_83ab0147-85b0-4307-8475-356ed97859b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_83ab0147-85b0-4307-8475-356ed97859b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6d8cec7a-a1e9-4eb5-a691-cb330714661c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6d8cec7a-a1e9-4eb5-a691-cb330714661c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherAssetsCurrentFairValueDisclosure_fbd97da9-db67-4f09-8d67-7d4216ce659c" xlink:href="bmrn-20210930.xsd#bmrn_OtherAssetsCurrentFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_bmrn_OtherAssetsCurrentFairValueDisclosure_fbd97da9-db67-4f09-8d67-7d4216ce659c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherAssetsNoncurrentFairValueDisclosure_e250cc13-883e-4368-a765-108ca44ee591" xlink:href="bmrn-20210930.xsd#bmrn_OtherAssetsNoncurrentFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_bmrn_OtherAssetsNoncurrentFairValueDisclosure_e250cc13-883e-4368-a765-108ca44ee591" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_526a0a49-66d5-4e0a-bd62-bde7b8eebbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_526a0a49-66d5-4e0a-bd62-bde7b8eebbb4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherLiabilitiesCurrentFairValueDisclosure_79b8446f-732d-4e78-8790-8b227a826ea4" xlink:href="bmrn-20210930.xsd#bmrn_OtherLiabilitiesCurrentFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_bmrn_OtherLiabilitiesCurrentFairValueDisclosure_79b8446f-732d-4e78-8790-8b227a826ea4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure_2c92bc51-7918-4f19-bb54-a740b7127b9c" xlink:href="bmrn-20210930.xsd#bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure_2c92bc51-7918-4f19-bb54-a740b7127b9c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d86045a6-2631-4fbb-9eb9-8b7196b88463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d86045a6-2631-4fbb-9eb9-8b7196b88463" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d0eda78a-5675-4e69-8e08-e05d4310fd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d0eda78a-5675-4e69-8e08-e05d4310fd3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d0eda78a-5675-4e69-8e08-e05d4310fd3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d0eda78a-5675-4e69-8e08-e05d4310fd3c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d0eda78a-5675-4e69-8e08-e05d4310fd3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a3a17e7b-073e-472b-86d1-241074e5d6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d0eda78a-5675-4e69-8e08-e05d4310fd3c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a3a17e7b-073e-472b-86d1-241074e5d6f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ec907e6a-12f0-4470-95f9-d3d42cedb8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a3a17e7b-073e-472b-86d1-241074e5d6f9" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ec907e6a-12f0-4470-95f9-d3d42cedb8dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1cbe5403-1fc9-4860-89bf-8c850b235f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1cbe5403-1fc9-4860-89bf-8c850b235f06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1cbe5403-1fc9-4860-89bf-8c850b235f06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1cbe5403-1fc9-4860-89bf-8c850b235f06" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1cbe5403-1fc9-4860-89bf-8c850b235f06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_db7f57c0-c57e-46d5-bb32-914289f59bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1cbe5403-1fc9-4860-89bf-8c850b235f06" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_db7f57c0-c57e-46d5-bb32-914289f59bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember_66ceddf5-2b3a-4ab8-b745-bba22632b0b8" xlink:href="bmrn-20210930.xsd#bmrn_NonqualifiedDeferredCompensationPlanAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_db7f57c0-c57e-46d5-bb32-914289f59bc7" xlink:to="loc_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember_66ceddf5-2b3a-4ab8-b745-bba22632b0b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RestrictedInvestmentsMember_4c3a15c4-7455-4beb-8614-69680bc579db" xlink:href="bmrn-20210930.xsd#bmrn_RestrictedInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_db7f57c0-c57e-46d5-bb32-914289f59bc7" xlink:to="loc_bmrn_RestrictedInvestmentsMember_4c3a15c4-7455-4beb-8614-69680bc579db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a75864a-ea0f-4062-9221-e7203326739c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a75864a-ea0f-4062-9221-e7203326739c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a75864a-ea0f-4062-9221-e7203326739c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a75864a-ea0f-4062-9221-e7203326739c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a75864a-ea0f-4062-9221-e7203326739c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a75864a-ea0f-4062-9221-e7203326739c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d48b6c58-c510-43de-876a-df348e06969e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d48b6c58-c510-43de-876a-df348e06969e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_98f33f90-bfd8-4c52-9b32-6577d0a52f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_98f33f90-bfd8-4c52-9b32-6577d0a52f5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_09ad0203-1ee5-4624-8c19-b7ea18f09f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_09ad0203-1ee5-4624-8c19-b7ea18f09f0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_c06752f9-55f6-467d-b6a0-ed1be8cd219f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_c06752f9-55f6-467d-b6a0-ed1be8cd219f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c06752f9-55f6-467d-b6a0-ed1be8cd219f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c06752f9-55f6-467d-b6a0-ed1be8cd219f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_c06752f9-55f6-467d-b6a0-ed1be8cd219f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_77b73a66-e84b-4335-a59b-4597bd174a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c06752f9-55f6-467d-b6a0-ed1be8cd219f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_77b73a66-e84b-4335-a59b-4597bd174a39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember_6029a234-509c-4fd1-9f38-c6fd5f2dbb6b" xlink:href="bmrn-20210930.xsd#bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_77b73a66-e84b-4335-a59b-4597bd174a39" xlink:to="loc_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember_6029a234-509c-4fd1-9f38-c6fd5f2dbb6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentConsiderationMember_4f8e7667-7816-46d7-94f0-b32a6326c71f" xlink:href="bmrn-20210930.xsd#bmrn_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_77b73a66-e84b-4335-a59b-4597bd174a39" xlink:to="loc_bmrn_ContingentConsiderationMember_4f8e7667-7816-46d7-94f0-b32a6326c71f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail" xlink:type="extended" id="i0b5ef15268494f7ebc3eb0049465c6f0_FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1c9cbc6a-2fc9-4bd8-bf1e-90b06784c1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1c9cbc6a-2fc9-4bd8-bf1e-90b06784c1fb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d380ab59-130c-4534-bd90-256c362c2b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d380ab59-130c-4534-bd90-256c362c2b86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e2fd9a73-5f71-4a74-ad8c-c3d6ae91ee09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e2fd9a73-5f71-4a74-ad8c-c3d6ae91ee09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement_d3e9f7cd-885a-4405-8eb0-00c8db6b810b" xlink:href="bmrn-20210930.xsd#bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:to="loc_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement_d3e9f7cd-885a-4405-8eb0-00c8db6b810b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d2f27684-d194-4255-bcb1-f468265a8a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f6e681a7-74b4-4983-b1c2-b5239376bc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1c9cbc6a-2fc9-4bd8-bf1e-90b06784c1fb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f6e681a7-74b4-4983-b1c2-b5239376bc4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1f9db0de-acdd-4dd1-b511-1b9730335ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f6e681a7-74b4-4983-b1c2-b5239376bc4c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1f9db0de-acdd-4dd1-b511-1b9730335ab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1f9db0de-acdd-4dd1-b511-1b9730335ab2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1f9db0de-acdd-4dd1-b511-1b9730335ab2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1f9db0de-acdd-4dd1-b511-1b9730335ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4ed28f4f-d627-4ce6-a6e9-872a65ec7f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1f9db0de-acdd-4dd1-b511-1b9730335ab2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4ed28f4f-d627-4ce6-a6e9-872a65ec7f67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentPaymentMember_181b9034-2bbf-4336-88a5-20cf8afddf94" xlink:href="bmrn-20210930.xsd#bmrn_ContingentPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4ed28f4f-d627-4ce6-a6e9-872a65ec7f67" xlink:to="loc_bmrn_ContingentPaymentMember_181b9034-2bbf-4336-88a5-20cf8afddf94" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables" xlink:type="extended" id="ica72643c982148cfbda76b71fa120235_DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_e935d054-8332-42ec-aaa9-edf4b2492052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:to="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_e935d054-8332-42ec-aaa9-edf4b2492052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7678b4fe-02ed-4180-b21a-441ee7890e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7678b4fe-02ed-4180-b21a-441ee7890e85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_f92d4494-8339-4cf9-b6f0-1478c5f3fd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_f92d4494-8339-4cf9-b6f0-1478c5f3fd3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_751ba00e-e105-4e34-bc5a-08e1fac8e85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:to="loc_us-gaap_DerivativeTable_751ba00e-e105-4e34-bc5a-08e1fac8e85c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b3ffea99-328d-41f7-9769-4ee5c9db9c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_751ba00e-e105-4e34-bc5a-08e1fac8e85c" xlink:to="loc_us-gaap_HedgingDesignationAxis_b3ffea99-328d-41f7-9769-4ee5c9db9c7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b3ffea99-328d-41f7-9769-4ee5c9db9c7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b3ffea99-328d-41f7-9769-4ee5c9db9c7a" xlink:to="loc_us-gaap_HedgingDesignationDomain_b3ffea99-328d-41f7-9769-4ee5c9db9c7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3878432b-6af7-46e2-ab87-f0d575e873e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b3ffea99-328d-41f7-9769-4ee5c9db9c7a" xlink:to="loc_us-gaap_HedgingDesignationDomain_3878432b-6af7-46e2-ab87-f0d575e873e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3b17e08f-a458-4f32-afcf-defb14bc134d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3878432b-6af7-46e2-ab87-f0d575e873e0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3b17e08f-a458-4f32-afcf-defb14bc134d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail" xlink:type="extended" id="ie8e2a60c3693472a9921da442b67b529_DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3c6d21e3-dda2-4b01-aba6-81c08a5475e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_0e77f100-d865-4fb6-bc36-70c052d93334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3c6d21e3-dda2-4b01-aba6-81c08a5475e4" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_0e77f100-d865-4fb6-bc36-70c052d93334" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_da7d7f5d-85f0-4e2b-bf09-b666ac7a0a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3c6d21e3-dda2-4b01-aba6-81c08a5475e4" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_da7d7f5d-85f0-4e2b-bf09-b666ac7a0a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_51074020-36b6-4ca5-a4c2-ff192d8268d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_3c6d21e3-dda2-4b01-aba6-81c08a5475e4" xlink:to="loc_us-gaap_DerivativeTable_51074020-36b6-4ca5-a4c2-ff192d8268d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_462e4f4b-902e-4b3d-bca7-36728a63c253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_51074020-36b6-4ca5-a4c2-ff192d8268d2" xlink:to="loc_us-gaap_HedgingDesignationAxis_462e4f4b-902e-4b3d-bca7-36728a63c253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_462e4f4b-902e-4b3d-bca7-36728a63c253_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_462e4f4b-902e-4b3d-bca7-36728a63c253" xlink:to="loc_us-gaap_HedgingDesignationDomain_462e4f4b-902e-4b3d-bca7-36728a63c253_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f90ce568-684b-442a-aebe-175c43cfcb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_462e4f4b-902e-4b3d-bca7-36728a63c253" xlink:to="loc_us-gaap_HedgingDesignationDomain_f90ce568-684b-442a-aebe-175c43cfcb5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3959e2ba-cb62-4cc0-9e18-fe727b5bff48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f90ce568-684b-442a-aebe-175c43cfcb5a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3959e2ba-cb62-4cc0-9e18-fe727b5bff48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f5025f40-73dc-4a41-b34b-ba35262b6e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f90ce568-684b-442a-aebe-175c43cfcb5a" xlink:to="loc_us-gaap_NondesignatedMember_f5025f40-73dc-4a41-b34b-ba35262b6e81" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail" xlink:type="extended" id="i8f9b6a7444da4ed1a5a2512ba1a0c64d_DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ac2a79f7-40c5-4554-a2dc-42920a0ac803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b7ac82cd-5e47-447c-9cd6-af25daa159ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ac2a79f7-40c5-4554-a2dc-42920a0ac803" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b7ac82cd-5e47-447c-9cd6-af25daa159ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ac2a79f7-40c5-4554-a2dc-42920a0ac803" xlink:to="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_fc99b77a-2778-46df-beac-9b37e65497ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:to="loc_us-gaap_HedgingDesignationAxis_fc99b77a-2778-46df-beac-9b37e65497ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fc99b77a-2778-46df-beac-9b37e65497ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_fc99b77a-2778-46df-beac-9b37e65497ce" xlink:to="loc_us-gaap_HedgingDesignationDomain_fc99b77a-2778-46df-beac-9b37e65497ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f5b16c0c-6b40-45e7-bef2-668d1a64b3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_fc99b77a-2778-46df-beac-9b37e65497ce" xlink:to="loc_us-gaap_HedgingDesignationDomain_f5b16c0c-6b40-45e7-bef2-668d1a64b3fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b8f4f9f9-e825-401f-8574-14c3ed87f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f5b16c0c-6b40-45e7-bef2-668d1a64b3fb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b8f4f9f9-e825-401f-8574-14c3ed87f9a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d81b1f90-c96d-4fb1-a503-d4f52877e71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f5b16c0c-6b40-45e7-bef2-668d1a64b3fb" xlink:to="loc_us-gaap_NondesignatedMember_d81b1f90-c96d-4fb1-a503-d4f52877e71c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_063e4094-6a9f-4043-8fde-15d90041715e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_063e4094-6a9f-4043-8fde-15d90041715e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_063e4094-6a9f-4043-8fde-15d90041715e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_063e4094-6a9f-4043-8fde-15d90041715e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_063e4094-6a9f-4043-8fde-15d90041715e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ea98f63e-c549-48f0-af98-0ad9ee165297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_063e4094-6a9f-4043-8fde-15d90041715e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ea98f63e-c549-48f0-af98-0ad9ee165297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2cdc4078-5c12-4acd-8144-8bc0953c3981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ea98f63e-c549-48f0-af98-0ad9ee165297" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2cdc4078-5c12-4acd-8144-8bc0953c3981" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_f31b0472-e4f1-4166-9e20-c2fc84fd4be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:to="loc_us-gaap_PositionAxis_f31b0472-e4f1-4166-9e20-c2fc84fd4be8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_f31b0472-e4f1-4166-9e20-c2fc84fd4be8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_f31b0472-e4f1-4166-9e20-c2fc84fd4be8" xlink:to="loc_us-gaap_PositionDomain_f31b0472-e4f1-4166-9e20-c2fc84fd4be8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_e42eae31-5273-4508-972b-1bf3539dce87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_f31b0472-e4f1-4166-9e20-c2fc84fd4be8" xlink:to="loc_us-gaap_PositionDomain_e42eae31-5273-4508-972b-1bf3539dce87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_88317532-4e48-4bc7-bbde-0ce5c800fda9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_e42eae31-5273-4508-972b-1bf3539dce87" xlink:to="loc_us-gaap_ShortMember_88317532-4e48-4bc7-bbde-0ce5c800fda9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_c8c9dbdc-4e26-44c4-963f-41a7c46c6a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_e42eae31-5273-4508-972b-1bf3539dce87" xlink:to="loc_us-gaap_LongMember_c8c9dbdc-4e26-44c4-963f-41a7c46c6a00" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail" xlink:type="extended" id="i304e9d1915ce4a64b45a8ff65a3eb397_DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_551991d9-d3f5-4da0-b72b-b37b7737894e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ab6d6078-49b7-4ad6-ac2a-7d1b1a589041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_551991d9-d3f5-4da0-b72b-b37b7737894e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ab6d6078-49b7-4ad6-ac2a-7d1b1a589041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5076c044-b088-46b0-8dc7-6c22b9d23dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_551991d9-d3f5-4da0-b72b-b37b7737894e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5076c044-b088-46b0-8dc7-6c22b9d23dc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_551991d9-d3f5-4da0-b72b-b37b7737894e" xlink:to="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_addc3059-34f6-4168-9d52-16711b594fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_addc3059-34f6-4168-9d52-16711b594fe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_addc3059-34f6-4168-9d52-16711b594fe7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_addc3059-34f6-4168-9d52-16711b594fe7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_addc3059-34f6-4168-9d52-16711b594fe7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40b9de2c-9ab4-4c9a-b8fa-4376e690ec47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_addc3059-34f6-4168-9d52-16711b594fe7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40b9de2c-9ab4-4c9a-b8fa-4376e690ec47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_548cedfd-56fa-4e89-b394-1e8abd8ca7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40b9de2c-9ab4-4c9a-b8fa-4376e690ec47" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_548cedfd-56fa-4e89-b394-1e8abd8ca7f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6b8a8712-33ac-478f-8b1b-8dd32260bdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:to="loc_us-gaap_HedgingDesignationAxis_6b8a8712-33ac-478f-8b1b-8dd32260bdc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6b8a8712-33ac-478f-8b1b-8dd32260bdc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_6b8a8712-33ac-478f-8b1b-8dd32260bdc6" xlink:to="loc_us-gaap_HedgingDesignationDomain_6b8a8712-33ac-478f-8b1b-8dd32260bdc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_41ea4fec-bcdb-4f7b-af44-adb7bc23d591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_6b8a8712-33ac-478f-8b1b-8dd32260bdc6" xlink:to="loc_us-gaap_HedgingDesignationDomain_41ea4fec-bcdb-4f7b-af44-adb7bc23d591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_310a0cd4-ce1f-440c-95c3-110e9332ba75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_41ea4fec-bcdb-4f7b-af44-adb7bc23d591" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_310a0cd4-ce1f-440c-95c3-110e9332ba75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_dc71cf4e-e9c7-4bc1-9840-3410f2b32ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_41ea4fec-bcdb-4f7b-af44-adb7bc23d591" xlink:to="loc_us-gaap_NondesignatedMember_dc71cf4e-e9c7-4bc1-9840-3410f2b32ce8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_10e7f9e6-745b-4668-9be8-21b1d3fe7563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_10e7f9e6-745b-4668-9be8-21b1d3fe7563" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_10e7f9e6-745b-4668-9be8-21b1d3fe7563_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_10e7f9e6-745b-4668-9be8-21b1d3fe7563" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_10e7f9e6-745b-4668-9be8-21b1d3fe7563_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_10e7f9e6-745b-4668-9be8-21b1d3fe7563" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_2d81dc23-fc79-4ef1-a8ac-6b3cf1d7ba7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_2d81dc23-fc79-4ef1-a8ac-6b3cf1d7ba7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_a1e75a9d-0fe8-4037-b32f-a60249fa5bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_a1e75a9d-0fe8-4037-b32f-a60249fa5bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_96709adf-486c-4dfd-8b3a-5f654fc0103d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_96709adf-486c-4dfd-8b3a-5f654fc0103d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_45b56438-4e83-4ad7-ae7d-e7d059fc32e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_45b56438-4e83-4ad7-ae7d-e7d059fc32e6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail" xlink:type="extended" id="i51aa116bab114b70ba7e170d0841f209_DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffc994d4-b47f-419d-bf73-e3f79e175eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffc994d4-b47f-419d-bf73-e3f79e175eba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5eecbcca-b242-4321-877f-51a695a6dd13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:to="loc_us-gaap_CostsAndExpenses_5eecbcca-b242-4321-877f-51a695a6dd13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0277518e-e075-4710-a090-2e07ba447578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0277518e-e075-4710-a090-2e07ba447578" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_b693ba8c-9de2-40df-aa56-0b020ff774a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_b693ba8c-9de2-40df-aa56-0b020ff774a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_32977b6c-508e-4fe0-be50-a628ca9cede9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:to="loc_srt_ProductOrServiceAxis_32977b6c-508e-4fe0-be50-a628ca9cede9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_32977b6c-508e-4fe0-be50-a628ca9cede9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_32977b6c-508e-4fe0-be50-a628ca9cede9" xlink:to="loc_srt_ProductsAndServicesDomain_32977b6c-508e-4fe0-be50-a628ca9cede9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c29665b4-8f4d-4b10-94ed-7c87e0456056" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_32977b6c-508e-4fe0-be50-a628ca9cede9" xlink:to="loc_srt_ProductsAndServicesDomain_c29665b4-8f4d-4b10-94ed-7c87e0456056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_0aaa4d69-ff00-4d89-bdfe-dc99233d671e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c29665b4-8f4d-4b10-94ed-7c87e0456056" xlink:to="loc_us-gaap_ProductMember_0aaa4d69-ff00-4d89-bdfe-dc99233d671e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4c62cfa9-aa2b-427d-a65d-040d00e8fe55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4c62cfa9-aa2b-427d-a65d-040d00e8fe55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4c62cfa9-aa2b-427d-a65d-040d00e8fe55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4c62cfa9-aa2b-427d-a65d-040d00e8fe55" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4c62cfa9-aa2b-427d-a65d-040d00e8fe55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8333f60c-156b-4398-a489-046ef4354889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4c62cfa9-aa2b-427d-a65d-040d00e8fe55" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8333f60c-156b-4398-a489-046ef4354889" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_19656469-eaae-4067-abef-7174a1c8baf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8333f60c-156b-4398-a489-046ef4354889" xlink:to="loc_us-gaap_OperatingExpenseMember_19656469-eaae-4067-abef-7174a1c8baf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e8da92d9-2a9d-4336-bb8f-66d9d54ed907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:to="loc_us-gaap_HedgingDesignationAxis_e8da92d9-2a9d-4336-bb8f-66d9d54ed907" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e8da92d9-2a9d-4336-bb8f-66d9d54ed907_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_e8da92d9-2a9d-4336-bb8f-66d9d54ed907" xlink:to="loc_us-gaap_HedgingDesignationDomain_e8da92d9-2a9d-4336-bb8f-66d9d54ed907_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_027314c6-f931-44d4-b59d-e3a077ce4a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_e8da92d9-2a9d-4336-bb8f-66d9d54ed907" xlink:to="loc_us-gaap_HedgingDesignationDomain_027314c6-f931-44d4-b59d-e3a077ce4a1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f05efdc1-edf7-4a45-9d52-b3eb0891e603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_027314c6-f931-44d4-b59d-e3a077ce4a1f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f05efdc1-edf7-4a45-9d52-b3eb0891e603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_99dee9d6-a1fb-4e08-85b8-a8295159fd84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_027314c6-f931-44d4-b59d-e3a077ce4a1f" xlink:to="loc_us-gaap_NondesignatedMember_99dee9d6-a1fb-4e08-85b8-a8295159fd84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_923d6243-cc1e-4128-bfec-e0eae192cde7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_923d6243-cc1e-4128-bfec-e0eae192cde7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_923d6243-cc1e-4128-bfec-e0eae192cde7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_923d6243-cc1e-4128-bfec-e0eae192cde7" xlink:to="loc_us-gaap_EquityComponentDomain_923d6243-cc1e-4128-bfec-e0eae192cde7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_56ea8214-772d-4c77-9108-f09c94fbb93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_923d6243-cc1e-4128-bfec-e0eae192cde7" xlink:to="loc_us-gaap_EquityComponentDomain_56ea8214-772d-4c77-9108-f09c94fbb93a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fc10f2e5-c708-4ee4-b250-2dee61ed59ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_56ea8214-772d-4c77-9108-f09c94fbb93a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fc10f2e5-c708-4ee4-b250-2dee61ed59ff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DebtAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DebtAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/DebtAdditionalInformationDetail" xlink:type="extended" id="i2be41af3244a4beb9801987b105b8080_DebtAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_7ee4a0d0-968f-451a-a1d0-d12912ae3e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_7ee4a0d0-968f-451a-a1d0-d12912ae3e64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7b45a7b-c044-4ed2-a4e4-d594f5d3104c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7b45a7b-c044-4ed2-a4e4-d594f5d3104c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a539de4b-d1d5-4594-912e-9f1be926134b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:to="loc_us-gaap_LineOfCredit_a539de4b-d1d5-4594-912e-9f1be926134b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_79133d30-d896-4374-8a7a-8b46d3fb795c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:to="loc_us-gaap_DebtInstrumentTable_79133d30-d896-4374-8a7a-8b46d3fb795c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3a3a69f2-c3b4-4ce0-b106-2aa693dc37e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_79133d30-d896-4374-8a7a-8b46d3fb795c" xlink:to="loc_us-gaap_DebtInstrumentAxis_3a3a69f2-c3b4-4ce0-b106-2aa693dc37e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3a3a69f2-c3b4-4ce0-b106-2aa693dc37e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a3a69f2-c3b4-4ce0-b106-2aa693dc37e8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3a3a69f2-c3b4-4ce0-b106-2aa693dc37e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2ce8339b-1a0f-42f2-bb66-48ff370ab86e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a3a69f2-c3b4-4ce0-b106-2aa693dc37e8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2ce8339b-1a0f-42f2-bb66-48ff370ab86e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember_0e0331c5-03f1-48a4-8cd9-d757715d126a" xlink:href="bmrn-20210930.xsd#bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2ce8339b-1a0f-42f2-bb66-48ff370ab86e" xlink:to="loc_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember_0e0331c5-03f1-48a4-8cd9-d757715d126a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DebtSummaryofConvertibleDebtDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail" xlink:type="extended" id="i008d9ea359d2429bb6933bf0df8c9219_DebtSummaryofConvertibleDebtDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c1538c63-a36b-4b72-9b1b-922ef4ae92af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c1538c63-a36b-4b72-9b1b-922ef4ae92af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2d1064da-27de-4ba9-91c2-9f2af3264357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2d1064da-27de-4ba9-91c2-9f2af3264357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4c3872db-8387-4631-840a-5e0fdc0b6baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4c3872db-8387-4631-840a-5e0fdc0b6baf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_2e3c60e2-fe0d-42d7-a9e4-f616d73dc167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_2e3c60e2-fe0d-42d7-a9e4-f616d73dc167" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_9df044fc-717b-4a63-af4b-0a0e796035fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_9df044fc-717b-4a63-af4b-0a0e796035fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_040627dd-5845-446c-bce1-bb64883c2119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_ConvertibleDebt_040627dd-5845-446c-bce1-bb64883c2119" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_5fc7f109-9802-4dbc-9e23-2496d37d7df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_5fc7f109-9802-4dbc-9e23-2496d37d7df6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8da29f52-419d-437b-8171-e0d942f7a538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_DebtInstrumentTable_8da29f52-419d-437b-8171-e0d942f7a538" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5b0b7b2b-ec4d-436e-852b-18717ffed783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8da29f52-419d-437b-8171-e0d942f7a538" xlink:to="loc_us-gaap_DebtInstrumentAxis_5b0b7b2b-ec4d-436e-852b-18717ffed783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b0b7b2b-ec4d-436e-852b-18717ffed783_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5b0b7b2b-ec4d-436e-852b-18717ffed783" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b0b7b2b-ec4d-436e-852b-18717ffed783_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e78e27d7-78e7-454c-ba67-32179544b8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5b0b7b2b-ec4d-436e-852b-18717ffed783" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e78e27d7-78e7-454c-ba67-32179544b8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member_e1ca567e-9c98-4d4a-b870-517463e0817d" xlink:href="bmrn-20210930.xsd#bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e78e27d7-78e7-454c-ba67-32179544b8a9" xlink:to="loc_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member_e1ca567e-9c98-4d4a-b870-517463e0817d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember_fe034c75-48d8-4860-b9c2-00175504ea0e" xlink:href="bmrn-20210930.xsd#bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e78e27d7-78e7-454c-ba67-32179544b8a9" xlink:to="loc_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember_fe034c75-48d8-4860-b9c2-00175504ea0e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DebtSummaryofInterestExpenseonConvertibleDebtDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail" xlink:type="extended" id="i2d005c691c71405480f169374ed21ae6_DebtSummaryofInterestExpenseonConvertibleDebtDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfInterestExpensesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b25ad83c-df36-477e-a8c6-080f887fd63e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b25ad83c-df36-477e-a8c6-080f887fd63e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_5e35d57f-c6da-488f-857c-e3e0ab3f1b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_5e35d57f-c6da-488f-857c-e3e0ab3f1b37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_ba5c98b1-b692-4df8-ad1e-6464a5d2b32d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_ba5c98b1-b692-4df8-ad1e-6464a5d2b32d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_35c03595-b856-41de-a80a-7999fd8b88f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:to="loc_us-gaap_InterestExpense_35c03595-b856-41de-a80a-7999fd8b88f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfInterestExpensesTable_a9916ce9-d895-4082-a9d5-46fd6f947173" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfInterestExpensesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:to="loc_bmrn_ScheduleOfInterestExpensesTable_a9916ce9-d895-4082-a9d5-46fd6f947173" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fdc1ea9e-d3e8-4dd3-b3fc-c5d8d84c8548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_ScheduleOfInterestExpensesTable_a9916ce9-d895-4082-a9d5-46fd6f947173" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fdc1ea9e-d3e8-4dd3-b3fc-c5d8d84c8548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fdc1ea9e-d3e8-4dd3-b3fc-c5d8d84c8548_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fdc1ea9e-d3e8-4dd3-b3fc-c5d8d84c8548" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fdc1ea9e-d3e8-4dd3-b3fc-c5d8d84c8548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6ff60f82-8e19-47fb-917f-932e31b23545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fdc1ea9e-d3e8-4dd3-b3fc-c5d8d84c8548" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6ff60f82-8e19-47fb-917f-932e31b23545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_42dff0b0-a11d-4455-b633-c6fc29ba88e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6ff60f82-8e19-47fb-917f-932e31b23545" xlink:to="loc_us-gaap_ConvertibleDebtMember_42dff0b0-a11d-4455-b633-c6fc29ba88e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail" xlink:type="extended" id="i350d1029331e48fcad2b3f76cc1c19ff_AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3dcbf7d2-5a2e-4799-9556-84c6d9146fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3dcbf7d2-5a2e-4799-9556-84c6d9146fc5" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_41fe9e1c-0146-4844-a939-e39efef28ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_StockholdersEquity_41fe9e1c-0146-4844-a939-e39efef28ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_1fd33051-650a-491f-bd7e-5d65ba60d203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_1fd33051-650a-491f-bd7e-5d65ba60d203" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_3ac1d9e2-818c-4b7e-af5c-5f7ce127034b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_3ac1d9e2-818c-4b7e-af5c-5f7ce127034b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_08546052-64e1-4f67-afbd-dc6026c34521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_08546052-64e1-4f67-afbd-dc6026c34521" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_66adcc0b-fc3f-41a5-9eb9-cff0bd083482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_66adcc0b-fc3f-41a5-9eb9-cff0bd083482" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9084e0bf-da0f-4730-9455-906add9ef209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2930df90-3090-4c2c-a0c6-8bf2cc92beac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3dcbf7d2-5a2e-4799-9556-84c6d9146fc5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2930df90-3090-4c2c-a0c6-8bf2cc92beac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fa7e41b9-3d9b-4c95-863c-67faf28208e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2930df90-3090-4c2c-a0c6-8bf2cc92beac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fa7e41b9-3d9b-4c95-863c-67faf28208e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fa7e41b9-3d9b-4c95-863c-67faf28208e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fa7e41b9-3d9b-4c95-863c-67faf28208e8" xlink:to="loc_us-gaap_EquityComponentDomain_fa7e41b9-3d9b-4c95-863c-67faf28208e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fa7e41b9-3d9b-4c95-863c-67faf28208e8" xlink:to="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_03671016-9714-4df4-8d3e-d151d272b988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_03671016-9714-4df4-8d3e-d151d272b988" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4891a801-3c45-40d9-8dd9-49b4094d262b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4891a801-3c45-40d9-8dd9-49b4094d262b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_AccumulatedGainLossFromOtherMember_28a1af5c-32c6-4dca-a31b-08cd45fbd9a1" xlink:href="bmrn-20210930.xsd#bmrn_AccumulatedGainLossFromOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:to="loc_bmrn_AccumulatedGainLossFromOtherMember_28a1af5c-32c6-4dca-a31b-08cd45fbd9a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df592aec-f4f6-4a89-af90-581782ec1269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df592aec-f4f6-4a89-af90-581782ec1269" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail" xlink:type="extended" id="ibee57aa5070549f39b98c014a8af701c_RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_e0e28324-66c5-451c-9315-37549f427bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:to="loc_us-gaap_NumberOfOperatingSegments_e0e28324-66c5-451c-9315-37549f427bdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_2c6e453c-511c-4b3a-bd2b-b1863b882796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_2c6e453c-511c-4b3a-bd2b-b1863b882796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_bdbf2759-4bf4-4faa-bdaf-749100ef7331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_bdbf2759-4bf4-4faa-bdaf-749100ef7331" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:to="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f03b54d2-726d-4624-a7a2-61d6a09aa5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f03b54d2-726d-4624-a7a2-61d6a09aa5f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f03b54d2-726d-4624-a7a2-61d6a09aa5f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f03b54d2-726d-4624-a7a2-61d6a09aa5f0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f03b54d2-726d-4624-a7a2-61d6a09aa5f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_137ffb4c-0ac0-48f5-af99-ab723661d204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f03b54d2-726d-4624-a7a2-61d6a09aa5f0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_137ffb4c-0ac0-48f5-af99-ab723661d204" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_8e438cf5-543c-4895-b03e-c9896675b36d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_137ffb4c-0ac0-48f5-af99-ab723661d204" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_8e438cf5-543c-4895-b03e-c9896675b36d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0cc43f0b-c9ec-4edc-ad66-ca0825760d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0cc43f0b-c9ec-4edc-ad66-ca0825760d8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0cc43f0b-c9ec-4edc-ad66-ca0825760d8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0cc43f0b-c9ec-4edc-ad66-ca0825760d8d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0cc43f0b-c9ec-4edc-ad66-ca0825760d8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86af0725-ac5d-42b1-8de2-2d620caeb6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0cc43f0b-c9ec-4edc-ad66-ca0825760d8d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86af0725-ac5d-42b1-8de2-2d620caeb6cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_b5f43153-0943-4431-995b-00be3600183d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86af0725-ac5d-42b1-8de2-2d620caeb6cb" xlink:to="loc_us-gaap_AccountsReceivableMember_b5f43153-0943-4431-995b-00be3600183d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_647f8931-7056-4acf-ac94-c4921d7bf7b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:to="loc_srt_MajorCustomersAxis_647f8931-7056-4acf-ac94-c4921d7bf7b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_647f8931-7056-4acf-ac94-c4921d7bf7b6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_647f8931-7056-4acf-ac94-c4921d7bf7b6" xlink:to="loc_srt_NameOfMajorCustomerDomain_647f8931-7056-4acf-ac94-c4921d7bf7b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_647f8931-7056-4acf-ac94-c4921d7bf7b6" xlink:to="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerOneMember_c8e98d2e-52a2-48e2-9837-9e693bb38090" xlink:href="bmrn-20210930.xsd#bmrn_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:to="loc_bmrn_CustomerOneMember_c8e98d2e-52a2-48e2-9837-9e693bb38090" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerTwoMember_fecc30ca-ecd2-4019-b995-642d1f12015b" xlink:href="bmrn-20210930.xsd#bmrn_CustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:to="loc_bmrn_CustomerTwoMember_fecc30ca-ecd2-4019-b995-642d1f12015b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomersMember_d7f81461-ede7-4213-8f51-31be114cf5a3" xlink:href="bmrn-20210930.xsd#bmrn_CustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:to="loc_bmrn_CustomersMember_d7f81461-ede7-4213-8f51-31be114cf5a3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail" xlink:type="extended" id="i91dae87c597e4be1849646b0fea17701_RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3faa2bd8-1645-4a69-8c17-5c3758cbae40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5999d179-09cd-48ff-83e7-f05662f15932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3faa2bd8-1645-4a69-8c17-5c3758cbae40" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5999d179-09cd-48ff-83e7-f05662f15932" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_15003660-f5ba-4c95-aeb1-45cd2668303b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3faa2bd8-1645-4a69-8c17-5c3758cbae40" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_15003660-f5ba-4c95-aeb1-45cd2668303b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e5873b80-2eea-4249-9132-521db1010422" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_15003660-f5ba-4c95-aeb1-45cd2668303b" xlink:to="loc_srt_StatementGeographicalAxis_e5873b80-2eea-4249-9132-521db1010422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e5873b80-2eea-4249-9132-521db1010422_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e5873b80-2eea-4249-9132-521db1010422" xlink:to="loc_srt_SegmentGeographicalDomain_e5873b80-2eea-4249-9132-521db1010422_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e5873b80-2eea-4249-9132-521db1010422" xlink:to="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4c7148fb-f627-48af-9c13-3eadc5511de2" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:to="loc_country_US_4c7148fb-f627-48af-9c13-3eadc5511de2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_bba7034a-581a-4c47-9fb4-514f2a5ba230" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:to="loc_srt_EuropeMember_bba7034a-581a-4c47-9fb4-514f2a5ba230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_b1ce5608-00ea-49f7-9f8d-5b9c72ee0f87" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:to="loc_srt_LatinAmericaMember_b1ce5608-00ea-49f7-9f8d-5b9c72ee0f87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RestOfWorldMember_af4c5cdf-5a53-4752-8ab3-dbb623947a2f" xlink:href="bmrn-20210930.xsd#bmrn_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:to="loc_bmrn_RestOfWorldMember_af4c5cdf-5a53-4752-8ab3-dbb623947a2f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail" xlink:type="extended" id="i6cd9ad97f2884652b4884e62844f4d51_RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_22339c37-c9f8-43a4-af73-d6c43bee368f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35655978-83cd-4aeb-852f-61f3518a128a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_22339c37-c9f8-43a4-af73-d6c43bee368f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35655978-83cd-4aeb-852f-61f3518a128a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4ab3ed06-0dca-43ae-a9a3-49b4cdd8bea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_22339c37-c9f8-43a4-af73-d6c43bee368f" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4ab3ed06-0dca-43ae-a9a3-49b4cdd8bea1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c903e35e-2c80-47e4-b094-19abbd1d7ac9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4ab3ed06-0dca-43ae-a9a3-49b4cdd8bea1" xlink:to="loc_srt_ProductOrServiceAxis_c903e35e-2c80-47e4-b094-19abbd1d7ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c903e35e-2c80-47e4-b094-19abbd1d7ac9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c903e35e-2c80-47e4-b094-19abbd1d7ac9" xlink:to="loc_srt_ProductsAndServicesDomain_c903e35e-2c80-47e4-b094-19abbd1d7ac9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c903e35e-2c80-47e4-b094-19abbd1d7ac9" xlink:to="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductFourMember_1838fc5a-8317-4278-a6c3-1c0b69fd914b" xlink:href="bmrn-20210930.xsd#bmrn_ProductFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductFourMember_1838fc5a-8317-4278-a6c3-1c0b69fd914b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductTwoMember_84c96295-75ba-411f-82a5-fbcde18a0666" xlink:href="bmrn-20210930.xsd#bmrn_ProductTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductTwoMember_84c96295-75ba-411f-82a5-fbcde18a0666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductThreeMember_db0b3788-da41-401f-a5e7-efa1f7d4a84b" xlink:href="bmrn-20210930.xsd#bmrn_ProductThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductThreeMember_db0b3788-da41-401f-a5e7-efa1f7d4a84b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductSevenMember_49e431df-edc0-4ad6-9b45-5ae82efa890b" xlink:href="bmrn-20210930.xsd#bmrn_ProductSevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductSevenMember_49e431df-edc0-4ad6-9b45-5ae82efa890b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductSixMember_22de33cf-45f8-4b7d-ab7b-a0499ff80875" xlink:href="bmrn-20210930.xsd#bmrn_ProductSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductSixMember_22de33cf-45f8-4b7d-ab7b-a0499ff80875" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductEightMember_8d40c4f7-242b-4d6b-8454-435cb9fcadbd" xlink:href="bmrn-20210930.xsd#bmrn_ProductEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductEightMember_8d40c4f7-242b-4d6b-8454-435cb9fcadbd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductFiveMember_e1c4d1fb-25aa-44b4-be47-f61eb8c44675" xlink:href="bmrn-20210930.xsd#bmrn_ProductFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductFiveMember_e1c4d1fb-25aa-44b4-be47-f61eb8c44675" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductsExcludingProductOneMember_f13f30f8-86c5-48e0-98e7-cc3edd5149b0" xlink:href="bmrn-20210930.xsd#bmrn_ProductsExcludingProductOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductsExcludingProductOneMember_f13f30f8-86c5-48e0-98e7-cc3edd5149b0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductOneMember_7a5d3df5-cddc-4121-bdbf-3a6272c41f59" xlink:href="bmrn-20210930.xsd#bmrn_ProductOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductOneMember_7a5d3df5-cddc-4121-bdbf-3a6272c41f59" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_e685a439-ece0-4966-be38-a55a92eaf39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_us-gaap_ProductMember_e685a439-ece0-4966-be38-a55a92eaf39f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_12696c05-517b-4de8-8367-b105fceb2af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4ab3ed06-0dca-43ae-a9a3-49b4cdd8bea1" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_12696c05-517b-4de8-8367-b105fceb2af1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12696c05-517b-4de8-8367-b105fceb2af1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_12696c05-517b-4de8-8367-b105fceb2af1" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12696c05-517b-4de8-8367-b105fceb2af1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_00fb396f-456d-49d0-8357-33b090608938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_12696c05-517b-4de8-8367-b105fceb2af1" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_00fb396f-456d-49d0-8357-33b090608938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_dd86f347-13ab-4d91-b2aa-af8ee65d0462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_00fb396f-456d-49d0-8357-33b090608938" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_dd86f347-13ab-4d91-b2aa-af8ee65d0462" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_f54cecea-1f09-452a-9139-9604c8883246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_00fb396f-456d-49d0-8357-33b090608938" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_f54cecea-1f09-452a-9139-9604c8883246" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail" xlink:type="extended" id="ied167614a36147e6aa068334c703fd6a_RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5dda7ef1-f234-4dde-96de-d427c236fa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe059c68-4584-4710-a5d6-630ae42060c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5dda7ef1-f234-4dde-96de-d427c236fa0d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe059c68-4584-4710-a5d6-630ae42060c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5dda7ef1-f234-4dde-96de-d427c236fa0d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e62fa92f-f00f-4218-8a2b-c87e9cccdcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e62fa92f-f00f-4218-8a2b-c87e9cccdcb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e62fa92f-f00f-4218-8a2b-c87e9cccdcb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e62fa92f-f00f-4218-8a2b-c87e9cccdcb8" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e62fa92f-f00f-4218-8a2b-c87e9cccdcb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_178e9de8-bce6-4afa-a8ca-0aae0f746515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e62fa92f-f00f-4218-8a2b-c87e9cccdcb8" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_178e9de8-bce6-4afa-a8ca-0aae0f746515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_50b05a46-1958-47d5-ae7f-5b5d74d03622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_178e9de8-bce6-4afa-a8ca-0aae0f746515" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_50b05a46-1958-47d5-ae7f-5b5d74d03622" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_18eefd29-ac0e-43d4-a80a-47ae7ef5e25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_178e9de8-bce6-4afa-a8ca-0aae0f746515" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_18eefd29-ac0e-43d4-a80a-47ae7ef5e25f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8dcdfa10-9c2f-4c96-8470-18b380a6e851" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:to="loc_srt_ProductOrServiceAxis_8dcdfa10-9c2f-4c96-8470-18b380a6e851" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8dcdfa10-9c2f-4c96-8470-18b380a6e851_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8dcdfa10-9c2f-4c96-8470-18b380a6e851" xlink:to="loc_srt_ProductsAndServicesDomain_8dcdfa10-9c2f-4c96-8470-18b380a6e851_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8dcdfa10-9c2f-4c96-8470-18b380a6e851" xlink:to="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductsExcludingProductOneMember_027314e9-987e-4ed4-8a04-e4f790d77c5e" xlink:href="bmrn-20210930.xsd#bmrn_ProductsExcludingProductOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:to="loc_bmrn_ProductsExcludingProductOneMember_027314e9-987e-4ed4-8a04-e4f790d77c5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductOneMember_f023944a-a052-4cba-820c-7383aca8f095" xlink:href="bmrn-20210930.xsd#bmrn_ProductOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:to="loc_bmrn_ProductOneMember_f023944a-a052-4cba-820c-7383aca8f095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_2a0fb65f-5cd0-4b44-b325-ea29a9ad0b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:to="loc_us-gaap_ProductMember_2a0fb65f-5cd0-4b44-b325-ea29a9ad0b57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e9766c34-4034-4339-a85b-cb4661d43f40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:to="loc_srt_StatementGeographicalAxis_e9766c34-4034-4339-a85b-cb4661d43f40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9766c34-4034-4339-a85b-cb4661d43f40_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e9766c34-4034-4339-a85b-cb4661d43f40" xlink:to="loc_srt_SegmentGeographicalDomain_e9766c34-4034-4339-a85b-cb4661d43f40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e9766c34-4034-4339-a85b-cb4661d43f40" xlink:to="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1f729b8e-d602-44d9-ad58-364f951c4cfe" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:to="loc_country_US_1f729b8e-d602-44d9-ad58-364f951c4cfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_35d3e982-27ab-4132-adeb-c20be4644be3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:to="loc_srt_EuropeMember_35d3e982-27ab-4132-adeb-c20be4644be3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_f54e0066-99c2-4c49-85a2-9cdaca311ca0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:to="loc_srt_LatinAmericaMember_f54e0066-99c2-4c49-85a2-9cdaca311ca0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RestOfWorldMember_1fa2cf62-56b9-4631-a2ad-9d861ef65ad7" xlink:href="bmrn-20210930.xsd#bmrn_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:to="loc_bmrn_RestOfWorldMember_1fa2cf62-56b9-4631-a2ad-9d861ef65ad7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail" xlink:type="extended" id="ic50a010c78724feaaf94ac5af7d77bf8_RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f6d65b55-4c2c-4c81-a6c5-4c88f27a960d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c457a442-a9e8-4ac2-a180-cd61915d8736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f6d65b55-4c2c-4c81-a6c5-4c88f27a960d" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c457a442-a9e8-4ac2-a180-cd61915d8736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f6d65b55-4c2c-4c81-a6c5-4c88f27a960d" xlink:to="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5ad99e56-4d2f-46ec-b350-617f3fd29cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5ad99e56-4d2f-46ec-b350-617f3fd29cf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5ad99e56-4d2f-46ec-b350-617f3fd29cf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5ad99e56-4d2f-46ec-b350-617f3fd29cf0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5ad99e56-4d2f-46ec-b350-617f3fd29cf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9a91483d-943a-4330-99bd-fae2cdc4cd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5ad99e56-4d2f-46ec-b350-617f3fd29cf0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9a91483d-943a-4330-99bd-fae2cdc4cd7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_a71e6782-a1c6-49d3-8ba0-1721ad475944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9a91483d-943a-4330-99bd-fae2cdc4cd7d" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_a71e6782-a1c6-49d3-8ba0-1721ad475944" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_534579d4-8bea-4d8a-a7e9-468b723c3497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_534579d4-8bea-4d8a-a7e9-468b723c3497" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_534579d4-8bea-4d8a-a7e9-468b723c3497_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_534579d4-8bea-4d8a-a7e9-468b723c3497" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_534579d4-8bea-4d8a-a7e9-468b723c3497_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_64442e95-98c0-4e3a-b3f8-a2a6040552a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_534579d4-8bea-4d8a-a7e9-468b723c3497" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_64442e95-98c0-4e3a-b3f8-a2a6040552a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_26afcc75-50a4-4c06-907b-e6734a7fff61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_64442e95-98c0-4e3a-b3f8-a2a6040552a3" xlink:to="loc_us-gaap_SalesRevenueNetMember_26afcc75-50a4-4c06-907b-e6734a7fff61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c55c2b8a-c994-4c28-bec8-b94d42f78421" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:to="loc_srt_MajorCustomersAxis_c55c2b8a-c994-4c28-bec8-b94d42f78421" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_c55c2b8a-c994-4c28-bec8-b94d42f78421_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_c55c2b8a-c994-4c28-bec8-b94d42f78421" xlink:to="loc_srt_NameOfMajorCustomerDomain_c55c2b8a-c994-4c28-bec8-b94d42f78421_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_437564fc-9431-4bcb-91bd-127442f69acd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_c55c2b8a-c994-4c28-bec8-b94d42f78421" xlink:to="loc_srt_NameOfMajorCustomerDomain_437564fc-9431-4bcb-91bd-127442f69acd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:href="bmrn-20210930.xsd#bmrn_CustomerOneTwoAndThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_437564fc-9431-4bcb-91bd-127442f69acd" xlink:to="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerOneMember_4c4bf6c4-128b-467c-8634-c55c30ad3960" xlink:href="bmrn-20210930.xsd#bmrn_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:to="loc_bmrn_CustomerOneMember_4c4bf6c4-128b-467c-8634-c55c30ad3960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerTwoMember_f28f7c6c-284d-47fc-beae-8ab359bfc34d" xlink:href="bmrn-20210930.xsd#bmrn_CustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:to="loc_bmrn_CustomerTwoMember_f28f7c6c-284d-47fc-beae-8ab359bfc34d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerThreeMember_86a314e2-71ca-4099-8777-53632af7c6aa" xlink:href="bmrn-20210930.xsd#bmrn_CustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:to="loc_bmrn_CustomerThreeMember_86a314e2-71ca-4099-8777-53632af7c6aa" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/StockBasedCompensationExpenseDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#StockBasedCompensationExpenseDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/StockBasedCompensationExpenseDetail" xlink:type="extended" id="i8dbedfac0dbd45da84bf16d588619eb5_StockBasedCompensationExpenseDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1916c0ce-5044-41e7-8610-ec3b48f3ce4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3f83d279-77e5-47d4-8650-c9bf755d926d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1916c0ce-5044-41e7-8610-ec3b48f3ce4d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3f83d279-77e5-47d4-8650-c9bf755d926d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3e5ce8c5-8bdc-4de5-b808-b1f518614d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1916c0ce-5044-41e7-8610-ec3b48f3ce4d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3e5ce8c5-8bdc-4de5-b808-b1f518614d2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b686daf9-6579-4439-b966-806d0023027a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3e5ce8c5-8bdc-4de5-b808-b1f518614d2b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b686daf9-6579-4439-b966-806d0023027a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b686daf9-6579-4439-b966-806d0023027a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b686daf9-6579-4439-b966-806d0023027a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b686daf9-6579-4439-b966-806d0023027a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b686daf9-6579-4439-b966-806d0023027a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2e101c70-22e5-4bae-aa0f-2923554dfb35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:to="loc_us-gaap_CostOfSalesMember_2e101c70-22e5-4bae-aa0f-2923554dfb35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_39812821-0964-4765-b551-fc156533ee32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_39812821-0964-4765-b551-fc156533ee32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3adda3d2-8fac-47eb-ad64-698dc4b9bbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3adda3d2-8fac-47eb-ad64-698dc4b9bbd3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails" xlink:type="extended" id="idc03b41d6a0644ca927b4ff5a153885e_NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e09339af-1cab-4c27-a7e8-75bea74a62f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e09339af-1cab-4c27-a7e8-75bea74a62f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_5e6a76af-627f-4681-bfeb-377312534dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_5e6a76af-627f-4681-bfeb-377312534dc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_32b26705-ce58-4f06-8246-b9c6ab7eba94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_32b26705-ce58-4f06-8246-b9c6ab7eba94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a39286bd-af7b-48f3-8aa6-f18fa7c8920a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a39286bd-af7b-48f3-8aa6-f18fa7c8920a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f9766797-88c8-4e19-9eab-acb62fb10477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a39286bd-af7b-48f3-8aa6-f18fa7c8920a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f9766797-88c8-4e19-9eab-acb62fb10477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_67ae1f13-1f22-4597-a56a-5d748d2b2ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_67ae1f13-1f22-4597-a56a-5d748d2b2ed1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_0f9f1f9e-4b72-4cb3-9688-00d55694a8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_67ae1f13-1f22-4597-a56a-5d748d2b2ed1" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_0f9f1f9e-4b72-4cb3-9688-00d55694a8d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_30f2ea88-2e42-41a2-90b8-64910c0e8d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_30f2ea88-2e42-41a2-90b8-64910c0e8d5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a9a5605a-c15c-4237-885d-ae03cf5a3d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_EarningsPerShareBasic_a9a5605a-c15c-4237-885d-ae03cf5a3d46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e6329f2f-a55c-4536-90ec-f2e94db545c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e6329f2f-a55c-4536-90ec-f2e94db545c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb434eaf-84d3-44f5-93e5-53e331d60fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb434eaf-84d3-44f5-93e5-53e331d60fe9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3d82068e-0d93-4453-8301-efa30f02dc78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb434eaf-84d3-44f5-93e5-53e331d60fe9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3d82068e-0d93-4453-8301-efa30f02dc78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3d82068e-0d93-4453-8301-efa30f02dc78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3d82068e-0d93-4453-8301-efa30f02dc78" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3d82068e-0d93-4453-8301-efa30f02dc78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3d82068e-0d93-4453-8301-efa30f02dc78" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4e8cd45a-b31c-4a67-96ef-3ed6b7b54317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4e8cd45a-b31c-4a67-96ef-3ed6b7b54317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember_9b6da097-27ea-4913-b359-caadc05730f7" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember_9b6da097-27ea-4913-b359-caadc05730f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_b7fecfc7-86a3-4a95-b5d9-e7bcc4b480cc" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_b7fecfc7-86a3-4a95-b5d9-e7bcc4b480cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_5a6e7d71-53fa-4634-9965-7bbad15288d3" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_5a6e7d71-53fa-4634-9965-7bbad15288d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_71cf71c5-f448-4dc7-bf02-f3ba887cadf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_us-gaap_RestrictedStockMember_71cf71c5-f448-4dc7-bf02-f3ba887cadf9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_4250c34c-ed13-4a2e-9f2f-13396f5c9a4a" xlink:href="bmrn-20210930.xsd#bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_4250c34c-ed13-4a2e-9f2f-13396f5c9a4a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_762cf907-525a-4ac5-bd98-7374a9b0af2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_us-gaap_StockCompensationPlanMember_762cf907-525a-4ac5-bd98-7374a9b0af2e" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail" xlink:type="extended" id="ia9d5782bc3e24306bb05064e7061ae11_NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f9aa1ab6-b4d6-491e-bcf9-a15bf56c4c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e2aa385c-1be0-4a74-a447-204af4f75335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f9aa1ab6-b4d6-491e-bcf9-a15bf56c4c7c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e2aa385c-1be0-4a74-a447-204af4f75335" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_45be7536-4f10-4bd3-9423-e2d202daf9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f9aa1ab6-b4d6-491e-bcf9-a15bf56c4c7c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_45be7536-4f10-4bd3-9423-e2d202daf9aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e613be70-bb07-4028-b606-c0af8dd9b1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_45be7536-4f10-4bd3-9423-e2d202daf9aa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e613be70-bb07-4028-b606-c0af8dd9b1df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e613be70-bb07-4028-b606-c0af8dd9b1df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e613be70-bb07-4028-b606-c0af8dd9b1df" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e613be70-bb07-4028-b606-c0af8dd9b1df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e613be70-bb07-4028-b606-c0af8dd9b1df" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f65b2730-05e7-4adc-b5f7-a84049274e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f65b2730-05e7-4adc-b5f7-a84049274e4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_5b2286c1-d4d0-4123-bfe2-8b6bc9080852" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_5b2286c1-d4d0-4123-bfe2-8b6bc9080852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_407bc020-6a23-405f-9a03-82aaa9df08a7" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_407bc020-6a23-405f-9a03-82aaa9df08a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e8eaa9a8-91bf-4159-b8a7-03363f4c3298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_us-gaap_RestrictedStockMember_e8eaa9a8-91bf-4159-b8a7-03363f4c3298" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_7c2c2992-8607-49ae-b1f6-a1b64e3e6861" xlink:href="bmrn-20210930.xsd#bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_7c2c2992-8607-49ae-b1f6-a1b64e3e6861" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_7b5b63d5-89e5-49bc-a004-1d8c97e7d2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_us-gaap_StockCompensationPlanMember_7b5b63d5-89e5-49bc-a004-1d8c97e7d2bd" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NetIncomeLossPerCommonShareAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail" xlink:type="extended" id="if9ca7de8d32f45959eb7917f3845a398_NetIncomeLossPerCommonShareAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_EarningsPerShareLineItems_90557fd2-fb30-4e54-8d5e-90c57ea96d81" xlink:href="bmrn-20210930.xsd#bmrn_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b6047f5-22f1-434a-a3d2-683b900f5302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_EarningsPerShareLineItems_90557fd2-fb30-4e54-8d5e-90c57ea96d81" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b6047f5-22f1-434a-a3d2-683b900f5302" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_33b8e025-736d-4d6e-b3f5-b064e37ca419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_EarningsPerShareLineItems_90557fd2-fb30-4e54-8d5e-90c57ea96d81" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_33b8e025-736d-4d6e-b3f5-b064e37ca419" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_EarningsPerShareTable_bafc0959-3fa5-44c5-b98f-62e808583338" xlink:href="bmrn-20210930.xsd#bmrn_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmrn_EarningsPerShareLineItems_90557fd2-fb30-4e54-8d5e-90c57ea96d81" xlink:to="loc_bmrn_EarningsPerShareTable_bafc0959-3fa5-44c5-b98f-62e808583338" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_83bc2ed3-020c-4276-95ad-9a3264aaf64f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_EarningsPerShareTable_bafc0959-3fa5-44c5-b98f-62e808583338" xlink:to="loc_us-gaap_DebtInstrumentAxis_83bc2ed3-020c-4276-95ad-9a3264aaf64f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_83bc2ed3-020c-4276-95ad-9a3264aaf64f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_83bc2ed3-020c-4276-95ad-9a3264aaf64f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_83bc2ed3-020c-4276-95ad-9a3264aaf64f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_121ed9f1-16c0-4c1e-bce9-564b262174f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_83bc2ed3-020c-4276-95ad-9a3264aaf64f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_121ed9f1-16c0-4c1e-bce9-564b262174f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember_23f89afe-8d7f-4417-badd-f24177f2e01d" xlink:href="bmrn-20210930.xsd#bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_121ed9f1-16c0-4c1e-bce9-564b262174f5" xlink:to="loc_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember_23f89afe-8d7f-4417-badd-f24177f2e01d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended" id="ia8dc10a124b248268e5c6968780c52cb_CommitmentsandContingenciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:href="bmrn-20210930.xsd#bmrn_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones_7afb7bfd-6c2f-48d2-89ba-34ea5196a53d" xlink:href="bmrn-20210930.xsd#bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones_7afb7bfd-6c2f-48d2-89ba-34ea5196a53d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones_6fcf1c95-d5f9-4b53-801a-9c17dc252c7b" xlink:href="bmrn-20210930.xsd#bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones_6fcf1c95-d5f9-4b53-801a-9c17dc252c7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_601414cd-743e-4fa2-bab0-edac1fe0a859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_601414cd-743e-4fa2-bab0-edac1fe0a859" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ed007d4f-95ea-423b-8718-b173349eca9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ed007d4f-95ea-423b-8718-b173349eca9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_525eba7a-1c57-4230-9fc5-a2d931c04e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_525eba7a-1c57-4230-9fc5-a2d931c04e27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommitmentsAndContingenciesTable_e4eb26b4-358a-42db-b3c5-3a751313703d" xlink:href="bmrn-20210930.xsd#bmrn_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_bmrn_CommitmentsAndContingenciesTable_e4eb26b4-358a-42db-b3c5-3a751313703d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_290ae565-d335-4ae8-9d36-5c894537dba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_CommitmentsAndContingenciesTable_e4eb26b4-358a-42db-b3c5-3a751313703d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_290ae565-d335-4ae8-9d36-5c894537dba8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_290ae565-d335-4ae8-9d36-5c894537dba8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_290ae565-d335-4ae8-9d36-5c894537dba8" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_290ae565-d335-4ae8-9d36-5c894537dba8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_290ae565-d335-4ae8-9d36-5c894537dba8" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_KuvanAndPalynziqMember_de38c47a-3b4f-4821-a631-5c00acd54b97" xlink:href="bmrn-20210930.xsd#bmrn_KuvanAndPalynziqMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:to="loc_bmrn_KuvanAndPalynziqMember_de38c47a-3b4f-4821-a631-5c00acd54b97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_EarlyStageDevelopmentProgramMember_ec9b3600-f07a-4abc-9ec2-af1502553177" xlink:href="bmrn-20210930.xsd#bmrn_EarlyStageDevelopmentProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:to="loc_bmrn_EarlyStageDevelopmentProgramMember_ec9b3600-f07a-4abc-9ec2-af1502553177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProgramsNoLongerBeingDevelopedMember_1936f12d-0b3b-4253-877e-16c6083bef51" xlink:href="bmrn-20210930.xsd#bmrn_ProgramsNoLongerBeingDevelopedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:to="loc_bmrn_ProgramsNoLongerBeingDevelopedMember_1936f12d-0b3b-4253-877e-16c6083bef51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5f3d2b1e-512a-495c-9129-7998d9a6278e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmrn_CommitmentsAndContingenciesTable_e4eb26b4-358a-42db-b3c5-3a751313703d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5f3d2b1e-512a-495c-9129-7998d9a6278e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f3d2b1e-512a-495c-9129-7998d9a6278e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f3d2b1e-512a-495c-9129-7998d9a6278e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f3d2b1e-512a-495c-9129-7998d9a6278e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a97c82-ee65-43b5-8c65-e7a3abd2454c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f3d2b1e-512a-495c-9129-7998d9a6278e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a97c82-ee65-43b5-8c65-e7a3abd2454c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ThirdPartyMember_8411e8b8-b0bb-45e6-9565-68de8175c958" xlink:href="bmrn-20210930.xsd#bmrn_ThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a97c82-ee65-43b5-8c65-e7a3abd2454c" xlink:to="loc_bmrn_ThirdPartyMember_8411e8b8-b0bb-45e6-9565-68de8175c958" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>bmrn-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f95636f6-9f25-4ee3-86c2-7b0315cdf3d9,g:ce424ef1-ab97-4f04-a4e9-8c3801ecff3b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_PositionAxis_10fb6474-1355-46ef-a4d3-a5db2ef395c7_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_a5f5148f-bec2-4fa9-b97d-e74212e384b9_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_cb0ecae3-3c27-4e9d-b0bd-9642d425bfd0_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW DISCLOSURES:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_6f15c3b2-846b-474c-b18f-a6703413bc9b_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_91b8b0d8-0610-4765-a33b-1c739f3999bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Available for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_226e1eca-8a60-49b0-8afe-ac0ab9f91ea7_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProductsExcludingProductOneMember_075d8fd1-e187-47c0-bc1d-6daf2b72fd38_terseLabel_en-US" xlink:label="lab_bmrn_ProductsExcludingProductOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim</link:label>
    <link:label id="lab_bmrn_ProductsExcludingProductOneMember_label_en-US" xlink:label="lab_bmrn_ProductsExcludingProductOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products Excluding Product One [Member]</link:label>
    <link:label id="lab_bmrn_ProductsExcludingProductOneMember_documentation_en-US" xlink:label="lab_bmrn_ProductsExcludingProductOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products excluding product one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductsExcludingProductOneMember" xlink:href="bmrn-20210930.xsd#bmrn_ProductsExcludingProductOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProductsExcludingProductOneMember" xlink:to="lab_bmrn_ProductsExcludingProductOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_318a6cb2-be65-40b9-9638-41224b0ac7fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_b4aa9466-83b2-42b2-8256-61a91f518f8d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_509faf98-b15f-40b5-a786-2b2ce363c460_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3f3dc94e-f869-41ca-a9e1-e0e93ed1594c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_de32416c-3770-4729-912f-c6b3f62f81c1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e6355185-3537-4c24-a111-7f9fb05ac06b_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_bf412e80-551e-4811-83ec-58415090faf0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Marketable Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_EarlyStageDevelopmentProgramMember_6b60f5f0-71fb-407b-90b9-021ee087a2be_terseLabel_en-US" xlink:label="lab_bmrn_EarlyStageDevelopmentProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Stage Development Program</link:label>
    <link:label id="lab_bmrn_EarlyStageDevelopmentProgramMember_label_en-US" xlink:label="lab_bmrn_EarlyStageDevelopmentProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Stage Development Program [Member]</link:label>
    <link:label id="lab_bmrn_EarlyStageDevelopmentProgramMember_documentation_en-US" xlink:label="lab_bmrn_EarlyStageDevelopmentProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Stage Development Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_EarlyStageDevelopmentProgramMember" xlink:href="bmrn-20210930.xsd#bmrn_EarlyStageDevelopmentProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_EarlyStageDevelopmentProgramMember" xlink:to="lab_bmrn_EarlyStageDevelopmentProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0c6919e9-ffcd-423c-9370-a2b955a6782e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_3ba36fdb-3206-47ea-90c2-4c6041290513_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_97f3003f-ef51-403e-9a8a-21f7e9f41564_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c3fc877c-2e72-419a-858e-2676f427e3e9_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_14b15907-b8df-447f-baca-29e242be7283_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_82262c4c-0f91-40c8-994f-5d7e53d4eb3b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value added taxes payable</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_d716fc7f-904c-4ab3-a518-169f2f867f1e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, convertible, conversion price, per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_f7764012-fa3a-40f0-b121-5155a8b71516_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f0e727fe-12ea-49ac-8023-e4e7c81171a6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ThirdPartyMember_2b2459c9-2ef9-4360-ac60-f281a386b2e3_terseLabel_en-US" xlink:label="lab_bmrn_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:label id="lab_bmrn_ThirdPartyMember_label_en-US" xlink:label="lab_bmrn_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party [Member]</link:label>
    <link:label id="lab_bmrn_ThirdPartyMember_documentation_en-US" xlink:label="lab_bmrn_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ThirdPartyMember" xlink:href="bmrn-20210930.xsd#bmrn_ThirdPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ThirdPartyMember" xlink:to="lab_bmrn_ThirdPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_3afa7fee-31a3-4dbd-bf70-e19f434f992a_terseLabel_en-US" xlink:label="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:label id="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Cash Cash Equivalents And Available For Sale Securities [Line Items]</link:label>
    <link:label id="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_documentation_en-US" xlink:label="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of cash, cash equivalents and available-for-sale securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems" xlink:to="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d2b40318-c2cb-49fc-b3f2-ae2e907aa91f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a632384-bcca-48ae-98f5-f5ac4e95d983_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ff07bff9-740f-4680-880a-b87701457336_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8473a309-e8ef-46c9-a5d0-d9ffbae45685_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a62c73fe-6701-4794-8507-31aa4767511c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6649f724-182f-47d2-a44d-7e2bd0198843_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_3e31ee0e-5164-4322-aad7-c7e26cce3105_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of nonfinancial assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets_14c5313d-e474-4904-a523-fa981f7a7ca3_terseLabel_en-US" xlink:label="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in accounts payable and accrued liabilities related to intangible assets</link:label>
    <link:label id="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets_label_en-US" xlink:label="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Accounts Payable And Accrued Liabilities Increase (Decrease), Intangible Assets</link:label>
    <link:label id="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets_documentation_en-US" xlink:label="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Accounts Payable And Accrued Liabilities Increase (Decrease), Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" xlink:href="bmrn-20210930.xsd#bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" xlink:to="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_9b9e75da-b811-489b-8c08-0164f6e60966_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_ce48de87-9a39-4381-8e6d-02436e35d349_terseLabel_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditConcentrationRiskMember" xlink:to="lab_us-gaap_CreditConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f938de63-46cd-4ee3-8d9c-c87d02092aca_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_e88a539b-4069-4a6f-8636-2b870b89aa43_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#160;current&#160;assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_44078ee7-64ea-40e4-b4c0-187d5b53a600_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5ab3cfa1-33d2-4c18-82b4-f6e836b1cbce_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of potentially issuable shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_80488531-ecdc-4ae7-8af3-dafb9582acbb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_8b1512c2-be2f-498e-905c-c498ad5222e4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProductFiveMember_03577ff4-aa8f-43f2-9278-4417ba42a3ff_terseLabel_en-US" xlink:label="lab_bmrn_ProductFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Firdapse</link:label>
    <link:label id="lab_bmrn_ProductFiveMember_label_en-US" xlink:label="lab_bmrn_ProductFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Five [Member]</link:label>
    <link:label id="lab_bmrn_ProductFiveMember_documentation_en-US" xlink:label="lab_bmrn_ProductFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product 5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductFiveMember" xlink:href="bmrn-20210930.xsd#bmrn_ProductFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProductFiveMember" xlink:to="lab_bmrn_ProductFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_91318be0-bee6-44f0-ba51-943e83f911aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock_790228ae-48e7-4136-813e-09d0c64e1d02_terseLabel_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION</link:label>
    <link:label id="lab_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk And Segment Reporting Disclosure [Text Block]</link:label>
    <link:label id="lab_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock_documentation_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk and segment reporting disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock" xlink:to="lab_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_78e872d6-6906-488e-86bc-7b9b76c2ec18_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4354b317-1396-478a-96fb-07710bb33c2d_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_ccf55b3a-5d4a-4f3f-9a6d-617a9465252b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketed by Genzyme</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ContingentConsiderationMember_a13235ed-e127-49f7-9b28-348f4466db4a_terseLabel_en-US" xlink:label="lab_bmrn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_bmrn_ContingentConsiderationMember_label_en-US" xlink:label="lab_bmrn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_bmrn_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_bmrn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentConsiderationMember" xlink:href="bmrn-20210930.xsd#bmrn_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ContingentConsiderationMember" xlink:to="lab_bmrn_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_7c55fc8c-81b6-495e-9fdf-87dd8ab8ee8c_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_3a33c9a8-8803-4c39-b85c-2be84f5a95fd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_8b1b486f-2509-44a8-99aa-fe9f003aef06_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_2372e74b-d657-46c1-b753-11e83a1a5f19_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_310d4ce6-594d-49f5-8eed-f78ff076b0bf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercises of awards under equity incentive plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1fb0b011-9935-42c8-9ef6-13edad9d3253_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_095f6b59-4673-411a-b547-c2cf85170395_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_873ad89a-9267-4ca9-9158-73f6b0effea2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_0bbee69c-d0de-4f44-9867-1ffbef8c3857_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c4b2e615-dee0-41f4-8e8a-86db65d79cd7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b69f0cae-cf83-4345-90e2-f898287733f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_StrategicInvestmentMember_0c42679c-5b32-44b9-882b-8430f9ffeeb5_terseLabel_en-US" xlink:label="lab_bmrn_StrategicInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Investment</link:label>
    <link:label id="lab_bmrn_StrategicInvestmentMember_label_en-US" xlink:label="lab_bmrn_StrategicInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Investment [Member]</link:label>
    <link:label id="lab_bmrn_StrategicInvestmentMember_documentation_en-US" xlink:label="lab_bmrn_StrategicInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_StrategicInvestmentMember" xlink:href="bmrn-20210930.xsd#bmrn_StrategicInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_StrategicInvestmentMember" xlink:to="lab_bmrn_StrategicInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_82e25752-361b-4ca1-a9ac-88da611b4e15_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bc0df999-f0b0-40be-ba4b-1ab23dfdbd87_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_651555f7-390d-4f17-9adc-da4e5fd3c068_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2bd38152-d53c-49a1-b04f-0afe0b5c1e3a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_08a11f71-ed87-4b73-a686-bf9805e743ac_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_CustomersMember_9966e811-9bf5-483c-9b1d-e3913ff9cbf5_terseLabel_en-US" xlink:label="lab_bmrn_CustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customers</link:label>
    <link:label id="lab_bmrn_CustomersMember_label_en-US" xlink:label="lab_bmrn_CustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customers [Member]</link:label>
    <link:label id="lab_bmrn_CustomersMember_documentation_en-US" xlink:label="lab_bmrn_CustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomersMember" xlink:href="bmrn-20210930.xsd#bmrn_CustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_CustomersMember" xlink:to="lab_bmrn_CustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_LongTermMarketableSecuritiesMaturityPeriod_c88ebb89-3367-4b14-b6fc-0beac4ce739f_terseLabel_en-US" xlink:label="lab_bmrn_LongTermMarketableSecuritiesMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term marketable securities maturity period</link:label>
    <link:label id="lab_bmrn_LongTermMarketableSecuritiesMaturityPeriod_label_en-US" xlink:label="lab_bmrn_LongTermMarketableSecuritiesMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Marketable Securities Maturity Period</link:label>
    <link:label id="lab_bmrn_LongTermMarketableSecuritiesMaturityPeriod_documentation_en-US" xlink:label="lab_bmrn_LongTermMarketableSecuritiesMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term marketable securities maturity period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_LongTermMarketableSecuritiesMaturityPeriod" xlink:href="bmrn-20210930.xsd#bmrn_LongTermMarketableSecuritiesMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_LongTermMarketableSecuritiesMaturityPeriod" xlink:to="lab_bmrn_LongTermMarketableSecuritiesMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40a878a8-ad5f-4992-892c-482e9c626c96_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b4c0a92e-7406-4c73-bf84-9e9f24d528a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ScheduleOfInterestExpensesLineItems_dcec4f70-05d8-417d-9a81-61097b804577_terseLabel_en-US" xlink:label="lab_bmrn_ScheduleOfInterestExpensesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expenses [Line Items]</link:label>
    <link:label id="lab_bmrn_ScheduleOfInterestExpensesLineItems_label_en-US" xlink:label="lab_bmrn_ScheduleOfInterestExpensesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expenses [Line Items]</link:label>
    <link:label id="lab_bmrn_ScheduleOfInterestExpensesLineItems_documentation_en-US" xlink:label="lab_bmrn_ScheduleOfInterestExpensesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfInterestExpensesLineItems" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfInterestExpensesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems" xlink:to="lab_bmrn_ScheduleOfInterestExpensesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_2c4ab756-cf40-452f-bfc2-faf0a6d50bab_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2928c44b-c43d-4a8f-9246-fd8ba6bc1f94_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_0ce81632-cab9-47ae-92a1-14316ad4b886_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayments of financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_cc4d0623-5296-4a9f-b881-9b3828181e83_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProceedsFromSaleOfNonfinancialAssets_c9eed3e2-f6b2-4409-8232-cc3bbbb9efe0_terseLabel_en-US" xlink:label="lab_bmrn_ProceedsFromSaleOfNonfinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of nonfinancial assets</link:label>
    <link:label id="lab_bmrn_ProceedsFromSaleOfNonfinancialAssets_label_en-US" xlink:label="lab_bmrn_ProceedsFromSaleOfNonfinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Nonfinancial Assets</link:label>
    <link:label id="lab_bmrn_ProceedsFromSaleOfNonfinancialAssets_documentation_en-US" xlink:label="lab_bmrn_ProceedsFromSaleOfNonfinancialAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Nonfinancial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProceedsFromSaleOfNonfinancialAssets" xlink:href="bmrn-20210930.xsd#bmrn_ProceedsFromSaleOfNonfinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProceedsFromSaleOfNonfinancialAssets" xlink:to="lab_bmrn_ProceedsFromSaleOfNonfinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_0eb33529-a377-485c-9fc7-d31b867d3161_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating business segment</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_940217f4-e93a-496e-9503-09c44c263ea7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses as reported</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_9d8a1b1a-17c3-4f20-8b6b-f3b4587df06f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) PER SHARE, BASIC (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e8628ba0-26d8-474a-a5ec-2a6d753c7dee_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_2f83bb2a-03cd-464b-98cc-03b86727c283_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_05b3ff61-532b-4499-ade1-a5d0febe9d3b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities remeasured</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_811df972-e48b-4ee3-8728-9bcc5b3014d5_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration as of December 31, 2020</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fcf441e2-958a-493d-a2db-ef5d349dc56a_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration as of September 30, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_RestrictedInvestmentsMember_d069b0d8-3826-47d1-ab64-68d2041d74fa_terseLabel_en-US" xlink:label="lab_bmrn_RestrictedInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Investments</link:label>
    <link:label id="lab_bmrn_RestrictedInvestmentsMember_label_en-US" xlink:label="lab_bmrn_RestrictedInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Investments [Member]</link:label>
    <link:label id="lab_bmrn_RestrictedInvestmentsMember_documentation_en-US" xlink:label="lab_bmrn_RestrictedInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RestrictedInvestmentsMember" xlink:href="bmrn-20210930.xsd#bmrn_RestrictedInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_RestrictedInvestmentsMember" xlink:to="lab_bmrn_RestrictedInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6b68f6d0-2051-4b60-8017-d51b8a6b1b48_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_OtherLiabilitiesCurrentFairValueDisclosure_6e2f199b-665a-47b1-8c6f-2a9177827234_verboseLabel_en-US" xlink:label="lab_bmrn_OtherLiabilitiesCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of other current liabilities</link:label>
    <link:label id="lab_bmrn_OtherLiabilitiesCurrentFairValueDisclosure_label_en-US" xlink:label="lab_bmrn_OtherLiabilitiesCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Current Fair Value Disclosure</link:label>
    <link:label id="lab_bmrn_OtherLiabilitiesCurrentFairValueDisclosure_documentation_en-US" xlink:label="lab_bmrn_OtherLiabilitiesCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities current fair value disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherLiabilitiesCurrentFairValueDisclosure" xlink:href="bmrn-20210930.xsd#bmrn_OtherLiabilitiesCurrentFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_OtherLiabilitiesCurrentFairValueDisclosure" xlink:to="lab_bmrn_OtherLiabilitiesCurrentFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_d8ec1362-bf1a-449b-a62e-bdb9bd5cb8a8_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Net Product Revenues Based on Patient Location</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3f32a0ff-f1c1-4e42-bf65-f32e2d9db6d9_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_fe275c33-c79b-455e-9068-b693f7bb5cfa_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_3354dfc0-5d67-419d-848f-368c005a6c8c_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_a50fed85-ff56-4b06-a8e3-e97d9e474384_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_EarningsPerShareTable_1a04b44e-04be-4bfb-8dcf-f2ef3cc51e13_terseLabel_en-US" xlink:label="lab_bmrn_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_bmrn_EarningsPerShareTable_label_en-US" xlink:label="lab_bmrn_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_bmrn_EarningsPerShareTable_documentation_en-US" xlink:label="lab_bmrn_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_EarningsPerShareTable" xlink:href="bmrn-20210930.xsd#bmrn_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_EarningsPerShareTable" xlink:to="lab_bmrn_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_1f0ebe89-8777-48d2-824b-6260aeadd120_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of equity component</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_99834b71-0c29-4cc4-844f-1f9057469944_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_67cf7d4d-2233-4b89-b4a1-aada5ab20abd_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial assets, Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_27c19717-90a8-48bc-b538-138db679bba4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1:</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ac96e295-f03d-4ad6-a8be-f87432691f54_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Price&#160;in Active Markets For Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_222ea06d-858b-4f8a-afed-3e61c67c8db4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_fe379c3d-a4be-4f2b-afe2-d9ade8352c78_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange (gain) loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_RoyaltyAndOtherMember_810ec767-8faa-4221-9062-ba716c0b5b74_terseLabel_en-US" xlink:label="lab_bmrn_RoyaltyAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty and other revenues</link:label>
    <link:label id="lab_bmrn_RoyaltyAndOtherMember_label_en-US" xlink:label="lab_bmrn_RoyaltyAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty And Other [Member]</link:label>
    <link:label id="lab_bmrn_RoyaltyAndOtherMember_documentation_en-US" xlink:label="lab_bmrn_RoyaltyAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty and other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RoyaltyAndOtherMember" xlink:href="bmrn-20210930.xsd#bmrn_RoyaltyAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_RoyaltyAndOtherMember" xlink:to="lab_bmrn_RoyaltyAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_cc257c0c-4f14-4964-9b18-fc397d8fd4d1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_983b0bd0-7246-4737-a4ba-dd0600553c0d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember_c13022a1-babd-460b-a44a-7c26d4ecabed_terseLabel_en-US" xlink:label="lab_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Senior Subordinated Convertible Notes Due in October 2020</link:label>
    <link:label id="lab_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember_label_en-US" xlink:label="lab_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Point Five Zero Percent Senior Subordinated Convertible Notes Due In October Twenty Twenty [Member]</link:label>
    <link:label id="lab_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember_documentation_en-US" xlink:label="lab_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One point five zero percent senior subordinated convertible notes due in October twenty twenty.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember" xlink:href="bmrn-20210930.xsd#bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember" xlink:to="lab_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_b89b2201-30c7-4ec8-9950-7cc1f6850a2b_terseLabel_en-US" xlink:label="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuable under the 2027 Notes</link:label>
    <link:label id="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_label_en-US" xlink:label="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due Two Thousand Twenty Seven [Member]</link:label>
    <link:label id="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_documentation_en-US" xlink:label="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due Two Thousand Twenty Seven</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember" xlink:to="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_c1639bf7-e622-42b5-ab8a-7e020dbc0a50_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bcba3c80-8148-4021-bbf8-7f4b7b89d4bb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_dadbb7df-081a-4c93-a3e5-0653c8157ea2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_07372f45-6d2c-422a-935c-5a6fe0ea3195_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember_16145a65-8f0a-474e-a88b-39d93ebc291c_terseLabel_en-US" xlink:label="lab_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign and other</link:label>
    <link:label id="lab_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember_label_en-US" xlink:label="lab_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Government And Other Debt Securities [Member]</link:label>
    <link:label id="lab_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember_documentation_en-US" xlink:label="lab_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign government and other debt securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember" xlink:href="bmrn-20210930.xsd#bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember" xlink:to="lab_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_4b679ced-6635-4010-b8eb-71acd6f74ba1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_CustomerOneMember_38a03026-36df-4ccf-ae5d-bd3dc04b103a_verboseLabel_en-US" xlink:label="lab_bmrn_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_bmrn_CustomerOneMember_bb6e08da-8f00-43f4-a433-19194d20d31c_terseLabel_en-US" xlink:label="lab_bmrn_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A</link:label>
    <link:label id="lab_bmrn_CustomerOneMember_label_en-US" xlink:label="lab_bmrn_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One [Member]</link:label>
    <link:label id="lab_bmrn_CustomerOneMember_documentation_en-US" xlink:label="lab_bmrn_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerOneMember" xlink:href="bmrn-20210930.xsd#bmrn_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_CustomerOneMember" xlink:to="lab_bmrn_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ad5714ac-84f5-400b-afa2-78ca2372e92d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_04174261-157d-4d18-9b8e-34c1b790bc62_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_fd17949f-24f1-4ff9-b79b-3f1a30a1ffda_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_72123a2e-459b-4aaf-b9ef-60335c442a4a_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_80054532-d139-4a2c-b605-f239f7f4b988_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) PER COMMON SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_6c36ad80-df8a-44f9-9e5f-41e8cd343da7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency exchange contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1aa52ec5-533e-4302-b2b9-2f263cc27a61_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a81bf075-9c8c-45f5-9c7c-c8691633586e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash changes in the fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIssuedEmployeeStockTrust_a4da32d7-a138-4c02-a333-7261b3bc672d_negatedLabel_en-US" xlink:label="lab_us-gaap_CommonStockIssuedEmployeeStockTrust" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company common stock held by Nonqualified Deferred Compensation Plan (the NQDC)</link:label>
    <link:label id="lab_us-gaap_CommonStockIssuedEmployeeStockTrust_label_en-US" xlink:label="lab_us-gaap_CommonStockIssuedEmployeeStockTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Issued, Employee Stock Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIssuedEmployeeStockTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIssuedEmployeeStockTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIssuedEmployeeStockTrust" xlink:to="lab_us-gaap_CommonStockIssuedEmployeeStockTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_f2e73f0d-bea7-4f7d-bcc3-3df9768368e5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding amount</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_06954c1c-32eb-48f4-a118-ab1c09b931e8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_7cfa5c4e-57e7-46dc-9727-11c13353645b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial liabilities, Total</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_82d9ec99-630d-4865-855b-bfa52613320a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_db4c050a-86c3-420f-a55a-8d5d5defdd97_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_36634bde-0f42-4c92-b75b-8705c810eaca_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_a8e8517e-ac96-4a5b-9d16-f2079b0edf14_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9298601c-1c73-4d23-9ad8-c3dc801fc053_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_0f6a2611-2576-4eba-a9fd-989dbb1e51d7_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_ad977716-d24b-457d-aa7a-bbbd335532c4_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e720eece-cdf0-4dcf-991c-0307591db945_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_382fa930-6fb7-4259-a898-43cb410236a1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level&#160;3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_80536db7-5c24-406b-b863-8b5e50d0130b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Stock Held By NQDC</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Share-based Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_128a86e6-602a-4287-aa40-d5c41e0c0fef_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_69af8abc-27f3-4bdf-8f1f-3dd9e0bfd6af_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_9be29d3b-ab33-4c19-87ee-7c4659f1d638_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Product Revenues by Product</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_e6cc7572-f499-4f6d-91a0-b6a8bddd223a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Interest Expense on Debt</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_01a607f0-4fe8-4ea1-abe7-dde6479c3b3b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value: 500,000,000 shares authorized; 183,567,424 and 181,740,999 shares issued and outstanding, respectively.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_2e95523f-5474-417a-8e02-83094c4091b8_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_8a6f9eb6-07ab-409b-867e-d94703ef6e85_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b3cc9b5f-13e6-4866-8f48-08526e8b7a46_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1c927223-7ccd-44c1-b519-e9bdba952266_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_db2b206d-5d38-4fcd-bc35-66b7638aecd3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_e399d153-918f-47b0-87aa-744b467cf289_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory reserves, net of stock-based compensation</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_9df5abaa-fb5d-4765-982a-9523ceca25a1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_c2b56a3c-41dc-49b6-b8e0-c0ad99a02b2d_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_6fae6edd-be0b-4914-956a-e0a46ce4565b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sell</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_40de1e85-ea44-4ddd-bebb-329bdc2d5627_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3992e4fe-c664-40a6-bdb2-a5489ecbaa18_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_eb66f8b9-d534-43cb-ac1b-1a690cda8141_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember_cc795182-188a-44b5-9e1c-209c728e74a5_terseLabel_en-US" xlink:label="lab_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuable under the 2020 Notes</link:label>
    <link:label id="lab_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember_label_en-US" xlink:label="lab_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due Twenty Twenty [Member]</link:label>
    <link:label id="lab_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember_documentation_en-US" xlink:label="lab_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes due twenty twenty.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember" xlink:to="lab_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock_2205ef06-1c9d-4678-ae7e-c160cf09ae15_terseLabel_en-US" xlink:label="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category</link:label>
    <link:label id="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock_label_en-US" xlink:label="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Cash Cash Equivalents And Available For Sale Securities Table [Text Block]</link:label>
    <link:label id="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of cash, cash equivalents and available-for-sale securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock" xlink:to="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_ba2cd1e9-7337-481c-aeb7-cb65d27656c5_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_2b4d1526-6dcb-46e8-824d-dc5117a72791_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses as reported</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_RestOfWorldMember_93a8a2ef-f549-4d55-87cf-3bcca4192f8b_terseLabel_en-US" xlink:label="lab_bmrn_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_bmrn_RestOfWorldMember_label_en-US" xlink:label="lab_bmrn_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:label id="lab_bmrn_RestOfWorldMember_documentation_en-US" xlink:label="lab_bmrn_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RestOfWorldMember" xlink:href="bmrn-20210930.xsd#bmrn_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_RestOfWorldMember" xlink:to="lab_bmrn_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_4136ccbf-eb98-4f1d-9d52-702045f59c85_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Revenues from External Customers and Collaborative Partners by Geographic Region</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_06cf514f-f101-44b0-85d0-96530cb8c10f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_OtherAssetsNoncurrentFairValueDisclosure_a416d82f-8fcb-420c-a02c-b4589d7b80ab_verboseLabel_en-US" xlink:label="lab_bmrn_OtherAssetsNoncurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of other non-current assets</link:label>
    <link:label id="lab_bmrn_OtherAssetsNoncurrentFairValueDisclosure_label_en-US" xlink:label="lab_bmrn_OtherAssetsNoncurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Noncurrent Fair Value Disclosure</link:label>
    <link:label id="lab_bmrn_OtherAssetsNoncurrentFairValueDisclosure_documentation_en-US" xlink:label="lab_bmrn_OtherAssetsNoncurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets noncurrent fair value disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherAssetsNoncurrentFairValueDisclosure" xlink:href="bmrn-20210930.xsd#bmrn_OtherAssetsNoncurrentFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_OtherAssetsNoncurrentFairValueDisclosure" xlink:to="lab_bmrn_OtherAssetsNoncurrentFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_92c886ff-e541-4d42-aa07-944bbf0a19bc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_a05874c5-87ef-46c4-aed3-00b8c9148d95_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember_e446b5da-7728-434a-827d-4b0916349c05_terseLabel_en-US" xlink:label="lab_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.599% Senior Subordinated Convertible Notes Due in August 2024</link:label>
    <link:label id="lab_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember_label_en-US" xlink:label="lab_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Point Five Nine Nine Percent Senior Subordinated Convertible Notes Due In August Two Thousand Twenty Four [Member]</link:label>
    <link:label id="lab_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember_documentation_en-US" xlink:label="lab_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero point five nine nine percent senior subordinated convertible notes due in August two thousand twenty four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember" xlink:href="bmrn-20210930.xsd#bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember" xlink:to="lab_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_47b358e7-5395-4903-bf4f-f095bc2fbd8c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90cb02ee-3a62-4833-be6a-10f33485c876_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6bdd0874-da3e-4a6e-ae48-e960e5e3f4dc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_KuvanAndPalynziqMember_d73a1ec7-1b35-42a3-a771-aea36bd5b7e1_terseLabel_en-US" xlink:label="lab_bmrn_KuvanAndPalynziqMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kuvan And Palynziq</link:label>
    <link:label id="lab_bmrn_KuvanAndPalynziqMember_label_en-US" xlink:label="lab_bmrn_KuvanAndPalynziqMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kuvan And Palynziq [Member]</link:label>
    <link:label id="lab_bmrn_KuvanAndPalynziqMember_documentation_en-US" xlink:label="lab_bmrn_KuvanAndPalynziqMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kuvan And Palynziq</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_KuvanAndPalynziqMember" xlink:href="bmrn-20210930.xsd#bmrn_KuvanAndPalynziqMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_KuvanAndPalynziqMember" xlink:to="lab_bmrn_KuvanAndPalynziqMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_79aaec2e-1f7b-4c46-bd13-0c2dede7d56c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_1c2d2be8-44ed-467c-bcfc-550ad17ce2eb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_3a31735e-b13f-4a39-b86e-54b5ff948966_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_8f28f2ff-2528-40f5-9236-09352155bada_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_6214e17e-18c5-4d88-96e6-6ba3d93079ef_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_36a98287-8d4a-4b9c-90c7-25d6984d558f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_b7c71c10-75cf-475e-ba5a-8548fef6c6c5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4a9564f3-45f4-4af6-a207-5bb0807a9a93_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_a06174ef-0e60-42ed-8c5f-ddd83a9f1df2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ConcentrationRiskAndGeographicInformationLineItems_1e50dc6a-e21c-4893-931d-38a866039127_terseLabel_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndGeographicInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk And Geographic Information [Line Items]</link:label>
    <link:label id="lab_bmrn_ConcentrationRiskAndGeographicInformationLineItems_label_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndGeographicInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk And Geographic Information [Line Items]</link:label>
    <link:label id="lab_bmrn_ConcentrationRiskAndGeographicInformationLineItems_documentation_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndGeographicInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk and geographic information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems" xlink:to="lab_bmrn_ConcentrationRiskAndGeographicInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1f36b0ce-bcec-49c5-a89f-5e9473c32a5d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME (LOSS) FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ContingentPaymentMember_e78a83f9-3b98-450f-aa20-0a50a738a6e2_terseLabel_en-US" xlink:label="lab_bmrn_ContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Payment</link:label>
    <link:label id="lab_bmrn_ContingentPaymentMember_label_en-US" xlink:label="lab_bmrn_ContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Payment [Member]</link:label>
    <link:label id="lab_bmrn_ContingentPaymentMember_documentation_en-US" xlink:label="lab_bmrn_ContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentPaymentMember" xlink:href="bmrn-20210930.xsd#bmrn_ContingentPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ContingentPaymentMember" xlink:to="lab_bmrn_ContingentPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c2cca99e-850a-415e-8269-2b555daaf41b_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_5f8bf492-312e-4282-9c51-02c5eec213f5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_91ec8db2-195c-4038-987e-5044fcb483ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares_4d1de6f2-a3dc-4d3d-b272-9d0be8f9bb43_terseLabel_en-US" xlink:label="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances under equity incentive plans (in shares)</link:label>
    <link:label id="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares_label_en-US" xlink:label="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Value New Issues Net Excess Tax Benefit Tax Deficiency Shares</link:label>
    <link:label id="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares_documentation_en-US" xlink:label="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period value new issues net excess tax benefit tax deficiency, shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" xlink:href="bmrn-20210930.xsd#bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" xlink:to="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e8533c69-5de3-40af-b620-0964c7564598_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2295aa4e-8e9b-40e1-9ae6-59e7b72d6ec0_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_a24454a0-2ffe-4506-b2f2-74dab62f89cc_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:to="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d64d1727-3a51-43e5-8ceb-5f97b76617a9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_076bc8c5-39f5-471e-aa97-38b063200ed3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_132cf006-c9b0-4927-8bff-698e57cf4a47_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_a1b9913c-a7d8-47df-80eb-0d3d05d15dd9_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense, net of amounts capitalized into inventory</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_881763c3-a6d8-42ff-a59d-7f380577bb10_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketed by Company</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_8dfa84c7-9a8c-42d6-9dd3-ea7c7aff8405_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_VoxzogoMember_0d44151c-59ad-4ade-a52a-ec8f857d7eed_terseLabel_en-US" xlink:label="lab_bmrn_VoxzogoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voxzogo</link:label>
    <link:label id="lab_bmrn_VoxzogoMember_label_en-US" xlink:label="lab_bmrn_VoxzogoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voxzogo [Member]</link:label>
    <link:label id="lab_bmrn_VoxzogoMember_documentation_en-US" xlink:label="lab_bmrn_VoxzogoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voxzogo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_VoxzogoMember" xlink:href="bmrn-20210930.xsd#bmrn_VoxzogoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_VoxzogoMember" xlink:to="lab_bmrn_VoxzogoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_72761794-56d4-4fd6-b61d-cb8e7b912059_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a376c82c-eaaa-4ffa-b3a9-d9c059668f5b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_5bc75c3e-0d36-4e9a-9a06-89242a7f0c87_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_0156cac3-f3e7-4caa-bea9-802a88ad7924_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_ea90e524-d29b-4b18-bff4-19a6b257ea05_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_f831dd7e-6eb9-49b1-88d9-0be8a13abe53_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets_b2ee402a-0aed-4760-9806-bff0540682d9_terseLabel_en-US" xlink:label="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in accounts payable and accrued liabilities related to fixed assets</link:label>
    <link:label id="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets_label_en-US" xlink:label="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Accounts Payable And Accrued Liabilities Increase (Decrease), Fixed Assets</link:label>
    <link:label id="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets_documentation_en-US" xlink:label="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in accounts payable and accrued liabilities related to purchase of property, plant and equipment during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" xlink:href="bmrn-20210930.xsd#bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" xlink:to="lab_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_135d5112-e897-4ed2-92ac-2565d7e7e33c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7dc938a9-4204-4d83-be75-d22f275374bf_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_74632a4c-cf24-415c-b724-dc1e8aef2c5f_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_66556b2b-3b20-4708-a7ab-803ada0f3b04_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_431c24f2-c558-4474-9037-c61feb93c16a_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_f47ffe70-004f-422c-8674-4b5946a97d70_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_cd351d83-8941-4217-8844-e4c4458aae12_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ScheduleOfInterestExpensesTable_c41dd7f4-12c0-4a1e-939e-f53dbc3a0a5c_terseLabel_en-US" xlink:label="lab_bmrn_ScheduleOfInterestExpensesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expenses [Table]</link:label>
    <link:label id="lab_bmrn_ScheduleOfInterestExpensesTable_label_en-US" xlink:label="lab_bmrn_ScheduleOfInterestExpensesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expenses [Table]</link:label>
    <link:label id="lab_bmrn_ScheduleOfInterestExpensesTable_documentation_en-US" xlink:label="lab_bmrn_ScheduleOfInterestExpensesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expenses table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfInterestExpensesTable" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfInterestExpensesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ScheduleOfInterestExpensesTable" xlink:to="lab_bmrn_ScheduleOfInterestExpensesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fc2ce2d-e080-476e-b60a-61a0053236f5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e8fc8fcb-27a2-4a05-a872-0af48bd2c796_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8636d767-234b-4e2f-9bbd-4358f3ec28d5_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a5aa95bb-7859-4e1f-84c6-6f0717e24767_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4b83a8c0-f816-4b5c-a261-de3307e94b3a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ae0f608d-1180-43ea-a597-6ee69078d7fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_9d18659f-a8bb-41f0-9ac8-82abde8ca06a_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated As Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember_b16ee3f3-f177-4ae1-b9e9-7aafebd06a35_terseLabel_en-US" xlink:label="lab_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NQDC Plan assets</link:label>
    <link:label id="lab_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember_label_en-US" xlink:label="lab_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Deferred Compensation Plan Assets [Member]</link:label>
    <link:label id="lab_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember_documentation_en-US" xlink:label="lab_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified deferred compensation plan assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember" xlink:href="bmrn-20210930.xsd#bmrn_NonqualifiedDeferredCompensationPlanAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember" xlink:to="lab_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_ad875e95-fce7-498a-8511-b6482a63596b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Interest on convertible notes</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_adb44046-8442-4074-af7b-661de936eef0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_64ad2965-ab58-45ae-b6a2-559cf7b6d9b8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a6e0e88f-09ce-406c-bfce-7abfbd127ec3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Accumulated Balances of AOCI Including Current Period Other Comprehensive Income (Loss) and Reclassifications Out of AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_c7585756-0ea0-4137-a5e5-72b435aecfb4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_cb6cbead-07e3-4aab-a18a-7d0c012df266_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable_5b4808ae-84bb-46ff-b3f0-10caa44dc372_negatedTerseLabel_en-US" xlink:label="lab_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in convertible note</link:label>
    <link:label id="lab_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable_label_en-US" xlink:label="lab_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Debt Securities, Available-For-Sale, Non-Marketable</link:label>
    <link:label id="lab_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable_documentation_en-US" xlink:label="lab_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Debt Securities, Available-For-Sale, Non-Marketable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" xlink:href="bmrn-20210930.xsd#bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" xlink:to="lab_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_f04f852a-4e16-4900-9120-a9c81b124b26_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_7fca8192-2198-4823-9e5d-2cc6cf516e1b_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_c28486f9-7cbd-4786-ae92-21bda3b55606_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense on convertible debt</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_bb064114-1383-47e2-84d5-4f0f180aaae5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_e8646332-2ea9-4e9e-86e1-fc6af64a8e4f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5e4d3a68-5856-410a-872a-46e229530a6f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_9f43f918-10f3-4815-a1fc-d74b49a84c80_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_f6c1489f-b4ad-4ac3-a632-e9f7245ec98c_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Company&#8217;s common stock held by the NQDC</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_985a6ecb-d985-4500-9c85-c6950122b5ed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_CustomerTwoMember_eb360aba-ecb5-4cb6-8cf7-9a27bdd26a31_verboseLabel_en-US" xlink:label="lab_bmrn_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two</link:label>
    <link:label id="lab_bmrn_CustomerTwoMember_dad78b38-db2e-4ae5-a686-03e22a48c72d_terseLabel_en-US" xlink:label="lab_bmrn_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer B</link:label>
    <link:label id="lab_bmrn_CustomerTwoMember_label_en-US" xlink:label="lab_bmrn_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two [Member]</link:label>
    <link:label id="lab_bmrn_CustomerTwoMember_documentation_en-US" xlink:label="lab_bmrn_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerTwoMember" xlink:href="bmrn-20210930.xsd#bmrn_CustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_CustomerTwoMember" xlink:to="lab_bmrn_CustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2747def9-76d3-40ea-be88-32ef9e885956_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Impact of Gains and Losses from Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0033ff51-c862-4302-b916-e032e1b1451b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2a277cf7-c20e-49f1-ba84-7d8e4be99303_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_bf99a442-9880-4416-a6b9-d02ffafd3f2f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3bd02e8e-f47d-4a18-bbce-88938c997e3e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_a527833f-f9cf-4bac-9427-2652d8c5cb85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivatives Designated as Hedging Instruments Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_7d03f9f2-e46f-41a1-b349-5b4f52853075_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_6176f6cb-3911-4d45-a791-93da27ea82b4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_36e54fc5-56e9-4a25-bb62-7491c9bcbbd2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_OtherAssetsCurrentFairValueDisclosure_795c5914-e23f-4e34-b713-25099eaf7109_verboseLabel_en-US" xlink:label="lab_bmrn_OtherAssetsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of other current assets</link:label>
    <link:label id="lab_bmrn_OtherAssetsCurrentFairValueDisclosure_label_en-US" xlink:label="lab_bmrn_OtherAssetsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Current Fair Value Disclosure</link:label>
    <link:label id="lab_bmrn_OtherAssetsCurrentFairValueDisclosure_documentation_en-US" xlink:label="lab_bmrn_OtherAssetsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets current fair value disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherAssetsCurrentFairValueDisclosure" xlink:href="bmrn-20210930.xsd#bmrn_OtherAssetsCurrentFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_OtherAssetsCurrentFairValueDisclosure" xlink:to="lab_bmrn_OtherAssetsCurrentFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebt_7ea9b99e-c57e-4480-859c-bc1486043e19_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total convertible debt, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_95bd8217-b6eb-4471-ac27-87204d4f95ea_terseLabel_en-US" xlink:label="lab_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock potentially issuable for ESPP purchases</link:label>
    <link:label id="lab_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Issuable To Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuable for employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember" xlink:href="bmrn-20210930.xsd#bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember" xlink:to="lab_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_32ea5d59-b824-4038-ac67-b9e0c3d9e336_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_99e2d3e6-f5f9-42ff-9a71-b41914dda3f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_374fc142-ec36-4dc8-966a-bc2f1c27845a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_af174b34-89c3-4a40-a1e4-eb5b9c885360_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProductFourMember_289155d9-7b96-4d92-b547-51e4b623ce54_terseLabel_en-US" xlink:label="lab_bmrn_ProductFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vimizim</link:label>
    <link:label id="lab_bmrn_ProductFourMember_label_en-US" xlink:label="lab_bmrn_ProductFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Four [Member]</link:label>
    <link:label id="lab_bmrn_ProductFourMember_documentation_en-US" xlink:label="lab_bmrn_ProductFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductFourMember" xlink:href="bmrn-20210930.xsd#bmrn_ProductFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProductFourMember" xlink:to="lab_bmrn_ProductFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_606ae066-474b-4e6b-96be-fe436ed802e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_aad892ac-4550-4219-9024-472b45810bf4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_68a9a9c3-0072-476d-beb0-d274ecc12dfe_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_38790fc2-d5f5-4ec7-b144-a6457b296ee1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_1cf48f24-e276-4e64-a36c-1ab6ca8cbe1e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones_bf5dbd4b-6103-4369-8c71-0e06aecbe1d2_terseLabel_en-US" xlink:label="lab_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones</link:label>
    <link:label id="lab_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones_label_en-US" xlink:label="lab_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Payments Upon Achievement Of Certain Regulatory Commercial Sales And Licensing Milestones</link:label>
    <link:label id="lab_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones_documentation_en-US" xlink:label="lab_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments upon achievement of certain regulatory, commercial sales and licensing milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones" xlink:href="bmrn-20210930.xsd#bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones" xlink:to="lab_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_9a707cf1-1d01-4a1b-9e0f-186b511dabd3_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_47a823e9-cf9a-4c1b-87ec-6ab2e8581f8a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_e6698cb5-cd97-4b7e-85ca-e5a6086640ec_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a818e518-e3f1-4f43-bbdb-351ec9d6a447_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_8c4725d3-ad25-4e29-934f-c3fb1c24732d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_9ed9734d-bcd2-4539-9ff0-0027a0e12177_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones_b3e3931f-8279-478f-8988-9af12bbce995_terseLabel_en-US" xlink:label="lab_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones</link:label>
    <link:label id="lab_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones_label_en-US" xlink:label="lab_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Payments Upon Achievement Of Certain Development And Regulatory Activities Commercial Sales And Licensing Milestones</link:label>
    <link:label id="lab_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones_documentation_en-US" xlink:label="lab_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" xlink:href="bmrn-20210930.xsd#bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" xlink:to="lab_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d7466953-ba52-47cd-a925-3dde40322c55_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_c528fd38-0b51-41a6-9e94-8823c3655941_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ca04167c-88f0-418b-86f0-74b4193f5fde_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_07d03cb4-4216-4c22-97fa-b98ff6bc5d6b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_56d2a23c-d649-4c03-9399-8d27606ec310_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_b5f8cd24-a930-45d3-a52b-98c8ffa48bb7_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e4f02c2c-f8d8-4658-b755-6628f52494ab_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_2e850ffb-4138-425b-b278-a73608e984cf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_42d8e81a-c4be-414a-a96e-20d360d7753c_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_4fcf7106-8ae8-4c4e-831e-9c15da6c645b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1c916512-3cdb-40f9-a894-5ed06fb43c1a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic investments fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProgramsNoLongerBeingDevelopedMember_426d8da2-f946-4b1e-958f-54283c004f98_terseLabel_en-US" xlink:label="lab_bmrn_ProgramsNoLongerBeingDevelopedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Programs No Longer Being Developed</link:label>
    <link:label id="lab_bmrn_ProgramsNoLongerBeingDevelopedMember_label_en-US" xlink:label="lab_bmrn_ProgramsNoLongerBeingDevelopedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Programs No Longer Being Developed [Member]</link:label>
    <link:label id="lab_bmrn_ProgramsNoLongerBeingDevelopedMember_documentation_en-US" xlink:label="lab_bmrn_ProgramsNoLongerBeingDevelopedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Programs No Longer Being Developed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProgramsNoLongerBeingDevelopedMember" xlink:href="bmrn-20210930.xsd#bmrn_ProgramsNoLongerBeingDevelopedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProgramsNoLongerBeingDevelopedMember" xlink:to="lab_bmrn_ProgramsNoLongerBeingDevelopedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_78fc1bf5-91f6-4dd6-ad02-393287dcd779_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_776ceca4-b3a5-4750-bcdb-a6661822f12b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Product Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_395460a7-dd4c-4841-a633-7da5bca37333_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_3cb35d2d-c858-4fbb-8405-64c8c0f8fe5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_4d667aaf-cea7-4e33-a47d-d7a4bb6705db_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of discount on convertible notes</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_ccc2679b-ec9a-457f-bd64-32fe9067888a_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term convertible debt, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_46e50390-f970-4865-8ea6-0a00ad23de06_totalLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, net of unamortized discount and deferred offering costs</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_e4a54742-3737-4a1d-b482-66bc384785f6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2597ab3a-05cf-4047-b96e-6f9fced07580_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_4a891f17-b7a1-41d1-93cc-3dc14f6d7533_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Marketable Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProductTwoMember_7572aa81-b183-494f-b25c-9028e76bb231_terseLabel_en-US" xlink:label="lab_bmrn_ProductTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Naglazyme</link:label>
    <link:label id="lab_bmrn_ProductTwoMember_label_en-US" xlink:label="lab_bmrn_ProductTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Two [Member]</link:label>
    <link:label id="lab_bmrn_ProductTwoMember_documentation_en-US" xlink:label="lab_bmrn_ProductTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductTwoMember" xlink:href="bmrn-20210930.xsd#bmrn_ProductTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProductTwoMember" xlink:to="lab_bmrn_ProductTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f275bae5-cc2e-4483-bc46-0bf3bef4a4d7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_2048f1e0-d334-4ec3-b1c9-882d502ca276_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities and sales of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_7904b87c-c3fb-4b88-87c2-ab4c1a4e48c9_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of fixed rate convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_535f379e-57a7-4529-80bf-05fc93ebb005_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_41f1dcee-7b6a-4d5c-9d34-67f313132896_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_de53236c-e1e6-432c-ab0d-a1f6b6dc29e8_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME (LOSS) BEFORE INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f34f945e-4a88-4cf0-83da-d37f8b2932de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2:</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_75066a25-4e63-49a3-a823-bac8ddfe1a1f_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant&#160;Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_f109a6c9-84c8-4fbd-b18e-d2f807d225e0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_13507dce-b8b1-4875-b43a-e9c95874fec2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) Recognized in Earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_19f49a42-353a-41fc-9b09-2b7fda6e130d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_43e6c99a-a5a3-4784-b264-3e5e488e0925_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_2244dfa7-1d6c-4046-839d-f6143704c3eb_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2e61a504-f2df-4b5e-a2c9-3b4d104b2444_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_3742207f-7cbd-42f5-8111-0c95205e2308_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProductSevenMember_d06fd131-7bc2-4ffa-af9b-bfd2c75d9e17_terseLabel_en-US" xlink:label="lab_bmrn_ProductSevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Palynziq</link:label>
    <link:label id="lab_bmrn_ProductSevenMember_label_en-US" xlink:label="lab_bmrn_ProductSevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Seven [Member]</link:label>
    <link:label id="lab_bmrn_ProductSevenMember_documentation_en-US" xlink:label="lab_bmrn_ProductSevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product 7 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductSevenMember" xlink:href="bmrn-20210930.xsd#bmrn_ProductSevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProductSevenMember" xlink:to="lab_bmrn_ProductSevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_56dae0e5-2c78-47f4-a3fb-e4f8215db584_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_5682860c-71b7-4980-aaa3-7ad0648039f7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fc116a17-c819-463a-99eb-8014c8ded6fc_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_29cfdc96-cf30-46da-ad41-6609d5f97596_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a49e882e-6106-476d-a924-e5472f208f46_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified from AOCI to earnings as related to forecasted revenue and operating expense transactions</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8b23f9b5-c488-4225-b742-bce3fddd5ab9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_3599c09f-0265-4bce-8c53-de5d22e3757e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_85d6822a-c121-438c-9760-3a14ec0eb16c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_f351f21c-63fe-4f33-b1bc-bcf8bd5d44f6_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (loss), diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_1a9975a8-071f-48f7-8b6c-949477093cce_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_28e979df-b074-488d-a5e2-210a9db255d3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (loss), basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_f89ce354-4787-4be0-9385-5f61b643294a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e2514562-ee08-4f06-886d-8ca96b7b9564_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProductThreeMember_fdcfdd1e-f038-4b96-8bf1-95ddfdbb388c_terseLabel_en-US" xlink:label="lab_bmrn_ProductThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kuvan</link:label>
    <link:label id="lab_bmrn_ProductThreeMember_label_en-US" xlink:label="lab_bmrn_ProductThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Three [Member]</link:label>
    <link:label id="lab_bmrn_ProductThreeMember_documentation_en-US" xlink:label="lab_bmrn_ProductThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductThreeMember" xlink:href="bmrn-20210930.xsd#bmrn_ProductThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProductThreeMember" xlink:to="lab_bmrn_ProductThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b23e0e8f-0048-41d5-8055-a823774d7c35_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL BALANCE SHEET INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_9ce04b05-2a36-410b-ba96-c812cb506334_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes stated rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_247f6de5-4ba3-4e3d-a63b-316d87bcba72_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ConcentrationRiskAndGeographicInformationAbstract_ebd68579-b7a3-4b7f-b3c0-9cedec91a60d_terseLabel_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndGeographicInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk And Geographic Information [Abstract]</link:label>
    <link:label id="lab_bmrn_ConcentrationRiskAndGeographicInformationAbstract_label_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndGeographicInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk And Geographic Information [Abstract]</link:label>
    <link:label id="lab_bmrn_ConcentrationRiskAndGeographicInformationAbstract_documentation_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndGeographicInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk and geographic information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract" xlink:to="lab_bmrn_ConcentrationRiskAndGeographicInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_1ac36f5f-9047-413c-aa2a-2d45f733c6d1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency_38894a6a-3582-4671-bf8c-ad267643b828_verboseLabel_en-US" xlink:label="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances under equity incentive plans, net of tax</link:label>
    <link:label id="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency_label_en-US" xlink:label="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Value New Issues Net Excess Tax Benefit Tax Deficiency</link:label>
    <link:label id="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency_documentation_en-US" xlink:label="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period value new issues net excess tax benefit tax deficiency.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" xlink:href="bmrn-20210930.xsd#bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" xlink:to="lab_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_CommitmentsAndContingenciesTable_6c6bc587-8613-4602-b031-5f5002e64a5c_terseLabel_en-US" xlink:label="lab_bmrn_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_bmrn_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_bmrn_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_bmrn_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_bmrn_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommitmentsAndContingenciesTable" xlink:href="bmrn-20210930.xsd#bmrn_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_CommitmentsAndContingenciesTable" xlink:to="lab_bmrn_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9de33b0a-4659-4ed5-adf2-ffb0a050c106_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_eedb3eec-60e5-4d26-b7ab-5270338c5e6f_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_5ab96178-640c-46f6-a324-ac1c34e9d9dd_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_c0a2f183-a47d-450c-a6dd-622046158782_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts&#160;payable&#160;and accrued&#160;liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_76b5c331-ea47-41d3-a16e-169430ed6fa3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_8ccb5ec3-7ac2-4568-bdb3-f3fda134b2f2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_IntangibleAssetAmortizationAndContingentConsideration_eeb7e4e5-dd34-46a5-93ec-2b70a71e15ab_terseLabel_en-US" xlink:label="lab_bmrn_IntangibleAssetAmortizationAndContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization and contingent consideration</link:label>
    <link:label id="lab_bmrn_IntangibleAssetAmortizationAndContingentConsideration_label_en-US" xlink:label="lab_bmrn_IntangibleAssetAmortizationAndContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Amortization And Contingent Consideration</link:label>
    <link:label id="lab_bmrn_IntangibleAssetAmortizationAndContingentConsideration_documentation_en-US" xlink:label="lab_bmrn_IntangibleAssetAmortizationAndContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets and expense charged against earnings resulting from the change in the fair value of contingent consideration during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_IntangibleAssetAmortizationAndContingentConsideration" xlink:href="bmrn-20210930.xsd#bmrn_IntangibleAssetAmortizationAndContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_IntangibleAssetAmortizationAndContingentConsideration" xlink:to="lab_bmrn_IntangibleAssetAmortizationAndContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7e0b9bd8-ee39-404b-8e79-0716e52c91ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ConcentrationRiskAndGeographicInformationTable_6e990563-b22d-4db6-b3c2-6657c29a1c46_terseLabel_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndGeographicInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk And Geographic Information [Table]</link:label>
    <link:label id="lab_bmrn_ConcentrationRiskAndGeographicInformationTable_label_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndGeographicInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk And Geographic Information [Table]</link:label>
    <link:label id="lab_bmrn_ConcentrationRiskAndGeographicInformationTable_documentation_en-US" xlink:label="lab_bmrn_ConcentrationRiskAndGeographicInformationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk and geographic information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationTable" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationTable" xlink:to="lab_bmrn_ConcentrationRiskAndGeographicInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_b5e6b8a4-3a1d-446d-a4c8-ef73670be3d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_AccruedGovernmentAndOtherRebates_6f0685d5-dd7d-4697-ae2f-e453c3b1bea3_terseLabel_en-US" xlink:label="lab_bmrn_AccruedGovernmentAndOtherRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates payable</link:label>
    <link:label id="lab_bmrn_AccruedGovernmentAndOtherRebates_label_en-US" xlink:label="lab_bmrn_AccruedGovernmentAndOtherRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Government And Other Rebates</link:label>
    <link:label id="lab_bmrn_AccruedGovernmentAndOtherRebates_documentation_en-US" xlink:label="lab_bmrn_AccruedGovernmentAndOtherRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Government And Other Rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_AccruedGovernmentAndOtherRebates" xlink:href="bmrn-20210930.xsd#bmrn_AccruedGovernmentAndOtherRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_AccruedGovernmentAndOtherRebates" xlink:to="lab_bmrn_AccruedGovernmentAndOtherRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_32f288ce-e6db-4b70-9e7d-d608f9b33ef2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_775889e0-a7c3-4a7e-a44b-10e7fce2d764_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_AccumulatedGainLossFromOtherMember_a7e5da50-427a-4bdf-8fb3-b8588e16775b_terseLabel_en-US" xlink:label="lab_bmrn_AccumulatedGainLossFromOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bmrn_AccumulatedGainLossFromOtherMember_label_en-US" xlink:label="lab_bmrn_AccumulatedGainLossFromOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain Loss From Other [Member]</link:label>
    <link:label id="lab_bmrn_AccumulatedGainLossFromOtherMember_documentation_en-US" xlink:label="lab_bmrn_AccumulatedGainLossFromOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated gain (loss) from other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_AccumulatedGainLossFromOtherMember" xlink:href="bmrn-20210930.xsd#bmrn_AccumulatedGainLossFromOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_AccumulatedGainLossFromOtherMember" xlink:to="lab_bmrn_AccumulatedGainLossFromOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_846c8447-33ee-43ca-9978-5857e4f24619_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_58e404f1-d12d-4f70-9c33-f20b6ddc13a3_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) PER SHARE, DILUTED (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a6ae5fd5-5f3c-4925-9cbf-cee685e460b3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_13d8fa13-c301-4428-96fb-131a7ca1abeb_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_a3b0df52-7f15-4132-b799-b7502e3d70ce_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product revenues</link:label>
    <link:label id="lab_us-gaap_ProductMember_adea2a16-258c-49d8-846e-8c836aeab11b_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net product revenues</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_0b3fbe61-ff44-4353-ab5a-73229d0cbb13_verboseLabel_en-US" xlink:label="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuable under the 2024 notes</link:label>
    <link:label id="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_label_en-US" xlink:label="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due Two Thousand Twenty Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember" xlink:to="lab_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c0302d30-d35c-498e-b68b-8b0144e61545_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_534d63c0-9625-4bb3-bf94-f34894a32036_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_a3deec7b-c4e5-4fc0-94eb-f81c5f70eaf7_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying value</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_336c4779-06bd-4b9e-b217-a3c6563f7973_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ad57b20d-b748-4959-a54e-286457d81cd7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_44d952f1-c8d9-4be9-911b-77809d38e83b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#160;long-term&#160;liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_ac52520d-bf10-4382-a20d-dac3be15143b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in the income (loss) of BioMarin/Genzyme LLC</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a5a11a6f-ffc0-4dbc-8541-314a04ade002_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_CustomerOneTwoAndThreeMember_2831f457-e9d7-46e3-a66c-1e6710d68fbb_terseLabel_en-US" xlink:label="lab_bmrn_CustomerOneTwoAndThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A, B, &amp; C</link:label>
    <link:label id="lab_bmrn_CustomerOneTwoAndThreeMember_label_en-US" xlink:label="lab_bmrn_CustomerOneTwoAndThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One, Two, And Three [Member]</link:label>
    <link:label id="lab_bmrn_CustomerOneTwoAndThreeMember_documentation_en-US" xlink:label="lab_bmrn_CustomerOneTwoAndThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One, Two, And Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerOneTwoAndThreeMember" xlink:href="bmrn-20210930.xsd#bmrn_CustomerOneTwoAndThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_CustomerOneTwoAndThreeMember" xlink:to="lab_bmrn_CustomerOneTwoAndThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember_376a960c-6bd2-427a-b8a2-044567e80145_terseLabel_en-US" xlink:label="lab_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Credit Facility</link:label>
    <link:label id="lab_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember_label_en-US" xlink:label="lab_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Two Thousand Eighteen Credit Facility [Member]</link:label>
    <link:label id="lab_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember_documentation_en-US" xlink:label="lab_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving two thousand eighteen credit facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember" xlink:href="bmrn-20210930.xsd#bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember" xlink:to="lab_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_2775d927-b427-478f-9483-58eaca2e30c4_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of nonfinancial assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_cbc19d81-3009-43b1-b638-fff2dd5d1746_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_a1e07969-1093-457d-988c-eb4edf4ebda8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_a7eabd5e-36fe-4fb2-9c1c-ba80b38b537b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_4edb24d5-3609-43a0-9307-6e0891f4dbc6_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_cef86aca-78c4-4b72-83b9-fa4bde0c03c1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible senior subordinated note offering, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_56b85a6a-a4e8-4841-bce1-20ed5af3a32d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bcac92a1-38ab-4c74-ad98-2b083b660e4f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2cdd9dd3-30b3-4dea-89bc-ed6cf178dbe9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_54544328-b026-49bf-ae2c-9ac41ae9c8b2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued royalties payable</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c2e889b8-cac7-47f0-b62b-4d8d2071d1b0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember_1d43da8d-2eca-4725-8472-20a67ef8f071_terseLabel_en-US" xlink:label="lab_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NQDC Plan liability</link:label>
    <link:label id="lab_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember_label_en-US" xlink:label="lab_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Deferred Compensation Plan Liability [Member]</link:label>
    <link:label id="lab_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember_documentation_en-US" xlink:label="lab_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified deferred compensation plan liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember" xlink:href="bmrn-20210930.xsd#bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember" xlink:to="lab_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_1c334d26-43bc-4ade-84f8-728196357dc7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_63790fdf-12ad-4a58-ba93-17d7e1a75891_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_185d5c0d-70cc-43aa-8ec4-def5b6a7b15a_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_e567d0dd-68f0-4b57-ac8f-2cc3ad04fb47_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_f5a97914-2fec-49b7-bd2e-32fd42593793_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_052f9486-5611-4047-9b7e-ad18bcf9a320_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b89ca58a-9311-4574-959e-4f44fbce778c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProductSixMember_d2f132f5-e9a2-4c3b-8959-2c170484afa5_terseLabel_en-US" xlink:label="lab_bmrn_ProductSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brineura</link:label>
    <link:label id="lab_bmrn_ProductSixMember_label_en-US" xlink:label="lab_bmrn_ProductSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Six [Member]</link:label>
    <link:label id="lab_bmrn_ProductSixMember_documentation_en-US" xlink:label="lab_bmrn_ProductSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product six.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductSixMember" xlink:href="bmrn-20210930.xsd#bmrn_ProductSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProductSixMember" xlink:to="lab_bmrn_ProductSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_c03a1a95-899b-4075-aed1-3786ec840cbd_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before &#160;&#160;&#160;&#160; reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_1de22a89-67ec-4ea4-8f75-c251aa473f63_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_8a30e59b-679e-4752-a84b-6f27a0a9ecda_totalLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term contingent consideration</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtCurrent" xlink:to="lab_us-gaap_ConvertibleDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_7dfd0b40-7d13-473b-bf0d-9b0f560c9db6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property Plant and Equipment Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_583c5258-9bda-4ebc-9258-8f2a91e3dc82_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_d8960fe9-1de1-415f-895a-d22142f521af_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_22852564-6c47-4574-ad21-90ca8d8de208_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW DISCLOSURES FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5f880256-1a16-4421-b1aa-f21194320cf6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e4597e9e-9a26-4ca5-8c5e-89e14373883d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4e13389b-e32a-4814-bc31-f630c1099746_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_10db4f9f-0226-411a-9471-f4596934ce11_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_58afed20-677f-4164-b6b9-59b9298791cc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_87040233-8b40-4b36-90e1-f89228967daa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_58da2590-0a7b-4901-9213-57e554dc660e_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_a0dfe2d6-5214-4e93-a29b-d1336401312d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_75b50e5e-369c-4a57-8a7e-d8c14aecc1dc_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_c04e14d5-9ac7-4a40-b8cf-b84861fead5a_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_29bf561f-e44e-4c0d-b606-58ddbf37c383_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_ed030ab7-967f-4266-9234-0a89346ed8d5_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_98fa0f1f-ebef-486f-8965-0bc9ec6e6a49_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_EarningsPerShareLineItems_c08f6800-c6f2-4003-bc81-a50ee10d55c0_terseLabel_en-US" xlink:label="lab_bmrn_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_bmrn_EarningsPerShareLineItems_label_en-US" xlink:label="lab_bmrn_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_bmrn_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_bmrn_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share line Items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_EarningsPerShareLineItems" xlink:href="bmrn-20210930.xsd#bmrn_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_EarningsPerShareLineItems" xlink:to="lab_bmrn_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_40ee7e99-5ac4-47dc-a689-c261634a8660_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement_4e155467-d8c6-452c-96d1-3551663a6370_verboseLabel_en-US" xlink:label="lab_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange remeasurement of Euro denominated contingent consideration</link:label>
    <link:label id="lab_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement_label_en-US" xlink:label="lab_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Foreign Exchange Remeasurement</link:label>
    <link:label id="lab_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement_documentation_en-US" xlink:label="lab_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurement with unobservable inputs reconciliations recurring basis foreign exchange remeasurement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement" xlink:href="bmrn-20210930.xsd#bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement" xlink:to="lab_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_4da773f7-7b3e-446e-aac1-ac4301e0af7a_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investments</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_CommitmentsAndContingenciesLineItems_5a3de811-3940-493c-96a4-0ab958b07528_terseLabel_en-US" xlink:label="lab_bmrn_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_bmrn_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_bmrn_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_bmrn_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_bmrn_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommitmentsAndContingenciesLineItems" xlink:href="bmrn-20210930.xsd#bmrn_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems" xlink:to="lab_bmrn_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_03cea04d-0e1e-4844-b6b8-40464ea1e60a_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a6925cce-08d0-4b15-9e11-90fdbfbb6e4e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_57d58ce6-2a6e-4130-877d-22ebcbf0c0d9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_4439580a-4f62-458e-a6f7-203841d444bb_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_ea30f202-a4be-4619-85ba-8cfee7f36243_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_0c34e48f-8b23-4441-807a-ae0b55340b74_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Product Revenue Concentrations Attributed to Largest Customers</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_837bc73f-b41a-4293-a7e1-44d114779f54_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6c650880-146f-405b-9c15-6f130ec8f1b2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5f2ca078-179e-459d-aae4-0fa103ba2672_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e147caba-d56e-40d8-a669-c9a122f2579f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_622be94b-038e-4546-9929-2985519d4a23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6c923f99-b560-40d8-aafc-a3f37a98a102_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ce960eb6-7943-40a3-aed6-98c00f52dec6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7838b4e1-f718-4571-bc2f-b076752bc356_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: gain (loss) reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure_2402b379-7fa8-4b3e-a743-a8ed0363233a_verboseLabel_en-US" xlink:label="lab_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of other non-current liabilities</link:label>
    <link:label id="lab_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure_label_en-US" xlink:label="lab_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Noncurrent Fair Value Disclosure</link:label>
    <link:label id="lab_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure_documentation_en-US" xlink:label="lab_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities noncurrent fair value disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure" xlink:href="bmrn-20210930.xsd#bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure" xlink:to="lab_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_90244a82-6fe8-48c4-b3ff-b6b49047f336_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_195e8b44-af86-4911-90f2-d0481bab7cef_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89df6d90-8e11-4772-b720-29bda6281e4e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0ebed873-7dd4-4ecf-8f68-c29059b65325_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets remeasured</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a30b630b-5a75-4fb0-a6ce-ae3b38a5b694_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_7c27c80d-6083-4d5f-8e73-03e127736b44_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_4a3a2581-90f4-4eb7-8fe0-f57654cae917_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_12aa6999-0a7d-444c-b401-708ff0c83251_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan_e0793a79-7c52-46e6-92e1-40cd3acfd3a4_negatedTerseLabel_en-US" xlink:label="lab_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock held by the NQDC</link:label>
    <link:label id="lab_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan_label_en-US" xlink:label="lab_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Shares Held By Nonqualified Deferred Compensation Plan</link:label>
    <link:label id="lab_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan_documentation_en-US" xlink:label="lab_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Shares Held By Nonqualified Deferred Compensation Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" xlink:href="bmrn-20210930.xsd#bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" xlink:to="lab_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5179e352-63f4-4b39-a3d4-99929cb3f3a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_47769d09-a700-4d89-b4c3-1ed3ec3672b0_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_69f56b83-d4eb-4a71-a19e-40543345c4e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_5d2bc706-0b68-4087-b047-770261c65e8f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_0e3f84b4-79b5-4c54-8a2f-0f757a4b149b_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_48e20732-29af-4eb2-92d9-ce3a65023316_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxes" xlink:to="lab_us-gaap_AccruedIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d61e663-b6cc-4df7-838d-45e2ca5858c6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member_b9169a87-6924-411b-9d1b-106d3789229e_terseLabel_en-US" xlink:label="lab_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.25% Senior Subordinated Convertible Notes Due in May 2027</link:label>
    <link:label id="lab_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member_label_en-US" xlink:label="lab_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.25% Senior Subordinated Convertible Notes Due in May 2027 [Member]</link:label>
    <link:label id="lab_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member_documentation_en-US" xlink:label="lab_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.25% Senior Subordinated Convertible Notes Due in May 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member" xlink:href="bmrn-20210930.xsd#bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member" xlink:to="lab_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_88acb8a5-a9c8-4be0-b82b-0b1254bb9f36_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_176f75ab-5eed-4699-b226-e2f5f2288acf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ae437b00-7de4-40a1-9a46-0ac6628d1fa2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_9c3ef115-9836-4419-843d-36086ca7c19d_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase commitments and other minimum contractual obligations</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:to="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_79e506f9-d37a-443b-8abe-30c3cc94a56e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6d464e9a-c482-41da-8f66-1952f727eeee_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0f6ca23d-9af6-425d-90b1-24ec22337007_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_5b5faf41-075a-402a-8756-cd7d5df9ec25_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market instruments</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_21b9b0b3-5466-4c8d-a119-8bb81c692ccc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LatinAmericaMember_61ea1cfb-d024-48ee-b40c-2a100aa88b97_terseLabel_en-US" xlink:label="lab_srt_LatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America</link:label>
    <link:label id="lab_srt_LatinAmericaMember_label_en-US" xlink:label="lab_srt_LatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LatinAmericaMember" xlink:to="lab_srt_LatinAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_620286af-e1c6-4969-a44c-de83aab606e3_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_2bdcf3c7-f264-456a-ace3-318afbf7b500_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount net of deferred offering costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_48585be4-3f6b-41e8-911a-ac8bb9033d86_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_9f1dfc5a-af4b-451a-aa56-f2a51e58966f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_0d06f646-73c9-4c82-8e41-3ffa69ad67dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_343e42f3-3f68-498c-b71c-8c78ce7f281e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_93c7d0ce-7440-49a2-931b-01b3dcc6475c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_c1f98d9e-f803-4726-8b72-cda4850d7f6d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProductEightMember_19ba8c10-7d6c-48e8-90ab-13b84199c25e_terseLabel_en-US" xlink:label="lab_bmrn_ProductEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voxzogo</link:label>
    <link:label id="lab_bmrn_ProductEightMember_label_en-US" xlink:label="lab_bmrn_ProductEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Eight [Member]</link:label>
    <link:label id="lab_bmrn_ProductEightMember_documentation_en-US" xlink:label="lab_bmrn_ProductEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Eight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductEightMember" xlink:href="bmrn-20210930.xsd#bmrn_ProductEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProductEightMember" xlink:to="lab_bmrn_ProductEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_b8687d88-3ea5-43a7-afca-558f561391ce_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e97682a3-8db7-4622-9f34-0401776d4fc8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_33a55cd1-30d8-4cc3-9f71-9317bcad7262_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ShortTermMarketableSecuritiesMaturityPeriod_7915af51-f424-4be8-83df-813283fb25e1_terseLabel_en-US" xlink:label="lab_bmrn_ShortTermMarketableSecuritiesMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term marketable securities maturity period</link:label>
    <link:label id="lab_bmrn_ShortTermMarketableSecuritiesMaturityPeriod_label_en-US" xlink:label="lab_bmrn_ShortTermMarketableSecuritiesMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Marketable Securities Maturity Period</link:label>
    <link:label id="lab_bmrn_ShortTermMarketableSecuritiesMaturityPeriod_documentation_en-US" xlink:label="lab_bmrn_ShortTermMarketableSecuritiesMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities maturity period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ShortTermMarketableSecuritiesMaturityPeriod" xlink:href="bmrn-20210930.xsd#bmrn_ShortTermMarketableSecuritiesMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ShortTermMarketableSecuritiesMaturityPeriod" xlink:to="lab_bmrn_ShortTermMarketableSecuritiesMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ProductOneMember_eeee5039-a6b7-4e8f-a648-4b0b41613b10_terseLabel_en-US" xlink:label="lab_bmrn_ProductOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aldurazyme</link:label>
    <link:label id="lab_bmrn_ProductOneMember_label_en-US" xlink:label="lab_bmrn_ProductOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product One [Member]</link:label>
    <link:label id="lab_bmrn_ProductOneMember_documentation_en-US" xlink:label="lab_bmrn_ProductOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductOneMember" xlink:href="bmrn-20210930.xsd#bmrn_ProductOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ProductOneMember" xlink:to="lab_bmrn_ProductOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ebfa5b18-a75a-4cdb-ba4d-e873e73aa546_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_dc82a965-8b08-48f2-822a-a55cdfe5246c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_43c0a85e-4ac9-49b3-951a-fb87b840422f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity of derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_label_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Remaining Maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeRemainingMaturity1" xlink:to="lab_us-gaap_DerivativeRemainingMaturity1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_164cdd6a-18cc-4f54-bd65-d796c59e59b4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_07f9598d-fc27-43d9-a039-d2ee5da15ee1_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_201f577b-9f72-4157-836e-72ccb6a960dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging Gains (Losses) Reclassified into Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_907a153c-4c84-4557-9fce-6d17dda29e65_terseLabel_en-US" xlink:label="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Cash Cash Equivalents And Available For Sale Securities [Table]</link:label>
    <link:label id="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Cash Cash Equivalents And Available For Sale Securities [Table]</link:label>
    <link:label id="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_documentation_en-US" xlink:label="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of cash, cash equivalents and available-for-sale securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable" xlink:to="lab_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_0f703d2b-73d0-4ca9-b10b-6ed43189d47a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_d6563171-4d89-4c4a-abf1-4b0e84040ea6_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF OPERATIONS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f356ddf0-0c88-40d6-8c38-8252ec9f21dd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_6b73c631-cbbe-42e7-b3fe-102be149a8c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Carrying Amount of Derivatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_ed6d7d18-c645-4d59-ac53-25dbb36b3242_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued operating expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_61b98f8e-00dc-4edc-aba7-8b407aa9db47_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_6d5469ef-b7d2-4e0b-8a6d-9800a25d448f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmrn_CustomerThreeMember_1c9cbe94-5212-40c5-8de9-624565f48d6c_terseLabel_en-US" xlink:label="lab_bmrn_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer C</link:label>
    <link:label id="lab_bmrn_CustomerThreeMember_label_en-US" xlink:label="lab_bmrn_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three [Member]</link:label>
    <link:label id="lab_bmrn_CustomerThreeMember_documentation_en-US" xlink:label="lab_bmrn_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerThreeMember" xlink:href="bmrn-20210930.xsd#bmrn_CustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmrn_CustomerThreeMember" xlink:to="lab_bmrn_CustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_c2406a0b-191e-464a-9c7b-55a6cd13062b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_2f8935ce-05bb-44c0-a94f-49003abb1f0f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>bmrn-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f95636f6-9f25-4ee3-86c2-7b0315cdf3d9,g:ce424ef1-ab97-4f04-a4e9-8c3801ecff3b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bmrn.com/role/CoverPage" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_71d93d78-d5f8-4e7b-8a26-042a75d1e603" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_DocumentType_71d93d78-d5f8-4e7b-8a26-042a75d1e603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_32912f3a-2e0a-424e-ae9e-927944328aec" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_DocumentQuarterlyReport_32912f3a-2e0a-424e-ae9e-927944328aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2e088b0d-1d93-4598-939b-3c985e8f3642" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_DocumentPeriodEndDate_2e088b0d-1d93-4598-939b-3c985e8f3642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_fac51a9c-8b6d-47ad-bd03-90b1c71ffeb9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_DocumentTransitionReport_fac51a9c-8b6d-47ad-bd03-90b1c71ffeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_12526c69-2360-43af-931e-c45291491a19" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityFileNumber_12526c69-2360-43af-931e-c45291491a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d818d71b-c5ad-4d93-b2fc-c5cd16bee56c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityRegistrantName_d818d71b-c5ad-4d93-b2fc-c5cd16bee56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f2b3b986-4b7b-4ed7-a2e6-e5d8a26366c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f2b3b986-4b7b-4ed7-a2e6-e5d8a26366c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d078aa5c-f3eb-4b6e-877b-282efe8c4933" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityTaxIdentificationNumber_d078aa5c-f3eb-4b6e-877b-282efe8c4933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c529bdd7-1f5c-40e9-9b5e-cc78f881213c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityAddressAddressLine1_c529bdd7-1f5c-40e9-9b5e-cc78f881213c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fe0f450f-b6d2-4de0-ab22-168d69b437e5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityAddressCityOrTown_fe0f450f-b6d2-4de0-ab22-168d69b437e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_12dfd9a8-81d9-4384-8ef0-4c76eceb617f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityAddressStateOrProvince_12dfd9a8-81d9-4384-8ef0-4c76eceb617f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_18968866-5e47-4d62-9e57-19e39640f0e4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityAddressPostalZipCode_18968866-5e47-4d62-9e57-19e39640f0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_87985bab-83fe-4853-a96c-70dbbb731ea7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_CityAreaCode_87985bab-83fe-4853-a96c-70dbbb731ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a6286c77-6e67-4c2a-a3e5-e7d6ee252416" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_LocalPhoneNumber_a6286c77-6e67-4c2a-a3e5-e7d6ee252416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_074892bd-c28f-4fd0-ba85-bdbbf2a293e4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_Security12bTitle_074892bd-c28f-4fd0-ba85-bdbbf2a293e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b8b7095d-7d59-443a-84df-b71e92373967" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_TradingSymbol_b8b7095d-7d59-443a-84df-b71e92373967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5d6e91e6-f0b7-4aef-a42a-79f7840b3a10" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_SecurityExchangeName_5d6e91e6-f0b7-4aef-a42a-79f7840b3a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_9d684f3e-2e37-4a17-8cad-e2cd0fc3f995" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityCurrentReportingStatus_9d684f3e-2e37-4a17-8cad-e2cd0fc3f995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5d89db9d-e461-4370-9a10-a2420e254505" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityInteractiveDataCurrent_5d89db9d-e461-4370-9a10-a2420e254505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_102c52ff-ccb0-40bd-9713-764e7e698f1e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityFilerCategory_102c52ff-ccb0-40bd-9713-764e7e698f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_df6d795b-ecd6-40d0-b2a6-dfb63fc19429" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntitySmallBusiness_df6d795b-ecd6-40d0-b2a6-dfb63fc19429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_fd14525a-8997-4118-96df-22a62ba4c8fc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityEmergingGrowthCompany_fd14525a-8997-4118-96df-22a62ba4c8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9291f778-453b-42d8-aeed-315e7303096f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityShellCompany_9291f778-453b-42d8-aeed-315e7303096f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a89a3110-2922-4297-a92a-0ef108c80da8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a89a3110-2922-4297-a92a-0ef108c80da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_54f9bb14-6c35-4948-bf7c-219021c1363d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_AmendmentFlag_54f9bb14-6c35-4948-bf7c-219021c1363d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_95feedea-c241-461d-91cd-7c3564534a23" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_DocumentFiscalYearFocus_95feedea-c241-461d-91cd-7c3564534a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_46e4ffda-1803-4c07-b823-2e97b29e68e0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_DocumentFiscalPeriodFocus_46e4ffda-1803-4c07-b823-2e97b29e68e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8bb2a356-8c5f-4e78-941e-bf6d8e5c4c44" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_EntityCentralIndexKey_8bb2a356-8c5f-4e78-941e-bf6d8e5c4c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d0e73503-814b-4586-83f6-5f5c1b71cb53" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_15cc8a54-c4b3-4160-9617-e6092752f088" xlink:to="loc_dei_CurrentFiscalYearEndDate_d0e73503-814b-4586-83f6-5f5c1b71cb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_02401593-70ea-4b00-acfe-55c32e42b7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_872d5f4a-24f0-47cc-83ec-43f16887fc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_02401593-70ea-4b00-acfe-55c32e42b7f8" xlink:to="loc_us-gaap_AssetsAbstract_872d5f4a-24f0-47cc-83ec-43f16887fc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_73d3828c-cf22-4b05-8aed-e371f526596c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_872d5f4a-24f0-47cc-83ec-43f16887fc83" xlink:to="loc_us-gaap_AssetsCurrentAbstract_73d3828c-cf22-4b05-8aed-e371f526596c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c09ca23-a6e1-4cbe-9beb-4ea5b9e39513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_73d3828c-cf22-4b05-8aed-e371f526596c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c09ca23-a6e1-4cbe-9beb-4ea5b9e39513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_71f48759-237e-4f7c-b44a-da9daeeff48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_73d3828c-cf22-4b05-8aed-e371f526596c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_71f48759-237e-4f7c-b44a-da9daeeff48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a3466c28-cd65-4c75-8c96-f9be8208e6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_73d3828c-cf22-4b05-8aed-e371f526596c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a3466c28-cd65-4c75-8c96-f9be8208e6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c8a33638-ccff-4d39-8303-06f14b2d8c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_73d3828c-cf22-4b05-8aed-e371f526596c" xlink:to="loc_us-gaap_InventoryNet_c8a33638-ccff-4d39-8303-06f14b2d8c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c9fef1ef-d99f-4671-a82a-a543bb88c05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_73d3828c-cf22-4b05-8aed-e371f526596c" xlink:to="loc_us-gaap_OtherAssetsCurrent_c9fef1ef-d99f-4671-a82a-a543bb88c05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ed00bfb5-d9a6-4282-8c51-530a94e7599c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_73d3828c-cf22-4b05-8aed-e371f526596c" xlink:to="loc_us-gaap_AssetsCurrent_ed00bfb5-d9a6-4282-8c51-530a94e7599c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_6e601703-1af6-4e3f-84d5-07d252db28d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_872d5f4a-24f0-47cc-83ec-43f16887fc83" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_6e601703-1af6-4e3f-84d5-07d252db28d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_b8712b25-70a2-4b93-a599-1967764355c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6e601703-1af6-4e3f-84d5-07d252db28d1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_b8712b25-70a2-4b93-a599-1967764355c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_eb2307d9-ec85-4607-b455-bfa99d81c87f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6e601703-1af6-4e3f-84d5-07d252db28d1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_eb2307d9-ec85-4607-b455-bfa99d81c87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6e9f1c0e-9ac2-4c72-bfab-a9faafcc3240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6e601703-1af6-4e3f-84d5-07d252db28d1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6e9f1c0e-9ac2-4c72-bfab-a9faafcc3240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3a4baa91-1e9d-4c24-9ecc-9d75a7c10262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6e601703-1af6-4e3f-84d5-07d252db28d1" xlink:to="loc_us-gaap_Goodwill_3a4baa91-1e9d-4c24-9ecc-9d75a7c10262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_4bf77fea-e818-4679-ab46-d7e28359f902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6e601703-1af6-4e3f-84d5-07d252db28d1" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_4bf77fea-e818-4679-ab46-d7e28359f902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_782c442e-ff87-48c7-8f86-f232df248651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6e601703-1af6-4e3f-84d5-07d252db28d1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_782c442e-ff87-48c7-8f86-f232df248651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fb7d6adc-4598-4378-8a0b-eb23a24ef80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_872d5f4a-24f0-47cc-83ec-43f16887fc83" xlink:to="loc_us-gaap_Assets_fb7d6adc-4598-4378-8a0b-eb23a24ef80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_368aaa2a-c077-471a-ab56-bc8dd980cbca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_02401593-70ea-4b00-acfe-55c32e42b7f8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_368aaa2a-c077-471a-ab56-bc8dd980cbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_48ff16e9-da79-4a55-9825-3f97e0043dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_368aaa2a-c077-471a-ab56-bc8dd980cbca" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_48ff16e9-da79-4a55-9825-3f97e0043dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_18e4126c-0759-4e13-b3ec-e2ed215bfbc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_48ff16e9-da79-4a55-9825-3f97e0043dc2" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_18e4126c-0759-4e13-b3ec-e2ed215bfbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_884cf72c-7162-4a37-8adf-b9910a0498e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_48ff16e9-da79-4a55-9825-3f97e0043dc2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_884cf72c-7162-4a37-8adf-b9910a0498e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d5302b28-d6e0-49d7-ac66-55c67075b309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_48ff16e9-da79-4a55-9825-3f97e0043dc2" xlink:to="loc_us-gaap_LiabilitiesCurrent_d5302b28-d6e0-49d7-ac66-55c67075b309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_72486e6e-12ed-48dd-808a-1f7f6c257575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_368aaa2a-c077-471a-ab56-bc8dd980cbca" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_72486e6e-12ed-48dd-808a-1f7f6c257575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_1a04684e-fbf4-423f-93ed-b0ac48d2316f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_72486e6e-12ed-48dd-808a-1f7f6c257575" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_1a04684e-fbf4-423f-93ed-b0ac48d2316f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5542aac1-51e6-44a4-b857-c20fa8c4daf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_72486e6e-12ed-48dd-808a-1f7f6c257575" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5542aac1-51e6-44a4-b857-c20fa8c4daf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_24e6c92e-6fdb-4635-b452-4044dc81fea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_72486e6e-12ed-48dd-808a-1f7f6c257575" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_24e6c92e-6fdb-4635-b452-4044dc81fea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1a34800b-3af1-4016-809d-4044fe09cb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_368aaa2a-c077-471a-ab56-bc8dd980cbca" xlink:to="loc_us-gaap_Liabilities_1a34800b-3af1-4016-809d-4044fe09cb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_0c1e0f0e-9c19-456b-ab6b-d0b34b504b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_368aaa2a-c077-471a-ab56-bc8dd980cbca" xlink:to="loc_us-gaap_StockholdersEquityAbstract_0c1e0f0e-9c19-456b-ab6b-d0b34b504b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8c6ef3aa-8807-418f-ba9e-69962676a369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c1e0f0e-9c19-456b-ab6b-d0b34b504b74" xlink:to="loc_us-gaap_CommonStockValue_8c6ef3aa-8807-418f-ba9e-69962676a369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bf33ce27-bf04-4762-95cb-5b7f002a5582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c1e0f0e-9c19-456b-ab6b-d0b34b504b74" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bf33ce27-bf04-4762-95cb-5b7f002a5582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIssuedEmployeeStockTrust_490c9639-2779-494b-839d-6fdf99ea7076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIssuedEmployeeStockTrust"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c1e0f0e-9c19-456b-ab6b-d0b34b504b74" xlink:to="loc_us-gaap_CommonStockIssuedEmployeeStockTrust_490c9639-2779-494b-839d-6fdf99ea7076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bba0656a-baf8-4e07-a6c6-b28a0fd801a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c1e0f0e-9c19-456b-ab6b-d0b34b504b74" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bba0656a-baf8-4e07-a6c6-b28a0fd801a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3cd15aca-56be-408a-be87-def46399598e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c1e0f0e-9c19-456b-ab6b-d0b34b504b74" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3cd15aca-56be-408a-be87-def46399598e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5abb0aa2-9480-4ab0-b178-7c674a75b328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c1e0f0e-9c19-456b-ab6b-d0b34b504b74" xlink:to="loc_us-gaap_StockholdersEquity_5abb0aa2-9480-4ab0-b178-7c674a75b328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e573243b-f98d-42e5-ae9f-d7f5c82b6754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_368aaa2a-c077-471a-ab56-bc8dd980cbca" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e573243b-f98d-42e5-ae9f-d7f5c82b6754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e5288410-e952-4c6b-8293-5be4929556e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_222083db-aef9-459a-84dd-2e97fb044a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e5288410-e952-4c6b-8293-5be4929556e8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_222083db-aef9-459a-84dd-2e97fb044a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f466eae6-072a-4be6-bd01-d915f3e2c07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e5288410-e952-4c6b-8293-5be4929556e8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f466eae6-072a-4be6-bd01-d915f3e2c07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9e232e39-d38d-46ac-959e-8e9a5a156a28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e5288410-e952-4c6b-8293-5be4929556e8" xlink:to="loc_us-gaap_CommonStockSharesIssued_9e232e39-d38d-46ac-959e-8e9a5a156a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_475a3d6a-2c74-481a-99a7-a078110a1833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e5288410-e952-4c6b-8293-5be4929556e8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_475a3d6a-2c74-481a-99a7-a078110a1833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1790d5a9-b17f-45cc-8405-55cfa27a6778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2c6e2121-0067-46ae-adab-35d126912360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1790d5a9-b17f-45cc-8405-55cfa27a6778" xlink:to="loc_us-gaap_StatementTable_2c6e2121-0067-46ae-adab-35d126912360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_15b876c5-cb88-4e6d-817d-bbcbef63b75a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2c6e2121-0067-46ae-adab-35d126912360" xlink:to="loc_srt_ProductOrServiceAxis_15b876c5-cb88-4e6d-817d-bbcbef63b75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d3abb5d9-ef70-4abd-a027-d0996c966b7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_15b876c5-cb88-4e6d-817d-bbcbef63b75a" xlink:to="loc_srt_ProductsAndServicesDomain_d3abb5d9-ef70-4abd-a027-d0996c966b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_413d590a-bb1f-42b1-8a6c-8d23d4ee86c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3abb5d9-ef70-4abd-a027-d0996c966b7b" xlink:to="loc_us-gaap_ProductMember_413d590a-bb1f-42b1-8a6c-8d23d4ee86c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RoyaltyAndOtherMember_3b86b774-f9e1-449c-ad90-a47dec34e496" xlink:href="bmrn-20210930.xsd#bmrn_RoyaltyAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3abb5d9-ef70-4abd-a027-d0996c966b7b" xlink:to="loc_bmrn_RoyaltyAndOtherMember_3b86b774-f9e1-449c-ad90-a47dec34e496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2c6e2121-0067-46ae-adab-35d126912360" xlink:to="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_5ff694dc-8c70-4078-ac79-4d89a81c226b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_RevenuesAbstract_5ff694dc-8c70-4078-ac79-4d89a81c226b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f14bd97-69f7-414e-b353-a9bb89e51954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_5ff694dc-8c70-4078-ac79-4d89a81c226b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f14bd97-69f7-414e-b353-a9bb89e51954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_51d5708e-f318-49a2-a92f-847248293af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_CostOfRevenue_51d5708e-f318-49a2-a92f-847248293af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_27c35778-b63b-45cd-b972-05fc294fcabb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_27c35778-b63b-45cd-b972-05fc294fcabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d803d5f4-ede5-43e3-966d-4f120d9a01ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d803d5f4-ede5-43e3-966d-4f120d9a01ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_IntangibleAssetAmortizationAndContingentConsideration_6096a2e9-1ab1-4db4-ac45-0a32463aee76" xlink:href="bmrn-20210930.xsd#bmrn_IntangibleAssetAmortizationAndContingentConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_bmrn_IntangibleAssetAmortizationAndContingentConsideration_6096a2e9-1ab1-4db4-ac45-0a32463aee76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_f52d51b9-6bdc-4658-a3c0-d1b84cb22daa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_f52d51b9-6bdc-4658-a3c0-d1b84cb22daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f10c886e-b39c-436b-ad91-ca467c6bed3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_3fe1291d-37bd-4a91-b03d-9716dd76298b" xlink:to="loc_us-gaap_CostsAndExpenses_f10c886e-b39c-436b-ad91-ca467c6bed3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_48d93e1e-a966-42bc-bcc6-14038fade335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_OperatingIncomeLoss_48d93e1e-a966-42bc-bcc6-14038fade335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_96fd0c50-6598-46bd-bb3a-e222793f5f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_96fd0c50-6598-46bd-bb3a-e222793f5f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c7775f39-5ce1-4c25-a0f1-c5662a865137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c7775f39-5ce1-4c25-a0f1-c5662a865137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0e66a231-8790-4f5f-8c2b-07db34a3ebf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_InterestExpense_0e66a231-8790-4f5f-8c2b-07db34a3ebf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_b87f6518-d507-4017-99a1-3c4b6f7ffe41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_b87f6518-d507-4017-99a1-3c4b6f7ffe41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e892cdfe-9971-46ac-9a08-bc9010b093d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e892cdfe-9971-46ac-9a08-bc9010b093d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dbbd16cd-af6f-44b9-a8e4-c9d13fc08c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dbbd16cd-af6f-44b9-a8e4-c9d13fc08c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d77a24d9-71ae-4f7d-aa06-70db009cc707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_NetIncomeLoss_d77a24d9-71ae-4f7d-aa06-70db009cc707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e25030b1-df4c-4dcb-b130-2cf586a929de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_EarningsPerShareBasic_e25030b1-df4c-4dcb-b130-2cf586a929de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e47941d4-8ab4-4de2-8a1e-de5b7f26f75a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e47941d4-8ab4-4de2-8a1e-de5b7f26f75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_974c6e6f-5779-4b8a-9d89-7fd905014e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_974c6e6f-5779-4b8a-9d89-7fd905014e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_09360373-9ba2-4a2d-a2b8-597af59ef9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_09360373-9ba2-4a2d-a2b8-597af59ef9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1db5c18d-8079-4813-826b-92e04c796506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ffde2fca-04a7-4536-ae1b-77fd47f82979" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1db5c18d-8079-4813-826b-92e04c796506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_248cd996-fcc7-4943-bc2f-b1427996e6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1c9ec3b0-99f7-4cc1-b4de-06128012a7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_248cd996-fcc7-4943-bc2f-b1427996e6c4" xlink:to="loc_us-gaap_StatementTable_1c9ec3b0-99f7-4cc1-b4de-06128012a7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dd931dfa-5f1f-44a5-83de-1293e5ee138f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1c9ec3b0-99f7-4cc1-b4de-06128012a7fe" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dd931dfa-5f1f-44a5-83de-1293e5ee138f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dd931dfa-5f1f-44a5-83de-1293e5ee138f" xlink:to="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bbd10b6c-adc8-4b69-9c1f-82eb188da93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_CommonStockMember_bbd10b6c-adc8-4b69-9c1f-82eb188da93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a1202625-de2e-4547-975b-a2fe07bf159d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a1202625-de2e-4547-975b-a2fe07bf159d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_56c50783-de88-4ae6-90a3-4606b652f478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_TreasuryStockMember_56c50783-de88-4ae6-90a3-4606b652f478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_a23f522f-5ce0-40b3-a303-e57e1a25d8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_a23f522f-5ce0-40b3-a303-e57e1a25d8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b53dd3ab-f503-4b3e-a0a8-7b678dfc274b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b53dd3ab-f503-4b3e-a0a8-7b678dfc274b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_491e3dbf-a78f-4d69-a9d5-da471b9126f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dba3b6ba-7150-4f19-b595-05f9851da5ca" xlink:to="loc_us-gaap_RetainedEarningsMember_491e3dbf-a78f-4d69-a9d5-da471b9126f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_67a3fcfb-2199-4041-b775-12f4aa183a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1c9ec3b0-99f7-4cc1-b4de-06128012a7fe" xlink:to="loc_us-gaap_StatementLineItems_67a3fcfb-2199-4041-b775-12f4aa183a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_67a3fcfb-2199-4041-b775-12f4aa183a05" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_eef44e20-1301-4196-9f43-56360baed22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_SharesOutstanding_eef44e20-1301-4196-9f43-56360baed22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares_fd884aae-b96c-409b-a0f6-bb9e8ae75d75" xlink:href="bmrn-20210930.xsd#bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares_fd884aae-b96c-409b-a0f6-bb9e8ae75d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_95bad75f-4cc6-405b-9f83-a6bff77200c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_95bad75f-4cc6-405b-9f83-a6bff77200c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0c95342c-fc32-4856-a06b-647caf4b0477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_SharesOutstanding_0c95342c-fc32-4856-a06b-647caf4b0477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ecbeb28b-4981-4497-bf50-f3fdd55c9488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_StockholdersEquity_ecbeb28b-4981-4497-bf50-f3fdd55c9488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency_e69af9ed-e2f0-4d00-93b5-a5797476d194" xlink:href="bmrn-20210930.xsd#bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency_e69af9ed-e2f0-4d00-93b5-a5797476d194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_36ca81f4-149f-4451-bc08-3a3096575774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_36ca81f4-149f-4451-bc08-3a3096575774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_88c7ede4-36ef-4411-90e1-417975b772f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_88c7ede4-36ef-4411-90e1-417975b772f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_ee214b18-f065-4d0d-b2e2-c149725e528a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_ee214b18-f065-4d0d-b2e2-c149725e528a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan_bc18acd8-9f56-4420-a222-607c2aae60d0" xlink:href="bmrn-20210930.xsd#bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan_bc18acd8-9f56-4420-a222-607c2aae60d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e92859d-21e0-45b2-8717-cfc19d12ab88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e92859d-21e0-45b2-8717-cfc19d12ab88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e0e83d8d-5e33-441b-9ed8-d90d8fd0d8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_NetIncomeLoss_e0e83d8d-5e33-441b-9ed8-d90d8fd0d8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_848b95c6-f6ad-443b-bd99-cb5b8e6b767e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0e26817-a455-4706-beaa-8d85e4841d71" xlink:to="loc_us-gaap_StockholdersEquity_848b95c6-f6ad-443b-bd99-cb5b8e6b767e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_599943ee-eb0e-4377-8833-3857f9c80ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0df83006-024d-402a-89b3-cc6e1cd2342b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_599943ee-eb0e-4377-8833-3857f9c80ef4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0df83006-024d-402a-89b3-cc6e1cd2342b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b0d91326-7afb-4f3f-be8b-146a05ac25d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0df83006-024d-402a-89b3-cc6e1cd2342b" xlink:to="loc_us-gaap_NetIncomeLoss_b0d91326-7afb-4f3f-be8b-146a05ac25d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0df83006-024d-402a-89b3-cc6e1cd2342b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_eba55677-99b8-4dcb-9fb9-4cb80ea74acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_eba55677-99b8-4dcb-9fb9-4cb80ea74acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_acdb19bf-e7d2-4eb5-a2ef-a4424b78764e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_acdb19bf-e7d2-4eb5-a2ef-a4424b78764e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_626c370a-d941-4fb7-ba59-54aaecca1723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_626c370a-d941-4fb7-ba59-54aaecca1723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8d20e6fb-6c7c-4dc7-9c22-57debab3782c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_ShareBasedCompensation_8d20e6fb-6c7c-4dc7-9c22-57debab3782c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_3da23f9a-70ac-434f-8635-3b71ec68546f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_3da23f9a-70ac-434f-8635-3b71ec68546f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_392fe5aa-a7b4-4d67-94c3-6ee2f4cace71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_InventoryWriteDown_392fe5aa-a7b4-4d67-94c3-6ee2f4cace71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3b618596-a2aa-4ff5-b84d-894b205d24c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3b618596-a2aa-4ff5-b84d-894b205d24c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_58b2f9c0-c241-4e82-9228-eed40f04b8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_58b2f9c0-c241-4e82-9228-eed40f04b8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_952a047e-08ca-4653-a649-612218c761d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_952a047e-08ca-4653-a649-612218c761d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e12b3185-49a8-4e7a-b390-af3f1862e6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e12b3185-49a8-4e7a-b390-af3f1862e6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_01f8d62c-bc35-4cc7-9d44-0a310de68596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bbc66032-f514-4df5-b5c2-d4651f436c77" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_01f8d62c-bc35-4cc7-9d44-0a310de68596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_af13a998-0edf-4e23-9490-917075e0aa70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_01f8d62c-bc35-4cc7-9d44-0a310de68596" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_af13a998-0edf-4e23-9490-917075e0aa70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_4f3d188e-054d-427e-b7e3-a00f7d206936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_01f8d62c-bc35-4cc7-9d44-0a310de68596" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_4f3d188e-054d-427e-b7e3-a00f7d206936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_ab5415ea-b9f0-4ab3-a157-d7b9869b967b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_01f8d62c-bc35-4cc7-9d44-0a310de68596" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_ab5415ea-b9f0-4ab3-a157-d7b9869b967b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e7caa633-27c1-4235-99cc-5c7df4f66940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_01f8d62c-bc35-4cc7-9d44-0a310de68596" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e7caa633-27c1-4235-99cc-5c7df4f66940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_af55960b-94d6-4fca-a9b8-c5135f44eba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_01f8d62c-bc35-4cc7-9d44-0a310de68596" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_af55960b-94d6-4fca-a9b8-c5135f44eba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5149d232-b98f-477d-b8ab-0d1bcef42de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_01f8d62c-bc35-4cc7-9d44-0a310de68596" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5149d232-b98f-477d-b8ab-0d1bcef42de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78f104dd-0afd-44c0-a04d-863e6b8110fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0df83006-024d-402a-89b3-cc6e1cd2342b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78f104dd-0afd-44c0-a04d-863e6b8110fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_599943ee-eb0e-4377-8833-3857f9c80ef4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_87afb7a1-2646-444d-82ec-1721a642bf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_87afb7a1-2646-444d-82ec-1721a642bf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_219b396b-b42e-4ae4-8151-c102336ccfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_219b396b-b42e-4ae4-8151-c102336ccfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_75cfa7a0-363e-4157-ade7-ea54faf37b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_75cfa7a0-363e-4157-ade7-ea54faf37b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProceedsFromSaleOfNonfinancialAssets_7b2e7678-1dfa-4407-8669-49ada344d4ef" xlink:href="bmrn-20210930.xsd#bmrn_ProceedsFromSaleOfNonfinancialAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:to="loc_bmrn_ProceedsFromSaleOfNonfinancialAssets_7b2e7678-1dfa-4407-8669-49ada344d4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b66bf51b-3696-45d3-a344-e64defad6513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b66bf51b-3696-45d3-a344-e64defad6513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable_a1050a81-42a9-4248-897c-bb2f96d48ffc" xlink:href="bmrn-20210930.xsd#bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:to="loc_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable_a1050a81-42a9-4248-897c-bb2f96d48ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_342fe040-498d-415c-8532-fdacfa13141b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_342fe040-498d-415c-8532-fdacfa13141b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de5d7f63-5a54-43bf-a783-c053f6d16566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08bdcd2b-e10d-436b-a720-9b2caff59884" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de5d7f63-5a54-43bf-a783-c053f6d16566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_121c47ae-551d-49f6-851b-b695255ebb86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_599943ee-eb0e-4377-8833-3857f9c80ef4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_121c47ae-551d-49f6-851b-b695255ebb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_eac7f69f-7eba-4a66-8008-414f26322dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_121c47ae-551d-49f6-851b-b695255ebb86" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_eac7f69f-7eba-4a66-8008-414f26322dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a79b0f78-d3aa-408e-b34c-19b12f361ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_121c47ae-551d-49f6-851b-b695255ebb86" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a79b0f78-d3aa-408e-b34c-19b12f361ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2693547d-ee26-4ac8-829c-afdc102e44b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_121c47ae-551d-49f6-851b-b695255ebb86" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2693547d-ee26-4ac8-829c-afdc102e44b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_ec03ee80-0c9d-4b34-aabb-ebb52ed3d5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_121c47ae-551d-49f6-851b-b695255ebb86" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_ec03ee80-0c9d-4b34-aabb-ebb52ed3d5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_a97ab653-2a31-4b40-ba7f-18b1bcd7337f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_121c47ae-551d-49f6-851b-b695255ebb86" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_a97ab653-2a31-4b40-ba7f-18b1bcd7337f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_35c28dfb-331d-46d1-82da-482552a8ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_121c47ae-551d-49f6-851b-b695255ebb86" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_35c28dfb-331d-46d1-82da-482552a8ba10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ef4ea0e0-ba5c-4bff-b821-aa14a692816f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_121c47ae-551d-49f6-851b-b695255ebb86" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ef4ea0e0-ba5c-4bff-b821-aa14a692816f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5ffc2810-7ee1-43ba-b88a-7ada423e316f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_599943ee-eb0e-4377-8833-3857f9c80ef4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5ffc2810-7ee1-43ba-b88a-7ada423e316f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_78f5b54f-2c11-49eb-99d9-63e9fb614d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_599943ee-eb0e-4377-8833-3857f9c80ef4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_78f5b54f-2c11-49eb-99d9-63e9fb614d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_469367c5-f90f-411b-b783-cea20a4496fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_599943ee-eb0e-4377-8833-3857f9c80ef4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_469367c5-f90f-411b-b783-cea20a4496fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_073de679-a0db-4196-a1a8-921ac7194843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_469367c5-f90f-411b-b783-cea20a4496fe" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_073de679-a0db-4196-a1a8-921ac7194843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_94d443c5-37d7-4e75-ba4c-16205724c36d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_469367c5-f90f-411b-b783-cea20a4496fe" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_94d443c5-37d7-4e75-ba4c-16205724c36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_59e70831-8fff-4192-85b5-0f8c310b30b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_599943ee-eb0e-4377-8833-3857f9c80ef4" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_59e70831-8fff-4192-85b5-0f8c310b30b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_e33bcec4-92cf-4824-977c-7b25bada5dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_59e70831-8fff-4192-85b5-0f8c310b30b9" xlink:to="loc_us-gaap_IncomeTaxesPaid_e33bcec4-92cf-4824-977c-7b25bada5dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_3d138c5a-2a6b-4f76-b239-5b9135c006af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_59e70831-8fff-4192-85b5-0f8c310b30b9" xlink:to="loc_us-gaap_InterestPaidNet_3d138c5a-2a6b-4f76-b239-5b9135c006af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_641e34a2-bdc6-4a2e-a0cc-84c3ea8a1b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_599943ee-eb0e-4377-8833-3857f9c80ef4" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_641e34a2-bdc6-4a2e-a0cc-84c3ea8a1b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets_b9353fbf-aae6-4c41-8165-d8ec841d8f5d" xlink:href="bmrn-20210930.xsd#bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_641e34a2-bdc6-4a2e-a0cc-84c3ea8a1b46" xlink:to="loc_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets_b9353fbf-aae6-4c41-8165-d8ec841d8f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets_f4a86807-9bfa-4aba-89ef-730af1808645" xlink:href="bmrn-20210930.xsd#bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_641e34a2-bdc6-4a2e-a0cc-84c3ea8a1b46" xlink:to="loc_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets_f4a86807-9bfa-4aba-89ef-730af1808645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NATUREOFOPERATIONS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NATUREOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/NATUREOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_82e7474a-fba4-4521-8edd-591075bbb2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_95190a65-ceb2-4cec-bc77-6a7103f8babd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_82e7474a-fba4-4521-8edd-591075bbb2cc" xlink:to="loc_us-gaap_NatureOfOperations_95190a65-ceb2-4cec-bc77-6a7103f8babd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="bmrn-20210930.xsd#BASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/BASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9c2dd009-312e-4b4a-9280-38367f026fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_7c69d862-43e6-4e68-9cee-6b2420e49b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9c2dd009-312e-4b4a-9280-38367f026fe7" xlink:to="loc_us-gaap_BasisOfAccounting_7c69d862-43e6-4e68-9cee-6b2420e49b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/BASISOFPRESENTATIONPolicies" xlink:type="simple" xlink:href="bmrn-20210930.xsd#BASISOFPRESENTATIONPolicies"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/BASISOFPRESENTATIONPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3871dad6-4830-4ff5-bea5-fbe198fde637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3dba4b17-ac9b-4f12-8fb7-ce942ab3ecf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3871dad6-4830-4ff5-bea5-fbe198fde637" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3dba4b17-ac9b-4f12-8fb7-ce942ab3ecf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7b696cd0-9235-4d3b-aea1-ee0919850297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_400ae796-3fed-4cda-a3e7-fa88da77920a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7b696cd0-9235-4d3b-aea1-ee0919850297" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_400ae796-3fed-4cda-a3e7-fa88da77920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RECENTACCOUNTINGPRONOUNCEMENTS"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ba4ddb11-f29c-40b3-95ae-07e321fa5c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_2afd6375-4bd6-46bd-9bf7-9440b34441fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ba4ddb11-f29c-40b3-95ae-07e321fa5c7f" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_2afd6375-4bd6-46bd-9bf7-9440b34441fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c58f5066-3437-4af3-adac-293bcb4e33aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_963e1d63-e2b8-491a-a514-73ef736f28a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c58f5066-3437-4af3-adac-293bcb4e33aa" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_963e1d63-e2b8-491a-a514-73ef736f28a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a962bae4-cde3-47dd-a7b9-5c2916c98577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock_1f3a3866-0108-48e5-aec5-b0fd0112bbb2" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a962bae4-cde3-47dd-a7b9-5c2916c98577" xlink:to="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock_1f3a3866-0108-48e5-aec5-b0fd0112bbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5eae7d95-5ad8-43a9-bc07-0eefd9813dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5eae7d95-5ad8-43a9-bc07-0eefd9813dad" xlink:to="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e339e35-5ab4-48b8-8577-cad6e872eff1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:to="loc_srt_RangeAxis_4e339e35-5ab4-48b8-8577-cad6e872eff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ae228a3f-5721-4b9e-b518-600b92fa6404" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4e339e35-5ab4-48b8-8577-cad6e872eff1" xlink:to="loc_srt_RangeMember_ae228a3f-5721-4b9e-b518-600b92fa6404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_02dab176-2162-4f9a-b3a4-569491506b2a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae228a3f-5721-4b9e-b518-600b92fa6404" xlink:to="loc_srt_MinimumMember_02dab176-2162-4f9a-b3a4-569491506b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bbea59a8-e18a-4e9e-bce6-602fa612262e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ae228a3f-5721-4b9e-b518-600b92fa6404" xlink:to="loc_srt_MaximumMember_bbea59a8-e18a-4e9e-bce6-602fa612262e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dcd1577-6e28-4fb9-8275-2e7171f0543d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dcd1577-6e28-4fb9-8275-2e7171f0543d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76d467d7-d8c3-4e9a-b1dc-f7c6fb60d2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3dcd1577-6e28-4fb9-8275-2e7171f0543d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76d467d7-d8c3-4e9a-b1dc-f7c6fb60d2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_453f92fc-da1f-4407-a7d5-cbe2c3cefe24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76d467d7-d8c3-4e9a-b1dc-f7c6fb60d2f3" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_453f92fc-da1f-4407-a7d5-cbe2c3cefe24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6894d795-7215-4eb7-a940-42befbd22fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76d467d7-d8c3-4e9a-b1dc-f7c6fb60d2f3" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6894d795-7215-4eb7-a940-42befbd22fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_39366da1-c40f-497d-943f-e09107059ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:to="loc_us-gaap_InvestmentTypeAxis_39366da1-c40f-497d-943f-e09107059ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_39366da1-c40f-497d-943f-e09107059ba2" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_d6ecfdb4-62c5-4139-84e4-1e1d40bcf847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_CashMember_d6ecfdb4-62c5-4139-84e4-1e1d40bcf847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ca224623-ca99-49c4-8651-b9dd6c0c5505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ca224623-ca99-49c4-8651-b9dd6c0c5505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e9aa49fb-31f1-45fd-820d-b7607f5dd14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e9aa49fb-31f1-45fd-820d-b7607f5dd14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5a9c1ecd-3284-4692-8a64-cd51ee79d879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5a9c1ecd-3284-4692-8a64-cd51ee79d879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0415861c-ae51-4b11-9211-1af5729897d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_CommercialPaperMember_0415861c-ae51-4b11-9211-1af5729897d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_cbeebddf-e768-45ad-8e64-bf7d5249a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_cbeebddf-e768-45ad-8e64-bf7d5249a7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember_fe69f263-5549-4acc-a325-e9412a8679e9" xlink:href="bmrn-20210930.xsd#bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ed81f313-238a-4b95-993b-452162bae3c0" xlink:to="loc_bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember_fe69f263-5549-4acc-a325-e9412a8679e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_6a506748-398e-44d9-a3f8-8c5d15323599" xlink:to="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_032f92b9-41e0-4502-92e7-795ea1b4801e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_032f92b9-41e0-4502-92e7-795ea1b4801e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_ee2e08d4-5034-409b-b379-aecf93d092c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_Cash_ee2e08d4-5034-409b-b379-aecf93d092c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3ed0a361-0447-4f37-b5b9-2a33faeac8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3ed0a361-0447-4f37-b5b9-2a33faeac8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_35412f33-379b-404a-bff4-a1f0773d270c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_35412f33-379b-404a-bff4-a1f0773d270c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3126c87f-21a9-4702-acc3-b42bddf850cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3126c87f-21a9-4702-acc3-b42bddf850cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e71935b2-9f60-4014-99cf-2d5881b463c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e71935b2-9f60-4014-99cf-2d5881b463c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_051d58c2-36c0-4a8e-b1f6-c52c1ae8b1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_051d58c2-36c0-4a8e-b1f6-c52c1ae8b1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_cf23b699-dbe7-45c9-8892-e312174d0997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_cf23b699-dbe7-45c9-8892-e312174d0997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ShortTermMarketableSecuritiesMaturityPeriod_65cd6cc9-1c82-4167-a80a-c79dc65c4f38" xlink:href="bmrn-20210930.xsd#bmrn_ShortTermMarketableSecuritiesMaturityPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_bmrn_ShortTermMarketableSecuritiesMaturityPeriod_65cd6cc9-1c82-4167-a80a-c79dc65c4f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_LongTermMarketableSecuritiesMaturityPeriod_cc37a9e7-1963-48d9-a13b-4f5232c5653e" xlink:href="bmrn-20210930.xsd#bmrn_LongTermMarketableSecuritiesMaturityPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_0f499776-3b89-4c61-8860-d8262d33d4cf" xlink:to="loc_bmrn_LongTermMarketableSecuritiesMaturityPeriod_cc37a9e7-1963-48d9-a13b-4f5232c5653e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FinancialInstrumentsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ff8501ee-f592-4bef-b651-56f83773ab44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_e4eba98e-dd80-40e8-b3c7-bd055a2e8cf8" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ff8501ee-f592-4bef-b651-56f83773ab44" xlink:to="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_e4eba98e-dd80-40e8-b3c7-bd055a2e8cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b0617a98-b23b-4fa2-92b9-e000369dd774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_e4eba98e-dd80-40e8-b3c7-bd055a2e8cf8" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b0617a98-b23b-4fa2-92b9-e000369dd774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cb213680-3e0e-4e98-aa30-252eca6d9041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b0617a98-b23b-4fa2-92b9-e000369dd774" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cb213680-3e0e-4e98-aa30-252eca6d9041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_StrategicInvestmentMember_66a90efe-ee22-47d2-9f79-b649505fd5ca" xlink:href="bmrn-20210930.xsd#bmrn_StrategicInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cb213680-3e0e-4e98-aa30-252eca6d9041" xlink:to="loc_bmrn_StrategicInvestmentMember_66a90efe-ee22-47d2-9f79-b649505fd5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a79282d7-c2a7-40aa-956c-670b04efd88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_e4eba98e-dd80-40e8-b3c7-bd055a2e8cf8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a79282d7-c2a7-40aa-956c-670b04efd88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3fc0cbc0-624e-49c4-9b29-6bfd2a237d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a79282d7-c2a7-40aa-956c-670b04efd88a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3fc0cbc0-624e-49c4-9b29-6bfd2a237d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ad5c2f11-63cd-4cb1-bde4-38a077f0faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3fc0cbc0-624e-49c4-9b29-6bfd2a237d7e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ad5c2f11-63cd-4cb1-bde4-38a077f0faa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_1c54431e-cf77-4fcf-b5f4-45702a96c761" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable_e4eba98e-dd80-40e8-b3c7-bd055a2e8cf8" xlink:to="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_1c54431e-cf77-4fcf-b5f4-45702a96c761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_449156fe-270e-4e6e-9d12-d4f1702f5e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems_1c54431e-cf77-4fcf-b5f4-45702a96c761" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_449156fe-270e-4e6e-9d12-d4f1702f5e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATION" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SUPPLEMENTALBALANCESHEETINFORMATION"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_527ff362-54fd-4520-84f0-297ac6a9e657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_4db9f7b5-3574-4da6-a8a4-cea8527962c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_527ff362-54fd-4520-84f0-297ac6a9e657" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_4db9f7b5-3574-4da6-a8a4-cea8527962c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATIONTables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SUPPLEMENTALBALANCESHEETINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59c60bc5-7717-43d2-8c2a-62c2131651ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_fba8a280-672d-43a3-aceb-4a2c68cbfe2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59c60bc5-7717-43d2-8c2a-62c2131651ae" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_fba8a280-672d-43a3-aceb-4a2c68cbfe2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5c750f72-63bf-4cf6-9968-312d203e6309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59c60bc5-7717-43d2-8c2a-62c2131651ae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5c750f72-63bf-4cf6-9968-312d203e6309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_977fbd9c-5665-4346-a744-ee3ea63eda3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59c60bc5-7717-43d2-8c2a-62c2131651ae" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_977fbd9c-5665-4346-a744-ee3ea63eda3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_e1212351-79cf-4e59-820b-9a65a646d41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59c60bc5-7717-43d2-8c2a-62c2131651ae" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_e1212351-79cf-4e59-820b-9a65a646d41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationScheduleofInventoryDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_658d4429-6cac-444b-9abc-267c07c1744a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3824d05b-26d2-41fc-99a8-db210878e036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_658d4429-6cac-444b-9abc-267c07c1744a" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3824d05b-26d2-41fc-99a8-db210878e036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_742c5b62-6605-4935-a129-dde9c746c1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_658d4429-6cac-444b-9abc-267c07c1744a" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_742c5b62-6605-4935-a129-dde9c746c1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_47d74779-1ef0-415b-813c-1b9d5e51194a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_658d4429-6cac-444b-9abc-267c07c1744a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_47d74779-1ef0-415b-813c-1b9d5e51194a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9ed938fa-0e9a-42f5-95dd-28044ccbbdc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_658d4429-6cac-444b-9abc-267c07c1744a" xlink:to="loc_us-gaap_InventoryNet_9ed938fa-0e9a-42f5-95dd-28044ccbbdc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_3d2aa03f-93fe-4986-838f-6c6109831ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_4716dd9f-b1dc-4919-9589-b5ebda0c14b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_3d2aa03f-93fe-4986-838f-6c6109831ba8" xlink:to="loc_us-gaap_InventoryCurrentTable_4716dd9f-b1dc-4919-9589-b5ebda0c14b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_5fc10249-89b2-4e52-98bd-86e0ca6769c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_4716dd9f-b1dc-4919-9589-b5ebda0c14b5" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_5fc10249-89b2-4e52-98bd-86e0ca6769c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_664f1c95-298a-456b-9629-626c8e94f4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_5fc10249-89b2-4e52-98bd-86e0ca6769c8" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_664f1c95-298a-456b-9629-626c8e94f4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_VoxzogoMember_f12096d8-c87f-40fa-9c00-19a3c576b6fa" xlink:href="bmrn-20210930.xsd#bmrn_VoxzogoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_664f1c95-298a-456b-9629-626c8e94f4fe" xlink:to="loc_bmrn_VoxzogoMember_f12096d8-c87f-40fa-9c00-19a3c576b6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_71bd9559-a3a0-4723-8e92-daa73717efea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_4716dd9f-b1dc-4919-9589-b5ebda0c14b5" xlink:to="loc_us-gaap_InventoryLineItems_71bd9559-a3a0-4723-8e92-daa73717efea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_31cad102-61e7-49d5-aafc-123997b76a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_71bd9559-a3a0-4723-8e92-daa73717efea" xlink:to="loc_us-gaap_InventoryNet_31cad102-61e7-49d5-aafc-123997b76a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7ad35184-3de4-4d3f-b399-6eab967140b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_71bd9559-a3a0-4723-8e92-daa73717efea" xlink:to="loc_us-gaap_Depreciation_7ad35184-3de4-4d3f-b399-6eab967140b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_374ff6a2-4225-4bd7-b095-91ae797a3e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_771f7e30-604d-4b3c-b793-4a6d70163728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_374ff6a2-4225-4bd7-b095-91ae797a3e1d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_771f7e30-604d-4b3c-b793-4a6d70163728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c3998981-3ea3-4e09-958c-eb390ddadd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_374ff6a2-4225-4bd7-b095-91ae797a3e1d" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c3998981-3ea3-4e09-958c-eb390ddadd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_aaede226-7251-4f1d-ad6c-3547e90dd39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_374ff6a2-4225-4bd7-b095-91ae797a3e1d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_aaede226-7251-4f1d-ad6c-3547e90dd39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_32ba8eb2-5b6c-4542-8d62-f3920c6b17cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_04d36c07-bd6f-442e-8a7c-f3d1e948d24e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_32ba8eb2-5b6c-4542-8d62-f3920c6b17cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_04d36c07-bd6f-442e-8a7c-f3d1e948d24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_362c56cf-ea52-4695-a973-5d4c78ed87ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_32ba8eb2-5b6c-4542-8d62-f3920c6b17cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_362c56cf-ea52-4695-a973-5d4c78ed87ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_37fbce82-7e64-490b-82ef-cb68542a237a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_32ba8eb2-5b6c-4542-8d62-f3920c6b17cc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_37fbce82-7e64-490b-82ef-cb68542a237a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_390a0d45-dd57-423d-aaab-7031d56d10c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_390a0d45-dd57-423d-aaab-7031d56d10c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bf442ef0-d023-435b-a3ff-6ca8469a4573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bf442ef0-d023-435b-a3ff-6ca8469a4573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_AccruedGovernmentAndOtherRebates_fd12214b-50e1-4890-bc1c-87546fb79acb" xlink:href="bmrn-20210930.xsd#bmrn_AccruedGovernmentAndOtherRebates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_bmrn_AccruedGovernmentAndOtherRebates_fd12214b-50e1-4890-bc1c-87546fb79acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_dad4ba44-7d35-4d4f-8fbf-cf152b3b4c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_dad4ba44-7d35-4d4f-8fbf-cf152b3b4c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_ed3ed447-90b8-4508-b899-6c59ff6847f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_ed3ed447-90b8-4508-b899-6c59ff6847f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_aea452e2-7151-4355-a207-27b83297a887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_aea452e2-7151-4355-a207-27b83297a887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_0a1b95fc-92ff-4322-bbca-1322472c74ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_0a1b95fc-92ff-4322-bbca-1322472c74ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_1bca38ed-7400-4753-abf4-cbfd86a19242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_us-gaap_AccruedIncomeTaxes_1bca38ed-7400-4753-abf4-cbfd86a19242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_9d2dbc76-3940-43d9-9e93-748f527a0584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_9d2dbc76-3940-43d9-9e93-748f527a0584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3de754cc-d9f4-4147-b656-e954c0049bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_464bc617-c010-4d96-ad64-f216dabda62b" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3de754cc-d9f4-4147-b656-e954c0049bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1398cf6b-712c-4da4-915a-46a58430d9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_2c5f0e28-b24b-41eb-8cdb-0119bbf9ad62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1398cf6b-712c-4da4-915a-46a58430d9ee" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_2c5f0e28-b24b-41eb-8cdb-0119bbf9ad62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_867857ec-3240-4a5c-a5e5-a016b99185c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_1125bb9b-67b5-4e35-a838-dae4712c4122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_867857ec-3240-4a5c-a5e5-a016b99185c4" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_1125bb9b-67b5-4e35-a838-dae4712c4122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f0c26215-7a58-4478-982c-932624f20473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_867857ec-3240-4a5c-a5e5-a016b99185c4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f0c26215-7a58-4478-982c-932624f20473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7aca90af-2352-4457-99ec-8d377c370909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7aca90af-2352-4457-99ec-8d377c370909" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d0eda78a-5675-4e69-8e08-e05d4310fd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d0eda78a-5675-4e69-8e08-e05d4310fd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a3a17e7b-073e-472b-86d1-241074e5d6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d0eda78a-5675-4e69-8e08-e05d4310fd3c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a3a17e7b-073e-472b-86d1-241074e5d6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ec907e6a-12f0-4470-95f9-d3d42cedb8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_a3a17e7b-073e-472b-86d1-241074e5d6f9" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ec907e6a-12f0-4470-95f9-d3d42cedb8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1cbe5403-1fc9-4860-89bf-8c850b235f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1cbe5403-1fc9-4860-89bf-8c850b235f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_db7f57c0-c57e-46d5-bb32-914289f59bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1cbe5403-1fc9-4860-89bf-8c850b235f06" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_db7f57c0-c57e-46d5-bb32-914289f59bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember_66ceddf5-2b3a-4ab8-b745-bba22632b0b8" xlink:href="bmrn-20210930.xsd#bmrn_NonqualifiedDeferredCompensationPlanAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_db7f57c0-c57e-46d5-bb32-914289f59bc7" xlink:to="loc_bmrn_NonqualifiedDeferredCompensationPlanAssetsMember_66ceddf5-2b3a-4ab8-b745-bba22632b0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RestrictedInvestmentsMember_4c3a15c4-7455-4beb-8614-69680bc579db" xlink:href="bmrn-20210930.xsd#bmrn_RestrictedInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_db7f57c0-c57e-46d5-bb32-914289f59bc7" xlink:to="loc_bmrn_RestrictedInvestmentsMember_4c3a15c4-7455-4beb-8614-69680bc579db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a75864a-ea0f-4062-9221-e7203326739c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a75864a-ea0f-4062-9221-e7203326739c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a75864a-ea0f-4062-9221-e7203326739c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d48b6c58-c510-43de-876a-df348e06969e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d48b6c58-c510-43de-876a-df348e06969e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_98f33f90-bfd8-4c52-9b32-6577d0a52f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_98f33f90-bfd8-4c52-9b32-6577d0a52f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_09ad0203-1ee5-4624-8c19-b7ea18f09f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb51df65-4170-47b5-b772-7e4da5d0b195" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_09ad0203-1ee5-4624-8c19-b7ea18f09f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_c06752f9-55f6-467d-b6a0-ed1be8cd219f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_c06752f9-55f6-467d-b6a0-ed1be8cd219f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_77b73a66-e84b-4335-a59b-4597bd174a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_c06752f9-55f6-467d-b6a0-ed1be8cd219f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_77b73a66-e84b-4335-a59b-4597bd174a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember_6029a234-509c-4fd1-9f38-c6fd5f2dbb6b" xlink:href="bmrn-20210930.xsd#bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_77b73a66-e84b-4335-a59b-4597bd174a39" xlink:to="loc_bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember_6029a234-509c-4fd1-9f38-c6fd5f2dbb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentConsiderationMember_4f8e7667-7816-46d7-94f0-b32a6326c71f" xlink:href="bmrn-20210930.xsd#bmrn_ContingentConsiderationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_77b73a66-e84b-4335-a59b-4597bd174a39" xlink:to="loc_bmrn_ContingentConsiderationMember_4f8e7667-7816-46d7-94f0-b32a6326c71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c4685740-b5e5-4b52-bb22-b9b48a07311e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_83ab0147-85b0-4307-8475-356ed97859b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_83ab0147-85b0-4307-8475-356ed97859b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6d8cec7a-a1e9-4eb5-a691-cb330714661c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6d8cec7a-a1e9-4eb5-a691-cb330714661c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherAssetsCurrentFairValueDisclosure_fbd97da9-db67-4f09-8d67-7d4216ce659c" xlink:href="bmrn-20210930.xsd#bmrn_OtherAssetsCurrentFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_bmrn_OtherAssetsCurrentFairValueDisclosure_fbd97da9-db67-4f09-8d67-7d4216ce659c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherAssetsNoncurrentFairValueDisclosure_e250cc13-883e-4368-a765-108ca44ee591" xlink:href="bmrn-20210930.xsd#bmrn_OtherAssetsNoncurrentFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_bmrn_OtherAssetsNoncurrentFairValueDisclosure_e250cc13-883e-4368-a765-108ca44ee591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_526a0a49-66d5-4e0a-bd62-bde7b8eebbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_526a0a49-66d5-4e0a-bd62-bde7b8eebbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherLiabilitiesCurrentFairValueDisclosure_79b8446f-732d-4e78-8790-8b227a826ea4" xlink:href="bmrn-20210930.xsd#bmrn_OtherLiabilitiesCurrentFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_bmrn_OtherLiabilitiesCurrentFairValueDisclosure_79b8446f-732d-4e78-8790-8b227a826ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure_2c92bc51-7918-4f19-bb54-a740b7127b9c" xlink:href="bmrn-20210930.xsd#bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure_2c92bc51-7918-4f19-bb54-a740b7127b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d86045a6-2631-4fbb-9eb9-8b7196b88463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_de60c418-942e-4591-ae40-c299025e258e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d86045a6-2631-4fbb-9eb9-8b7196b88463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1d17841b-609d-48cd-92c9-6fa906910c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f6e681a7-74b4-4983-b1c2-b5239376bc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1d17841b-609d-48cd-92c9-6fa906910c99" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f6e681a7-74b4-4983-b1c2-b5239376bc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1f9db0de-acdd-4dd1-b511-1b9730335ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f6e681a7-74b4-4983-b1c2-b5239376bc4c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1f9db0de-acdd-4dd1-b511-1b9730335ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4ed28f4f-d627-4ce6-a6e9-872a65ec7f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1f9db0de-acdd-4dd1-b511-1b9730335ab2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4ed28f4f-d627-4ce6-a6e9-872a65ec7f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentPaymentMember_181b9034-2bbf-4336-88a5-20cf8afddf94" xlink:href="bmrn-20210930.xsd#bmrn_ContingentPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4ed28f4f-d627-4ce6-a6e9-872a65ec7f67" xlink:to="loc_bmrn_ContingentPaymentMember_181b9034-2bbf-4336-88a5-20cf8afddf94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1c9cbc6a-2fc9-4bd8-bf1e-90b06784c1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_f6e681a7-74b4-4983-b1c2-b5239376bc4c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1c9cbc6a-2fc9-4bd8-bf1e-90b06784c1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1c9cbc6a-2fc9-4bd8-bf1e-90b06784c1fb" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d380ab59-130c-4534-bd90-256c362c2b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d380ab59-130c-4534-bd90-256c362c2b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e2fd9a73-5f71-4a74-ad8c-c3d6ae91ee09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e2fd9a73-5f71-4a74-ad8c-c3d6ae91ee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement_d3e9f7cd-885a-4405-8eb0-00c8db6b810b" xlink:href="bmrn-20210930.xsd#bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:to="loc_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement_d3e9f7cd-885a-4405-8eb0-00c8db6b810b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d2f27684-d194-4255-bcb1-f468265a8a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_af2b606d-6944-473b-958f-25b9977415aa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d2f27684-d194-4255-bcb1-f468265a8a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIES" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIES"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d0d07e80-0ba9-43e2-aea1-5e3babef3488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5edea6ae-f80f-47d9-a566-34bfd519bfb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d0d07e80-0ba9-43e2-aea1-5e3babef3488" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5edea6ae-f80f-47d9-a566-34bfd519bfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d3ce6988-03ca-41bf-81a1-3d48421743ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_751ba00e-e105-4e34-bc5a-08e1fac8e85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d3ce6988-03ca-41bf-81a1-3d48421743ca" xlink:to="loc_us-gaap_DerivativeTable_751ba00e-e105-4e34-bc5a-08e1fac8e85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b3ffea99-328d-41f7-9769-4ee5c9db9c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_751ba00e-e105-4e34-bc5a-08e1fac8e85c" xlink:to="loc_us-gaap_HedgingDesignationAxis_b3ffea99-328d-41f7-9769-4ee5c9db9c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3878432b-6af7-46e2-ab87-f0d575e873e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b3ffea99-328d-41f7-9769-4ee5c9db9c7a" xlink:to="loc_us-gaap_HedgingDesignationDomain_3878432b-6af7-46e2-ab87-f0d575e873e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3b17e08f-a458-4f32-afcf-defb14bc134d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3878432b-6af7-46e2-ab87-f0d575e873e0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3b17e08f-a458-4f32-afcf-defb14bc134d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_751ba00e-e105-4e34-bc5a-08e1fac8e85c" xlink:to="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_e935d054-8332-42ec-aaa9-edf4b2492052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:to="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_e935d054-8332-42ec-aaa9-edf4b2492052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7678b4fe-02ed-4180-b21a-441ee7890e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7678b4fe-02ed-4180-b21a-441ee7890e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_f92d4494-8339-4cf9-b6f0-1478c5f3fd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6349811e-0199-4b75-a51c-11f9c6c72ef3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_f92d4494-8339-4cf9-b6f0-1478c5f3fd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_21b156f6-79e7-4833-a923-4411f08396a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_51074020-36b6-4ca5-a4c2-ff192d8268d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_21b156f6-79e7-4833-a923-4411f08396a5" xlink:to="loc_us-gaap_DerivativeTable_51074020-36b6-4ca5-a4c2-ff192d8268d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_462e4f4b-902e-4b3d-bca7-36728a63c253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_51074020-36b6-4ca5-a4c2-ff192d8268d2" xlink:to="loc_us-gaap_HedgingDesignationAxis_462e4f4b-902e-4b3d-bca7-36728a63c253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f90ce568-684b-442a-aebe-175c43cfcb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_462e4f4b-902e-4b3d-bca7-36728a63c253" xlink:to="loc_us-gaap_HedgingDesignationDomain_f90ce568-684b-442a-aebe-175c43cfcb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3959e2ba-cb62-4cc0-9e18-fe727b5bff48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f90ce568-684b-442a-aebe-175c43cfcb5a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3959e2ba-cb62-4cc0-9e18-fe727b5bff48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f5025f40-73dc-4a41-b34b-ba35262b6e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f90ce568-684b-442a-aebe-175c43cfcb5a" xlink:to="loc_us-gaap_NondesignatedMember_f5025f40-73dc-4a41-b34b-ba35262b6e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3c6d21e3-dda2-4b01-aba6-81c08a5475e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_51074020-36b6-4ca5-a4c2-ff192d8268d2" xlink:to="loc_us-gaap_DerivativeLineItems_3c6d21e3-dda2-4b01-aba6-81c08a5475e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_0e77f100-d865-4fb6-bc36-70c052d93334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3c6d21e3-dda2-4b01-aba6-81c08a5475e4" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_0e77f100-d865-4fb6-bc36-70c052d93334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_da7d7f5d-85f0-4e2b-bf09-b666ac7a0a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3c6d21e3-dda2-4b01-aba6-81c08a5475e4" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_da7d7f5d-85f0-4e2b-bf09-b666ac7a0a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2e9ba5d8-c778-433d-ae5e-1bcaff041572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2e9ba5d8-c778-433d-ae5e-1bcaff041572" xlink:to="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_fc99b77a-2778-46df-beac-9b37e65497ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:to="loc_us-gaap_HedgingDesignationAxis_fc99b77a-2778-46df-beac-9b37e65497ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f5b16c0c-6b40-45e7-bef2-668d1a64b3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_fc99b77a-2778-46df-beac-9b37e65497ce" xlink:to="loc_us-gaap_HedgingDesignationDomain_f5b16c0c-6b40-45e7-bef2-668d1a64b3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b8f4f9f9-e825-401f-8574-14c3ed87f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f5b16c0c-6b40-45e7-bef2-668d1a64b3fb" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b8f4f9f9-e825-401f-8574-14c3ed87f9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d81b1f90-c96d-4fb1-a503-d4f52877e71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f5b16c0c-6b40-45e7-bef2-668d1a64b3fb" xlink:to="loc_us-gaap_NondesignatedMember_d81b1f90-c96d-4fb1-a503-d4f52877e71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_063e4094-6a9f-4043-8fde-15d90041715e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_063e4094-6a9f-4043-8fde-15d90041715e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ea98f63e-c549-48f0-af98-0ad9ee165297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_063e4094-6a9f-4043-8fde-15d90041715e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ea98f63e-c549-48f0-af98-0ad9ee165297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2cdc4078-5c12-4acd-8144-8bc0953c3981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ea98f63e-c549-48f0-af98-0ad9ee165297" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2cdc4078-5c12-4acd-8144-8bc0953c3981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_f31b0472-e4f1-4166-9e20-c2fc84fd4be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:to="loc_us-gaap_PositionAxis_f31b0472-e4f1-4166-9e20-c2fc84fd4be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_e42eae31-5273-4508-972b-1bf3539dce87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_f31b0472-e4f1-4166-9e20-c2fc84fd4be8" xlink:to="loc_us-gaap_PositionDomain_e42eae31-5273-4508-972b-1bf3539dce87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_88317532-4e48-4bc7-bbde-0ce5c800fda9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_e42eae31-5273-4508-972b-1bf3539dce87" xlink:to="loc_us-gaap_ShortMember_88317532-4e48-4bc7-bbde-0ce5c800fda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_c8c9dbdc-4e26-44c4-963f-41a7c46c6a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_e42eae31-5273-4508-972b-1bf3539dce87" xlink:to="loc_us-gaap_LongMember_c8c9dbdc-4e26-44c4-963f-41a7c46c6a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ac2a79f7-40c5-4554-a2dc-42920a0ac803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_19e417a0-0b07-452d-839f-050c86103f27" xlink:to="loc_us-gaap_DerivativeLineItems_ac2a79f7-40c5-4554-a2dc-42920a0ac803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b7ac82cd-5e47-447c-9cd6-af25daa159ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ac2a79f7-40c5-4554-a2dc-42920a0ac803" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b7ac82cd-5e47-447c-9cd6-af25daa159ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_311078cc-00ae-4826-8f2b-92dc5c89074b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_311078cc-00ae-4826-8f2b-92dc5c89074b" xlink:to="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_addc3059-34f6-4168-9d52-16711b594fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_addc3059-34f6-4168-9d52-16711b594fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40b9de2c-9ab4-4c9a-b8fa-4376e690ec47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_addc3059-34f6-4168-9d52-16711b594fe7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40b9de2c-9ab4-4c9a-b8fa-4376e690ec47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_548cedfd-56fa-4e89-b394-1e8abd8ca7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40b9de2c-9ab4-4c9a-b8fa-4376e690ec47" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_548cedfd-56fa-4e89-b394-1e8abd8ca7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6b8a8712-33ac-478f-8b1b-8dd32260bdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:to="loc_us-gaap_HedgingDesignationAxis_6b8a8712-33ac-478f-8b1b-8dd32260bdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_41ea4fec-bcdb-4f7b-af44-adb7bc23d591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_6b8a8712-33ac-478f-8b1b-8dd32260bdc6" xlink:to="loc_us-gaap_HedgingDesignationDomain_41ea4fec-bcdb-4f7b-af44-adb7bc23d591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_310a0cd4-ce1f-440c-95c3-110e9332ba75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_41ea4fec-bcdb-4f7b-af44-adb7bc23d591" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_310a0cd4-ce1f-440c-95c3-110e9332ba75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_dc71cf4e-e9c7-4bc1-9840-3410f2b32ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_41ea4fec-bcdb-4f7b-af44-adb7bc23d591" xlink:to="loc_us-gaap_NondesignatedMember_dc71cf4e-e9c7-4bc1-9840-3410f2b32ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_10e7f9e6-745b-4668-9be8-21b1d3fe7563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_10e7f9e6-745b-4668-9be8-21b1d3fe7563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_10e7f9e6-745b-4668-9be8-21b1d3fe7563" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_2d81dc23-fc79-4ef1-a8ac-6b3cf1d7ba7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_2d81dc23-fc79-4ef1-a8ac-6b3cf1d7ba7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_a1e75a9d-0fe8-4037-b32f-a60249fa5bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_a1e75a9d-0fe8-4037-b32f-a60249fa5bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_96709adf-486c-4dfd-8b3a-5f654fc0103d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_96709adf-486c-4dfd-8b3a-5f654fc0103d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_45b56438-4e83-4ad7-ae7d-e7d059fc32e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3c35e7cf-539b-4fa2-a72d-22602c236c48" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_45b56438-4e83-4ad7-ae7d-e7d059fc32e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_551991d9-d3f5-4da0-b72b-b37b7737894e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b7f7555-0134-420e-80e4-420566ad7766" xlink:to="loc_us-gaap_DerivativeLineItems_551991d9-d3f5-4da0-b72b-b37b7737894e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ab6d6078-49b7-4ad6-ac2a-7d1b1a589041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_551991d9-d3f5-4da0-b72b-b37b7737894e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ab6d6078-49b7-4ad6-ac2a-7d1b1a589041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5076c044-b088-46b0-8dc7-6c22b9d23dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_551991d9-d3f5-4da0-b72b-b37b7737894e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5076c044-b088-46b0-8dc7-6c22b9d23dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_51801282-fe29-49aa-9f76-8a928f176a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_51801282-fe29-49aa-9f76-8a928f176a9a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_32977b6c-508e-4fe0-be50-a628ca9cede9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:to="loc_srt_ProductOrServiceAxis_32977b6c-508e-4fe0-be50-a628ca9cede9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c29665b4-8f4d-4b10-94ed-7c87e0456056" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_32977b6c-508e-4fe0-be50-a628ca9cede9" xlink:to="loc_srt_ProductsAndServicesDomain_c29665b4-8f4d-4b10-94ed-7c87e0456056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_0aaa4d69-ff00-4d89-bdfe-dc99233d671e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c29665b4-8f4d-4b10-94ed-7c87e0456056" xlink:to="loc_us-gaap_ProductMember_0aaa4d69-ff00-4d89-bdfe-dc99233d671e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4c62cfa9-aa2b-427d-a65d-040d00e8fe55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4c62cfa9-aa2b-427d-a65d-040d00e8fe55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8333f60c-156b-4398-a489-046ef4354889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4c62cfa9-aa2b-427d-a65d-040d00e8fe55" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8333f60c-156b-4398-a489-046ef4354889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_19656469-eaae-4067-abef-7174a1c8baf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8333f60c-156b-4398-a489-046ef4354889" xlink:to="loc_us-gaap_OperatingExpenseMember_19656469-eaae-4067-abef-7174a1c8baf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e8da92d9-2a9d-4336-bb8f-66d9d54ed907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:to="loc_us-gaap_HedgingDesignationAxis_e8da92d9-2a9d-4336-bb8f-66d9d54ed907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_027314c6-f931-44d4-b59d-e3a077ce4a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e8da92d9-2a9d-4336-bb8f-66d9d54ed907" xlink:to="loc_us-gaap_HedgingDesignationDomain_027314c6-f931-44d4-b59d-e3a077ce4a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f05efdc1-edf7-4a45-9d52-b3eb0891e603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_027314c6-f931-44d4-b59d-e3a077ce4a1f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f05efdc1-edf7-4a45-9d52-b3eb0891e603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_99dee9d6-a1fb-4e08-85b8-a8295159fd84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_027314c6-f931-44d4-b59d-e3a077ce4a1f" xlink:to="loc_us-gaap_NondesignatedMember_99dee9d6-a1fb-4e08-85b8-a8295159fd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_923d6243-cc1e-4128-bfec-e0eae192cde7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_923d6243-cc1e-4128-bfec-e0eae192cde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_56ea8214-772d-4c77-9108-f09c94fbb93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_923d6243-cc1e-4128-bfec-e0eae192cde7" xlink:to="loc_us-gaap_EquityComponentDomain_56ea8214-772d-4c77-9108-f09c94fbb93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fc10f2e5-c708-4ee4-b250-2dee61ed59ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_56ea8214-772d-4c77-9108-f09c94fbb93a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_fc10f2e5-c708-4ee4-b250-2dee61ed59ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a30c03c8-955e-4bdc-b776-74754fab0010" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffc994d4-b47f-419d-bf73-e3f79e175eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffc994d4-b47f-419d-bf73-e3f79e175eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5eecbcca-b242-4321-877f-51a695a6dd13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:to="loc_us-gaap_CostsAndExpenses_5eecbcca-b242-4321-877f-51a695a6dd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0277518e-e075-4710-a090-2e07ba447578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0277518e-e075-4710-a090-2e07ba447578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_b693ba8c-9de2-40df-aa56-0b020ff774a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2ac50c21-a54b-4618-8fd8-c67ca4516fbf" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_b693ba8c-9de2-40df-aa56-0b020ff774a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DEBT" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_10333906-c213-45cb-bd8f-6615fd7001e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_24113b99-6156-4e10-907e-4ffc171e0d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_10333906-c213-45cb-bd8f-6615fd7001e4" xlink:to="loc_us-gaap_LongTermDebtTextBlock_24113b99-6156-4e10-907e-4ffc171e0d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DEBTTables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a5b43948-2158-4aae-b3a7-a344000a57aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_728af531-be7e-4ffb-bad2-bb97c275984d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a5b43948-2158-4aae-b3a7-a344000a57aa" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_728af531-be7e-4ffb-bad2-bb97c275984d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_c17a9cdf-fbfd-4c45-9e32-4885c6003bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a5b43948-2158-4aae-b3a7-a344000a57aa" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_c17a9cdf-fbfd-4c45-9e32-4885c6003bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DebtAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DebtAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DebtAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_83e48cc3-57aa-43dc-8e82-59884753c091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_79133d30-d896-4374-8a7a-8b46d3fb795c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_83e48cc3-57aa-43dc-8e82-59884753c091" xlink:to="loc_us-gaap_DebtInstrumentTable_79133d30-d896-4374-8a7a-8b46d3fb795c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3a3a69f2-c3b4-4ce0-b106-2aa693dc37e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_79133d30-d896-4374-8a7a-8b46d3fb795c" xlink:to="loc_us-gaap_DebtInstrumentAxis_3a3a69f2-c3b4-4ce0-b106-2aa693dc37e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2ce8339b-1a0f-42f2-bb66-48ff370ab86e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a3a69f2-c3b4-4ce0-b106-2aa693dc37e8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2ce8339b-1a0f-42f2-bb66-48ff370ab86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember_0e0331c5-03f1-48a4-8cd9-d757715d126a" xlink:href="bmrn-20210930.xsd#bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2ce8339b-1a0f-42f2-bb66-48ff370ab86e" xlink:to="loc_bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember_0e0331c5-03f1-48a4-8cd9-d757715d126a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_79133d30-d896-4374-8a7a-8b46d3fb795c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_7ee4a0d0-968f-451a-a1d0-d12912ae3e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_7ee4a0d0-968f-451a-a1d0-d12912ae3e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7b45a7b-c044-4ed2-a4e4-d594f5d3104c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7b45a7b-c044-4ed2-a4e4-d594f5d3104c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a539de4b-d1d5-4594-912e-9f1be926134b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a0c7f8b-6f4e-4825-a655-b92f391192b7" xlink:to="loc_us-gaap_LineOfCredit_a539de4b-d1d5-4594-912e-9f1be926134b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DebtSummaryofConvertibleDebtDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_64d9d088-e89b-41c3-a527-a2b2a8252ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8da29f52-419d-437b-8171-e0d942f7a538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_64d9d088-e89b-41c3-a527-a2b2a8252ceb" xlink:to="loc_us-gaap_DebtInstrumentTable_8da29f52-419d-437b-8171-e0d942f7a538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5b0b7b2b-ec4d-436e-852b-18717ffed783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8da29f52-419d-437b-8171-e0d942f7a538" xlink:to="loc_us-gaap_DebtInstrumentAxis_5b0b7b2b-ec4d-436e-852b-18717ffed783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e78e27d7-78e7-454c-ba67-32179544b8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5b0b7b2b-ec4d-436e-852b-18717ffed783" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e78e27d7-78e7-454c-ba67-32179544b8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member_e1ca567e-9c98-4d4a-b870-517463e0817d" xlink:href="bmrn-20210930.xsd#bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e78e27d7-78e7-454c-ba67-32179544b8a9" xlink:to="loc_bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member_e1ca567e-9c98-4d4a-b870-517463e0817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember_fe034c75-48d8-4860-b9c2-00175504ea0e" xlink:href="bmrn-20210930.xsd#bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e78e27d7-78e7-454c-ba67-32179544b8a9" xlink:to="loc_bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember_fe034c75-48d8-4860-b9c2-00175504ea0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8da29f52-419d-437b-8171-e0d942f7a538" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c1538c63-a36b-4b72-9b1b-922ef4ae92af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c1538c63-a36b-4b72-9b1b-922ef4ae92af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2d1064da-27de-4ba9-91c2-9f2af3264357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2d1064da-27de-4ba9-91c2-9f2af3264357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4c3872db-8387-4631-840a-5e0fdc0b6baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4c3872db-8387-4631-840a-5e0fdc0b6baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_2e3c60e2-fe0d-42d7-a9e4-f616d73dc167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_2e3c60e2-fe0d-42d7-a9e4-f616d73dc167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_9df044fc-717b-4a63-af4b-0a0e796035fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_9df044fc-717b-4a63-af4b-0a0e796035fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_040627dd-5845-446c-bce1-bb64883c2119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_ConvertibleDebt_040627dd-5845-446c-bce1-bb64883c2119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_5fc7f109-9802-4dbc-9e23-2496d37d7df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d478ae4c-64cb-47aa-b5e6-bf759681ab4b" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_5fc7f109-9802-4dbc-9e23-2496d37d7df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#DebtSummaryofInterestExpenseonConvertibleDebtDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c8c93de3-a115-400f-950d-21afa1e51e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfInterestExpensesTable_a9916ce9-d895-4082-a9d5-46fd6f947173" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfInterestExpensesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c8c93de3-a115-400f-950d-21afa1e51e27" xlink:to="loc_bmrn_ScheduleOfInterestExpensesTable_a9916ce9-d895-4082-a9d5-46fd6f947173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fdc1ea9e-d3e8-4dd3-b3fc-c5d8d84c8548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfInterestExpensesTable_a9916ce9-d895-4082-a9d5-46fd6f947173" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fdc1ea9e-d3e8-4dd3-b3fc-c5d8d84c8548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6ff60f82-8e19-47fb-917f-932e31b23545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fdc1ea9e-d3e8-4dd3-b3fc-c5d8d84c8548" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6ff60f82-8e19-47fb-917f-932e31b23545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_42dff0b0-a11d-4455-b633-c6fc29ba88e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6ff60f82-8e19-47fb-917f-932e31b23545" xlink:to="loc_us-gaap_ConvertibleDebtMember_42dff0b0-a11d-4455-b633-c6fc29ba88e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:href="bmrn-20210930.xsd#bmrn_ScheduleOfInterestExpensesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfInterestExpensesTable_a9916ce9-d895-4082-a9d5-46fd6f947173" xlink:to="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b25ad83c-df36-477e-a8c6-080f887fd63e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b25ad83c-df36-477e-a8c6-080f887fd63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_5e35d57f-c6da-488f-857c-e3e0ab3f1b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_5e35d57f-c6da-488f-857c-e3e0ab3f1b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_ba5c98b1-b692-4df8-ad1e-6464a5d2b32d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_ba5c98b1-b692-4df8-ad1e-6464a5d2b32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_35c03595-b856-41de-a80a-7999fd8b88f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ScheduleOfInterestExpensesLineItems_45b39cac-f62a-47df-9598-040642fcc24d" xlink:to="loc_us-gaap_InterestExpense_35c03595-b856-41de-a80a-7999fd8b88f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="bmrn-20210930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5aae390f-b3ae-451e-9d2a-7c944515acb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c9e75a09-1115-4a42-8a0f-71b22b54a813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5aae390f-b3ae-451e-9d2a-7c944515acb9" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_c9e75a09-1115-4a42-8a0f-71b22b54a813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_053113c4-4362-455a-bddb-fe1a74c24ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5144d69d-a18b-4186-b2dc-d0c38e71feca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_053113c4-4362-455a-bddb-fe1a74c24ad2" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5144d69d-a18b-4186-b2dc-d0c38e71feca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_50786d03-a99b-4bac-b2f5-2a603e13fa90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2930df90-3090-4c2c-a0c6-8bf2cc92beac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_50786d03-a99b-4bac-b2f5-2a603e13fa90" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2930df90-3090-4c2c-a0c6-8bf2cc92beac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fa7e41b9-3d9b-4c95-863c-67faf28208e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2930df90-3090-4c2c-a0c6-8bf2cc92beac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fa7e41b9-3d9b-4c95-863c-67faf28208e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fa7e41b9-3d9b-4c95-863c-67faf28208e8" xlink:to="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_03671016-9714-4df4-8d3e-d151d272b988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_03671016-9714-4df4-8d3e-d151d272b988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4891a801-3c45-40d9-8dd9-49b4094d262b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4891a801-3c45-40d9-8dd9-49b4094d262b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_AccumulatedGainLossFromOtherMember_28a1af5c-32c6-4dca-a31b-08cd45fbd9a1" xlink:href="bmrn-20210930.xsd#bmrn_AccumulatedGainLossFromOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:to="loc_bmrn_AccumulatedGainLossFromOtherMember_28a1af5c-32c6-4dca-a31b-08cd45fbd9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df592aec-f4f6-4a89-af90-581782ec1269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb1cb1c2-1b3b-4825-a64e-4ec82e1274cb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df592aec-f4f6-4a89-af90-581782ec1269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3dcbf7d2-5a2e-4799-9556-84c6d9146fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2930df90-3090-4c2c-a0c6-8bf2cc92beac" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3dcbf7d2-5a2e-4799-9556-84c6d9146fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3dcbf7d2-5a2e-4799-9556-84c6d9146fc5" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_41fe9e1c-0146-4844-a939-e39efef28ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_StockholdersEquity_41fe9e1c-0146-4844-a939-e39efef28ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_1fd33051-650a-491f-bd7e-5d65ba60d203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_1fd33051-650a-491f-bd7e-5d65ba60d203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_3ac1d9e2-818c-4b7e-af5c-5f7ce127034b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_3ac1d9e2-818c-4b7e-af5c-5f7ce127034b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_08546052-64e1-4f67-afbd-dc6026c34521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_08546052-64e1-4f67-afbd-dc6026c34521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_66adcc0b-fc3f-41a5-9eb9-cff0bd083482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_66adcc0b-fc3f-41a5-9eb9-cff0bd083482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9084e0bf-da0f-4730-9455-906add9ef209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_13c2ef0b-8b1b-43d6-9394-85065df0b904" xlink:to="loc_us-gaap_StockholdersEquity_9084e0bf-da0f-4730-9455-906add9ef209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATION" xlink:type="simple" xlink:href="bmrn-20210930.xsd#REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATION"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_fd9bc046-5104-4919-b306-ca46273a6dea" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock_69e181eb-8e75-4b36-a41b-7afbdc36ece8" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_fd9bc046-5104-4919-b306-ca46273a6dea" xlink:to="loc_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock_69e181eb-8e75-4b36-a41b-7afbdc36ece8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_9e345197-b3b2-4443-be70-b65d2f753cf8" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_796550aa-4cb0-4896-9ec5-2c044f0e6e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_9e345197-b3b2-4443-be70-b65d2f753cf8" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_796550aa-4cb0-4896-9ec5-2c044f0e6e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_585f368a-dacf-4d1a-9af0-243ded7f84d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_9e345197-b3b2-4443-be70-b65d2f753cf8" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_585f368a-dacf-4d1a-9af0-243ded7f84d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_85aab5d7-3430-4074-9759-f900d90f4488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_9e345197-b3b2-4443-be70-b65d2f753cf8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_85aab5d7-3430-4074-9759-f900d90f4488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_03f41864-f0d4-4601-93b0-4dc83d56e383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_9e345197-b3b2-4443-be70-b65d2f753cf8" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_03f41864-f0d4-4601-93b0-4dc83d56e383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_8e6c195d-ac73-40ec-9ea1-99d5d9db426f" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_8e6c195d-ac73-40ec-9ea1-99d5d9db426f" xlink:to="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f03b54d2-726d-4624-a7a2-61d6a09aa5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f03b54d2-726d-4624-a7a2-61d6a09aa5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_137ffb4c-0ac0-48f5-af99-ab723661d204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f03b54d2-726d-4624-a7a2-61d6a09aa5f0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_137ffb4c-0ac0-48f5-af99-ab723661d204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_8e438cf5-543c-4895-b03e-c9896675b36d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_137ffb4c-0ac0-48f5-af99-ab723661d204" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_8e438cf5-543c-4895-b03e-c9896675b36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0cc43f0b-c9ec-4edc-ad66-ca0825760d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0cc43f0b-c9ec-4edc-ad66-ca0825760d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86af0725-ac5d-42b1-8de2-2d620caeb6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0cc43f0b-c9ec-4edc-ad66-ca0825760d8d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86af0725-ac5d-42b1-8de2-2d620caeb6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_b5f43153-0943-4431-995b-00be3600183d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_86af0725-ac5d-42b1-8de2-2d620caeb6cb" xlink:to="loc_us-gaap_AccountsReceivableMember_b5f43153-0943-4431-995b-00be3600183d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_647f8931-7056-4acf-ac94-c4921d7bf7b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:to="loc_srt_MajorCustomersAxis_647f8931-7056-4acf-ac94-c4921d7bf7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_647f8931-7056-4acf-ac94-c4921d7bf7b6" xlink:to="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerOneMember_c8e98d2e-52a2-48e2-9837-9e693bb38090" xlink:href="bmrn-20210930.xsd#bmrn_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:to="loc_bmrn_CustomerOneMember_c8e98d2e-52a2-48e2-9837-9e693bb38090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerTwoMember_fecc30ca-ecd2-4019-b995-642d1f12015b" xlink:href="bmrn-20210930.xsd#bmrn_CustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:to="loc_bmrn_CustomerTwoMember_fecc30ca-ecd2-4019-b995-642d1f12015b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomersMember_d7f81461-ede7-4213-8f51-31be114cf5a3" xlink:href="bmrn-20210930.xsd#bmrn_CustomersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7e5f5aea-1474-46f2-bca4-2d207f974db2" xlink:to="loc_bmrn_CustomersMember_d7f81461-ede7-4213-8f51-31be114cf5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationTable_3329bd8b-d97f-4859-8652-be51330678bb" xlink:to="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_e0e28324-66c5-451c-9315-37549f427bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:to="loc_us-gaap_NumberOfOperatingSegments_e0e28324-66c5-451c-9315-37549f427bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_2c6e453c-511c-4b3a-bd2b-b1863b882796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_2c6e453c-511c-4b3a-bd2b-b1863b882796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_bdbf2759-4bf4-4faa-bdaf-749100ef7331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationLineItems_8ce5ed08-07c9-4ee4-8604-333463df1c79" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_bdbf2759-4bf4-4faa-bdaf-749100ef7331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_ea9acff7-8395-473c-affc-0430cd5911fb" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_15003660-f5ba-4c95-aeb1-45cd2668303b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_ea9acff7-8395-473c-affc-0430cd5911fb" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_15003660-f5ba-4c95-aeb1-45cd2668303b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e5873b80-2eea-4249-9132-521db1010422" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_15003660-f5ba-4c95-aeb1-45cd2668303b" xlink:to="loc_srt_StatementGeographicalAxis_e5873b80-2eea-4249-9132-521db1010422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e5873b80-2eea-4249-9132-521db1010422" xlink:to="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4c7148fb-f627-48af-9c13-3eadc5511de2" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:to="loc_country_US_4c7148fb-f627-48af-9c13-3eadc5511de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_bba7034a-581a-4c47-9fb4-514f2a5ba230" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:to="loc_srt_EuropeMember_bba7034a-581a-4c47-9fb4-514f2a5ba230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_b1ce5608-00ea-49f7-9f8d-5b9c72ee0f87" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:to="loc_srt_LatinAmericaMember_b1ce5608-00ea-49f7-9f8d-5b9c72ee0f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RestOfWorldMember_af4c5cdf-5a53-4752-8ab3-dbb623947a2f" xlink:href="bmrn-20210930.xsd#bmrn_RestOfWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_00594e94-05e4-49c8-8c4c-826f87ff77cb" xlink:to="loc_bmrn_RestOfWorldMember_af4c5cdf-5a53-4752-8ab3-dbb623947a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3faa2bd8-1645-4a69-8c17-5c3758cbae40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_15003660-f5ba-4c95-aeb1-45cd2668303b" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3faa2bd8-1645-4a69-8c17-5c3758cbae40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5999d179-09cd-48ff-83e7-f05662f15932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3faa2bd8-1645-4a69-8c17-5c3758cbae40" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5999d179-09cd-48ff-83e7-f05662f15932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_4ab74a80-42f2-4f73-a69e-bfcdf5543740" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4ab3ed06-0dca-43ae-a9a3-49b4cdd8bea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_4ab74a80-42f2-4f73-a69e-bfcdf5543740" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4ab3ed06-0dca-43ae-a9a3-49b4cdd8bea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c903e35e-2c80-47e4-b094-19abbd1d7ac9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4ab3ed06-0dca-43ae-a9a3-49b4cdd8bea1" xlink:to="loc_srt_ProductOrServiceAxis_c903e35e-2c80-47e4-b094-19abbd1d7ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c903e35e-2c80-47e4-b094-19abbd1d7ac9" xlink:to="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductFourMember_1838fc5a-8317-4278-a6c3-1c0b69fd914b" xlink:href="bmrn-20210930.xsd#bmrn_ProductFourMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductFourMember_1838fc5a-8317-4278-a6c3-1c0b69fd914b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductTwoMember_84c96295-75ba-411f-82a5-fbcde18a0666" xlink:href="bmrn-20210930.xsd#bmrn_ProductTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductTwoMember_84c96295-75ba-411f-82a5-fbcde18a0666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductThreeMember_db0b3788-da41-401f-a5e7-efa1f7d4a84b" xlink:href="bmrn-20210930.xsd#bmrn_ProductThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductThreeMember_db0b3788-da41-401f-a5e7-efa1f7d4a84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductSevenMember_49e431df-edc0-4ad6-9b45-5ae82efa890b" xlink:href="bmrn-20210930.xsd#bmrn_ProductSevenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductSevenMember_49e431df-edc0-4ad6-9b45-5ae82efa890b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductSixMember_22de33cf-45f8-4b7d-ab7b-a0499ff80875" xlink:href="bmrn-20210930.xsd#bmrn_ProductSixMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductSixMember_22de33cf-45f8-4b7d-ab7b-a0499ff80875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductEightMember_8d40c4f7-242b-4d6b-8454-435cb9fcadbd" xlink:href="bmrn-20210930.xsd#bmrn_ProductEightMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductEightMember_8d40c4f7-242b-4d6b-8454-435cb9fcadbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductFiveMember_e1c4d1fb-25aa-44b4-be47-f61eb8c44675" xlink:href="bmrn-20210930.xsd#bmrn_ProductFiveMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductFiveMember_e1c4d1fb-25aa-44b4-be47-f61eb8c44675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductsExcludingProductOneMember_f13f30f8-86c5-48e0-98e7-cc3edd5149b0" xlink:href="bmrn-20210930.xsd#bmrn_ProductsExcludingProductOneMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductsExcludingProductOneMember_f13f30f8-86c5-48e0-98e7-cc3edd5149b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductOneMember_7a5d3df5-cddc-4121-bdbf-3a6272c41f59" xlink:href="bmrn-20210930.xsd#bmrn_ProductOneMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_bmrn_ProductOneMember_7a5d3df5-cddc-4121-bdbf-3a6272c41f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_e685a439-ece0-4966-be38-a55a92eaf39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_35a10479-079f-4518-bc09-598c88754ade" xlink:to="loc_us-gaap_ProductMember_e685a439-ece0-4966-be38-a55a92eaf39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_12696c05-517b-4de8-8367-b105fceb2af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4ab3ed06-0dca-43ae-a9a3-49b4cdd8bea1" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_12696c05-517b-4de8-8367-b105fceb2af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_00fb396f-456d-49d0-8357-33b090608938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_12696c05-517b-4de8-8367-b105fceb2af1" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_00fb396f-456d-49d0-8357-33b090608938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_dd86f347-13ab-4d91-b2aa-af8ee65d0462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_00fb396f-456d-49d0-8357-33b090608938" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_dd86f347-13ab-4d91-b2aa-af8ee65d0462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_f54cecea-1f09-452a-9139-9604c8883246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_00fb396f-456d-49d0-8357-33b090608938" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_f54cecea-1f09-452a-9139-9604c8883246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_22339c37-c9f8-43a4-af73-d6c43bee368f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4ab3ed06-0dca-43ae-a9a3-49b4cdd8bea1" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_22339c37-c9f8-43a4-af73-d6c43bee368f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35655978-83cd-4aeb-852f-61f3518a128a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_22339c37-c9f8-43a4-af73-d6c43bee368f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35655978-83cd-4aeb-852f-61f3518a128a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_59b51f17-233d-4701-b5e4-b1be920c7c41" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_59b51f17-233d-4701-b5e4-b1be920c7c41" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e62fa92f-f00f-4218-8a2b-c87e9cccdcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e62fa92f-f00f-4218-8a2b-c87e9cccdcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_178e9de8-bce6-4afa-a8ca-0aae0f746515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_e62fa92f-f00f-4218-8a2b-c87e9cccdcb8" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_178e9de8-bce6-4afa-a8ca-0aae0f746515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_50b05a46-1958-47d5-ae7f-5b5d74d03622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_178e9de8-bce6-4afa-a8ca-0aae0f746515" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_50b05a46-1958-47d5-ae7f-5b5d74d03622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_18eefd29-ac0e-43d4-a80a-47ae7ef5e25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_178e9de8-bce6-4afa-a8ca-0aae0f746515" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_18eefd29-ac0e-43d4-a80a-47ae7ef5e25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8dcdfa10-9c2f-4c96-8470-18b380a6e851" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:to="loc_srt_ProductOrServiceAxis_8dcdfa10-9c2f-4c96-8470-18b380a6e851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8dcdfa10-9c2f-4c96-8470-18b380a6e851" xlink:to="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductsExcludingProductOneMember_027314e9-987e-4ed4-8a04-e4f790d77c5e" xlink:href="bmrn-20210930.xsd#bmrn_ProductsExcludingProductOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:to="loc_bmrn_ProductsExcludingProductOneMember_027314e9-987e-4ed4-8a04-e4f790d77c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProductOneMember_f023944a-a052-4cba-820c-7383aca8f095" xlink:href="bmrn-20210930.xsd#bmrn_ProductOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:to="loc_bmrn_ProductOneMember_f023944a-a052-4cba-820c-7383aca8f095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_2a0fb65f-5cd0-4b44-b325-ea29a9ad0b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e252ccf8-2bc1-449b-b995-2ba5c79664cf" xlink:to="loc_us-gaap_ProductMember_2a0fb65f-5cd0-4b44-b325-ea29a9ad0b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e9766c34-4034-4339-a85b-cb4661d43f40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:to="loc_srt_StatementGeographicalAxis_e9766c34-4034-4339-a85b-cb4661d43f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e9766c34-4034-4339-a85b-cb4661d43f40" xlink:to="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1f729b8e-d602-44d9-ad58-364f951c4cfe" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:to="loc_country_US_1f729b8e-d602-44d9-ad58-364f951c4cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_35d3e982-27ab-4132-adeb-c20be4644be3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:to="loc_srt_EuropeMember_35d3e982-27ab-4132-adeb-c20be4644be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_f54e0066-99c2-4c49-85a2-9cdaca311ca0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LatinAmericaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:to="loc_srt_LatinAmericaMember_f54e0066-99c2-4c49-85a2-9cdaca311ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_RestOfWorldMember_1fa2cf62-56b9-4631-a2ad-9d861ef65ad7" xlink:href="bmrn-20210930.xsd#bmrn_RestOfWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f4da33e7-b0fe-474b-add5-2f29a8a21f1f" xlink:to="loc_bmrn_RestOfWorldMember_1fa2cf62-56b9-4631-a2ad-9d861ef65ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5dda7ef1-f234-4dde-96de-d427c236fa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2945a1a4-6bde-455d-85c0-ca70f246ef98" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_5dda7ef1-f234-4dde-96de-d427c236fa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe059c68-4584-4710-a5d6-630ae42060c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5dda7ef1-f234-4dde-96de-d427c236fa0d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe059c68-4584-4710-a5d6-630ae42060c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_6c712d1d-f474-4422-961e-ff4baa249b2d" xlink:href="bmrn-20210930.xsd#bmrn_ConcentrationRiskAndGeographicInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_ConcentrationRiskAndGeographicInformationAbstract_6c712d1d-f474-4422-961e-ff4baa249b2d" xlink:to="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5ad99e56-4d2f-46ec-b350-617f3fd29cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5ad99e56-4d2f-46ec-b350-617f3fd29cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9a91483d-943a-4330-99bd-fae2cdc4cd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5ad99e56-4d2f-46ec-b350-617f3fd29cf0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9a91483d-943a-4330-99bd-fae2cdc4cd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_a71e6782-a1c6-49d3-8ba0-1721ad475944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9a91483d-943a-4330-99bd-fae2cdc4cd7d" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_a71e6782-a1c6-49d3-8ba0-1721ad475944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_534579d4-8bea-4d8a-a7e9-468b723c3497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_534579d4-8bea-4d8a-a7e9-468b723c3497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_64442e95-98c0-4e3a-b3f8-a2a6040552a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_534579d4-8bea-4d8a-a7e9-468b723c3497" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_64442e95-98c0-4e3a-b3f8-a2a6040552a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_26afcc75-50a4-4c06-907b-e6734a7fff61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_64442e95-98c0-4e3a-b3f8-a2a6040552a3" xlink:to="loc_us-gaap_SalesRevenueNetMember_26afcc75-50a4-4c06-907b-e6734a7fff61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c55c2b8a-c994-4c28-bec8-b94d42f78421" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:to="loc_srt_MajorCustomersAxis_c55c2b8a-c994-4c28-bec8-b94d42f78421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_437564fc-9431-4bcb-91bd-127442f69acd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_c55c2b8a-c994-4c28-bec8-b94d42f78421" xlink:to="loc_srt_NameOfMajorCustomerDomain_437564fc-9431-4bcb-91bd-127442f69acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:href="bmrn-20210930.xsd#bmrn_CustomerOneTwoAndThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_437564fc-9431-4bcb-91bd-127442f69acd" xlink:to="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerOneMember_4c4bf6c4-128b-467c-8634-c55c30ad3960" xlink:href="bmrn-20210930.xsd#bmrn_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:to="loc_bmrn_CustomerOneMember_4c4bf6c4-128b-467c-8634-c55c30ad3960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerTwoMember_f28f7c6c-284d-47fc-beae-8ab359bfc34d" xlink:href="bmrn-20210930.xsd#bmrn_CustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:to="loc_bmrn_CustomerTwoMember_f28f7c6c-284d-47fc-beae-8ab359bfc34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CustomerThreeMember_86a314e2-71ca-4099-8777-53632af7c6aa" xlink:href="bmrn-20210930.xsd#bmrn_CustomerThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CustomerOneTwoAndThreeMember_710f0e0d-fd09-47e2-a6f7-8aee406e1737" xlink:to="loc_bmrn_CustomerThreeMember_86a314e2-71ca-4099-8777-53632af7c6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f6d65b55-4c2c-4c81-a6c5-4c88f27a960d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_407b79e2-5830-4f71-9dbf-5f4b356f39d6" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_f6d65b55-4c2c-4c81-a6c5-4c88f27a960d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c457a442-a9e8-4ac2-a180-cd61915d8736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f6d65b55-4c2c-4c81-a6c5-4c88f27a960d" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c457a442-a9e8-4ac2-a180-cd61915d8736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="bmrn-20210930.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1557466f-fafb-4da2-8793-77e255f67adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2092ec09-3301-42f3-ad9e-586bb59729b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1557466f-fafb-4da2-8793-77e255f67adb" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2092ec09-3301-42f3-ad9e-586bb59729b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_96073b00-c97f-441d-a2e2-4f160ae82a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9c90a448-1dae-4ccb-95dc-fc5e8d6bfe36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_96073b00-c97f-441d-a2e2-4f160ae82a24" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9c90a448-1dae-4ccb-95dc-fc5e8d6bfe36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/StockBasedCompensationExpenseDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#StockBasedCompensationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/StockBasedCompensationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_73bb9169-06f0-41c4-ab7b-206b59554e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3e5ce8c5-8bdc-4de5-b808-b1f518614d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_73bb9169-06f0-41c4-ab7b-206b59554e33" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3e5ce8c5-8bdc-4de5-b808-b1f518614d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b686daf9-6579-4439-b966-806d0023027a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3e5ce8c5-8bdc-4de5-b808-b1f518614d2b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b686daf9-6579-4439-b966-806d0023027a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b686daf9-6579-4439-b966-806d0023027a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_2e101c70-22e5-4bae-aa0f-2923554dfb35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:to="loc_us-gaap_CostOfSalesMember_2e101c70-22e5-4bae-aa0f-2923554dfb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_39812821-0964-4765-b551-fc156533ee32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_39812821-0964-4765-b551-fc156533ee32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3adda3d2-8fac-47eb-ad64-698dc4b9bbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4b02c3e7-736f-4338-be2c-09e40c8dd00f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3adda3d2-8fac-47eb-ad64-698dc4b9bbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1916c0ce-5044-41e7-8610-ec3b48f3ce4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3e5ce8c5-8bdc-4de5-b808-b1f518614d2b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1916c0ce-5044-41e7-8610-ec3b48f3ce4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3f83d279-77e5-47d4-8650-c9bf755d926d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1916c0ce-5044-41e7-8610-ec3b48f3ce4d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3f83d279-77e5-47d4-8650-c9bf755d926d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARE" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NETINCOMELOSSPERCOMMONSHARE"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_572c8cbc-eb02-44ad-8f11-da89c9f4f4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8b302f9e-c93e-4b97-b212-7638b4be27eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_572c8cbc-eb02-44ad-8f11-da89c9f4f4f9" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8b302f9e-c93e-4b97-b212-7638b4be27eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARETables" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NETINCOMELOSSPERCOMMONSHARETables"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2a6f15a9-ca2e-4206-a62b-e063620e145e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b353d3c0-185b-4b0b-9ec7-104c9f50f16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a6f15a9-ca2e-4206-a62b-e063620e145e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b353d3c0-185b-4b0b-9ec7-104c9f50f16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c5232df4-6863-49ac-bf94-95c9366291c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2a6f15a9-ca2e-4206-a62b-e063620e145e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c5232df4-6863-49ac-bf94-95c9366291c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_468329ef-387a-409f-b6b9-3b3698231768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb434eaf-84d3-44f5-93e5-53e331d60fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_468329ef-387a-409f-b6b9-3b3698231768" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb434eaf-84d3-44f5-93e5-53e331d60fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3d82068e-0d93-4453-8301-efa30f02dc78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb434eaf-84d3-44f5-93e5-53e331d60fe9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3d82068e-0d93-4453-8301-efa30f02dc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3d82068e-0d93-4453-8301-efa30f02dc78" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4e8cd45a-b31c-4a67-96ef-3ed6b7b54317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4e8cd45a-b31c-4a67-96ef-3ed6b7b54317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember_9b6da097-27ea-4913-b359-caadc05730f7" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember_9b6da097-27ea-4913-b359-caadc05730f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_b7fecfc7-86a3-4a95-b5d9-e7bcc4b480cc" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_b7fecfc7-86a3-4a95-b5d9-e7bcc4b480cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_5a6e7d71-53fa-4634-9965-7bbad15288d3" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_5a6e7d71-53fa-4634-9965-7bbad15288d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_71cf71c5-f448-4dc7-bf02-f3ba887cadf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_us-gaap_RestrictedStockMember_71cf71c5-f448-4dc7-bf02-f3ba887cadf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_4250c34c-ed13-4a2e-9f2f-13396f5c9a4a" xlink:href="bmrn-20210930.xsd#bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_4250c34c-ed13-4a2e-9f2f-13396f5c9a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_762cf907-525a-4ac5-bd98-7374a9b0af2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_218ae4e2-2f80-4bac-b24c-7379f2ab4865" xlink:to="loc_us-gaap_StockCompensationPlanMember_762cf907-525a-4ac5-bd98-7374a9b0af2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb434eaf-84d3-44f5-93e5-53e331d60fe9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e09339af-1cab-4c27-a7e8-75bea74a62f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e09339af-1cab-4c27-a7e8-75bea74a62f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_5e6a76af-627f-4681-bfeb-377312534dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_5e6a76af-627f-4681-bfeb-377312534dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_32b26705-ce58-4f06-8246-b9c6ab7eba94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_404e249c-40bb-4efd-a706-c7cd9492ea4a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_32b26705-ce58-4f06-8246-b9c6ab7eba94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a39286bd-af7b-48f3-8aa6-f18fa7c8920a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a39286bd-af7b-48f3-8aa6-f18fa7c8920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f9766797-88c8-4e19-9eab-acb62fb10477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a39286bd-af7b-48f3-8aa6-f18fa7c8920a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f9766797-88c8-4e19-9eab-acb62fb10477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_67ae1f13-1f22-4597-a56a-5d748d2b2ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_67ae1f13-1f22-4597-a56a-5d748d2b2ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_0f9f1f9e-4b72-4cb3-9688-00d55694a8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_67ae1f13-1f22-4597-a56a-5d748d2b2ed1" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_0f9f1f9e-4b72-4cb3-9688-00d55694a8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_30f2ea88-2e42-41a2-90b8-64910c0e8d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_30f2ea88-2e42-41a2-90b8-64910c0e8d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a9a5605a-c15c-4237-885d-ae03cf5a3d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_EarningsPerShareBasic_a9a5605a-c15c-4237-885d-ae03cf5a3d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e6329f2f-a55c-4536-90ec-f2e94db545c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_320568bc-61c9-429e-8242-0fde489430b2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e6329f2f-a55c-4536-90ec-f2e94db545c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a4670ac6-c53c-4f50-bdb5-077a4e47d63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_45be7536-4f10-4bd3-9423-e2d202daf9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a4670ac6-c53c-4f50-bdb5-077a4e47d63a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_45be7536-4f10-4bd3-9423-e2d202daf9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e613be70-bb07-4028-b606-c0af8dd9b1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_45be7536-4f10-4bd3-9423-e2d202daf9aa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e613be70-bb07-4028-b606-c0af8dd9b1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e613be70-bb07-4028-b606-c0af8dd9b1df" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f65b2730-05e7-4adc-b5f7-a84049274e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f65b2730-05e7-4adc-b5f7-a84049274e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_5b2286c1-d4d0-4123-bfe2-8b6bc9080852" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember_5b2286c1-d4d0-4123-bfe2-8b6bc9080852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_407bc020-6a23-405f-9a03-82aaa9df08a7" xlink:href="bmrn-20210930.xsd#bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember_407bc020-6a23-405f-9a03-82aaa9df08a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e8eaa9a8-91bf-4159-b8a7-03363f4c3298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_us-gaap_RestrictedStockMember_e8eaa9a8-91bf-4159-b8a7-03363f4c3298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_7c2c2992-8607-49ae-b1f6-a1b64e3e6861" xlink:href="bmrn-20210930.xsd#bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember_7c2c2992-8607-49ae-b1f6-a1b64e3e6861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_7b5b63d5-89e5-49bc-a004-1d8c97e7d2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_37060d11-411e-4634-8ba7-ef8d4a593fc5" xlink:to="loc_us-gaap_StockCompensationPlanMember_7b5b63d5-89e5-49bc-a004-1d8c97e7d2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f9aa1ab6-b4d6-491e-bcf9-a15bf56c4c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_45be7536-4f10-4bd3-9423-e2d202daf9aa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f9aa1ab6-b4d6-491e-bcf9-a15bf56c4c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e2aa385c-1be0-4a74-a447-204af4f75335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f9aa1ab6-b4d6-491e-bcf9-a15bf56c4c7c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e2aa385c-1be0-4a74-a447-204af4f75335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#NetIncomeLossPerCommonShareAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ed3b6911-a103-4ccb-956a-5117d7c4fd13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_EarningsPerShareTable_bafc0959-3fa5-44c5-b98f-62e808583338" xlink:href="bmrn-20210930.xsd#bmrn_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ed3b6911-a103-4ccb-956a-5117d7c4fd13" xlink:to="loc_bmrn_EarningsPerShareTable_bafc0959-3fa5-44c5-b98f-62e808583338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_83bc2ed3-020c-4276-95ad-9a3264aaf64f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_EarningsPerShareTable_bafc0959-3fa5-44c5-b98f-62e808583338" xlink:to="loc_us-gaap_DebtInstrumentAxis_83bc2ed3-020c-4276-95ad-9a3264aaf64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_121ed9f1-16c0-4c1e-bce9-564b262174f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_83bc2ed3-020c-4276-95ad-9a3264aaf64f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_121ed9f1-16c0-4c1e-bce9-564b262174f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember_23f89afe-8d7f-4417-badd-f24177f2e01d" xlink:href="bmrn-20210930.xsd#bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_121ed9f1-16c0-4c1e-bce9-564b262174f5" xlink:to="loc_bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember_23f89afe-8d7f-4417-badd-f24177f2e01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_EarningsPerShareLineItems_90557fd2-fb30-4e54-8d5e-90c57ea96d81" xlink:href="bmrn-20210930.xsd#bmrn_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_EarningsPerShareTable_bafc0959-3fa5-44c5-b98f-62e808583338" xlink:to="loc_bmrn_EarningsPerShareLineItems_90557fd2-fb30-4e54-8d5e-90c57ea96d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b6047f5-22f1-434a-a3d2-683b900f5302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_EarningsPerShareLineItems_90557fd2-fb30-4e54-8d5e-90c57ea96d81" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4b6047f5-22f1-434a-a3d2-683b900f5302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_33b8e025-736d-4d6e-b3f5-b064e37ca419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_EarningsPerShareLineItems_90557fd2-fb30-4e54-8d5e-90c57ea96d81" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_33b8e025-736d-4d6e-b3f5-b064e37ca419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="bmrn-20210930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_09793d77-2592-4197-9149-fccbac0607d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5ac81699-db92-460e-8ea4-b54b3ea53559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_09793d77-2592-4197-9149-fccbac0607d0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5ac81699-db92-460e-8ea4-b54b3ea53559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="bmrn-20210930.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bdb2d1a2-1130-4219-bc58-91647bf10bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommitmentsAndContingenciesTable_e4eb26b4-358a-42db-b3c5-3a751313703d" xlink:href="bmrn-20210930.xsd#bmrn_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bdb2d1a2-1130-4219-bc58-91647bf10bcf" xlink:to="loc_bmrn_CommitmentsAndContingenciesTable_e4eb26b4-358a-42db-b3c5-3a751313703d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_290ae565-d335-4ae8-9d36-5c894537dba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CommitmentsAndContingenciesTable_e4eb26b4-358a-42db-b3c5-3a751313703d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_290ae565-d335-4ae8-9d36-5c894537dba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_290ae565-d335-4ae8-9d36-5c894537dba8" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_KuvanAndPalynziqMember_de38c47a-3b4f-4821-a631-5c00acd54b97" xlink:href="bmrn-20210930.xsd#bmrn_KuvanAndPalynziqMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:to="loc_bmrn_KuvanAndPalynziqMember_de38c47a-3b4f-4821-a631-5c00acd54b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_EarlyStageDevelopmentProgramMember_ec9b3600-f07a-4abc-9ec2-af1502553177" xlink:href="bmrn-20210930.xsd#bmrn_EarlyStageDevelopmentProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:to="loc_bmrn_EarlyStageDevelopmentProgramMember_ec9b3600-f07a-4abc-9ec2-af1502553177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ProgramsNoLongerBeingDevelopedMember_1936f12d-0b3b-4253-877e-16c6083bef51" xlink:href="bmrn-20210930.xsd#bmrn_ProgramsNoLongerBeingDevelopedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_6301d13a-5bd6-489b-8ea6-3939d796078c" xlink:to="loc_bmrn_ProgramsNoLongerBeingDevelopedMember_1936f12d-0b3b-4253-877e-16c6083bef51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5f3d2b1e-512a-495c-9129-7998d9a6278e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CommitmentsAndContingenciesTable_e4eb26b4-358a-42db-b3c5-3a751313703d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5f3d2b1e-512a-495c-9129-7998d9a6278e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a97c82-ee65-43b5-8c65-e7a3abd2454c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f3d2b1e-512a-495c-9129-7998d9a6278e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a97c82-ee65-43b5-8c65-e7a3abd2454c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ThirdPartyMember_8411e8b8-b0bb-45e6-9565-68de8175c958" xlink:href="bmrn-20210930.xsd#bmrn_ThirdPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a97c82-ee65-43b5-8c65-e7a3abd2454c" xlink:to="loc_bmrn_ThirdPartyMember_8411e8b8-b0bb-45e6-9565-68de8175c958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:href="bmrn-20210930.xsd#bmrn_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CommitmentsAndContingenciesTable_e4eb26b4-358a-42db-b3c5-3a751313703d" xlink:to="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones_7afb7bfd-6c2f-48d2-89ba-34ea5196a53d" xlink:href="bmrn-20210930.xsd#bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones_7afb7bfd-6c2f-48d2-89ba-34ea5196a53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones_6fcf1c95-d5f9-4b53-801a-9c17dc252c7b" xlink:href="bmrn-20210930.xsd#bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones_6fcf1c95-d5f9-4b53-801a-9c17dc252c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_601414cd-743e-4fa2-bab0-edac1fe0a859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_601414cd-743e-4fa2-bab0-edac1fe0a859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ed007d4f-95ea-423b-8718-b173349eca9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ed007d4f-95ea-423b-8718-b173349eca9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_525eba7a-1c57-4230-9fc5-a2d931c04e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmrn_CommitmentsAndContingenciesLineItems_c6136d02-a14c-4977-9b6b-9f6c67a3e9d5" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_525eba7a-1c57-4230-9fc5-a2d931c04e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>bmrn-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bmrn="http://www.bmrn.com/20210930"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bmrn-20210930.xsd" xlink:type="simple"/>
    <context id="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8c2ba3fa4ed8493e8f1f5c6fdc1abfac_I20211026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <instant>2021-10-26</instant>
        </period>
    </context>
    <context id="icce161e9967344ce804b1ab36f4ae711_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8b17bc4d253c44789e173a8f801f46a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia9940e707613405199a97fc351ad73ef_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i055b5a733006483d91da202b094f7799_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:RoyaltyAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3f40e6fd2d594084b575d40ed0c6f0c8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:RoyaltyAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i342150f2921d4dc2a5acc57613812db0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:RoyaltyAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4549f3adaa5948939b7e0555d551796b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:RoyaltyAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i52f4f9636243498cb577db395fe3d626_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5ea54e8805bf4cd2bf97a56c86ecfccd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9bcd0ccc805b4b2f9e84aa347f9675e2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i99f00eb5b129417a84d6a7ccff242457_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac1a61de8d9a4f648cd0094a00ba3a7c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5a1d232828b343fc85f1f99a3762f4b6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if0ad0618f364452792421d091dfef160_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic0d7c667fbcb49a492cc496e20a9533b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i17802777da7643c6ab25cac57f541c1e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icebcf4632bc041ecb270987af3929f4b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifaca57bc041147b381f06e8aa17857c6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i42ac9247fd2e436cb417f1972275fb4a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1c5c0d0d2b0e4255835d887bcfa9bc17_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7268a9baa84143e28737ef38b1cfc7a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i64cc87601ea34f3381da0fca0b298bc6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i731188fc3d2044b7a23a6e217ea305e4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i89b52d173ad54772a29d1b6f7bbf6459_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4caba0337f8f4b2e8f9100f7d140d5ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7778fc67467846b8a67a75902f463e54_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if5f0aad336a3452ea25f24ba710ac93a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i627eef1092454bb98b2d4c1cea40f20e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibc9d74897922454eac93c39ab9193ed7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia07691e24f2f4f37b1f16b61b6cc50ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6703cd6e3a77492f925f347aaebd345a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i88dc8a11226046f1a9d9868cad8f27ca_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6f1406297b474f139305e89552bbcad7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5f2a6e362d84481d9b46790a952c3eb8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifedfb7039355401494da9d79b4b019f7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib1bb9f866ca4475eaf5dfcb3fa669cb2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia8d3c91fa0884ce985a56dd462a786fd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i76ba0bfe4241498cabc063f575c0fe8c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if019850925824862b004fe4ce0fba35f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibd15da83cca44176a0b4b0f67a931a98_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia5e64d06d88e4e6bacfa1c4bee506c2d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6dd786401f3846dc9ebfe35c03ae7cf0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i80fd59e3ac5943d4a4576ec081be6729_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib796b32eb4e84dd39329cb270e0eb237_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icdb4d2c8bde5486194ee9f8978433d7b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i42144fd1c7cc40b4a19862971243a6c2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibe71756343b8462d9a1e0b2139797942_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ice2e3bd0516f4927a3ea54940b0473b8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i10986a90b6074a24befea81408205ba6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i847ccef2e0f749cdbc16c784f8bc20d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5980981b2d94a21af89adbff48bff67_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib502302b9e2f484da8ae334c586b7015_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i139ebe39eaac4c3d89f8d6a430777353_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3cfe02f4a80f4b47b9a60dde2af5de31_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia2a90b89293d4d568258cb84a8b82013_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id0db40041dc54511b7a5f5d17ab13fa6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i51c38a2eb11344c1ac10d203ceb97e13_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i768baa6d2e434ec181651dc6bc5d351d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i65c51e81a86e484d8e7ecfbdeae9fe9b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d51116bdb2447edbdb006552af68df6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i803bcd43ae324221accf1b091be40cd1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if010a0db0da649f79724c29782c82b57_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6033594232bd45b1956bdbbb3ec09c3b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4d08ea1a9cb14bb59451b5d3e37c8e09_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1f6ffb6089bc436588ddb4e558536c98_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i84daa993a3914c4c816bec79eb0a2d5a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id6c0821a737d46339e19959fec1fb613_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i69394941701f4792bc6f78d5bfdc9119_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i092d463f25cb4152ba73021fba9889ce_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4d20f611273a4520a0ddf24ac3708e9a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id2bca3ca974d463382d836efec728b90_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9ec348bbb7f64676b204903ae8051084_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i83982dff494c4b33a4599c8c6a1968ad_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bmrn:ForeignGovernmentAndOtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia86cd7b86979490aa97d8927574181fd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2a59471cdb774223b5fed280196aaf44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i488ef63d388c46e596c31f59acedb699_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i298462249e6b46a59433814c9c95bc6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25d3fa48aabf431f9fa22df5de090b3f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i162aeed19afc494baff177a2e9200423_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">bmrn:ForeignGovernmentAndOtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i16cd77d91ae74138b0023e6dd344da16_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0773e69a8654dc28600db905fe0c0c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i006e8ae23bc74eac869d8244cb0ea0e0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic294b781dea64354bcafffc53a309b98_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia39f9739911c4c249c40c8527867d977_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i00b5b9602a84434ca20f4f840240bef5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:StrategicInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i91df24e30587451888b969c1c50cf8b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:StrategicInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7c76bf362194f4c9c4a2b8976accd00_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">bmrn:VoxzogoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i90bb59f2a5034770af163bb6ee32ed42_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i66dbe62d10fc46af9552314aa77c1455_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa92d196dfad4856ba23ebe72dc99f42_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7cd9d72b38ed4e9ab14a43d4125dd712_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i702edec792f8459193e0e7428f963179_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5eac74c17ffb48aaa66512c312d26ffc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if941c596ef754cf388dd3fe27f85f62f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if961eb44a8474191b0fe4f51e700bec0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id075d2f472a347109be07404276f404d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2d63e3d6780541b5a95aef5456b53700_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4c71299431fd4b1d9395950472c5dd54_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8f9c820d5a2d477c8a45f38d368f4ad4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaaf21895256243eba4baadc21bba8dfd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie1a690d1f00e43688891861ad4caf2bb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i120bad79c9cf44618fab7a064046a548_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6a982d145fec445ab50db51d29d51ec4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4853afdcb6b3425eade1470b05d78550_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85d0caf2974040c1832284f6ac9f30c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48430041f0f14488a182cdf2a6fba1ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:NonqualifiedDeferredCompensationPlanAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf61805c0d2a4049b81025cec2ddb75a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1deec9d3e3eb4a42adefe62e56bfd128_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c1a81b9cccd4a1cba5fc0003b7aea8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">bmrn:RestrictedInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4efa93be091e41e2a53f2f9cfc80f758_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i671e3945deec4183bb208f00b654f148_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29763c9514834fa79c4c3fc2e884e8dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i357642068229410d9b9eb92835bff095_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a7e416850cb47f6aefc2fb4df37b5f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if27816fb13254b9694f700f40dbdbbff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:NonqualifiedDeferredCompensationPlanLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5add67eb11e7443caf320c8d4619f132_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i33751b4c2ccd47d3bf56b6c79e05210a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c8d2de98a23439b8a9c5086c8a66fc1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i615edf13dd9645ddb17b1b2bd0c8b9e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8fcd6f6536d4855824ff24db3d6b5c7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie591deab87f84651a1f0e8a8b378340d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">bmrn:ContingentPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i14bf2ac4d92840cb8a1f7aae38462abd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id61c318f76764a7fa034c58b06aedb1b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i801ae299848e42d9a8bba895edfc93ae_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4255a1344130421b867098a0db4b4234_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3b9c04057d24a85901bdc543d7f5881_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8911e37b2bf14742badb679e3603864b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c536cb7054e4cb6b74a31bf41dbf674_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2d28061c88a44b7aa46deded1cf2e6a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87c65af7fe274f899122097d464a1bf4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id6af4b58a85d47a2a7ed411542576cd3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia65f45b20e934503b719a9058ffc0aa1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if4fa8d281e98402cbfe0bbf358bd183d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i998dfa69cd654bfbbac7b62ef70c8ee1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2959731ccc2d46129ed431c7d2b06d80_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib57861f66fb846acac9f83cdc9e47785_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5d72a61dbc164a95830296964a405193_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i653a9dcd97a14cdd9a1732d3b2674534_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i45acdc04438043e3a8bd6387c422da66_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i56a8390484ae4b6f877f15cfcbcb0f27_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibd69df912beb45dbad86a43d5165bd04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibcf858e58d4a42deb0197ad3a84b8e2a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8d22d4a686e04d89add5ad2e6c2dbb50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife95d4f1adbe4a8fa995aa600c1b72ae_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id2ddd51b05b44b81b4cac9334ce55095_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a0867d2abd245aeb03cd68ad004aa7a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifa5e54ce01d4462f8417aa877f5454bd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i93a85736fa1a4177831386b25c03128a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3dc4e113aded47d28e12f99a50683bbe_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5396b9f8638140eab847f0bdfcab099a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6257cb31e6a74435a04b92f18161c169_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icbedd8a5f7224c52a0e6a43b72b26b32_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i63cb5ebbe7144d7cbd04769985192b4d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2f69cb4b88254f89ae7a84113b9ef9e4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia10f257e647949e8a3b8943db642b6ba_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5bd960385e494621870825c06ea5d0dc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2d0ec83a5e8c401ab387d676b8db9044_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:A125SeniorSubordinatedConvertibleNotesDueInMay2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4e007e38fb6a46adacda2d712f243e5e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:A125SeniorSubordinatedConvertibleNotesDueInMay2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ffe2646b01c4c7c8c425382618ea995_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i43b959de93cc4964a01bc54cd284fd1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i38a00422432443d785988f4c838194eb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iba2ae00a5eea4923b638351403ec6b48_I20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="iee37fe35ae7740dbbf5492520ad69a15_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7a1454c700cf4b51a23d6f33d90c7c8a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8717ee13ca8c430dbecd711039a7e46f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if511f9ed24f948619a2e53651da7e114_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5608486f3aab45158217508c7361b8db_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie4f8068feed342d0852f9c527519b97c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3faf010302b3404ebb5a5088bb42c52b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7a6b9095a67c4e829c8badebfb6d9376_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2825e372b0ea4c4db7b030d62cb5b3f7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2551e7c9a1f04acdbbd714ef15b18e6f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i75e63c14188b429a96626e5e45c2c116_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ica6ad443b63d459f92df9ffbcae2b88a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i99ca830558c94af29e572b85e6fb0ab0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibd5abfbe741a48819ae2f94da173f77b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id254242e029e4cd29e695890e7e368f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02c79f2fe3684a398bd2294ebbe2c99b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e57bf81424a40c5b3adb66b880dae12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2c8a1231bd26440ca6973d994e0f4e4d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieadae4e29a7041f4a3ad734dc312b2df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i67f6d6511e9149758c5097fab5fffa22_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i81fa1b38663f441883ba5f2445470397_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmrn:AccumulatedGainLossFromOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id6aa5a87b7f84d18a23293902aaa2e41_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i68586ccb7def4122a05e7dc73d213d39_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7b53329fe7c14a3683433e7d34adb246_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b96c70e0c2243afb027cbcdf282e765_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i10f485d362c24177a8d80735201ecbee_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i430f9e39597d43d393863a8ba5c47dc4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic3df6603453545b7adf0538e4c3b867e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i750ce40f585c411fa47c2bf163efafec_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9d097b6776c84a1290432379dfafe6e5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4a82d895132f4cf6aee55df85842bf75_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2cc4be5e7bfe4c5887dec731969031b7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i692ea98645da4650a217fb7fa5bc5f98_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0c01dec0e80c49a8a216d3ccf0b483f5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iadfc6366c9ee4fde9f1d3c3304473be1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6b3baec2de8a480aa194af6ef4b7e7ce_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ief7778f7e8ed4c60a7007014fbf78a94_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i26cfa0a05050405c8fc26ff4270b410b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia499a895b89d43c8802609e44742ca26_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i56ce74ad21854f5b8073837e7f9d4f30_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie2a8b2e0af7d4f48bdd2df8ec9a9c5ba_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i54e5f5c18fb24ebbbdbdc5dbbd131b25_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i39e0766182094853983cc6543e242eda_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i75f418730286417b9103ef1bc9d70fec_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id740cf897d394b40be718d4aa51cddf7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2d38170f263d4c87b138198d14dfb01d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i52c332e9563842deac7a1a89d768fb91_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id8d768a033874a13a0aece3c89f824e3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieee6144f7440430d96c3ea711e06e0dd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3631083badb04533a1ccf53e70983c60_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i875080367e32474e9692930d4f70440d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie9cac278154a4c64a3a2d789e69239d0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0fc0dde4f53c44c9ab53a2e5cd3dac81_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id0a6844bfd4f4df3937b1bc5c15c6c0c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ec5b3fcbcc741d5a41938c2bff9a968_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iba2fef5336cd4754aac2a52f8ee715a2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie1e72a8e38a54f589382be95578b29c1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i670eba932fa44bb4bd105fa2472fdee7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7163a6ce6d8a4b90ba5be5da895aca0d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i77f222cc3eb0499293097be2613706be_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i631b06fa4a4a46759658c5e1ed96fe88_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2ce796da9cb04582bb8c002435a42a15_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i596ae291f078453886ecff564ae864a5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5625d09abfec4da9b5135b5a49fd61c5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3c767f53af74489081063ce938ee5371_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i78de7c806e9548728df05080cfa9fdef_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i765f4a74e39242298ebb8e42f5429fd3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6306c147c133472a919f7ac957a8c7b2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id2b11e951dfb403a9db9d7fa77793d35_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icca877ecc41644f7a512279ba3a5aebf_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i12c53d3790994dfb8fd77b8b0750df93_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idf2f153984e34dcfb6ebf47a69c25d0e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i587f8139747846de862e02316f943301_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i807900e9e70040c78da438a82a6b9728_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7ea93a722dde4f8eb67bfd01814148e7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7f6996af9c2645e7ad8462878e32a8fa_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id813d823802b4adeae79cd8494384ba1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1624a814864c43ecbbd5abad76321c1f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i673c282af5fc4cf3828509c09115858e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5e031326bd7645bf8c67c80bc0590247_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia3fada62c864453b990f024e22826a2a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8815ae63b15048de91d1036580169b4f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b38429ecef7410fb6e6cb17cf99bc23_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i36276fddfb9440c49f578739c2e2e93b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib5a9b8c4c57440bd972de38d327ff06d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i903cb5741f0c454ab0cd6e60497f87f1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i12e8c0e180a24083884a28374d6b19aa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib327b203d9f641f4b16be80c7a022310_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i15c17cda19c7411bbf1a312a56665382_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmrn:ProductsExcludingProductOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmrn:RestOfWorldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4d24f4221ce54b7587582cc1483c6c20_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia22dd234fb9743fd92d299421432bd77_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4522cd9712214bb087ea4996aa558624_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ida8af263c560424abb1f9b025ffbc888_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i85eed5105d974313b640fec757ed2132_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic605b00f4bfb47dd91d3f6f7057661fb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifd471de3fee2400e88e55081b5edc7f4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i35e7d66a6cac42129aa948cfaf2eb317_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie383b687557e497388831485ea18b47a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5bae986f7e264602844d3457fa91c27c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieb287505a9684940b9d27b688febaea4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i687b7d4238fe4663857bbb9e1446ee16_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i06311aaf1fc84255bf7c628cde958a0e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneTwoAndThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i17442b5bbd98454d91144658893a0d26_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneTwoAndThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iad3b61ba06404cd29a53bc8482a92839_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneTwoAndThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6c313f30b00c4ffbbe6049bf40e5fce8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneTwoAndThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id03d4506cf9848689c776b8acd1a1fd9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icc7289dbd839469db4eb56c8b0923f40_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice7397073cd84c17909c8a881afdc5a5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9318c02208c342038447a03fa145e77f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i88011345f9af4a4eb848131cb3723ff8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4642aed64b8147e68d905a18605026ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">bmrn:CustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i366685cece5e413497a14d201c6aaeec_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i600447fd1d334ac4a8cf19039623fed1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4341d0928f7b46a9bb9a16aba139dad9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id1af7d3e6ac447faad8ad74652f4be9c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5bbe544e6bb7468ab675761c05ac7036_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i240305f0192242b4933888c226e238e1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icd8bde7f09ba4955bdcbbb6490d77c3c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb2e6a3e17a54d9294f3f2237cb340fe_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id5f1a069c36941e09fb5bea33a6ddbe9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if8128c3889a44d2e9cc52bdcfafa283e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic471c1470b9e42899741b0b5a360a28d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iea947a2a70cd4cc48f0e3fa73c7b87e4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8e0d79598b4a4fe0894f5f0b5c8d05d2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i12651120f91f4b4f8cebb3b98050584d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i90f88b98995241caafd2941a4333cb2b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5acc9dcae0254e3a91a091eaad031510_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ide7de364296046cd8ec673ebf4f708e4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i99d8ea1fded44a5dbe57d52c95b8740d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icfb006a5635c4e3786096f48ad41e1c1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1e1a43efe88f4d2b8dbb12448e0fcfbb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifc32bd96b3014e92b2f0efc81b2ae66a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i483fea5cfb454ba7a3044cf8f94b872c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0936ac22ba0641e3baa0b8544e010e8f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6693bf5374b04cec9cbcc298b6b9df9b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i712f67daf8994797927c8bdb430e55c9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9264da2f9bbd4f2fb33480144d2f85a9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0589f3a72cba42008e9af75b85655bfc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i747d9cadb0334a97b76371c9665c4ff0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6195d3f0e2374354b38eb0cc2ab77d14_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i88ec953e8f554e02994b61549a84b786_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i210b958efc1e4be3928a76fb8c2b4d1b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id68539b93ebe41578d0997661f7c7067_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i635b1aa8136841889975e9745d917b9f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:CommonStockIssuableToEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i70906b8925394dfeb8414b49b6c11841_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:CommonStockIssuableToEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia7b754b4139a4554aa9b7b4108bd3cb4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:CommonStockIssuableToEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9cfa47a706aa4d73921235a75ded8670_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bmrn:CommonStockIssuableToEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia6a4e7a972ff46bea3882f3ced06ea4b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i857f8284e96b4d529652faaf70a41f4f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7718da1375c940c7aad6f404d81e8204_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0a415fe6e6094b7ab63c7d3ca2b9aa95_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic20a7b693de94d51a8059e3b28b30754_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib965f565ed34406a849028c30350f306_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmrn:OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib0c45fdc691545eca329a4b5abc34572_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmrn:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmrn:KuvanAndPalynziqMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0f2e2c7117c147a3bf29ed90d8327de7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmrn:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmrn:EarlyStageDevelopmentProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5eacd8a06aed4d4fa25cd448dd9cefbe_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmrn:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmrn:ProgramsNoLongerBeingDevelopedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>bmrn:Segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV8yLTEtMS0xLTA_50399816-70dd-4ef6-84ae-ad72110d84f9">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV8zLTEtMS0xLTA_df3653c7-86c1-4f21-8814-72415d6529b8">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV80LTEtMS0xLTA_f9f91dfa-514d-4785-bd97-207162235243">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV81LTEtMS0xLTA_9b506237-5c70-4c05-8242-942159fbe068">0001048477</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183L2ZyYWc6YjkxNWE2MjE3ZGU1NDg0MjlkMWRjMzI4ZDViMTM2OGEvdGFibGU6ZDk0NTc2ODBiNjEyNGYyOWJlNGY0ZDNhYjY2ODMxODEvdGFibGVyYW5nZTpkOTQ1NzY4MGI2MTI0ZjI5YmU0ZjRkM2FiNjY4MzE4MV82LTEtMS0xLTA_550863e5-3316-46e7-bf59-825edd40cc29">--12-31</dei:CurrentFiscalYearEndDate>
    <bmrn:LongTermMarketableSecuritiesMaturityPeriod
      contextRef="ic294b781dea64354bcafffc53a309b98_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_846ad3c9-24f9-4d1a-9f5f-7c49adee4aad">P1Y</bmrn:LongTermMarketableSecuritiesMaturityPeriod>
    <bmrn:LongTermMarketableSecuritiesMaturityPeriod
      contextRef="ia39f9739911c4c249c40c8527867d977_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_a635e30b-c744-47ea-a80a-981c71554d83">P1Y</bmrn:LongTermMarketableSecuritiesMaturityPeriod>
    <dei:DocumentType
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8xMjU_8320ec15-320c-4f78-b6a5-c3dc42d1a808">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6ZjRmZTkwZTFlMWZiNDNmYjg5MjNiZGYxMjFmMjdmMDMvdGFibGVyYW5nZTpmNGZlOTBlMWUxZmI0M2ZiODkyM2JkZjEyMWYyN2YwM18wLTAtMS0xLTA_27a96363-0096-455f-b6f7-398f1be83834">true</dei:DocumentQuarterlyReport>
    <dei:DocumentQuarterlyReport
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6ZjRmZTkwZTFlMWZiNDNmYjg5MjNiZGYxMjFmMjdmMDMvdGFibGVyYW5nZTpmNGZlOTBlMWUxZmI0M2ZiODkyM2JkZjEyMWYyN2YwM18wLTAtMS0xLTA_ec38811f-b825-4ae0-b2af-a4802478ef2e">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8yMTE_b39ad858-a0bf-4aa1-bb95-b6eed6ad9ec3">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6M2Q0ODkyNDlhMzExNDVjYWExNzM3ZWEwYjM3MDEwYmIvdGFibGVyYW5nZTozZDQ4OTI0OWEzMTE0NWNhYTE3MzdlYTBiMzcwMTBiYl8wLTAtMS0xLTA_030ed44c-b17e-43e7-810f-8e5be59d9915">false</dei:DocumentTransitionReport>
    <dei:DocumentTransitionReport
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6M2Q0ODkyNDlhMzExNDVjYWExNzM3ZWEwYjM3MDEwYmIvdGFibGVyYW5nZTozZDQ4OTI0OWEzMTE0NWNhYTE3MzdlYTBiMzcwMTBiYl8wLTAtMS0xLTA_9c5801b3-e7e4-4988-ab0d-b534a5b5abe8">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8zMjE_74b1ceed-a644-4c14-b232-82972881bcea">000-26727</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8zNjU_4b4c0165-d6e0-4109-9259-3bdd939711de">BioMarin Pharmaceutical Inc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8wLTAtMS0xLTA_83eff6d1-7fb1-4580-97a5-2af14fc31e4d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8wLTAtMS0xLTA_c3225537-fea5-4f62-b023-9eaa1031e5a3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8wLTMtMS0xLTA_13dc1af7-79e8-439d-8427-e53317e834f7">68-0397820</dei:EntityTaxIdentificationNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8wLTMtMS0xLTA_82671717-caaf-4fe4-af3c-22ccf1598ef3">68-0397820</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTAtMS0xLTA_7a784409-7ada-4993-bfea-6cb76a8853c7">770 Lindaro Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine1
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTAtMS0xLTA_9602357d-4c24-4a20-8970-fa397292e754">770 Lindaro Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTEtMS0xLTA_04852476-b636-48eb-87b7-327407feea9a">San Rafael</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCityOrTown
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTEtMS0xLTA_ae3137d5-4c53-45fc-bf2e-f3eed93cff56">San Rafael</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTItMS0xLTA_3c314a6b-f48f-4795-9b87-dda1e1c110c6">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressStateOrProvince
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTItMS0xLTA_d4754644-618d-489c-94b1-317f1d887f60">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTMtMS0xLTA_9b6f9526-fda8-4909-8b8d-bd72c9804b39">94901</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6MDZlYmQ1NDc2MGQwNGFmZmJhMDA4OGE2MjYzYWY4MTAvdGFibGVyYW5nZTowNmViZDU0NzYwZDA0YWZmYmEwMDg4YTYyNjNhZjgxMF8zLTMtMS0xLTA_f8086c0c-4620-4ae9-8dc1-7e43665a48fe">94901</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl80Njk_f7a7cccf-20cd-43cd-baaa-b764d836f82b">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl80NzM_d62faba4-c919-4433-8b42-1d9b36c04fc5">506-6700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTAtMS0xLTA_681853f8-9738-498d-83d6-88a0378c96c4">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTAtMS0xLTA_8fc6cfc8-fecc-4e48-96c1-e1de0517fd48">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTItMS0xLTA_86d3f9c1-db4b-4a82-8104-8c72ca26d9cb">BMRN</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTItMS0xLTA_b49cb37a-0a7d-47d9-a06d-964c41149230">BMRN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTQtMS0xLTA_456c598d-2e9d-449e-9f44-ef17cd4b1c8a">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NWJkZTI0MmRiODU0NDNiODk2M2Y2MmI0M2QwM2NmYzUvdGFibGVyYW5nZTo1YmRlMjQyZGI4NTQ0M2I4OTYzZjYyYjQzZDAzY2ZjNV8xLTQtMS0xLTA_7bbafa67-3fbb-45c4-ad79-6003775c246e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8xMDE5_d4203ada-28c2-4407-946b-af6ab0c29ef7">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8xMzQ3_aefc1c1a-1e16-4998-b3d0-a7805ec5cbfe">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8wLTAtMS0xLTA_94f4eb4d-3ce3-49a4-b829-156b1d97a2c7">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityFilerCategory
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8wLTAtMS0xLTA_f4ca7ae7-4ffb-4d48-bd1c-0ff2d13bb189">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8yLTYtMS0xLTA_19382a66-f01e-417b-80e1-603c2f0856fb">false</dei:EntitySmallBusiness>
    <dei:EntitySmallBusiness
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8yLTYtMS0xLTA_2a44f3f9-e686-4a2e-89e8-3aceff1358f5">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8zLTItMS0xLTA_19e1d111-b42b-4b11-9f8c-99cc72ec24cb">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGFibGU6NThjZDc4ZGYwYWY0NGI0MDg0MmNhNWUxZGEyNWIxYzAvdGFibGVyYW5nZTo1OGNkNzhkZjBhZjQ0YjQwODQyY2E1ZTFkYTI1YjFjMF8zLTItMS0xLTA_8112a4ef-23ad-4f35-8ef9-7c4434e94f65">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8yMDg3_55033c35-524b-401e-af0c-5f2fc73aa0d2">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i8c2ba3fa4ed8493e8f1f5c6fdc1abfac_I20211026"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xL2ZyYWc6OTc5NTIxNjE0NGVmNDZkMjg4OTc2ZTVhNTY1Njk4YWIvdGV4dHJlZ2lvbjo5Nzk1MjE2MTQ0ZWY0NmQyODg5NzZlNWE1NjU2OThhYl8zMjk4NTM0ODg1NzYw_69501a2c-10f2-40bf-9127-71faf37af0ab"
      unitRef="shares">183593434</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMy0xLTEtMS0w_1c2fe5d2-e79f-4105-8204-a916d8649e78"
      unitRef="usd">617143000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMy0zLTEtMS0w_963a8511-19cd-4d3b-b379-dc85f72b46aa"
      unitRef="usd">649158000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNC0xLTEtMS0w_e1910c4c-214f-4943-99a8-a8efe8f60c2e"
      unitRef="usd">462333000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNC0zLTEtMS0w_2af7c84e-15a2-469f-b3a2-40f9942c0465"
      unitRef="usd">416228000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNS0xLTEtMS0w_75ed21e9-2ba8-42ea-b200-73c3cb171b49"
      unitRef="usd">374937000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNS0zLTEtMS0w_ef7e6176-5a24-43b3-b8a2-3739ebaf709a"
      unitRef="usd">448351000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNi0xLTEtMS0w_cb9067dc-2c7f-4209-aff1-a441dd1e7f2b"
      unitRef="usd">749406000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNi0zLTEtMS0w_04862746-47e9-481f-b137-44e29e1163a1"
      unitRef="usd">698548000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNy0xLTEtMS0w_79f7ff89-9f00-4657-84d5-0a08128da7e6"
      unitRef="usd">107751000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNy0zLTEtMS0w_d739060c-a214-4c3a-96e9-aa59f7e45b2e"
      unitRef="usd">129934000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfOC0xLTEtMS0w_cf13643a-3257-438b-8526-37674e5d90fc"
      unitRef="usd">2311570000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfOC0zLTEtMS0w_b171cb64-0d12-49c8-b234-4ba21419be22"
      unitRef="usd">2342219000</us-gaap:AssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTAtMS0xLTEtMA_65099031-c6f3-4a13-9181-3c22d53d03e6"
      unitRef="usd">466618000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTAtMy0xLTEtMA_5021714b-41f4-4186-97af-827af3879f97"
      unitRef="usd">285473000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTEtMS0xLTEtMA_7dccf76e-62a7-41ae-a769-3a49b87b5388"
      unitRef="usd">1024787000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTEtMy0xLTEtMA_8a434401-71b4-4fed-860e-e33037f86e30"
      unitRef="usd">1032471000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTItMS0xLTEtMA_694faf1c-d80d-4b11-8962-297d6c8c83df"
      unitRef="usd">388487000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTItMy0xLTEtMA_440b4086-be9e-4834-8028-38898b0ec0a3"
      unitRef="usd">417271000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTMtMS0xLTEtMA_0bd282f7-6ab3-46cd-8ca2-726c8532a3b9"
      unitRef="usd">196199000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTMtMy0xLTEtMA_e43ea724-b6c9-4507-90eb-1e0e5d1f128a"
      unitRef="usd">196199000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTQtMS0xLTEtMA_8c0c5f5e-5571-485e-8871-dbad4853e2ef"
      unitRef="usd">1445109000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTQtMy0xLTEtMA_db827f36-5b7a-4bc7-942c-a859676323d1"
      unitRef="usd">1432150000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTUtMS0xLTEtMA_d79ae7cd-d8c3-4ca2-aebe-70f7f45e14da"
      unitRef="usd">144705000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTUtMy0xLTEtMA_7754568c-0ccf-4705-b267-dcd4e8a01736"
      unitRef="usd">142237000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTYtMS0xLTEtMA_f3dc5a40-9979-4ed6-84ab-ba535f859c7a"
      unitRef="usd">5977475000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTYtMy0xLTEtMA_1c993f34-625e-4306-a646-d7023a602565"
      unitRef="usd">5848020000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTktMS0xLTEtMA_6997f921-efe4-41bd-b7bc-c3cc68a7e822"
      unitRef="usd">466711000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTktMy0xLTEtMA_be2bf46a-bb44-4592-afef-c68248e5b1e1"
      unitRef="usd">492548000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjAtMS0xLTEtMA_50f3cfd7-5914-4904-b65d-86d53868c905"
      unitRef="usd">48187000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjAtMy0xLTEtMA_e50909c2-33f9-467b-81bb-cc16fc65ec8c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjEtMS0xLTEtMA_de7fb1af-ea17-48e5-8ce1-b0b3f2d32a66"
      unitRef="usd">514898000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjEtMy0xLTEtMA_720e73e0-635b-439e-9636-dce68aecaac9"
      unitRef="usd">492548000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjQtMS0xLTEtMA_31027e45-2405-40eb-8c8c-57ab3fe3659e"
      unitRef="usd">1078093000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjQtMy0xLTEtMA_848e667a-fd89-455e-959c-16985e3ddf57"
      unitRef="usd">1075145000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjUtMS0xLTEtMA_9f87f94c-3ef6-402d-ade5-faa6d304059c"
      unitRef="usd">15204000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjUtMy0xLTEtMA_ef878db6-765a-4c07-8bdd-66a9d9ab891f"
      unitRef="usd">60130000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjYtMS0xLTEtMA_63f67b24-cc6e-46d4-bd11-a0a9b8dcf7e3"
      unitRef="usd">103131000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjYtMy0xLTEtMA_eb2dac2a-2bb4-4a15-ae9d-a418aee0af6a"
      unitRef="usd">114195000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjctMS0xLTEtMA_da1fa412-8ce6-4d65-ad04-4a583158af75"
      unitRef="usd">1711326000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjctMy0xLTEtMA_2b8ca420-b415-4866-8e39-2de9ae3b70d0"
      unitRef="usd">1742018000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzE4_37ab95b7-bde9-4b5b-a43a-08563ccc10f0"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzE4_a6b05af5-ceea-4db8-bc89-bb903d3954af"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzMy_2272e61f-c28d-406f-9d32-89451ca7a17f"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzMy_8fd4fa30-ae08-457e-9662-559af063282d"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzU0_47df38e5-ef0a-4658-9abc-48b776f23986"
      unitRef="shares">183567424</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzU0_feb1116a-a305-4122-b296-77d558c61644"
      unitRef="shares">183567424</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzYx_c8319fc3-a057-4179-b234-17dfc4ce6573"
      unitRef="shares">181740999</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmI5MmVlOThkN2FiZDQ4OTc5YmQyY2RjNDY2MzY4YTA0XzYx_d3ed7f40-9005-433b-aa7a-a6b7b335a0f2"
      unitRef="shares">181740999</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMS0xLTEtMA_50abd420-260f-4c87-8109-baf30c88a89e"
      unitRef="usd">184000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMy0xLTEtMA_f77147f8-14f4-46ce-ba75-39ed2a695044"
      unitRef="usd">182000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzAtMS0xLTEtMA_5079317e-e77e-4d28-ba8f-4190feadcd76"
      unitRef="usd">5133742000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzAtMy0xLTEtMA_3a751c61-52c3-4c35-b74f-7be0a7f656ae"
      unitRef="usd">4993407000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:CommonStockIssuedEmployeeStockTrust
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzEtMS0xLTEtMA_6204fa3a-8746-43c6-a44c-ea30f1b78271"
      unitRef="usd">10225000</us-gaap:CommonStockIssuedEmployeeStockTrust>
    <us-gaap:CommonStockIssuedEmployeeStockTrust
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzEtMy0xLTEtMA_f90ceb0a-0a8d-484c-bd86-7b5eb48578b3"
      unitRef="usd">9839000</us-gaap:CommonStockIssuedEmployeeStockTrust>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzItMS0xLTEtMA_b90dacff-7483-41de-855e-8e8525c315a9"
      unitRef="usd">10239000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzItMy0xLTEtMA_aee410e3-2710-492c-be12-ff105db632d4"
      unitRef="usd">-16139000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzMtMS0xLTEtMA_904561a6-b894-46d5-83eb-f54cca5b1062"
      unitRef="usd">-867791000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzMtMy0xLTEtMA_768b19d3-3929-492e-b163-68865a2bb538"
      unitRef="usd">-861609000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzQtMS0xLTEtMA_7ef8e509-7e86-4a43-94ea-882baa084134"
      unitRef="usd">4266149000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzQtMy0xLTEtMA_ab8e1abd-438c-4bbf-8e67-ef972f7e8e57"
      unitRef="usd">4106002000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzUtMS0xLTEtMA_130b9be1-6fbb-4a83-9213-73db4c1dfc40"
      unitRef="usd">5977475000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzUtMy0xLTEtMA_c5cca7ad-592b-43c3-90e3-1ecd7964bf98"
      unitRef="usd">5848020000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMy0xLTEtMS0w_b9bed7b5-40fc-4a87-bba8-2884ca9ad03b"
      unitRef="usd">393840000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMy0zLTEtMS0w_a4acdcb0-07cb-460a-b8be-6a8e64d51732"
      unitRef="usd">460741000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9940e707613405199a97fc351ad73ef_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMy01LTEtMS0w_50f61e94-c61e-4f6d-bbb0-47e170fc84c0"
      unitRef="usd">1348279000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMy03LTEtMS0w_6798dbb7-2eb5-4b3b-84be-dc9fdb7bbbdf"
      unitRef="usd">1368816000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i055b5a733006483d91da202b094f7799_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNC0xLTEtMS0w_574e1ae7-e0d7-4f55-a878-77a075e15929"
      unitRef="usd">14902000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f40e6fd2d594084b575d40ed0c6f0c8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNC0zLTEtMS0w_93479910-9ebf-4547-a468-90271bfedcfa"
      unitRef="usd">16043000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i342150f2921d4dc2a5acc57613812db0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNC01LTEtMS0w_0ad2d95a-2053-4d33-aaa8-379d093a4ffa"
      unitRef="usd">48186000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4549f3adaa5948939b7e0555d551796b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNC03LTEtMS0w_1b144a5f-cb5e-4ab2-b734-029808c0dcbe"
      unitRef="usd">39522000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNS0xLTEtMS0w_88ea3993-f1a5-4ead-8066-1c0bb147dba1"
      unitRef="usd">408742000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNS0zLTEtMS0w_e2ea8023-ac80-4d71-a1ec-5997b69ebaa6"
      unitRef="usd">476784000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNS01LTEtMS0w_ff849845-0a5b-408c-82bb-77c9b20ae5cd"
      unitRef="usd">1396465000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNS03LTEtMS0w_771c7ad1-0d05-4288-853a-c3a110d1ce8e"
      unitRef="usd">1408338000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNy0xLTEtMS0w_00204dd7-977b-4a69-9f71-67108d7cb794"
      unitRef="usd">103537000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNy0zLTEtMS0w_4e658f80-6cf0-4838-9662-c45db5fe25d2"
      unitRef="usd">188793000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNy01LTEtMS0w_179deeba-8295-410f-b34c-00e39cf3da54"
      unitRef="usd">350765000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfNy03LTEtMS0w_9ce2ef30-5ceb-4781-8931-a3c1a5bdc03a"
      unitRef="usd">398134000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOC0xLTEtMS0w_1d994998-6887-4624-a949-c2026044319d"
      unitRef="usd">157869000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOC0zLTEtMS0w_adc2a920-a82e-4828-ab8a-2b2c05782365"
      unitRef="usd">147053000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOC01LTEtMS0w_80c5e24c-cc1c-4ac2-a597-f17f1917e03c"
      unitRef="usd">467701000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOC03LTEtMS0w_4cb66aa6-e244-4a09-a37b-dcdd36e1163c"
      unitRef="usd">471449000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOS0xLTEtMS0w_bbda2c8f-9862-4cfb-9fd8-65fcf0eec62a"
      unitRef="usd">183333000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOS0zLTEtMS0w_02cbe313-0f58-4dcb-bb87-b51ab3665f55"
      unitRef="usd">179450000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOS01LTEtMS0w_c4e0ba58-a277-4dfc-b875-55a524468507"
      unitRef="usd">541812000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfOS03LTEtMS0w_d16953ed-a726-470b-a42d-d169c8b1e957"
      unitRef="usd">542157000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <bmrn:IntangibleAssetAmortizationAndContingentConsideration
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTAtMS0xLTEtMA_5ed43ede-19cf-4c0a-a80e-8392c2883777"
      unitRef="usd">17222000</bmrn:IntangibleAssetAmortizationAndContingentConsideration>
    <bmrn:IntangibleAssetAmortizationAndContingentConsideration
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTAtMy0xLTEtMA_83dd3be3-8a22-4f43-9891-6a42e2688ca8"
      unitRef="usd">17429000</bmrn:IntangibleAssetAmortizationAndContingentConsideration>
    <bmrn:IntangibleAssetAmortizationAndContingentConsideration
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTAtNS0xLTEtMA_11588718-4714-414a-99be-2e8727876579"
      unitRef="usd">52648000</bmrn:IntangibleAssetAmortizationAndContingentConsideration>
    <bmrn:IntangibleAssetAmortizationAndContingentConsideration
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTAtNy0xLTEtMA_0ec4f7de-da3d-4afb-a480-fb963878dc56"
      unitRef="usd">48018000</bmrn:IntangibleAssetAmortizationAndContingentConsideration>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTEtMS0xLTEtMA_7203943b-cbf7-4536-b6e1-a7970149556d"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTEtMy0xLTEtMA_94760e64-a7dd-4af4-8372-391b440aa547"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTEtNS0xLTEtMA_ebaf22b5-900f-4020-baae-4d6383e4b3e7"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTEtNy0xLTEtMA_d3a2e566-aaa7-4771-b3b8-0e2fc56662eb"
      unitRef="usd">59495000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:CostsAndExpenses
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTItMS0xLTEtMA_91afa0b1-99fd-4813-a2fb-f1bccda7e52e"
      unitRef="usd">461961000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTItMy0xLTEtMA_c6d564df-f84d-4f60-a8d8-e5daaeb23109"
      unitRef="usd">532725000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTItNS0xLTEtMA_9b05afdc-d7b0-4918-b54c-65aca3a2f090"
      unitRef="usd">1412926000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTItNy0xLTEtMA_755f2124-c156-4866-8f6b-8b484f518333"
      unitRef="usd">1400263000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTMtMS0xLTEtMA_8637f2e6-13d6-4fc4-9bdb-060a65ec748f"
      unitRef="usd">-53219000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTMtMy0xLTEtMA_7ad543b7-e6d9-4396-8870-95828f620b05"
      unitRef="usd">-55941000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTMtNS0xLTEtMA_ddf3f4fe-e0dc-420f-9ec6-cc2a4c7b51ef"
      unitRef="usd">-16461000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTMtNy0xLTEtMA_4d20126f-75fb-4b19-b63e-72e283ed30fc"
      unitRef="usd">8075000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTUtMS0xLTEtMA_4d65e0c4-99e9-4ab8-ba0f-f29640593e3b"
      unitRef="usd">177000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTUtMy0xLTEtMA_e5b97a84-e338-4d8c-9910-153b5b73b7f7"
      unitRef="usd">-921000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTUtNS0xLTEtMA_0c933173-93c7-452c-9458-e9dc072c07ba"
      unitRef="usd">-1349000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTUtNy0xLTEtMA_61e2c0a1-de22-46d0-af28-c6c697eb12fa"
      unitRef="usd">-1077000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTYtMS0xLTEtMA_c648754e-20dc-4a94-8c45-b2d18b240ee1"
      unitRef="usd">1827000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTYtMy0xLTEtMA_887ee7d8-8afb-4864-918a-87ec2fe7695f"
      unitRef="usd">4004000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTYtNS0xLTEtMA_79acbacf-8b84-4847-a6f4-edbecf1d0f1e"
      unitRef="usd">8737000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTYtNy0xLTEtMA_820811b6-e31b-472a-89a4-b5815f95a18e"
      unitRef="usd">13539000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTctMS0xLTEtMA_5d934d62-539a-463b-92f0-2f4f0e019f8d"
      unitRef="usd">3870000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTctMy0xLTEtMA_008f6cd1-80b8-4c89-92a0-8050f7038480"
      unitRef="usd">9597000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTctNS0xLTEtMA_51dd6dc2-89a3-4f33-819b-c972d1d0d0b0"
      unitRef="usd">11491000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTctNy0xLTEtMA_53977175-0dcd-4b9a-90b9-95ac609a1a13"
      unitRef="usd">24560000</us-gaap:InterestExpense>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTgtMS0xLTEtMA_a4046502-54a2-4fff-9fab-eaa7d962e262"
      unitRef="usd">8925000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTgtMy0xLTEtMA_b9cc218b-f974-4936-ac0c-82340fdb4723"
      unitRef="usd">1239000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTgtNS0xLTEtMA_dcca6ad0-42f3-4373-8733-a9c6a16924d5"
      unitRef="usd">11788000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTgtNy0xLTEtMA_bde16a17-71f5-402d-85cc-591183c24aa1"
      unitRef="usd">1886000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTktMS0xLTEtMA_0ab6dfb9-5167-46fd-b757-5beaaec4eb0d"
      unitRef="usd">-46160000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTktMy0xLTEtMA_9745e203-2742-4699-a03e-87d76df35c91"
      unitRef="usd">-61216000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTktNS0xLTEtMA_9a6741bc-52ea-4361-9c04-7cdb8c458aea"
      unitRef="usd">-8776000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMTktNy0xLTEtMA_742ce445-4461-439d-8a9f-8a563707b4b8"
      unitRef="usd">-2137000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjAtMS0xLTEtMA_c097066f-1231-40c2-a096-ef256d4c1cfa"
      unitRef="usd">-9666000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjAtMy0xLTEtMA_da6bd3bd-a7fa-4a3f-aa31-2103cd60961c"
      unitRef="usd">-846019000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjAtNS0xLTEtMA_6d550cbc-fe2b-4460-b252-e0eab4bf5699"
      unitRef="usd">-2594000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjAtNy0xLTEtMA_be0bcbfa-9df7-40ea-ba7d-20b8d0c30346"
      unitRef="usd">-839138000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjEtMS0xLTEtMA_293df2f5-09f5-41f1-8e06-232e4d3ecc95"
      unitRef="usd">-36494000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjEtMy0xLTEtMA_8eb7d823-2848-4b30-84ff-bc8869c530ca"
      unitRef="usd">784803000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjEtNS0xLTEtMA_2d794241-35d9-4d02-bd38-3a87ebacd79c"
      unitRef="usd">-6182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjEtNy0xLTEtMA_9e2ce1a2-5842-49d3-86f7-8e39e2c5028b"
      unitRef="usd">837001000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjItMS0xLTEtMA_88d22610-2f60-473d-a7e2-eb7b352a52c7"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjItMy0xLTEtMA_394f29bd-4d03-4982-a9c0-938c84888273"
      unitRef="usdPerShare">4.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjItNS0xLTEtMA_29541864-e9e4-47e4-8188-96f001927a02"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjItNy0xLTEtMA_92887749-a834-402d-ae52-48ba280deb64"
      unitRef="usdPerShare">4.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjMtMS0xLTEtMA_75902beb-5b17-4c3e-baee-b56b44d133c3"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjMtMy0xLTEtMA_aebb4f0f-c098-4b62-b4b2-029a23a13131"
      unitRef="usdPerShare">4.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjMtNS0xLTEtMA_fe87e3fe-799e-40a6-ada0-b48cde12c92c"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjMtNy0xLTEtMA_12b8b658-9540-48fe-996c-093f1f3ec755"
      unitRef="usdPerShare">4.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjQtMS0xLTEtMA_413e258b-4f08-44c0-b590-57118bd1feaf"
      unitRef="shares">183214000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjQtMy0xLTEtMA_914bf33d-153b-4aee-a6d2-d7b2b47f06c6"
      unitRef="shares">181142000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjQtNS0xLTEtMA_74acf773-f3fb-4730-a830-de766a1bf137"
      unitRef="shares">182616000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjQtNy0xLTEtMA_44b96c31-6a6b-41dd-98a6-9e77b95fe454"
      unitRef="shares">180592000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjUtMS0xLTEtMA_85564155-fe20-4016-a5b9-6c06d4489a2b"
      unitRef="shares">183214000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjUtMy0xLTEtMA_e1f2611d-43f7-4f79-90c7-55fc35d573c1"
      unitRef="shares">197674000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjUtNS0xLTEtMA_0d4d6213-a419-4f5d-be48-adc6bffa2eb4"
      unitRef="shares">182616000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjUtNy0xLTEtMA_609170db-5953-4cc4-b4cb-e80c2964ac7a"
      unitRef="shares">194959000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjctMS0xLTEtMA_bd724870-368c-4e3a-86fd-bb4c5278c91d"
      unitRef="usd">-25316000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjctMy0xLTEtMA_761a5e46-586d-41d6-98f9-9ad0cfa59eff"
      unitRef="usd">765138000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjctNS0xLTEtMA_9fab06d8-cc4a-488f-bcd6-abd54ca8322b"
      unitRef="usd">20196000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yMi9mcmFnOmU4NzdjZTkwZjRiMTQ2YjhhZDQxNjQyYmQ0YTljZTMyL3RhYmxlOmFhZTMxOWRkNWNjYzRjYThiODc5NmI4ZDMxZTIzYjAxL3RhYmxlcmFuZ2U6YWFlMzE5ZGQ1Y2NjNGNhOGI4Nzk2YjhkMzFlMjNiMDFfMjctNy0xLTEtMA_94aaf25f-250f-44a1-8618-de460594963d"
      unitRef="usd">827222000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i5ea54e8805bf4cd2bf97a56c86ecfccd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0xLTEtMS0w_9da5c243-f2ba-428d-88f4-fff099590b2f"
      unitRef="shares">183322000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i9bcd0ccc805b4b2f9e84aa347f9675e2_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0zLTEtMS0w_80e1e025-549a-45c2-84d4-d428b04bc25d"
      unitRef="shares">181148000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i99f00eb5b129417a84d6a7ccff242457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy01LTEtMS0w_80590d6d-6042-4df1-a54f-e96d14ee3755"
      unitRef="shares">181741000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="iac1a61de8d9a4f648cd0094a00ba3a7c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy03LTEtMS0w_9945da9e-d5c5-4a4b-9e1f-fa7bd5cb744a"
      unitRef="shares">179838000</us-gaap:SharesOutstanding>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares
      contextRef="i5a1d232828b343fc85f1f99a3762f4b6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNC0xLTEtMS0w_49606c83-ec19-4481-b000-4ad04e15fe88"
      unitRef="shares">246000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares
      contextRef="if0ad0618f364452792421d091dfef160_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNC0zLTEtMS0w_2a02a7d7-5f83-4ac8-ac30-3af836cb7878"
      unitRef="shares">344000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares
      contextRef="ic0d7c667fbcb49a492cc496e20a9533b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNC01LTEtMS0w_f9a1cef7-8548-4acf-8a52-569165b8fc58"
      unitRef="shares">1827000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares
      contextRef="i17802777da7643c6ab25cac57f541c1e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNC03LTEtMS0w_37486d0a-3d74-4f3f-9a16-82124531df0b"
      unitRef="shares">2172000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i5a1d232828b343fc85f1f99a3762f4b6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNS0xLTEtMS0w_e9f5fe69-e6ef-40b2-9168-3d9aaa8d9f5b"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="if0ad0618f364452792421d091dfef160_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNS0zLTEtMS0w_945e266b-ebc0-4287-94a6-3504b16af84d"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ic0d7c667fbcb49a492cc496e20a9533b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNS01LTEtMS0w_5bec2ca3-f68e-4573-89fd-10d6f88ce260"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i17802777da7643c6ab25cac57f541c1e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNS03LTEtMS0w_9a1c8bcb-61ac-4930-9b05-45d5427242d0"
      unitRef="shares">518000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:SharesOutstanding
      contextRef="icebcf4632bc041ecb270987af3929f4b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNi0xLTEtMS0w_e6f5a670-6fb0-4984-9cf0-9ac25141ef02"
      unitRef="shares">183568000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ifaca57bc041147b381f06e8aa17857c6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNi0zLTEtMS0w_a0a7b74c-9c06-4c27-878e-62ff8a3654f1"
      unitRef="shares">181492000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="icebcf4632bc041ecb270987af3929f4b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNi01LTEtMS0w_cf743d6c-2968-4b38-83fd-00c4dfc4786d"
      unitRef="shares">183568000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ifaca57bc041147b381f06e8aa17857c6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfNi03LTEtMS0w_33658d31-e90b-40f4-be36-a66b800bfa1f"
      unitRef="shares">181492000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i42ac9247fd2e436cb417f1972275fb4a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0xLTEtMS0w_72870b1f-4e17-4559-9fab-07aecaab6bde"
      unitRef="usd">4241571000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c5c0d0d2b0e4255835d887bcfa9bc17_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0zLTEtMS0w_abf81c9d-4f10-4caa-8485-a937624d5b0a"
      unitRef="usd">3236679000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC01LTEtMS0w_622fde87-890f-4579-a8c4-8f538731d0a5"
      unitRef="usd">4106002000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7268a9baa84143e28737ef38b1cfc7a8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC03LTEtMS0w_40abc157-7a92-4b2e-b4c1-636c8a1c095f"
      unitRef="usd">3122381000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ea54e8805bf4cd2bf97a56c86ecfccd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMS0xLTEtMA_fa8c23b8-dffb-4769-aae5-62ccbe33d132"
      unitRef="usd">183000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9bcd0ccc805b4b2f9e84aa347f9675e2_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMy0xLTEtMA_67818c24-e760-4a44-8b3b-cae1351b1f8e"
      unitRef="usd">181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99f00eb5b129417a84d6a7ccff242457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNS0xLTEtMA_2ba8b51a-3d12-4c40-9732-b59b4096cb92"
      unitRef="usd">182000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iac1a61de8d9a4f648cd0094a00ba3a7c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNy0xLTEtMA_478d5aec-1723-40c5-beea-a858d1dbfc9b"
      unitRef="usd">180000</us-gaap:StockholdersEquity>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency
      contextRef="i5a1d232828b343fc85f1f99a3762f4b6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTEtMS0xLTEtMA_7f175401-ee57-4119-b075-aa7395fd1b81"
      unitRef="usd">1000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency
      contextRef="if0ad0618f364452792421d091dfef160_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTEtMy0xLTEtMA_fb062550-e987-4bc0-918a-d8994087deaf"
      unitRef="usd">0</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency
      contextRef="ic0d7c667fbcb49a492cc496e20a9533b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTEtNS0xLTEtMA_2299fe53-37d9-474b-9aa5-a2feacbf52d0"
      unitRef="usd">2000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency
      contextRef="i17802777da7643c6ab25cac57f541c1e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTEtNy0xLTEtMA_d44d7c62-0ddc-4439-ac6c-8710bcaefed0"
      unitRef="usd">1000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency>
    <us-gaap:StockholdersEquity
      contextRef="icebcf4632bc041ecb270987af3929f4b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTItMS0xLTEtMA_ba5e6501-e176-4de8-a9f7-bc1a37527060"
      unitRef="usd">184000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifaca57bc041147b381f06e8aa17857c6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTItMy0xLTEtMA_8de59c76-dabd-4f11-8996-a9d68092f007"
      unitRef="usd">181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icebcf4632bc041ecb270987af3929f4b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTItNS0xLTEtMA_597bbbea-5c30-42f7-84fc-3132d8d5a1bd"
      unitRef="usd">184000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifaca57bc041147b381f06e8aa17857c6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTItNy0xLTEtMA_2f8c9bba-e901-4be7-9f60-39c3f08f5f57"
      unitRef="usd">181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i64cc87601ea34f3381da0fca0b298bc6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMS0xLTEtMA_1615b675-9dc0-4931-b33b-c18a216d1013"
      unitRef="usd">5083831000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i731188fc3d2044b7a23a6e217ea305e4_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMy0xLTEtMA_19f99bfb-dc72-4b96-857a-b4f591a35d5b"
      unitRef="usd">4885637000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i89b52d173ad54772a29d1b6f7bbf6459_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNS0xLTEtMA_c754fec8-9ca8-4726-a876-e54479025051"
      unitRef="usd">4993407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4caba0337f8f4b2e8f9100f7d140d5ce_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNy0xLTEtMA_52688cf7-cdb3-44b7-9af1-18d255bc03c2"
      unitRef="usd">4832707000</us-gaap:StockholdersEquity>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency
      contextRef="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTUtMS0xLTEtMA_ca39dd88-979c-4ba7-934e-1fed8aac400a"
      unitRef="usd">-460000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency
      contextRef="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTUtMy0xLTEtMA_6cdc526d-4911-4ed5-a4b2-09e780696c36"
      unitRef="usd">7319000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency
      contextRef="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTUtNS0xLTEtMA_9354acc3-db7c-4dea-9b10-d3f3e9811c7e"
      unitRef="usd">-11551000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency>
    <bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency
      contextRef="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTUtNy0xLTEtMA_12652ffb-652f-44a7-95f0-5da48d5acea0"
      unitRef="usd">17601000</bmrn:StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTYtMS0xLTEtMA_98d89863-ef3f-48e1-af24-9c454a57c728"
      unitRef="usd">50353000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTYtMy0xLTEtMA_0927ce2c-6d9b-4af6-bd8d-5d7838f99394"
      unitRef="usd">44757000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTYtNS0xLTEtMA_0654ee6c-4b65-4196-b33c-c84c92db4127"
      unitRef="usd">151500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTYtNy0xLTEtMA_190d0281-1ba7-452b-b3c7-50c158817def"
      unitRef="usd">136688000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTctMS0xLTEtMA_7b1b3f38-398d-4d70-8654-221ac54568ae"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTctMy0xLTEtMA_1c648f56-72b4-4f64-9156-c59e64e9c0da"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTctNS0xLTEtMA_376371e0-f73c-491d-92c3-5cd8fd7fe094"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTctNy0xLTEtMA_98bc1c3a-8ffe-44f8-a8ba-6dd9667fe8e9"
      unitRef="usd">50000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan
      contextRef="ic73b0fdc7faa456cab57ed77818b62d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTgtMS0xLTEtMA_2c1a99ca-3290-4be0-8b16-d64c07cb384a"
      unitRef="usd">-18000</bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan>
    <bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan
      contextRef="ice301800e5ea4ebaafd7de51c3bc9c72_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTgtMy0xLTEtMA_74a8652f-c4c5-431e-9d39-4f60bede6273"
      unitRef="usd">-78000</bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan>
    <bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan
      contextRef="i23a716603ad247b5a0e27b756de5cadc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTgtNS0xLTEtMA_4a5d6f92-791e-4d95-86e4-0827b9ff2f9e"
      unitRef="usd">-386000</bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan>
    <bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan
      contextRef="i68185ef1b2344ce185c2e85fe7b31c88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTgtNy0xLTEtMA_6c154eba-b4a0-4b06-a266-c393f36e62b1"
      unitRef="usd">-795000</bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan>
    <us-gaap:StockholdersEquity
      contextRef="i7778fc67467846b8a67a75902f463e54_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTktMS0xLTEtMA_a2384674-8677-49fc-83f4-4b9c03f41b19"
      unitRef="usd">5133742000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if5f0aad336a3452ea25f24ba710ac93a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTktMy0xLTEtMA_a2faade8-ff9d-4418-a096-34812c02830e"
      unitRef="usd">4937791000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7778fc67467846b8a67a75902f463e54_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTktNS0xLTEtMA_93afa54b-a90e-4077-9851-6d9e20f0f606"
      unitRef="usd">5133742000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if5f0aad336a3452ea25f24ba710ac93a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTktNy0xLTEtMA_fe3af8d3-83da-433a-a3b7-56d631199bfa"
      unitRef="usd">4937791000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i627eef1092454bb98b2d4c1cea40f20e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMS0xLTEtMA_b3ac2687-39cd-4b15-a8e0-278133489a77"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc9d74897922454eac93c39ab9193ed7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMy0xLTEtMA_6606cdb6-977b-49ba-8a09-d376a76e6dda"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia07691e24f2f4f37b1f16b61b6cc50ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNS0xLTEtMA_ce5b790a-8f10-4f4d-a51c-6f62fbf0f0fe"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6703cd6e3a77492f925f347aaebd345a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNy0xLTEtMA_e1dc97ee-6443-43a8-9e6f-fe83e219f499"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i88dc8a11226046f1a9d9868cad8f27ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjItMS0xLTEtMA_f1fed961-7f0f-46e9-8139-13970fe7188d"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i6f1406297b474f139305e89552bbcad7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjItMy0xLTEtMA_91656744-cd17-4eed-9757-5f328ac5e578"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5f2a6e362d84481d9b46790a952c3eb8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjItNS0xLTEtMA_7fc070cc-8f14-46a5-921d-caec167bdc8d"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifedfb7039355401494da9d79b4b019f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjItNy0xLTEtMA_cce7c11c-9c73-4203-8409-b7c54bc80793"
      unitRef="usd">50000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i88dc8a11226046f1a9d9868cad8f27ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjMtMS0xLTEtMA_9f4cb137-765e-42f4-a686-8f51d3c101c8"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i6f1406297b474f139305e89552bbcad7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjMtMy0xLTEtMA_a343ce42-a66e-4290-9b35-a1b6f3908169"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5f2a6e362d84481d9b46790a952c3eb8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjMtNS0xLTEtMA_932ee5ef-2afb-4d33-a2f0-4933065cfdf9"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ifedfb7039355401494da9d79b4b019f7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjMtNy0xLTEtMA_1d08813b-49ea-446e-baea-6f94267585d2"
      unitRef="usd">-50000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockholdersEquity
      contextRef="ib1bb9f866ca4475eaf5dfcb3fa669cb2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjQtMS0xLTEtMA_dad45229-2531-4302-be7c-73d04d10b781"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia8d3c91fa0884ce985a56dd462a786fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjQtMy0xLTEtMA_d0de676d-95cc-42b2-bde2-b2eb32fe78ea"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib1bb9f866ca4475eaf5dfcb3fa669cb2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjQtNS0xLTEtMA_58b91e21-0123-450e-87ed-97e123e59a16"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia8d3c91fa0884ce985a56dd462a786fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjQtNy0xLTEtMA_3a63b088-f04f-49df-9a97-e2e529453617"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i76ba0bfe4241498cabc063f575c0fe8c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMS0xLTEtMA_817fdbd8-1213-4898-be7c-f08d3b5d4c12"
      unitRef="usd">-10207000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if019850925824862b004fe4ce0fba35f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMy0xLTEtMA_9b2f553e-3253-4009-8223-5f14dee5a1a4"
      unitRef="usd">-10678000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd15da83cca44176a0b4b0f67a931a98_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNS0xLTEtMA_a69260cb-11f7-4d4f-98bc-513018bfe44b"
      unitRef="usd">-9839000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia5e64d06d88e4e6bacfa1c4bee506c2d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNy0xLTEtMA_b899b85f-8b47-41ff-89c6-effe257d0c28"
      unitRef="usd">-9961000</us-gaap:StockholdersEquity>
    <bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan
      contextRef="i6dd786401f3846dc9ebfe35c03ae7cf0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjctMS0xLTEtMA_d304c08e-d933-402f-8051-59d09de16576"
      unitRef="usd">18000</bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan>
    <bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan
      contextRef="i80fd59e3ac5943d4a4576ec081be6729_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjctMy0xLTEtMA_45df67b7-aefb-4615-8333-d8ed23426247"
      unitRef="usd">78000</bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan>
    <bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan
      contextRef="ib796b32eb4e84dd39329cb270e0eb237_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjctNS0xLTEtMA_f888b597-7e56-4409-b4e6-d78d107c9fd7"
      unitRef="usd">386000</bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan>
    <bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan
      contextRef="icdb4d2c8bde5486194ee9f8978433d7b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjctNy0xLTEtMA_ce5ff3b0-d27c-473d-a002-2fd13b1301f8"
      unitRef="usd">795000</bmrn:AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan>
    <us-gaap:StockholdersEquity
      contextRef="i42144fd1c7cc40b4a19862971243a6c2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjgtMS0xLTEtMA_41abc8b2-f2a4-40ad-99fa-ed10d2553672"
      unitRef="usd">-10225000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe71756343b8462d9a1e0b2139797942_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjgtMy0xLTEtMA_d69c7fce-5d64-4ab0-9e08-97843d79a3cb"
      unitRef="usd">-10756000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i42144fd1c7cc40b4a19862971243a6c2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjgtNS0xLTEtMA_b880a846-6257-41b2-a0bd-d2cf6fd0bf49"
      unitRef="usd">-10225000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe71756343b8462d9a1e0b2139797942_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjgtNy0xLTEtMA_8a0f7292-97bf-4c80-9f12-41806c21c341"
      unitRef="usd">-10756000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ice2e3bd0516f4927a3ea54940b0473b8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMS0xLTEtMA_83aea445-0665-4f90-8ba3-7712949883a1"
      unitRef="usd">-939000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i10986a90b6074a24befea81408205ba6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMy0xLTEtMA_7f4a62eb-845e-49ff-9889-65ebd2382598"
      unitRef="usd">30050000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i847ccef2e0f749cdbc16c784f8bc20d7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNS0xLTEtMA_8cbf41fe-e697-457e-a1ff-f93d617fb15a"
      unitRef="usd">-16139000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5980981b2d94a21af89adbff48bff67_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNy0xLTEtMA_d6836a05-7ef2-4eea-b180-796e09dfac57"
      unitRef="usd">20164000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib502302b9e2f484da8ae334c586b7015_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzItMS0xLTEtMA_cbdddbf4-37af-4798-95d4-50eb1675d0a1"
      unitRef="usd">11178000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i139ebe39eaac4c3d89f8d6a430777353_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzItMy0xLTEtMA_1c47be15-28b2-4000-9300-ffe1f0d9e48c"
      unitRef="usd">-19665000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3cfe02f4a80f4b47b9a60dde2af5de31_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzItNS0xLTEtMA_250dc50a-4b99-477c-ad1e-44b8e1b75a04"
      unitRef="usd">26378000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia2a90b89293d4d568258cb84a8b82013_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzItNy0xLTEtMA_a94411d2-60a0-4c8d-8286-650d2e0dc67e"
      unitRef="usd">-9779000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzMtMS0xLTEtMA_0c820c9a-6c94-4ad7-9793-2bd5eb41e390"
      unitRef="usd">10239000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id0db40041dc54511b7a5f5d17ab13fa6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzMtMy0xLTEtMA_da8fdcfe-0516-41fc-a985-deb1c2d9d7d3"
      unitRef="usd">10385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzMtNS0xLTEtMA_e973faa7-0248-4258-8f1e-499b663902b3"
      unitRef="usd">10239000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id0db40041dc54511b7a5f5d17ab13fa6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzMtNy0xLTEtMA_5ba6a709-7a88-43c2-89c4-b404520228ee"
      unitRef="usd">10385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i51c38a2eb11344c1ac10d203ceb97e13_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMS0xLTEtMA_f2211914-b58c-4762-a749-aae4b1cd3052"
      unitRef="usd">-831297000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i768baa6d2e434ec181651dc6bc5d351d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMy0xLTEtMA_0472a5e3-0a8f-4691-b9c8-b0387c815ce1"
      unitRef="usd">-1668511000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i65c51e81a86e484d8e7ecfbdeae9fe9b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNS0xLTEtMA_989d4272-2948-4a7a-bd0c-3fd121d0047c"
      unitRef="usd">-861609000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7d51116bdb2447edbdb006552af68df6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNy0xLTEtMA_ee908d3a-c4e8-4e65-b4e2-151b4adb3de0"
      unitRef="usd">-1720709000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i803bcd43ae324221accf1b091be40cd1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzctMS0xLTEtMA_519c8878-2c5b-4c2e-8667-3fa89c0a845f"
      unitRef="usd">-36494000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if010a0db0da649f79724c29782c82b57_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzctMy0xLTEtMA_c906cdf7-dcc0-45dd-8c55-ded5d31e895f"
      unitRef="usd">784803000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6033594232bd45b1956bdbbb3ec09c3b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzctNS0xLTEtMA_17648dab-0b78-4226-bfe4-f85571d474ce"
      unitRef="usd">-6182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4d08ea1a9cb14bb59451b5d3e37c8e09_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzctNy0xLTEtMA_6743ccfe-176d-4b91-8e39-2ff1b49c4588"
      unitRef="usd">837001000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="i1f6ffb6089bc436588ddb4e558536c98_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzgtMS0xLTEtMA_8bf4c9bf-f18b-47d6-b9b0-33f2ca36c0f9"
      unitRef="usd">-867791000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i84daa993a3914c4c816bec79eb0a2d5a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzgtMy0xLTEtMA_44dd2803-d9e1-4109-8763-7e65189a59fa"
      unitRef="usd">-883708000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1f6ffb6089bc436588ddb4e558536c98_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzgtNS0xLTEtMA_4588c5e0-ed62-46dd-8f32-00e3558437a6"
      unitRef="usd">-867791000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i84daa993a3914c4c816bec79eb0a2d5a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzgtNy0xLTEtMA_ba4218cb-47e7-4d72-a6a8-cb1086404515"
      unitRef="usd">-883708000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzktMS0xLTEtMA_218e0414-a7ab-40ee-999b-4312e94abbcb"
      unitRef="usd">4266149000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id6c0821a737d46339e19959fec1fb613_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzktMy0xLTEtMA_149a8c38-1916-479c-a45f-e72674c3b349"
      unitRef="usd">4053893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzktNS0xLTEtMA_d4b8c083-d47a-4ea1-86bb-121ce100bfa5"
      unitRef="usd">4266149000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id6c0821a737d46339e19959fec1fb613_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzktNy0xLTEtMA_3d1c06d5-56ac-40e2-aa4a-1a1a1ccb9fb9"
      unitRef="usd">4053893000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMy0xLTEtMS0w_4d308df3-d8f7-4ef4-b12a-8418a98ed988"
      unitRef="usd">-6182000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMy0zLTEtMS0w_f34aa016-27a8-4859-a28b-b8f8f7060bef"
      unitRef="usd">837001000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNS0xLTEtMS0w_84bdcc4e-d88f-4078-afaf-08a45c650ee4"
      unitRef="usd">82053000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNS0zLTEtMS0w_04691889-aeba-4bf5-902a-d3d4dac0901a"
      unitRef="usd">77814000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNi0xLTEtMS0w_331e2feb-7eb3-41fe-950f-c15aea111c11"
      unitRef="usd">3114000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNi0zLTEtMS0w_bcdc801a-9050-4a81-b81d-b91a882b6291"
      unitRef="usd">14766000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNy0xLTEtMS0w_e9910fab-facd-4dc4-ad95-c6a972cda97f"
      unitRef="usd">-3279000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNy0zLTEtMS0w_ac237bce-0a84-4f12-b4c7-cebb55ec3f6b"
      unitRef="usd">-175000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:ShareBasedCompensation
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfOC0xLTEtMS0w_1d046325-0a9d-4047-8065-cd9713391ae4"
      unitRef="usd">153372000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfOC0zLTEtMS0w_a05304d3-d71a-4234-b7b6-4d63ac2bcfd9"
      unitRef="usd">142125000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfOS0xLTEtMS0w_3ff686b0-253f-45ae-ad43-5ec762753495"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfOS0zLTEtMS0w_50b6b91f-faba-488c-865f-8c92a1193b3c"
      unitRef="usd">59495000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:InventoryWriteDown
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTAtMS0xLTEtMA_d7e5a27a-1cfa-4fcd-bc3a-84c144d22d2f"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTAtMy0xLTEtMA_95ee27fd-fb7c-455e-a2fc-13121e7bc5ad"
      unitRef="usd">75609000</us-gaap:InventoryWriteDown>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTEtMS0xLTEtMA_5d012338-0ee6-4f11-9214-5d47421fcb02"
      unitRef="usd">-12020000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTEtMy0xLTEtMA_7ac62b82-f320-4e3e-95ba-54663ac4271e"
      unitRef="usd">-854199000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTItMS0xLTEtMA_e2cc8593-63ce-43dc-84c6-29f980eee167"
      unitRef="usd">1347000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTItMy0xLTEtMA_e76de4f9-583c-4b73-8567-d136be3088aa"
      unitRef="usd">-9082000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTMtMS0xLTEtMA_6ac2f09f-c874-4c3f-8ef9-f1e71d753a37"
      unitRef="usd">6254000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTMtMy0xLTEtMA_52d8965a-836f-4189-9941-67bae9e066a4"
      unitRef="usd">1352000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTQtMS0xLTEtMA_3a2eff2e-279c-48b3-9466-5ab13d9bd0bd"
      unitRef="usd">1317000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTQtMy0xLTEtMA_db4654bd-73fa-4bc5-99f0-86afdef631bf"
      unitRef="usd">-388000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTYtMS0xLTEtMA_5ab09045-e001-4464-9ba0-f111a667f7b3"
      unitRef="usd">-65513000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTYtMy0xLTEtMA_3014d124-6c60-40eb-87b8-8b184c6a914e"
      unitRef="usd">32915000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTctMS0xLTEtMA_5194dc79-3956-470a-a64d-eefb7e20c2d0"
      unitRef="usd">19125000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTctMy0xLTEtMA_6818a23a-42eb-4b9e-9d8f-0a5356a8638e"
      unitRef="usd">73310000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTgtMS0xLTEtMA_8b1b866e-e14a-442d-ac19-1f18086809bb"
      unitRef="usd">-27029000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTgtMy0xLTEtMA_7a1facd9-624b-495c-84b3-4de9902ed136"
      unitRef="usd">-32848000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTktMS0xLTEtMA_5e741220-f244-4a11-995c-7d09a17cca83"
      unitRef="usd">407000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMTktMy0xLTEtMA_918f99f8-5a54-42e1-b942-2d6b2117c087"
      unitRef="usd">5543000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjAtMS0xLTEtMA_ce576303-1964-4ca8-ba6a-520061d35904"
      unitRef="usd">-7129000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjAtMy0xLTEtMA_ec514857-69db-4c63-bfd3-85124d65767d"
      unitRef="usd">-76174000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjEtMS0xLTEtMA_90e23185-08a0-429b-9152-7ff3a7c5b557"
      unitRef="usd">269000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjEtMy0xLTEtMA_3cf5788d-0966-4e08-9197-91e3693ca717"
      unitRef="usd">9225000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjItMS0xLTEtMA_c24fa730-f4c9-4149-b8c1-3a83a5b9f5c4"
      unitRef="usd">293356000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjItMy0xLTEtMA_1c53a2fd-1644-468d-9b06-ef0407efb87d"
      unitRef="usd">98749000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjQtMS0xLTEtMA_832b3d5a-b519-4570-831d-a8908dc0f2a7"
      unitRef="usd">66840000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjQtMy0xLTEtMA_29eab5d9-b1cf-417a-90d4-3c34603b91c1"
      unitRef="usd">83286000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjUtMS0xLTEtMA_8025a369-0c4d-46d8-acdc-95ae1ef17b85"
      unitRef="usd">502112000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjUtMy0xLTEtMA_46aa4c9a-a8e4-46b9-b17f-0d804602f9c3"
      unitRef="usd">345224000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjYtMS0xLTEtMA_6a6f756b-bd64-4923-a7bd-23be9e55fc4c"
      unitRef="usd">737144000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjYtMy0xLTEtMA_c7a19a90-b06d-4fcf-8d99-c430f2a594a2"
      unitRef="usd">369942000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <bmrn:ProceedsFromSaleOfNonfinancialAssets
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjctMS0xLTEtMA_2f8945e7-b823-4cb4-ac94-1db20101a8f6"
      unitRef="usd">0</bmrn:ProceedsFromSaleOfNonfinancialAssets>
    <bmrn:ProceedsFromSaleOfNonfinancialAssets
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjctMy0xLTEtMA_46179ecd-9476-4566-a81a-3a300a14c277"
      unitRef="usd">67159000</bmrn:ProceedsFromSaleOfNonfinancialAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjgtMS0xLTEtMA_3d397b65-33e7-4d4f-9a0a-f9e4e2f2256c"
      unitRef="usd">8026000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjgtMy0xLTEtMA_c3c33200-44cc-4393-b0e7-20d29ede58a5"
      unitRef="usd">14369000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <bmrn:PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjktMS0xLTEtMA_ec30a43d-0cb6-4d7a-8fd8-b49d8f1670af"
      unitRef="usd">0</bmrn:PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable>
    <bmrn:PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMjktMy0xLTEtMA_4c961909-213c-4c01-82f0-617cf87ce36a"
      unitRef="usd">8709000</bmrn:PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzAtMS0xLTEtMA_10ddef88-c38a-4570-9517-d2ce35ea20b5"
      unitRef="usd">994000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzAtMy0xLTEtMA_21149010-0478-4060-9aaf-4f73e505c8ee"
      unitRef="usd">725000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzEtMS0xLTEtMA_0a4fca3f-c0b8-45d8-b362-7c5c57835e90"
      unitRef="usd">-310892000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzEtMy0xLTEtMA_4845c269-7ce0-4e3a-b595-702dfd5cae58"
      unitRef="usd">-64648000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzMtMS0xLTEtMA_1e3b2a75-0b3b-466c-bd42-24bd36c3b1b2"
      unitRef="usd">32877000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzMtMy0xLTEtMA_ba16c361-95e8-4b48-8296-ba2b64fe0478"
      unitRef="usd">60268000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzQtMS0xLTEtMA_05eea483-443e-4028-aaf9-c5298542202f"
      unitRef="usd">44428000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzQtMy0xLTEtMA_178ef52c-0511-4703-bb4c-bb7d9297ec34"
      unitRef="usd">42667000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzYtMS0xLTEtMA_d473aba2-37fa-4603-a8e6-17d785094fb0"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzYtMy0xLTEtMA_428320f2-8f27-48cd-82c3-8abb0a83440b"
      unitRef="usd">50000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzctMS0xLTEtMA_64ab9af7-5edf-4887-973f-dfa4ee076bc4"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzctMy0xLTEtMA_57199112-f166-4843-9ccc-9ab31d0d823d"
      unitRef="usd">585752000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzktMS0xLTEtMA_67c39635-f48c-4e5c-a211-bad3bfa20d4c"
      unitRef="usd">2492000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfMzktMy0xLTEtMA_cdce8c69-7fda-4264-96c0-b95cd07be015"
      unitRef="usd">6080000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDAtMS0xLTEtMA_6db144de-e5b8-4f73-9c26-2aa89fe57293"
      unitRef="usd">-401000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDAtMy0xLTEtMA_c760de28-c16f-4fe7-aa41-f21e88e1ed34"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDEtMS0xLTEtMA_f05f3d58-690f-4cc6-8ff6-ba6854b56f71"
      unitRef="usd">-14444000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDEtMy0xLTEtMA_c1f5c9e2-e743-4af0-b8fa-f2f297c8595d"
      unitRef="usd">547273000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDItMS0xLTEtMA_28fda695-14ee-4a69-a1f1-260dece34550"
      unitRef="usd">-35000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDItMy0xLTEtMA_bde334c0-a4c7-4b40-94cf-a5ff25d0f465"
      unitRef="usd">-3145000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDMtMS0xLTEtMA_09728d6d-af51-48e8-a278-cd9d683c0142"
      unitRef="usd">-32015000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDMtMy0xLTEtMA_533046a3-0f2e-4092-ad05-c777e1889ba6"
      unitRef="usd">578229000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDUtMS0xLTEtMA_525b463d-a598-4419-96a2-aa6d029741c9"
      unitRef="usd">649158000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7268a9baa84143e28737ef38b1cfc7a8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDUtMy0xLTEtMA_1b4b31b4-81f6-44ea-ae01-9d8edde0b248"
      unitRef="usd">437446000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDYtMS0xLTEtMA_abc1a436-db6a-4338-adf6-66a52e75d467"
      unitRef="usd">617143000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id6c0821a737d46339e19959fec1fb613_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDYtMy0xLTEtMA_8329b9d1-d5d7-4f5c-95f5-1e5fe1fe01bb"
      unitRef="usd">1015675000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDgtMS0xLTEtMA_d322c2f4-2d2d-42b8-89ad-94b773d82052"
      unitRef="usd">15531000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDgtMy0xLTEtMA_77832153-45f6-4f13-b8f9-511431e02b72"
      unitRef="usd">4355000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDktMS0xLTEtMA_d8048cdb-54af-41e0-bc7f-1ac84c591002"
      unitRef="usd">6673000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNDktMy0xLTEtMA_5e65c33e-ec60-40e1-b5c9-1767a9624a53"
      unitRef="usd">5615000</us-gaap:InterestPaidNet>
    <bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNTEtMS0xLTEtMA_08f8e845-36ce-4597-acb3-127f2888ce6d"
      unitRef="usd">-7690000</bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets>
    <bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNTEtMy0xLTEtMA_af57d4ee-a1f3-4d27-a0dd-77c4adebbf86"
      unitRef="usd">-13281000</bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets>
    <bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNTItMS0xLTEtMA_10dc5300-60e7-418d-8a53-7f0c38ee5e94"
      unitRef="usd">9389000</bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets>
    <bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yOC9mcmFnOjQwYWQ1OTZhODRlNjRjNzc4NjhkNGFhZGQ5OWUyOTQ5L3RhYmxlOjYwOWYyNTg3ZmNhMTQ4OGFiMGQzNDNkOGJmMzBjNDEwL3RhYmxlcmFuZ2U6NjA5ZjI1ODdmY2ExNDg4YWIwZDM0M2Q4YmYzMGM0MTBfNTItMy0xLTEtMA_cf758706-f992-4a50-8bd9-528addcea960"
      unitRef="usd">-3043000</bmrn:SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets>
    <us-gaap:NatureOfOperations
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18zNC9mcmFnOjNhNDViOWZkYWM5YjQ2ZDA5YjJjZjkyZjVhYWFmNGQzL3RleHRyZWdpb246M2E0NWI5ZmRhYzliNDZkMDliMmNmOTJmNWFhYWY0ZDNfMTIyMg_e50f818b-9163-4415-abf2-bc296676296f">NATURE OF OPERATIONS&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;BioMarin Pharmaceutical Inc. (the Company) is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions. The Company selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market or offer a significant benefit over existing products. The Company&#x2019;s portfolio consists of several commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. Voxzogo (formerly known as vosoritide) was granted marketing approval in the European Union (EU) on August 27, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company expects to continue to finance future cash needs that exceed its operating activities primarily through its current cash, cash equivalents and investments and through proceeds from debt or equity offerings, commercial borrowing, or through collaborative agreements with corporate partners. If the Company elects to increase its spending on development programs significantly above current long-term plans or enters into potential licenses and other acquisitions of complementary technologies, products or companies, the Company may need additional capital.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfAccounting
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18zNy9mcmFnOjk3NWQzMzIyZmE5MDQ5YzNiN2VlMzE2ODY4YzU2ZDQ4L3RleHRyZWdpb246OTc1ZDMzMjJmYTkwNDljM2I3ZWUzMTY4NjhjNTZkNDhfMjcwOA_2d986584-1095-43d8-b605-e14dcce229da">BASIS OF PRESENTATION&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements have been prepared pursuant to United States generally accepted accounting principles (U.S. GAAP) and the rules and regulations of the Securities and Exchange Commission (the SEC) for Quarterly Reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, although the Company believes that the disclosures herein are adequate to ensure that the information presented is not misleading. The Condensed Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended December&#160;31, 2020 included in the Company&#x2019;s Annual Report on Form 10-K. The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions have been eliminated. The results of operations for the three and nine months ended September&#160;30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending December&#160;31, 2021 or any other period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying disclosures. Although these estimates are based on management&#x2019;s best knowledge of current events and actions that the Company may undertake in the future, actual results may be different from those estimates. The Condensed Consolidated Financial Statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair presentation of results for these interim periods. The full extent to which the novel coronavirus (referred to as COVID-19) pandemic could continue to directly or indirectly impact the Company&#x2019;s business, results of operations and financial condition, including revenues, expenses, reserves and allowances, manufacturing, clinical trials and research and development costs, will depend on future developments that remain uncertain at this time, particularly as virus variants continue to spread. As events continue to evolve and additional information becomes available, the Company&#x2019;s estimates may change materially in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Management performed an evaluation of the Company&#x2019;s activities through the date of filing of this Quarterly Report on Form 10-Q, and has concluded that there were no subsequent events or transactions that occurred subsequent to the balance sheet date prior to filing this Quarterly Report on Form 10-Q that would require recognition or disclosure in the Condensed Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18zNy9mcmFnOjk3NWQzMzIyZmE5MDQ5YzNiN2VlMzE2ODY4YzU2ZDQ4L3RleHRyZWdpb246OTc1ZDMzMjJmYTkwNDljM2I3ZWUzMTY4NjhjNTZkNDhfMjcxMQ_b8fdd6af-ed1f-4b66-a5be-3b76ba4ac8cc">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements have been prepared pursuant to United States generally accepted accounting principles (U.S. GAAP) and the rules and regulations of the Securities and Exchange Commission (the SEC) for Quarterly Reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, although the Company believes that the disclosures herein are adequate to ensure that the information presented is not misleading. The Condensed Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended December&#160;31, 2020 included in the Company&#x2019;s Annual Report on Form 10-K. The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions have been eliminated. The results of operations for the three and nine months ended September&#160;30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending December&#160;31, 2021 or any other period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying disclosures. Although these estimates are based on management&#x2019;s best knowledge of current events and actions that the Company may undertake in the future, actual results may be different from those estimates. The Condensed Consolidated Financial Statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair presentation of results for these interim periods. The full extent to which the novel coronavirus (referred to as COVID-19) pandemic could continue to directly or indirectly impact the Company&#x2019;s business, results of operations and financial condition, including revenues, expenses, reserves and allowances, manufacturing, clinical trials and research and development costs, will depend on future developments that remain uncertain at this time, particularly as virus variants continue to spread. As events continue to evolve and additional information becomes available, the Company&#x2019;s estimates may change materially in future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180MC9mcmFnOjUwZjg1YTBmYjEwYTQ1ZDliNjIxZGJiZDBhZmU3YjRjL3RleHRyZWdpb246NTBmODVhMGZiMTBhNDVkOWI2MjFkYmJkMGFmZTdiNGNfMzYw_976eb767-af2c-4b76-a079-bab9adc40c63">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There have been no material changes to the Company&#x2019;s significant accounting policies during the nine months ended September&#160;30, 2021, as compared to the significant accounting policies disclosed in Note 3 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.&lt;/span&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180My9mcmFnOmZkNTQ1NDZkMDRkNTQ5ZTQ5MGY1Mzg0MzI1ODA2ZWExL3RleHRyZWdpb246ZmQ1NDU0NmQwNGQ1NDllNDkwZjUzODQzMjU4MDZlYTFfNDU2_33d2ba06-4ee0-46f3-a34f-e84eba813ae9">RECENT ACCOUNTING PRONOUNCEMENTSThere have been no new accounting pronouncements adopted by the Company or new accounting pronouncements issued by the Financial Accounting Standards Board during the nine months ended September&#160;30, 2021, as compared to the recent accounting pronouncements described in Note 4 of the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, that the Company believes are of significance or potential significance to the Company.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMTM4OQ_8bfa6d8c-7f5b-429e-99da-55784986e350">FINANCIAL INSTRUMENTS&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All marketable securities were classified as available-for-sale at September&#160;30, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s cash, cash equivalents and available-for-sale securities by significant investment category for each period presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;560,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;561,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;382,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,251,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;322,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;462,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,544,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,546,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;617,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;462,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;980,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;278,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,345,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,350,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;649,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The Company&#x2019;s short-term marketable securities mature in one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;The Company&#x2019;s long-term marketable securities mature between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_846ad3c9-24f9-4d1a-9f5f-7c49adee4aad"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_a635e30b-c744-47ea-a80a-981c71554d83"&gt;one&lt;/span&gt;&lt;/span&gt; and five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the Company had the ability and intent to hold all investments that were in an unrealized loss position until maturity. The Company considered its intent and ability to hold the securities until recovery of amortized cost basis, the extent to which fair value is less than amortized cost basis, conditions specifically related to the security&#x2019;s industry and geography, payment structure and history and changes to the ratings (if any) in determining that the decline in fair value compared to carrying value is not related to a credit loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has certain investments in non-marketable equity securities, measured using unobservable valuation inputs and remeasured on a nonrecurring basis, which are collectively considered strategic investments. As of September&#160;30, 2021 and &lt;/span&gt;&lt;/div&gt;December&#160;31, 2020, the fair value of the Company&#x2019;s strategic investments was $16.3 million and $10.5 million, respectively. These investments were recorded in Other Assets in the Company&#x2019;s Condensed Consolidated Balance Sheets.</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <bmrn:ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMTM5MA_30251fd6-2b9f-46dc-9d34-805714e0d04f">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s cash, cash equivalents and available-for-sale securities by significant investment category for each period presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;560,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;561,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;382,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,251,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;322,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;462,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,544,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,546,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;617,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;462,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;975,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;980,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;278,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,345,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,350,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;649,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The Company&#x2019;s short-term marketable securities mature in one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;The Company&#x2019;s long-term marketable securities mature between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_846ad3c9-24f9-4d1a-9f5f-7c49adee4aad"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_a635e30b-c744-47ea-a80a-981c71554d83"&gt;one&lt;/span&gt;&lt;/span&gt; and five years.&lt;/span&gt;&lt;/div&gt;</bmrn:ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock>
    <us-gaap:Cash
      contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy0xLTEtMS0w_6c4eeccd-10ee-4c5e-9c80-76826d3848c6"
      unitRef="usd">294209000</us-gaap:Cash>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy0zLTEtMS0w_1154ed87-7206-45ef-8874-d7ba1fcee2c9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy01LTEtMS0w_cb31cb3c-4356-4071-8e60-6ada2da892f0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy03LTEtMS0w_7d56e416-3cd6-4a81-9193-6e1135d9bdc4"
      unitRef="usd">294209000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy05LTEtMS0w_f6133d2f-9717-4a87-9b1e-cb18663d4d40"
      unitRef="usd">294209000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy0xMS0xLTEtMA_82889ede-c36b-4543-a7d8-5f235fafc8e1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i69394941701f4792bc6f78d5bfdc9119_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMy0xMy0xLTEtMA_6e7aca07-b61d-4a8c-959e-6414c4263402"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi0xLTEtMS0w_28ef5d0a-9da1-47e9-b6ef-a169dc8fe8e3"
      unitRef="usd">291735000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi0zLTEtMS0w_b06f4d1b-9d90-4f2a-b21c-f3b252fee959"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi01LTEtMS0w_fbd222d5-c02f-49f7-973f-4aaaf58ade2e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi03LTEtMS0w_3b990191-f0d2-4a61-acb9-bd2846120ef9"
      unitRef="usd">291735000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi05LTEtMS0w_9456caad-1b82-4b08-85ca-0159b6d24f1c"
      unitRef="usd">291735000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi0xMS0xLTEtMA_37bcd209-1923-447a-af05-8de08c8bcaa4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i092d463f25cb4152ba73021fba9889ce_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNi0xMy0xLTEtMA_3ef468ca-2347-4005-95af-2c3973a99492"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy0xLTEtMS0w_74f8a77f-35c9-4182-942b-af17f90ea48b"
      unitRef="usd">560004000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy0zLTEtMS0w_df516537-cf30-40b2-aaa7-c183766be6b7"
      unitRef="usd">1230000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy01LTEtMS0w_b774a08e-a6b4-44d6-b93c-9ed373a2ade0"
      unitRef="usd">198000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy03LTEtMS0w_9a6a51d9-8eb8-488e-ad01-6952a25456fe"
      unitRef="usd">561036000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy05LTEtMS0w_6df2f3fc-ddee-488b-a86e-95287b79faaa"
      unitRef="usd">703000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy0xMS0xLTEtMA_bf842795-cf7f-4129-8476-b54424ad5584"
      unitRef="usd">177468000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i4d20f611273a4520a0ddf24ac3708e9a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfNy0xMy0xLTEtMA_fe535943-415b-4479-9c22-29487f9a8f68"
      unitRef="usd">382865000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id2bca3ca974d463382d836efec728b90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC0xLTEtMS0w_b556ca92-07f6-44a5-9b59-a20f4cb5f454"
      unitRef="usd">210444000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id2bca3ca974d463382d836efec728b90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC0zLTEtMS0w_2a4ed63e-413f-4f6a-8ef4-3ca615ee546e"
      unitRef="usd">416000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id2bca3ca974d463382d836efec728b90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC01LTEtMS0w_819ca301-a62b-48f5-b98f-96ae7209f328"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id2bca3ca974d463382d836efec728b90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC03LTEtMS0w_ddf42b2c-1a01-4cc2-a562-a1bde49911a1"
      unitRef="usd">210853000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id2bca3ca974d463382d836efec728b90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC05LTEtMS0w_34d13fc8-69f1-483d-b4a0-88a45eab7fc6"
      unitRef="usd">12999000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="id2bca3ca974d463382d836efec728b90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC0xMS0xLTEtMA_bd256efd-147a-4278-8752-2951b36f3ff2"
      unitRef="usd">161207000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="id2bca3ca974d463382d836efec728b90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOC0xMy0xLTEtMA_7d9ceb9d-01ee-4863-8acb-20dff30c3371"
      unitRef="usd">36647000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS0xLTEtMS0w_989ad440-08f4-433c-bfb0-781123872328"
      unitRef="usd">129818000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS0zLTEtMS0w_3cc2809f-a342-4c1a-96f1-25239ff8e20f"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS01LTEtMS0w_39b35d9c-508e-44d2-9059-d488c13323ef"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS03LTEtMS0w_3fa9a06f-070c-4d4f-b009-9e4a08ea1121"
      unitRef="usd">129818000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS05LTEtMS0w_3fb129f4-25de-46aa-b2e1-e2b4eb539da2"
      unitRef="usd">17497000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS0xMS0xLTEtMA_aead4f3e-2fde-4258-a824-ebfc12ac25ac"
      unitRef="usd">112321000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i9ec348bbb7f64676b204903ae8051084_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfOS0xMy0xLTEtMA_94b65ea5-432a-46bf-8d46-537413febba1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtMS0xLTEtMA_595bc127-0257-4a46-9e1f-86be7655a85e"
      unitRef="usd">55182000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtMy0xLTEtMA_79a7eccd-a6ce-4c74-b4cb-6837c98e33bd"
      unitRef="usd">26000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtNS0xLTEtMA_1e256bea-cb65-48cc-88cc-6f99d9c5e0bc"
      unitRef="usd">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtNy0xLTEtMA_593030da-b60a-4bd9-933c-8f1a39938917"
      unitRef="usd">55185000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtOS0xLTEtMA_d4087c48-06bc-4286-aeee-0ecc372f7473"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtMTEtMS0xLTA_8702bf29-dd70-4e3d-81f1-e031abd91526"
      unitRef="usd">8272000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i83982dff494c4b33a4599c8c6a1968ad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTAtMTMtMS0xLTA_9b1a8adb-2b43-4e12-bb63-24012f399d75"
      unitRef="usd">46913000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtMS0xLTEtMA_f1c1350e-1e88-4980-9839-ca1e05c45e1c"
      unitRef="usd">3114000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtMy0xLTEtMA_a274defd-15f8-4c75-9c13-2b38c42a1927"
      unitRef="usd">150000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtNS0xLTEtMA_eedcb849-84c2-45d9-bd9a-0a51fae0974d"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtNy0xLTEtMA_7c5b5d9b-92cc-4316-89e4-4d9910a34580"
      unitRef="usd">3258000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtOS0xLTEtMA_95c4d562-0c9a-4350-9abd-cd6a7b5ef410"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtMTEtMS0xLTA_c722a98f-81ba-4f82-99b8-7f66c106ab7d"
      unitRef="usd">3065000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i493ab075b1ab4fe4aaeae9716844a4fa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTEtMTMtMS0xLTA_26c529eb-1ff6-43f5-ab57-0bf4c0eb6d99"
      unitRef="usd">193000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItMS0xLTEtMA_7a53ea46-40fc-449d-95fc-2e40e5641b4b"
      unitRef="usd">1250297000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItMy0xLTEtMA_6a7e1143-2959-4db6-97f5-f2db7d1182a4"
      unitRef="usd">1823000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItNS0xLTEtMA_e273dddc-39b2-4755-8f8f-3a2bdea86202"
      unitRef="usd">235000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItNy0xLTEtMA_36e5bd83-da83-4100-9b7a-8dc29c1ab102"
      unitRef="usd">1251885000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItOS0xLTEtMA_42ec599c-f1db-49e0-81e9-8d5499486c0e"
      unitRef="usd">322934000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItMTEtMS0xLTA_242202ac-bafa-4240-b071-a542ad3fedd2"
      unitRef="usd">462333000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ia86cd7b86979490aa97d8927574181fd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTItMTMtMS0xLTA_4223f894-cbab-477f-9673-c50364c304b9"
      unitRef="usd">466618000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtMS0xLTEtMA_e11c20b5-a0e5-4705-a1ff-20868c049dc0"
      unitRef="usd">1544506000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtMy0xLTEtMA_baf638cc-cfd0-4335-83b8-ca8a25187aee"
      unitRef="usd">1823000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtNS0xLTEtMA_04c94dcb-aecc-4ad9-9b75-5349fe957f07"
      unitRef="usd">235000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtNy0xLTEtMA_7068bfe8-d595-4ea4-b680-5130baf3e662"
      unitRef="usd">1546094000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtOS0xLTEtMA_337f1fc6-7f32-453c-a7c3-624b47238cd2"
      unitRef="usd">617143000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtMTEtMS0xLTA_685c553e-63d0-42b7-8ae4-81f56424584b"
      unitRef="usd">462333000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjg2Yzc4ZjczZDYxZTQ2M2ZiNDQ4ZGU2MjI1YjE0ZjEwL3RhYmxlcmFuZ2U6ODZjNzhmNzNkNjFlNDYzZmI0NDhkZTYyMjViMTRmMTBfMTMtMTMtMS0xLTA_13452680-9612-4556-a7c9-8fa04caeb1ef"
      unitRef="usd">466618000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:Cash
      contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy0xLTEtMS0w_0233fd25-eb79-48b8-88fa-18ad4740c6cd"
      unitRef="usd">370325000</us-gaap:Cash>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy0zLTEtMS0w_6490935e-99df-4c61-bfbc-e5bcea805715"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy01LTEtMS0w_534175dc-b4e7-411a-a896-b6169019cead"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy03LTEtMS0w_ff5e5d2c-374a-4e2f-8969-7b4a141556bf"
      unitRef="usd">370325000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy05LTEtMS0w_88548675-d721-43b0-b0f4-75c2a6c0bfc5"
      unitRef="usd">370325000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy0xMS0xLTEtMA_82c8624f-6acd-4ce2-bd4a-445755cf41c9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i2a59471cdb774223b5fed280196aaf44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMy0xMy0xLTEtMA_6e6d60fa-0f65-4e9c-8ef9-49dd77a3cdf9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi0xLTEtMS0w_12af5fa7-642e-4ee4-8091-25ea902b1ff8"
      unitRef="usd">264833000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi0zLTEtMS0w_9c30b2a2-ff01-444d-8bee-3785df635a82"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi01LTEtMS0w_470009ca-5e9d-4238-b247-6d1f7d89dd20"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi03LTEtMS0w_89505106-ce5a-43d3-9bec-836db98ae66c"
      unitRef="usd">264833000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi05LTEtMS0w_f81dfb50-124b-4418-92b5-95090762d205"
      unitRef="usd">264833000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi0xMS0xLTEtMA_b64c6d71-d0d9-4229-bb29-3ad5303ded32"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i7f7a1efc10524deaa1419da35f5fbb0e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNi0xMy0xLTEtMA_7837766f-2a3c-4397-a414-1102ad814d53"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i488ef63d388c46e596c31f59acedb699_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy0xLTEtMS0w_7e1ead5d-05a9-4053-a598-9c4aa14be79e"
      unitRef="usd">413137000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i488ef63d388c46e596c31f59acedb699_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy0zLTEtMS0w_5c0a236c-5316-479f-b302-98882e474796"
      unitRef="usd">3261000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i488ef63d388c46e596c31f59acedb699_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy01LTEtMS0w_a5305b24-c50d-4f97-902c-a2daf2c008e6"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i488ef63d388c46e596c31f59acedb699_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy03LTEtMS0w_3fd8508f-4e72-4956-bbff-fcfa3d2500e4"
      unitRef="usd">416390000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i488ef63d388c46e596c31f59acedb699_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy05LTEtMS0w_12e527cc-5495-4ad8-b37e-735fc3abebdf"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i488ef63d388c46e596c31f59acedb699_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy0xMS0xLTEtMA_e9bb92d3-43a7-46d9-8605-b6d9783f8324"
      unitRef="usd">220551000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i488ef63d388c46e596c31f59acedb699_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfNy0xMy0xLTEtMA_9b1a59b5-37d1-40f3-9e2c-76f5aa986b34"
      unitRef="usd">195839000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS0xLTEtMS0w_60f9e24b-03e8-492e-8bfa-779c7e8c0963"
      unitRef="usd">265298000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS0zLTEtMS0w_0d5113b7-ae34-48b5-b318-77484a98258e"
      unitRef="usd">1555000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS01LTEtMS0w_d2f448f2-a283-415e-84ad-172d13372a8f"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS03LTEtMS0w_21bfc741-b852-495d-b5d6-4f8d752f5acd"
      unitRef="usd">266852000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS05LTEtMS0w_4560e25e-3ff5-4258-9f96-bc6790b4b264"
      unitRef="usd">14000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS0xMS0xLTEtMA_b1e9a6a8-b2de-4ea8-b4a1-dce9867592c6"
      unitRef="usd">192488000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i298462249e6b46a59433814c9c95bc6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfOS0xMy0xLTEtMA_d76b0e4e-c400-492f-bddc-f763f936b806"
      unitRef="usd">60364000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtMS0xLTEtMA_3832fbf3-f4fc-427d-a326-c449f2c414cd"
      unitRef="usd">31659000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtMy0xLTEtMA_7ff718b9-8d75-429d-a4ea-c73f8f6b8a60"
      unitRef="usd">85000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtNS0xLTEtMA_1b8be465-ca1b-4a21-ac7b-3d424ac45596"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtNy0xLTEtMA_025d701a-ee0d-41f9-a522-bfc3c139eb03"
      unitRef="usd">31742000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtOS0xLTEtMA_1fc0ffc1-4a0f-4c59-81ba-f6352f0fc298"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtMTEtMS0xLTA_c004be35-fc63-420b-bac4-263da19ecc20"
      unitRef="usd">3189000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i25d3fa48aabf431f9fa22df5de090b3f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTAtMTMtMS0xLTA_e0730e13-27f6-4b82-a23a-f0b7266ccab1"
      unitRef="usd">28553000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i162aeed19afc494baff177a2e9200423_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtMS0xLTEtMA_0818149e-3432-482b-a306-ace829c5f2a0"
      unitRef="usd">549000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i162aeed19afc494baff177a2e9200423_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtMy0xLTEtMA_7a569dc9-892a-4a6a-8a3b-14660a030259"
      unitRef="usd">168000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i162aeed19afc494baff177a2e9200423_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtNS0xLTEtMA_d9a1f0ef-74ff-400b-b14e-f85a0f7df825"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i162aeed19afc494baff177a2e9200423_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtNy0xLTEtMA_bf876f17-20a6-47b1-baf9-61cd362f69a6"
      unitRef="usd">717000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i162aeed19afc494baff177a2e9200423_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtOS0xLTEtMA_078e8b03-694e-4fdd-b7f7-409fd580bf01"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i162aeed19afc494baff177a2e9200423_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtMTEtMS0xLTA_39660b7c-fcf4-45a9-ae8b-a858c17f7291"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i162aeed19afc494baff177a2e9200423_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTEtMTMtMS0xLTA_92c94fcd-af57-4d9d-9b37-1c07619b0915"
      unitRef="usd">717000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItMS0xLTEtMA_b62c1e37-79c5-4611-89e3-939837a1ab95"
      unitRef="usd">975476000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItMy0xLTEtMA_fb9c7272-af07-4126-8b0c-059567a71c48"
      unitRef="usd">5069000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItNS0xLTEtMA_ce1d1053-6f70-460a-8e1a-01e91cb2ad4e"
      unitRef="usd">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItNy0xLTEtMA_f3502d77-15bf-4fd8-894a-0a3b5b812aa5"
      unitRef="usd">980534000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItOS0xLTEtMA_2968c50d-754b-4b60-a2a1-6f010674fca7"
      unitRef="usd">278833000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItMTEtMS0xLTA_363c479c-2d1e-474e-a102-c4048f233413"
      unitRef="usd">416228000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i16cd77d91ae74138b0023e6dd344da16_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTItMTMtMS0xLTA_939eae97-9a01-429b-b425-0d2e54d03936"
      unitRef="usd">285473000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtMS0xLTEtMA_cf7075ee-bfbb-4bc2-ae36-469bda444b57"
      unitRef="usd">1345801000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtMy0xLTEtMA_4a5e28d8-dcd7-4d8e-b027-92752a1076a1"
      unitRef="usd">5069000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtNS0xLTEtMA_1f9755bf-c531-418a-88cc-47c912379c88"
      unitRef="usd">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtNy0xLTEtMA_232bdc22-b492-48d2-b477-dd046c0d7682"
      unitRef="usd">1350859000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtOS0xLTEtMA_059a33fa-758e-4220-946c-69d4d9c6e57b"
      unitRef="usd">649158000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtMTEtMS0xLTA_4dc7b79e-95ca-4721-8cd8-14a3aab684f2"
      unitRef="usd">416228000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RhYmxlOjBiZjMzMDNmZTQwMDRlZDg4MjJjZjlhMTc0MDdiYmY4L3RhYmxlcmFuZ2U6MGJmMzMwM2ZlNDAwNGVkODgyMmNmOWExNzQwN2JiZjhfMTMtMTMtMS0xLTA_88cb2411-f76f-4d25-ab47-aaa1e3a9c43a"
      unitRef="usd">285473000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <bmrn:ShortTermMarketableSecuritiesMaturityPeriod
      contextRef="ib0773e69a8654dc28600db905fe0c0c1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMzMz_2677288f-9ab8-4d2d-b72e-4b5274b4cb2b">P1Y</bmrn:ShortTermMarketableSecuritiesMaturityPeriod>
    <bmrn:ShortTermMarketableSecuritiesMaturityPeriod
      contextRef="i006e8ae23bc74eac869d8244cb0ea0e0_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMzMz_bc7eabe4-ee53-4fc9-af85-d319fd5749e1">P1Y</bmrn:ShortTermMarketableSecuritiesMaturityPeriod>
    <bmrn:LongTermMarketableSecuritiesMaturityPeriod
      contextRef="i006e8ae23bc74eac869d8244cb0ea0e0_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDE3_29520578-063e-4af9-b628-3591b00c012a">P5Y</bmrn:LongTermMarketableSecuritiesMaturityPeriod>
    <bmrn:LongTermMarketableSecuritiesMaturityPeriod
      contextRef="ib0773e69a8654dc28600db905fe0c0c1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDE3_f22d2fb7-412c-4549-91e6-138f5b8b793d">P5Y</bmrn:LongTermMarketableSecuritiesMaturityPeriod>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i00b5b9602a84434ca20f4f840240bef5_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMTI1OA_60a056f4-156f-4a17-944d-1035b56fc224"
      unitRef="usd">16300000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i91df24e30587451888b969c1c50cf8b1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfMTI2NQ_9084f08e-691e-4849-9f23-8b2fcb7073c1"
      unitRef="usd">10500000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1Nw_2c7abd9a-97c2-4662-8b58-266be67e4d89">SUPPLEMENTAL BALANCE SHEET INFORMATION&lt;div style="margin-bottom:12pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;308,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;261,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;749,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;698,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inventory as of September&#160;30, 2021 included $4.8 million of Voxzogo pre-launch manufacturing-related costs incurred during the third quarter of 2021 that are intended for the U.S. Voxzogo, which was granted marketing approval in the EU on August 27, 2021, is still a product candidate in other regions, including the U.S., for the treatment of achondroplasia in children, the most common form of disproportionate short stature in humans. The Company must receive marketing approval from the U.S. Food and Drug Administration (FDA) before the Voxzogo inventory can be sold commercially in the U.S. Starting in 2021, the Company believed that material uncertainties related to the ultimate regulatory approval of Voxzogo had been significantly reduced. A number of factors were taken into consideration, including the current status in the drug development process, pivotal clinical trial results for the underlying product candidate, results from meetings with the relevant regulatory authorities, historical experience, as well as potential impediments to the approval process such as product safety or efficacy, as well as commercialization and marketplace trends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;See Note 3 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2020 for additional information related to the Company&#x2019;s policies on inventory produced prior to regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment, Net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,724,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,668,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(699,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(635,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,024,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,032,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Depreciation expense, net of amounts capitalized into inventory, for the three and nine months ended September&#160;30, 2021 was $11.4 million and $35.7 million, respectively. Depreciation expense, net of amounts capitalized into inventory, for the three and nine months ended September&#160;30, 2020 was $11.1 million and $31.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible Assets, Net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;661,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(273,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(226,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;417,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts Payable and Accrued Liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;203,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued rebates payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued royalties payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forward foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Value added taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1MQ_fe9ad556-98e8-41bf-8db1-138170a865db">&lt;div style="margin-bottom:12pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;412,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;308,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;261,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;749,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;698,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMS0xLTEtMS0w_8f0a4c2c-edd4-40f7-bd67-a95221bc868f"
      unitRef="usd">75328000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMS0zLTEtMS0w_e5c3b21d-5c03-496b-a9b9-27dc60c201e2"
      unitRef="usd">76673000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMi0xLTEtMS0w_331179ab-f990-4f27-a146-415c64aa2538"
      unitRef="usd">412434000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMi0zLTEtMS0w_c026db11-9738-4a8b-9de4-8200a4b57b27"
      unitRef="usd">308286000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMy0xLTEtMS0w_1287bbd9-f989-4a52-9c64-9bf669bd2de6"
      unitRef="usd">261644000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfMy0zLTEtMS0w_4eac469a-fdf1-4bae-8be0-b3c7a68bace6"
      unitRef="usd">313589000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfNC0xLTEtMS0w_acd2a44d-e4b9-417c-bb6c-dc5cca310bc8"
      unitRef="usd">749406000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmQzNjM2OWZhNDU3ZjRhNTM4ZjQ2ODg0NWZlY2Y5YWI0L3RhYmxlcmFuZ2U6ZDM2MzY5ZmE0NTdmNGE1MzhmNDY4ODQ1ZmVjZjlhYjRfNC0zLTEtMS0w_9c6e45e0-47e0-4c27-9898-96570e601451"
      unitRef="usd">698548000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib7c76bf362194f4c9c4a2b8976accd00_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTA0NDUzNjA0NzczNzA_e358aa58-26c4-4a65-8036-6e22adf0fa66"
      unitRef="usd">4800000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1Ng_6e7c0d95-ebde-4669-a58a-3bc7a9c6bb77">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment, Net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,724,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,668,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(699,915)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(635,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,024,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,032,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMS0xLTEtMS0w_c2796d65-db27-45b3-8a03-1a0c9e1ca109"
      unitRef="usd">1724702000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMS0zLTEtMS0w_8bd646e3-ef55-4e0a-a395-3f810505af36"
      unitRef="usd">1668066000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMi0xLTEtMS0w_9a2905a6-5365-42fc-93d2-41acedd714e0"
      unitRef="usd">699915000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMi0zLTEtMS0w_730d9c7d-d292-4c8d-b968-b94ce5b3b3a8"
      unitRef="usd">635595000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMy0xLTEtMS0w_32312f5d-074e-4d78-b5f8-8a7124e9fd6e"
      unitRef="usd">1024787000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmM0NDU0M2IzYzI5ZDQwYzdiMTcyODJkZjMzYTU3YmRiL3RhYmxlcmFuZ2U6YzQ0NTQzYjNjMjlkNDBjN2IxNzI4MmRmMzNhNTdiZGJfMy0zLTEtMS0w_71120d1d-8f01-4f93-9cb5-3036559dfacb"
      unitRef="usd">1032471000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTU3NA_da624f96-df3f-4581-bf45-8df032a63f98"
      unitRef="usd">11400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTU4MQ_71bc878d-6171-46da-a516-b5a880c101fd"
      unitRef="usd">35700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTcwMg_65a80fa4-81a5-4138-9f28-e6ee80ce5c9a"
      unitRef="usd">11100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTcwOQ_95bfa2cc-f103-403d-ac9a-5e6c1c6ac80a"
      unitRef="usd">31100000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1Mg_e7689a2c-6bac-47d1-ac3a-3aa9726397ef">Intangible Assets, Net consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;661,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(273,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(226,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;417,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMS0xLTEtMS0w_980de1fa-9f0c-4431-9c00-755059979029"
      unitRef="usd">661781000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMS0zLTEtMS0w_eac94ee3-7c94-4ae0-adca-f21da31be296"
      unitRef="usd">644087000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMi0xLTEtMS0w_fbe2cdd6-63b4-43f1-a63f-2544cd6bc5d2"
      unitRef="usd">273294000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMi0zLTEtMS0w_77e64e27-fb23-41e2-b84e-9efb9935d736"
      unitRef="usd">226816000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMy0xLTEtMS0w_cfe23456-1665-4593-9ada-6ee28fcd210a"
      unitRef="usd">388487000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOjkzODNlNDRjOGM2YzQ1MmU4M2I4NWY2YWI4NjAxYjA4L3RhYmxlcmFuZ2U6OTM4M2U0NGM4YzZjNDUyZTgzYjg1ZjZhYjg2MDFiMDhfMy0zLTEtMS0w_55dde98a-aaa9-4283-a0a5-4cb79172c6cf"
      unitRef="usd">417271000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RleHRyZWdpb246YTU5ZTdhMjQ5ZTAxNDU2YTk0ZGU0MmZkMzRkMmQxYTlfMTg1Mw_407fcd19-0a48-40d5-aa74-bcf74a4ccb7b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts Payable and Accrued Liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.974%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;203,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued rebates payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued royalties payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forward foreign currency exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Value added taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;492,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMS0xLTEtMS0w_d3001fdd-9986-4b8f-b032-efa148bf09ac"
      unitRef="usd">203321000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMS0zLTEtMS0w_3b80d4ba-07f8-4bdf-ba26-124ac125c67e"
      unitRef="usd">191429000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMi0xLTEtMS0w_8f680079-c0a5-4f86-8309-7830ddc08aac"
      unitRef="usd">158130000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMi0zLTEtMS0w_109b4572-c18e-4bcb-acfa-9a59bc3d6df3"
      unitRef="usd">165023000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bmrn:AccruedGovernmentAndOtherRebates
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMy0xLTEtMS0w_c3d87101-b0ea-4044-b50b-9263b82571e6"
      unitRef="usd">68329000</bmrn:AccruedGovernmentAndOtherRebates>
    <bmrn:AccruedGovernmentAndOtherRebates
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMy0zLTEtMS0w_0181e83a-867d-488d-b193-0f49022d0aed"
      unitRef="usd">65526000</bmrn:AccruedGovernmentAndOtherRebates>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNC0xLTEtMS0w_5b12e60c-eebf-4bb4-9f10-bd4733b7cfeb"
      unitRef="usd">14512000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNC0zLTEtMS0w_41cba6a3-edd7-476e-b24f-24b8d9d082b0"
      unitRef="usd">17155000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNi0xLTEtMS0w_18019f76-b141-432f-8aa8-acf20da425e3"
      unitRef="usd">9659000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNi0zLTEtMS0w_5db86edb-3268-4255-91af-960cac91b06f"
      unitRef="usd">11754000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNS0xLTEtMS0w_1239b45a-87c4-4e0b-97dd-da6474025133"
      unitRef="usd">5323000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNS0zLTEtMS0w_78b96de4-3af7-4dc4-8ed5-f7ed511a272e"
      unitRef="usd">17798000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNy0xLTEtMS0w_d7d15e6c-1327-4305-bf20-067492025c4d"
      unitRef="usd">1412000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfNy0zLTEtMS0w_fa170cea-0f7a-4bbf-bee7-483c839c4279"
      unitRef="usd">9562000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:AccruedIncomeTaxes
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfOC0xLTEtMS0w_393a0e11-1e09-4405-b980-f366deb797f9"
      unitRef="usd">564000</us-gaap:AccruedIncomeTaxes>
    <us-gaap:AccruedIncomeTaxes
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfOC0zLTEtMS0w_269d180f-7263-43b5-8dfc-487b70b0bc5e"
      unitRef="usd">9661000</us-gaap:AccruedIncomeTaxes>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfOS0xLTEtMS0w_6f5ccccb-6a19-41fa-8d16-9e02d2d19da0"
      unitRef="usd">5461000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfOS0zLTEtMS0w_9e4ebc5c-9671-467b-89a4-446728b52539"
      unitRef="usd">4640000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMTAtMS0xLTEtMA_02627ae8-fc1e-4f04-a0b6-d561f78c4fe4"
      unitRef="usd">466711000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180OS9mcmFnOmE1OWU3YTI0OWUwMTQ1NmE5NGRlNDJmZDM0ZDJkMWE5L3RhYmxlOmEzNWVlY2VlMjhmYzRlNzc5ZWRkYWQyNjgyNzExOGJjL3RhYmxlcmFuZ2U6YTM1ZWVjZWUyOGZjNGU3NzllZGRhZDI2ODI3MTE4YmNfMTAtMy0xLTEtMA_2f00bdcc-9d02-4dbc-b7b3-053b5ad5e949"
      unitRef="usd">492548000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfMTE5Mg_de48f9e4-ac3c-4759-9cb9-d71071c7e8e7">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company measures certain financial assets and liabilities at fair value in accordance with the policy described in Note 3 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables present the classification within the fair value hierarchy of financial assets and liabilities not disclosed elsewhere in these Condensed Consolidated Financial Statements that are remeasured on a recurring basis as of September&#160;30, 2021 and December&#160;31, 2020.&#160;Other than the Company&#x2019;s fixed-rate convertible debt disclosed in Note 9 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, there were no financial assets or liabilities that were remeasured using a quoted price in active markets for identical assets (Level 1) as of September&#160;30, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&#160;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&#160;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The restricted investments at September&#160;30, 2021 and December&#160;31, 2020 secure the Company's irrevocable standby letters of credit obtained in connection with certain commercial agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There were no transfers between levels during the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Liabilities measured at fair value using Level 3 inputs primarily consisted of contingent consideration. The following tables represent a roll-forward of contingent consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in the fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange remeasurement of Euro denominated contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfMTE4NQ_f6da709b-2af6-455c-ba43-27e25071e0b0">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables present the classification within the fair value hierarchy of financial assets and liabilities not disclosed elsewhere in these Condensed Consolidated Financial Statements that are remeasured on a recurring basis as of September&#160;30, 2021 and December&#160;31, 2020.&#160;Other than the Company&#x2019;s fixed-rate convertible debt disclosed in Note 9 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, there were no financial assets or liabilities that were remeasured using a quoted price in active markets for identical assets (Level 1) as of September&#160;30, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&#160;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&#160;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;NQDC Plan liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The restricted investments at September&#160;30, 2021 and December&#160;31, 2020 secure the Company's irrevocable standby letters of credit obtained in connection with certain commercial agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i90bb59f2a5034770af163bb6ee32ed42_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfNjIz_0264608c-16ec-482e-a04e-63809c787672"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i66dbe62d10fc46af9552314aa77c1455_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfNjIz_add938db-e823-43eb-8d69-046ebba36f46"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i66dbe62d10fc46af9552314aa77c1455_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfNjIz_c4f03a11-3a2f-43a9-beba-576db7913410"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i90bb59f2a5034770af163bb6ee32ed42_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfNjIz_e9e3db0f-9642-4b9b-873d-b840effa8e2f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <bmrn:OtherAssetsCurrentFairValueDisclosure
      contextRef="ifa92d196dfad4856ba23ebe72dc99f42_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNC0yLTEtMS0w_22d5c860-f5be-4083-815f-5031e8a54e11"
      unitRef="usd">2089000</bmrn:OtherAssetsCurrentFairValueDisclosure>
    <bmrn:OtherAssetsCurrentFairValueDisclosure
      contextRef="i7cd9d72b38ed4e9ab14a43d4125dd712_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNC00LTEtMS0w_838bec18-b5b6-4d4c-b65d-3379ab7ec579"
      unitRef="usd">0</bmrn:OtherAssetsCurrentFairValueDisclosure>
    <bmrn:OtherAssetsCurrentFairValueDisclosure
      contextRef="i702edec792f8459193e0e7428f963179_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNC02LTEtMS0w_bde1d914-473e-49ed-b2ed-e3357238783a"
      unitRef="usd">2089000</bmrn:OtherAssetsCurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="ifa92d196dfad4856ba23ebe72dc99f42_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNy0yLTEtMS0w_8c76ef7c-e3df-49f2-a510-57a3a1b3edb1"
      unitRef="usd">22521000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i7cd9d72b38ed4e9ab14a43d4125dd712_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNy00LTEtMS0w_1c636831-b9cb-44ae-8985-17bf76bc3d48"
      unitRef="usd">0</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i702edec792f8459193e0e7428f963179_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfNy02LTEtMS0w_5b801bf5-c755-4480-850d-9661e6ef6285"
      unitRef="usd">22521000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i5eac74c17ffb48aaa66512c312d26ffc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOC0yLTEtMS0w_97d371e5-4986-411a-8116-c41cd75deb11"
      unitRef="usd">2835000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="if941c596ef754cf388dd3fe27f85f62f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOC00LTEtMS0w_c9daa615-c956-4c74-983f-aec2dff8cb44"
      unitRef="usd">0</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="if961eb44a8474191b0fe4f51e700bec0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOC02LTEtMS0w_7019d577-57f1-4c28-a394-fac1d0b1985a"
      unitRef="usd">2835000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="id075d2f472a347109be07404276f404d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOS0yLTEtMS0w_e89cca5a-707e-4743-aee8-95e8e2429bae"
      unitRef="usd">25356000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOS00LTEtMS0w_aa791181-9db7-4f89-b9b2-47cf37b5e102"
      unitRef="usd">0</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfOS02LTEtMS0w_f9c07add-c327-45e8-84f8-da54b5ba19ba"
      unitRef="usd">25356000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id075d2f472a347109be07404276f404d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTAtMi0xLTEtMA_e1622cda-5be9-4b07-90b8-adbccf617594"
      unitRef="usd">27445000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTAtNC0xLTEtMA_0f682f05-b25f-4d0b-9f18-d0c7b69b8921"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTAtNi0xLTEtMA_0e567090-a39e-4a27-b7b3-315908823d05"
      unitRef="usd">27445000</us-gaap:AssetsFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="i4c71299431fd4b1d9395950472c5dd54_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTMtMi0xLTEtMA_68b3b6d5-e32f-4ea2-b9af-861753c5a4bf"
      unitRef="usd">2089000</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="i8f9c820d5a2d477c8a45f38d368f4ad4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTMtNC0xLTEtMA_8c6178bd-dbb7-4a56-ba01-71e215950d3d"
      unitRef="usd">0</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="iaaf21895256243eba4baadc21bba8dfd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTMtNi0xLTEtMA_fd9b5496-e9ba-45da-bb17-f5e851117d0d"
      unitRef="usd">2089000</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="ie1a690d1f00e43688891861ad4caf2bb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTQtMi0xLTEtMA_44893cb1-4556-46ab-95b5-3701ded6c57d"
      unitRef="usd">0</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="i120bad79c9cf44618fab7a064046a548_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTQtNC0xLTEtMA_835c60ae-9946-400a-b9e7-1285c023d439"
      unitRef="usd">48187000</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="i6a982d145fec445ab50db51d29d51ec4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTQtNi0xLTEtMA_2fac3e80-429f-4046-9a80-70af8c445c3f"
      unitRef="usd">48187000</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="id075d2f472a347109be07404276f404d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTUtMi0xLTEtMA_340ec48d-4746-4049-899f-dcf21c88ce39"
      unitRef="usd">2089000</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTUtNC0xLTEtMA_f61397d0-e09e-4bbc-85ee-0a60dcc59f86"
      unitRef="usd">48187000</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTUtNi0xLTEtMA_481d349a-f4a9-422c-b6ca-65ff5a51ec0f"
      unitRef="usd">50276000</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i4c71299431fd4b1d9395950472c5dd54_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTctMi0xLTEtMA_d4c0708d-0e91-411e-954a-1cf8c5e4db47"
      unitRef="usd">22521000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i8f9c820d5a2d477c8a45f38d368f4ad4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTctNC0xLTEtMA_40491300-26ef-4b38-981b-fbaa716d14cf"
      unitRef="usd">0</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="iaaf21895256243eba4baadc21bba8dfd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTctNi0xLTEtMA_73a97073-c624-405c-8eb9-9511b3da2d6f"
      unitRef="usd">22521000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="ie1a690d1f00e43688891861ad4caf2bb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTgtMi0xLTEtMA_9a5c41f4-d050-4d5c-a8e1-9b50daff9e22"
      unitRef="usd">0</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i120bad79c9cf44618fab7a064046a548_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTgtNC0xLTEtMA_bec3ec8d-c218-43d7-b825-1d7e3ebaba9c"
      unitRef="usd">15204000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i6a982d145fec445ab50db51d29d51ec4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTgtNi0xLTEtMA_08fa7123-b254-4a9b-bcd7-143d7ea02e54"
      unitRef="usd">15204000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="id075d2f472a347109be07404276f404d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTktMi0xLTEtMA_76845012-00e5-4f0a-a06f-d50c5531d04e"
      unitRef="usd">22521000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTktNC0xLTEtMA_01064d20-46b2-4459-902e-6eab337bcb77"
      unitRef="usd">15204000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMTktNi0xLTEtMA_10acac83-2eb7-4462-ac8d-fbcc53b21848"
      unitRef="usd">37725000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id075d2f472a347109be07404276f404d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMjAtMi0xLTEtMA_f6a05980-1cf0-4ecd-bda5-c709acbf2979"
      unitRef="usd">24610000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2d63e3d6780541b5a95aef5456b53700_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMjAtNC0xLTEtMA_d23aca56-fc62-418b-bc4c-3657f371118a"
      unitRef="usd">63391000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5b56e5655bbe4dc08c9eeb59de88d4ed_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmFkOWNmN2ZmYjQ1ZDRjMTg5Zjk1YThhZWI2NDczNDJhL3RhYmxlcmFuZ2U6YWQ5Y2Y3ZmZiNDVkNGMxODlmOTVhOGFlYjY0NzM0MmFfMjAtNi0xLTEtMA_9be3e342-bef5-4528-8b93-7cd14a8464cc"
      unitRef="usd">88001000</us-gaap:LiabilitiesFairValueDisclosure>
    <bmrn:OtherAssetsCurrentFairValueDisclosure
      contextRef="i4853afdcb6b3425eade1470b05d78550_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfNC0zLTEtMS0w_3e289e8f-e547-4c87-80e7-58fe8fd26893"
      unitRef="usd">2415000</bmrn:OtherAssetsCurrentFairValueDisclosure>
    <bmrn:OtherAssetsCurrentFairValueDisclosure
      contextRef="i85d0caf2974040c1832284f6ac9f30c9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfNC01LTEtMS0w_7975f3ba-6b0f-4fc5-819d-44786c6c046b"
      unitRef="usd">0</bmrn:OtherAssetsCurrentFairValueDisclosure>
    <bmrn:OtherAssetsCurrentFairValueDisclosure
      contextRef="i48430041f0f14488a182cdf2a6fba1ea_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfNC03LTEtMS0w_6dae20c6-2d81-4319-a390-f388db8cccd7"
      unitRef="usd">2415000</bmrn:OtherAssetsCurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i4853afdcb6b3425eade1470b05d78550_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOC0zLTEtMS0w_7bd6cae6-6390-40b7-acdd-e5fae6b22c44"
      unitRef="usd">19962000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i85d0caf2974040c1832284f6ac9f30c9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOC01LTEtMS0w_6ad3aea9-c05f-4870-ac99-9173ccd95f30"
      unitRef="usd">0</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i48430041f0f14488a182cdf2a6fba1ea_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOC03LTEtMS0w_2ea9167d-8528-4de0-b99c-34a7dfc1aafb"
      unitRef="usd">19962000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="idf61805c0d2a4049b81025cec2ddb75a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOS0zLTEtMS0w_c5f2ec1e-f7b3-4eb4-8221-32b20465d319"
      unitRef="usd">4487000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i1deec9d3e3eb4a42adefe62e56bfd128_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOS01LTEtMS0w_f2b405f3-2b24-43a5-b224-ae1809bb2d88"
      unitRef="usd">0</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i2c1a81b9cccd4a1cba5fc0003b7aea8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfOS03LTEtMS0w_b97d85b8-1c83-423a-9336-3a8d9745b88d"
      unitRef="usd">4487000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i4efa93be091e41e2a53f2f9cfc80f758_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTEtMy0xLTEtMA_86e1ad60-4203-4858-aad1-f6822dcf0fcd"
      unitRef="usd">24449000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i671e3945deec4183bb208f00b654f148_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTEtNS0xLTEtMA_dc938788-7adf-4a81-a71a-ff0faf9237e8"
      unitRef="usd">0</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <bmrn:OtherAssetsNoncurrentFairValueDisclosure
      contextRef="i29763c9514834fa79c4c3fc2e884e8dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTEtNy0xLTEtMA_338e2897-44dc-435e-be99-c0d1a90b04d6"
      unitRef="usd">24449000</bmrn:OtherAssetsNoncurrentFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4efa93be091e41e2a53f2f9cfc80f758_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTItMy0xLTEtMA_d5e4862c-105d-4928-ae25-58b47fe53774"
      unitRef="usd">26864000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i671e3945deec4183bb208f00b654f148_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTItNS0xLTEtMA_7be11e6e-6e81-4a03-808d-4978065bc7dd"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i29763c9514834fa79c4c3fc2e884e8dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTItNy0xLTEtMA_40a5d563-b396-4eb6-b7d4-6c66206b2468"
      unitRef="usd">26864000</us-gaap:AssetsFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="i357642068229410d9b9eb92835bff095_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTUtMy0xLTEtMA_167b2e89-79cd-4ebc-953a-059db75efecf"
      unitRef="usd">2415000</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="i7a7e416850cb47f6aefc2fb4df37b5f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTUtNS0xLTEtMA_7752412d-5d8f-446f-9747-fb013f85dbd8"
      unitRef="usd">0</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesCurrentFairValueDisclosure
      contextRef="if27816fb13254b9694f700f40dbdbbff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTUtNy0xLTEtMA_ef4d36ad-da47-4894-9198-6f2787c46d81"
      unitRef="usd">2415000</bmrn:OtherLiabilitiesCurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i357642068229410d9b9eb92835bff095_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTktMy0xLTEtMA_b5f605d5-ebfe-4237-ae1d-45591a1b519f"
      unitRef="usd">19962000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i7a7e416850cb47f6aefc2fb4df37b5f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTktNS0xLTEtMA_ee1650d0-e1d1-4931-a643-499b9d002fe7"
      unitRef="usd">0</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="if27816fb13254b9694f700f40dbdbbff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMTktNy0xLTEtMA_af89d82f-114d-484f-a18f-c0a7f0178b2a"
      unitRef="usd">19962000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i5add67eb11e7443caf320c8d4619f132_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjAtMy0xLTEtMA_a395b517-2e2c-4317-a6bd-9e0e6d417ae8"
      unitRef="usd">0</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i33751b4c2ccd47d3bf56b6c79e05210a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjAtNS0xLTEtMA_9a3498e3-c779-486a-9493-073f8f1a02bc"
      unitRef="usd">60130000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i9c8d2de98a23439b8a9c5086c8a66fc1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjAtNy0xLTEtMA_61fe4791-ab5b-4988-95e4-debf9b716bf8"
      unitRef="usd">60130000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i4efa93be091e41e2a53f2f9cfc80f758_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjEtMy0xLTEtMA_2e225846-1649-40aa-99eb-8b7414c271c5"
      unitRef="usd">19962000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i671e3945deec4183bb208f00b654f148_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjEtNS0xLTEtMA_ce9bf3ce-e2fe-4cc0-a99d-492823a670d6"
      unitRef="usd">60130000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure
      contextRef="i29763c9514834fa79c4c3fc2e884e8dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjEtNy0xLTEtMA_600301bd-50aa-4765-b34c-51fba03969ee"
      unitRef="usd">80092000</bmrn:OtherLiabilitiesNoncurrentFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4efa93be091e41e2a53f2f9cfc80f758_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjItMy0xLTEtMA_57ec63fb-e17c-4c39-83e6-a3fcf95fd195"
      unitRef="usd">22377000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i671e3945deec4183bb208f00b654f148_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjItNS0xLTEtMA_2a32ca27-fdf0-4c66-b9ce-c194697a6a5b"
      unitRef="usd">60130000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i29763c9514834fa79c4c3fc2e884e8dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmI5NjViODY3NzA5ZDRkNzRhMTJhMDM2Y2ViYjY3YTgyL3RhYmxlcmFuZ2U6Yjk2NWI4Njc3MDlkNGQ3NGExMmEwMzZjZWJiNjdhODJfMjItNy0xLTEtMA_46411722-b6df-421a-8504-c8484925da7d"
      unitRef="usd">82507000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RleHRyZWdpb246MzJiNmNmOWUxNDg2NDU0Y2JkZDZjMmQ1MTExYWI1MzhfMTE4Ng_b3ad6b20-6b42-4732-82ca-87ca0cccd162">Liabilities measured at fair value using Level 3 inputs primarily consisted of contingent consideration. The following tables represent a roll-forward of contingent consideration.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in the fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange remeasurement of Euro denominated contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i615edf13dd9645ddb17b1b2bd0c8b9e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmRkZTQwNGRlODA0NTQ5Y2NhNmMzM2YxODRlNmE4M2YzL3RhYmxlcmFuZ2U6ZGRlNDA0ZGU4MDQ1NDljY2E2YzMzZjE4NGU2YTgzZjNfMC0xLTEtMS0w_a67822b7-33fc-4f03-b3d6-b225e61f1239"
      unitRef="usd">60130000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="id8fcd6f6536d4855824ff24db3d6b5c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmRkZTQwNGRlODA0NTQ5Y2NhNmMzM2YxODRlNmE4M2YzL3RhYmxlcmFuZ2U6ZGRlNDA0ZGU4MDQ1NDljY2E2YzMzZjE4NGU2YTgzZjNfMS0xLTEtMS0w_45f76e93-3966-4e53-9876-19e177a6fe72"
      unitRef="usd">6254000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <bmrn:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement
      contextRef="id8fcd6f6536d4855824ff24db3d6b5c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmRkZTQwNGRlODA0NTQ5Y2NhNmMzM2YxODRlNmE4M2YzL3RhYmxlcmFuZ2U6ZGRlNDA0ZGU4MDQ1NDljY2E2YzMzZjE4NGU2YTgzZjNfMi0xLTEtMS0w_47412fac-d540-4d08-a55b-ed1d0f33028a"
      unitRef="usd">-2993000</bmrn:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ie591deab87f84651a1f0e8a8b378340d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181Mi9mcmFnOjMyYjZjZjllMTQ4NjQ1NGNiZGQ2YzJkNTExMWFiNTM4L3RhYmxlOmRkZTQwNGRlODA0NTQ5Y2NhNmMzM2YxODRlNmE4M2YzL3RhYmxlcmFuZ2U6ZGRlNDA0ZGU4MDQ1NDljY2E2YzMzZjE4NGU2YTgzZjNfMy0xLTEtMS0w_7c4f8029-f78d-49ad-a2a5-d38ba5c53e8e"
      unitRef="usd">63391000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMjIzMg_d495bc05-4c8a-400b-a654-3e3fa299f764">DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIESThe Company uses foreign currency exchange forward contracts (forward contracts) to protect against the reduction in value of forecasted foreign currency cash flows resulting from product revenues, royalty revenues and operating expenses denominated in currencies other than the U.S. Dollar (USD), primarily the Euro. Certain of these forward contracts are designated as cash flows hedges and have maturities of up to two years. The Company also enters into forward contracts to manage foreign exchange risk related to asset or liability positions denominated in currencies other than USD. Such forward contracts are considered to be economic hedges, are not designated as hedging instruments and have maturities of up to three months. The Company does not use derivative instruments for speculative trading purposes. The Company is exposed to counterparty credit risk on its derivatives. The Company has established and maintains strict counterparty credit guidelines and enters into hedging &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;agreements with financial institutions that are investment grade or better to minimize the Company&#x2019;s exposure to potential defaults. The Company is not required to pledge collateral under these agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the aggregate notional amounts for the Company&#x2019;s derivatives outstanding as of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;654,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;782,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value carrying amounts of the Company&#x2019;s derivatives, as classified within the fair value hierarchy, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Derivatives - Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability Derivatives - Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts&#160;payable&#160;and accrued&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Derivatives - Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability Derivatives - Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts&#160;payable&#160;and accrued&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Derivatives Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Derivatives Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;For additional discussion of fair value measurements, see Note 3 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables summarize the impact of gains and losses from the Company's derivatives on its Condensed Consolidated Statements of Comprehensive Income (Loss) for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedging Gains (Losses) &lt;br/&gt;Reclassified into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedging Gains (Losses) &lt;br/&gt;Reclassified into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net product revenues as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;461,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;532,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(815)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedging Gains (Losses) &lt;br/&gt;Reclassified into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedging Gains (Losses) &lt;br/&gt;Reclassified into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net product revenues as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,348,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,368,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,412,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,400,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;text-indent:45pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the Company expects to reclassify unrealized gains of $6.2 million from Accumulated Other Comprehensive Income (AOCI) to earnings as the forecasted revenues and operating expense transactions occur over the next 12 months. For additional discussion of balances in AOCI see Note 10 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeRemainingMaturity1
      contextRef="i14bf2ac4d92840cb8a1f7aae38462abd_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMzI5ODUzNDg4NTYxOQ_c1bc60e7-2274-488b-8979-fbde72735f22">P2Y</us-gaap:DerivativeRemainingMaturity1>
    <us-gaap:DerivativeRemainingMaturity1
      contextRef="id61c318f76764a7fa034c58b06aedb1b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfNzky_015ef936-b5e2-4c1c-9d6d-9edf259cbfda">P3M</us-gaap:DerivativeRemainingMaturity1>
    <us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock
      contextRef="i14bf2ac4d92840cb8a1f7aae38462abd_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMjIzMw_9c1a2466-18f4-456d-b745-c8627ae7d92c">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the aggregate notional amounts for the Company&#x2019;s derivatives outstanding as of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;654,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;782,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i801ae299848e42d9a8bba895edfc93ae_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfMi0xLTEtMS0w_5857ef05-304d-4ceb-b9f4-aa119a56fb7c"
      unitRef="usd">654516000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4255a1344130421b867098a0db4b4234_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfMi0zLTEtMS0w_e068eef4-0d91-4568-8621-b14ec865ab3b"
      unitRef="usd">782327000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia3b9c04057d24a85901bdc543d7f5881_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfMy0xLTEtMS0w_860da84f-2d4c-4ca3-b0ad-c170987d22de"
      unitRef="usd">168080000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8911e37b2bf14742badb679e3603864b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfMy0zLTEtMS0w_9c7c8c8b-a7a2-4da2-8651-2992b34e5f42"
      unitRef="usd">189540000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5c536cb7054e4cb6b74a31bf41dbf674_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfNi0xLTEtMS0w_6bf13c38-4931-4033-a4bd-080f6807b34b"
      unitRef="usd">77040000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2d28061c88a44b7aa46deded1cf2e6a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfNi0zLTEtMS0w_76715b01-03a4-45bc-9275-39f716a80635"
      unitRef="usd">98343000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i87c65af7fe274f899122097d464a1bf4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfNy0xLTEtMS0w_94bd3e9b-e9e5-40a8-9f4c-979fc5b05dc6"
      unitRef="usd">37285000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id6af4b58a85d47a2a7ed411542576cd3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjkyZDVkNWZjYTEwOTRiY2NiY2UxNTljMDRjNGVmODBiL3RhYmxlcmFuZ2U6OTJkNWQ1ZmNhMTA5NGJjY2JjZTE1OWMwNGM0ZWY4MGJfNy0zLTEtMS0w_3ca389cb-9252-4bb7-b8ce-3bc19edfa4cd"
      unitRef="usd">12277000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMjIzNA_8fca06f1-6a07-4490-a46d-3cbd88922573">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value carrying amounts of the Company&#x2019;s derivatives, as classified within the fair value hierarchy, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Derivatives - Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability Derivatives - Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts&#160;payable&#160;and accrued&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#160;long-term&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Derivatives - Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&#160;current&#160;assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability Derivatives - Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts&#160;payable&#160;and accrued&#160;liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Derivatives Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Derivatives Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;For additional discussion of fair value measurements, see Note 3 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia65f45b20e934503b719a9058ffc0aa1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMy0xLTEtMS0w_a5dd5193-0c7d-42d4-88b9-d0e918564621"
      unitRef="usd">11883000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if4fa8d281e98402cbfe0bbf358bd183d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMy0zLTEtMS0w_086c6b83-b657-4ded-aa95-cdb87d957586"
      unitRef="usd">6268000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i998dfa69cd654bfbbac7b62ef70c8ee1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfNC0xLTEtMS0w_51806f6e-74ed-4eb5-8542-9270529447df"
      unitRef="usd">4320000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2959731ccc2d46129ed431c7d2b06d80_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfNC0zLTEtMS0w_8313a3ec-8323-4f9e-89da-442127cef3bf"
      unitRef="usd">3148000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib57861f66fb846acac9f83cdc9e47785_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfNS0xLTEtMS0w_3b4785a5-b181-4f0b-8770-78d9ae24b93e"
      unitRef="usd">16203000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5d72a61dbc164a95830296964a405193_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfNS0zLTEtMS0w_221e3d0b-3010-4161-991f-4db56602cb9c"
      unitRef="usd">9416000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i653a9dcd97a14cdd9a1732d3b2674534_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfOC0xLTEtMS0w_8b3e7240-679e-45fd-ad4c-eb800af46514"
      unitRef="usd">5257000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i45acdc04438043e3a8bd6387c422da66_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfOC0zLTEtMS0w_8e98037f-838f-4b0d-9e7c-49dfdafa7e38"
      unitRef="usd">17551000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i56a8390484ae4b6f877f15cfcbcb0f27_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfOS0xLTEtMS0w_0bb9a075-55a0-431e-add0-bcbe3a62fb86"
      unitRef="usd">1486000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibd69df912beb45dbad86a43d5165bd04_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfOS0zLTEtMS0w_cd0347ac-a344-45af-ac64-595f2fda5557"
      unitRef="usd">11020000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib57861f66fb846acac9f83cdc9e47785_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTAtMS0xLTEtMA_b476d512-7a9d-4729-940b-86dd7f1ac4ee"
      unitRef="usd">6743000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5d72a61dbc164a95830296964a405193_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTAtMy0xLTEtMA_6bd7381a-7850-4332-b625-d4e087b8bb8e"
      unitRef="usd">28571000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibcf858e58d4a42deb0197ad3a84b8e2a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTQtMS0xLTEtMA_18607fd7-791a-4d26-8177-179d15f1b790"
      unitRef="usd">252000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8d22d4a686e04d89add5ad2e6c2dbb50_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTQtMy0xLTEtMA_69fafe17-f04d-40c6-9f25-8cb0bd6f5e21"
      unitRef="usd">84000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ife95d4f1adbe4a8fa995aa600c1b72ae_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTgtMS0xLTEtMA_b0116829-0744-4502-a14b-ac19b1bc6e71"
      unitRef="usd">66000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id2ddd51b05b44b81b4cac9334ce55095_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMTgtMy0xLTEtMA_1926b597-9f45-4da7-9bbc-299658b2d95b"
      unitRef="usd">247000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMjItMS0xLTEtMA_d1b57ad8-2448-46d3-9149-e384cda4513a"
      unitRef="usd">16455000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMjItMy0xLTEtMA_b1adb7ea-a2ce-4d47-8452-00523f954bcd"
      unitRef="usd">9500000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMjMtMS0xLTEtMA_cf08ce0b-8b53-473f-9727-05fb81314c0a"
      unitRef="usd">6809000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmZlMzZmZmZmMzkxYzQ2Y2Y4NTY1YWM2ZjM4OWVkZTVkL3RhYmxlcmFuZ2U6ZmUzNmZmZmYzOTFjNDZjZjg1NjVhYzZmMzg5ZWRlNWRfMjMtMy0xLTEtMA_a9a0522e-30df-413d-8987-4e4e1aa8af7c"
      unitRef="usd">28818000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMjIzNw_0350a842-6560-456f-8649-a3443bff0c70">The following tables summarize the impact of gains and losses from the Company's derivatives on its Condensed Consolidated Statements of Comprehensive Income (Loss) for the periods presented.&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedging Gains (Losses) &lt;br/&gt;Reclassified into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedging Gains (Losses) &lt;br/&gt;Reclassified into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net product revenues as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;461,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;532,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(815)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedging Gains (Losses) &lt;br/&gt;Reclassified into Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash Flow Hedging Gains (Losses) &lt;br/&gt;Reclassified into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net product revenues as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,348,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,368,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses as reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,412,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,400,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gains (Losses) Recognized in Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNC0xLTEtMS0w_069b9be1-21c4-4ade-8505-93fa9c1df770"
      unitRef="usd">393840000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i8a0867d2abd245aeb03cd68ad004aa7a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNC0zLTEtMS0w_d67cf104-a9a8-4544-a3c0-5e7cba569d92"
      unitRef="usd">401000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNC01LTEtMS0w_27c90a8b-cae1-4bca-b6de-c18745c62391"
      unitRef="usd">460741000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ifa5e54ce01d4462f8417aa877f5454bd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNC03LTEtMS0w_6ceb89ef-a3b0-4a0d-9cfb-1547f7bcebc8"
      unitRef="usd">2693000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CostsAndExpenses
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNS0xLTEtMS0w_a206f99d-f40b-4849-bd10-0c2339a130d6"
      unitRef="usd">461961000</us-gaap:CostsAndExpenses>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i93a85736fa1a4177831386b25c03128a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNS0zLTEtMS0w_31a7b404-e930-48a7-a85c-b92b208d5499"
      unitRef="usd">-268000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CostsAndExpenses
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNS01LTEtMS0w_6e122948-419e-4a80-a7b8-63e70369000c"
      unitRef="usd">532725000</us-gaap:CostsAndExpenses>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i3dc4e113aded47d28e12f99a50683bbe_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfNS03LTEtMS0w_ba2d707d-f78d-4d51-b19e-d89c9250c83f"
      unitRef="usd">-815000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5396b9f8638140eab847f0bdfcab099a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfOC0zLTEtMS0w_54114474-ac96-4222-85ec-472bc2404f89"
      unitRef="usd">1302000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i6257cb31e6a74435a04b92f18161c169_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOjIzNTcxYTZlNWU3YjQyOTE5NTJmMjA4YmI4MzM2NzBhL3RhYmxlcmFuZ2U6MjM1NzFhNmU1ZTdiNDI5MTk1MmYyMDhiYjgzMzY3MGFfOC03LTEtMS0w_aa4bd56d-be47-4d92-80ea-39079914b0af"
      unitRef="usd">4166000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9940e707613405199a97fc351ad73ef_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNC0xLTEtMS0w_18531048-a517-4fbe-9713-5df7eb2de8ad"
      unitRef="usd">1348279000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="icbedd8a5f7224c52a0e6a43b72b26b32_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNC0zLTEtMS0w_0f0c336b-4c3a-4ce8-ab03-526d60c76a88"
      unitRef="usd">-5034000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNC01LTEtMS0w_a8a35845-3015-475e-a6bd-44e699a74ec4"
      unitRef="usd">1368816000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i63cb5ebbe7144d7cbd04769985192b4d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNC03LTEtMS0w_364dd5b4-e7b5-489d-ad0d-33fa0d45b6cb"
      unitRef="usd">17301000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CostsAndExpenses
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNS0xLTEtMS0w_185ca6a7-8da1-4426-889a-5534c1e18c09"
      unitRef="usd">1412926000</us-gaap:CostsAndExpenses>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i2f69cb4b88254f89ae7a84113b9ef9e4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNS0zLTEtMS0w_b5fb7ee3-ff09-493a-a0fc-0d14f37f6baf"
      unitRef="usd">81000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CostsAndExpenses
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNS01LTEtMS0w_0ca34d78-5fb0-40fd-a4bb-203ef0cf116e"
      unitRef="usd">1400263000</us-gaap:CostsAndExpenses>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia10f257e647949e8a3b8943db642b6ba_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfNS03LTEtMS0w_a6c4a03b-177d-439a-8792-80ed02d2df55"
      unitRef="usd">-4274000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="id61c318f76764a7fa034c58b06aedb1b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfOC0zLTEtMS0w_0a8731dc-3123-468b-9d94-67628b0a7bfa"
      unitRef="usd">2310000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5bd960385e494621870825c06ea5d0dc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RhYmxlOmVlZGJiYzE5ZmM0ZTQ4ODE4OGE4N2VkNWQ0ZTQyOWJlL3RhYmxlcmFuZ2U6ZWVkYmJjMTlmYzRlNDg4MTg4YTg3ZWQ1ZDRlNDI5YmVfOC03LTEtMS0w_30efb188-601c-46a9-ba6a-8d4fdbe0ef42"
      unitRef="usd">9600000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM181NS9mcmFnOjMyN2FlN2NmOTFlMzRjNDZhYWM2MmRjOTUxNGE5OTBjL3RleHRyZWdpb246MzI3YWU3Y2Y5MWUzNGM0NmFhYzYyZGM5NTE0YTk5MGNfMTk3Mg_70ae9ebb-21e8-420e-a0d4-5a67c045348b"
      unitRef="usd">6200000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTc2Mw_034864a4-ede7-4be7-9e23-51fc082d8ca3">DEBT&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the Company had outstanding fixed-rate notes with varying maturities for an undiscounted aggregate principal amount of $1.1 billion (collectively the Notes). The Notes are senior subordinated convertible obligations, and interest is payable in arrears, semi-annually. The following table summarizes information regarding the Company&#x2019;s convertible debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.25% senior subordinated convertible notes due in May 2027 (the 2027 Notes)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount net of deferred offering costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027 Notes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;588,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.599% senior subordinated convertible notes due in August 2024 (the 2024 Notes)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount net of deferred offering costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024 Notes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;489,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total convertible debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,075,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value of fixed rate convertible debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;627,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;510,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total fair value of fixed rate convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,111,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,157,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The fair value of the Company&#x2019;s fixed-rate convertible debt is based on open market trades and is classified as Level 1 in the fair value hierarchy. For additional discussion of fair value measurements, see Note 3 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest expense on the Company&#x2019;s convertible debt consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Coupon interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accretion of discount on convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total interest expense on convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;See Note 13 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 for additional information related to the Company&#x2019;s convertible debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In October 2018, the Company entered into an unsecured revolving credit facility of up to $200.0&#160;million which includes a letter of credit subfacility and a swingline loan subfacility. The credit facility is intended to finance ongoing working capital needs and for other general corporate purposes. In May 2021, the Company entered into an amendment agreement in respect of the credit facility, extending the maturity date from October 19, 2021 to May 28, 2024, among other changes. The amended credit facility contains financial covenants including a maximum leverage ratio and a minimum interest coverage ratio. As of September&#160;30, 2021, there were no amounts outstanding under the credit facility and the Company and certain of its subsidiaries that serve as guarantors were in compliance with all covenants.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTYx_7faeda8f-d615-4c0b-bddf-52458c22cd05"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTc1OA_fd34ea68-e12a-44bf-b02d-3e8d2c7cb6ea">The following table summarizes information regarding the Company&#x2019;s convertible debt:&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.25% senior subordinated convertible notes due in May 2027 (the 2027 Notes)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount net of deferred offering costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027 Notes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;588,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;587,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.599% senior subordinated convertible notes due in August 2024 (the 2024 Notes)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount net of deferred offering costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024 Notes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;489,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total convertible debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,075,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value of fixed rate convertible debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;627,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;510,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total fair value of fixed rate convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,111,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,157,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The fair value of the Company&#x2019;s fixed-rate convertible debt is based on open market trades and is classified as Level 1 in the fair value hierarchy. For additional discussion of fair value measurements, see Note 3 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMS0wLTEtMS0wL3RleHRyZWdpb246YWY3ZWFhMzY2ZTQwNGMzYmEzY2ZlZTUwNjJkY2RiNmJfNA_28ee94f2-769a-4636-8d7b-4aec5ab48d09"
      unitRef="number">0.0125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMS0wLTEtMS0wL3RleHRyZWdpb246YWY3ZWFhMzY2ZTQwNGMzYmEzY2ZlZTUwNjJkY2RiNmJfNA_6c454736-2873-4de9-be18-d2d07ee00099"
      unitRef="number">0.0125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMS0xLTEtMS0w_d0fe202a-8669-43de-b528-b4f45b27dd9f"
      unitRef="usd">600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMS0zLTEtMS0w_4fc44851-832b-4bf7-a9db-2e15dcb7ad51"
      unitRef="usd">600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMi0xLTEtMS0w_08ad92d6-6a8c-40a5-bacf-7023df6d4836"
      unitRef="usd">11478000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMi0zLTEtMS0w_90b6f7fd-c3cb-4bdc-8568-fa98342c6e48"
      unitRef="usd">12995000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMy0xLTEtMS0w_f3533cb1-0d17-41a7-a363-c3efe207c688"
      unitRef="usd">588522000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMy0zLTEtMS0w_2dbe5e6e-2886-4bba-90a0-8490f53f96ed"
      unitRef="usd">587005000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNS0wLTEtMS0wL3RleHRyZWdpb246ZmI4NDNlMjNjYzFhNDIwYjlkNjZmNTQ4ZTNhZjJiZTVfNA_30e8355d-4598-4881-aa1a-d86f1e4fb0ed"
      unitRef="number">0.00599</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNS0wLTEtMS0wL3RleHRyZWdpb246ZmI4NDNlMjNjYzFhNDIwYjlkNjZmNTQ4ZTNhZjJiZTVfNA_efadfbbf-6c56-42ee-96fe-af3b9b8fae74"
      unitRef="number">0.00599</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNS0xLTEtMS0w_b1b735fe-21e0-473a-a03c-f78d6e958a84"
      unitRef="usd">495000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNS0zLTEtMS0w_5acff0d7-d674-4005-b601-2773b449d21e"
      unitRef="usd">495000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNi0xLTEtMS0w_716322f8-fdbe-4105-aab0-dd4c28c13b27"
      unitRef="usd">5429000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNi0zLTEtMS0w_a18cd714-3820-4015-9cf8-b6b7ad4afd1c"
      unitRef="usd">6860000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNy0xLTEtMS0w_7f19c4ce-d023-490b-943a-5e5dc32078e6"
      unitRef="usd">489571000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfNy0zLTEtMS0w_63557254-1401-4af6-8127-5a57721dc90b"
      unitRef="usd">488140000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebt
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfOS0xLTEtMS0w_46dad1d3-9db1-4c2d-9996-873863b6dcb2"
      unitRef="usd">1078093000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfOS0zLTEtMS0w_53174bf0-31e1-4d26-894f-bea34b4e9949"
      unitRef="usd">1075145000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i2d0ec83a5e8c401ab387d676b8db9044_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTItMS0xLTEtMA_ce08b061-ce99-4619-a062-fca040ee5041"
      unitRef="usd">600858000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i4e007e38fb6a46adacda2d712f243e5e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTItMy0xLTEtMA_7b042bca-c729-47f5-99ee-fa0db261eb13"
      unitRef="usd">627090000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i5ffe2646b01c4c7c8c425382618ea995_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTMtMS0xLTEtMA_9286cdf6-f664-4703-8f8a-b6e5f05fa0ee"
      unitRef="usd">510954000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i43b959de93cc4964a01bc54cd284fd1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTMtMy0xLTEtMA_e7e08db8-cb4c-4617-82e6-b6df6496178d"
      unitRef="usd">530714000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTQtMS0xLTEtMA_9c26bce0-8b9b-4b2a-a3c6-6e9bdf997c31"
      unitRef="usd">1111812000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i8b17bc4d253c44789e173a8f801f46a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOmIwNDAzYjMxNzI1MzRlYzFiNmU1Y2FjMWEzYzVhMGQ5L3RhYmxlcmFuZ2U6YjA0MDNiMzE3MjUzNGVjMWI2ZTVjYWMxYTNjNWEwZDlfMTQtMy0xLTEtMA_5fbbb260-81d1-403a-a19d-c716a0313abe"
      unitRef="usd">1157804000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTc1OQ_a65b3f6f-ef1a-4f50-a2dd-9a081cc30121">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest expense on the Company&#x2019;s convertible debt consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Coupon interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accretion of discount on convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total interest expense on convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMi0xLTEtMS0w_fd9ad274-1fde-4bc5-9315-f4bf8c071243"
      unitRef="usd">2617000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i38a00422432443d785988f4c838194eb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMi0zLTEtMS0w_62467fdb-d512-48de-ad4c-98b2e56f1adc"
      unitRef="usd">4255000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMi01LTEtMS0w_8c0843ac-71fb-42b2-9fa4-70465fd5fb26"
      unitRef="usd">7849000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMi03LTEtMS0w_d4ca8688-98c4-4799-a605-e5e7811ef09f"
      unitRef="usd">9443000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMy0xLTEtMS0w_cde68393-a498-4611-b144-b159da1f7377"
      unitRef="usd">835000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i38a00422432443d785988f4c838194eb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMy0zLTEtMS0w_326483b2-60e2-4db3-bbf4-547a4a5b3dcc"
      unitRef="usd">4696000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMy01LTEtMS0w_1375d978-445a-45a0-98a9-6a1158e7ca3f"
      unitRef="usd">2503000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfMy03LTEtMS0w_5737c0a0-39cf-4d4b-8cc1-62926a9a3cd9"
      unitRef="usd">13201000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNC0xLTEtMS0w_6d4af28e-3ed5-4d77-857f-f41ca506d222"
      unitRef="usd">148000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i38a00422432443d785988f4c838194eb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNC0zLTEtMS0w_f1898a96-e11a-4d23-bba1-cc4c1b45e5c8"
      unitRef="usd">535000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNC01LTEtMS0w_03fe06d6-485a-4474-a505-7132acfba856"
      unitRef="usd">445000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNC03LTEtMS0w_1b5c52e7-b4d7-4ba6-86e7-7bf55e5aeee9"
      unitRef="usd">1565000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpense
      contextRef="iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNS0xLTEtMS0w_a934f71a-0a7f-424e-896a-16149d7681b2"
      unitRef="usd">3600000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i38a00422432443d785988f4c838194eb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNS0zLTEtMS0w_6055a8fa-de14-47ec-abbb-90fbc527d202"
      unitRef="usd">9486000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i19e6fbe8e0714c5796b90855410f8007_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNS01LTEtMS0w_28fcdab4-525a-42d3-b73a-34a3320ef85a"
      unitRef="usd">10797000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib7a0febc607f40cfab35e22a7a78b8a9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RhYmxlOjMxMjVmNjE2NTY2NDRjMmJiYjc1MjI0NjNmNzU1NGJhL3RhYmxlcmFuZ2U6MzEyNWY2MTY1NjY0NGMyYmJiNzUyMjQ2M2Y3NTU0YmFfNS03LTEtMS0w_5c162d5c-30ae-4ae7-a869-9ce163b405e3"
      unitRef="usd">24209000</us-gaap:InterestExpense>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iba2ae00a5eea4923b638351403ec6b48_I20181031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTA4OA_37307291-514b-445c-8bd5-8dd71b620aad"
      unitRef="usd">200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="iee37fe35ae7740dbbf5492520ad69a15_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182MS9mcmFnOjRhZGVkMDhkMzFiNDQ1OTU5MTE4NDc3Y2VkYWYxZjlhL3RleHRyZWdpb246NGFkZWQwOGQzMWI0NDU5NTkxMTg0NzdjZWRhZjFmOWFfMTU5OA_70c7d84d-ea83-4478-973f-df942859dce0"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RleHRyZWdpb246YzQ4MmMzMGQ5Y2RjNGUxY2FjZTEwNjVkMDU0ZmJhMWRfNDUw_ecfa5896-997d-4475-8475-c774582f55f5">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables summarize changes in the accumulated balances for each component of Accumulated Other Comprehensive Income (Loss) (AOCI), including current-period other comprehensive income (loss) and reclassifications out of AOCI, for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on Cash&lt;br/&gt;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on&lt;br/&gt;Available for-Sale&lt;br/&gt;Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;&#160;&#160;&#160;&#160; reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: gain (loss) reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on Cash&lt;br/&gt;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on&lt;br/&gt;Available for-Sale&lt;br/&gt;Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;&#160;&#160;&#160;&#160; reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: gain (loss) reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on Cash&lt;br/&gt;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on&lt;br/&gt;Available for-Sale&lt;br/&gt;Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;&#160;&#160;&#160;&#160; reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: gain (loss) reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on Cash&lt;br/&gt;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on&lt;br/&gt;Available for-Sale&lt;br/&gt;Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;&#160;&#160;&#160;&#160; reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: gain (loss) reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;For additional discussion of reclassifications from AOCI see Note 8 &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Derivative Instruments and Hedging Strategies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RleHRyZWdpb246YzQ4MmMzMGQ5Y2RjNGUxY2FjZTEwNjVkMDU0ZmJhMWRfNDQ1_7bfec557-ffba-41f4-98c3-06503c9315f9">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables summarize changes in the accumulated balances for each component of Accumulated Other Comprehensive Income (Loss) (AOCI), including current-period other comprehensive income (loss) and reclassifications out of AOCI, for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on Cash&lt;br/&gt;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on&lt;br/&gt;Available for-Sale&lt;br/&gt;Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;&#160;&#160;&#160;&#160; reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: gain (loss) reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on Cash&lt;br/&gt;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on&lt;br/&gt;Available for-Sale&lt;br/&gt;Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;&#160;&#160;&#160;&#160; reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: gain (loss) reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on Cash&lt;br/&gt;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on&lt;br/&gt;Available for-Sale&lt;br/&gt;Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;&#160;&#160;&#160;&#160; reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: gain (loss) reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.404%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on Cash&lt;br/&gt;Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses) on&lt;br/&gt;Available for-Sale&lt;br/&gt;Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;&#160;&#160;&#160;&#160; reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: gain (loss) reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AOCI balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i7a1454c700cf4b51a23d6f33d90c7c8a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMi0xLTEtMS0w_5720740d-40fb-42bc-ac23-5e830c93d4cb"
      unitRef="usd">-2760000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8717ee13ca8c430dbecd711039a7e46f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMi0zLTEtMS0w_8f6eb418-1a66-4ef7-a578-9da8da410cfd"
      unitRef="usd">1821000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if511f9ed24f948619a2e53651da7e114_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMi01LTEtMS0w_d8c39402-010e-4848-a922-1bc01cd3e907"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ice2e3bd0516f4927a3ea54940b0473b8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMi03LTEtMS0w_b8c2e94e-e926-4ded-8e28-91627cd58223"
      unitRef="usd">-939000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMy0xLTEtMS0w_cd5540b2-9de9-49c6-a3a2-1ec7e83f0eca"
      unitRef="usd">11914000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMy0zLTEtMS0w_b22bce46-f0e6-4020-8e43-e0a7018880e8"
      unitRef="usd">-786000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i5608486f3aab45158217508c7361b8db_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMy01LTEtMS0w_6d899b15-1952-4cc0-a958-95492dd8a906"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfMy03LTEtMS0w_e1c1e0c4-8a77-46db-a335-0d3d6ffa9de3"
      unitRef="usd">11128000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNC0xLTEtMS0w_b7762818-0f8a-446b-821e-01c4c6e054e6"
      unitRef="usd">133000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNC0zLTEtMS0w_11be99a9-2cc7-426e-bc07-16ff29c8fb83"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i5608486f3aab45158217508c7361b8db_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNC01LTEtMS0w_efed474b-dded-4587-a559-d3f02e0f0a65"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNC03LTEtMS0w_1d24c725-c0e0-4687-b5e8-707c9bd329d8"
      unitRef="usd">133000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNS0xLTEtMS0w_da11cbd5-183b-4749-922a-d77243927b9a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNS0zLTEtMS0w_a3e06573-0dac-42ad-ac52-20eabd6d6067"
      unitRef="usd">-183000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i5608486f3aab45158217508c7361b8db_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNS01LTEtMS0w_537014ae-8303-462f-835d-0d628b08e91a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNS03LTEtMS0w_66775d4d-6d75-4a6b-9ce1-ab0256306812"
      unitRef="usd">-183000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i843c1691cfe241eb949e957f6d4f630b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNi0xLTEtMS0w_21513818-c906-4600-a455-6108a21098b5"
      unitRef="usd">11781000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4338d18b563442b1b680101b0c95c19a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNi0zLTEtMS0w_eefa96d6-93df-42c3-b0db-051e1e0ba428"
      unitRef="usd">-603000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5608486f3aab45158217508c7361b8db_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNi01LTEtMS0w_15f7ba77-a819-44c8-a1dd-457cb09c121a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNi03LTEtMS0w_8a93fe31-2ac0-45c2-ab8b-417bfe5c535c"
      unitRef="usd">11178000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ie4f8068feed342d0852f9c527519b97c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNy0xLTEtMS0w_7082fbce-baf6-46a5-9333-9e5f217fce93"
      unitRef="usd">9021000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3faf010302b3404ebb5a5088bb42c52b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNy0zLTEtMS0w_7d20b93b-cb70-4d56-b0aa-845d600e58c9"
      unitRef="usd">1218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a6b9095a67c4e829c8badebfb6d9376_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNy01LTEtMS0w_21cc4aac-1b2f-40eb-9eff-afe1974ae4ea"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmFkYjE0MjRlYTNiMDQ2MGVhZjE3YmQwMGRiMGY4OGU3L3RhYmxlcmFuZ2U6YWRiMTQyNGVhM2IwNDYwZWFmMTdiZDAwZGIwZjg4ZTdfNy03LTEtMS0w_99e6cc74-81f2-454e-a9c9-24ec77cf8e05"
      unitRef="usd">10239000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2825e372b0ea4c4db7b030d62cb5b3f7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMi0xLTEtMS0w_9c39d2c6-92cf-4424-b127-6b48f324ce24"
      unitRef="usd">22963000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2551e7c9a1f04acdbbd714ef15b18e6f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMi0zLTEtMS0w_ae7e1ef7-e988-4d08-bbc5-a12848cb7cd6"
      unitRef="usd">7087000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i75e63c14188b429a96626e5e45c2c116_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMi01LTEtMS0w_b966aa3a-4678-434e-a105-4162865ee38b"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i10986a90b6074a24befea81408205ba6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMi03LTEtMS0w_2f4a0c6c-a8cc-4f59-9205-cb8e7d33cd11"
      unitRef="usd">30050000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMy0xLTEtMS0w_0efc305f-4d29-494f-8e8d-6152e9cdaa59"
      unitRef="usd">-16094000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMy0zLTEtMS0w_786ad413-1cba-4bd1-8309-96f51edda8ba"
      unitRef="usd">-2201000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMy01LTEtMS0w_7c6a18c9-ed4a-479d-8d0d-f6fed3427eca"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfMy03LTEtMS0w_1f4ac6eb-0eee-42de-b05a-b3b7624281ca"
      unitRef="usd">-18295000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNC0xLTEtMS0w_3950d7fc-d654-4e15-aca9-60bc823939c0"
      unitRef="usd">1878000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNC0zLTEtMS0w_b7708a86-bae9-44a8-acd1-29a334044445"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNC01LTEtMS0w_e102ce3b-bdf6-4a96-90e4-255e5bea6c72"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNC03LTEtMS0w_b8be6bab-4777-4bb0-a741-2f5eb783304a"
      unitRef="usd">1878000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNS0xLTEtMS0w_b62b7a9a-a37f-4da3-ad53-b59d0e5242ba"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNS0zLTEtMS0w_b63a3b30-2640-4b44-850a-d885c4fc7589"
      unitRef="usd">-508000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNS01LTEtMS0w_cfa26517-8581-420b-965f-bde49f8d7e86"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNS03LTEtMS0w_bfdd6d67-6bdc-47a1-96a5-ed2cab6c1179"
      unitRef="usd">-508000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0ea24232e1d14db3b5d58011db3f91d2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNi0xLTEtMS0w_5fce4f07-bc05-4773-bd7b-b6fc80277e6e"
      unitRef="usd">-17972000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1324a5bbfd184069b9040ba3a09f1066_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNi0zLTEtMS0w_d96ad423-fc13-4082-8824-202f36ea09ae"
      unitRef="usd">-1693000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5632a4dba6bf43bba6caac919577052f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNi01LTEtMS0w_def537fe-e347-465b-b508-f5fd90e8d2b2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNi03LTEtMS0w_e39e439e-5588-4591-b14b-d4a954256d7b"
      unitRef="usd">-19665000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ica6ad443b63d459f92df9ffbcae2b88a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNy0xLTEtMS0w_3abfe1e3-d39b-4510-8430-f4c09cad9f23"
      unitRef="usd">4991000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99ca830558c94af29e572b85e6fb0ab0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNy0zLTEtMS0w_f6c75b09-a641-4340-a421-1f03465de7fd"
      unitRef="usd">5394000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd5abfbe741a48819ae2f94da173f77b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNy01LTEtMS0w_72cbed96-5994-4baa-9f66-a3d36674a5c3"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id0db40041dc54511b7a5f5d17ab13fa6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjNlNmZiN2ZmYWQxYjRiODliOGIwY2E0NGM3NjUzOTg5L3RhYmxlcmFuZ2U6M2U2ZmI3ZmZhZDFiNGI4OWI4YjBjYTQ0Yzc2NTM5ODlfNy03LTEtMS0w_8e7bef74-305a-4330-a73d-312375a3d108"
      unitRef="usd">10385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id254242e029e4cd29e695890e7e368f3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMi0xLTEtMS0w_287a5a57-f517-438f-adb0-71db0c617c02"
      unitRef="usd">-20028000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02c79f2fe3684a398bd2294ebbe2c99b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMi0zLTEtMS0w_85da3798-f1f5-4a28-94a4-f89b070bead0"
      unitRef="usd">3889000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e57bf81424a40c5b3adb66b880dae12_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMi01LTEtMS0w_84c44634-1940-4945-b5df-1e09fcb655a1"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i847ccef2e0f749cdbc16c784f8bc20d7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMi03LTEtMS0w_18e72576-73fe-47d8-bb4f-ee3611f923dd"
      unitRef="usd">-16139000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMy0xLTEtMS0w_467f3ef1-5c89-4529-8b48-22bb7c7cea2a"
      unitRef="usd">24096000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMy0zLTEtMS0w_b71d1643-5128-462a-ac87-60a45edc9e01"
      unitRef="usd">-3470000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMy01LTEtMS0w_c73cd050-54bf-401b-8438-5e82f07b815b"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfMy03LTEtMS0w_3072fe72-30ed-44bd-8de2-554b03427db0"
      unitRef="usd">20626000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNC0xLTEtMS0w_cc694db7-52ef-47dd-a4a9-cf478ff0dfd1"
      unitRef="usd">-4953000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNC0zLTEtMS0w_04b217e0-b04d-4037-9a89-f74ae8b21a6c"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNC01LTEtMS0w_02777d1f-231f-4d75-a5de-7c99bc944b10"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNC03LTEtMS0w_164a4ade-7f14-46ef-85d8-33fdf8bcec03"
      unitRef="usd">-4953000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNS0xLTEtMS0w_63582961-de5b-46af-87f1-1f3660820258"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNS0zLTEtMS0w_c46e1181-128e-488e-aa71-4ba2167e8e43"
      unitRef="usd">-799000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNS01LTEtMS0w_d6de13a7-8a58-4a44-a9b1-f50da9475fb6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNS03LTEtMS0w_d95babfb-22f0-4520-b7fb-2e31c9d05dfb"
      unitRef="usd">-799000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3e3dab892f3e402d82bedb488946ff91_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNi0xLTEtMS0w_22fe6e32-4e48-4b40-bf64-50772762e64d"
      unitRef="usd">29049000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib7770faa631d4b86b356b24576071b3d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNi0zLTEtMS0w_e6f625c6-0109-4f34-980e-b016e27dd1fe"
      unitRef="usd">-2671000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2a3c92ba95fe4395b60788efa3abe455_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNi01LTEtMS0w_3c583bef-d126-4214-8364-931ece581ac2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNi03LTEtMS0w_7b3b174d-9062-4491-acc9-418811457e51"
      unitRef="usd">26378000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ie4f8068feed342d0852f9c527519b97c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNy0xLTEtMS0w_f7d6fc9d-f211-4995-8e36-1318b221b5ce"
      unitRef="usd">9021000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3faf010302b3404ebb5a5088bb42c52b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNy0zLTEtMS0w_3d2fd1ab-0f9f-4e83-9379-406b41ce481b"
      unitRef="usd">1218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a6b9095a67c4e829c8badebfb6d9376_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNy01LTEtMS0w_198f66e6-8ac1-41ed-ba47-be590fe15082"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e7b9971a3de417fb4bf5cbb762a9383_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOjJjODY3ZTEyZWJlNjRiMmRhNGMyNmY1ZmVhYTc5NDRjL3RhYmxlcmFuZ2U6MmM4NjdlMTJlYmU2NGIyZGE0YzI2ZjVmZWFhNzk0NGNfNy03LTEtMS0w_b7bd9877-07ab-4a0f-8a7a-83da711d386a"
      unitRef="usd">10239000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2c8a1231bd26440ca6973d994e0f4e4d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMi0xLTEtMS0w_446abfca-fe21-4241-ad2f-d5ff74e171fd"
      unitRef="usd">16614000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieadae4e29a7041f4a3ad734dc312b2df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMi0zLTEtMS0w_8b799a44-e722-45f3-9ba4-2d10e8d0d5f8"
      unitRef="usd">3565000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67f6d6511e9149758c5097fab5fffa22_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMi01LTEtMS0w_a2e2ebe0-00cd-43ad-8d09-0dc73596286a"
      unitRef="usd">-15000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5980981b2d94a21af89adbff48bff67_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMi03LTEtMS0w_58a54881-b457-41b6-a75c-7d17fa3d29c9"
      unitRef="usd">20164000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMy0xLTEtMS0w_484fa505-1318-4c5c-917e-e0dd7936b580"
      unitRef="usd">1404000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i81fa1b38663f441883ba5f2445470397_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMy0zLTEtMS0w_a19ab418-bbad-4730-8de1-55419b36bfc7"
      unitRef="usd">2379000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMy01LTEtMS0w_4fe5cae1-e75f-42b3-988c-9e0378dacd9d"
      unitRef="usd">15000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfMy03LTEtMS0w_a22cd8c9-9e39-4edc-b74c-aa757b0ba637"
      unitRef="usd">3798000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNC0xLTEtMS0w_ec6fdd0f-0e43-4055-8659-14d529d3a704"
      unitRef="usd">13027000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i81fa1b38663f441883ba5f2445470397_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNC0zLTEtMS0w_ce92128d-775f-4ce2-8c88-ad134ad75ccc"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNC01LTEtMS0w_9481ad55-b1a0-4d2a-ae30-0fad8612d7e9"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNC03LTEtMS0w_b5865119-9a4b-4109-a3ab-bfbc0e8c7661"
      unitRef="usd">13027000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNS0xLTEtMS0w_faab192f-481e-4fca-b7f4-5ad007dbac76"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i81fa1b38663f441883ba5f2445470397_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNS0zLTEtMS0w_10289f3c-3a8b-4bbb-85e2-47878f78114a"
      unitRef="usd">550000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNS01LTEtMS0w_186406c1-bf2b-4d9c-9d3a-c8a7d93b494f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNS03LTEtMS0w_1a6ce92e-b90c-4efd-a515-4e1de8758e85"
      unitRef="usd">550000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0999a4d3f31c4ed88221b31015955011_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNi0xLTEtMS0w_3640069d-5cdd-42e0-ae3d-8ea1e3d017cf"
      unitRef="usd">-11623000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i81fa1b38663f441883ba5f2445470397_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNi0zLTEtMS0w_161905e9-2caf-41f2-8448-e9b42a0b5326"
      unitRef="usd">1829000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0d1c664ec6654c659f20a3db10f35a9f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNi01LTEtMS0w_f3666e39-e055-40f5-9edc-6519367f64ff"
      unitRef="usd">15000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNi03LTEtMS0w_a547f70c-bd65-476e-a36d-0a45487c6ae7"
      unitRef="usd">-9779000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ica6ad443b63d459f92df9ffbcae2b88a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNy0xLTEtMS0w_9e270087-7705-43b2-9fa1-be45aaaae1b6"
      unitRef="usd">4991000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99ca830558c94af29e572b85e6fb0ab0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNy0zLTEtMS0w_c4519103-0dd8-4bc1-9740-341419f1c2d5"
      unitRef="usd">5394000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd5abfbe741a48819ae2f94da173f77b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNy01LTEtMS0w_53a2cfe3-d1d4-4ff4-b9a5-bf77ec784755"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id0db40041dc54511b7a5f5d17ab13fa6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182NC9mcmFnOmM0ODJjMzBkOWNkYzRlMWNhY2UxMDY1ZDA1NGZiYTFkL3RhYmxlOmNhZTY3MThjZGZjNTQ3MjZhMWNmNmRmN2I0MWEyY2E1L3RhYmxlcmFuZ2U6Y2FlNjcxOGNkZmM1NDcyNmExY2Y2ZGY3YjQxYTJjYTVfNy03LTEtMS0w_bd3c3521-6910-49d5-9585-6f285ba4e1fa"
      unitRef="usd">10385000</us-gaap:StockholdersEquity>
    <bmrn:ConcentrationRiskAndSegmentReportingDisclosureTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQzMg_5b8cc248-df39-4a6b-8589-9402c5f3093c">REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates in one business segment, which primarily focuses on the development and commercialization of innovative therapies for people with serious and life-threatening rare diseases and medical conditions. The Company considers there to be revenue concentration risks for regions where Net Product Revenues exceed 10% of consolidated Net Product Revenues. The concentration of the Company&#x2019;s Net Product Revenues within the regions below may have a material adverse effect on the Company&#x2019;s revenues and results of operations if sales in the respective regions experience difficulties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table disaggregates Total Revenues from external customers and collaborative partners by geographic region. Net product revenues by geographic region are based on patient location for the Company&#x2019;s commercial products, except for Aldurazyme, which is sold exclusively to Sanofi Genzyme (Genzyme) who markets and sells Aldurazyme worldwide. Aldurazyme revenues earned by the Company are included in the U.S. region as the transactions are with Genzyme, whose headquarters is located in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues by geographic region:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;252,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;608,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;729,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;450,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;476,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,396,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,408,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table disaggregates total Net Product Revenues by product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net product revenues by product:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vimizim&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Naglazyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kuvan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;368,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Palynziq&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Brineura&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Voxzogo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Firdapse&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net product revenues marketed by the Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,245,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,239,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aldurazyme net product revenues marketed by Genzyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net product revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,348,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,368,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The table below disaggregates total Net Product Revenues based on patient location for products sold directly by the Company, and global sales of Aldurazyme, which is marketed by Genzyme.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;203,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;424,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net product revenues marketed by the Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,245,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,239,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aldurazyme net product revenues marketed by Genzyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net product revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,348,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,368,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table illustrates the percentage of the Company&#x2019;s total Net Product Revenues attributed to the Company&#x2019;s largest customers for the periods presented.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On a consolidated basis, two customers accounted for 31% and 14% of the Company&#x2019;s September&#160;30, 2021 accounts receivable balance, respectively, compared to December&#160;31, 2020, when two customers accounted for 24% and 22% of the accounts receivable balance, respectively. As of September&#160;30, 2021, and December&#160;31, 2020, the accounts receivable balance for Genzyme included $83.9 million and $72.1 million, respectively, of unbilled accounts receivable, which becomes payable to the Company when the product is sold through by Genzyme. The Company does not require collateral from its customers, but does perform periodic credit evaluations of its customers&#x2019; financial condition and requires prepayments in certain circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic continues to affect economies and business around the world. The Company&#x2019;s global revenue sources, mostly in the form of demand interruptions such as missed patient infusions and delayed treatment starts for new patients, and its business operations were impacted by the COVID-19 pandemic during the nine months ended September&#160;30, 2021 and 2020, and the Company anticipates a continued impact due to COVID-19 on its financial results in the remainder of 2021. The extent and duration of such effects remain uncertain and difficult to predict, particularly as virus variants continue to spread. The Company is actively monitoring and managing its response and assessing actual and potential impacts to its operating results and financial condition, as well as developments in its business, which could further impact developments, trends and expectations. See the risk factor related to the impact of the coronavirus pandemic, &#x201c;The COVID-19 pandemic could continue to materially adversely affect our business, results of operations and financial condition.&#x201d; described in &#x201c;Risk Factors&#x201d; in Part II, Item&#160;1A of this Quarterly Report, for additional details on the impact of the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is mindful that conditions in the current macroeconomic environment could affect the Company&#x2019;s ability to achieve its goals. The Company sells its products in countries that face economic volatility and weakness. Although the Company has historically collected receivables from customers in certain countries, sustained weakness or further deterioration of the local economies and currencies and effects of the impact of the ongoing COVID-19 pandemic may cause customers in those countries to delay payment or be unable to pay for the Company&#x2019;s products. The Company believes that the allowances for doubtful accounts related to these countries, if any, are adequate based on its analysis of the specific business circumstances and expectations of collection for each of the underlying accounts in these countries. The Company will continue to monitor these conditions and will attempt to adjust its business processes, as appropriate, to mitigate macroeconomic risks to its business.&lt;/span&gt;&lt;/div&gt;</bmrn:ConcentrationRiskAndSegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfOTI_b048afc1-c0ae-45dc-b39b-df869086368e"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQ0MA_de2c37ae-a5ca-427a-9208-2a6caa74d082">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table disaggregates Total Revenues from external customers and collaborative partners by geographic region. Net product revenues by geographic region are based on patient location for the Company&#x2019;s commercial products, except for Aldurazyme, which is sold exclusively to Sanofi Genzyme (Genzyme) who markets and sells Aldurazyme worldwide. Aldurazyme revenues earned by the Company are included in the U.S. region as the transactions are with Genzyme, whose headquarters is located in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues by geographic region:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;252,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;608,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;729,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;450,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;476,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,396,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,408,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6aa5a87b7f84d18a23293902aaa2e41_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfMy0xLTEtMS0w_a083d789-7d78-47e8-ab78-5c3161096fbe"
      unitRef="usd">196239000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68586ccb7def4122a05e7dc73d213d39_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfMy0zLTEtMS0w_c3957e48-f9c7-4ca5-9b44-c1d515be1542"
      unitRef="usd">252948000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b53329fe7c14a3683433e7d34adb246_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfMy01LTEtMS0w_8b9333e6-d6bc-4039-aa09-1214ef4014ac"
      unitRef="usd">608670000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b96c70e0c2243afb027cbcdf282e765_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfMy03LTEtMS0w_89aba76a-be07-4640-8ff3-f1ddd40a9b67"
      unitRef="usd">729672000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10f485d362c24177a8d80735201ecbee_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNC0xLTEtMS0w_462cad23-570a-4eb9-ad12-10000a1bfd0b"
      unitRef="usd">115497000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i430f9e39597d43d393863a8ba5c47dc4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNC0zLTEtMS0w_27ad9f37-d98e-458f-8ccf-b0b1b965e7d2"
      unitRef="usd">121158000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3df6603453545b7adf0538e4c3b867e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNC01LTEtMS0w_09d678b2-26b2-46a9-8043-0b79aea94655"
      unitRef="usd">450016000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i750ce40f585c411fa47c2bf163efafec_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNC03LTEtMS0w_3f580bc8-6ce2-49f8-83fb-2726834d9828"
      unitRef="usd">375453000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d097b6776c84a1290432379dfafe6e5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNS0xLTEtMS0w_f37e5fc6-850e-4b78-ac28-41c1ec65d885"
      unitRef="usd">38958000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a82d895132f4cf6aee55df85842bf75_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNS0zLTEtMS0w_6607dde1-8cf1-42c6-a6f9-5d088cf2ea9c"
      unitRef="usd">44064000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cc4be5e7bfe4c5887dec731969031b7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNS01LTEtMS0w_edeeee70-532b-42eb-898f-5de94437937a"
      unitRef="usd">140911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i692ea98645da4650a217fb7fa5bc5f98_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNS03LTEtMS0w_22ce2293-4190-41bf-950c-cbfa7bb3613e"
      unitRef="usd">141852000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c01dec0e80c49a8a216d3ccf0b483f5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNi0xLTEtMS0w_f2714a1b-d5bd-4919-984f-7eeeb5d7bc84"
      unitRef="usd">58048000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iadfc6366c9ee4fde9f1d3c3304473be1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNi0zLTEtMS0w_23b34c2f-8245-4cf9-9b43-5db9a0f099ec"
      unitRef="usd">58614000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b3baec2de8a480aa194af6ef4b7e7ce_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNi01LTEtMS0w_f9162897-3f6c-4797-bc1b-6e17bf1f7ca7"
      unitRef="usd">196868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief7778f7e8ed4c60a7007014fbf78a94_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNi03LTEtMS0w_ddc0b0ae-bc82-446e-a280-5102f3545ef5"
      unitRef="usd">161361000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNy0xLTEtMS0w_34f26a51-9050-4324-bc6b-cd297adf8623"
      unitRef="usd">408742000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNy0zLTEtMS0w_c2c1d973-b7e3-4a91-aa8a-c7b857f953ae"
      unitRef="usd">476784000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNy01LTEtMS0w_bac07061-1093-4c48-86ef-eec5de5bfaff"
      unitRef="usd">1396465000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjNhNjExYjc0ZGY5NjRmOTM5N2QzMmM0N2M4ZDU3NTgwL3RhYmxlcmFuZ2U6M2E2MTFiNzRkZjk2NGY5Mzk3ZDMyYzQ3YzhkNTc1ODBfNy03LTEtMS0w_e0355f16-293c-4962-b5ec-dab446ea02ef"
      unitRef="usd">1408338000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQzMw_f90b2a60-0300-4569-ac74-033d2314ad36">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table disaggregates total Net Product Revenues by product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net product revenues by product:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vimizim&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Naglazyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kuvan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;368,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Palynziq&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Brineura&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Voxzogo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Firdapse&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net product revenues marketed by the Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,245,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,239,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aldurazyme net product revenues marketed by Genzyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net product revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,348,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,368,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26cfa0a05050405c8fc26ff4270b410b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMy0xLTEtMS0w_8e636f13-ce32-4f24-813d-a5cf6b410f44"
      unitRef="usd">136744000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia499a895b89d43c8802609e44742ca26_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMy0zLTEtMS0w_1addb43e-ec59-4139-9fc9-ada279a752ed"
      unitRef="usd">147891000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56ce74ad21854f5b8073837e7f9d4f30_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMy01LTEtMS0w_0496e420-1b1b-4e92-ba7d-31206198bbca"
      unitRef="usd">466697000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2a8b2e0af7d4f48bdd2df8ec9a9c5ba_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMy03LTEtMS0w_f838a34e-a47a-4915-aec8-bbb19d747220"
      unitRef="usd">401789000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54e5f5c18fb24ebbbdbdc5dbbd131b25_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNC0xLTEtMS0w_478ec7d9-0fbc-41b0-bb7d-bd595940fd25"
      unitRef="usd">71172000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39e0766182094853983cc6543e242eda_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNC0zLTEtMS0w_ebaeda6a-3827-466e-8a53-64dee247d2a0"
      unitRef="usd">76323000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75f418730286417b9103ef1bc9d70fec_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNC01LTEtMS0w_fb648830-3a00-45ce-9ccd-e335ab624953"
      unitRef="usd">297321000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id740cf897d394b40be718d4aa51cddf7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNC03LTEtMS0w_67e5d419-0ac4-4ee6-bb4a-9ad57285c1fd"
      unitRef="usd">271585000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d38170f263d4c87b138198d14dfb01d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNS0xLTEtMS0w_9e07c6a8-4f65-4f44-88d0-4f72960fce11"
      unitRef="usd">67687000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52c332e9563842deac7a1a89d768fb91_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNS0zLTEtMS0w_9135cb73-29d4-41a7-9909-f08b3ae4f753"
      unitRef="usd">123993000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8d768a033874a13a0aece3c89f824e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNS01LTEtMS0w_a4d53ea7-f702-40eb-be38-a9971a1482ac"
      unitRef="usd">217257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieee6144f7440430d96c3ea711e06e0dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNS03LTEtMS0w_8abca16c-ac9f-4b47-b2d5-9844e9d96771"
      unitRef="usd">368604000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3631083badb04533a1ccf53e70983c60_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNi0xLTEtMS0w_2866ca84-5a92-4ca6-8294-e6c8db097021"
      unitRef="usd">60729000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i875080367e32474e9692930d4f70440d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNi0zLTEtMS0w_10101dd2-67fe-4c01-81b1-b13ca83ac22a"
      unitRef="usd">46092000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9cac278154a4c64a3a2d789e69239d0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNi01LTEtMS0w_dc73ccbd-18ae-4d01-99f1-133be79b8c11"
      unitRef="usd">173702000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0fc0dde4f53c44c9ab53a2e5cd3dac81_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNi03LTEtMS0w_6ffc10f1-90b2-4365-8de7-a5b47729e202"
      unitRef="usd">121354000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0a6844bfd4f4df3937b1bc5c15c6c0c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNy0xLTEtMS0w_94addb5a-f031-41f4-96ff-1cb836751309"
      unitRef="usd">32984000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ec5b3fcbcc741d5a41938c2bff9a968_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNy0zLTEtMS0w_dce5f6a0-eee5-4172-b138-28fbede6af9f"
      unitRef="usd">25455000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba2fef5336cd4754aac2a52f8ee715a2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNy01LTEtMS0w_b7caf807-48ba-4423-befd-58f6f4c56a9b"
      unitRef="usd">90641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1e72a8e38a54f589382be95578b29c1_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfNy03LTEtMS0w_90505ed2-85d3-4eab-aa0d-bbe9eea692b2"
      unitRef="usd">75223000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i670eba932fa44bb4bd105fa2472fdee7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC0xLTEtMS0xNjI3Mg_01a06a84-8a5b-4af2-bf0c-d0f09b765042"
      unitRef="usd">144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7163a6ce6d8a4b90ba5be5da895aca0d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC0zLTEtMS0xNjI3Mg_7d0f2e6e-39ba-49a0-ac36-230ffe4ac0d4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77f222cc3eb0499293097be2613706be_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC01LTEtMS0xNjI3Mg_d41ee35d-b0f9-4efe-b3a9-e5faca5ea681"
      unitRef="usd">144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i631b06fa4a4a46759658c5e1ed96fe88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC03LTEtMS0xNjI3Mg_8b2c2129-b09e-4b2d-9d2c-f945aba8b52d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ce796da9cb04582bb8c002435a42a15_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC0xLTEtMS0w_365e5b72-a1df-478d-bcc6-068383796e3c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i596ae291f078453886ecff564ae864a5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC0zLTEtMS0w_97c7cf7f-3a9b-479d-aba2-164037b90e6d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5625d09abfec4da9b5135b5a49fd61c5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC01LTEtMS0w_2ac4ea84-d103-43d3-86e6-90fc58935781"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c767f53af74489081063ce938ee5371_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOC03LTEtMS0w_eed546e7-7e2e-4779-a964-3f96b29c514f"
      unitRef="usd">1316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78de7c806e9548728df05080cfa9fdef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOS0xLTEtMS0w_9487ebb6-6436-43ea-8f13-3df2f3c3fa20"
      unitRef="usd">369460000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i765f4a74e39242298ebb8e42f5429fd3_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOS0zLTEtMS0w_1d5031b6-4c9c-4609-8748-32d44772c2f6"
      unitRef="usd">419754000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6306c147c133472a919f7ac957a8c7b2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOS01LTEtMS0w_4f60aead-c803-4063-851d-19a312356441"
      unitRef="usd">1245762000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2b11e951dfb403a9db9d7fa77793d35_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfOS03LTEtMS0w_52776924-6a8f-4865-a3ea-06a8e9174cbd"
      unitRef="usd">1239871000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icca877ecc41644f7a512279ba3a5aebf_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTAtMS0xLTEtMA_38c52555-4afc-4b92-8737-28cc5882ca4a"
      unitRef="usd">24380000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12c53d3790994dfb8fd77b8b0750df93_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTAtMy0xLTEtMA_accb93a4-1b54-4e21-8474-dd8f758bbf4d"
      unitRef="usd">40987000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf2f153984e34dcfb6ebf47a69c25d0e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTAtNS0xLTEtMA_961a0c81-b561-468a-8e05-ce68b156cd98"
      unitRef="usd">102517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i587f8139747846de862e02316f943301_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTAtNy0xLTEtMA_5c0bcf0a-34d0-4ef2-ad9d-5181d0133cdb"
      unitRef="usd">128945000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTEtMS0xLTEtMA_930aef44-e255-45f9-aac9-4d87b2160e60"
      unitRef="usd">393840000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTEtMy0xLTEtMA_3a467504-eaff-417c-a561-1f078d8de7d0"
      unitRef="usd">460741000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9940e707613405199a97fc351ad73ef_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTEtNS0xLTEtMA_e02e10ec-1b2f-4f76-b808-d7bce0e32955"
      unitRef="usd">1348279000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjY1MjAyMDA3MDVmMjQxMzNiYTkzMWNiZTkxZGZiY2ZjL3RhYmxlcmFuZ2U6NjUyMDIwMDcwNWYyNDEzM2JhOTMxY2JlOTFkZmJjZmNfMTEtNy0xLTEtMA_92cac183-fb3c-4af5-8a37-c4db6fe1d399"
      unitRef="usd">1368816000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQzNg_1d8909d0-612b-4cac-9f6e-902e952ddb30">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The table below disaggregates total Net Product Revenues based on patient location for products sold directly by the Company, and global sales of Aldurazyme, which is marketed by Genzyme.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;166,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;203,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;424,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net product revenues marketed by the Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;419,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,245,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,239,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aldurazyme net product revenues marketed by Genzyme&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total net product revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,348,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,368,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i807900e9e70040c78da438a82a6b9728_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMi0xLTEtMS0w_5df4409d-315d-4cc5-a90c-c890c4e0c318"
      unitRef="usd">166554000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ea93a722dde4f8eb67bfd01814148e7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMi0zLTEtMS0w_0943e01b-1a36-4d72-99bc-294f81b417f5"
      unitRef="usd">203892000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f6996af9c2645e7ad8462878e32a8fa_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMi01LTEtMS0w_db0af8e6-dfa4-4653-a1c5-8d7e9ed43037"
      unitRef="usd">491028000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id813d823802b4adeae79cd8494384ba1_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMi03LTEtMS0w_b1d47d45-4fbc-464b-8efe-ba87453858d5"
      unitRef="usd">582734000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1624a814864c43ecbbd5abad76321c1f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMy0xLTEtMS0w_e3a24c99-0f30-4b61-a5db-df2ae21ecc90"
      unitRef="usd">108568000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i673c282af5fc4cf3828509c09115858e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMy0zLTEtMS0w_e819795d-bab7-4f31-b957-a0533ae60904"
      unitRef="usd">115548000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e031326bd7645bf8c67c80bc0590247_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMy01LTEtMS0w_a2e92b2a-b35c-4388-980b-f6dccd139328"
      unitRef="usd">424144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3fada62c864453b990f024e22826a2a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfMy03LTEtMS0w_d882f8e1-b236-4ba8-830d-6f3d6ac73b11"
      unitRef="usd">360718000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8815ae63b15048de91d1036580169b4f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNC0xLTEtMS0w_88050e50-721f-4af8-a475-1ec945f68de7"
      unitRef="usd">38958000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b38429ecef7410fb6e6cb17cf99bc23_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNC0zLTEtMS0w_18730bbc-4faf-4881-8570-5ed9671f84a3"
      unitRef="usd">44064000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36276fddfb9440c49f578739c2e2e93b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNC01LTEtMS0w_112e620b-327e-4269-8586-ae01887dd26e"
      unitRef="usd">140911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5a9b8c4c57440bd972de38d327ff06d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNC03LTEtMS0w_053f81d4-bd72-4bb3-bc36-bc1ed4313e17"
      unitRef="usd">141852000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i903cb5741f0c454ab0cd6e60497f87f1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNS0xLTEtMS0w_d8db8aae-a7cc-49e8-b50c-f26fdb580eba"
      unitRef="usd">55380000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12e8c0e180a24083884a28374d6b19aa_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNS0zLTEtMS0w_226409a0-8616-476c-81cf-4dbc77cd9849"
      unitRef="usd">56250000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib327b203d9f641f4b16be80c7a022310_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNS01LTEtMS0w_9ecbac18-5ef3-48ba-b123-cd269714d3c1"
      unitRef="usd">189679000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15c17cda19c7411bbf1a312a56665382_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNS03LTEtMS0w_e5c3137b-0483-4797-923d-fab0d82f7925"
      unitRef="usd">154567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78de7c806e9548728df05080cfa9fdef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNi0xLTEtMS0w_ff1518e3-302e-4cb4-ae11-5e00d742a318"
      unitRef="usd">369460000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i765f4a74e39242298ebb8e42f5429fd3_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNi0zLTEtMS0w_169e1b90-6d80-4b9d-b9a6-cf8d32e7ffdf"
      unitRef="usd">419754000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6306c147c133472a919f7ac957a8c7b2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNi01LTEtMS0w_0e2a94e5-bfc9-4493-a98e-7cacea8f66b8"
      unitRef="usd">1245762000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2b11e951dfb403a9db9d7fa77793d35_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNi03LTEtMS0w_8e3a84a1-7fbb-4053-b16c-e030b7cdec06"
      unitRef="usd">1239871000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icca877ecc41644f7a512279ba3a5aebf_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNy0xLTEtMS0w_17e79f25-a83b-4424-b843-cb8ccd27ab9d"
      unitRef="usd">24380000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12c53d3790994dfb8fd77b8b0750df93_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNy0zLTEtMS0w_8b5771c7-0b05-4a98-80f7-4a1e99a86ea6"
      unitRef="usd">40987000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf2f153984e34dcfb6ebf47a69c25d0e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNy01LTEtMS0w_ed2b9b76-49dc-4504-91b4-9644c398d2ea"
      unitRef="usd">102517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i587f8139747846de862e02316f943301_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfNy03LTEtMS0w_35282173-95b1-42d4-bbc0-614e2a6c34fe"
      unitRef="usd">128945000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66a7c32a0ce0478eab7ea3f4f01d8566_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfOC0xLTEtMS0w_d500f25c-d87e-437a-bb72-236a89f2849c"
      unitRef="usd">393840000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09fb9e54118a4b458ebbb3ed8048b869_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfOC0zLTEtMS0w_f4a064b2-e95d-46a2-a5b7-05b9bc2e5f2e"
      unitRef="usd">460741000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9940e707613405199a97fc351ad73ef_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfOC01LTEtMS0w_69a9069b-78ac-4111-ab3f-926bd7f74e18"
      unitRef="usd">1348279000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf4670e2329e43f68e92e7b5bc8f8181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjk2MTQzM2MxZGI1NzRiZTVhYjI1N2ZjNWZmZjFlNmIyL3RhYmxlcmFuZ2U6OTYxNDMzYzFkYjU3NGJlNWFiMjU3ZmM1ZmZmMWU2YjJfOC03LTEtMS0w_678f59b5-f428-412a-bea5-19ff01c5fce6"
      unitRef="usd">1368816000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfNDQzNw_37984278-3e24-41b6-aedf-e7134d9bf4b3">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table illustrates the percentage of the Company&#x2019;s total Net Product Revenues attributed to the Company&#x2019;s largest customers for the periods presented.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4d24f4221ce54b7587582cc1483c6c20_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMi0xLTEtMS0w_455588d4-eee2-434c-a4f5-6ee9f0d5262b"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia22dd234fb9743fd92d299421432bd77_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMi0zLTEtMS0w_c8aa5366-007b-4020-bad6-e25fd88b5c0a"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4522cd9712214bb087ea4996aa558624_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMi01LTEtMS0w_52853080-9a38-47cc-8c34-e40edf64f45a"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ida8af263c560424abb1f9b025ffbc888_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMi03LTEtMS0w_01e9e8f4-6ec0-4bd7-8a70-83fd54c40d9e"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i85eed5105d974313b640fec757ed2132_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMy0xLTEtMS0w_4cf1dcbc-d199-4617-b4a2-47bf6d4c21b6"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic605b00f4bfb47dd91d3f6f7057661fb_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMy0zLTEtMS0w_ceb91e19-6b0e-4e6e-b69b-e397fe481100"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifd471de3fee2400e88e55081b5edc7f4_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMy01LTEtMS0w_7f30c085-8409-487b-8913-3efc325f6fd6"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i35e7d66a6cac42129aa948cfaf2eb317_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfMy03LTEtMS0w_c37990a0-1699-4c9d-83ae-e272a8e12ef9"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie383b687557e497388831485ea18b47a_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNC0xLTEtMS0w_8bc65bd7-9954-4430-a218-1f52476668d2"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5bae986f7e264602844d3457fa91c27c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNC0zLTEtMS0w_27980409-7496-408a-9d18-9759b814eea8"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ieb287505a9684940b9d27b688febaea4_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNC01LTEtMS0w_ebcd47d3-7ed5-48d4-b1fd-f47a02f8ce53"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i687b7d4238fe4663857bbb9e1446ee16_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNC03LTEtMS0w_4748e16e-8dac-4045-8173-b38d61ede9aa"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i06311aaf1fc84255bf7c628cde958a0e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNi0xLTEtMS0w_663b39d9-31cb-4eba-ab62-c3d68ff8fcb2"
      unitRef="number">0.47</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i17442b5bbd98454d91144658893a0d26_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNi0zLTEtMS0w_15a25d11-04b4-40cc-b33f-2d6a7835e6c0"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iad3b61ba06404cd29a53bc8482a92839_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNi01LTEtMS0w_1c338091-77dc-428f-ac96-3815471de425"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6c313f30b00c4ffbbe6049bf40e5fce8_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RhYmxlOjBhNWE5YWJmYjg2YzQwYmY5MjdlZWMwMmRhYmQxYzNkL3RhYmxlcmFuZ2U6MGE1YTlhYmZiODZjNDBiZjkyN2VlYzAyZGFiZDFjM2RfNi03LTEtMS0w_5049338e-d8cd-4918-82fd-adbf058e37a7"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id03d4506cf9848689c776b8acd1a1fd9_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTY1OA_3ef39a7e-2964-4937-ab8b-4c0c32b9cb8f"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icc7289dbd839469db4eb56c8b0923f40_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTY2NQ_6896c156-e167-40eb-b85e-443a683f489f"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ice7397073cd84c17909c8a881afdc5a5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTc3OQ_0c3c43de-7d9a-42d8-b118-94243daa6446"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9318c02208c342038447a03fa145e77f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTc4Ng_3a61188c-cddf-4569-97a7-7ca37b16ad6c"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i88011345f9af4a4eb848131cb3723ff8_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTkxMA_3a5bbf90-987e-4f7c-94c3-e4bd4f46a287"
      unitRef="usd">83900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4642aed64b8147e68d905a18605026ae_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM182Ny9mcmFnOmEzNTViMTdjZTBkZjRhYzJiMzUwNjU0ZGFmMTk4ZmEyL3RleHRyZWdpb246YTM1NWIxN2NlMGRmNGFjMmIzNTA2NTRkYWYxOThmYTJfMTkxNw_1be2a761-50cc-4d6d-aa3f-db64774bdb79"
      unitRef="usd">72100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RleHRyZWdpb246YzVlZDY5NTk3YmU3NGZlMGE0MTc3ZTJlOTkxMzk1MWVfNDg5_d359dd73-1ea9-4875-8c64-91fa8174591b">STOCK-BASED COMPENSATIONThe Company has stockholder-approved equity incentive plans that provide for the granting of service-based restricted stock units (RSUs), market-based RSUs, performance-based RSUs, stock options and other types of awards to its employees, &lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;officers and non-employee directors. Compensation expense included in the Company&#x2019;s Condensed Consolidated Statements of Comprehensive Income (Loss) for all stock-based compensation arrangements was as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RleHRyZWdpb246YzVlZDY5NTk3YmU3NGZlMGE0MTc3ZTJlOTkxMzk1MWVfNDg3_148fe7f7-453f-4745-bd36-48edfa33a014">Compensation expense included in the Company&#x2019;s Condensed Consolidated Statements of Comprehensive Income (Loss) for all stock-based compensation arrangements was as follows:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i366685cece5e413497a14d201c6aaeec_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMi0xLTEtMS0w_e517d2f6-39a2-4adb-b080-da040b0e1968"
      unitRef="usd">4339000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i600447fd1d334ac4a8cf19039623fed1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMi0zLTEtMS0w_0a1683fc-e7b1-40d4-9558-7b50b8bd5371"
      unitRef="usd">10342000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4341d0928f7b46a9bb9a16aba139dad9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMi01LTEtMS0w_44e99d2e-f0f2-46cd-b69c-9eea8aafca9b"
      unitRef="usd">16907000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id1af7d3e6ac447faad8ad74652f4be9c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMi03LTEtMS0w_7e1d5604-26d7-4d9b-ad2f-66793f3627b9"
      unitRef="usd">20381000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5bbe544e6bb7468ab675761c05ac7036_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMy0xLTEtMS0w_4796511d-499b-4594-afba-10ca88c93024"
      unitRef="usd">17866000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i240305f0192242b4933888c226e238e1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMy0zLTEtMS0w_eb84fc78-497c-4eab-8174-bb9d3cfe5b2d"
      unitRef="usd">15705000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icd8bde7f09ba4955bdcbbb6490d77c3c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMy01LTEtMS0w_0cdef3ad-d2f1-4ed6-bab8-8eeffe3aa434"
      unitRef="usd">56199000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifb2e6a3e17a54d9294f3f2237cb340fe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfMy03LTEtMS0w_7b8a13a5-0c1f-4ec7-a71a-286d1d61c56d"
      unitRef="usd">45333000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id5f1a069c36941e09fb5bea33a6ddbe9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNC0xLTEtMS0w_c427fbe3-454f-4a7a-98dd-2222b5093a42"
      unitRef="usd">26821000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if8128c3889a44d2e9cc52bdcfafa283e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNC0zLTEtMS0w_7a691711-6927-4657-a525-4109f50827e9"
      unitRef="usd">24122000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic471c1470b9e42899741b0b5a360a28d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNC01LTEtMS0w_4e6ad8bf-1cd1-4dc1-9e88-cc9f9ad1d20c"
      unitRef="usd">80266000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iea947a2a70cd4cc48f0e3fa73c7b87e4_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNC03LTEtMS0w_299fc8cf-b4ad-464a-ba28-64148ececc33"
      unitRef="usd">76411000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNS0xLTEtMS0w_617f88fb-2883-4496-a4ae-7d9660b92cb7"
      unitRef="usd">49026000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNS0zLTEtMS0w_471c23a8-1401-4ce8-ad6d-15b2c6bda9fa"
      unitRef="usd">50169000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNS01LTEtMS0w_31713cb0-46bf-43e8-b781-d015993dffee"
      unitRef="usd">153372000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183MC9mcmFnOmM1ZWQ2OTU5N2JlNzRmZTBhNDE3N2UyZTk5MTM5NTFlL3RhYmxlOjM4ZDc0NzgwM2FkYzQ5NGFiNWM0OWJlOTI1YmIyOWNkL3RhYmxlcmFuZ2U6MzhkNzQ3ODAzYWRjNDk0YWI1YzQ5YmU5MjViYjI5Y2RfNS03LTEtMS0w_6478efc9-d0e8-46fc-a744-5deb73095a4c"
      unitRef="usd">142125000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfMTMyMw_befd743a-446c-4bcd-ae60-78b6011e779d">NET INCOME (LOSS) PER COMMON SHARE&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Potentially issuable shares of common stock include shares issuable upon the exercise of outstanding employee stock option awards, common stock issuable under the Company&#x2019;s Employee Share Purchase Plan (ESPP), unvested RSUs, the Company&#x2019;s common stock held by the NQDC and contingent issuances of common stock related to the Company&#x2019;s convertible debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per common share (common shares in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Income (loss), basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;784,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;837,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Add: Interest on convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Income (loss), diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;791,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;855,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2020 notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2024 notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2027 notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock potentially issuable for ESPP purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The Company&#x2019;s common stock held by the NQDC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;197,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) per common share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) per common share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In addition to the equity instruments included in the table above, the table below presents potential shares of common stock that were excluded from the computation of basic and diluted income (loss) per common share as they were anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock potentially issuable for ESPP purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The Company&#x2019;s common stock held by the NQDC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total number of potentially issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s 1.50% senior subordinated convertible notes due in October 2020 (the 2020 Notes) matured on October 15, 2020 and were settled in cash. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The potential effect of the capped call transactions and potential shares issuable under the 2020 Notes were excluded from the calculation of diluted net income (loss) per share in the three and nine months ended September&#160;30, 2020, as the Company&#x2019;s closing price on September&#160;30, 2020 did not exceed the conversion price of $94.15 per share. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;There is no similar capped call transaction associated with the 2024 Notes or the 2027 Notes.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfMTMyMA_8d3c8884-5432-453e-be7a-46d463d0ebba">&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per common share (common shares in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Income (loss), basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;784,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;837,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Add: Interest on convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Income (loss), diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;791,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;855,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2020 notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2024 notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2027 notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock potentially issuable for ESPP purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The Company&#x2019;s common stock held by the NQDC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;197,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) per common share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss) per common share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMy0xLTEtMS0w_563efecf-7998-4c17-9f84-8eb228b4898c"
      unitRef="usd">-36494000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMy0zLTEtMS0w_b3c2af08-02da-4685-9efa-124288fe3e81"
      unitRef="usd">784803000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMy01LTEtMS0w_20d5b98f-7278-416d-97ad-fc755ed37468"
      unitRef="usd">-6182000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMy03LTEtMS0w_51afacb3-4cf1-4f11-9e8b-2b726f8f2aa3"
      unitRef="usd">837001000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNC0xLTEtMS0w_27214026-6ca8-495f-8a4a-4541a2c13e3a"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNC0zLTEtMS0w_4f79750d-c20a-4981-84b7-ada59066a173"
      unitRef="usd">7070000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNC01LTEtMS0w_21e3e58e-a8a3-4b8f-8b4d-45cc31e1576f"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNC03LTEtMS0w_f97c0f9f-6df9-46fd-84dd-94a565500a25"
      unitRef="usd">18333000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNS0xLTEtMS0w_65f34039-ce22-4ad3-bca3-6f44f8e9579a"
      unitRef="usd">-36494000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNS0zLTEtMS0w_14f5209a-1c8b-4741-af0b-16673ce3da74"
      unitRef="usd">791873000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNS01LTEtMS0w_e0f64896-3e97-4ad0-9268-355909bbb538"
      unitRef="usd">-6182000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNS03LTEtMS0w_00c9cf77-e5f5-4a43-95e5-89643a9386ae"
      unitRef="usd">855334000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNy0xLTEtMS0w_f29d8d7a-2c33-45f9-a0f9-490073d3baea"
      unitRef="shares">183214000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNy0zLTEtMS0w_76ccb48a-1de6-4e74-b5a4-8c7aff803eb0"
      unitRef="shares">181142000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNy01LTEtMS0w_acadb1c8-204a-4693-a85b-64d2b3c445d7"
      unitRef="shares">182616000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfNy03LTEtMS0w_20168c09-1fea-4164-8fb7-b381200dd2f6"
      unitRef="shares">180592000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i8e0d79598b4a4fe0894f5f0b5c8d05d2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfOS0xLTEtMS0w_c5debedd-5b1a-497a-ab48-262b825b919d"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i12651120f91f4b4f8cebb3b98050584d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfOS0zLTEtMS0w_0207b357-2c88-4b0f-86ab-658e83ea04ec"
      unitRef="shares">1731000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i90f88b98995241caafd2941a4333cb2b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfOS01LTEtMS0w_1ee1b7bb-0e57-486c-886b-811d2071b73a"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i5acc9dcae0254e3a91a091eaad031510_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfOS03LTEtMS0w_e7cf9364-4315-4728-a4bf-1a2847effd94"
      unitRef="shares">1728000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ide7de364296046cd8ec673ebf4f708e4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtMS0xLTEtMjQz_7afbaa74-66a8-4561-891a-4d685fc1a136"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i99d8ea1fded44a5dbe57d52c95b8740d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtMy0xLTEtMjQz_5755f066-c442-404f-a4e3-c8fdc5bf170e"
      unitRef="shares">3983000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="icfb006a5635c4e3786096f48ad41e1c1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtNS0xLTEtMjQz_43e5fb48-2f53-4695-9c46-00877d69ab64"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i1e1a43efe88f4d2b8dbb12448e0fcfbb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtNy0xLTEtMjQz_e95eb378-f8b7-4c75-91b6-79e2eaf30b4e"
      unitRef="shares">3983000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ifc32bd96b3014e92b2f0efc81b2ae66a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtMS0xLTEtMA_0620c3ec-10b8-48e5-8502-2f69ce5564e2"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i483fea5cfb454ba7a3044cf8f94b872c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtMy0xLTEtMA_9c2716cb-58dd-4e98-a6c8-c8524f68ca25"
      unitRef="shares">3970000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i0936ac22ba0641e3baa0b8544e010e8f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtNS0xLTEtMA_35d8d4b5-0414-41d8-8b8d-edc4562530d6"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i6693bf5374b04cec9cbcc298b6b9df9b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTAtNy0xLTEtMA_50d6b8ca-39ee-4841-b162-8982f7bde4a0"
      unitRef="shares">3970000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i712f67daf8994797927c8bdb430e55c9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTEtMS0xLTEtMA_e7d46580-6966-4a4b-b436-dc981a4d6062"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i9264da2f9bbd4f2fb33480144d2f85a9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTEtMy0xLTEtMA_6eed5dde-aa6c-43c1-8627-dd79d3800387"
      unitRef="shares">4365000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i0589f3a72cba42008e9af75b85655bfc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTEtNS0xLTEtMA_b2223fb8-4c63-4010-af84-b4fa3737ab58"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i747d9cadb0334a97b76371c9665c4ff0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTEtNy0xLTEtMA_17d96542-41d5-47c3-80a5-4b8bc3779a58"
      unitRef="shares">2373000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i6195d3f0e2374354b38eb0cc2ab77d14_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTItMS0xLTEtMA_4d373f89-9b22-4215-83a9-0a2083b6dc06"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i88ec953e8f554e02994b61549a84b786_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTItMy0xLTEtMA_0a94eee2-c2fd-42e0-96ec-2b5649a1fc57"
      unitRef="shares">1926000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i210b958efc1e4be3928a76fb8c2b4d1b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTItNS0xLTEtMA_f4f64642-9947-4003-b10d-4cdd52e29f62"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="id68539b93ebe41578d0997661f7c7067_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTItNy0xLTEtMA_457e2dcc-70c5-46d6-83bb-dc94ab140136"
      unitRef="shares">1765000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i635b1aa8136841889975e9745d917b9f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTMtMS0xLTEtMA_ca6f3b79-0a35-4216-b7dc-308e072aa07d"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i70906b8925394dfeb8414b49b6c11841_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTMtMy0xLTEtMA_9bd0ceb1-1a55-4821-adfb-e483b5fb162c"
      unitRef="shares">346000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ia7b754b4139a4554aa9b7b4108bd3cb4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTMtNS0xLTEtMA_8b50b763-c3d6-4ae2-bd51-e0a81fb8403d"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i9cfa47a706aa4d73921235a75ded8670_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTMtNy0xLTEtMA_12797e68-0c26-488c-a904-494f99714403"
      unitRef="shares">337000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ia6a4e7a972ff46bea3882f3ced06ea4b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTQtMS0xLTEtMA_17233818-503b-4984-a9ae-ca713f124ec7"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i857f8284e96b4d529652faaf70a41f4f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTQtMy0xLTEtMA_cbf116ef-3096-48df-9966-103eb789dc51"
      unitRef="shares">211000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i7718da1375c940c7aad6f404d81e8204_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTQtNS0xLTEtMA_b02972d4-c470-480e-8e0a-965be19a4583"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i0a415fe6e6094b7ab63c7d3ca2b9aa95_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTQtNy0xLTEtMA_6f40d5c9-0659-4a0c-9bfe-8965bf690127"
      unitRef="shares">211000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTUtMS0xLTEtMA_8b2a582a-b66e-43d8-ae30-415be800c3de"
      unitRef="shares">183214000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTUtMy0xLTEtMA_8743f73f-7537-4943-9c67-3982caba64c4"
      unitRef="shares">197674000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTUtNS0xLTEtMA_8c2afd90-d8b6-46af-b52d-66908fc5e882"
      unitRef="shares">182616000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTUtNy0xLTEtMA_42524e41-35ec-4ffd-9747-73559b4595a5"
      unitRef="shares">194959000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTYtMS0xLTEtMA_69226396-05dc-48fc-a0ba-7051dc52ed04"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTYtMy0xLTEtMA_62ff7cd6-9928-41ba-a149-ee3fa1aa0f96"
      unitRef="usdPerShare">4.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTYtNS0xLTEtMA_505ff8eb-9361-43b2-96dc-7bb17ff3781c"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTYtNy0xLTEtMA_f37d6b6d-8843-46e8-9d9a-c43f752281dc"
      unitRef="usdPerShare">4.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTctMS0xLTEtMA_6fafbcce-c6b2-4edf-8b38-909387f61548"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTctMy0xLTEtMA_182028c8-e545-4c6e-9f95-d613ea97b01e"
      unitRef="usdPerShare">4.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTctNS0xLTEtMA_c34c8198-2509-4d21-bf1e-d793efd019fd"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOmRmOWU2OTg1ZGVmYjRkZmJhMDNlZDczYmNkZDJlZDJjL3RhYmxlcmFuZ2U6ZGY5ZTY5ODVkZWZiNGRmYmEwM2VkNzNiY2RkMmVkMmNfMTctNy0xLTEtMA_78aad338-d186-44e6-86c1-05cd64389472"
      unitRef="usdPerShare">4.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfMTMyMQ_2c5dab5d-a862-41aa-be7d-152814bfd2a5">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In addition to the equity instruments included in the table above, the table below presents potential shares of common stock that were excluded from the computation of basic and diluted income (loss) per common share as they were anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock issuable under the 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Common stock potentially issuable for ESPP purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The Company&#x2019;s common stock held by the NQDC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total number of potentially issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8e0d79598b4a4fe0894f5f0b5c8d05d2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfMi0xLTEtMS0w_e9522eb7-0f7a-4955-91b5-5150efbf48d2"
      unitRef="shares">6649000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i12651120f91f4b4f8cebb3b98050584d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfMi0zLTEtMS0w_3d9d8540-4ba5-4521-9c6d-8479827c5e22"
      unitRef="shares">5172000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i90f88b98995241caafd2941a4333cb2b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfMi01LTEtMS0w_204fefe7-5e18-40dc-8028-ee10df8f373d"
      unitRef="shares">6649000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5acc9dcae0254e3a91a091eaad031510_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfMi03LTEtMS0w_9abed0db-b6c2-43ba-8b5d-c95e1a9440a6"
      unitRef="shares">5175000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifc32bd96b3014e92b2f0efc81b2ae66a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNC0xLTEtMS0w_5283e59c-c035-4c72-8958-5d9cb0c1965d"
      unitRef="shares">3970000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i483fea5cfb454ba7a3044cf8f94b872c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNC0zLTEtMS0w_819fd6b1-623b-46ab-b308-b7f17e5ecb5a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0936ac22ba0641e3baa0b8544e010e8f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNC01LTEtMS0w_db61891c-d870-4400-8107-adf8a9ed6f83"
      unitRef="shares">3970000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6693bf5374b04cec9cbcc298b6b9df9b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNC03LTEtMS0w_8b8ff82b-bd93-4208-82ff-3981e96f9b91"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i712f67daf8994797927c8bdb430e55c9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNS0xLTEtMS0w_a847c97f-fc29-4168-878f-d7c3ca4a1a3f"
      unitRef="shares">4365000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9264da2f9bbd4f2fb33480144d2f85a9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNS0zLTEtMS0w_323aacdf-40cc-4cc8-b754-0993aeace6f6"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0589f3a72cba42008e9af75b85655bfc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNS01LTEtMS0w_321d35c5-d8e6-478e-8109-e2c792c5ed28"
      unitRef="shares">4365000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i747d9cadb0334a97b76371c9665c4ff0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNS03LTEtMS0w_4b2fdb36-3c41-4a6d-aa78-952a0ad3dd10"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6195d3f0e2374354b38eb0cc2ab77d14_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNi0xLTEtMS0w_0e0eb4ca-dbe7-40e3-996d-f1d89a20e44f"
      unitRef="shares">5292000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i88ec953e8f554e02994b61549a84b786_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNi0zLTEtMS0w_1c39cd13-6b19-4072-8f3c-67825d07e1dd"
      unitRef="shares">2900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i210b958efc1e4be3928a76fb8c2b4d1b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNi01LTEtMS0w_762ac765-9c71-4775-b8d9-37c407002a8f"
      unitRef="shares">5292000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id68539b93ebe41578d0997661f7c7067_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNi03LTEtMS0w_36d63ad1-739e-4669-8523-36cad0cb1efe"
      unitRef="shares">3060000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i635b1aa8136841889975e9745d917b9f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNy0xLTEtMS0w_fa729b9c-ae27-4d5b-bec5-6827600f05aa"
      unitRef="shares">582000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i70906b8925394dfeb8414b49b6c11841_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNy0zLTEtMS0w_6eae8480-4040-48e3-a527-292cbd8691e6"
      unitRef="shares">193000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia7b754b4139a4554aa9b7b4108bd3cb4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNy01LTEtMS0w_d3552162-5885-464e-88e1-8784ad25a1f0"
      unitRef="shares">582000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9cfa47a706aa4d73921235a75ded8670_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfNy03LTEtMS0w_4dac7772-f873-471e-92c3-0d191b7c5439"
      unitRef="shares">204000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia6a4e7a972ff46bea3882f3ced06ea4b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOC0xLTEtMS0w_7404050d-d93f-4c6f-a6cf-bca5cb4deb9e"
      unitRef="shares">197000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i857f8284e96b4d529652faaf70a41f4f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOC0zLTEtMS0w_08cf2464-0a17-486f-8bb1-b14e155b0139"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7718da1375c940c7aad6f404d81e8204_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOC01LTEtMS0w_a7deb219-c719-460a-9992-429e6cdd5a0e"
      unitRef="shares">197000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0a415fe6e6094b7ab63c7d3ca2b9aa95_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOC03LTEtMS0w_c6db50c3-6832-47c5-9943-bad0de35314f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i52f4f9636243498cb577db395fe3d626_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOS0xLTEtMS0w_32648edf-0aff-463e-8cc4-58482c50a62c"
      unitRef="shares">21055000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib16448759e0c45c7b1d3a970a9d65358_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOS0zLTEtMS0w_ee8ebaae-69cf-4e8e-a5e6-96fd73e85607"
      unitRef="shares">8265000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOS01LTEtMS0w_631adbee-a89c-40cc-8365-63bddce5e1e9"
      unitRef="shares">21055000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i29e26d691ec94dbe811b2446c4fd7e6c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RhYmxlOjZjN2Q4N2ZlYmYwODRmODk5MTAyMWJkZjk1ZGVlMTY0L3RhYmxlcmFuZ2U6NmM3ZDg3ZmViZjA4NGY4OTkxMDIxYmRmOTVkZWUxNjRfOS03LTEtMS0w_c35d0fa8-5ff5-43c6-a92f-908e183a5480"
      unitRef="shares">8439000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic20a7b693de94d51a8059e3b28b30754_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfODAw_a372ffb6-f7c2-4fbf-8653-175053e81617"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ib965f565ed34406a849028c30350f306_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183My9mcmFnOmE0ZjVmMWMzN2JkYTQzYzhhZWE0ZDhhMTc2NDZjZjU2L3RleHRyZWdpb246YTRmNWYxYzM3YmRhNDNjOGFlYTRkOGExNzY0NmNmNTZfMTIxMw_fa5b7561-52e3-4764-9894-61ca0074ff66"
      unitRef="usdPerShare">94.15</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMjM3OA_da75a051-cc67-4e7b-844e-7714ba614263">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time the Company is involved in legal actions arising in the normal course of its business. The process of&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;resolving matters through litigation or other means is inherently uncertain and it is possible that an unfavorable resolution of these&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;matters could adversely affect the Company, its results of operations, financial condition or cash flows. The Company&#x2019;s general&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;practice is to expense legal fees as services are rendered in connection with legal matters, and to accrue for liabilities when losses are probable and reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the Company was subject to contingent payments totaling approximately $708.8 million upon achievement of certain development and regulatory activities and commercial sales milestones if they occur before certain dates in the future. Of this amount, $70.0 million were considered probable and comprised of commercial milestones related to the acquisition of certain rights and other assets with respect to Kuvan and Palynziq from a third party, $405.5 million were considered reasonably possible and primarily related to development milestones and $233.3 million were considered remote as the Company is no longer developing the related programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the fair value of contingent liabilities recorded on the Company&#x2019;s Condensed Consolidated Balance Sheet was $63.4 million of which $48.2 million was short term. See Note 7 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to these Condensed Consolidated Financial Statements for further information regarding the fair value of the Company&#x2019;s contingent consideration. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company uses experts and laboratories at universities and other institutions to perform certain research and development (R&amp;amp;D) activities. These amounts are included as R&amp;amp;D expense as services are provided. In the normal course of business, the Company enters into various firm purchase commitments primarily related to active pharmaceutical ingredients, certain inventory-related items and certain third-party R&amp;amp;D services. As of September&#160;30, 2021, such commitments and other minimum contractual obligations for clinical and post-marketing services were estimated at approximately $107.7 million. The Company has also licensed technology, for which it is required to pay royalties upon future sales, subject to certain annual minimums.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfNzEx_4381d491-c1d4-4d78-b424-c4e20fc731f6"
      unitRef="usd">708800000</bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones>
    <bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones
      contextRef="ib0c45fdc691545eca329a4b5abc34572_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfODc4_9bab2276-eb04-4e47-ad37-8d12c8e554f6"
      unitRef="usd">70000000</bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones>
    <bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones
      contextRef="i0f2e2c7117c147a3bf29ed90d8327de7_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMTA2Mg_66964ff2-d439-44c5-8834-e489c06a21ef"
      unitRef="usd">405500000</bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones>
    <bmrn:ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones
      contextRef="i5eacd8a06aed4d4fa25cd448dd9cefbe_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMTIyNg_86312f09-7e79-4633-95c7-6135ec8d9837"
      unitRef="usd">233300000</bmrn:ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMTQzMg_de8001cf-bdf2-4a14-a78d-32a9394d581d"
      unitRef="usd">63400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMTQ0NA_5d97b9a4-39ef-4182-b860-245538ea7dec"
      unitRef="usd">48200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted
      contextRef="icce161e9967344ce804b1ab36f4ae711_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM183Ni9mcmFnOjRhOGFiYTBkODk4ZjQ5NzliMmM1OTJlZTk1Y2EzOTg2L3RleHRyZWdpb246NGE4YWJhMGQ4OThmNDk3OWIyYzU5MmVlOTVjYTM5ODZfMjIzNQ_bb37a454-ac03-48c9-ba92-dbc9558b063a"
      unitRef="usd">107700000</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNC0zLTEtMS0w_2af7c84e-15a2-469f-b3a2-40f9942c0465"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNC0zLTEtMS0w_2af7c84e-15a2-469f-b3a2-40f9942c0465"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzAtMy0xLTEtMA_3a751c61-52c3-4c35-b74f-7be0a7f656ae"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzAtMy0xLTEtMA_3a751c61-52c3-4c35-b74f-7be0a7f656ae"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTktMy0xLTEtMA_be2bf46a-bb44-4592-afef-c68248e5b1e1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTktMy0xLTEtMA_be2bf46a-bb44-4592-afef-c68248e5b1e1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfOC0zLTEtMS0w_b171cb64-0d12-49c8-b234-4ba21419be22"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfOC0zLTEtMS0w_b171cb64-0d12-49c8-b234-4ba21419be22"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzEtMy0xLTEtMA_f90ceb0a-0a8d-484c-bd86-7b5eb48578b3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzEtMy0xLTEtMA_f90ceb0a-0a8d-484c-bd86-7b5eb48578b3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjAtMy0xLTEtMA_e50909c2-33f9-467b-81bb-cc16fc65ec8c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjAtMy0xLTEtMA_e50909c2-33f9-467b-81bb-cc16fc65ec8c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTEtMy0xLTEtMA_8a434401-71b4-4fed-860e-e33037f86e30"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTEtMy0xLTEtMA_8a434401-71b4-4fed-860e-e33037f86e30"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzMtMy0xLTEtMA_768b19d3-3929-492e-b163-68865a2bb538"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzMtMy0xLTEtMA_768b19d3-3929-492e-b163-68865a2bb538"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjUtMy0xLTEtMA_ef878db6-765a-4c07-8bdd-66a9d9ab891f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjUtMy0xLTEtMA_ef878db6-765a-4c07-8bdd-66a9d9ab891f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzItMy0xLTEtMA_aee410e3-2710-492c-be12-ff105db632d4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzItMy0xLTEtMA_aee410e3-2710-492c-be12-ff105db632d4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTUtMy0xLTEtMA_7754568c-0ccf-4705-b267-dcd4e8a01736"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTUtMy0xLTEtMA_7754568c-0ccf-4705-b267-dcd4e8a01736"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzQtMy0xLTEtMA_ab8e1abd-438c-4bbf-8e67-ef972f7e8e57"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzQtMy0xLTEtMA_ab8e1abd-438c-4bbf-8e67-ef972f7e8e57"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjYtMy0xLTEtMA_eb2dac2a-2bb4-4a15-ae9d-a418aee0af6a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjYtMy0xLTEtMA_eb2dac2a-2bb4-4a15-ae9d-a418aee0af6a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjQtMy0xLTEtMA_848e667a-fd89-455e-959c-16985e3ddf57"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjQtMy0xLTEtMA_848e667a-fd89-455e-959c-16985e3ddf57"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzUtMy0xLTEtMA_c5cca7ad-592b-43c3-90e3-1ecd7964bf98"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzUtMy0xLTEtMA_c5cca7ad-592b-43c3-90e3-1ecd7964bf98"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTAtMy0xLTEtMA_5021714b-41f4-4186-97af-827af3879f97"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTAtMy0xLTEtMA_5021714b-41f4-4186-97af-827af3879f97"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTYtMy0xLTEtMA_1c993f34-625e-4306-a646-d7023a602565"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTYtMy0xLTEtMA_1c993f34-625e-4306-a646-d7023a602565"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTQtMy0xLTEtMA_db827f36-5b7a-4bc7-942c-a859676323d1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTQtMy0xLTEtMA_db827f36-5b7a-4bc7-942c-a859676323d1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTItMy0xLTEtMA_440b4086-be9e-4834-8028-38898b0ec0a3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTItMy0xLTEtMA_440b4086-be9e-4834-8028-38898b0ec0a3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNi0zLTEtMS0w_04862746-47e9-481f-b137-44e29e1163a1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNi0zLTEtMS0w_04862746-47e9-481f-b137-44e29e1163a1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjctMy0xLTEtMA_2b8ca420-b415-4866-8e39-2de9ae3b70d0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjctMy0xLTEtMA_2b8ca420-b415-4866-8e39-2de9ae3b70d0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMy0xLTEtMA_f77147f8-14f4-46ce-ba75-39ed2a695044"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMy0xLTEtMA_f77147f8-14f4-46ce-ba75-39ed2a695044"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMy0zLTEtMS0w_963a8511-19cd-4d3b-b379-dc85f72b46aa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMy0zLTEtMS0w_963a8511-19cd-4d3b-b379-dc85f72b46aa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNy0zLTEtMS0w_d739060c-a214-4c3a-96e9-aa59f7e45b2e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNy0zLTEtMS0w_d739060c-a214-4c3a-96e9-aa59f7e45b2e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNS0zLTEtMS0w_ef7e6176-5a24-43b3-b8a2-3739ebaf709a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNS0zLTEtMS0w_ef7e6176-5a24-43b3-b8a2-3739ebaf709a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjEtMy0xLTEtMA_720e73e0-635b-439e-9636-dce68aecaac9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjEtMy0xLTEtMA_720e73e0-635b-439e-9636-dce68aecaac9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTMtMy0xLTEtMA_e43ea724-b6c9-4507-90eb-1e0e5d1f128a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTMtMy0xLTEtMA_e43ea724-b6c9-4507-90eb-1e0e5d1f128a"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</xhtml:span><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNC0zLTEtMS0w_2af7c84e-15a2-469f-b3a2-40f9942c0465"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzAtMy0xLTEtMA_3a751c61-52c3-4c35-b74f-7be0a7f656ae"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTktMy0xLTEtMA_be2bf46a-bb44-4592-afef-c68248e5b1e1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfOC0zLTEtMS0w_b171cb64-0d12-49c8-b234-4ba21419be22"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzEtMy0xLTEtMA_f90ceb0a-0a8d-484c-bd86-7b5eb48578b3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjAtMy0xLTEtMA_e50909c2-33f9-467b-81bb-cc16fc65ec8c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTEtMy0xLTEtMA_8a434401-71b4-4fed-860e-e33037f86e30"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzMtMy0xLTEtMA_768b19d3-3929-492e-b163-68865a2bb538"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjUtMy0xLTEtMA_ef878db6-765a-4c07-8bdd-66a9d9ab891f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzItMy0xLTEtMA_aee410e3-2710-492c-be12-ff105db632d4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTUtMy0xLTEtMA_7754568c-0ccf-4705-b267-dcd4e8a01736"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzQtMy0xLTEtMA_ab8e1abd-438c-4bbf-8e67-ef972f7e8e57"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjYtMy0xLTEtMA_eb2dac2a-2bb4-4a15-ae9d-a418aee0af6a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjQtMy0xLTEtMA_848e667a-fd89-455e-959c-16985e3ddf57"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMzUtMy0xLTEtMA_c5cca7ad-592b-43c3-90e3-1ecd7964bf98"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTAtMy0xLTEtMA_5021714b-41f4-4186-97af-827af3879f97"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTYtMy0xLTEtMA_1c993f34-625e-4306-a646-d7023a602565"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTQtMy0xLTEtMA_db827f36-5b7a-4bc7-942c-a859676323d1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTItMy0xLTEtMA_440b4086-be9e-4834-8028-38898b0ec0a3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNi0zLTEtMS0w_04862746-47e9-481f-b137-44e29e1163a1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjctMy0xLTEtMA_2b8ca420-b415-4866-8e39-2de9ae3b70d0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjktMy0xLTEtMA_f77147f8-14f4-46ce-ba75-39ed2a695044"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMy0zLTEtMS0w_963a8511-19cd-4d3b-b379-dc85f72b46aa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNy0zLTEtMS0w_d739060c-a214-4c3a-96e9-aa59f7e45b2e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfNS0zLTEtMS0w_ef7e6176-5a24-43b3-b8a2-3739ebaf709a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMjEtMy0xLTEtMA_720e73e0-635b-439e-9636-dce68aecaac9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RhYmxlOjdjZDk0YWFiZGY3ODQxNjk5MDE5ZDc3ZDc2ODdiNzViL3RhYmxlcmFuZ2U6N2NkOTRhYWJkZjc4NDE2OTkwMTlkNzdkNzY4N2I3NWJfMTMtMy0xLTEtMA_e43ea724-b6c9-4507-90eb-1e0e5d1f128a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18xOS9mcmFnOmIyMTFmMTgwZGNiZTQ5OTg4ZjBjNTMyMzZlNzJmMmQyL3RleHRyZWdpb246YjIxMWYxODBkY2JlNDk5ODhmMGM1MzIzNmU3MmYyZDJfMzk3_064cc767-b5de-4e1a-acc5-c17c356fe16f"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMy0xLTEtMA_6606cdb6-977b-49ba-8a09-d376a76e6dda"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMy0xLTEtMA_6606cdb6-977b-49ba-8a09-d376a76e6dda"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMS0xLTEtMA_fa8c23b8-dffb-4769-aae5-62ccbe33d132"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMS0xLTEtMA_fa8c23b8-dffb-4769-aae5-62ccbe33d132"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMS0xLTEtMA_83aea445-0665-4f90-8ba3-7712949883a1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMS0xLTEtMA_83aea445-0665-4f90-8ba3-7712949883a1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNS0xLTEtMA_989d4272-2948-4a7a-bd0c-3fd121d0047c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNS0xLTEtMA_989d4272-2948-4a7a-bd0c-3fd121d0047c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMy0xLTEtMA_7f4a62eb-845e-49ff-9889-65ebd2382598"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMy0xLTEtMA_7f4a62eb-845e-49ff-9889-65ebd2382598"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNy0xLTEtMA_ee908d3a-c4e8-4e65-b4e2-151b4adb3de0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNy0xLTEtMA_ee908d3a-c4e8-4e65-b4e2-151b4adb3de0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0xLTEtMS0w_72870b1f-4e17-4559-9fab-07aecaab6bde"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0xLTEtMS0w_72870b1f-4e17-4559-9fab-07aecaab6bde"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC03LTEtMS0w_40abc157-7a92-4b2e-b4c1-636c8a1c095f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC03LTEtMS0w_40abc157-7a92-4b2e-b4c1-636c8a1c095f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMy0xLTEtMA_19f99bfb-dc72-4b96-857a-b4f591a35d5b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMy0xLTEtMA_19f99bfb-dc72-4b96-857a-b4f591a35d5b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNS0xLTEtMA_8cbf41fe-e697-457e-a1ff-f93d617fb15a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNS0xLTEtMA_8cbf41fe-e697-457e-a1ff-f93d617fb15a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNy0xLTEtMA_d6836a05-7ef2-4eea-b180-796e09dfac57"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNy0xLTEtMA_d6836a05-7ef2-4eea-b180-796e09dfac57"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMS0xLTEtMA_1615b675-9dc0-4931-b33b-c18a216d1013"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMS0xLTEtMA_1615b675-9dc0-4931-b33b-c18a216d1013"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC01LTEtMS0w_622fde87-890f-4579-a8c4-8f538731d0a5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC01LTEtMS0w_622fde87-890f-4579-a8c4-8f538731d0a5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy03LTEtMS0w_9945da9e-d5c5-4a4b-9e1f-fa7bd5cb744a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy03LTEtMS0w_9945da9e-d5c5-4a4b-9e1f-fa7bd5cb744a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNy0xLTEtMA_b899b85f-8b47-41ff-89c6-effe257d0c28"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNy0xLTEtMA_b899b85f-8b47-41ff-89c6-effe257d0c28"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNy0xLTEtMA_e1dc97ee-6443-43a8-9e6f-fe83e219f499"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNy0xLTEtMA_e1dc97ee-6443-43a8-9e6f-fe83e219f499"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNS0xLTEtMA_c754fec8-9ca8-4726-a876-e54479025051"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNS0xLTEtMA_c754fec8-9ca8-4726-a876-e54479025051"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMy0xLTEtMA_9b2f553e-3253-4009-8223-5f14dee5a1a4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMy0xLTEtMA_9b2f553e-3253-4009-8223-5f14dee5a1a4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0zLTEtMS0w_80e1e025-549a-45c2-84d4-d428b04bc25d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0zLTEtMS0w_80e1e025-549a-45c2-84d4-d428b04bc25d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNy0xLTEtMA_478d5aec-1723-40c5-beea-a858d1dbfc9b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNy0xLTEtMA_478d5aec-1723-40c5-beea-a858d1dbfc9b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy01LTEtMS0w_80590d6d-6042-4df1-a54f-e96d14ee3755"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy01LTEtMS0w_80590d6d-6042-4df1-a54f-e96d14ee3755"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMy0xLTEtMA_67818c24-e760-4a44-8b3b-cae1351b1f8e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMy0xLTEtMA_67818c24-e760-4a44-8b3b-cae1351b1f8e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMy0xLTEtMA_0472a5e3-0a8f-4691-b9c8-b0387c815ce1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMy0xLTEtMA_0472a5e3-0a8f-4691-b9c8-b0387c815ce1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNS0xLTEtMA_ce5b790a-8f10-4f4d-a51c-6f62fbf0f0fe"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNS0xLTEtMA_ce5b790a-8f10-4f4d-a51c-6f62fbf0f0fe"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0xLTEtMS0w_9da5c243-f2ba-428d-88f4-fff099590b2f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0xLTEtMS0w_9da5c243-f2ba-428d-88f4-fff099590b2f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNS0xLTEtMA_a69260cb-11f7-4d4f-98bc-513018bfe44b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNS0xLTEtMA_a69260cb-11f7-4d4f-98bc-513018bfe44b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMS0xLTEtMA_f2211914-b58c-4762-a749-aae4b1cd3052"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMS0xLTEtMA_f2211914-b58c-4762-a749-aae4b1cd3052"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNS0xLTEtMA_2ba8b51a-3d12-4c40-9732-b59b4096cb92"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNS0xLTEtMA_2ba8b51a-3d12-4c40-9732-b59b4096cb92"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMS0xLTEtMA_b3ac2687-39cd-4b15-a8e0-278133489a77"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMS0xLTEtMA_b3ac2687-39cd-4b15-a8e0-278133489a77"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMS0xLTEtMA_817fdbd8-1213-4898-be7c-f08d3b5d4c12"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMS0xLTEtMA_817fdbd8-1213-4898-be7c-f08d3b5d4c12"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0zLTEtMS0w_abf81c9d-4f10-4caa-8485-a937624d5b0a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0zLTEtMS0w_abf81c9d-4f10-4caa-8485-a937624d5b0a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNy0xLTEtMA_52688cf7-cdb3-44b7-9af1-18d255bc03c2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNy0xLTEtMA_52688cf7-cdb3-44b7-9af1-18d255bc03c2"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The beginning balances for the nine-month periods were derived from the audited Consolidated Financial Statements included in Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMy0xLTEtMA_6606cdb6-977b-49ba-8a09-d376a76e6dda"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMS0xLTEtMA_fa8c23b8-dffb-4769-aae5-62ccbe33d132"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMS0xLTEtMA_83aea445-0665-4f90-8ba3-7712949883a1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNS0xLTEtMA_989d4272-2948-4a7a-bd0c-3fd121d0047c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtMy0xLTEtMA_7f4a62eb-845e-49ff-9889-65ebd2382598"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtNy0xLTEtMA_ee908d3a-c4e8-4e65-b4e2-151b4adb3de0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0xLTEtMS0w_72870b1f-4e17-4559-9fab-07aecaab6bde"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC03LTEtMS0w_40abc157-7a92-4b2e-b4c1-636c8a1c095f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMy0xLTEtMA_19f99bfb-dc72-4b96-857a-b4f591a35d5b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNS0xLTEtMA_8cbf41fe-e697-457e-a1ff-f93d617fb15a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzAtNy0xLTEtMA_d6836a05-7ef2-4eea-b180-796e09dfac57"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtMS0xLTEtMA_1615b675-9dc0-4931-b33b-c18a216d1013"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC01LTEtMS0w_622fde87-890f-4579-a8c4-8f538731d0a5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy03LTEtMS0w_9945da9e-d5c5-4a4b-9e1f-fa7bd5cb744a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNy0xLTEtMA_b899b85f-8b47-41ff-89c6-effe257d0c28"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNy0xLTEtMA_e1dc97ee-6443-43a8-9e6f-fe83e219f499"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNS0xLTEtMA_c754fec8-9ca8-4726-a876-e54479025051"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMy0xLTEtMA_9b2f553e-3253-4009-8223-5f14dee5a1a4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0zLTEtMS0w_80e1e025-549a-45c2-84d4-d428b04bc25d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNy0xLTEtMA_478d5aec-1723-40c5-beea-a858d1dbfc9b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy01LTEtMS0w_80590d6d-6042-4df1-a54f-e96d14ee3755"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtMy0xLTEtMA_67818c24-e760-4a44-8b3b-cae1351b1f8e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMy0xLTEtMA_0472a5e3-0a8f-4691-b9c8-b0387c815ce1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtNS0xLTEtMA_ce5b790a-8f10-4f4d-a51c-6f62fbf0f0fe"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMy0xLTEtMS0w_9da5c243-f2ba-428d-88f4-fff099590b2f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtNS0xLTEtMA_a69260cb-11f7-4d4f-98bc-513018bfe44b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMzUtMS0xLTEtMA_f2211914-b58c-4762-a749-aae4b1cd3052"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTAtNS0xLTEtMA_2ba8b51a-3d12-4c40-9732-b59b4096cb92"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjEtMS0xLTEtMA_b3ac2687-39cd-4b15-a8e0-278133489a77"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMjYtMS0xLTEtMA_817fdbd8-1213-4898-be7c-f08d3b5d4c12"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfOC0zLTEtMS0w_abf81c9d-4f10-4caa-8485-a937624d5b0a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RhYmxlOjQ5Mzc0OGQxZDNiYjQ2N2Y5YzhmODdhNGZmMGM5MzhjL3RhYmxlcmFuZ2U6NDkzNzQ4ZDFkM2JiNDY3ZjljOGY4N2E0ZmYwYzkzOGNfMTQtNy0xLTEtMA_52688cf7-cdb3-44b7-9af1-18d255bc03c2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM18yNS9mcmFnOjMxNTg3MWZkYWQxZDQwZWFhZmM4OGIwNDIxZWIyY2M2L3RleHRyZWdpb246MzE1ODcxZmRhZDFkNDBlYWFmYzg4YjA0MjFlYjJjYzZfNDU5_8f53fdc9-b1d3-4dbe-8645-9cd7f9ecaa13"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707085624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 26, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-26727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BioMarin Pharmaceutical Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0397820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">770 Lindaro Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Rafael<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">506-6700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMRN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,593,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001048477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866710506280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 617,143<span></span>
</td>
<td class="nump">$ 649,158<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">462,333<span></span>
</td>
<td class="nump">416,228<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">374,937<span></span>
</td>
<td class="nump">448,351<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">749,406<span></span>
</td>
<td class="nump">698,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">107,751<span></span>
</td>
<td class="nump">129,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,311,570<span></span>
</td>
<td class="nump">2,342,219<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Noncurrent assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">466,618<span></span>
</td>
<td class="nump">285,473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,024,787<span></span>
</td>
<td class="nump">1,032,471<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">388,487<span></span>
</td>
<td class="nump">417,271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">196,199<span></span>
</td>
<td class="nump">196,199<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">1,445,109<span></span>
</td>
<td class="nump">1,432,150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">144,705<span></span>
</td>
<td class="nump">142,237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,977,475<span></span>
</td>
<td class="nump">5,848,020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">466,711<span></span>
</td>
<td class="nump">492,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Short-term contingent consideration</a></td>
<td class="nump">48,187<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">514,898<span></span>
</td>
<td class="nump">492,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Noncurrent liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Long-term convertible debt, net</a></td>
<td class="nump">1,078,093<span></span>
</td>
<td class="nump">1,075,145<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Long-term contingent consideration</a></td>
<td class="nump">15,204<span></span>
</td>
<td class="nump">60,130<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">103,131<span></span>
</td>
<td class="nump">114,195<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,711,326<span></span>
</td>
<td class="nump">1,742,018<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value: 500,000,000 shares authorized; 183,567,424 and 181,740,999 shares issued and outstanding, respectively.</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,133,742<span></span>
</td>
<td class="nump">4,993,407<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockIssuedEmployeeStockTrust', window );">Company common stock held by Nonqualified Deferred Compensation Plan (the NQDC)</a></td>
<td class="num">(10,225)<span></span>
</td>
<td class="num">(9,839)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">10,239<span></span>
</td>
<td class="num">(16,139)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(867,791)<span></span>
</td>
<td class="num">(861,609)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">4,266,149<span></span>
</td>
<td class="nump">4,106,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 5,977,475<span></span>
</td>
<td class="nump">$ 5,848,020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The beginning balances for the nine-month periods were derived from the audited Consolidated Financial Statements included in Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockIssuedEmployeeStockTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of common stock issued to a trust (for example, a 'rabbi trust') set up specifically to accumulate stock for the sole purpose of distribution to participating employees. This trust does not allow employees to immediately or after a holding period diversify into nonemployer securities. The deferred compensation plan for which this trust is set up must be settled by the delivery of a fixed number of shares of employer stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123585891&amp;loc=d3e19833-108362<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockIssuedEmployeeStockTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707046808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">183,567,424<span></span>
</td>
<td class="nump">181,740,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">183,567,424<span></span>
</td>
<td class="nump">181,740,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707456824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 408,742<span></span>
</td>
<td class="nump">$ 476,784<span></span>
</td>
<td class="nump">$ 1,396,465<span></span>
</td>
<td class="nump">$ 1,408,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>OPERATING EXPENSES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">103,537<span></span>
</td>
<td class="nump">188,793<span></span>
</td>
<td class="nump">350,765<span></span>
</td>
<td class="nump">398,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">157,869<span></span>
</td>
<td class="nump">147,053<span></span>
</td>
<td class="nump">467,701<span></span>
</td>
<td class="nump">471,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">183,333<span></span>
</td>
<td class="nump">179,450<span></span>
</td>
<td class="nump">541,812<span></span>
</td>
<td class="nump">542,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_IntangibleAssetAmortizationAndContingentConsideration', window );">Intangible asset amortization and contingent consideration</a></td>
<td class="nump">17,222<span></span>
</td>
<td class="nump">17,429<span></span>
</td>
<td class="nump">52,648<span></span>
</td>
<td class="nump">48,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on sale of nonfinancial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(59,495)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">461,961<span></span>
</td>
<td class="nump">532,725<span></span>
</td>
<td class="nump">1,412,926<span></span>
</td>
<td class="nump">1,400,263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME (LOSS) FROM OPERATIONS</a></td>
<td class="num">(53,219)<span></span>
</td>
<td class="num">(55,941)<span></span>
</td>
<td class="num">(16,461)<span></span>
</td>
<td class="nump">8,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in the income (loss) of BioMarin/Genzyme LLC</a></td>
<td class="nump">177<span></span>
</td>
<td class="num">(921)<span></span>
</td>
<td class="num">(1,349)<span></span>
</td>
<td class="num">(1,077)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">1,827<span></span>
</td>
<td class="nump">4,004<span></span>
</td>
<td class="nump">8,737<span></span>
</td>
<td class="nump">13,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(3,870)<span></span>
</td>
<td class="num">(9,597)<span></span>
</td>
<td class="num">(11,491)<span></span>
</td>
<td class="num">(24,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other income, net</a></td>
<td class="nump">8,925<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">11,788<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">INCOME (LOSS) BEFORE INCOME TAXES</a></td>
<td class="num">(46,160)<span></span>
</td>
<td class="num">(61,216)<span></span>
</td>
<td class="num">(8,776)<span></span>
</td>
<td class="num">(2,137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="num">(9,666)<span></span>
</td>
<td class="num">(846,019)<span></span>
</td>
<td class="num">(2,594)<span></span>
</td>
<td class="num">(839,138)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME (LOSS)</a></td>
<td class="num">$ (36,494)<span></span>
</td>
<td class="nump">$ 784,803<span></span>
</td>
<td class="num">$ (6,182)<span></span>
</td>
<td class="nump">$ 837,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">NET INCOME (LOSS) PER SHARE, BASIC (in dollars per share)</a></td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="nump">$ 4.33<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 4.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">NET INCOME (LOSS) PER SHARE, DILUTED (in dollars per share)</a></td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="nump">$ 4.01<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 4.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">183,214<span></span>
</td>
<td class="nump">181,142<span></span>
</td>
<td class="nump">182,616<span></span>
</td>
<td class="nump">180,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">183,214<span></span>
</td>
<td class="nump">197,674<span></span>
</td>
<td class="nump">182,616<span></span>
</td>
<td class="nump">194,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="num">$ (25,316)<span></span>
</td>
<td class="nump">$ 765,138<span></span>
</td>
<td class="nump">$ 20,196<span></span>
</td>
<td class="nump">$ 827,222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net product revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">393,840<span></span>
</td>
<td class="nump">460,741<span></span>
</td>
<td class="nump">1,348,279<span></span>
</td>
<td class="nump">1,368,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_RoyaltyAndOtherMember', window );">Royalty and other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 14,902<span></span>
</td>
<td class="nump">$ 16,043<span></span>
</td>
<td class="nump">$ 48,186<span></span>
</td>
<td class="nump">$ 39,522<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_IntangibleAssetAmortizationAndContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets and expense charged against earnings resulting from the change in the fair value of contingent consideration during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_IntangibleAssetAmortizationAndContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_RoyaltyAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_RoyaltyAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866704912744">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Company Stock Held By NQDC</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">179,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares', window );">Issuances under equity incentive plans (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">181,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 3,122,381<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 4,832,707<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (9,961)<span></span>
</td>
<td class="nump">$ 20,164<span></span>
</td>
<td class="num">$ (1,720,709)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency', window );">Issuances under equity incentive plans, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="nump">17,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Retirement of treasury stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan', window );">Common stock held by the NQDC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,779)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">837,001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">837,001<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,053,893<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 181<span></span>
</td>
<td class="nump">4,937,791<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,756)<span></span>
</td>
<td class="nump">10,385<span></span>
</td>
<td class="num">(883,708)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">181,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares', window );">Issuances under equity incentive plans (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">181,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,236,679<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 181<span></span>
</td>
<td class="nump">4,885,637<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,678)<span></span>
</td>
<td class="nump">30,050<span></span>
</td>
<td class="num">(1,668,511)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency', window );">Issuances under equity incentive plans, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Retirement of treasury stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan', window );">Common stock held by the NQDC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">784,803<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784,803<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,053,893<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 181<span></span>
</td>
<td class="nump">4,937,791<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,756)<span></span>
</td>
<td class="nump">10,385<span></span>
</td>
<td class="num">(883,708)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">181,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares', window );">Issuances under equity incentive plans (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">183,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,106,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">4,993,407<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,839)<span></span>
</td>
<td class="num">(16,139)<span></span>
</td>
<td class="num">(861,609)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency', window );">Issuances under equity incentive plans, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="num">(11,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Retirement of treasury stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan', window );">Common stock held by the NQDC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,182)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,266,149<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">5,133,742<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,225)<span></span>
</td>
<td class="nump">10,239<span></span>
</td>
<td class="num">(867,791)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">183,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares', window );">Issuances under equity incentive plans (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">183,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,241,571<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 183<span></span>
</td>
<td class="nump">5,083,831<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,207)<span></span>
</td>
<td class="num">(939)<span></span>
</td>
<td class="num">(831,297)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency', window );">Issuances under equity incentive plans, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="num">(460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Retirement of treasury stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan', window );">Common stock held by the NQDC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36,494)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,494)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,266,149<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">$ 5,133,742<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (10,225)<span></span>
</td>
<td class="nump">$ 10,239<span></span>
</td>
<td class="num">$ (867,791)<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The beginning balances for the nine-month periods were derived from the audited Consolidated Financial Statements included in Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Shares Held By Nonqualified Deferred Compensation Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value new issues net excess tax benefit tax deficiency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value new issues net excess tax benefit tax deficiency, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866710285912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (6,182)<span></span>
</td>
<td class="nump">$ 837,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">82,053<span></span>
</td>
<td class="nump">77,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">3,114<span></span>
</td>
<td class="nump">14,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on investments</a></td>
<td class="nump">3,279<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">153,372<span></span>
</td>
<td class="nump">142,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain on sale of nonfinancial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(59,495)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory reserves, net of stock-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(12,020)<span></span>
</td>
<td class="num">(854,199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized foreign exchange (gain) loss</a></td>
<td class="num">(1,347)<span></span>
</td>
<td class="nump">9,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Non-cash changes in the fair value of contingent consideration</a></td>
<td class="nump">6,254<span></span>
</td>
<td class="nump">1,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(1,317)<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">65,513<span></span>
</td>
<td class="num">(32,915)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(19,125)<span></span>
</td>
<td class="num">(73,310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">27,029<span></span>
</td>
<td class="nump">32,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(5,543)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(7,129)<span></span>
</td>
<td class="num">(76,174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">9,225<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">293,356<span></span>
</td>
<td class="nump">98,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(66,840)<span></span>
</td>
<td class="num">(83,286)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Maturities and sales of investments</a></td>
<td class="nump">502,112<span></span>
</td>
<td class="nump">345,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of available-for-sale securities</a></td>
<td class="num">(737,144)<span></span>
</td>
<td class="num">(369,942)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ProceedsFromSaleOfNonfinancialAssets', window );">Proceeds from sale of nonfinancial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">67,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="num">(8,026)<span></span>
</td>
<td class="num">(14,369)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable', window );">Investment in convertible note</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,709)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(994)<span></span>
</td>
<td class="num">(725)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(310,892)<span></span>
</td>
<td class="num">(64,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from exercises of awards under equity incentive plans</a></td>
<td class="nump">32,877<span></span>
</td>
<td class="nump">60,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(44,428)<span></span>
</td>
<td class="num">(42,667)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible senior subordinated note offering, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">585,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal repayments of financing leases</a></td>
<td class="num">(2,492)<span></span>
</td>
<td class="num">(6,080)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(401)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(14,444)<span></span>
</td>
<td class="nump">547,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(3,145)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(32,015)<span></span>
</td>
<td class="nump">578,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">649,158<span></span>
</td>
<td class="nump">437,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">617,143<span></span>
</td>
<td class="nump">1,015,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL CASH FLOW DISCLOSURES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">15,531<span></span>
</td>
<td class="nump">4,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">6,673<span></span>
</td>
<td class="nump">5,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>SUPPLEMENTAL CASH FLOW DISCLOSURES FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets', window );">Decrease in accounts payable and accrued liabilities related to fixed assets</a></td>
<td class="num">(7,690)<span></span>
</td>
<td class="num">(13,281)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets', window );">Increase (decrease) in accounts payable and accrued liabilities related to intangible assets</a></td>
<td class="nump">$ 9,389<span></span>
</td>
<td class="num">$ (3,043)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Debt Securities, Available-For-Sale, Non-Marketable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ProceedsFromSaleOfNonfinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Nonfinancial Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ProceedsFromSaleOfNonfinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in accounts payable and accrued liabilities related to purchase of property, plant and equipment during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Accounts Payable And Accrued Liabilities Increase (Decrease), Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866702194744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">NATURE OF OPERATIONS</a></td>
<td class="text">NATURE OF OPERATIONS<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">BioMarin Pharmaceutical Inc. (the Company) is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions. The Company selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market or offer a significant benefit over existing products. The Company&#8217;s portfolio consists of several commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. Voxzogo (formerly known as vosoritide) was granted marketing approval in the European Union (EU) on August 27, 2021.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company expects to continue to finance future cash needs that exceed its operating activities primarily through its current cash, cash equivalents and investments and through proceeds from debt or equity offerings, commercial borrowing, or through collaborative agreements with corporate partners. If the Company elects to increase its spending on development programs significantly above current long-term plans or enters into potential licenses and other acquisitions of complementary technologies, products or companies, the Company may need additional capital.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866701935592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">BASIS OF PRESENTATION</a></td>
<td class="text">BASIS OF PRESENTATION<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements have been prepared pursuant to United States generally accepted accounting principles (U.S. GAAP) and the rules and regulations of the Securities and Exchange Commission (the SEC) for Quarterly Reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, although the Company believes that the disclosures herein are adequate to ensure that the information presented is not misleading. The Condensed Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended December&#160;31, 2020 included in the Company&#8217;s Annual Report on Form 10-K. The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions have been eliminated. The results of operations for the three and nine months ended September&#160;30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending December&#160;31, 2021 or any other period.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying disclosures. Although these estimates are based on management&#8217;s best knowledge of current events and actions that the Company may undertake in the future, actual results may be different from those estimates. The Condensed Consolidated Financial Statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair presentation of results for these interim periods. The full extent to which the novel coronavirus (referred to as COVID-19) pandemic could continue to directly or indirectly impact the Company&#8217;s business, results of operations and financial condition, including revenues, expenses, reserves and allowances, manufacturing, clinical trials and research and development costs, will depend on future developments that remain uncertain at this time, particularly as virus variants continue to spread. As events continue to evolve and additional information becomes available, the Company&#8217;s estimates may change materially in future periods.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management performed an evaluation of the Company&#8217;s activities through the date of filing of this Quarterly Report on Form 10-Q, and has concluded that there were no subsequent events or transactions that occurred subsequent to the balance sheet date prior to filing this Quarterly Report on Form 10-Q that would require recognition or disclosure in the Condensed Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866705864056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no material changes to the Company&#8217;s significant accounting policies during the nine months ended September&#160;30, 2021, as compared to the significant accounting policies disclosed in Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866704218360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text">RECENT ACCOUNTING PRONOUNCEMENTSThere have been no new accounting pronouncements adopted by the Company or new accounting pronouncements issued by the Financial Accounting Standards Board during the nine months ended September&#160;30, 2021, as compared to the recent accounting pronouncements described in Note 4 of the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, that the Company believes are of significance or potential significance to the Company.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866705864056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities were classified as available-for-sale at September&#160;30, 2021 and December&#160;31, 2020.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s cash, cash equivalents and available-for-sale securities by significant investment category for each period presented:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.851%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Short-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">560,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">561,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,251,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">322,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,544,506&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">617,143&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462,333&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,618&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.851%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Short-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975,476&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">980,534&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">278,833&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,473&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,345,801&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,350,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649,158&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,228&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,473&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Company&#8217;s short-term marketable securities mature in one year or less.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The Company&#8217;s long-term marketable securities mature between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_846ad3c9-24f9-4d1a-9f5f-7c49adee4aad"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_a635e30b-c744-47ea-a80a-981c71554d83">one</span></span> and five years.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company had the ability and intent to hold all investments that were in an unrealized loss position until maturity. The Company considered its intent and ability to hold the securities until recovery of amortized cost basis, the extent to which fair value is less than amortized cost basis, conditions specifically related to the security&#8217;s industry and geography, payment structure and history and changes to the ratings (if any) in determining that the decline in fair value compared to carrying value is not related to a credit loss.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has certain investments in non-marketable equity securities, measured using unobservable valuation inputs and remeasured on a nonrecurring basis, which are collectively considered strategic investments. As of September&#160;30, 2021 and </span></div>December&#160;31, 2020, the fair value of the Company&#8217;s strategic investments was $16.3 million and $10.5 million, respectively. These investments were recorded in Other Assets in the Company&#8217;s Condensed Consolidated Balance Sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707447656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">SUPPLEMENTAL BALANCE SHEET INFORMATION</a></td>
<td class="text">SUPPLEMENTAL BALANCE SHEET INFORMATION<div style="margin-bottom:12pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventory consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,328&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,673&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412,434&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,644&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,589&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">749,406&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698,548&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventory as of September&#160;30, 2021 included $4.8 million of Voxzogo pre-launch manufacturing-related costs incurred during the third quarter of 2021 that are intended for the U.S. Voxzogo, which was granted marketing approval in the EU on August 27, 2021, is still a product candidate in other regions, including the U.S., for the treatment of achondroplasia in children, the most common form of disproportionate short stature in humans. The Company must receive marketing approval from the U.S. Food and Drug Administration (FDA) before the Voxzogo inventory can be sold commercially in the U.S. Starting in 2021, the Company believed that material uncertainties related to the ultimate regulatory approval of Voxzogo had been significantly reduced. A number of factors were taken into consideration, including the current status in the drug development process, pivotal clinical trial results for the underlying product candidate, results from meetings with the relevant regulatory authorities, historical experience, as well as potential impediments to the approval process such as product safety or efficacy, as well as commercialization and marketplace trends.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020 for additional information related to the Company&#8217;s policies on inventory produced prior to regulatory approval.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, Plant and Equipment, Net consisted of the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, gross</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,724,702&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,668,066&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(699,915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(635,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,024,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,032,471&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation expense, net of amounts capitalized into inventory, for the three and nine months ended September&#160;30, 2021 was $11.4 million and $35.7 million, respectively. Depreciation expense, net of amounts capitalized into inventory, for the three and nine months ended September&#160;30, 2020 was $11.1 million and $31.1 million, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible Assets, Net consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finite-lived intangible assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">661,781&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644,087&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(273,294)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(226,816)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying value</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388,487&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417,271&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts Payable and Accrued Liabilities consisted of the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued rebates payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued royalties payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward foreign currency exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value added taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,548&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866704225000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value in accordance with the policy described in Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables present the classification within the fair value hierarchy of financial assets and liabilities not disclosed elsewhere in these Condensed Consolidated Financial Statements that are remeasured on a recurring basis as of September&#160;30, 2021 and December&#160;31, 2020.&#160;Other than the Company&#8217;s fixed-rate convertible debt disclosed in Note 9 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, there were no financial assets or liabilities that were remeasured using a quoted price in active markets for identical assets (Level 1) as of September&#160;30, 2021 or December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements as of September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant&#160;Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.917%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant&#160;Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,377&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,507&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The restricted investments at September&#160;30, 2021 and December&#160;31, 2020 secure the Company's irrevocable standby letters of credit obtained in connection with certain commercial agreements.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no transfers between levels during the three and nine months ended September&#160;30, 2021.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Liabilities measured at fair value using Level 3 inputs primarily consisted of contingent consideration. The following tables represent a roll-forward of contingent consideration.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange remeasurement of Euro denominated contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866703662840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIESThe Company uses foreign currency exchange forward contracts (forward contracts) to protect against the reduction in value of forecasted foreign currency cash flows resulting from product revenues, royalty revenues and operating expenses denominated in currencies other than the U.S. Dollar (USD), primarily the Euro. Certain of these forward contracts are designated as cash flows hedges and have maturities of up to two years. The Company also enters into forward contracts to manage foreign exchange risk related to asset or liability positions denominated in currencies other than USD. Such forward contracts are considered to be economic hedges, are not designated as hedging instruments and have maturities of up to three months. The Company does not use derivative instruments for speculative trading purposes. The Company is exposed to counterparty credit risk on its derivatives. The Company has established and maintains strict counterparty credit guidelines and enters into hedging <div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">agreements with financial institutions that are investment grade or better to minimize the Company&#8217;s exposure to potential defaults. The Company is not required to pledge collateral under these agreements.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the aggregate notional amounts for the Company&#8217;s derivatives outstanding as of the periods presented.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sell</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">782,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sell</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value carrying amounts of the Company&#8217;s derivatives, as classified within the fair value hierarchy, were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#160;current&#160;assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts&#160;payable&#160;and accrued&#160;liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,743&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#160;current&#160;assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts&#160;payable&#160;and accrued&#160;liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Derivatives Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Derivatives Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,809&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,818&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;For additional discussion of fair value measurements, see Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables summarize the impact of gains and losses from the Company's derivatives on its Condensed Consolidated Statements of Comprehensive Income (Loss) for the periods presented.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues as reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses as reported</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">461,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">532,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(815)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues as reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,348,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,368,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses as reported</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,412,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,400,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt;text-indent:45pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company expects to reclassify unrealized gains of $6.2 million from Accumulated Other Comprehensive Income (AOCI) to earnings as the forecasted revenues and operating expense transactions occur over the next 12 months. For additional discussion of balances in AOCI see Note 10 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866701963864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company had outstanding fixed-rate notes with varying maturities for an undiscounted aggregate principal amount of $1.1 billion (collectively the Notes). The Notes are senior subordinated convertible obligations, and interest is payable in arrears, semi-annually. The following table summarizes information regarding the Company&#8217;s convertible debt:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.25% senior subordinated convertible notes due in May 2027 (the 2027 Notes)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount net of deferred offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 Notes, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588,522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.599% senior subordinated convertible notes due in August 2024 (the 2024 Notes)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount net of deferred offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Notes, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total convertible debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,075,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value of fixed rate convertible debt </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 Notes</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">510,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value of fixed rate convertible debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,111,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,157,804&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The fair value of the Company&#8217;s fixed-rate convertible debt is based on open market trades and is classified as Level 1 in the fair value hierarchy. For additional discussion of fair value measurements, see Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense on the Company&#8217;s convertible debt consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.672%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Coupon interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accretion of discount on convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total interest expense on convertible debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,486&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,797&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,209&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 13 - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 for additional information related to the Company&#8217;s convertible debt.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Facility</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2018, the Company entered into an unsecured revolving credit facility of up to $200.0&#160;million which includes a letter of credit subfacility and a swingline loan subfacility. The credit facility is intended to finance ongoing working capital needs and for other general corporate purposes. In May 2021, the Company entered into an amendment agreement in respect of the credit facility, extending the maturity date from October 19, 2021 to May 28, 2024, among other changes. The amended credit facility contains financial covenants including a maximum leverage ratio and a minimum interest coverage ratio. As of September&#160;30, 2021, there were no amounts outstanding under the credit facility and the Company and certain of its subsidiaries that serve as guarantors were in compliance with all covenants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866703597816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables summarize changes in the accumulated balances for each component of Accumulated Other Comprehensive Income (Loss) (AOCI), including current-period other comprehensive income (loss) and reclassifications out of AOCI, for the periods presented.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,760)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(939)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,128&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(603)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,239&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.991%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,094)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,201)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,295)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,972)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,665)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,991&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,394&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,028)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,139)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,470)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,671)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,239&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,379&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,798&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,779)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,991&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,394&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For additional discussion of reclassifications from AOCI see Note 8 &#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Derivative Instruments and Hedging Strategies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866702252424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ConcentrationRiskAndGeographicInformationAbstract', window );"><strong>Concentration Risk And Geographic Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock', window );">REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION</a></td>
<td class="text">REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates in one business segment, which primarily focuses on the development and commercialization of innovative therapies for people with serious and life-threatening rare diseases and medical conditions. The Company considers there to be revenue concentration risks for regions where Net Product Revenues exceed 10% of consolidated Net Product Revenues. The concentration of the Company&#8217;s Net Product Revenues within the regions below may have a material adverse effect on the Company&#8217;s revenues and results of operations if sales in the respective regions experience difficulties.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table disaggregates Total Revenues from external customers and collaborative partners by geographic region. Net product revenues by geographic region are based on patient location for the Company&#8217;s commercial products, except for Aldurazyme, which is sold exclusively to Sanofi Genzyme (Genzyme) who markets and sells Aldurazyme worldwide. Aldurazyme revenues earned by the Company are included in the U.S. region as the transactions are with Genzyme, whose headquarters is located in the U.S.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues by geographic region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">252,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">608,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">729,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408,742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">476,784&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396,465&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,408,338&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table disaggregates total Net Product Revenues by product.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues by product:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vimizim</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Naglazyme</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kuvan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palynziq</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brineura</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voxzogo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Firdapse</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues marketed by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,245,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,239,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldurazyme net product revenues marketed by Genzyme</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,741&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,348,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,368,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The table below disaggregates total Net Product Revenues based on patient location for products sold directly by the Company, and global sales of Aldurazyme, which is marketed by Genzyme.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">424,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues marketed by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,245,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,239,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldurazyme net product revenues marketed by Genzyme</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,741&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,348,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,368,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table illustrates the percentage of the Company&#8217;s total Net Product Revenues attributed to the Company&#8217;s largest customers for the periods presented.&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On a consolidated basis, two customers accounted for 31% and 14% of the Company&#8217;s September&#160;30, 2021 accounts receivable balance, respectively, compared to December&#160;31, 2020, when two customers accounted for 24% and 22% of the accounts receivable balance, respectively. As of September&#160;30, 2021, and December&#160;31, 2020, the accounts receivable balance for Genzyme included $83.9 million and $72.1 million, respectively, of unbilled accounts receivable, which becomes payable to the Company when the product is sold through by Genzyme. The Company does not require collateral from its customers, but does perform periodic credit evaluations of its customers&#8217; financial condition and requires prepayments in certain circumstances.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to affect economies and business around the world. The Company&#8217;s global revenue sources, mostly in the form of demand interruptions such as missed patient infusions and delayed treatment starts for new patients, and its business operations were impacted by the COVID-19 pandemic during the nine months ended September&#160;30, 2021 and 2020, and the Company anticipates a continued impact due to COVID-19 on its financial results in the remainder of 2021. The extent and duration of such effects remain uncertain and difficult to predict, particularly as virus variants continue to spread. The Company is actively monitoring and managing its response and assessing actual and potential impacts to its operating results and financial condition, as well as developments in its business, which could further impact developments, trends and expectations. See the risk factor related to the impact of the coronavirus pandemic, &#8220;The COVID-19 pandemic could continue to materially adversely affect our business, results of operations and financial condition.&#8221; described in &#8220;Risk Factors&#8221; in Part II, Item&#160;1A of this Quarterly Report, for additional details on the impact of the COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is mindful that conditions in the current macroeconomic environment could affect the Company&#8217;s ability to achieve its goals. The Company sells its products in countries that face economic volatility and weakness. Although the Company has historically collected receivables from customers in certain countries, sustained weakness or further deterioration of the local economies and currencies and effects of the impact of the ongoing COVID-19 pandemic may cause customers in those countries to delay payment or be unable to pay for the Company&#8217;s products. The Company believes that the allowances for doubtful accounts related to these countries, if any, are adequate based on its analysis of the specific business circumstances and expectations of collection for each of the underlying accounts in these countries. The Company will continue to monitor these conditions and will attempt to adjust its business processes, as appropriate, to mitigate macroeconomic risks to its business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ConcentrationRiskAndGeographicInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration risk and geographic information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ConcentrationRiskAndGeographicInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration risk and segment reporting disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866702243144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATIONThe Company has stockholder-approved equity incentive plans that provide for the granting of service-based restricted stock units (RSUs), market-based RSUs, performance-based RSUs, stock options and other types of awards to its employees, <div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">officers and non-employee directors. Compensation expense included in the Company&#8217;s Condensed Consolidated Statements of Comprehensive Income (Loss) for all stock-based compensation arrangements was as follows:&#160;</span></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,026&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,372&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,125&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866701964984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER COMMON SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME (LOSS) PER COMMON SHARE</a></td>
<td class="text">NET INCOME (LOSS) PER COMMON SHARE<div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Potentially issuable shares of common stock include shares issuable upon the exercise of outstanding employee stock option awards, common stock issuable under the Company&#8217;s Employee Share Purchase Plan (ESPP), unvested RSUs, the Company&#8217;s common stock held by the NQDC and contingent issuances of common stock related to the Company&#8217;s convertible debt.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per common share (common shares in thousands):</span></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (loss), basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">837,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Interest on convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (loss), diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,494)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">791,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,182)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">855,334&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding, basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2020 notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2024 notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2027 notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock potentially issuable for ESPP purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Company&#8217;s common stock held by the NQDC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding, diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) per common share, basic</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) per common share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the equity instruments included in the table above, the table below presents potential shares of common stock that were excluded from the computation of basic and diluted income (loss) per common share as they were anti-dilutive (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.503%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.536%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2024 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2027 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock potentially issuable for ESPP purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Company&#8217;s common stock held by the NQDC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total number of potentially issuable shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,055&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,055&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company&#8217;s 1.50% senior subordinated convertible notes due in October 2020 (the 2020 Notes) matured on October 15, 2020 and were settled in cash. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The potential effect of the capped call transactions and potential shares issuable under the 2020 Notes were excluded from the calculation of diluted net income (loss) per share in the three and nine months ended September&#160;30, 2020, as the Company&#8217;s closing price on September&#160;30, 2020 did not exceed the conversion price of $94.15 per share. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There is no similar capped call transaction associated with the 2024 Notes or the 2027 Notes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866703473528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time the Company is involved in legal actions arising in the normal course of its business. The process of</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">resolving matters through litigation or other means is inherently uncertain and it is possible that an unfavorable resolution of these</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">matters could adversely affect the Company, its results of operations, financial condition or cash flows. The Company&#8217;s general</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">practice is to expense legal fees as services are rendered in connection with legal matters, and to accrue for liabilities when losses are probable and reasonably estimable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contingent Payments</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company was subject to contingent payments totaling approximately $708.8 million upon achievement of certain development and regulatory activities and commercial sales milestones if they occur before certain dates in the future. Of this amount, $70.0 million were considered probable and comprised of commercial milestones related to the acquisition of certain rights and other assets with respect to Kuvan and Palynziq from a third party, $405.5 million were considered reasonably possible and primarily related to development milestones and $233.3 million were considered remote as the Company is no longer developing the related programs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the fair value of contingent liabilities recorded on the Company&#8217;s Condensed Consolidated Balance Sheet was $63.4 million of which $48.2 million was short term. See Note 7 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to these Condensed Consolidated Financial Statements for further information regarding the fair value of the Company&#8217;s contingent consideration. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses experts and laboratories at universities and other institutions to perform certain research and development (R&amp;D) activities. These amounts are included as R&amp;D expense as services are provided. In the normal course of business, the Company enters into various firm purchase commitments primarily related to active pharmaceutical ingredients, certain inventory-related items and certain third-party R&amp;D services. As of September&#160;30, 2021, such commitments and other minimum contractual obligations for clinical and post-marketing services were estimated at approximately $107.7 million. The Company has also licensed technology, for which it is required to pay royalties upon future sales, subject to certain annual minimums.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866703589976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements have been prepared pursuant to United States generally accepted accounting principles (U.S. GAAP) and the rules and regulations of the Securities and Exchange Commission (the SEC) for Quarterly Reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, although the Company believes that the disclosures herein are adequate to ensure that the information presented is not misleading. The Condensed Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended December&#160;31, 2020 included in the Company&#8217;s Annual Report on Form 10-K. The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions have been eliminated. The results of operations for the three and nine months ended September&#160;30, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending December&#160;31, 2021 or any other period.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying disclosures. Although these estimates are based on management&#8217;s best knowledge of current events and actions that the Company may undertake in the future, actual results may be different from those estimates. The Condensed Consolidated Financial Statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair presentation of results for these interim periods. The full extent to which the novel coronavirus (referred to as COVID-19) pandemic could continue to directly or indirectly impact the Company&#8217;s business, results of operations and financial condition, including revenues, expenses, reserves and allowances, manufacturing, clinical trials and research and development costs, will depend on future developments that remain uncertain at this time, particularly as virus variants continue to spread. As events continue to evolve and additional information becomes available, the Company&#8217;s estimates may change materially in future periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866701964984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock', window );">Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s cash, cash equivalents and available-for-sale securities by significant investment category for each period presented:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.851%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Short-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">560,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">561,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,251,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">322,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,544,506&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,546,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">617,143&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462,333&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,618&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:20.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.851%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Short-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975,476&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">980,534&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">278,833&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,473&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,345,801&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,350,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649,158&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,228&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285,473&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Company&#8217;s short-term marketable securities mature in one year or less.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The Company&#8217;s long-term marketable securities mature between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_846ad3c9-24f9-4d1a-9f5f-7c49adee4aad"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM3NTU1Y2U0M2Y3MjQ0ZDNhZmEyMzFhMmE1MGU3NDIzL3NlYzozNzU1NWNlNDNmNzI0NGQzYWZhMjMxYTJhNTBlNzQyM180Ni9mcmFnOjg2NTFkMDQyYWE0NDRhNWE4NzE1MzdiNmNiNDgwMWZiL3RleHRyZWdpb246ODY1MWQwNDJhYTQ0NGE1YTg3MTUzN2I2Y2I0ODAxZmJfNDEw_a635e30b-c744-47ea-a80a-981c71554d83">one</span></span> and five years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of cash, cash equivalents and available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866796996792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventory consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,328&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,673&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412,434&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,644&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,589&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">749,406&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698,548&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property Plant and Equipment Net</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, Plant and Equipment, Net consisted of the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, gross</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,724,702&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,668,066&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(699,915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(635,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,024,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,032,471&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text">Intangible Assets, Net consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finite-lived intangible assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">661,781&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644,087&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Accumulated amortization</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(273,294)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(226,816)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying value</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388,487&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417,271&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts Payable and Accrued Liabilities consisted of the following:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued rebates payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued royalties payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward foreign currency exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value added taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,548&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866703453080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value of Financial Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables present the classification within the fair value hierarchy of financial assets and liabilities not disclosed elsewhere in these Condensed Consolidated Financial Statements that are remeasured on a recurring basis as of September&#160;30, 2021 and December&#160;31, 2020.&#160;Other than the Company&#8217;s fixed-rate convertible debt disclosed in Note 9 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, there were no financial assets or liabilities that were remeasured using a quoted price in active markets for identical assets (Level 1) as of September&#160;30, 2021 or December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements as of September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant&#160;Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.917%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant&#160;Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted investments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,864&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NQDC Plan liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,377&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,507&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The restricted investments at September&#160;30, 2021 and December&#160;31, 2020 secure the Company's irrevocable standby letters of credit obtained in connection with certain commercial agreements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs</a></td>
<td class="text">Liabilities measured at fair value using Level 3 inputs primarily consisted of contingent consideration. The following tables represent a roll-forward of contingent consideration.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in the fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange remeasurement of Euro denominated contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration as of September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707332824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Fair Value Carrying Amount of Derivatives</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value carrying amounts of the Company&#8217;s derivatives, as classified within the fair value hierarchy, were as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#160;current&#160;assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts&#160;payable&#160;and accrued&#160;liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#160;long-term&#160;liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,743&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,571&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other&#160;current&#160;assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability Derivatives - Level 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts&#160;payable&#160;and accrued&#160;liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Derivatives Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Derivatives Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,809&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,818&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;For additional discussion of fair value measurements, see Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Summary of Impact of Gains and Losses from Derivatives Designated as Hedging Instruments</a></td>
<td class="text">The following tables summarize the impact of gains and losses from the Company's derivatives on its Condensed Consolidated Statements of Comprehensive Income (Loss) for the periods presented.<div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues as reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses as reported</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">461,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">532,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(815)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Hedging Gains (Losses) <br/>Reclassified into Earnings</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues as reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,348,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,368,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses as reported</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,412,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,400,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gains (Losses) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated As Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock', window );">Summary of Derivatives Designated as Hedging Instruments Outstanding</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the aggregate notional amounts for the Company&#8217;s derivatives outstanding as of the periods presented.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sell</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">654,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">782,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sell</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866702223896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Summary of Convertible Debt</a></td>
<td class="text">The following table summarizes information regarding the Company&#8217;s convertible debt:<div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.25% senior subordinated convertible notes due in May 2027 (the 2027 Notes)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount net of deferred offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 Notes, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588,522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.599% senior subordinated convertible notes due in August 2024 (the 2024 Notes)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount net of deferred offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Notes, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total convertible debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,075,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value of fixed rate convertible debt </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 Notes</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">510,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value of fixed rate convertible debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,111,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,157,804&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The fair value of the Company&#8217;s fixed-rate convertible debt is based on open market trades and is classified as Level 1 in the fair value hierarchy. For additional discussion of fair value measurements, see Note 3 &#8211; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Summary of Interest Expense on Debt</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense on the Company&#8217;s convertible debt consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.670%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.672%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Coupon interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accretion of discount on convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total interest expense on convertible debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,486&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,797&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,209&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866703774376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Summary of Changes in Accumulated Balances of AOCI Including Current Period Other Comprehensive Income (Loss) and Reclassifications Out of AOCI</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables summarize changes in the accumulated balances for each component of Accumulated Other Comprehensive Income (Loss) (AOCI), including current-period other comprehensive income (loss) and reclassifications out of AOCI, for the periods presented.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,760)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(939)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,128&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(603)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,239&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.991%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,094)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,201)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,295)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,972)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,665)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,991&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,394&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,028)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,139)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,470)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,671)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,239&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on Cash<br/>Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses) on<br/>Available for-Sale<br/>Debt Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>&#160;&#160;&#160;&#160; reclassifications</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,379&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,798&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: gain (loss) reclassified from AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,779)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AOCI balance at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,991&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,394&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,385&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866704095448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ConcentrationRiskAndGeographicInformationAbstract', window );"><strong>Concentration Risk And Geographic Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Total Revenues from External Customers and Collaborative Partners by Geographic Region</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table disaggregates Total Revenues from external customers and collaborative partners by geographic region. Net product revenues by geographic region are based on patient location for the Company&#8217;s commercial products, except for Aldurazyme, which is sold exclusively to Sanofi Genzyme (Genzyme) who markets and sells Aldurazyme worldwide. Aldurazyme revenues earned by the Company are included in the U.S. region as the transactions are with Genzyme, whose headquarters is located in the U.S.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues by geographic region:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">252,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">608,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">729,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408,742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">476,784&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396,465&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,408,338&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of Net Product Revenues by Product</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table disaggregates total Net Product Revenues by product.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net product revenues by product:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vimizim</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Naglazyme</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kuvan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palynziq</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brineura</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Voxzogo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Firdapse</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues marketed by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,245,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,239,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldurazyme net product revenues marketed by Genzyme</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,741&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,348,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,368,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Total Net Product Revenues Based on Patient Location</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The table below disaggregates total Net Product Revenues based on patient location for products sold directly by the Company, and global sales of Aldurazyme, which is marketed by Genzyme.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">424,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues marketed by the Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">419,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,245,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,239,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aldurazyme net product revenues marketed by Genzyme</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total net product revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,741&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,348,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,368,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Net Product Revenue Concentrations Attributed to Largest Customers</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table illustrates the percentage of the Company&#8217;s total Net Product Revenues attributed to the Company&#8217;s largest customers for the periods presented.&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ConcentrationRiskAndGeographicInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration risk and geographic information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ConcentrationRiskAndGeographicInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866702191016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text">Compensation expense included in the Company&#8217;s Condensed Consolidated Statements of Comprehensive Income (Loss) for all stock-based compensation arrangements was as follows:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,026&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,372&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,125&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866702194744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER COMMON SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per common share (common shares in thousands):</span></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.392%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (loss), basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">837,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Interest on convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income (loss), diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,494)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">791,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,182)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">855,334&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding, basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2020 notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2024 notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2027 notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock potentially issuable for ESPP purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Company&#8217;s common stock held by the NQDC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding, diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) per common share, basic</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) per common share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the equity instruments included in the table above, the table below presents potential shares of common stock that were excluded from the computation of basic and diluted income (loss) per common share as they were anti-dilutive (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.503%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.536%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2024 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the 2027 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock potentially issuable for ESPP purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Company&#8217;s common stock held by the NQDC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total number of potentially issuable shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,055&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,055&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866706000520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 1,544,506<span></span>
</td>
<td class="nump">$ 1,345,801<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1,823<span></span>
</td>
<td class="nump">5,069<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(235)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">1,546,094<span></span>
</td>
<td class="nump">1,350,859<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">617,143<span></span>
</td>
<td class="nump">649,158<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term Marketable Securities</a></td>
<td class="nump">462,333<span></span>
</td>
<td class="nump">416,228<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Marketable Securities</a></td>
<td class="nump">466,618<span></span>
</td>
<td class="nump">285,473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1: | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">294,209<span></span>
</td>
<td class="nump">370,325<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">294,209<span></span>
</td>
<td class="nump">370,325<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">294,209<span></span>
</td>
<td class="nump">370,325<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,250,297<span></span>
</td>
<td class="nump">975,476<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1,823<span></span>
</td>
<td class="nump">5,069<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(235)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">1,251,885<span></span>
</td>
<td class="nump">980,534<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">322,934<span></span>
</td>
<td class="nump">278,833<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term Marketable Securities</a></td>
<td class="nump">462,333<span></span>
</td>
<td class="nump">416,228<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Marketable Securities</a></td>
<td class="nump">466,618<span></span>
</td>
<td class="nump">285,473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Money market instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">291,735<span></span>
</td>
<td class="nump">264,833<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">291,735<span></span>
</td>
<td class="nump">264,833<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">291,735<span></span>
</td>
<td class="nump">264,833<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">560,004<span></span>
</td>
<td class="nump">413,137<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1,230<span></span>
</td>
<td class="nump">3,261<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(198)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">561,036<span></span>
</td>
<td class="nump">416,390<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">703<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term Marketable Securities</a></td>
<td class="nump">177,468<span></span>
</td>
<td class="nump">220,551<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Marketable Securities</a></td>
<td class="nump">382,865<span></span>
</td>
<td class="nump">195,839<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">210,444<span></span>
</td>
<td class="nump">265,298<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">416<span></span>
</td>
<td class="nump">1,555<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">210,853<span></span>
</td>
<td class="nump">266,852<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">12,999<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term Marketable Securities</a></td>
<td class="nump">161,207<span></span>
</td>
<td class="nump">192,488<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Marketable Securities</a></td>
<td class="nump">36,647<span></span>
</td>
<td class="nump">60,364<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">129,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">129,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">17,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term Marketable Securities</a></td>
<td class="nump">112,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">55,182<span></span>
</td>
<td class="nump">31,659<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">55,185<span></span>
</td>
<td class="nump">31,742<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term Marketable Securities</a></td>
<td class="nump">8,272<span></span>
</td>
<td class="nump">3,189<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Marketable Securities</a></td>
<td class="nump">46,913<span></span>
</td>
<td class="nump">28,553<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Foreign and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">3,114<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair Value</a></td>
<td class="nump">3,258<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term Marketable Securities</a></td>
<td class="nump">3,065<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term Marketable Securities</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 717<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_LongTermMarketableSecuritiesMaturityPeriod', window );">Long term marketable securities maturity period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ShortTermMarketableSecuritiesMaturityPeriod', window );">Short term marketable securities maturity period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_LongTermMarketableSecuritiesMaturityPeriod', window );">Long term marketable securities maturity period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_LongTermMarketableSecuritiesMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term marketable securities maturity period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_LongTermMarketableSecuritiesMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of cash, cash equivalents and available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ShortTermMarketableSecuritiesMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-term marketable securities maturity period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ShortTermMarketableSecuritiesMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866703727848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=bmrn_StrategicInvestmentMember', window );">Strategic Investment | Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Strategic investments fair value</a></td>
<td class="nump">$ 16.3<span></span>
</td>
<td class="nump">$ 10.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of cash, cash equivalents and available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bmrn_StrategicInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bmrn_StrategicInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866706811320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Schedule of Inventory (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 75,328<span></span>
</td>
<td class="nump">$ 76,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">412,434<span></span>
</td>
<td class="nump">308,286<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">261,644<span></span>
</td>
<td class="nump">313,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 749,406<span></span>
</td>
<td class="nump">$ 698,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866706488632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 749,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 749,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">$ 698,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense, net of amounts capitalized into inventory</a></td>
<td class="nump">11,400<span></span>
</td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="nump">35,700<span></span>
</td>
<td class="nump">$ 31,100<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=bmrn_VoxzogoMember', window );">Voxzogo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=bmrn_VoxzogoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=bmrn_VoxzogoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866703583880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 1,724,702<span></span>
</td>
<td class="nump">$ 1,668,066<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(699,915)<span></span>
</td>
<td class="num">(635,595)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 1,024,787<span></span>
</td>
<td class="nump">$ 1,032,471<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707329336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets</a></td>
<td class="nump">$ 661,781<span></span>
</td>
<td class="nump">$ 644,087<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(273,294)<span></span>
</td>
<td class="num">(226,816)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying value</a></td>
<td class="nump">$ 388,487<span></span>
</td>
<td class="nump">$ 417,271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866706696728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Schedule of Accounts Payable and Accrued Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued operating expenses</a></td>
<td class="nump">$ 203,321<span></span>
</td>
<td class="nump">$ 191,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation expense</a></td>
<td class="nump">158,130<span></span>
</td>
<td class="nump">165,023<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_AccruedGovernmentAndOtherRebates', window );">Accrued rebates payable</a></td>
<td class="nump">68,329<span></span>
</td>
<td class="nump">65,526<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued royalties payable</a></td>
<td class="nump">14,512<span></span>
</td>
<td class="nump">17,155<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Forward foreign currency exchange contracts</a></td>
<td class="nump">5,323<span></span>
</td>
<td class="nump">17,798<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">9,659<span></span>
</td>
<td class="nump">11,754<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Value added taxes payable</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">9,562<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxes', window );">Accrued income taxes</a></td>
<td class="nump">564<span></span>
</td>
<td class="nump">9,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Other</a></td>
<td class="nump">5,461<span></span>
</td>
<td class="nump">4,640<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 466,711<span></span>
</td>
<td class="nump">$ 492,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_AccruedGovernmentAndOtherRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Government And Other Rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_AccruedGovernmentAndOtherRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due.  This amount is the total of current and noncurrent accrued income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866710563848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Price&#160;in Active Markets For Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Financial assets remeasured</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Liabilities remeasured</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure', window );">Fair value of other non-current assets</a></td>
<td class="nump">25,356,000<span></span>
</td>
<td class="nump">24,449,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets, Total</a></td>
<td class="nump">27,445,000<span></span>
</td>
<td class="nump">26,864,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure', window );">Fair value of other current liabilities</a></td>
<td class="nump">50,276,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure', window );">Fair value of other non-current liabilities</a></td>
<td class="nump">37,725,000<span></span>
</td>
<td class="nump">80,092,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value of financial liabilities, Total</a></td>
<td class="nump">88,001,000<span></span>
</td>
<td class="nump">82,507,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | NQDC Plan liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure', window );">Fair value of other current liabilities</a></td>
<td class="nump">2,089,000<span></span>
</td>
<td class="nump">2,415,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure', window );">Fair value of other non-current liabilities</a></td>
<td class="nump">22,521,000<span></span>
</td>
<td class="nump">19,962,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure', window );">Fair value of other current liabilities</a></td>
<td class="nump">48,187,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure', window );">Fair value of other non-current liabilities</a></td>
<td class="nump">15,204,000<span></span>
</td>
<td class="nump">60,130,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant&#160;Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure', window );">Fair value of other non-current assets</a></td>
<td class="nump">25,356,000<span></span>
</td>
<td class="nump">24,449,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets, Total</a></td>
<td class="nump">27,445,000<span></span>
</td>
<td class="nump">26,864,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure', window );">Fair value of other current liabilities</a></td>
<td class="nump">2,089,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure', window );">Fair value of other non-current liabilities</a></td>
<td class="nump">22,521,000<span></span>
</td>
<td class="nump">19,962,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value of financial liabilities, Total</a></td>
<td class="nump">24,610,000<span></span>
</td>
<td class="nump">22,377,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant&#160;Other Observable Inputs (Level 2) | NQDC Plan liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure', window );">Fair value of other current liabilities</a></td>
<td class="nump">2,089,000<span></span>
</td>
<td class="nump">2,415,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure', window );">Fair value of other non-current liabilities</a></td>
<td class="nump">22,521,000<span></span>
</td>
<td class="nump">19,962,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant&#160;Other Observable Inputs (Level 2) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure', window );">Fair value of other current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure', window );">Fair value of other non-current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure', window );">Fair value of other non-current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets, Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure', window );">Fair value of other current liabilities</a></td>
<td class="nump">48,187,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure', window );">Fair value of other non-current liabilities</a></td>
<td class="nump">15,204,000<span></span>
</td>
<td class="nump">60,130,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value of financial liabilities, Total</a></td>
<td class="nump">63,391,000<span></span>
</td>
<td class="nump">60,130,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level&#160;3) | NQDC Plan liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure', window );">Fair value of other current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure', window );">Fair value of other non-current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level&#160;3) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure', window );">Fair value of other current liabilities</a></td>
<td class="nump">48,187,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure', window );">Fair value of other non-current liabilities</a></td>
<td class="nump">15,204,000<span></span>
</td>
<td class="nump">60,130,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | NQDC Plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsCurrentFairValueDisclosure', window );">Fair value of other current assets</a></td>
<td class="nump">2,089,000<span></span>
</td>
<td class="nump">2,415,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure', window );">Fair value of other non-current assets</a></td>
<td class="nump">22,521,000<span></span>
</td>
<td class="nump">19,962,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | NQDC Plan assets | Significant&#160;Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsCurrentFairValueDisclosure', window );">Fair value of other current assets</a></td>
<td class="nump">2,089,000<span></span>
</td>
<td class="nump">2,415,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure', window );">Fair value of other non-current assets</a></td>
<td class="nump">22,521,000<span></span>
</td>
<td class="nump">19,962,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | NQDC Plan assets | Significant Unobservable Inputs (Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsCurrentFairValueDisclosure', window );">Fair value of other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure', window );">Fair value of other non-current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Restricted Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure', window );">Fair value of other non-current assets</a></td>
<td class="nump">2,835,000<span></span>
</td>
<td class="nump">4,487,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Restricted Investments | Significant&#160;Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure', window );">Fair value of other non-current assets</a></td>
<td class="nump">2,835,000<span></span>
</td>
<td class="nump">4,487,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Restricted Investments | Significant Unobservable Inputs (Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure', window );">Fair value of other non-current assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_OtherAssetsCurrentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other assets current fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_OtherAssetsCurrentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_OtherAssetsNoncurrentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other assets noncurrent fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_OtherAssetsNoncurrentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_OtherLiabilitiesCurrentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other liabilities current fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_OtherLiabilitiesCurrentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other liabilities noncurrent fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=bmrn_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=bmrn_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bmrn_NonqualifiedDeferredCompensationPlanAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bmrn_NonqualifiedDeferredCompensationPlanAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=bmrn_RestrictedInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=bmrn_RestrictedInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707039896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs (Detail) - Contingent Payment<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent consideration as of December 31, 2020</a></td>
<td class="nump">$ 60,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in the fair value of contingent consideration</a></td>
<td class="nump">6,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement', window );">Foreign exchange remeasurement of Euro denominated contingent consideration</a></td>
<td class="num">(2,993)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Contingent consideration as of September 30, 2021</a></td>
<td class="nump">$ 63,391<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value measurement with unobservable inputs reconciliations recurring basis foreign exchange remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=bmrn_ContingentPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=bmrn_ContingentPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866706835576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Strategies - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Amount reclassified from AOCI to earnings as related to forecasted revenue and operating expense transactions</a></td>
<td class="nump">$ 6.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated As Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeRemainingMaturity1', window );">Maturity of derivatives</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeRemainingMaturity1', window );">Maturity of derivatives</a></td>
<td class="text">3 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeRemainingMaturity1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeRemainingMaturity1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707772664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Strategies - Summary of Derivatives Designated as and Not Designated as Hedging Instruments Outstanding (Detail) - Foreign exchange contracts - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated As Hedging Instruments | Sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 654,516<span></span>
</td>
<td class="nump">$ 782,327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated As Hedging Instruments | Purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">168,080<span></span>
</td>
<td class="nump">189,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">77,040<span></span>
</td>
<td class="nump">98,343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 37,285<span></span>
</td>
<td class="nump">$ 12,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866706239848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Strategies - Fair Value Carrying Amount of Derivatives (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">$ 16,455<span></span>
</td>
<td class="nump">$ 9,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">6,809<span></span>
</td>
<td class="nump">28,818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Derivatives Designated As Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">16,203<span></span>
</td>
<td class="nump">9,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">6,743<span></span>
</td>
<td class="nump">28,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Derivatives Designated As Hedging Instruments | Other&#160;current&#160;assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">11,883<span></span>
</td>
<td class="nump">6,268<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Derivatives Designated As Hedging Instruments | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">4,320<span></span>
</td>
<td class="nump">3,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Derivatives Designated As Hedging Instruments | Accounts&#160;payable&#160;and accrued&#160;liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">5,257<span></span>
</td>
<td class="nump">17,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Derivatives Designated As Hedging Instruments | Other&#160;long-term&#160;liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">1,486<span></span>
</td>
<td class="nump">11,020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Not Designated as Hedging Instrument | Other&#160;current&#160;assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Not Designated as Hedging Instrument | Accounts&#160;payable&#160;and accrued&#160;liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866812426472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Strategies - Summary of Impact of Gains and Losses from Derivatives Designated as Hedging Instruments (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 408,742<span></span>
</td>
<td class="nump">$ 476,784<span></span>
</td>
<td class="nump">$ 1,396,465<span></span>
</td>
<td class="nump">$ 1,408,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Operating expenses as reported</a></td>
<td class="nump">461,961<span></span>
</td>
<td class="nump">532,725<span></span>
</td>
<td class="nump">1,412,926<span></span>
</td>
<td class="nump">1,400,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gains (Losses) Recognized in Earnings</a></td>
<td class="nump">1,302<span></span>
</td>
<td class="nump">4,166<span></span>
</td>
<td class="nump">2,310<span></span>
</td>
<td class="nump">9,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember', window );">Operating expenses as reported | Derivatives Designated As Hedging Instruments | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Cash Flow Hedging Gains (Losses) Reclassified into Earnings</a></td>
<td class="num">(268)<span></span>
</td>
<td class="num">(815)<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="num">(4,274)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net product revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">393,840<span></span>
</td>
<td class="nump">460,741<span></span>
</td>
<td class="nump">1,348,279<span></span>
</td>
<td class="nump">1,368,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net product revenues | Derivatives Designated As Hedging Instruments | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Cash Flow Hedging Gains (Losses) Reclassified into Earnings</a></td>
<td class="nump">$ 401<span></span>
</td>
<td class="nump">$ 2,693<span></span>
</td>
<td class="num">$ (5,034)<span></span>
</td>
<td class="nump">$ 17,301<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866705709448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value of equity component</a></td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember', window );">The 2018 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707572888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Convertible Debt (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible notes</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible notes, net of unamortized discount and deferred offering costs</a></td>
<td class="nump">1,078,093<span></span>
</td>
<td class="nump">$ 1,075,145<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total convertible debt, net</a></td>
<td class="nump">1,078,093<span></span>
</td>
<td class="nump">1,075,145<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of fixed rate convertible debt</a></td>
<td class="nump">$ 1,111,812<span></span>
</td>
<td class="nump">$ 1,157,804<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member', window );">1.25% Senior Subordinated Convertible Notes Due in May 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Convertible notes stated rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible notes</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized discount net of deferred offering costs</a></td>
<td class="num">(11,478)<span></span>
</td>
<td class="num">(12,995)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Short-term contingent consideration</a></td>
<td class="nump">588,522<span></span>
</td>
<td class="nump">587,005<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of fixed rate convertible debt</a></td>
<td class="nump">$ 600,858<span></span>
</td>
<td class="nump">$ 627,090<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember', window );">0.599% Senior Subordinated Convertible Notes Due in August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Convertible notes stated rate</a></td>
<td class="nump">0.599%<span></span>
</td>
<td class="nump">0.599%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Convertible notes</a></td>
<td class="nump">$ 495,000<span></span>
</td>
<td class="nump">$ 495,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized discount net of deferred offering costs</a></td>
<td class="num">(5,429)<span></span>
</td>
<td class="num">(6,860)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible notes, net of unamortized discount and deferred offering costs</a></td>
<td class="nump">489,571<span></span>
</td>
<td class="nump">488,140<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Total fair value of fixed rate convertible debt</a></td>
<td class="nump">$ 510,954<span></span>
</td>
<td class="nump">$ 530,714<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707721416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Summary of Interest Expense on Convertible Debt (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfInterestExpensesLineItems', window );"><strong>Schedule Of Interest Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total interest expense on convertible debt</a></td>
<td class="nump">$ 3,870<span></span>
</td>
<td class="nump">$ 9,597<span></span>
</td>
<td class="nump">$ 11,491<span></span>
</td>
<td class="nump">$ 24,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ScheduleOfInterestExpensesLineItems', window );"><strong>Schedule Of Interest Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Coupon interest expense</a></td>
<td class="nump">2,617<span></span>
</td>
<td class="nump">4,255<span></span>
</td>
<td class="nump">7,849<span></span>
</td>
<td class="nump">9,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of discount on convertible notes</a></td>
<td class="nump">835<span></span>
</td>
<td class="nump">4,696<span></span>
</td>
<td class="nump">2,503<span></span>
</td>
<td class="nump">13,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="nump">445<span></span>
</td>
<td class="nump">1,565<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total interest expense on convertible debt</a></td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 9,486<span></span>
</td>
<td class="nump">$ 10,797<span></span>
</td>
<td class="nump">$ 24,209<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ScheduleOfInterestExpensesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ScheduleOfInterestExpensesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866703845608">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) - Summary of Changes in Accumulated Balances of AOCI Including Current Period Other Comprehensive Income (Loss) and Reclassifications Out of AOCI (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th" colspan="2"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 4,241,571<span></span>
</td>
<td class="nump">$ 3,236,679<span></span>
</td>
<td class="nump">$ 4,106,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 3,122,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before &#160;&#160;&#160;&#160; reclassifications</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,128<span></span>
</td>
<td class="num">(18,295)<span></span>
</td>
<td class="nump">20,626<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Less: gain (loss) reclassified from AOCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">133<span></span>
</td>
<td class="nump">1,878<span></span>
</td>
<td class="num">(4,953)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax effect</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">183<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(550)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,178<span></span>
</td>
<td class="num">(19,665)<span></span>
</td>
<td class="nump">26,378<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,779)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,266,149<span></span>
</td>
<td class="nump">4,053,893<span></span>
</td>
<td class="nump">4,266,149<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,053,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Unrealized Gains (Losses) on Cash Flow Hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,760)<span></span>
</td>
<td class="nump">22,963<span></span>
</td>
<td class="num">(20,028)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before &#160;&#160;&#160;&#160; reclassifications</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,914<span></span>
</td>
<td class="num">(16,094)<span></span>
</td>
<td class="nump">24,096<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Less: gain (loss) reclassified from AOCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">133<span></span>
</td>
<td class="nump">1,878<span></span>
</td>
<td class="num">(4,953)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax effect</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,781<span></span>
</td>
<td class="num">(17,972)<span></span>
</td>
<td class="nump">29,049<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,623)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,021<span></span>
</td>
<td class="nump">4,991<span></span>
</td>
<td class="nump">9,021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Gains (Losses) on Available for-Sale Debt Securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">7,087<span></span>
</td>
<td class="nump">3,889<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before &#160;&#160;&#160;&#160; reclassifications</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(786)<span></span>
</td>
<td class="num">(2,201)<span></span>
</td>
<td class="num">(3,470)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Less: gain (loss) reclassified from AOCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax effect</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">183<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(550)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(603)<span></span>
</td>
<td class="num">(1,693)<span></span>
</td>
<td class="num">(2,671)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,218<span></span>
</td>
<td class="nump">5,394<span></span>
</td>
<td class="nump">1,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,394<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=bmrn_AccumulatedGainLossFromOtherMember', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before &#160;&#160;&#160;&#160; reclassifications</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Less: gain (loss) reclassified from AOCI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax effect</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(939)<span></span>
</td>
<td class="nump">30,050<span></span>
</td>
<td class="num">(16,139)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10,239<span></span>
</td>
<td class="nump">$ 10,385<span></span>
</td>
<td class="nump">$ 10,239<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 10,385<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The beginning balances for the nine-month periods were derived from the audited Consolidated Financial Statements included in Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=bmrn_AccumulatedGainLossFromOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=bmrn_AccumulatedGainLossFromOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707751864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Credit Concentrations and Geographic Information - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ConcentrationRiskAndGeographicInformationLineItems', window );"><strong>Concentration Risk And Geographic Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating business segment | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 374,937<span></span>
</td>
<td class="nump">$ 448,351<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=bmrn_CustomersMember', window );">Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ConcentrationRiskAndGeographicInformationLineItems', window );"><strong>Concentration Risk And Geographic Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 83,900<span></span>
</td>
<td class="nump">$ 72,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember', window );">Credit Concentration Risk | Accounts Receivable | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ConcentrationRiskAndGeographicInformationLineItems', window );"><strong>Concentration Risk And Geographic Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember', window );">Credit Concentration Risk | Accounts Receivable | Customer Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ConcentrationRiskAndGeographicInformationLineItems', window );"><strong>Concentration Risk And Geographic Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ConcentrationRiskAndGeographicInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration risk and geographic information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ConcentrationRiskAndGeographicInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=bmrn_CustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=bmrn_CustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=bmrn_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=bmrn_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=bmrn_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=bmrn_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866799342632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Revenues from External Customers and Collaborative Partners by Geographic Region (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 408,742<span></span>
</td>
<td class="nump">$ 476,784<span></span>
</td>
<td class="nump">$ 1,396,465<span></span>
</td>
<td class="nump">$ 1,408,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">196,239<span></span>
</td>
<td class="nump">252,948<span></span>
</td>
<td class="nump">608,670<span></span>
</td>
<td class="nump">729,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">115,497<span></span>
</td>
<td class="nump">121,158<span></span>
</td>
<td class="nump">450,016<span></span>
</td>
<td class="nump">375,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember', window );">Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">38,958<span></span>
</td>
<td class="nump">44,064<span></span>
</td>
<td class="nump">140,911<span></span>
</td>
<td class="nump">141,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmrn_RestOfWorldMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 58,048<span></span>
</td>
<td class="nump">$ 58,614<span></span>
</td>
<td class="nump">$ 196,868<span></span>
</td>
<td class="nump">$ 161,361<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmrn_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmrn_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707573816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Credit Concentrations and Geographic Information - Disaggregates of Net Product Revenues by Product (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 408,742<span></span>
</td>
<td class="nump">$ 476,784<span></span>
</td>
<td class="nump">$ 1,396,465<span></span>
</td>
<td class="nump">$ 1,408,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_ProductFourMember', window );">Vimizim | Marketed by Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">136,744<span></span>
</td>
<td class="nump">147,891<span></span>
</td>
<td class="nump">466,697<span></span>
</td>
<td class="nump">401,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_ProductTwoMember', window );">Naglazyme | Marketed by Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">71,172<span></span>
</td>
<td class="nump">76,323<span></span>
</td>
<td class="nump">297,321<span></span>
</td>
<td class="nump">271,585<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_ProductThreeMember', window );">Kuvan | Marketed by Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">67,687<span></span>
</td>
<td class="nump">123,993<span></span>
</td>
<td class="nump">217,257<span></span>
</td>
<td class="nump">368,604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_ProductSevenMember', window );">Palynziq | Marketed by Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">60,729<span></span>
</td>
<td class="nump">46,092<span></span>
</td>
<td class="nump">173,702<span></span>
</td>
<td class="nump">121,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_ProductSixMember', window );">Brineura | Marketed by Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">32,984<span></span>
</td>
<td class="nump">25,455<span></span>
</td>
<td class="nump">90,641<span></span>
</td>
<td class="nump">75,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_ProductEightMember', window );">Voxzogo | Marketed by Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_ProductFiveMember', window );">Firdapse | Marketed by Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_ProductsExcludingProductOneMember', window );">Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim | Marketed by Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">369,460<span></span>
</td>
<td class="nump">419,754<span></span>
</td>
<td class="nump">1,245,762<span></span>
</td>
<td class="nump">1,239,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmrn_ProductOneMember', window );">Aldurazyme | Marketed by Genzyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">24,380<span></span>
</td>
<td class="nump">40,987<span></span>
</td>
<td class="nump">102,517<span></span>
</td>
<td class="nump">128,945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total net product revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 393,840<span></span>
</td>
<td class="nump">$ 460,741<span></span>
</td>
<td class="nump">$ 1,348,279<span></span>
</td>
<td class="nump">$ 1,368,816<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductsExcludingProductOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductsExcludingProductOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866704994232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Net Product Revenues Based on Patient Location (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 408,742<span></span>
</td>
<td class="nump">$ 476,784<span></span>
</td>
<td class="nump">$ 1,396,465<span></span>
</td>
<td class="nump">$ 1,408,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">196,239<span></span>
</td>
<td class="nump">252,948<span></span>
</td>
<td class="nump">608,670<span></span>
</td>
<td class="nump">729,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">115,497<span></span>
</td>
<td class="nump">121,158<span></span>
</td>
<td class="nump">450,016<span></span>
</td>
<td class="nump">375,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember', window );">Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">38,958<span></span>
</td>
<td class="nump">44,064<span></span>
</td>
<td class="nump">140,911<span></span>
</td>
<td class="nump">141,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmrn_RestOfWorldMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">58,048<span></span>
</td>
<td class="nump">58,614<span></span>
</td>
<td class="nump">196,868<span></span>
</td>
<td class="nump">161,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total net product revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">393,840<span></span>
</td>
<td class="nump">460,741<span></span>
</td>
<td class="nump">1,348,279<span></span>
</td>
<td class="nump">1,368,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Marketed by Company | Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">369,460<span></span>
</td>
<td class="nump">419,754<span></span>
</td>
<td class="nump">1,245,762<span></span>
</td>
<td class="nump">1,239,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Marketed by Company | Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">166,554<span></span>
</td>
<td class="nump">203,892<span></span>
</td>
<td class="nump">491,028<span></span>
</td>
<td class="nump">582,734<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Marketed by Company | Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">108,568<span></span>
</td>
<td class="nump">115,548<span></span>
</td>
<td class="nump">424,144<span></span>
</td>
<td class="nump">360,718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Marketed by Company | Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim | Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">38,958<span></span>
</td>
<td class="nump">44,064<span></span>
</td>
<td class="nump">140,911<span></span>
</td>
<td class="nump">141,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Marketed by Company | Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim | Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">55,380<span></span>
</td>
<td class="nump">56,250<span></span>
</td>
<td class="nump">189,679<span></span>
</td>
<td class="nump">154,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Marketed by Genzyme | Aldurazyme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 24,380<span></span>
</td>
<td class="nump">$ 40,987<span></span>
</td>
<td class="nump">$ 102,517<span></span>
</td>
<td class="nump">$ 128,945<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmrn_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmrn_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductsExcludingProductOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductsExcludingProductOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmrn_ProductOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmrn_ProductOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866709121320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue, Credit Concentrations and Geographic Information - Total Net Product Revenue Concentrations Attributed to Largest Customers (Detail) - Customer Concentration Risk - Net Product Revenue<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer A, B, &amp; C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=bmrn_CustomerOneTwoAndThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=bmrn_CustomerOneTwoAndThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=bmrn_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=bmrn_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=bmrn_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=bmrn_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=bmrn_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=bmrn_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866796982200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 49,026<span></span>
</td>
<td class="nump">$ 50,169<span></span>
</td>
<td class="nump">$ 153,372<span></span>
</td>
<td class="nump">$ 142,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">4,339<span></span>
</td>
<td class="nump">10,342<span></span>
</td>
<td class="nump">16,907<span></span>
</td>
<td class="nump">20,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">17,866<span></span>
</td>
<td class="nump">15,705<span></span>
</td>
<td class="nump">56,199<span></span>
</td>
<td class="nump">45,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 26,821<span></span>
</td>
<td class="nump">$ 24,122<span></span>
</td>
<td class="nump">$ 80,266<span></span>
</td>
<td class="nump">$ 76,411<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866707468312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Common Share - Schedule of Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income (loss), basic</a></td>
<td class="num">$ (36,494)<span></span>
</td>
<td class="nump">$ 784,803<span></span>
</td>
<td class="num">$ (6,182)<span></span>
</td>
<td class="nump">$ 837,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Add: Interest on convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,070<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,333<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net Income (loss), diluted</a></td>
<td class="num">$ (36,494)<span></span>
</td>
<td class="nump">$ 791,873<span></span>
</td>
<td class="num">$ (6,182)<span></span>
</td>
<td class="nump">$ 855,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">183,214<span></span>
</td>
<td class="nump">181,142<span></span>
</td>
<td class="nump">182,616<span></span>
</td>
<td class="nump">180,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">183,214<span></span>
</td>
<td class="nump">197,674<span></span>
</td>
<td class="nump">182,616<span></span>
</td>
<td class="nump">194,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per common share, basic (in dollars per share)</a></td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="nump">$ 4.33<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 4.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per common share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.20)<span></span>
</td>
<td class="nump">$ 4.01<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 4.39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember', window );">Common stock issuable under the 2020 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,983<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember', window );">Common stock issuable under the 2024 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,970<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember', window );">Common stock issuable under the 2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,365<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,926<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember', window );">Common stock potentially issuable for ESPP purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">The Company&#8217;s common stock held by the NQDC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866711109528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Common Share - Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total number of potentially issuable shares (in shares)</a></td>
<td class="nump">21,055<span></span>
</td>
<td class="nump">8,265<span></span>
</td>
<td class="nump">21,055<span></span>
</td>
<td class="nump">8,439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total number of potentially issuable shares (in shares)</a></td>
<td class="nump">6,649<span></span>
</td>
<td class="nump">5,172<span></span>
</td>
<td class="nump">6,649<span></span>
</td>
<td class="nump">5,175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember', window );">Common stock issuable under the 2024 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total number of potentially issuable shares (in shares)</a></td>
<td class="nump">3,970<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,970<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember', window );">Common stock issuable under the 2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total number of potentially issuable shares (in shares)</a></td>
<td class="nump">4,365<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,365<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total number of potentially issuable shares (in shares)</a></td>
<td class="nump">5,292<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">5,292<span></span>
</td>
<td class="nump">3,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember', window );">Common stock potentially issuable for ESPP purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total number of potentially issuable shares (in shares)</a></td>
<td class="nump">582<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">The Company&#8217;s common stock held by the NQDC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total number of potentially issuable shares (in shares)</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866702022536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Net Income (Loss) Per Common Share - Additional Information (Detail) - 1.50% Senior Subordinated Convertible Notes Due in October 2020 - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Convertible notes stated rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt instrument, convertible, conversion price, per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings per share line Items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866797021848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones', window );">Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones</a></td>
<td class="nump">$ 708,800<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent liabilities</a></td>
<td class="nump">63,400<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Short-term contingent consideration</a></td>
<td class="nump">48,187<span></span>
</td>
<td colspan="2" class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Purchase commitments and other minimum contractual obligations</a></td>
<td class="nump">107,700<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=bmrn_KuvanAndPalynziqMember', window );">Kuvan And Palynziq | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones', window );">Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones</a></td>
<td class="nump">70,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=bmrn_EarlyStageDevelopmentProgramMember', window );">Early Stage Development Program | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones', window );">Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones</a></td>
<td class="nump">405,500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=bmrn_ProgramsNoLongerBeingDevelopedMember', window );">Programs No Longer Being Developed | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones', window );">Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones</a></td>
<td class="nump">$ 233,300<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">December&#160;31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February&#160;26, 2021.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent payments upon achievement of certain regulatory, commercial sales and licensing milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bmrn_KuvanAndPalynziqMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bmrn_KuvanAndPalynziqMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bmrn_ThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bmrn_ThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bmrn_EarlyStageDevelopmentProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bmrn_EarlyStageDevelopmentProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bmrn_ProgramsNoLongerBeingDevelopedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bmrn_ProgramsNoLongerBeingDevelopedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>68
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MS\1'G?CH ^*;XT>X5@47Y"_DUD2SVJN\(1_N:1IZ[>^%^O=$/G,P[!P,/^Z
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MM#HILT7]!<IU5I;9O#Z<B5#.7P60]V^RK'PXJ1I8?QUV\"]02P,$%     @
M\VY=4Z=/<N8."0  NB0  !@   !X;"]W;W)K<VAE971S+W-H965T-BYX;6RE
MFEU3X[@2AO^*BMH+J)I,;$G^F@*J0@B[J8+ (3![;1R%>,>QL[838'_]MF03
M&>LC<'8N!B=IRV^WI7ZZ99^^%.6O:L58C5[765Z=':WJ>O-C.*R2%5O'U?=B
MPW+X95F4Z[B&C^7SL-J4+%Z(D];9$#N./US':7YT?BJ^NRO/3XMMG:4YNRM1
MM5VOX_+M@F7%R]F1>_3^Q7WZO*KY%\/STTW\S.:L?MS<E?!IN!]ED:Y97J5%
MCDJV/#L:N3_&GCA!6/Q,V4O5.4;<E:>B^,4_3!=G1PY7Q#*6U'R(&/[LV)AE
M&1\)=/S=#GJTOR8_L7O\/OJ5<!Z<>8HK-BZR/]-%O3H["H_0@BWC;5;?%R]_
ML-8ACX^7%%DE_D<OK:USA))M51?K]F10L$[SYF_\V@:B<P*,HS\!MR?@_@G4
M< )I3R#"T4:9<.LRKN/ST[)X026WAM'X@8B-.!N\27-^&^=U";^F<%Y]/KZ=
M74YF\\DE@J/Y[?7T<O0 '^8/\.=F,GN8H]LK-![-_T!7U[=_SM$ /<XOT?%O
M)^@WE.;H855LJSA?5*?#&M3P,8=)>^6+YLK8<.4(W11YO:K0)%^PQ<?SA^#%
MWA7\[LH%M@XX9YOOB#C?$':PJ]$S_OSICD4.V4>6B/&(*;(R:%?WMS?H]FYR
M/WJ8SGY'H_'#].?T83J9_[!<A^ZO0\5UJ.$Z,UCK:9X4:X:.LZ*J3G2WHAG"
M%T/PE;T['_ANB$^'NVZ 5*N0!([C[LT^"/3V CUK($:+OV >P]*O*U07L/:3
M(D_2C*&\KYS_S+],XFJ%MA5;\"D&&:N,ZS1_;I9\6J>LLL7-W\ORK7&[9)#W
MDC1NLDF^0/&Z*.OT'_&%+H;-<%XW.MCQ2"^&JE40A"[5AS#8:PWL][C(!R(H
M:5ZSDE4U8J^0R"NFTQDH"HC;$=#(5(U<&OB^7F:XEQE:98XZ$43%$D& U^EV
MC>!3FN]8.PETFD-5,PZBGF;5R T\O>)HKSBR*I[71?)KP#FP0# 1>4R-]S]2
M+^\1$O07D<:,8A<;A+J.3-2.5>KO,5\,.:IB6#H0W+S(EVD>PU**,Q17%=-'
MMAVUJ\?I*=:8#+R(1B;)';:X5LE3N.EY791OL.@K5L(,^";6-ZBOOA#X]BI6
M%U23P/.=R. !EA[@ TEBR<I2)"*1I^KXE>G#C-48N@U)/@K5V(4>=2.35(D;
MEUBE/N90QF7I/R 6JCLH7W)($LDJSI\AO3[#Y#E!/,EJQ1.->$*#OG;5+'(Z
M$/DH7/++/0"P]^36B*UXTJ]7#"WCM$2[.-N*Z0[0X!" ^<0/JW0AJ&"8,%01
MZF.OGP(U5B[Q3.Y(VKF>U9U;T%YJ57FZ*+M*E%4S$H8&51)VKF^O1F1L.T 5
M64/ +TOCIS0["%=7$LNU(VN4),66(Q\@R])=_)0QL?BUD5%IY'N>VT>KQFQ
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MJO5&@S!**0[[[NCLL.\'!G\DZH@==?=LT\E=2;%>\RT8OGFAE:N22TD"JLG
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M'.0![FL/HM8;4;#]Y#K[&U!+ P04    " #S;EU3M),<>E &   C#P  &
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M5UJFOMT9://-VJM<20?*3L02W%)(B&NK4*!S&"^SQ/%]C8$(:-/L3G(5><2
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MK .=KR2ET1HVP.YG,_H#4$L#!!0    ( /-N75/B%%54@08  ),/   9
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;-576V_;.!;^*P?>8#$!%%NB[IDD
M@)NVLP&F15&GLP^+?: EVB8JBQZ2CNO]]?N1LF4%M8,!]FE?;%[.^<Y=Y_!N
MI_1WLQ+"TH]UTYK[T<K:S>UD8JJ56',S5AO1XF:A])I;;/5R8C9:\-HSK9L)
M"\-LLN:R'3W<^;,O^N%.;6TC6_%%D]FNUUSOWXE&[>Y'T>AX\%4N5]8=3![N
M-GPI9L)^VWS1V$UZE%JN16ND:DF+Q?UH&MV^2QR])_A#BIT9K,E9,E?JN]L\
MU?>CT"DD&E%9A\#Q]R(>1=,X(*CQYP%SU(MTC,/U$?VCMQVVS+D1CZKYIZSM
MZGY4C*@6"[YM[%>U^X<XV),ZO$HUQO_2KJ--(;':&JO6!V;LU[+M_OF/@Q\&
M#$5X@8$=&)C7NQ/DM7S/+7^XTVI'VE$#S2V\J9X;RLG6!65F-6XE^.S#QZ?/
MT\^/3]/?Z>GS[/GKMT\?/C_/[B86T(Y@4AU@WG4P[ ),29]4:U>&/K2UJ%_S
M3Z!2KQ<[ZO6.O0DX$YLQQ6% +&31&WAQ;V?L\>(+>$_MBS 6V61-0._%W!)O
M:_KPYU;:/<U$M=722F'H7].YL1JY\N\WA":]T,0+3?Y7Y[X)X^KRUFQX)>Y'
M*#PC](L8G<>F:=,@._1W8?F\$61.ANV$%E0UW!BYD*(F;HB_<-DXNAL4]XWA
M8. 6SMA8L9X+W;O?N^J]J ZGD3\-Q_2\$K10#>I:MDOR$@V9%7QD<?.HUAO>
M[O_^MX)%^:^&*FY6@?\E ;>_0!R"X;'/*#+0?+XG(Y<MU*YX:TGVD028%4NE
M]]!"D^#5BC9"2U63=U-K17U[SISI6FDK_P,G/"ICZ3>MC#G\3I=++9: I8]<
M:OJ#-UM8XG1V>OK%AX'RLQ60;JS0:_IT\OH@G7Z)KNEWU2[?I&&@$2^BH>BV
M$W%%K$P"%I98>?^Q7U^M3K=OT768[-:5IM@?T@+N0WYO?2& .PKR..TYCO_'
M\TOWCTIOE'9>JETE#6*59F$0A@E% 8M#6%\6USB+@C#.* ]CBO(\2+*"XH(%
M19;2M_%L3$OU(G3K(XH^T%;[(2*+PB!)$DJBC'[)K_V^2('$@K(L*0(X"W.*
MLR!+<I=T:Z$KR1O:<"0#R,J@B J*?"CZ';0H<XH $B,ACG9-C1'V9LZK[\B-
MH55I$!6,&#1@\76W/7FE"%C.*,F",HH)K0*-H/7IHE &2+L@BN"0%.[(KK%C
M:=&SQD$()T1E3+/MW"H+M6%.&@;,:1<4+'82TVM_BCVDQ@R&Q_!'!MWC&/^P
M'"8]>^XK4*9)$J1AYM<.X>J T=UE05@F6&?P092XVR/258_U4ZW_/Y1,G(<(
M9GJA9$ZW;]']A9+)DJ" LWXJF</YI?O+)9-$R) X=YF1(4M1,$CU("[#$S8+
M@S2-D"<IL,N_4C19BA0J7,#3U'N4(;1%RBA*4)\AH%B0% 6A7.,LN9CXB'^6
MEH2T<Q['+D_8('FCHB160,:YO$\35YVG7,^C_">ON+,^\\L\#9(\HQ1%44)I
M:%T6L!S)SO+">]5YAK$"0AUI/$CZ.(%OP@CKCOVJ _!7J?MBN*,L*8,(Y7?5
M UWU4,Y)SV?:ECGEZ_G&BLEPB]8J6T+.T%YP3>A&:(5F[+UV#K3I\_M-S+FP
M.R$ZX*DAM3C3S8)ALZ45K_V>SV7C)AL7#HE&B"RQBE:J0;/%B'#JH0;D:/I^
M.I N?+1M,=PWOM8;5]\;9:0?H+>ME4VG&J#'0\.H4AC3:X! '# /(GUO/VAR
M%.^T&UC:@6I1N73>.Q-Y_ZFIW*<&([<TG9'BQ]&0W4JBV2_<]^;%?V^D\1YW
MQK07$*!B[0U!3#>B\N-$T^PANT%9U@YVH-LI5K*M,8;KSI=+H9::;U;[ /UE
M[ZO/?1LJ'RY'L)(8V0_$%919PL8#,JH?<Q(^7A)&MOMKY^]:N"R0K1^@7" <
M82TJ-P*Z^X&)E7.U[A2MN-9[Q]-;WRH[M(13!5)I?0A?AVJ%R:\2VN+!]BH/
ML&U5>S-(2-%-QZ=H!;06W&R=$EOCQ&];-7?SJ"=WNG"?*;+=; ^CG18]BWN#
M.1':X6G'?HA,%TWNYE-,D\*_TYI7.>5&<HQZLAIJ/+Y8$U[RN?E],G@H84Y8
M^N<@W*&0AMV;J3_M7YS3[J%U(N^>JVA,2S0&I-T"K.$X3T>DNR=@M[%JXY]=
M<V7QB//+%5[-0CL"W"^4LL>-$]"_PQ_^"U!+ P04    " #S;EU3_Y3=TU,'
M  "&$   &0   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6S%6%%OVS@2_BL#
M7W'8 HIMR;)L9Y, 3II@@TO3($F[#X=[8"3:(BJ)*DG%\?[Z^X:29:?;#1:[
M!]Q+3$F<F6]FOAD.<[+1YJO-I73T4A:5/1WDSM7'HY%-<UD*.]2UK/!EI4TI
M'![->F1K(T7FA<IB%(W'R:@4JAJ<G?AW=^;L1#>N4)6\,V2;LA1F>RX+O3D=
MA(/=BWNUSAV_&)V=U&(M'Z3[7-\9/(UZ+9DJ9665KLC(U>E@&1Z?Q[S?;_BB
MY,8>K(D]>=+Z*S]<9Z>#,0.2A4P=:Q#X>987LBA8$6!\ZW0.>I,L>+C>:;_R
MOL.7)V'EA2Y^59G+3P?S 65R)9K"W>O-+[+S9\KZ4EU8_Y<VW=[Q@-+&.EUV
MPD!0JJK]%2]='/Z,0-0)1!YW:\BC_""<.#LQ>D.&=T,;+[RK7AK@5,5)>7 &
M7Q7DW-G#Y[N[F\N/E[>/RQLZ7]XL;R\NZ>&7R\M'NKZ]^G3_<?EX_>GV9.1@
MBR5&::?WO-4;_8'>!7W4E<LM75:9S%[+CX"Q!QKM@)Y';RI\D/60)N. HG$4
MOJ%OTCL^\?HF?Z#ODUF+2OTFF!L!7>C*ZD)EHJ5*E=&=D596KGVA5W2E*E&E
M2A3T@)<2O'26_KU\LLZ 6?]Y U'<(XH]HOA_GHHW]7)9']M:I/)T4+-3YED.
M_J0QNJZ>X:@V6TH1(66=S#@8+I>TT@4J6E7K8T)N$)$G:7R"/LBT>P@#NA<;
MT-5)@\A9>D>S:3")YKQ(@F0VH5]1LT>J.JJ-3J6U%(=1$$]B*)H'T3SAL"NP
M.Z.UUIFE* F#),;G<!),YPMZU X943U*Z(T703Q.L$H6\V :SP]\$);!OT;+
M=(*"M&C 4WH7#^<HLZ+HLOY%O_RFUYH0N*-"-%6:PYNJ62'EC8'O1T86@H.2
M:@L^0$]C#!XS_]7'R>7*9/2M$0918)W>HLN%(V$D1)SD$D$\C=__>?@PW-D-
M:),KV-P ^=J(BBVA=WZ5CK6+&E%[]OY[R<O/!-3+9HVV0=&L]2T@9<DZN$0"
M;NBL21VE8#B3G<V3AJQ!@UW#9QMTL=BA9S1!C\VA[SNF/OLATEQ7F=%U(:P2
MK"G-59$9B7KBS25"@KB4)4#QZ<$RF<+9H6MMN*S8OLVQ!CZ!>'HT>8, VR$]
M0L.%+FM1;:EDAPQHA0;^(_]71I?[V%V!*;Z$/YAF3<NL9 JA2GTE_W3U8?F>
MGB0 22^RR_">0P@.-A#Z0>;A2\-E7VQW8?9&T 2,!X&7;9C= > G62CYC&3Y
M-._X3^"/- XGI5/2THXZ3GM9'".*=W(F&GSQA-UY>$#%7&30+RNR:EVIE0)<
M!W!@79/*;$A+JAK/;L@P3[6QM)'LK?@**1C7;3%GTG3=[W7*/86K+BEVYW7&
MP<S@5*%KSX"N8@.JU;.OPA2-!V@*L(2=1:N!2[;G3@.6FV++5GY'PV"_FU-9
M2I]@X%8N]\*(E7R&HZ^"TSB01W$L \J18CRP>?E2(]P2L0ZXXC>2J6^IUB@T
MQ\A464L_6<!>%_P^T+L^9!N4'4MU4*U82;<E^")7'/-T^TKYGB?=D>()V%(5
M]9'ZTJDR\/I!2KH%%)K0/_\QC\+P9WIH!R+?F_8YI66:ZJ;R)+O#V90R9_I&
MU66E(YS7-/O9TK*J&GAQ+[G$N!OPZ$+A^.A??1ZV4L )WW)>=6JP>.PWB2Q3
MOCRYL;1C7SN!O:+K]Y;K'41='=12&SY(U4:Q??TC=@]QV&+*- XQO2O8=0[>
MY;=&>:8%="O=7SU_]IKK7K/<:UX;;?E8"H-9% >S<>3723(/QDG"&6C*IG4[
MDS@#D."VBR2+1; (I^^QFDR#Z0*K]BBJW[97P1.V,&9K\UF[GN#(FX7 ?6"!
M25Q9V4IPLRV9"R":J)5CEGD.N(.^=="E<P.2L>4*HP#ZL!_$VI3_X/#CP^5=
M& [C_N!CT7>3Z7"V>^/KLY9^@BZVP_\3U'$/-?P.ZL&;[Z%>8X:KUNJID+2T
M5CK[M^C$XXC#**">6Z=VJH57S4,'!I39/.15' =CI/@&[>3X%940()P=79_X
M*9I-@F@1@TI1E 3S,'G? A3&^&:) FDD]$WF\R#VE(G#61"!,%V#L'0GML*C
M0##PTC0P<J/$DRI\=_RKSO;ZZP/]HM//-!>^.77Y9^^C\03C'7L?+L(@CA8]
M'#1(WO6*,11.YT$X&5.83%$1DWZSD4\(U-XNRG$"7=@UC9+]+KT5A?=OMR^,
M@VD8$<(33J<(/&YK5!S$81$DTP6%R- TYLZX$<;/7;BZ5=VQEVZ!+LV15\EA
M\\.])1Y:)ZQWMIC3%Y\0=$ENAN+ET'Z \156IDG4HT3'UJ7L-DZ3F$$D(7WR
M0]<TB+&.,=*.N_XAWHKYH2^@09($LY"#'2\B/^G^Z!(R.K@;XHA:^QLP4P)6
MVFMB_[:_9"_;N^5^>WM#_RC,6E66"KF"Z'@XFP[(M+?>]L'IVM\TG[3#O=4O
M<REP[/,&?%]I''S= QOH__5P]E]02P,$%     @ \VY=4]]#XB[)!0  \P\
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M%YUAA^4PXU5A']3Z'=3Q] @O4X5Q3[;VMDG:85EEK"KKP>A!*:1_\\>:A]:
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MANUS?GM?1]3?@*":OCSUE6(EC'?2@0._^R:+H_GW]@A4B22Y.''],UD,+XA
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M.B#JAT#=47QABN\)5UC*F^8<WTY,Z DX/N6XO::C%VA?8\?_ E!+ P04
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M0^LH 7Q-HM]A8)A^QS&7#D!+\(8UB;7W"LVF_?D&E;1AAG>6]:.VZ;<BG@;
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M'4 0]Z'-_[&J=1^WELH"F.Z6#AJ%I@5XOU(H5?T?8C!^[7SS7U!+ P04
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M /R^$D"S,<P$W?\#+O\%4$L#!!0    ( /-N75,SK)JA( 8   <.   9
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M6^N4GZ<QB]*$8C1%#M)@G6?('&(7:>:KZBHC1(:@SC0\$'T8H38!Q[AU[[<
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M?VGS"R-7[J(TEP:O7>XUQWLN558!OR\D3FS5P@9H;LZ7?P-02P,$%     @
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M8,;F=)6K.[Z^8$T\OL9+>"ZK7U@W:VT#DI54O&@V(X,B*^LG?6SR\)H-I-E
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MN7OC&_S'>;-BR"^,'# #V]TG'49/<G= C$\06_73L8@3[:7/L2WBQJ]2U?Y
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M:@"/F#=:<[G]H'C2%T]\\>1<<;JC12,05 FW>_*9;00.R?VA8;2Z=J5H5]#
MKQ\$A97%ROS^H/"D+SSYI&K>JS90.M%[)_J];6T9OWE&]U;LL_'U*$G#_>GF
MO9,4C:9]4MML>')\W=-QS_262P,"2X)%HR_3 '1['=N)5;4_T1MEZ7[XX8Y>
M,-0N@>*E4O8X<9>D?Q.S?U!+ P04    " #S;EU3!<)YR7 #  #<"   &0
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M8$,;;I[D_B-TYQE9?[GDVOV2?6<;>"1OM)%5!T8&%1/MEW[O=/@90-0!HA-
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M*KC-,&-4VZS:B9&U*]]K:; 9N&&)_1V4-<#]C93F>6(#]/\89O\"4$L#!!0
M   ( /-N75/.J!RC7@0  $ -   9    >&PO=V]R:W-H965T<R]S:&5E=#,W
M+GAM;(V77V_;-A# OPKA%4,"I)&H?[8[QT!BKUBQ#@WBMGLH]D!+M$V4(CV2
MBN-]^ATI178L6LF++9)WQQ_OJ+O39"?53[VAU*"GD@M],]@8L_T0!#K?T)+H
M:[FE E964I7$P%"M [U5E!1.J>1!%(994!(F!M.)F[M7TXFL#&>"WBNDJ[(D
M:G]'N=S=#/#@>>*!K3?&3@33R9:LZ8*:;]M[!:.@M5*PD@K-I$"*KFX&M_C#
M'"=6P4E\9W2GCYZ1/<I2RI]V\*FX&826B'*:&VN"P-\CG5'.K27@^+<Q.FCW
MM(K'S\_6/[K#PV&61-.9Y'^SPFQN!J,!*NB*5-P\R-T?M#E0:NWEDFOWBW:-
M;#A >:6-+!ME("B9J/_)4^.(MRA$C4)TH@">\2O$C4)\JA"?44@:!>?JH#Z*
M\\.<&#*=*+E#RDJ#-?O@G.FTX?A,V+@OC()5!GIFNJBV6TXAD(9P=$<X$3E%
M"W?C/HGZ6MGPO$<+N'%%Q2F2*W2;Y[(21J-[LB=+F".BL).JH@7ZS,B2<688
MU>AB3@UA_!+TORWFZ.+=)7J'F$!?-[+2H*0G@8%#6)0@;X#O:N#H'##=7J,X
MO$)1&&&/^JQ??4YS4,=./7RI'H#K6O]%K?\B9R\^8^^+6A/!_G->ND(S*;3D
MK*B=9KURKZBVSG43X+J/3("+&3A[ 9/.\1K]N%UJH^ 5^*>'*&Z)8D>4G"%J
M@[,]"@YI@@/Y0@&+6"/Z!*E#4V\$Z@TRMX%-'(_3*(QCZ^['8T]WQ? 8)]&X
M%7O!G[3\R6O\#C67I26L/=?0^F!K:^DQ13K"<7@"ZQ'+TC"*_;!I"YN^"5;1
M)42S];F/,^T 9*/XR%DUID<J3:/,3YFUE-G;*.6></=B]G!F74<E*8Y..#U2
M0YRF?LYARSGLY81,OB.J0)!W(%\+R']*49'O(?SYAH@UA4LAW(OBO;;##E,:
M'P6X!N\*X>%P//*#CUKP42_X9PJE!_%#YO/AC3H[C[/T-/Y=(8R':>+'&[=X
MXUZ\[X17D >* NZ (4_]\1][XM\)?U=HG&:1GQ*'AUH4ONF>,@$O/ZU1O14B
M[$8Z2TX0/4+C+,-G&(_J)>YE_&(V5'FA<!<JR4YSID<JR9+P#-6A"N&HE^JK
MM/6;]*7^5VYGLT'V BP;XLX!/'+C*$U&+^7FKP#_P'VU#MMB]W+F4#YP?_WH
M6&[.UZ]U@2\1] :T7%+5]@?04;J&2*,=513:204]*J0G)4L$UP"1JF &)@YE
M'P;>"@\WFE>%N]I.<P;%C8C]K[^,(CS\3:-;(2K0>*!;J0R"@F>;6H3#]W_:
M9.A4]I0H1(4UT@&]0BO&86''S,8)+WZ?.2MTJ2IHYU&4U0W3M<_IP5'[6%*U
M=FVX1NXNU7U'.UNW^C/;ZMOV\V3^%L>P$'M6P/W/7P?!88OZV^(OHM9,:,3I
M"K8+KX?P<JBZ7:\'1FY= [N4!MIA][B!3QRJK "LKZ0TSP.[0?O1-/T?4$L#
M!!0    ( /-N75,'-":ELP8  ! R   9    >&PO=V]R:W-H965T<R]S:&5E
M=#,X+GAM;,V;[V_:.!C'_Q6+.YTVJ1N)?P5V+=+6:KI*W=:UM]V+T[UPP4"T
MD'")H9MT?_PY(>5)%L<DA4AYTQ)X;+ZVO_''SP.</T;QMV0II4+?5T&87 R6
M2JW?#(?)="E7(GD=K66H7YE'\4HH?1DOALDZEF*6-5H%0^PX?+@2?CB8G&?/
MW<:3\VBC C^4MS%*-JN5B'^\DT'T>#%P!T]/W/F+I4J?&$[.UV(A[Z7ZLKZ-
M]=5PW\O,7\DP\:,0Q7)^,7CKOKGTL@99Q%=?/B:%QR@=RD,4?4LOKF<7 R=5
M) ,Y56D70O_;RDL9!&E/6L>_>:>#_7NF#8N/GWI_GPU>#^9!)/(R"O[R9VIY
M,1@-T$S.Q290=]'C'S(?$$O[FT9!DOU%CWFL,T#33:*B5=Y8*UCYX>Z_^)Y/
M1*&!2VL:X+P!;MJ Y U(-M"=LFQ85T*)R7D</:(XC=:]I0^RN<E:Z]'X8;J,
M]RK6K_JZG9J\%WZ,OHI@(]$'*9)-+/4:J02]0H57HCEZ[X<BG/HB0&^31.H
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MU<@#1@9LL0;8.M+(QZ7C'&#&G3Z:F .I>/N\[+ />#7)^MD UI"R6& ;;Y.
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MD,(6!!;DFG0NZ?R;NO_7$Z?7H><^:D<=/ Q7]&:B\0:T7VCM]A,?H'F%Q_\
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ML62R?B?4$RT6U57[(#1>W-4PP[<52&. ^W,A]'IB;N_VM3;^#U!+ P04
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M[6'8 V/1ME!)U$C*SH;^^)&4(LL2K64M8.PEUL<Y]^K<>\0K9GR@["O?$2+
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MF,BY%$BQQ57O&E]."3$*5N)/SC;YUC,R4.92?C4O-\E5SS41L93%VIB@\//
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M-"Y^KBGA_2T _/TR3=GC@ZA@?Z'OXC]02P,$%     @ \VY=4W5/DE\'!
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M.#%_7[']KY\F=G!AL.8('*E7I/X*Z%NW,FH4:JM\,V'(KGW_V]KRW@P,VJ?
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M:6(SR=[<2+ZL1K4/7"KJJLL%HS$3)4 ]GW$NMS>E@>;_"</_ %!+ P04
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MFC7BW\ BK=AZ7?(UD[P"X@Y\%I)EX*-:WM>E2'8K"3KW%;A2,!.@S*Z5M1H
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M,%9%RL!MT4%$@I :_>?2*L1Q%!YY3)&N&\A=-_YWW,KZN7THTCD?D9'QZV*
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M4"V9LMU!:4^DV#9;!+="2I$WAQO.$E[6 O7[G1#RZ:0>H-_'FOT+4$L#!!0
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M2D!^WU"9=^H7-4%S7S?_!U!+ P04    " #S;EU3J>2QR$@$  #&$P  &0
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M(UQPNNH)JQ>C<M<EK93!GLL]IMA'@[8#\/M:*?/X8@,TG?GL7U!+ P04
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MB>/F'-P[C\+-.15N?WV9_ 902P,$%     @ \VY=4Y>*NQS     $P(   L
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M&^IM!'H;ZFT$>AOJ;01Z&^IM!'H[ZNT$>COJ[01Z.^KM!'H[ZNT$>OMHLYM
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M<' N>&UL4$L! A0#%     @ \VY=4U#1O;/O    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ \VY=4YE<G",0
M!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " #S;EU3$,"L.#4%  !C%0  &               @($."
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ \VY=4_GNNT11
M!P  $AP  !@              ("!>0T  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( /-N75/(OOY?DP(  -P&   8              "
M@0 5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #S;EU3
M6<05""<'  !_'0  &               @(')%P  >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ \VY=4^!C&^"/"0  *38  !@
M     ("!)A\  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M /-N75.G3W+F#@D  +HD   8              " @>LH  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " #S;EU3T:X(\(,$  !^"0  &
M            @($O,@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ \VY=4[23''I0!@  (P\  !@              ("!Z#8  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( /-N75.EM3.5IP(   0&
M   8              " @6X]  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " #S;EU3H"_*UN "  !X!@  &0              @(%+0
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( /-N75/B%%54
M@08  ),/   9              " @6)#  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ \VY=4_^4W=-3!P  AA   !D
M ("!&DH  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #S
M;EU3WT/B+LD%  #S#P  &0              @(&D40  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( /-N75,>@)")R@<  .$4   9
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M970Q."YX;6Q02P$"% ,4    " #S;EU3%(GZC]\%   ;$   &0
M    @(%X>@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M /-N75,SK)JA( 8   <.   9              " @8Z   !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ \VY=4PBE(4CE!0  @PT  !D
M             ("!Y88  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " #S;EU3,B3VH1(%   D#   &0              @($!C0  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( /-N75.*:8M<G@0
M 'D+   9              " @4J2  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ \VY=4UBK*$=L!0  10\  !D              ("!
M'Y<  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #S;EU3
M?U"<[NP%  #N$   &0              @('"G   >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( /-N75/6D;K[I 0  .0*   9
M      " @>6B  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ \VY=4WR#"0:3!   < T  !D              ("!P*<  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " #S;EU3!CIMT% &   T$0
M&0              @(&*K   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( /-N75,^J>80*0,  &T&   9              " @1&S  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ \VY=4]E5M!GR
M!   ,@T  !D              ("!<;8  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " #S;EU3JVFFR1@*  !4.P  &0
M@(&:NP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( /-N
M75/76;Y'5 (  !\%   9              " @>G%  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ \VY=4P7"><EP P  W @  !D
M         ("!=,@  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    " #S;EU3/<4R[]8#  #Q"P  &0              @($;S   >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( /-N75,[^A? 6@,  %T(
M   9              " @2C0  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ \VY=4XEXVW-? P  /0@  !D              ("!N=,
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #S;EU3SJ@<
MHUX$  ! #0  &0              @(%/UP  >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    ( /-N75,'-":ELP8  ! R   9
M  " @>3;  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
M\VY=4Z '@_'F @  &@<  !D              ("!SN(  'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    " #S;EU3;T[&V,<"  "1!P  &0
M            @('KY0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    ( /-N75/K^P8PZP(  +D)   9              " @>GH  !X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ \VY=4SZW39;B P
MCA$  !D              ("!"^P  'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    " #S;EU3,)7$CC0$  !$$   &0              @($D
M\   >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( /-N75.7
MJ%,28@(   0&   9              " @8_T  !X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ \VY=4X>2RC3=!   01(  !D
M     ("!*/<  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /-N75.[#><G*@4  %L8   9              "
M@280 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ \VY=
M4VU.Z8.8!0  TQH  !D              ("!AQ4! 'AL+W=O<FMS:&5E=',O
M<VAE970U,2YX;6Q02P$"% ,4    " #S;EU3*!W522P#  "I#0  &0
M        @(%6&P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0
M   ( /-N75,(+C8X< ,  +@,   9              " @;D> 0!X;"]W;W)K
M<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ \VY=4Z]78$BJ!0  NQL
M !D              ("!8"(! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q0
M2P$"% ,4    " #S;EU3J>2QR$@$  #&$P  &0              @(%!* $
M>&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( /-N75-V /H8
M<0(  'X%   9              " @< L 0!X;"]W;W)K<VAE971S+W-H965T
M-38N>&UL4$L! A0#%     @ \VY=4^AN83=^!   I0\  !D
M ("!:"\! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " #S
M;EU392AN-1@#  "*$0  #0              @ $=- $ >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( /-N75.7BKL<P    !,"   +              "  6 W
M 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( /-N75/*)S>?,P4  $$F   /
M          "  4DX 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #S;EU3
M\R"+>>D!   2(@  &@              @ &I/0$ >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #S;EU3LFA)V-4!  "_(0  $P
M        @ '*/P$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     00!! +X1
(  #000$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>346</ContextCount>
  <ElementCount>300</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>84</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - NATURE OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/NATUREOFOPERATIONS</Role>
      <ShortName>NATURE OF OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2105104 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/RECENTACCOUNTINGPRONOUNCEMENTS</Role>
      <ShortName>RECENT ACCOUNTING PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106105 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110106 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATION</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2117107 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2121108 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIES</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2127109 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2132110 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2135111 - Disclosure - REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATION</Role>
      <ShortName>REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2142112 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2145113 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARE</Role>
      <ShortName>NET INCOME (LOSS) PER COMMON SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2150114 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/BASISOFPRESENTATIONPolicies</Role>
      <ShortName>BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bmrn.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATIONTables</Role>
      <ShortName>SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATION</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bmrn.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bmrn.com/role/DEBT</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables</Role>
      <ShortName>REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATION</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2343308 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bmrn.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2346309 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARETables</Role>
      <ShortName>NET INCOME (LOSS) PER COMMON SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARE</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2408401 - Disclosure - Financial Instruments - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail</Role>
      <ShortName>Financial Instruments - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - Financial Instruments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail</Role>
      <ShortName>Financial Instruments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - Supplemental Balance Sheet Information - Schedule of Inventory (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail</Role>
      <ShortName>Supplemental Balance Sheet Information - Schedule of Inventory (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2413404 - Disclosure - Supplemental Balance Sheet Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails</Role>
      <ShortName>Supplemental Balance Sheet Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails</Role>
      <ShortName>Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Supplemental Balance Sheet Information - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Supplemental Balance Sheet Information - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Supplemental Balance Sheet Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail</Role>
      <ShortName>Supplemental Balance Sheet Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2419408 - Disclosure - Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail</Role>
      <ShortName>Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - Fair Value Measurements - Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail</Role>
      <ShortName>Fair Value Measurements - Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - Derivative Instruments and Hedging Strategies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail</Role>
      <ShortName>Derivative Instruments and Hedging Strategies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2424411 - Disclosure - Derivative Instruments and Hedging Strategies - Summary of Derivatives Designated as and Not Designated as Hedging Instruments Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail</Role>
      <ShortName>Derivative Instruments and Hedging Strategies - Summary of Derivatives Designated as and Not Designated as Hedging Instruments Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Derivative Instruments and Hedging Strategies - Fair Value Carrying Amount of Derivatives (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail</Role>
      <ShortName>Derivative Instruments and Hedging Strategies - Fair Value Carrying Amount of Derivatives (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Derivative Instruments and Hedging Strategies - Summary of Impact of Gains and Losses from Derivatives Designated as Hedging Instruments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail</Role>
      <ShortName>Derivative Instruments and Hedging Strategies - Summary of Impact of Gains and Losses from Derivatives Designated as Hedging Instruments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - Debt - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DebtAdditionalInformationDetail</Role>
      <ShortName>Debt - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - Debt - Summary of Convertible Debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail</Role>
      <ShortName>Debt - Summary of Convertible Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - Debt - Summary of Interest Expense on Convertible Debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail</Role>
      <ShortName>Debt - Summary of Interest Expense on Convertible Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Summary of Changes in Accumulated Balances of AOCI Including Current Period Other Comprehensive Income (Loss) and Reclassifications Out of AOCI (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) - Summary of Changes in Accumulated Balances of AOCI Including Current Period Other Comprehensive Income (Loss) and Reclassifications Out of AOCI (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2437418 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail</Role>
      <ShortName>Revenue, Credit Concentrations and Geographic Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Revenues from External Customers and Collaborative Partners by Geographic Region (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail</Role>
      <ShortName>Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Revenues from External Customers and Collaborative Partners by Geographic Region (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Disaggregates of Net Product Revenues by Product (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail</Role>
      <ShortName>Revenue, Credit Concentrations and Geographic Information - Disaggregates of Net Product Revenues by Product (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2440421 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Net Product Revenues Based on Patient Location (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail</Role>
      <ShortName>Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Net Product Revenues Based on Patient Location (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2441422 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Total Net Product Revenue Concentrations Attributed to Largest Customers (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail</Role>
      <ShortName>Revenue, Credit Concentrations and Geographic Information - Total Net Product Revenue Concentrations Attributed to Largest Customers (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2444423 - Disclosure - Stock-Based Compensation - Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/StockBasedCompensationExpenseDetail</Role>
      <ShortName>Stock-Based Compensation - Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2447424 - Disclosure - Net Income (Loss) Per Common Share - Schedule of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Common Share - Schedule of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2448425 - Disclosure - Net Income (Loss) Per Common Share - Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail</Role>
      <ShortName>Net Income (Loss) Per Common Share - Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2449426 - Disclosure - Net Income (Loss) Per Common Share - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail</Role>
      <ShortName>Net Income (Loss) Per Common Share - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bmrn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2451427 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bmrn-20210930.htm">bmrn-20210930.htm</File>
    <File>bmrn-20210930.xsd</File>
    <File>bmrn-20210930_cal.xml</File>
    <File>bmrn-20210930_def.xml</File>
    <File>bmrn-20210930_lab.xml</File>
    <File>bmrn-20210930_pre.xml</File>
    <File>exhibit311-30sep21x10q.htm</File>
    <File>exhibit312-30sep21x10q.htm</File>
    <File>exhibit321-30sep21x10q.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>74
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bmrn-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 24,
   "contextCount": 346,
   "dts": {
    "calculationLink": {
     "local": [
      "bmrn-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bmrn-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bmrn-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bmrn-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmrn-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bmrn-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 442,
   "entityCount": 1,
   "hidden": {
    "http://www.bmrn.com/20210930": 2,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 7
   },
   "keyCustom": 20,
   "keyStandard": 280,
   "memberCustom": 37,
   "memberStandard": 47,
   "nsprefix": "bmrn",
   "nsuri": "http://www.bmrn.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.bmrn.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105104 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS",
     "role": "http://www.bmrn.com/role/RECENTACCOUNTINGPRONOUNCEMENTS",
     "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106105 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://www.bmrn.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110106 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION",
     "role": "http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATION",
     "shortName": "SUPPLEMENTAL BALANCE SHEET INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117107 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.bmrn.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121108 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES",
     "role": "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIES",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127109 - Disclosure - DEBT",
     "role": "http://www.bmrn.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132110 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmrn:ConcentrationRiskAndSegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135111 - Disclosure - REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION",
     "role": "http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATION",
     "shortName": "REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmrn:ConcentrationRiskAndSegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142112 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://www.bmrn.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145113 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE",
     "role": "http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARE",
     "shortName": "NET INCOME (LOSS) PER COMMON SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150114 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.bmrn.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - BASIS OF PRESENTATION (Policies)",
     "role": "http://www.bmrn.com/role/BASISOFPRESENTATIONPolicies",
     "shortName": "BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmrn:ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://www.bmrn.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmrn:ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables)",
     "role": "http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATIONTables",
     "shortName": "SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.bmrn.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES (Tables)",
     "role": "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - DEBT (Tables)",
     "role": "http://www.bmrn.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)",
     "role": "http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION (Tables)",
     "role": "http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables",
     "shortName": "REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343308 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://www.bmrn.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346309 - Disclosure - NET INCOME (LOSS) PER COMMON SHARE (Tables)",
     "role": "http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARETables",
     "shortName": "NET INCOME (LOSS) PER COMMON SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmrn:ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408401 - Disclosure - Financial Instruments - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Detail)",
     "role": "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail",
     "shortName": "Financial Instruments - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmrn:ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i00b5b9602a84434ca20f4f840240bef5_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409402 - Disclosure - Financial Instruments - Additional Information (Detail)",
     "role": "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail",
     "shortName": "Financial Instruments - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i00b5b9602a84434ca20f4f840240bef5_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412403 - Disclosure - Supplemental Balance Sheet Information - Schedule of Inventory (Detail)",
     "role": "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail",
     "shortName": "Supplemental Balance Sheet Information - Schedule of Inventory (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413404 - Disclosure - Supplemental Balance Sheet Information - Narrative (Details)",
     "role": "http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails",
     "shortName": "Supplemental Balance Sheet Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details)",
     "role": "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails",
     "shortName": "Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Supplemental Balance Sheet Information - Schedule of Intangible Assets (Details)",
     "role": "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails",
     "shortName": "Supplemental Balance Sheet Information - Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Supplemental Balance Sheet Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)",
     "role": "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail",
     "shortName": "Supplemental Balance Sheet Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i90bb59f2a5034770af163bb6ee32ed42_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419408 - Disclosure - Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Detail)",
     "role": "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
     "shortName": "Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i90bb59f2a5034770af163bb6ee32ed42_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i615edf13dd9645ddb17b1b2bd0c8b9e1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - Fair Value Measurements - Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs (Detail)",
     "role": "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail",
     "shortName": "Fair Value Measurements - Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i615edf13dd9645ddb17b1b2bd0c8b9e1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - Derivative Instruments and Hedging Strategies - Additional Information (Detail)",
     "role": "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail",
     "shortName": "Derivative Instruments and Hedging Strategies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i801ae299848e42d9a8bba895edfc93ae_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424411 - Disclosure - Derivative Instruments and Hedging Strategies - Summary of Derivatives Designated as and Not Designated as Hedging Instruments Outstanding (Detail)",
     "role": "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail",
     "shortName": "Derivative Instruments and Hedging Strategies - Summary of Derivatives Designated as and Not Designated as Hedging Instruments Outstanding (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i801ae299848e42d9a8bba895edfc93ae_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Derivative Instruments and Hedging Strategies - Fair Value Carrying Amount of Derivatives (Detail)",
     "role": "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
     "shortName": "Derivative Instruments and Hedging Strategies - Fair Value Carrying Amount of Derivatives (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Derivative Instruments and Hedging Strategies - Summary of Impact of Gains and Losses from Derivatives Designated as Hedging Instruments (Detail)",
     "role": "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail",
     "shortName": "Derivative Instruments and Hedging Strategies - Summary of Impact of Gains and Losses from Derivatives Designated as Hedging Instruments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i5396b9f8638140eab847f0bdfcab099a_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - Debt - Additional Information (Detail)",
     "role": "http://www.bmrn.com/role/DebtAdditionalInformationDetail",
     "shortName": "Debt - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "iba2ae00a5eea4923b638351403ec6b48_I20181031",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - Debt - Summary of Convertible Debt (Detail)",
     "role": "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail",
     "shortName": "Debt - Summary of Convertible Debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - Debt - Summary of Interest Expense on Convertible Debt (Detail)",
     "role": "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail",
     "shortName": "Debt - Summary of Interest Expense on Convertible Debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "iffc9a23aee2644cbbd732f8295f5a2ca_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i42ac9247fd2e436cb417f1972275fb4a_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Summary of Changes in Accumulated Balances of AOCI Including Current Period Other Comprehensive Income (Loss) and Reclassifications Out of AOCI (Detail)",
     "role": "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail",
     "shortName": "Accumulated Other Comprehensive Income (Loss) - Summary of Changes in Accumulated Balances of AOCI Including Current Period Other Comprehensive Income (Loss) and Reclassifications Out of AOCI (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437418 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Additional Information (Detail)",
     "role": "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
     "shortName": "Revenue, Credit Concentrations and Geographic Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Revenues from External Customers and Collaborative Partners by Geographic Region (Detail)",
     "role": "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail",
     "shortName": "Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Revenues from External Customers and Collaborative Partners by Geographic Region (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "iac1a61de8d9a4f648cd0094a00ba3a7c_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "iac1a61de8d9a4f648cd0094a00ba3a7c_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Disaggregates of Net Product Revenues by Product (Detail)",
     "role": "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
     "shortName": "Revenue, Credit Concentrations and Geographic Information - Disaggregates of Net Product Revenues by Product (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i26cfa0a05050405c8fc26ff4270b410b_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440421 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Net Product Revenues Based on Patient Location (Detail)",
     "role": "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail",
     "shortName": "Revenue, Credit Concentrations and Geographic Information - Disaggregates of Total Net Product Revenues Based on Patient Location (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i807900e9e70040c78da438a82a6b9728_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i06311aaf1fc84255bf7c628cde958a0e_D20210701-20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441422 - Disclosure - Revenue, Credit Concentrations and Geographic Information - Total Net Product Revenue Concentrations Attributed to Largest Customers (Detail)",
     "role": "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail",
     "shortName": "Revenue, Credit Concentrations and Geographic Information - Total Net Product Revenue Concentrations Attributed to Largest Customers (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i06311aaf1fc84255bf7c628cde958a0e_D20210701-20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444423 - Disclosure - Stock-Based Compensation - Expense (Detail)",
     "role": "http://www.bmrn.com/role/StockBasedCompensationExpenseDetail",
     "shortName": "Stock-Based Compensation - Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447424 - Disclosure - Net Income (Loss) Per Common Share - Schedule of Earnings Per Share (Details)",
     "role": "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails",
     "shortName": "Net Income (Loss) Per Common Share - Schedule of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448425 - Disclosure - Net Income (Loss) Per Common Share - Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share (Detail)",
     "role": "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
     "shortName": "Net Income (Loss) Per Common Share - Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i52f4f9636243498cb577db395fe3d626_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "ic20a7b693de94d51a8059e3b28b30754_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449426 - Disclosure - Net Income (Loss) Per Common Share - Additional Information (Detail)",
     "role": "http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail",
     "shortName": "Net Income (Loss) Per Common Share - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "ic20a7b693de94d51a8059e3b28b30754_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451427 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "role": "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "icce161e9967344ce804b1ab36f4ae711_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "bmrn:ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - NATURE OF OPERATIONS",
     "role": "http://www.bmrn.com/role/NATUREOFOPERATIONS",
     "shortName": "NATURE OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - BASIS OF PRESENTATION",
     "role": "http://www.bmrn.com/role/BASISOFPRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.bmrn.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmrn-20210930.htm",
      "contextRef": "i67169beb0dcf4e3abf0929a994ed1912_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 84,
   "tag": {
    "bmrn_A125SeniorSubordinatedConvertibleNotesDueInMay2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.25% Senior Subordinated Convertible Notes Due in May 2027",
        "label": "1.25% Senior Subordinated Convertible Notes Due in May 2027 [Member]",
        "terseLabel": "1.25% Senior Subordinated Convertible Notes Due in May 2027"
       }
      }
     },
     "localname": "A125SeniorSubordinatedConvertibleNotesDueInMay2027Member",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_AccruedGovernmentAndOtherRebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Government And Other Rebates",
        "label": "Accrued Government And Other Rebates",
        "terseLabel": "Accrued rebates payable"
       }
      }
     },
     "localname": "AccruedGovernmentAndOtherRebates",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_AccumulatedGainLossFromOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated gain (loss) from other.",
        "label": "Accumulated Gain Loss From Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "AccumulatedGainLossFromOtherMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital, Shares Held By Nonqualified Deferred Compensation Plan",
        "label": "Adjustments To Additional Paid In Capital, Shares Held By Nonqualified Deferred Compensation Plan",
        "negatedTerseLabel": "Common stock held by the NQDC"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharesHeldByNonqualifiedDeferredCompensationPlan",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies.",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies.",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_CommonStockIssuableToEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issuable for employee Stock Purchase Plan [Member]",
        "label": "Common Stock Issuable To Employee Stock Purchase Plan [Member]",
        "terseLabel": "Common stock potentially issuable for ESPP purchases"
       }
      }
     },
     "localname": "CommonStockIssuableToEmployeeStockPurchasePlanMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ConcentrationRiskAndGeographicInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration risk and geographic information.",
        "label": "Concentration Risk And Geographic Information [Abstract]",
        "terseLabel": "Concentration Risk And Geographic Information [Abstract]"
       }
      }
     },
     "localname": "ConcentrationRiskAndGeographicInformationAbstract",
     "nsuri": "http://www.bmrn.com/20210930",
     "xbrltype": "stringItemType"
    },
    "bmrn_ConcentrationRiskAndGeographicInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration risk and geographic information.",
        "label": "Concentration Risk And Geographic Information [Line Items]",
        "terseLabel": "Concentration Risk And Geographic Information [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskAndGeographicInformationLineItems",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_ConcentrationRiskAndGeographicInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration risk and geographic information.",
        "label": "Concentration Risk And Geographic Information [Table]",
        "terseLabel": "Concentration Risk And Geographic Information [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskAndGeographicInformationTable",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_ConcentrationRiskAndSegmentReportingDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration risk and segment reporting disclosure.",
        "label": "Concentration Risk And Segment Reporting Disclosure [Text Block]",
        "terseLabel": "REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION"
       }
      }
     },
     "localname": "ConcentrationRiskAndSegmentReportingDisclosureTextBlock",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmrn_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration.",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ContingentPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Payment",
        "label": "Contingent Payment [Member]",
        "terseLabel": "Contingent Payment"
       }
      }
     },
     "localname": "ContingentPaymentMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones.",
        "label": "Contingent Payments Upon Achievement Of Certain Development And Regulatory Activities Commercial Sales And Licensing Milestones",
        "terseLabel": "Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones"
       }
      }
     },
     "localname": "ContingentPaymentsUponAchievementOfCertainDevelopmentAndRegulatoryActivitiesCommercialSalesAndLicensingMilestones",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent payments upon achievement of certain regulatory, commercial sales and licensing milestones.",
        "label": "Contingent Payments Upon Achievement Of Certain Regulatory Commercial Sales And Licensing Milestones",
        "terseLabel": "Contingent payments upon achievement of certain development and regulatory activities and commercial sales and licensing milestones"
       }
      }
     },
     "localname": "ContingentPaymentsUponAchievementOfCertainRegulatoryCommercialSalesAndLicensingMilestones",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_ConvertibleSeniorNotesDueTwentyTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible senior notes due twenty twenty.",
        "label": "Convertible Senior Notes Due Twenty Twenty [Member]",
        "terseLabel": "Common stock issuable under the 2020 Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDueTwentyTwentyMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ConvertibleSeniorNotesDueTwoThousandTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Senior Notes Due Two Thousand Twenty Four [Member]",
        "verboseLabel": "Common stock issuable under the 2024 notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDueTwoThousandTwentyFourMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ConvertibleSeniorNotesDueTwoThousandTwentySevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes Due Two Thousand Twenty Seven",
        "label": "Convertible Senior Notes Due Two Thousand Twenty Seven [Member]",
        "terseLabel": "Common stock issuable under the 2027 Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDueTwoThousandTwentySevenMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer 1",
        "label": "Customer One [Member]",
        "terseLabel": "Customer A",
        "verboseLabel": "Customer One"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_CustomerOneTwoAndThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer One, Two, And Three",
        "label": "Customer One, Two, And Three [Member]",
        "terseLabel": "Customer A, B, &amp; C"
       }
      }
     },
     "localname": "CustomerOneTwoAndThreeMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_CustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer 3",
        "label": "Customer Three [Member]",
        "terseLabel": "Customer C"
       }
      }
     },
     "localname": "CustomerThreeMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer 2",
        "label": "Customer Two [Member]",
        "terseLabel": "Customer B",
        "verboseLabel": "Customer Two"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_CustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customers.",
        "label": "Customers [Member]",
        "terseLabel": "Customers"
       }
      }
     },
     "localname": "CustomersMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_EarlyStageDevelopmentProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Early Stage Development Program",
        "label": "Early Stage Development Program [Member]",
        "terseLabel": "Early Stage Development Program"
       }
      }
     },
     "localname": "EarlyStageDevelopmentProgramMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings per share line Items.",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings per share.",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement with unobservable inputs reconciliations recurring basis foreign exchange remeasurement.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Foreign Exchange Remeasurement",
        "verboseLabel": "Foreign exchange remeasurement of Euro denominated contingent consideration"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForeignExchangeRemeasurement",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_ForeignGovernmentAndOtherDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign government and other debt securities.",
        "label": "Foreign Government And Other Debt Securities [Member]",
        "terseLabel": "Foreign and other"
       }
      }
     },
     "localname": "ForeignGovernmentAndOtherDebtSecuritiesMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_IntangibleAssetAmortizationAndContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets and expense charged against earnings resulting from the change in the fair value of contingent consideration during the reporting period.",
        "label": "Intangible Asset Amortization And Contingent Consideration",
        "terseLabel": "Intangible asset amortization and contingent consideration"
       }
      }
     },
     "localname": "IntangibleAssetAmortizationAndContingentConsideration",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_KuvanAndPalynziqMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kuvan And Palynziq",
        "label": "Kuvan And Palynziq [Member]",
        "terseLabel": "Kuvan And Palynziq"
       }
      }
     },
     "localname": "KuvanAndPalynziqMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_LongTermMarketableSecuritiesMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term marketable securities maturity period.",
        "label": "Long Term Marketable Securities Maturity Period",
        "terseLabel": "Long term marketable securities maturity period"
       }
      }
     },
     "localname": "LongTermMarketableSecuritiesMaturityPeriod",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bmrn_NonqualifiedDeferredCompensationPlanAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonqualified deferred compensation plan assets.",
        "label": "Nonqualified Deferred Compensation Plan Assets [Member]",
        "terseLabel": "NQDC Plan assets"
       }
      }
     },
     "localname": "NonqualifiedDeferredCompensationPlanAssetsMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_NonqualifiedDeferredCompensationPlanLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonqualified deferred compensation plan liability.",
        "label": "Nonqualified Deferred Compensation Plan Liability [Member]",
        "terseLabel": "NQDC Plan liability"
       }
      }
     },
     "localname": "NonqualifiedDeferredCompensationPlanLiabilityMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One point five zero percent senior subordinated convertible notes due in October twenty twenty.",
        "label": "One Point Five Zero Percent Senior Subordinated Convertible Notes Due In October Twenty Twenty [Member]",
        "terseLabel": "1.50% Senior Subordinated Convertible Notes Due in October 2020"
       }
      }
     },
     "localname": "OnePointFiveZeroPercentSeniorSubordinatedConvertibleNotesDueInOctoberTwentyTwentyMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_OtherAssetsCurrentFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other assets current fair value disclosure.",
        "label": "Other Assets Current Fair Value Disclosure",
        "verboseLabel": "Fair value of other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrentFairValueDisclosure",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_OtherAssetsNoncurrentFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other assets noncurrent fair value disclosure.",
        "label": "Other Assets Noncurrent Fair Value Disclosure",
        "verboseLabel": "Fair value of other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentFairValueDisclosure",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_OtherLiabilitiesCurrentFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other liabilities current fair value disclosure.",
        "label": "Other Liabilities Current Fair Value Disclosure",
        "verboseLabel": "Fair value of other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentFairValueDisclosure",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_OtherLiabilitiesNoncurrentFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other liabilities noncurrent fair value disclosure.",
        "label": "Other Liabilities Noncurrent Fair Value Disclosure",
        "verboseLabel": "Fair value of other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentFairValueDisclosure",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire Debt Securities, Available-For-Sale, Non-Marketable",
        "label": "Payments To Acquire Debt Securities, Available-For-Sale, Non-Marketable",
        "negatedTerseLabel": "Investment in convertible note"
       }
      }
     },
     "localname": "PaymentsToAcquireDebtSecuritiesAvailableForSaleNonMarketable",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_ProceedsFromSaleOfNonfinancialAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Nonfinancial Assets",
        "label": "Proceeds From Sale Of Nonfinancial Assets",
        "terseLabel": "Proceeds from sale of nonfinancial assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfNonfinancialAssets",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_ProductEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Eight",
        "label": "Product Eight [Member]",
        "terseLabel": "Voxzogo"
       }
      }
     },
     "localname": "ProductEightMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ProductFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product 5 [Member]",
        "label": "Product Five [Member]",
        "terseLabel": "Firdapse"
       }
      }
     },
     "localname": "ProductFiveMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ProductFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product 4 [Member]",
        "label": "Product Four [Member]",
        "terseLabel": "Vimizim"
       }
      }
     },
     "localname": "ProductFourMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ProductOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product 1 [Member]",
        "label": "Product One [Member]",
        "terseLabel": "Aldurazyme"
       }
      }
     },
     "localname": "ProductOneMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ProductSevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product 7 [Member]",
        "label": "Product Seven [Member]",
        "terseLabel": "Palynziq"
       }
      }
     },
     "localname": "ProductSevenMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ProductSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product six.",
        "label": "Product Six [Member]",
        "terseLabel": "Brineura"
       }
      }
     },
     "localname": "ProductSixMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ProductThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product 3 [Member]",
        "label": "Product Three [Member]",
        "terseLabel": "Kuvan"
       }
      }
     },
     "localname": "ProductThreeMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ProductTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product 2 [Member]",
        "label": "Product Two [Member]",
        "terseLabel": "Naglazyme"
       }
      }
     },
     "localname": "ProductTwoMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ProductsExcludingProductOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products excluding product one.",
        "label": "Products Excluding Product One [Member]",
        "terseLabel": "Brineura, Firdapse, Kuvan, Naglazyme, Palynziq, and Vimizim"
       }
      }
     },
     "localname": "ProductsExcludingProductOneMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ProgramsNoLongerBeingDevelopedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Programs No Longer Being Developed.",
        "label": "Programs No Longer Being Developed [Member]",
        "terseLabel": "Programs No Longer Being Developed"
       }
      }
     },
     "localname": "ProgramsNoLongerBeingDevelopedMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_RestOfWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of world.",
        "label": "Rest Of World [Member]",
        "terseLabel": "Rest of world"
       }
      }
     },
     "localname": "RestOfWorldMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_RestrictedInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted investments.",
        "label": "Restricted Investments [Member]",
        "terseLabel": "Restricted Investments"
       }
      }
     },
     "localname": "RestrictedInvestmentsMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_RoyaltyAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty and other.",
        "label": "Royalty And Other [Member]",
        "terseLabel": "Royalty and other revenues"
       }
      }
     },
     "localname": "RoyaltyAndOtherMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash, cash equivalents and available-for-sale securities.",
        "label": "Schedule Of Cash Cash Equivalents And Available For Sale Securities [Line Items]",
        "terseLabel": "Schedule of Available-for-sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash, cash equivalents and available-for-sale securities.",
        "label": "Schedule Of Cash Cash Equivalents And Available For Sale Securities [Table]",
        "terseLabel": "Schedule Of Cash Cash Equivalents And Available For Sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTable",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash, cash equivalents and available-for-sale securities.",
        "label": "Schedule Of Cash Cash Equivalents And Available For Sale Securities Table [Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndAvailableForSaleSecuritiesTableTextBlock",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmrn_ScheduleOfInterestExpensesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of interest expenses.",
        "label": "Schedule Of Interest Expenses [Line Items]",
        "terseLabel": "Schedule Of Interest Expenses [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInterestExpensesLineItems",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_ScheduleOfInterestExpensesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of interest expenses table.",
        "label": "Schedule Of Interest Expenses [Table]",
        "terseLabel": "Schedule Of Interest Expenses [Table]"
       }
      }
     },
     "localname": "ScheduleOfInterestExpensesTable",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "bmrn_SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior unsecured revolving two thousand eighteen credit facility.",
        "label": "Senior Unsecured Revolving Two Thousand Eighteen Credit Facility [Member]",
        "terseLabel": "The 2018 Credit Facility"
       }
      }
     },
     "localname": "SeniorUnsecuredRevolvingTwoThousandEighteenCreditFacilityMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ShortTermMarketableSecuritiesMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term marketable securities maturity period.",
        "label": "Short Term Marketable Securities Maturity Period",
        "terseLabel": "Short term marketable securities maturity period"
       }
      }
     },
     "localname": "ShortTermMarketableSecuritiesMaturityPeriod",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value new issues net excess tax benefit tax deficiency.",
        "label": "Stock Issued During Period Value New Issues Net Excess Tax Benefit Tax Deficiency",
        "verboseLabel": "Issuances under equity incentive plans, net of tax"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiency",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value new issues net excess tax benefit tax deficiency, shares.",
        "label": "Stock Issued During Period Value New Issues Net Excess Tax Benefit Tax Deficiency Shares",
        "terseLabel": "Issuances under equity incentive plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesNetExcessTaxBenefitTaxDeficiencyShares",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "bmrn_StrategicInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic investment.",
        "label": "Strategic Investment [Member]",
        "terseLabel": "Strategic Investment"
       }
      }
     },
     "localname": "StrategicInvestmentMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in accounts payable and accrued liabilities related to purchase of property, plant and equipment during the reporting period.",
        "label": "Supplemental Accounts Payable And Accrued Liabilities Increase (Decrease), Fixed Assets",
        "terseLabel": "Decrease in accounts payable and accrued liabilities related to fixed assets"
       }
      }
     },
     "localname": "SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseFixedAssets",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Accounts Payable And Accrued Liabilities Increase (Decrease), Intangible Assets",
        "label": "Supplemental Accounts Payable And Accrued Liabilities Increase (Decrease), Intangible Assets",
        "terseLabel": "Increase (decrease) in accounts payable and accrued liabilities related to intangible assets"
       }
      }
     },
     "localname": "SupplementalAccountsPayableAndAccruedLiabilitiesIncreaseDecreaseIntangibleAssets",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmrn_ThirdPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third party.",
        "label": "Third Party [Member]",
        "terseLabel": "Third Party"
       }
      }
     },
     "localname": "ThirdPartyMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_VoxzogoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voxzogo",
        "label": "Voxzogo [Member]",
        "terseLabel": "Voxzogo"
       }
      }
     },
     "localname": "VoxzogoMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmrn_ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zero point five nine nine percent senior subordinated convertible notes due in August two thousand twenty four.",
        "label": "Zero Point Five Nine Nine Percent Senior Subordinated Convertible Notes Due In August Two Thousand Twenty Four [Member]",
        "terseLabel": "0.599% Senior Subordinated Convertible Notes Due in August 2024"
       }
      }
     },
     "localname": "ZeroPointFiveNineNinePercentSeniorSubordinatedConvertibleNotesDueInAugustTwoThousandTwentyFourMember",
     "nsuri": "http://www.bmrn.com/20210930",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bmrn.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LatinAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latin America [Member]",
        "terseLabel": "Latin America"
       }
      }
     },
     "localname": "LatinAmericaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r191",
      "r282",
      "r286",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r248",
      "r271",
      "r306",
      "r308",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r481",
      "r485",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r248",
      "r271",
      "r306",
      "r308",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r481",
      "r485",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r191",
      "r282",
      "r286",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r187",
      "r282",
      "r284",
      "r439",
      "r480",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r187",
      "r282",
      "r284",
      "r439",
      "r480",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r248",
      "r271",
      "r296",
      "r306",
      "r308",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r481",
      "r485",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r248",
      "r271",
      "r296",
      "r306",
      "r308",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r481",
      "r485",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r188",
      "r189",
      "r282",
      "r285",
      "r483",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r188",
      "r189",
      "r282",
      "r285",
      "r483",
      "r513",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities",
        "totalLabel": "Total accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accounts\u00a0payable\u00a0and accrued\u00a0liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued operating expenses"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r21",
      "r192",
      "r193"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium on investments"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxes": {
     "auth_ref": [
      "r15",
      "r17",
      "r330",
      "r448",
      "r466"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due.  This amount is the total of current and noncurrent accrued income taxes.",
        "label": "Accrued Income Taxes",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r42"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued royalties payable"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r36",
      "r223"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r63",
      "r71",
      "r72",
      "r73",
      "r74",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent",
        "verboseLabel": "Unrealized Gains (Losses) on Cash Flow Hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r57",
      "r58",
      "r59",
      "r63",
      "r71",
      "r72",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Available for-Sale Debt Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r24",
      "r61",
      "r62",
      "r63",
      "r469",
      "r490",
      "r493"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r71",
      "r72",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r60",
      "r63",
      "r71",
      "r72",
      "r73",
      "r119",
      "r120",
      "r121",
      "r354",
      "r486",
      "r487",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail",
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r317",
      "r318",
      "r319",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r309",
      "r310",
      "r323",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r310",
      "r314",
      "r322"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "verboseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/StockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r87",
      "r106",
      "r261",
      "r416"
     ],
     "calculation": {
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Accretion of discount on convertible notes"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r82",
      "r106",
      "r261",
      "r418"
     ],
     "calculation": {
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "verboseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r106",
      "r261",
      "r268",
      "r269",
      "r418"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total number of potentially issuable shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r204",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r113",
      "r176",
      "r179",
      "r185",
      "r207",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r351",
      "r355",
      "r401",
      "r424",
      "r426",
      "r446",
      "r465"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r51",
      "r113",
      "r207",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r351",
      "r355",
      "r401",
      "r424",
      "r426"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Fair value of financial assets, Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r203"
     ],
     "calculation": {
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r200",
      "r211"
     ],
     "calculation": {
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r197",
      "r201",
      "r211",
      "r452"
     ],
     "calculation": {
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Aggregate Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r199",
      "r211"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term Marketable Securities",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r199",
      "r211"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-sale, Noncurrent",
        "terseLabel": "Long-term Marketable Securities",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r363",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/BASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r305",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r305",
      "r307",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r105",
      "r348"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Non-cash changes in the fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r344",
      "r345",
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r344",
      "r346"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Short-term contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r344",
      "r346"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Long-term contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r34",
      "r426",
      "r496",
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r34",
      "r108"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value [Abstract]",
        "terseLabel": "Cash and cash equivalents:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r101",
      "r108",
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r101",
      "r407"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Amount reclassified from AOCI to earnings as related to forecasted revenue and operating expense transactions"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW DISCLOSURES FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r230",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockIssuedEmployeeStockTrust": {
     "auth_ref": [
      "r295"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of common stock issued to a trust (for example, a 'rabbi trust') set up specifically to accumulate stock for the sole purpose of distribution to participating employees. This trust does not allow employees to immediately or after a holding period diversify into nonemployer securities. The deferred compensation plan for which this trust is set up must be settled by the delivery of a fixed number of shares of employer stock.",
        "label": "Common Stock Issued, Employee Stock Trust",
        "negatedLabel": "Company common stock held by Nonqualified Deferred Compensation Plan (the NQDC)"
       }
      }
     },
     "localname": "CommonStockIssuedEmployeeStockTrust",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20",
      "r426"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value: 500,000,000 shares authorized; 183,567,424 and 181,740,999 shares issued and outstanding, respectively."
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r67",
      "r69",
      "r70",
      "r80",
      "r457",
      "r476"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r79",
      "r89",
      "r456",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r164",
      "r165",
      "r191",
      "r398",
      "r399",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r164",
      "r165",
      "r191",
      "r398",
      "r399",
      "r495",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r164",
      "r165",
      "r191",
      "r398",
      "r399",
      "r495",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r164",
      "r165",
      "r191",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r162",
      "r164",
      "r165",
      "r166",
      "r398",
      "r400",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r164",
      "r165",
      "r191",
      "r398",
      "r399",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r279",
      "r280",
      "r283"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r282",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r282",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r16",
      "r449",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "terseLabel": "Total convertible debt, net"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Convertible Debt, Current",
        "totalLabel": "Short-term contingent consideration"
       }
      }
     },
     "localname": "ConvertibleDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Total fair value of fixed rate convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r248",
      "r252",
      "r253",
      "r254",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r266",
      "r267",
      "r268",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Long-term convertible debt, net",
        "totalLabel": "Convertible notes, net of unamortized discount and deferred offering costs"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Summary of Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r297",
      "r304",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r84",
      "r113",
      "r207",
      "r233",
      "r234",
      "r235",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r401"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/StockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses",
        "verboseLabel": "Operating expenses as reported"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.",
        "label": "Credit Concentration Risk [Member]",
        "terseLabel": "Credit Concentration Risk"
       }
      }
     },
     "localname": "CreditConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r163",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r112",
      "r117",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r266",
      "r267",
      "r268",
      "r269",
      "r419",
      "r447",
      "r449",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtAdditionalInformationDetail",
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r263",
      "r449",
      "r464"
     ],
     "calculation": {
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_ConvertibleDebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Convertible notes",
        "verboseLabel": "Carrying value of equity component"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtAdditionalInformationDetail",
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r247",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Debt instrument, convertible, conversion price, per share (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r44",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Convertible notes stated rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtAdditionalInformationDetail",
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45",
      "r112",
      "r117",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r266",
      "r267",
      "r268",
      "r269",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtAdditionalInformationDetail",
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r112",
      "r117",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r266",
      "r267",
      "r268",
      "r269",
      "r273",
      "r274",
      "r275",
      "r276",
      "r416",
      "r417",
      "r419",
      "r420",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtAdditionalInformationDetail",
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r252",
      "r264",
      "r266",
      "r267",
      "r418"
     ],
     "calculation": {
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_ConvertibleDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Unamortized discount net of deferred offering costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationShareBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation arrangements (such as stock or unit options and share or unit awards) that are equity-based payments with individual employees. The arrangements are generally based on employment contracts between the entity and one or more selected officers or key employees, and contain a promise by the employer to pay certain amounts or benefits at designated future dates, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Other \"sub-members\" can be added as necessary.",
        "label": "Deferred Compensation, Share-based Payments [Member]",
        "terseLabel": "Company Stock Held By NQDC"
       }
      }
     },
     "localname": "DeferredCompensationShareBasedPaymentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r327",
      "r328"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r106",
      "r114",
      "r331",
      "r338",
      "r339",
      "r340"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r106",
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense, net of amounts capitalized into inventory"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r106",
      "r173"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r52",
      "r54",
      "r55",
      "r366",
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative asset, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r52",
      "r54",
      "r55",
      "r366",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative liability, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r365"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gains (Losses) Recognized in Earnings"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r54",
      "r364",
      "r367",
      "r371",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r381",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r361",
      "r364",
      "r371",
      "r374",
      "r375",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Forward foreign currency exchange contracts"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r358",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeRemainingMaturity1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Remaining Maturity",
        "terseLabel": "Maturity of derivatives"
       }
      }
     },
     "localname": "DerivativeRemainingMaturity1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r369",
      "r371",
      "r376",
      "r377",
      "r379",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Designated As Hedging Instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r282",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Total Net Product Revenues Based on Patient Location"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r81",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r139",
      "r142",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r384",
      "r385",
      "r458",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss) per common share, basic (in dollars per share)",
        "verboseLabel": "NET INCOME (LOSS) PER SHARE, BASIC (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r81",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r142",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r384",
      "r385",
      "r458",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income (loss) per common share, diluted (in dollars per share)",
        "verboseLabel": "NET INCOME (LOSS) PER SHARE, DILUTED (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME (LOSS) PER COMMON SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation expense"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Options to purchase common stock",
        "verboseLabel": "Options to purchase common stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r71",
      "r72",
      "r73",
      "r119",
      "r120",
      "r121",
      "r125",
      "r133",
      "r135",
      "r160",
      "r208",
      "r272",
      "r277",
      "r317",
      "r318",
      "r319",
      "r332",
      "r333",
      "r383",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r414",
      "r486",
      "r487",
      "r488",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail",
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Strategic investments fair value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r387",
      "r388",
      "r389",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r387",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r387",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value of Financial Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r254",
      "r266",
      "r267",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r388",
      "r427",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r394",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r387",
      "r388",
      "r390",
      "r391",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r254",
      "r297",
      "r298",
      "r303",
      "r304",
      "r388",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1:",
        "verboseLabel": "Quoted\u00a0Price\u00a0in Active Markets For Identical Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r254",
      "r266",
      "r267",
      "r297",
      "r298",
      "r303",
      "r304",
      "r388",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2:",
        "verboseLabel": "Significant\u00a0Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r254",
      "r266",
      "r267",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r388",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level\u00a03)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r392",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r392",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Liabilities Measured at Fair Value on Recurring Basis Using Level 3 Inputs"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "terseLabel": "Financial assets remeasured"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "verboseLabel": "Changes in the fair value of contingent consideration"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Contingent consideration as of September 30, 2021",
        "periodStartLabel": "Contingent consideration as of December 31, 2020",
        "terseLabel": "Liabilities remeasured"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FairValueMeasurementsLiabilitiesMeasuredatFairValueonRecurringBasisUsingLevel3InputsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r254",
      "r266",
      "r267",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r427",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r394",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail",
      "http://www.bmrn.com/role/FinancialInstrumentsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r421",
      "r422"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Principal repayments of financing leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Less: Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r220",
      "r443"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r107",
      "r405",
      "r406"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedLabel": "Unrealized foreign exchange (gain) loss"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r54",
      "r297",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "negatedTerseLabel": "Gain on sale of nonfinancial assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedLabel": "Gain on sale of nonfinancial assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r214",
      "r215",
      "r426",
      "r445"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r361",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r76",
      "r176",
      "r178",
      "r181",
      "r184",
      "r186",
      "r444",
      "r454",
      "r460",
      "r478"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "INCOME (LOSS) BEFORE INCOME TAXES"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r77",
      "r106",
      "r174",
      "r206",
      "r453",
      "r473"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity in the income (loss) of BioMarin/Genzyme LLC"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r225",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail",
      "http://www.bmrn.com/role/StockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail",
      "http://www.bmrn.com/role/StockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r134",
      "r135",
      "r175",
      "r329",
      "r337",
      "r341",
      "r479"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Benefit from income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r103",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r147",
      "r148",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r216",
      "r218"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net carrying value"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r75",
      "r172",
      "r415",
      "r418",
      "r459"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "totalLabel": "Total interest expense on convertible debt"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r88",
      "r260",
      "r268",
      "r269"
     ],
     "calculation": {
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Coupon interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Summary of Interest Expense on Debt"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "auth_ref": [
      "r141",
      "r144",
      "r153"
     ],
     "calculation": {
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.",
        "label": "Interest on Convertible Debt, Net of Tax",
        "terseLabel": "Add: Interest on convertible notes"
       }
      }
     },
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r100",
      "r102",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r28",
      "r213"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r49",
      "r426"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails",
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r30",
      "r213"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r29",
      "r213"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory reserves, net of stock-based compensation"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r86",
      "r171"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r41",
      "r113",
      "r180",
      "r207",
      "r233",
      "r234",
      "r235",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r352",
      "r355",
      "r356",
      "r401",
      "r424",
      "r425"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r27",
      "r113",
      "r207",
      "r401",
      "r426",
      "r451",
      "r471"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r43",
      "r113",
      "r207",
      "r233",
      "r234",
      "r235",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r352",
      "r355",
      "r356",
      "r401",
      "r424",
      "r425",
      "r426"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Fair value of financial liabilities, Total"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FairValueMeasurementsFairValueofFinancialAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r16",
      "r449",
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Outstanding amount"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Purchase"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DebtSummaryofInterestExpenseonConvertibleDebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market instruments"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r161",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "NATURE OF OPERATIONS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NATUREOFOPERATIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r101",
      "r104",
      "r107"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r65",
      "r68",
      "r73",
      "r78",
      "r107",
      "r113",
      "r124",
      "r128",
      "r129",
      "r130",
      "r131",
      "r134",
      "r135",
      "r149",
      "r176",
      "r178",
      "r181",
      "r184",
      "r186",
      "r207",
      "r233",
      "r234",
      "r235",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r385",
      "r401",
      "r455",
      "r474"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "NET INCOME (LOSS)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r139",
      "r140",
      "r150",
      "r153",
      "r176",
      "r178",
      "r181",
      "r184",
      "r186"
     ],
     "calculation": {
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net Income (loss), basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r141",
      "r143",
      "r144",
      "r145",
      "r146",
      "r150",
      "r153"
     ],
     "calculation": {
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net Income (loss), diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r1",
      "r122",
      "r123",
      "r126",
      "r127",
      "r136",
      "r137",
      "r138",
      "r195",
      "r196",
      "r209",
      "r210",
      "r291",
      "r292",
      "r293",
      "r294",
      "r320",
      "r334",
      "r335",
      "r336",
      "r382",
      "r402",
      "r403",
      "r404",
      "r423",
      "r440",
      "r441",
      "r442",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "RECENT ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RECENTACCOUNTINGPRONOUNCEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesAdditionalInformationDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "verboseLabel": "Number of operating business segment"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss) before \u00a0\u00a0\u00a0\u00a0 reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating expenses as reported"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r176",
      "r178",
      "r181",
      "r184",
      "r186"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "INCOME (LOSS) FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "Other Accounts Payable and Accrued Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r50",
      "r426"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r61",
      "r64",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Cash Flow Hedging Gains (Losses) Reclassified into Earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r66",
      "r69",
      "r71",
      "r72",
      "r74",
      "r79",
      "r272",
      "r408",
      "r413",
      "r414",
      "r456",
      "r475"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r66",
      "r69",
      "r349",
      "r350",
      "r353"
     ],
     "calculation": {
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "auth_ref": [
      "r349",
      "r350",
      "r353"
     ],
     "calculation": {
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "negatedLabel": "Tax effect"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r363",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other\u00a0current\u00a0assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other\u00a0long-term\u00a0liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesFairValueCarryingAmountofDerivativesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r91",
      "r94"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r90",
      "r92",
      "r198"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedLabel": "Purchases of available-for-sale securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from convertible senior subordinated note offering, net"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r95",
      "r316"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from exercises of awards under equity incentive plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r97",
      "r99"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "terseLabel": "Maturities and sales of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Net product revenues",
        "verboseLabel": "Total net product revenues"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r35",
      "r222"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r224",
      "r426",
      "r462",
      "r472"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r12",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property Plant and Equipment Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Inventory [Axis]",
        "terseLabel": "Inventory [Axis]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Inventory [Domain]",
        "terseLabel": "Inventory [Domain]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": {
     "auth_ref": [
      "r18",
      "r450",
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.",
        "label": "Purchase Commitment, Remaining Minimum Amount Committed",
        "terseLabel": "Purchase commitments and other minimum contractual obligations"
       }
      }
     },
     "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "terseLabel": "Less: gain (loss) reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r326",
      "r438",
      "r527"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/StockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Unvested RSUs",
        "verboseLabel": "Unvested RSUs"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r277",
      "r321",
      "r426",
      "r470",
      "r489",
      "r493"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r119",
      "r120",
      "r121",
      "r125",
      "r133",
      "r135",
      "r208",
      "r317",
      "r318",
      "r319",
      "r332",
      "r333",
      "r383",
      "r486",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r169",
      "r170",
      "r177",
      "r182",
      "r183",
      "r187",
      "r188",
      "r191",
      "r281",
      "r282",
      "r439"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Total Revenues from External Customers and Collaborative Partners by Geographic Region"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUES:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r9",
      "r38"
     ],
     "calculation": {
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales and Excise Tax Payable, Current",
        "terseLabel": "Value added taxes payable"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SupplementalBalanceSheetInformationScheduleofAccountsPayableandAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Marketed by Company"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Marketed by Genzyme"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalNetProductRevenuesBasedonPatientLocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r164",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Net Product Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationTotalNetProductRevenueConcentrationsAttributedtoLargestCustomersDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r63",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Summary of Changes in Accumulated Balances of AOCI Including Current Period Other Comprehensive Income (Loss) and Reclassifications Out of AOCI"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule Of Anti-Dilutive Common Stock Excluded From Computation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r364",
      "r371",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Summary of Impact of Gains and Losses from Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Fair Value Carrying Amount of Derivatives"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NETINCOMELOSSPERCOMMONSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r310",
      "r313",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofNetProductRevenuesbyProductDetail",
      "http://www.bmrn.com/role/RevenueCreditConcentrationsandGeographicInformationDisaggregatesofTotalRevenuesfromExternalCustomersandCollaborativePartnersbyGeographicRegionDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of Net Product Revenues by Product"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r217",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.",
        "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]",
        "terseLabel": "Summary of Derivatives Designated as Hedging Instruments Outstanding"
       }
      }
     },
     "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGSTRATEGIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r10",
      "r31",
      "r32",
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r311",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/StockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r162",
      "r164",
      "r165",
      "r166",
      "r398",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedule of Net Product Revenue Concentrations Attributed to Largest Customers"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/REVENUECREDITCONCENTRATIONSANDGEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/StockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/StockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Sell"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofDerivativesDesignatedasandNotDesignatedasHedgingInstrumentsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r111",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r48",
      "r71",
      "r72",
      "r73",
      "r119",
      "r120",
      "r121",
      "r125",
      "r133",
      "r135",
      "r160",
      "r208",
      "r272",
      "r277",
      "r317",
      "r318",
      "r319",
      "r332",
      "r333",
      "r383",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r414",
      "r486",
      "r487",
      "r488",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail",
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.bmrn.com/role/DerivativeInstrumentsandHedgingStrategiesSummaryofImpactofGainsandLossesfromDerivativesDesignatedasHedgingInstrumentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r160",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "The Company\u2019s common stock held by the NQDC"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleOfAntiDilutiveCommonStockExcludedFromComputationofDilutedNetLossPerShareDetail",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r19",
      "r20",
      "r272",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Retirement of treasury stock"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r19",
      "r20",
      "r272",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r19",
      "r20",
      "r272",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r25",
      "r26",
      "r113",
      "r194",
      "r207",
      "r401",
      "r426"
     ],
     "calculation": {
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/AccumulatedOtherComprehensiveIncomeLossSummaryofChangesinAccumulatedBalancesofAOCIIncludingCurrentPeriodOtherComprehensiveIncomeLossandReclassificationsOutofAOCIDetail",
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL BALANCE SHEET INFORMATION"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/SUPPLEMENTALBALANCESHEETINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW DISCLOSURES:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r47",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r116",
      "r297",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government agency securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/FinancialInstrumentsScheduleofCashCashEquivalentsandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r141",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Weighted average common shares outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r139",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Weighted average common shares outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bmrn.com/role/NetIncomeLossPerCommonShareScheduleofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=123585891&loc=d3e19833-108362"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r528": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r529": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r530": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r531": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r532": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r533": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>75
<FILENAME>0001048477-21-000032-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001048477-21-000032-xbrl.zip
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M/Y[=?G7P_!+GQ\[?MVM\5 \Q&T);4<0>(5F.55>7?2U9BTXP_^-^>WRMC-\
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MG]I<,*ZQJT72FFT@0U5# $-8R(?$UBL;/=!H&D<P7IEE=-E9GRDH!PQM"6(
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MGP-HA!AUDJ%6$Y2V(T4-@0:ON=Z9[=J:*CH0:LM*!E>K,T[LDXM)<6#K8QW
M-C,#LXWK*B56)H=436UJ K0I4C&FU9T2FYP2;:/B^K6-:VL+*5Z,:M0R[A!4
M=F2QD/?"1%1!UF;PFNO;-JY+499M08K)5,N@3(F&N)"XLP2^2MP_H*K@S3>2
MFU X+-%>1?16%Z#HR3I/!ESP*FBR9:O5W?M<_]7KVZ#-R1 F5QEL<B1ZCI$K
M6B0&Y[9'WWU'_?VH-T=L3E1XD0?QL^A3L"4)15(5&%;;<.LT8#>[ 4;[0N5X
M6IO;910:!&P2!@6Z"KG%$BR4;+4A4^HV*JY'9KM&S?E6!^F=UIPTI.!B=BJ%
MBN1JK6C,X#77*[-=HZ)42@FAV&IU!BXQ&B,,1SR=2\XIK0>T1FKSC63_RZBB
MKBCZC=[;"FVVV1*Z:@ <!&53V&IU]SZ?=?7Z5D5G[X'E+P?9NU2-0EM(JVH=
MIKH]^NZ;V5YY[YZS)_U#\YZSA6FK@^?7^.+V/<4C.HR!0HU0=$1C3;))&40T
M#'H 5<^M+^4'K-SCV?,YOCJ<9#S;46>UD<W\].:3QU\SR.FA]7%TT>=,H7 %
M;0PJQZ%D"72,ML4.H?5Q_YKK95(ZD+,RRBJ'K"7$\=&"M:(["UC(@!] ]J%_
MS?636*#D<U"L<FO^@964"9ERJ28:#MX-P+OVK[E>>)'P'XBN6&^R:=NZ8"Q1
M!>LDMN),S,/W<^WPG9/Y[-7GNG,.TMN!536Q32Z% LV]24AC,4HPDT&\'@S?
MVUV9_OHIQ+*E>J\L..O 4<!2E;.1(5N*/O#P?=Y5CK^K]WS!J<R@JHLRX+2N
M""$;JMI;KEAY" U@-T5_O?B_5%0*Y$/P.0)JDQ188T,J37N>W7;XOP>M2?6M
M8Q%+QJWT@AA-B<EI:RKDZI'9N5(E$@09C,%MAQ>\0BWVX@M-SD LT3I5\7\N
M1@GA)6[7R2=E-0VAY=QF:;&?'5V284S1@RL(WBDT.E0*%1UE5U/<#H]XM6.Q
MAWQY5EI&G^*H,B2,HD5?;,Y5$41;M\ OKM+#CWBQ?%B?SN12V^@7)9K(WGJ?
M$S/4PJEJ4:*U"B!88CU\OWC%6NS%+WJRA)Q-X8@0%:)N2S\\5Z# (6]!C'CU
M8_'J_2+7$$*L@2,7R%YA6 T\J$)0(R88OE^\^K'8PY9>/E=4J)S\ >5RK-GX
M6L$$<8QZ$,W._O5^=2L%GAWZ@A;RG[W3A;:\RSGFY=/)\O#VR6(Y$][T&(]X
M<?L0IU,^NERH</'(SF3.>7ETNC^3:RQ.CK>S!Q-"$HJ5',54P.88E?$JL3AI
M,!G-$!97CZ#:--;@?.8 6(R.#JI@2P4;K1"&*B"K5@V$-8R@VB@28S"2884U
M"(@@4BFFU,@Y8<IN$!O\C:#:-$[E@%UU6<=*IJW6I$(EN]:T25M-9BBYAL^#
M:O_-[!O$5#];T216P7L=C4H0G4W1YNP=6&Y+NPMN#:7Z-C'53WV:JZ!CL,I$
M#SI0TLIRU913">I\KG<;&-6WB:E>"%4);4.>F$*Q"0@4<="Q *+3N90ZA'4(
M(Z8VC$^98J,6BV1:<Z<< ^FV_UIL??HJ*5VVAT\=SGEM>VX/"%7]]($WV5K#
MR7D;P13&'%!C%-_GA;BGH<PEC:C:*$Y58L,/*FMC -06%7)FFV.J48)!NSV<
MZAM%53]I*F:O 6H 4&W7I^2S90Q:L_*L2MD>5O6-HJH77F6]U:HM%"ZDP%F+
M.N?J+ ?5L@M>;0VO>LRO>?H-HJH77A7;;CK*^L#60 !./AE!3A'KI<1\E:WA
M5=\JJGKA59PR9A.B=H"0?>L88TJ(K9>EL:ELS^S?MXJJ7GB5JEG8$X-XO0R0
M$Y*S;5O&7&S!'(?0)&5$U<;QJJ+01P"J;4JY5)ML($W99>VRSRIO#Z^:O/T&
M,=5/MHI;%]F:*>< NC@$G6QL2_-JVU0F;@^K^B8QU0NG(C25Q?59GPL$(5;"
ML-"9&IF#=FBVAU-]DYCJ)U.E.1B,;".V*KTH1LH0)^="))/R%C&J;Q)3O? I
M'Q03)FLJ"JLBH**5JV@@F%K$5FT-G[HS>7ZX_ 91U0NC"MI;])E]B0B4%*$C
M=J75K6/&+<I3?:NHZJ>F*E1C3,Z624%:93Y3(#9>VZ \#65MVXBJC6)5WFI2
M7MQ?^^.#2[XU7A:N59*O'(>R!GU$U4;Q*I,Y)%\PY3;_)SR=8E;*@'4(!O7V
MU*G?G;S^%B>5^TE4)8]LDJXJ1' V1L^Y5N<!.<I?0VE=,X)JDUB5\\85E9 J
M9Q"#14Y;1V*F4BU>YR'LXS*":M-(E<W!A^HLMK*JF%34RMO,R49F9\/VI*J^
M45#UPJE"+!QR5)Z3@QA,;/TO552YHM@JK@/@5#VH>DU 7]QYFX].RF3Z_/S<
MZ58VR0W>5<  ;),!8U)DH>X,ICHP@C([ (XU@FS3.9>WRF<-(6MK(1A,.M6
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MCVT-AB'0TPNSG:WGFBJ^=%Z!X+-4+90>:L?)%RWCWP8WSG9^/D:ZD!;1):?
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M$-+FQ7XXZW3[*PG"[QOVPY?TZ'2_=53_?GY4?]\$"[L1WW=X>BRJI[5X&!D
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M-I<S\0I;TXMFW>J8=0GSCIA,(JEC83VF/5*<2A0$8T0&Q7@F2V*N"#$5!6+
M_Y S)HO-TC@R&7.(4N<R(K0*&>!0JA &FTY1_" DFK>B-;=(Q6]-OQR/WN1[
M7-+I)IW^2>@FIX-NH^<;+G?2=[+\ $UC>D_,+^T>FW;C,O_[CV7'Y7NNP^[Z
M_OK!>K+3.FMV+D(WG_A5V4MJG?4_;J/]M7,LXA?G6&X]IO+LESX^6>#5;*N;
MWG=#KS?\\1$&0$H4_AT*7TYK@])(Q3G62!IO$->:(0N*(4J=E:E12C"WB"VU
M).2LA-0I*/%">L1C=P%N*$9*2PS2#-LGU31(P=<VI,0)K*XWW4YRT.^&T"\5
M_'DR\!;\NM<%,K9+]KT'^^Y,$I*X$I3+%-F4I8BK6-5(6HD8E1S++ 2C34G&
MI2>C"8PPZ06@4.P7(S('VPD-*&,A>,U<EHET;>, I'[?9"8T2_19C -MR->Y
M6;'7_017@OE0>L[NP]R[8^9FCA%N4HLR'@LL2BV0MDHB[PT)Q!&"75H2^X40
MVW-0F&+"1TKRUN/:(<TM08S(C'BE9);BM8TM@!2@3[MA2B2;YP;\J0-<WCQJ
MG)4._GMR[L2QIFV::4%3E/G8+4/'GFT6>-AZ29U6F%NF2TJN B4SA57JXN']
ME,9F<0$HZ1U!,G"6IL+ -A36-C20^,81HA?M'1VR5LR*.>O"WM8X,\TD_ QN
MT&_\B,DR6<.%WI/X0!<]51"<)$K.+2[.&TGFKS<W[W[ILV^>$/.BQ;C9#69E
M4>[1.7D8GO$MDT8ZYS)8F]A#C,$_UAB#K$RY5RS-%+5K&YR(Z[CTQY!_GHXR
M'SL@O9]..NU7F<$,>T[UFT]I9JSAR&FB$>>,Q0:Y%!&O+8,-AF=.K&T(G*(4
M)&<A"<QS2(^<),+^SW\I2N1?O:0?FN$LDCIIY[1.8'-H#B+")P:$,W%7D/1E
M9 K.5'?O-TC=:,=8VUN6YE&I)P#JVQ?@ ';R;J/?@"4MLEY#-_CD;-#M#6+Z
M:[^3P!5Y\(_0-_:/J ?$@TR;KO_VN0KTR759G %^: (E(^N*W^_T\,.^$TS,
M/=61LG4I[I?J^/R#97H]9?=+]USF4.O]%,5ZHU^4Y@S&G22N:7J]!ZB_#PA1
M+_,:=$T.]0<7+=MIOGF0 ? R5J V/"N0,T'XZ4Y,^Q@^:"?G)PWX9 *FOS<'
M;U3YC!L#3#OI=9H-?Z/"Y[T7I=7POAD6M)L\M<]JN%%=$&IS 5Q)W;+P;]2^
M_OO[47T75UO[C;WHJ]BNQ?)%%,9)JWDYH\_G55IK'5Y^N>[?((>M_2;,Y>+H
MPRZO@4Y:I;OPKL/+H]/#B\/3SY='VYN7A_3HM/:/^CD=LTX548)E*O9ZBYZJ
MV)60^10I93"3RNG4/46!JY)^<Z*?RESJ,J=0%IQ#/'"@9.H("L0'+&('3ZZ*
M4ZL 00?]COM>2<Y,-_EAFH.0_#=>QP]T7,V,X266W2D+P]VSV#Q+0;B'($R"
M12KU+-/ ^=YRB[A1-)93X4@Y29VAJ=?.EL1;4N)9#M1ATB!L8OJ4]!H9G'J
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M(<L\1D8J+((3SL;LM!)"2PA='@@%T#))$T8?$N,<0&C71!R,H-*-:MZMGR;
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MARUST_QK-)O7/W.=0=.//SR_\M?H\=W.Z6T#C>O?: ]NF5BOWVC=.M!.]
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MB#+FG3 <(ZVE1CSX%"EN++)&,)&!%>8D*$2BHJ6L<#FS2K1BIY9+!'O%"+;
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M(%H;+3/'!#%>LI --2=2:DXK DYD#$X"9S&)GB,'/Q#/4@^:$V 5EX%(4*9
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MF$,.+_,8@PA&\* 4%C;CSE.;:6E$ZE0:7.:<_[:;!Y[3F>(QRWL^H78PC,+
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M"S4&+*&,%, ^'V!)#;!@18,,2&).$0^)()!("44C ^$QLJJ9= :LXO/:W*,
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MM$D!$1QDTMH#Q'%!\4*A^/8&G(\5!BAP?5RXUI("+/$:^!9)8CWB,!;(."P
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MH;IB&)50J;/AF];N]+KA<-WH<_QRT \G/N^- Y_+XG%\YDO'FAYC?"^#>#P
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MS=W\;9C;U12&*P!=49MGKC\8]+_#G]NM:KZ,#^2S G&54 8@V8-!''MS8U(
M!7W<KW9VR&YA#_#UIK51^8;3!]8]?UZ=\Z6,?&_#X]@+5=^YWCDW53,3+APF
MU]&PCB]X+' )</KS!]+M]PX02+:CUG$7AK6ZM2SA,I7!B8[[68SG>^IV?/9.
MQ\^F$DGPU.$A#"=T CC(+#F) @W@\9_3)XQ*>PH].,&83:L_UV_OR)Y6 ]W*
M,85\T Q>8-"1[5Z9W+]=L5'S4V.J:6J,/KH:>VN!,K?3)&P'\^BYQ=CIN1C[
MRK8^?SC;/-LXA6.+S;4/8N]LJ[-%_^YNGJW3[;4]OG?V"03:!WY5C&WO>K*_
MMGFV^>6_1WN[7[]OK76_;-(-MO_YT]GF[EX.VWW9VMW_NK5VF#:_^._;*__0
M8+04FB-X2 )Q%C1R$@L4"0_>1TI-L%?%&)<LXMRH66'&\Z;"/$B"O7=<*@4S
M^:H8>[NRL[&3M=C[C^L[.3LPR[%[J+&?GG?YJ>?,>S"__G3\<Q?.]+;;]U]?
MWT3ZL?GA'Z=3"-(F!$\S(>ZD1%:XB)A3TEENO?;75'J3S?6E0.8,0<JQ7G0Q
M]K*H J,&GSL^&0Q/LLP#TP)J)G^U^@+((-!]H-:R??+9/X_A?&%^K/^J;="[
M\,%?*F_^SY65][].S'1L#4ZZ$\,TB <G77MAD?*;.Q%LW5@;Y$^<MY[.9N>H
M,QQ6DJKZW/KJKY6^^W "!K@2;1]CEI;5'DOO0,BU"$8?JH.$?@[I9C/</<F"
MM]L]/UNG-UXSR8?-G\R1W_-( LB9G$4 1G,PWK3RXE:J\X[-YRB>[V )3W-X
M\33;<)(<U  =4;>9+G8[8/(GVBB_4S\7&.F8,QQRD"/ >;.Z@"</ YB5U<57
MZM<\<0>RPAI6]PC/J!MMUA?GXOON,V (%]RMAF@0X11Y-L#]VZRU,B5].>F-
M5[,J 32^K9\=,C_3K2J:7ATUZ\6))$^=O&;4.HTV2YB\+>A:]/'(Q<%X69:1
M2BCC\U$+Y_KZJCNQT@.R[4X&OS[V_V_V)W ^0T83((T#39=E724^LPP\[.?Y
M#WX"'&UXXH:=T $EF_V)E6YW7/%WX8B"US <+]K4@0:SX0@N RYG?*DPF.#E
M5&?L7P1;IDX,N)WC=!?P/&/K".C@<#AY=CL9@[6'A\=>1C67\K3HP;,=#L="
M&\@)Q&6E:B>W=G[>:HIE70<#/Y;[,=PV8!GG-XX8J2)S<--CU3GNK[<8[LX4
MX!/8#^%I].Q!-3LR%(_L5W@RX.0>52Q8I1X-AR='QS4?W8YW@#L/4PZJ>5F?
MOG>?CI/4IBF?U]@BS[(IPPPO75:&KLVG #1,;^ ",0X^6GFXW1@.JDEP[EX
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M0R 5/VZS7W>)?7^83>GW#CS$$+/?G&?T)-)0^^!%=.S(=G*RA<^3,UO2_ C
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MY%$(N2"EUJ !:QD18%0KITP"D7EE36%6 %H ^GBG;'&2W<^<57.2N:0Y54:
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M*UK9Y0@U;4U*_$T!<W&/-0;$4_<8\YYJ;!*RC%/$/;'(2%#UJ:#,I*0CQ0E
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MIB$E;KCGCN6\5F.\]M(2([4-Q3_6=![:VET?U60*880#X4$A3(5"W (%F4B
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M4\2#\\@IQQ 6S D;1#0\2\.&M@6?57C-4[+FQ68AYVTXIH7@;VC+,4;B6E6
M]VH=[FK7_;2E@J K/R[>3>AC%26_H3Z_^K7UR&7P_[#=014QM#&NX7\RB,.&
MU+DG6]T)7#]MG>Y]^@#_'QX"5'GG$\#UST[WPY]OZ-[WOSYW=E]_VWK_1[>S
MN\4OU[G?^OY7%^YT!##_UMG8IYV-=WB/_O7YP\:'3UM';PC [MO>^TVR]?T
MH/=:;.U_#)'K!%HHLIYYQ)4PR'AG4% $*^)5U%&-&1=V8 SKF2\3X\"GFB9O
M.4_):!T"@[\P0:UF7%RNB__'^N;;UK_K?[][W=IZO;[S[NU9FXC+>[V^DZ]M
MI/#S.U\<J?/42B.DD#9R'(5SL"_@=8C8<&_(M37[SS;_DY;HWSV(K5?]([C=
M:>LHVFJKMCR0B>WV6JG;LSW?S>IIU9^J4DIKRFC+CEH)]OJX560+OI'5V$&
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M2=-NW\( [;4QF9$^L\CAG:ARM01K%K7?KHG>%8+$IO]HT[(<]RPP]..CX1%
M5.;HJ?,M!@3*$JAXGH+J!"RNZE\[.,WO@BUW/  *!J^G#%+9?,S@E&$K'U)_
M^3*(7_*UAX/.@>\< F,?8=I#34_O(Y$D&B,5XSE='G-'K&,R<1L5(9\W;K4X
M]0/]2.YH?)C^U@[JAURM!WQI5IH7!S [WSZK9&.P.J$@<V*PQPZY$!(2E OM
M*?4!"^"YRS>CL"MW;E2"<NYVH\_$OGM:;[E:I%XO5^V+WZNL\X;QH -;:7B<
M'4&=4;"#GQ#$O@/E7<,+:,QL3W:R%H_#HZHSK [M:<W+P/Z#U8NU5AW&7@?9
M \"D;O=T^5?KI G,J-52'LX+UDUD<_5S"HQ'*S6*A%K$N4O(81H0BSI0K[R3
MT5[7399)IZ34SC+#O>8..VV5MX%CH@EUUW53NW8X=+O]DPQ+Y\6TCWL PH"2
MV1\P@H&\$3,B#6ILF\"]VCF@?AM>V6H!%O#-3VB\'P[^@;IC:8'*@TNUS!F?
M?F5HODP56Y0RUGFP]RN1_MAZS#<_.L?!,E?+4F?'T#WK,#^O:5B+_GP6R.4L
M/&V1Y>^Y@&9XC@CT#*;E>@I-P& S,"NB]H"?P/FT"E))IX,SF//;F=]&Z]WW
MV=W&.6O8 H*Q?919QM]QD'>(_1(ON1ZBBZFQS\\+-TY::ZMG.W!?^![2/-N"
M[X=K>WF\[_:;G];/=L[^V6N^_R"NGQ?N[*_BYEJKTSQ;AV?*YP[_P.<WZ&[[
MG_V=3WF<K?W6I_63W;5NRN>$%^>%U]D"C(GM?H)Y.-N!:S^<M-[#;[WU_%=W
MM_WQI+7_Y]<=N@5C^C.U5C]3':/AB2(E#3 %R23203D$'-\+Z[@..0GY8?N'
M1XQ59#HY:;FTP?J0.]82FBAG4<1Z_V!"&2G[9]'WC_1<< 6[AFK%$ _1(!>)
M1@% 1$78"-CD)/;E6SJEWWCA?__0$AG9P^&X-C>:]C1;TZIZE5EE_=O(OKGF
MH7OL*?B+#(UY9M$Q/Z?2'AP4<P]GQA/'PRP*/HW+9 2<(BR.15I*@S@+$3E!
M-7(\<>&H"L&DI16)<0/_^HB8.8LY+)CV@C'MYVA6P;0GP[1Q"#5/GG,M"-*,
M M=V22%K@D,T$A&\4S8(LG"8]B*JJWT$\>C#&')$W\6Q2W40Z].5$%,<#."-
M?H)?LKO3Y_(0=WI;Z,/FYE:,GA/8>DB2_!-PL8E56SM?M+\'L=<Y[JT>A/JC
MP^%QCF.KZWG,4?CR8D!;9X*N86V#H4$B:;5''%N!8'<GI#!E(<G -9-@$)(&
M5WH^$N&GG8/Y0L7Z">A($>M?+-9CQF*PDTDEV,C,9\82/-)":MAK1C-.O8Q<
M@UC3AC$W/3U/6=]B*EF_5"RKN:0C8Z]7([.0GZ(:4[$5YP2PYHV&7(M->'L,
M_+ 83@^#H=,)=I&88 ! )-<B5(@3"X83DPQ0*68OD?*R;N*A=4/0F^D6<VHX
M33MYM C[TY"3(NS3$/8QYZ#!P=+(B*C6$CB'L\A@BY'F!B?!DI$Q9&%7#8QO
MDHXY%?:IE-UZTMZ5"S'($L\QD1J>0#=*+ATFGGOE@>]0P3251$<+?+W$<SPQ
MZK6^<QZ_V]N \;6ZS?W6/GSW'LS#R<Y^]VMK?[?7:G_@NVV8J_T_.W#??![/
M<-1,B("X,!IQK0FREE@4M$PD\N1PQLP'QG,P9X0)T3#ON9'<8N*\X#Y0S5,@
MJ<1S/)_]$Y,-R;F$I!>@<VF,R,@4D4VP"9Q.-BJ^M(*7A;G9X?.Q 1VKQU^.
MAT<YDH-?QG3P[\9T/(3R/D-6^W/ 7DX GTQ*QX:L(TXQ 8)%2<2(J[K&/O,H
M*1UD-$);#7+&C9CB">""VJK/4'!_3J,6P7TRP1T;I<+ZE'!0*$C%$>P$@9S,
MV4E*,<>Y"2#0\RBXY72^G,[/*:<HQWB_%+TF3^<5D8S2I%$N)88X ?2RUF$4
M O=4>\(<5;D)-J<WZ7TYG%]<J7X"PE&D^A=+]9B36*)]4(0CP.G<.X<(9#P(
MN9,YE)!;6&&_M"(;6MYD).5L_A>>S?-R-C^_CHUKQW6M_H$O)W8/!Z+)XWF5
MB($%BRC@7!K:8(<,9Q:)*()G%"L=)1A'VC2$FE9CZ'(\O_CR/A-Z4N1]2O(^
M)AZ2":&HX(@ Z4! -"32A"HDK%"*DN ! ;*\ZP9\8%'D?6%.Z.?_>/Z7GLW7
MB\O4/%*_=O_(=F\4MKF5!I84OA><PO>3-=8>I?>*MGN MMN</+/C,MA  D,F
M.-!VG@9D8.F05DQ+YF3PCN86M4!S&[!FBZ+O2BYR ;+' IEV1#G/ UCIGG.E
M322*69TT)HE+RWX%@2] ]C @FSC#9$1QES!B) *0!0H89GA"+EK&'0=]Q,T(
MR 00]Q):^WA:S."10O\X,\$YCJV][RB?2W#M[<7BWMG.H/K7=H_K8O-U-=ZJ
MKL9[G<]/LZ^%6-;B'J.[I65#7CC$ELDM92:='<91I?]7Y/44!WN_>7SS@YB]
M1>^U-NL>R-=+ZI]7MB9L>79=D:XE'3ZPTM9]#U@7C>S=]ER+S>>>(CDRX^X_
M&7;71KT6C@=Q6#C>0Y*GVAM'EZ6S5C_[B'-W58(\$#K$)3'(8DE1\A9S'*/
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M@=CW#^-!!9/Q-1Y51P,;<F/7W*=U6/FN'0X[J9-; P^KO^*_L5N17&SGZ.H
M]CIQ8 =^[W2Y>I?;"L,\YAT#G#[GT1_#/?+7I,E+>M%F@<ZYGG7/UU%+V8I5
M]?#);],,C_AQ/^G;5V"[;DAZ6O=BALT%$^'MP5&UZNM\U%P$X&_8K[XS=G;.
M;'/ (OCN<8CA8C6N+_YJW4"WVHJ'_<%17F58F%Y%,/J_=>?G?,EIM(,J'N2;
M7+0X/.\T3>I.TWCYF@_W6O/4E5_<FO>BQ-?&@>_WXNI!N'AA_1OLV.&$6BA=
M>S]\ME(XEF1",1&+>!(861H",A9KXCT#Y4RN=^%=H);H%VM?Q='BYRU]GW[
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M#E>;,0E%<3[M1!R/2OE[9#UE2$3-L#<L<.]R*3LE;Y[(O_YE\E"J^!<P>ZI
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MV:#TR^9CM7&4^Q)\UB"$0PB@:P564#DY#BXXXUL>:\5P=);'*H#<0) LUW;
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M 4YG%([B(&RYD.\%9H/Y)BPN1*-KHM=[#0Q <892.":*ED !JG%)$I@MJF_
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M"*\/+\;#JRFJCN603,;,Q%YSF6Z!8CUONNQU:>H0,\GEY>7.JRT[O)C _G3
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M.6MADRR&*5]9>3 %%BJ]84(.// LO'%KCZ&OU.W*V04SD2U@Y]XB^\(UD'O
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MB+47!PX)N(@D#T)?)BE)0R>2Q&0:MM!P'7W81Z.ELPU__?KESY"E"6,AL8,
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MP;D=.IS:)! !P/8DP;5 PA*7.&K7LSL([[]"8,H8[E'&,"D;T ]X9'XY+VD
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M&+I!G,C$$3S%OGE)ZL1>S.*82.'&KG?'G(:Q"4]J$_HU$-QCJ8@=6T1)8).
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M__K-QP^'K_=_L0Z/7P\W<\3')Q_>G%H?3JS7)\<';XY/WQS@;Z<GOQP>['^
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M\H[P9;UX6/](YL)*+M5>A^-?#UZ;8H1K8"-@1(8L#KTT)4$BF1]%7NIS*1P
MH20Q:8"-MT\G_>,30HP8J"-L$?LI]I]-;1;PU$XXHX =A4QBB9%#N$&92K,J
ML:YJ QJFD1<1&0? :NK% ?52QM+08<1-26JV,6RSDL_3 T[$4P\""=MA;FB3
M")0\2A+73EPB74H3QT40LGG[+(VBKRO?%[J18*X?4AX3AX>,B2 %RR\B5T8
M/DV*8!L4>IXB8"$X9L^-;1YBY5#@,#N.8\\F7BP#+@1ECO':NZK,Z)QI*@,9
M.#%)0I8$/@^%SYF7Q(S%U.Q3V&8EGZ<.>" 2ZG#?#B(?5#OD%)2<^';"A".D
M3WT72X$WSVOO;"'!A[)AN55,51^G,KVYED"K[!HZBJS43OF[.0#8@W D#OS
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M[F#!&%Z@3$R3OY2*E*W+5!.>M!.&CY%<8%D 5E;E9V!@@WKUU<#F:DX$0HS
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M=/9]V W8:"R;V50+*0%-*81R(?/<5I:W;LI2H$PH:= E2&HM C<XE!.$;9@
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MJ!M6-;I)3@%BV)72#&8R7*HF)?E\!KVFF*HENV[6.:\]N$X>,:VRMBEI <^
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M."Y=-H+S8><LRWLZS]HL&"AQI1:IDJQLK\GAMGJ,2&E<YI)/(:3.LT^R&^_
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MY1?LLG[VPZ**@7ZU#P^Q:_?5"2^=5IJNV=HJDH)?+;7$O)B"GE=X%0R$/>T
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M!,BK@#%;R&5E +#Y@GW5^;H?L&1.GRX-Q@M-'DY&HGE ]#]&F:C[^3>=51B
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M:2= Q4\V2V&$+UA^P2[K9S\L2C4(</OP$&7XZH273BM-USLMK3T@PF7%% ]
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M6R.H7:S#7[U@VQ<<3"9'DW@KE,7N(5__K=(<CH0XQ^ 22,D7M5#%);C3\>8
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MY)]_9+L$5\,RNAAA@/87SB]C5=5MCH>3TX=',DA*'.ZFGV]GOOG\P."E.3O
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M'$97 F>46#KF(0@4>860/R(K)>.SYF%^)I/Q!332*UM)Y0JC#)K2GAL]9O^
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M]DK>F)=%WYL3P!!E=9BH5IKEFE2D)?S8>9.U:U:H^_AXXP!>7F3.9?Z0$D;
M$0W8I;L4M6!"60=NW&SLKBU)MV$V]]YU!8F%]I0./F? ^CHELN7.'#*;N7&N
M&4AB.,#:7@WU^8@YQ'WU]<O=)$" H9(),?@0+N-!G1_CEVL$OU-TLK'[^!6P
M$A:OU/.#33HCJ$^AB>O(I(KQZ2Y^>Y$BRA@_YZ&#>FUXT"_O/WJOL(<[A3+)
MH:?23K]R)9EX5]*.4^P&RF(3R'.E;6R/<%K7$(:3R0<#0-V., W3,^"FGLG&
M( 1Y49F>1C9)@>6#?N&)7PS#@<V\M4%^+;*P#SGNI([3J0FR0KXFCMF28VX+
MF##\Z'D,A')6$XR(.%/@)("- AWW!!:H2U?\EF#XWB]>E6N4'":&Z]5.0X(G
M+3N+%3F5CF<9D;DS(4A9@SF0:+-M\F4]!=2@<8)H:>E>@\>)J?XR%0'TZ0Y@
MKJ6<Q*Y51G51Z1A^1C-'MDJ6Q6>?Q3\/6?R0Q=]%QZ5Y[Q6;PN5]_N'8<8#G
MQ6;79!7_62>LI6!4_L"^ !'>4+@\/.66$Z4MH(*'IJD:Y0;/2=D9=( 3W052
M=\%2\$?;1GV1+(A6R%K[:9%?5:N5V]919G+9?;KZ2EQFS<3X;#5'&IZL;=X)
M?^<Z=Y^I5.E:L:;N77'5G>41;AU,HR1OW9-\R!^5][MK-B6DD;F(;U[F5QY)
M,KDR*RS)0FC!GACE8M8,UE&SD80FEHDPR3)P=^@L7QFQ\.(E&:9)*<C6Y,8S
MIZDC>&@Z11YUFA?+WQ,_OAU@:7@*G&-5%1-F-,FU*..V@?)3!L0O%N\V!2A=
M.=9L@M=;4H[>%@5@SEQ:HYI>#*U+9^FX]'A,!;6-(4AH8Y#LR'W-XUWHPCS?
M33-OS*E5)-_MZ_^SOA30D?7Z2=SI)NDOC[T-N=?!Z!9%HBN$Z5C?D)/S?J.
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MO2WLWEL^";T^7Y[X6UU)4#=@//YPJ?4,S(SZSN"9Q^T*"87>F:D1&\$Q>J%
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M<28Q]A[I?6T&XZ:4I6UW]Z_DLT:N"!I12H8,&T[#&TF:<R' 3^;,,,&XG=:
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M3_[$3_X1/D-7(4HF)W,I:^7GVB*(5&';%?+#+Y,Q-FB9:\JNEY6R1Y2G^=3
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M1W9ZS:=<?PJ**PC9)N'B6-6*87&KS-3SXHH\/^_ 'Y>P7^@#+8?+Z_+FL0W
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M.F%24P5$IT[UP',)P?.;!2:RX[0^T+2:M636$"ZX60A%["@5,DP#(T..X_Y
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MJ>!)+9J0)QD7QU,OX?5*7#F3L0X?*N;$7(IC#$R0J!.I)PD&C=64PH>24J.
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MG562)_".E-Z0\3':D<E+X#'D,%.$A0YZ/QPV-P)HZI<F8[<KC:?0/D&U7AH
M;LHA?PD[@DL(^MC2YA_GC>>T[PUYLMJU .Y=E]2:,_?,LKFX.D]/<@OEHA5Q
MM(N28B.7/2R8^T&=/!X]Z1^G <SOS!O?31SO9"JO54(CX1]NPF0BZ7"Z_C0C
M/I\ Q;8>EU*JIFFO--O&AE.N20Y 3>U 0U@PI+!QG)77+EIMLL0#";;?\3\O
M/!39>[A6H,[@WGJGML>V%&2+\2.7H:SCP8#I8F*B;$7UW-K7.Y<Z->\)2SI3
MHF?T*$@H40E9F:"==Z)H/7R;D!LHCF:$J-Q02IGQN[L)'I.5/)N</=&5VI+E
MP]"Y]*=2(*+WF2 Q@8GD:1<0SC._CO,$XM#0=6F9!/84\4=4SJ[8^: I86*@
M0V^$'?C>EGM6,+J>TY:3^?)H(&J97O2<J0VIE;3:3!\1[I=[3BE)2ZB$5=O(
MG7U1(G$F7J-]D2-!AJY,RN3S]Z1(O1\R5Y=8C2X9NSVDPBH9DSAE'5/XPA%)
MM"CI1:_C<02A\[B9J.FFL-_$O1W0@T._:,^O",>4V2GX.MZY*MWB5R1=&B/L
MXRS7;6V,<2M40%$Q&$.<"T,!S%1>4/+7UX(>?48$.N^L<!#!X:MC2T/=+9IW
MUV2N/BYU2"<B%<>+1 WJNU V0J0S^%V-9]:+^OIK5DN,STC;Q,!4C%VMW>BT
ML^6#IV$;?B&V)N^$70M@FIU865N+&=Z[J>R=](Y LJSD^MA&=1ZQY$W"4OLP
MK5LX:#)N,&MSIZ=3+F4FY(ELJ5'C)L<P/NL]2^);Y3-^(I@4$8CG@Z18Y9V$
M<&SAQ@/Z-#^@(^^(S;^WZ.^TBX1-@??14B>KZD%%0]+&:'O=TAI==>V',L[P
M51S/=9%$,FC^RSW ,MQ4R;.:\!K([2CA\);!,8A]"9=6=G2K9I,]">@#_8(:
MPU&^=*A/ "%O5?UDLT:X)@I^;3 *=P(2HX+X_WJ8CE./M_E_VBVLLS4F[?K%
M%T)2B-&]G$<;T8--,[/F55RV]09L&\!Q]!FN1I\END-#+U\H_,DM7V:N:!!R
MP+/ES*_$7DC_;J9 $,S6V),@7*U/J>!0!HXNC<O0WX)WY%,5N'%_%N,TG[1=
M'1$/#YDB_C)L!>.0=!B(6B)/4(4/87T89%^[5)509%P1ZTVB&#O.RS\^+\[]
M)#:>C>:HYW>Z]XPM$W([OA@;7:00?'?EIMR5%_>$#Q\G\2/A1 K*JU(2E[-9
M>6YC84X*6Q(,.A3ZJ$-&#U6 ^1/_4)H'I0,MA/]4@(DIOZT+2A!-T[-"H'39
MG^#(<"XK_W#5>W6<#2M*E0R/+/52$F I=R65'%*'1*XHD"#;C'9,Z@H<K+'_
M'[K=6/'KCI7>M3?"#--*A2:>PT09F]ZVS0+A!=S?<:L\Q%:1KH=@38A<,LZ4
MK5I:&9LV]+G3Q1F'VQTOAKS? LCZE8!M/CV";8Y@FZ-]^@5@F]2R\U V:5Q<
ME?/.4,"6Y53NQ(S1&5I66F)^&CD0,?+(-"L7E5("E^>M<G!8[D"8XYA9W[57
MMMU%V50_:WU$.<R!R:Z0$=5CG3-8QFTUHB^V'G"]H9'G&2FRJYDG)Z9!JWM]
MX$P'SR>E+"PF%HX_3F'%_8Q@VC=QV@L_M92K9$XD)6T^GKE,5 R5LIG1;R5M
M5NDRKO)SW:>'PG8+,8CKRZI&&8/:67;[P:'(I&-.NMQ2,EOF3/UB'7%UBP_<
M0V<N\-0_5HD%GP-VOKDH&$S>5-G9%#93,ALM8]RJ?G\8)&U:=B F51V*^ZR<
ME&+-UXR4P&0(D$@;<S=J6IPB]OI*..7L>9#>/9>DV-Q;T:7(&UMJ2-6T>6M]
MI_?C*[NSQ?C_- ..[N+5V]00]/TUV8/+:D\&FT!-[UBH.@[X(]NUR_14S"3!
MHF^R2:Y0_88L,L@V4+'K(>"BNY._Q3N8-!0#%<J$BX*I!^K#$SEW:!#H<5.9
M;3PDB!&;%C6WN-=)3ME+)0-9)F@VZ+3$[W=,F^@8JWIE\H@_$:6Q-OQ(?EMP
M"''Q$+E(D@)>MUHM]0*21/R)A^1Q9LP(;S1^[#FV$"2DE>4D*(& *H];'O5_
MCGTI#^ 23@67,RWK<47V\^.8_^-CGFKHG.J*3B1C0S.E]N5.X[S:>)R;!]X/
M%UWHQU $/_PJ5\T,*X9T\!*F8P4XXX5B=)VK$Y<J6INW%6COP@S5_W&:'V":
M'=W,"-U&SD334@> T.*XBBP^Y@!]M&<%@\]S=WXC *L1[/@X9P\P9XH6,ETG
MKCN ^V %@+FFM]OK#0C2<X:"Z-D,M<RJB6<-U^UJ1*>10)8Q5EN3'$9T+L_;
M*^%MB!$2.=BKK\4AZ;4WWBO7S3TK CE!TQ[7Q@.OC1DYEB3CQ71#HZ27!^)D
M:)WI]I5JY-)9[+6PSUM96-R_T#CU"Z,W.\[X \RXR[?TXCMQ4B!&(FL1;E#X
MZAR/T'$2'LHD4\#',9U31P24T#%5FFY/-, =P+]$I3PPM&ID@)4"+*R/]O&!
M)LJ$^-P4^>X_ A"?=VVY.8[V XRV41]S3PQ% =&!. R&O@_C):\R"\?A?X#A
MS^C&0TZEQ<TM:R8M8]90[K,]VID'&?J;<\*7([L,Q72T7W$_:3Q_H?22@B2F
M!Y14[7$+/. \P);/,49/!1Z_^A'4KXTKQ"A#+&F U<<CX2$FQ.ECQ0AQ7>U1
MFQG/S*QTAL<.*YMP!;[^.$O,G@F%R-YPS:GW ]P'RLU(/WU+EU8.!>H-H:*?
MIP'>UX1@YLO2GFTWI$R<KI]S(OXU/LC/U>ZX1![VV!)A+Y1C^MYBG-2;0PIL
M.Q8EN%GU5LV+<U+6\3@['F8/LV?_?J@<\VK:5MJJC-R! C18P.5SVA?'T?_'
M1U^HU#D-SW30J9X('X+S-A[BCS\R@I=G9A>H#\,ND_C3Z(]?M-2W'O_T9=5Q
MK/FKIS'[PQ%9>416/D;T0T;JPE$=V0'V</O4\04""Q]MQ&<FI53!&Y#/<A4W
M8/Q%YGNECD#5%Y J:V+KD(;9801A@&TA>-60'<3QEZ($+L4$-(*#]9HX8WJE
MX\V>(K4D'AKE\Y749M>*Y!A!(@1ZE3S%^ ]0D31KX<^!R%9V:VYZZ(?"U3?2
M6_L1$U@-!W"3]Y70H%)L37IF+\Z1!F)=EU04Y4Q\ZA,?]P4VJW=A/\!:KSYY
M^<G+0DBGRKR') Y##NWA9\*+<$\=9BZKX0F/'+>'N>K 84\I?.&<H;_>UDUZ
MS6MGQ,$"A5\Z7\!E@[9]T#>P5.95&+V]M*9!(1<WS"1RT1<8-DBHN@%,HLDL
MK!O7MVBHJ\(/$>F7M<J%5WT=2KQ/DKP"_:Z@IE#U(O>>2?<2ZYEKXE>.\.%F
M;VSE4KD23;L3AR'+VO^%T\CD?!/)C9_(==M+L6Y#6-=A=#I;^Y<1F1*"LDEE
M-!%J5\88R?G?)8%\/RK;_W-;E[%CC9>Z="NZN9]JHY![I'BI\W#3"B)!9.%3
M^W0T+** C:CCHF[/"91M489:5Y2Y):5)@G(;2R.<5ZV#?7+&7M<RYYQO"NO,
MS4E^>F>_L*(>V=PLL0LTPE:AK_E=.ZAVUZ8BUXYMLT$NP?@".I(M2QKPUO2.
M:HKOY5=Q&9-4W ;T/\0I MP(W7DPMA;<MU#,,#;$-4%S-V'?60/<$LCNL0WV
ML@3&.AMPEHWH6*GPX\:_7YP $4Q&O)%+,R@H>"L:\ ZE2'W=\*D.>_H=4[C9
MHRZP;=!TEE7-QGOD0TRF*&?)PXZ"(H8=\OKN-/^ IT-=JK^DC@2%@)_?V)V0
M!ZKVX"I498YA,L+ILB8[?1 ITCYNUGY[(W<P49)BG-5:NF"<B=9%<A/@IU*9
M/,'U.V\L3N.@O*!&=&ACPPWI?:J/A-/14="N#SOKSH2+O_HR^G_75*:(_\,,
MQT,_P+5)60D:F4,FQGM.OE@3HE="]EN!+YFQ ?G7IB+/)1[,CVT@%WMNF#HJ
MQD%[M-C T=(Q.EF=J:+2THA3E.]'5%%Z,U/0*TJZA@,LLHEI"H3[E?-T.%%Y
M'D8CF\Z]N6^8LED^71;9F&DBV/?B6_'!$6:6%ED\WHQQ9) >&0)SD.@0*HJ\
MW+%JIM#%\[?.;^!V)L^9.4?=DRDF9A? -\16J&T@S!*=E+IF-X2>Y>RRK"@X
M82-&WJFGX(PCUHG?T$FT\;>V<]CC:9I&>,*$I\L_E35Y#)@J]KOC8UQWQ$6)
MX>^5S=4WQ8Q>3OI>0E^QJA[5SA%Y44@7O99>2$1"+> OV6DSC\JT:[)Y@1*-
MAC-.]O6HK=X<(Y8(2EUC)9%2RBA;.LP_*ZN$"MFF4FRQ$!D8:_7AWH%\E! P
M=&_$*73WN#B() 6I?M,D1&__E<:3!E*5QX@'YB:Q=A9+KWY9LA4O#S$@[00+
M"SX4=PI$8[\-';5?\2& J77*(1RO4&-\BFS'V4"5E:'GW'*BP,W]>,"X#2%U
M,.HXSAU)(]')(?LB_>2^S-.;OXUI?I+J$WC=^.[P'F1TQ]_A8Q KAC@$,J,B
M5&^)? ACBB.A8]'7?.]X)<JK-GD^)R-K2"U?VG-&)[^9"*%E",U%>2%<FZ6/
MNW;G5>.:N6@,W)"\^OU_PD%M.Y<W6)=H=)2W9=69-)18-=!X2UD>Q@YU(3"]
MDE \%$2M1'N"ZY9H.*6T1:6(OCG#P71;O"Z'+IY(I1#(?S__!66X$_&D9&<=
M-^<(;^"2S)I#LC,B[IPXU(6<\8XXTT_'XM.S>&R['WS8GA\.UGJ3LS ]LE-^
MWEWZ <_;;$J0G-=Z:G9A?^CBORE;%DH%<N3N+ZN2L);D%8^\"XG<&>LZ,7%$
M$!(ACMMC&Z#E>,B90AT [:QFWA4W7-[UY@#B2KANRYF!CFMS9>N(/1KV4H9H
M\B[H=Y(J /M9T,.+D@)NR\/@IW7-MS=ZF)F'Q,&"CXD$;Z([N4RBU5N>8F%]
M<>2\Y?B9F=<,#^Y7P!U^,6,@J'V0F\S2V#VVI;'<(GF;)\=MQZ5$QV<@X*%J
MP"6=0MV-SMR[0?Q$LT>J/J"92>Y16@]&V^[IVGL)4[6M/!KNPRYA/\O-WPX;
MIT.HV53%[N;INT2X..=WNO8:I19=;<NK>&S1LL-]*J89/>R8[5D!PCBH4IN&
MNI]]8>E<1+3&\O_8%L!R>^C=KGQ(;O-'K(&*Y[5O:Y4/S2;8YM=8[9 X9J=H
M;9TR:) *&P0+HQB7'O6 I'QK#EC\TY$<[R%0#,T-LS=81:+:89B1 +(I6IVC
MJVU0!9OS<%G6VR..Y(%F8''8:>]0+7U]*>=R%>.^BJ*TS8'\^&N.HS&+8JG,
M4#ER$#%6=(TOJO9UV55-HOL>V]#CK/ZS9]65P9 <M8!LYK29SF(/E@T4=@\=
M!8KP5R5]P &(&NL_20?&F<OJ?!LCNB5;7GQ$=NC7#H;YXQ$,<P3#W-<R_BM7
MIICT6]R]SU>WFB<BZ);.6)3'8CPU% C;J%RKLD7=* L'!0*77+J?%;G'PQZ/
MHW_V<82@FX.K7W)J0$F'CJJ_'>+!1'I>DO3^N$#BB(U]"KX'(L08\G%7 +N?
MR@38(>.XW9951U+QZZ&#N/>3B)"17++0]06'KLFA2JHHL(/,VT'9< V,G$A*
M*<XYD0IK(D+I[V6T'#Q*%"I???;;WT)W3TRAM-]\D#0G/B7SQ21+F&"*#]+&
M19I%4S&2@1$ GX;D?HN., 1WV.%ICN ^29_X;Y7D5 W5F220*(P1BQNR=@*-
MK$ED$\CY3K)YD]4LGC!G#*8C^S2R,S^!"9">WIG4-'MVSDI9D^$DEZV@'T9+
ME36!MJ402.-8)EIM%^()#S$!ABX#^+"AR4&UQ:YR4I(L-D7J+Z:30F0:J+)9
MRM D'<9SFIZ(T:WTU&1ZZ!APF@@$+N7ZV55UT78,9^(YS_T*U@@372/CG[K]
MSFK<;EG7+J]L)*2N:<#54@26V/?MNL(%M$HKRY:!<[PPK6/.;S@G8:5(O::E
M"QXZE/ML9[D7,.5A?G,.]X4CO=+)F+G5TUCY3$YZR_S1M'"J-UO!!@%UB=Z9
MM3M*]/+9-1"&<=.[?/ O20"/SD4/LR&I08%;":BW]\>N@DMFKYPTB5*&V0MU
ML2QFBU=8A0J?E#5^RR@R:J!J7.F%V/$SF3#@8V3Y&B-F=-9)?4:JYK]P7PPL
MOTC#N[ O"H7L^0P_K2BV!C-0W;L2VOK(V:'E\!F4PF^&2D6<I$;.Q+>&R218
M<@Y(RXK3NC4W(>P8 R<<BT.ER(B-8DJ2TFENG)3=2RWE$R45U9#!<Q\],@,T
M_^ _ 1(;"%BWE]SV^Z"KI GU'&%;.4#&6=8=JDM/L!PDB'U'M")$=(*6Y5&I
M&NWV+3O+_FOCRV9F5 H9DD*0#MQV$+?$%<*]0V;8J&1=M[VYC#TIS@KBE78B
M-^@9KBDT53MNT^/8PSW')9W@<"=Y9ESOBOMFFN!;I._<55D>*.0H]>B@-J)G
M+09JTI[]--;#%\$<:TP# ;_ 0!@7Q;HB0[DE>;1&AQ#:P8VA+?R@X.CH:" O
M0WE5$75E<X\-]/=#O!^P9NF&!7/K@0)E=&^;/KB6J8E=0(2RI$BNRP&,W!I*
M:D\6ZQJ@.;K;7278!RZ25)X7G/O &A.%UVT#(55:$(05V#IQMGC*=]380XX
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M'0XJQX$ZWK/;38DD7P=JZQ>V /ZABB[BCQ9)WCYKO!YY(;AU6:1,0GS_YD)
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MO7\3,@<=DJO9+9$]B&=14-^Z8^YD3."J/:^5QUD\O!C$AIOE01C%2VJN$Y[
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M*I2L-^$N\6D 6-8I5F!^Y5)L>4[P51$;63T)P5G#KKP *FG$YG88#HBMQ/6
M_L!IU10^\WX4?_:3:)J'\#N9#HB;HP?U0^(1>'#:MWMV3?$;(.?*V,17Z1\=
MF'1,'7Q:&QENV2P)*91'XEQ0I<A8#K@<X$)1+AP#R]#.]K^LK6,H.#J+;4N\
MMFVWW7$[BKT]0@1B"5(*\-))"!E,.&A!*.-!"(@QB<(@34?(/4[CV8*^GP%3
MREA870,0CA\-^I9X$J7(O62T\_C81 3YYB%UY&NPAA2 6NAL_EQ^4SY=WY1>
MW#P$?A]DKS'?H5W@A506[Q$6SZTLWJ98/(\LWL.-V_D@C<&V.:]OVKS*M%6F
M;4VFS:M,V]LR;:UVL]5M.")F=YL[7OUJDDS%=-SV?YO=)MFVXR@16H4^W1(?
MS7')M"C&XI=R K,'U*]B38_#JP3-J4OVM).UI^TR>]HCMNZ<.74:E3VM[.FC
MS)!7!<=OS9ZRJ]@19J'I-.M!L^'MM#SA*GHNF5-E"P^(S6[ T.DG4Z-&%_ZP
MS'2MXO(!&S1;Y8R!\FSW%1R^2N&?1^&KV/"E%7[^*(UW&Y[KM+Q./6BYGM<
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MRZSOKN*" BP2]$V9!5\ZI*C@ .)"V.**_I^7W\!64?D!Q/"M_P_Q)V1:5'P
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M"DB=]9L8=-KPZ:'3^WJD(;S&)M;F9:UVM=>@!?R($S@A'7:UT<M [SWT^OI
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M:9=5#X_#I"W%UII0/UJ-G('+FAG+/2>9E>TXZ^BBFQ_1EBK/32K)R+ODU#K
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MQ3;]HJ]B&=+QQ [5SS82J=,!ZPS$/V=?H9L6I^1<"WZ$@/3M1RH ][&TE>3
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MJ\I&C:<N:(Y?19M#^'L"'=*&ZVZ)UE*B&UK;L]?+E^![^,??_A]02P,$%
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M-O@P&>?3-'L_^823K\.$!]^&TP'7T5F3-*3H'"@T1%5NZSU/BEB,C&N:J/2
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M"4$R":@M\B T>?1MKJ@V0?D<B-),*PV2I0Y2.CTY/:[3*.^*""Z//2US+?.
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M=ACB0DH[9/=V\-A=,WZ[7OE*]".B$S):GH/QBL@1BDS295&$#EES\T"_C?4
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MN9PFU]YX+$#,1M3;<!L=8HR-3,$[(7V/9.I63QT6^5^R_(I([MD?K8].*5/
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M]AER$!/SH+U+SEFM0EYKCM=CU/T]<>B>5+^)=+M..UR@^G5\NFSIR)UT)>E
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MM4&I]P5H:@Y*U<&V[H:3U]J#WXS^H ; <<,V_"=DM\1.ZL,8>%6=T#?1O6K
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MX6AGA@>&#_Q6R3O-<L;MV$ZUOO$1J?^K%CQN'X0!*R"?Z/B,?$/&8D]-%U6
MVHS@D'E,># )D,G'%B;FG(!"(;S8\Z(HY)YPSCVTT\G46'V3BF<M:!TAV2$I
MT2Z@[2S<%TP#$V<'A+IE+CH"P7E9C'8;'3^CT1&U#F8W.O9LETQ'F;Q?I-GR
M8_I5_A^9+^ZE_AZRY8/,TD7^\,IT0R9AN!0-E[);XU'VP5S>W/'E0ENUCW_H
M5]ZJ_]:[(>Z'7F#JHS/*3%T$CVF20!0F/(@%DEQ+8D420PHY-9+Q_QQY_QU4
M6H&F6J#ISU<J!K1F(,U K9M#5N=!1]WBA& "8SDP$VH-0:DB,#H"HR2HM708
MW)O-X%9ZKO[H<& QU'"[I(5Z_V$?*X>4'OZ7<OB5&?Y_F.%_J8>_J(:_: X_
MW_75!6)[;B^K<:_^Z"WEU+#CT9Z?:J"^1TQF-2QZVYFO!NZK@]'0Z*D28]7?
MXQ^+QR^+UX)FHNKKP9P]UVS!,&%!8#:3'D^@M@$P)"32VPC.?17CR*.!5=6.
M[B),;<&_JHNO+1?\=Y 6Q6N9R^DU$V;6?Y%F54^J)<&![+L-CL7*/3CD Z_+
MS76V7H<WRZW6 :R46*VTI1I=UMMN0^"PF@X^%".ME=V&I*<E\"P06Q>X;BV/
MMWR=I?G6XG1>2]TN01IG99>9>##D^64QU^\7UV4TF=Y[QB%A*H$R#@*( A9!
MRK#>>TJ]2Q*,>S3R7"(Z3G7HM*R,$-A1Y6)L9C$U,ZAHR/W/_X0#/_F7.OS.
M[5;B)/QVEPI]@CKPPO%I!\GK=M2<[P!LH>CU"/]DIZ.>P-M"L'N ;OU>-ZII
MY.\WL6FZBZK9!W,RO^VMRCBC(<<>Q#["T)1XAXPI#!.%6*)-7X&84TTZ^ZZG
M9M4V)+\HPRH;DP9LQ+=Q9#UW4.RH:!BH!R:E'E%V)BQWP'JE+H?N1R4Q=UAV
MZ:Q#"UVS0V9E,Z;HT]6K-@V>-]FUUU5S!16,)4)!#YLDUYR$D(8R@EX<::;S
MHT32P"U9Y.E.IT9FGR0MI'OU B><[5BJ;_2&WVV7XE:%[58"#UMOV 6BGE-/
M6G0\<B9*>RCV$U,ZO-N-?WY]^&FA-XZ9H;K+)YEQ/;,,XVV(KCX4\9(P"12*
M8"P";AQX*21AQ&%$8R4]24.?1"X<9-OQU'CHUS\__!D\K44']*GTE"_68KOQ
MDC7^=MPT!*H#\].O#V C,U@)75E23?.I]SA15ZQZ)2KKSD<E*U=(=@G+^?T.
M=QYU'$.CH]JQ]^"T\6,?:8J*(%:>J0J%)*08,Q@204+)>$!\;GW7X=3UU(AK
M%=RS]B%W.$=WP]SB"F,P) <FJQ6(3<9:1S X4]:Y0#M<5 P&^$@7%"O@FROO
M.K!&&. W*W!?5_.=,&N]CW!K<;Q[B$Z:;MT_=&NA\Y[97+Q7E=8_I\7OG]),
MWBSE<S%#)N\+EP+&<1A!Y/D>9%@RF/B4BU@EB%&GJ(GC74V-WK<D!494\)L1
M%I32.I[LM2!LO4?N ;?A=\:=(.NR'3Z!1M^;X&/=C;WU/:'V@0WOJ3>Z>,G4
M6^>[3-8+9XBI%WI!#,-8*).24D$J(P&9" 7W$/.]D#K4"MWKP.4C'RGC9RTB
MT#*Z.%#L0<=8+#TLJ#&H/8A"A2!%80A]XA,D D^$#@;U6<"-PJHKV"[/ LW"
M(CX+BJ&)LO'Q='+#V0/$Q<7F'&#&<I]9 >3WY1)S3.EV=Y>]MT9T93DF\;:;
MRM&GAG%!65] 4A$E/J(<8J2,86C"(!0-8((Y#<(DD"2P"H-P[7AJA/;IYO+'
MFT]EXBAP>?L!/#S>7?W'SW>?/EQ_?E@YHUS_YZ\WC_^[7V<4QYO@(> =F"0/
M.Z<,<NWKBLZH_BKO<^7K"HFK_TI/U[V;,AZ;'96'_ 0%L0_]*!$0"1]#HC>M
M,$3<9PGQ&(^=;G</]#$U%FH4I^F^23V$I1V[G(G0P$3B"LX9=7J&W8<>ZN>=
MJO"<W'FV/=HQT3GG)EUZ<4_?3#2!9A7]F_Q5BOWBZ3,E_(0@HF" E ^14@0R
M4Q<T5#X-/>HK)9RJ@3KT/35J6(D.7BK9R[645M)W=_]P&8PD\(.0!A*BR)1F
MI51!1J2"L1>&$4<HH(@ZY:$?:#!&<V"F[SXD=K0^$- #T_WZ@[]OH%L+#AJ2
M#^"FTP&P?I/=._0_;OI[=V#V$N)W:*+;0K-7/6E5QWZ&/2]"41A X8=$,UG
M(8N]"*H@),KX0Q.,79:5HSU-;1&YO7X$-[=7=[]<@^\^W3T\? _NKS\#_?=?
M[F[!P\^7GZ_=N.HXQ';,U MP _/0P8)O6DY0"MJC^7D2C%XYYGAOHS+*2:5W
M^>/T"^?O0/?6V9B',178@\(D7T=(VZ%$1@HB7V(N0A0*FG3=BD[=\/RXR/^@
M^2:Q,%\EP5UG&.:U.Z9S$:\6Q-TWK!,V91H[UR&]BVW0&&PC^[Z&B8WJ;5O;
MGDR/(E_.?DFS]/GU>>5G1VD42![!* SUSBGT L@"1F"@@CCD/$AH;.5XL=?R
MU&BB%LZ. O9Q:I_O9VD_\.2NY>K1$?>HMFV35[_4F+CZ;[N3=K_546;H4656
MT_'X ]T6\A]?BS2317&U>&8F[TBZR$R\@+89]+S6/Q6I;JO\]66>F_6KC&:Z
M*I>RFZRJY7>GCKRRIF]_1K'/E)=$D'#,(8J4^2GAD..8^'$81CB6+C;!2')/
MC3=N%QGDIL)(94P4)K&022VBMHK_\;5:YL>-7FX6QUB?AIWQ,L$!'Y@J5QJ#
MALH78*,!V%(!--76CU7&IJD\5JIN/HMCKS:BN/HSKT8>KUXMM;%D']7H&WE
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M)8D]&<E0(>&TX@P\"..XS98J#(^]W0HS,*(#KS-;SEPK^<$?6H&U1]<%6.L
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M;BJ1!SZ'"),0DM 7,,04Q[$7$M^NSG''_J=&'EL: *-"Z2K7R$S9T +\9O0
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M$BIC&!&9L"00L>2>"V,X]#TU&C&B@Z;L)G%&)?TZVYFQWLXYO7 9&LLKI6$
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MD$%C<-/E:!G\4=ILHQ9R#NMNPG&-H._US<#@V61QN0-QJ"Z##9B*HHL&3-&
M6:H?.4N6,@.G.P'JS#T&3&HR\V8W4<GPFGZ!G6)N70WX=3'_7G#!/_S\7:WJ
M[F:?BAF9L9U$@,W.2"Y9S$3,@0BQWG]& E 4$H B$H9I$B=(6M56V9LP-F:^
MN7[Z6_#I\\,_GH)/CP]?@D]W]]?W-W?WOP77-\]W?[][OKM]^JM=0-AC7LP"
M1+]H>V9Q'1:6Q:N-^?HP[!?M@>*A7X.-$ZT$)2\[5_U!=!I5]C!CT"BS/TS[
M4><%=^HII7S0CWPBL&3J?RF(,Q*KV#-, <%9#$(B(:8\9EF.;#:D#H<8Y[[4
MLF7G?_X'5@O[_ZX[>EMJ)A]"BE&">(8R$">0 BAB"7)*.8!)BF4B6(QY.JFR
MKY]69+$: MC]X?S!^T&\%+.9IBM*IKI?^L5XDI20/*449#C-%9Z1!!@R!) ,
MLR@3L7I99S6>MS/#)#H7:#:#^<-2C> 22+-WZ670^%[QM(S[_X+*/.^2M:<1
M<:O*?3C,L!K<)]T\4-P^_<F^N6>OK_-9>=NJ 7?5QGL"*4X(9B&0.$+ZD(0!
M$J,(<)$D829R2!.K0^83XXPN]"[-K-Y13:_ZJL$]#WXI9O5O?K5--SN.L1DK
M.$#.,S74H#U5H%5&7@65F2[SR3IQ<)Q%=GRL@7/'.AT^S!CK_K@K#023ZJ8)
M$:%$(>8@BO2B/A%$=P7) !("Y6&&>2;%97(()F:,C5VN#6L-+Y5),)HBTP,@
MW\![/Q0Z*IYP4-=+CM?U^E12L$'2LZB"D2GOK*]@ ]=YJ06KN_65DUH6+S.=
MYG*]_)O@:G7V<C=;KA;EGGJ=59KS"*,TEVKMK]99,)(AR G# ,>$<H$9"2V3
M^<Z/.396W*KW+(.M^<'U,J@="+8>6%*CR0R8\:!C7#V37@M&<@Q&#UJ[%@ Y
M5JPZ/^[ XE7&0!SJ6)E?VN,T_'X^^]>:3 M9"/Y12+%8Z 2\;4Z>KFNJ2M#K
M1X-&*EY+9 )DE&4 $A$!FHL<9(1(0;FBIL3H:*;7Z&.CJ?O_^7A3EO+9R[)8
M V]P5NX33M_'+BW3@\;VH&U\A7-E?I_.)=: 6YRO^P1^H /WG0G@S02P]@2\
M;;_HKL[>^P+7>1AO?=/A3N?[^KMS7-_[)GV7^U5.P,/L9C[[+A:K0L7&6B&Y
M3,EZ)C\FA.,L%7D*)-/:QCDF *>1>C$@J&)6E*0YLNK=<';$L;T'KCG_ZS;G
M1STJ;&MW,)NO[)?OYR W7:D[!-+[HGP+7\O:NO=+G:VI3':Y^C9$Q_%"^]RH
M Z^I#4$X7#Z;7GBQ9M&C:-2URH*19DM3\0Z%,(0(8 AC ,,, B(S"A"*N,@3
M%:C*L)'S>#:GG_,C&STVNUH>ST-DAXNV"AEKG5OT%BXZ!;T9_SA"\AWDB7:A
M;)]F>)$C.H..+P6B4\.^E^C0&1@Z=(;.7>DJ16>3"H<@X7&.4D"HKKA-B4Y1
M)#%(TYPI#D(\I]BJQ_G)H<86[+0MW4W6L4Q [$#7C%[<8.:95BR2)+PD$IX'
MR7/>Q/LD!IYW^WP>A:M$OTUZ]353:_EU6>7:W>U7-_<5/U8?IF68@T0H,)8@
MS)E080YB@*J5%L@(E91'<2:8E8[\A?:,CH_6KZ]D\;-\3W_3U>3+^C"O<2WX
M4*5LE3IGUP\W=UJ8=[HNL[ENUHORR?M:)I$%9_MSEV>"CX)-R7*I%N"L7' O
M@X?UJKFY)0=>^-TP),KA9MPWF[;J0MI3?'[BJ@*<0#L5E%ZYY%@W^+HEX@MM
M&I:MW0!X0.F.;MN/]VO:>?HFQ.KSO***4DF,92E.LQ2!4) 0P"C) $E%"K*8
MPD1%DDQ2JUY@IP8:&U/7=@:EH4%CJ1UAG@35C E=0.69XHZCY%R+[1P23LGH
MY&"#LLPYE_?IX^SG>^?7[G//_7S5>JDSBA@5A(,P$PF A%! (DQ QD,61C&7
M,4*6B;:= XZ-)ZYO;G[_\OOGZ^?;C\'#\]]N'X.;AR]?'V__=GO_=/?WV^#N
M7OW[5KW8'YZ>[/-NN[$WHQ&7B'JFDZZ82-NL B,?(9$I0JYS=+L''3I9UPB"
M(UF[9M?UR/<X$+#5._;;QJ?[+5'OY[,O9/%/46Y43%(*<8B) !CJQ#0D):")
M#$$4,D(@Y"S)8HO]]HL-&NDV?"5Q7N94%8='@18I"Q=-5C>1#8/]P!OWST8=
MG)4W0+NC^S/.P-:CH2;&(J]DJ D:*,?$]T39Y9ZX +<S#^6B 8;+27&!PTY^
MBI,;]@NM/Y%B\7<R78LO@FB!06W'IX7XUUK,V,^/\U=2S"8RA!*G,='%JPC
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M!S"6$N1$!:$41GD$.2>)-*IY-1EL;-RPD<E?;(SML>;LA#?)H%1K]A@(EB
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M3'=\LISOB V IMM8SZ.]PX:&_H$_B"0'&+*_ON)RI7=4GM4-2C)(<):'DL6
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MH&.C_(W-.FS=6!TT9O<6<3*: --0UBVLWJ/9BQ'MK]QK )$? =^N@=]'Q]<
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MF H "=8*NC($..$$\"23F,9Y$O=L]'LXUMABT=*V(/YKSQ:[1\#,TA A$J<
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MJ:GN&ZU_K=4-&%GJ?RWJ;$O-1?-* &'VTM1H!BM%6TM2:8%:*DWVG&FS]\@
M\^?Y+:$]"+0+0>G#3MF4FB$J@K8KP9^E+T'E3%!YXU"L\C(XW0I8]K1E6%'+
MRP [$+J\\'8]:[3TSNMR@FF<R)RF@$$M+!+'*:"ZI2!E(I&<\Y30W*KRJKSM
MV'9)*EE=4MIF64U5P61&3/;.#W'6X9 J=AUT6Z)4W7K8PJ,==P[*B7;_VE?W
M^O5U/BO7<57?^.OUZMM\H2.L29+F.0MS"<(8I0"J1PY@EB: BY3'L4BR-+,2
M]>D8:VRQ2V5JL-2V7@7+TMJ ;,P-?E&ON^JWEKN577@;1A=N4/0=050 /E4
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M;X_'\**>F5_'-2:W$J@??FX_4BND7O])%ORS6F_=K<3K<I)SD20T)(J1TQQ
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MOGX2LV*^N-<-L#^NQ?.?\^=O\_52O2:?_Q2SU<]/ZHM1?R_5RDY2@2(@)80
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M<1WUVG'*UNX8 V=G'77P,!'K^,?Z/<"?Y[.79K&(4YZRD(,L9$SG>!* !8-
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MX(#SYILAE?V!]N4JJ+T)-NZ4B[Z-0\'6HU9K)2^%.J[P=<NREQHU+ D[@O"
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M'U5RUT<^_F"W]7QO+@JT+7GX+A<51^&3P F.PS2$2!##"(@HI$R%)J]1FOO
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M!O59Z8]__*WY&_V#T4+^XV__!U!+ P04    " #S;EU3E >'VPR"  !0S@4
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M?_F)N"ZX7&)^>:Z5>YG;<+8F<XJ;3PZA\?]U&I;TC;.SM_AYL5Q/I/!<%!E
M( M0S2($] @D!*^4%"Y@&D3Y-QZ\%0Y$_S@X1)Z=0.(-+J>+_&R>G](6/"&Z
MG8LL0\4V*.T=>.DCR.2=1E>D46(00'SWV*W@(/N'P_ZR[ 0,[Y=AOII6P5\
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M*V$5-Q"X>.CY:L/9>G7YSD;<P/C%;?S_O@MU^YJ6RV><K%:X7EWQZJS(NJ@
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M_KRJPW9H!R?WKWB/P3+[T)B:0<S4?<2-ZTRUMUR#*&5WG/ESG,WQ0UA??':
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M/5??7*_/V4N>2P!=ZEUG%30XF>L<)2]1(W+IVO2'>Y"L3A"UA[[O@\[!PN\
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MZ,%032&1:#% T7@4#I%(:C?WV 4#N^0>NPB\@;OGF2R)],1KSSRD4"8Y<97
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M4$/[3TGQ];+C*Y9X4"25_2,$W1-6EC;:)" KJJ+F,5!5QP@^3\_839G# VT
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M3@I#Z_8.DP0W 5F0@H>2X)+@"4\0K+%*:>FYJK2;[#6R&@-57^5O@VHP3;0
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MU5O].K?U'Y0?/++Q___/_P!02P,$%     @ \VY=4R/7KHO(!P  12(  !H
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MJ*9$D.#*C5A"!\$L>2R5= N*TO<-2QO)H\P#*.R!6UW7$DD?%*[K"965*1'
MUF<52:*-\ ;XE'(*!28+"G&,+5#2!J$NF"X'K.)&DB7R\DM':_)]T=KOMKL>
MK>,95Y7G(7(EI"EF=7*&3K#W9&<W6<$6O!IN[T_8/#A1$#G1AK0PUI5[V()M
MF)_?] ;*>=-O5R0L7F;3?K]!6 FTQV.+!GC!^!+/A0V#ZS8A0$5PG6SYEGMQ
M]@@.I+"LDZ0RY.BU&'B/UEQ;A\_I4 ]U63H/^1H.4MC> R(I(A;9Z4[OVG L
M:,#7[U3:%]6-7:^"51FW-PD#\9I'. A/^'X]:C)>8)5^!:HNYN_T;_[A)?IC
MJ'X>E=+P15=*_@!/+#=$<\4_1(?KH%Q1$<'J$2G$1N9Y8QW'[--I8V^BMG^
M*O-<.@?P/\@^UI@74+N0:)]7LH?016ZUQ-WXEW+@Y7Z#KY5$\_W>JHK$E_VO
M_BZ(_APV/5.856&6)Q%95'!2Z9I(0!S4$?>F,)D#OZ(0&K(L'T1]?N@/%9?G
M,8]"5UU#A'+_'LKB @4MW##6@TBLLTH403AA\M<,<=QB$+=5CF# 1?*3J2/%
MO2=7?X48_5PJEC,,Q:E!0FBBC\'3&*+$'_C6<&J&2":+F58SH'!6\&E];FUJ
MYH.\5'H!V#K/=. Z?@NL"*X_)=:WG^/KL M<*<]R[ -29 QF=R?:[Q[WCIKA
MU>TC;':^,*N;8]P@8%IHN^*EA='RXACC2*GX8B0+;XP7.JZ5Q=HYG8\H8,\H
M'F'.4K_(]) /S?6KW,%^^ZAW1&]SG<'_8CEP_:*W[5_T=IS8;#LZ;!]U'V[N
MMJ.;MH[7'?3C#&S)B]>-?F,I4,-RU"NO673[S2LA]>XD@OU/Y%T_P]V= 4+4
M_[*WX[/WK;=GYY]^&?^;O9F,WY]-WNWN]+K1*L!M,>7:K][M)4Z"CH/8TOI'
MK@<J><K%>/BU+WT%<)Y)2-GX&I**RCCV(61!FVO3\9!=VQ$/?DJPMEON?(U0
MZO YQBB<O<U@X_N$U7K[+=%=B? 8%[URFR+?^*2A_@T?6/A//4[_"U!+ P04
M    " #S;EU3@4==1]\'   X(P  &@   &5X:&EB:70S,3(M,S!S97 R,7@Q
M,'$N:'1M[5II;^,X$OV^OX+C8#-IP)=\)+&3#I##C0W0UP29:>RG!251-A%:
MU)"4'>^OGU>D'#M7MQN9S0%L ^U(8K%89#V^JJ)T^,O9E]/+?W\=L8F;*O;U
M]Y./YZ>LUFBUOG5/6ZVSRS/VK\M/'UFOV8[8I>&YE4[JG*M6:_2YQFH3YXIA
MJS6?SYOS;E.;<>ORHD6J>BVEM17-U*6UHT-Z@E_!TZ-_'/[2:+ SG913D3N6
M&,&=2%EI93YFWU)AKUBC44F=ZF)AY'CB6*?=B=@W;:[DC(=V)YT21TL]AZUP
M?]CR@QS&.ET<':9RQF3ZOB;CW;U!?[?;CW?YH-?O)/O=SEZ[G26]7F>W*Z+>
M?R(8V8)XZ&/=0HGWM:G,&Q-!XP][G>9>OW '<YFZR3!JM_]9\Z)'AYG.'<8S
MZ!\N@YK[RK@90Y_3Q3#J0),3UZ[!E1SG0S_%6E"U%$^TTF:XU?;_#JBED?&I
M5(OAK\=&<O5KW<(9#2N,S$*SE?\5PP$T^[MYL!NS/% R%\MY1!VR?'0]D;%T
MK!LU.[?-WLS@!"LNS'-:?#JZN#S_<'YZ?'G^Y?.F)O]O#.P]:.!YG9U 2<XN
MFNQ3*902ILX289S,%LQ-N-O>ZN\?;+S8!4]3;(B&$AE&["^77^8IEG[8B/:?
M=W91<VGY,PUY>P&B=K-/$SYG$SX3S(B9%'.0AIM(RWXKN0$:U8)=B$(;QW3.
M/F@S95&[\1O3&3N1^A,W,F=?)]Q,>2)*)Q.NV'F>-.&5P9OU2N=U>.6$6_@"
MJSY=L*M<SY5(QZ(>G&."2U(M+,LUZ!XC<+B"YPM6YLZ4 F8C /A8 %]Q-L4=
MF<DRGN"187H*IG(ZR-T3R$4BK.5F02)3?B4P[II.BV<IC,&0R@<2C$$"B30(
M'!#+T1V6I,*P^40F$V9+^EGUGPLC*B4T@:FT"A&&@M5<N@DF: N1> -);P'3
M=(IISM M9?%B?1G>--BZKQQL@F4RASL)&2OWU8$TB*/9K+7+/ -!<,ID<)VH
M,H5.0&3-5W7 2Q*I%/ P@9- J]0*?97C[9VA ?#4ITAUDB@5!  Y#5SXX:RW
M)^%VPC*EYW:)1R/&TCKD5XYQ>ACLAI7U-5C9I3'WK'W3R.J]#F1=WG+#]M9^
M)]H[L!5VJDA.VUYGF<3MCGWG?73.N!$>#?"NC)4@KS$!",9*V@GU(+$I6(^8
MC^Y3:1.E;8E^Q(=&JP"+PNA$I'ALV0Y0D K *KAZ=)U,>#X6[!A4<U$J2$1=
MWHCZ.R)8$?73<!=N)>5G>8 CZ6?$1VLH#:@A6S8>*+LU4(:!:)YWL0L)"M%/
M2';V.G?QV-E[7CSR=R^+QP%J+9KQF;!(MN$7'Y)^#)HZ1<N$EW;S+A2V8@$
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M<0_!YQTP9^D6-S4M/ZB86,6QN]/"S\]>X2SN7SIG_<&'ZWA2?Q3'P_BR/[S
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M+FAT;5!+ 0(4 Q0    ( /-N75-Z-*#25!,  '.\   1              "
M 5$6 P!B;7)N+3(P,C$P.3,P+GAS9%!+ 0(4 Q0    ( /-N75-00!&FXAX
M "<I 0 5              "  =0I P!B;7)N+3(P,C$P.3,P7V-A;"YX;6Q0
M2P$"% ,4    " #S;EU3;GE[?_-7   $SP, %0              @ 'I2 ,
M8FUR;BTR,#(Q,#DS,%]D968N>&UL4$L! A0#%     @ \VY=4^DKGX:5T@
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A<#(Q>#$P<2YH=&U02P4&      D "0!B @  PPL%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
